FINAL PROGRAMME
FINAL PROGRAMME
Contents
Welcome from the President of the European Society of Hypertension and the Chairman
of the 26th European Meeting on Hypertension and Cardiovascular Protection
3
GENERAL INFORMATION
5
MEETING OUTLINE
Industry Sponsored Satellite Symposium
Industry Sponsored Educational Session
Industry Sponsored Minisymposia
Industry Sponsored How-to Sessions
Industry Sponsored Minisymposium in French language
Awards
Accommodation Grants
Meetings
Investigator Generated Satellite Symposia
ESH Working Groups and related Business Meetings
List of ESH Working Groups
CONGRESS INFORMATION
Congress Venue
Exhibition
Useful Information
Registration Information
OpeningCeremonyandReception
SCIENTIFIC INFORMATION
ESH Credits
Abstract Book
Guidelines for Chairpersons and Speakers
Posters
6
6
6
7
8
10
11
11
11
12
13
13
14
15
16
16
17
18
20
20
22
24
26
27
28
28
28
28
29
SCIENTIFIC PROGRAMME
31
COMMITTEES AND ACKNOWLEDGEMENTS
ESH Council 2015-2017
Committees
ScientificandOrganisingSecretariat
Abstract Reviewers
Sponsors Acknowledgements
TIMETABLE
FRIDAY, JUNE 10
SATURDAY, JUNE 11
SUNDAY, JUNE 12
MONDAY, JUNE 13
32
40
41
76
110
POSTERS
137
SATURDAY, JUNE 11
SUNDAY, JUNE 12
MONDAY, JUNE 13
138
175
210
INDEX OF CHAIRPERSONS, SPEAKERS AND AUTHORS
243
2
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Welcome Letter
Dear Colleagues and Friends,
It is our great pleasure to welcome you to the 26th Meeting of the European Society of Hypertension
(ESH) held in Paris, France, June 10-13, 2016.
As you may know, Paris has been a pioneer city in the emergence and development of the
management and research on arterial hypertension and cardiovascular disorders in Europe and has
hosted the successful 14th ESH Meeting in 2004.
ThescientificprogrammecontinuesthetraditionofthepreviousESH/ISHmeetingsandincludes:
Originalresearchwithoralandposterpresentations
State-of-the-Art Lectures
Plenary Sessions
Joint Sessions with other Societies
Debates
Topical Workshops
Breakfast Seminars
Meet-the-Expert Sessions
Clinical Cases
Training Session in new techniques
Satellite Symposia organised by industry
Themeetingcoversalargeareaofknowledgeinthefieldnotonlyofhypertensionbutalsoofother
cardiovascular and metabolic disorders related to hypertension. We deem to pay a particular attention
to new technologies, such as innovative devices, new communicating tools and biological “omics”
research.
The presence of opinion leaders and experts from all around the world shall ensure the success of the
meeting.
We expect a large number of investigators, researchers, specialist physicians and general practitioners
from all parts of Europe, but also a special attendance from French speaking countries from other parts
of the world.
The meeting is held in Paris, “Ville Lumière”, one of the world’s most attractive destinations.
The Palais des Congrès is located in the west part of the city, close to the Champs-Elysées and the Arc
de Triomphe within walking distance from numerous hotels. It is also a well-known location for shows,
concerts and stores. Participants should be able to enjoy the beauty of Paris, either before or after the
meeting, as well as the rest of France.
Welcome to Paris and to the ESH 2016 Meeting.
Prof. Xavier Jeunemaitre
ESH 2016 Chairman
Prof. Enrico Agabiti Rosei
ESH President
F I N A L P R OG R A M M E
3
GENERAL INFORMATION
6
11
20
28
Committees and Acknowledgements
Meeting Outline
Congress Information
Scientific Information
CO M M I T T E E S A N D A CK N O W LE D G E M E N T S
ESH Council 2015-2017
President
Vice-President
Secretary
Treasurer
Officer-at-large
Immediate Past President
E. Agabiti Rosei (Italy)
M. Azizi (France) - ESH Hypertension Specialist Programme
K.Tsioufis(Greece)
M. Burnier (Switzerland)
B. Jelakovic (Croatia) - ESH Excellence Centres Programme
A.F. Dominiczak (United Kingdom)
Members
P.vandeBorne (Belgium) T. Kahan (Sweden)
R. Kreutz (Germany)
B. Williams (United Kingdom)
G.Grassi (Italy)-Ex-officio ISH representative
I.E. Chazova (Russia) - Ex-officio representative of the Presidents of ESH Affiliated Societies
Executive Officers
G. Mancia (Italy) - Chair, ESH Educational Committee, ESH Foundation
G. Parati (Italy) - Coordinator Working Group Activities
D.L. Clement (Belgium) - ESH Representative for contacts with the EU Officers
A. Coca (Spain) - Chairman of the ESC Council for Hypertension (ESH Latin American Affiliation program)
Committees
Scientific Organisation
President
Organising Committee
Secretary
Finances
Scientific Programme
X. Jeunemaitre (Paris, France)
S. Laurent (Paris, France)
J.-M. Halimi (Tours, France)
J. Blacher (Paris, France)
M. Azizi (Paris, France)
Local Committee
M. Azizi (Paris, France)
J.-P. Baguet (Grenoble, France)
J. Blacher (Paris, France)
T. Denolle (Dinard, France)
J.-M. Halimi (Tours, France)
F. Jarraya (Sfax, Tunisia)
6
X. Jeunemaitre (Paris, France)
J.-Y. Le Heuzey (Paris, France)
S. Laurent (Paris, France)
M. Lopez-Sublet (Bobigny, France)
J.-J. Mourad (Bobigny, France)
A. Persu (Brussels, Belgium)
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
C OM M I T T E E S A N D A CK N OW L E D GE M E N T S
Committee for relations with pharma
industry and device company
FRANCE
J. Blacher (Paris, France)
S. Laurent (Paris, France)
ESH
A. Coca (Barcelona, Spain)
K. Narkiewicz (Gdansk, Poland)
G. Mancia (Milan, Italy)
R.E. Schmieder (Erlangen, Germany)
Scientific and Organising Secretariat
AIMGROUPINTERNATIONAL
RomeOffice
Via Flaminia, 1068 – 00189 Rome, Italy
Ph:+39.06.33053.1Fax:+39.06.23325630
E-mail:esh2016@aimgroup.eu
Web:www.esh2016.org
F I N A L P R OG R A M M E
7
CO M M I T T E E S A N D A CK N O W LE D G E M E N T S
Abstract Reviewers
TheESHCouncilandtheLocalScientificCommitteegratefullyacknowledgethefollowingreferees
fortheirhelpinreviewingtheabstracts:
R. Accetto
E. Agabiti Rosei
F.L. Albini
L. Amar
E. Ambrosioni
P. Armario
R. Asmar
A. Avolio
M. Azizi
J.-P. Baguet
I. Ben-Dov
K. Bengtsson Boström
A.E. Berbari
E. Berge
G. Bilo
J. Blacher
M. Bombelli
C. Borghi
P. Boutouyrie
S.-M. Brand
J. Brguljan
W. Bsata
M. Burnier
M. Bursztyn
F.P. Cappuccio
B. Carlberg
S. Carugo
E. Casiglia
M. Castellano
J.M. Castellano Vázquez
G. Castoldi
M.J.Caulfield
G. Ceolotto
I.E. Chazova
K.L. Christensen
A.F.G. Cicero
R. Cifková
D.L. Clement
A. Coca
J. Cockcroft
J.K. Cruickshank
C. Cuspidi
D. Czarnecka
8
A.H.J. Danser
T. De Backer
M. De Buyzere
A. de la Sierra
P.W. de Leeuw
N. De Luca
J. Deinum
S. Del Prato
C. Delles
T. Denolle
G. Desideri
P. Dessì-Fulgheri
J. Diez
K. Dimitriadis
E. Dolan
A.F. Dominiczak
M. Dorobantu
S. Douma
J. Duggan
S. Engeli
S. Erdine
F.E. Fadl Elmula
C. Farsang
I. Ferreira
C. Ferri
S. Filipova
J. Filipovsky
Z. Gaciong
D. Gasecki
L. Ghiadoni
C. Giannattasio
X. Girerd
P. Gosse
A. Gottsater
G. Grassi
O.Grisk
T. Grodzicki
P.-H. Groop
F.Gueyffier
J.-M. Halimi
H. Haller
T.W. Hansen
S.B. Harrap
M. Hausberg
G.A. Head
A.M. Heagerty
K.F. Hilgers
M.M. Hirschl
H. Ibsen
F. Iellamo
C. Invitti
P. Jankowski
A. Januszewicz
A. Jardine
F. Jarraya
B. Jelakovic
B.L. Jensen
X. Jeunemaitre
J. Jordan
T. Kahan
I. Kantola
V. Kapil
K. Kawecka-Jaszcz
M. Keltai
U. Kintscher
S.E. Kjeldsen
A.O.Konradi
V. Kotsis
R. Kreutz
T. Kuznetsova
S. Laurent
I. Lazareva
J.-Y. Le Heuzey
A. Lejnieks
J. Lenders
B. Levy
L.H. Lindholm
M. Lobo
C. Lombardi
L.M. Lonati
M. Lopez-Sublet
D. Lovic
E. Lurbe
F. Magrini
F. Mahfoud
J.M. Mallion
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
C OM M I T T E E S A N D A CK N OW L E D GE M E N T S
G. Mancia
A.J. Manolis
F. Mantero
P. Manunta
N. Martell-Claros
F. Martínez García
T. Martynyuk
F. Mattace Raso
R. McManus
R. Meazza
O.Melander
J. Menne
E. Mervaala
F.H. Messerli
M.C. Michel
M. Miglinas
A. Mimran
H. Mischak
P.A. Modesti
T.O.Morgan
A. Morganti
J.-J. Mourad
M.L. Muiesan
P. Mulatero
P. Munroe
K. Narkiewicz
P.M. Nilsson
J. Nussberger
E.O’Brien
M.J.O’Donnell
A.Oliveras
M.H.Olsen
S.Omboni
P.Omvik
S. Padmanabhan
P. Palatini
B. Pannier
G. Parati
A. Pathak
M. Paul
P. Pauletto
S. Perlini
A. Persu
A.C. Pessina
F. Pieruzzi
F. Pinto
F. Pinto
A. Pittaras
P.-F. Plouin
R. Pontremoli
K. Poulsen
A. Protogerou
M. Pruijm
A.J. Ramirez
A. Rappelli
S. Ravassa
G. Reboldi
J. Redon
C. Reid
J. Ribstein
D. Rizzoni
T. Rosenthal
G.P. Rossi
L.M. Ruilope
M.E. Safar
C. Sala
F. Saladini
M. Salvetti
R. Sánchez
R. Sarzani
M. Saxena
S. Scalvini
G. Schillaci
M.P. Schlaich
R.E. Schmieder
A.E. Schutte
W. Sebba Barroso
P. Segers
J.J. Segura
A. Semplicini
G.L. Seravalle
P.S. Sever
Y. Sharabi
C. Sierra
F. Simko
Y. Sirenko
S. Sokolovic
J.A. Staessen
C.D.A. Stehouwer
A. Stella
G.S. Stergiou
M. Stornello
T.E. Strandberg
M. Strauss
P. Strazzullo
H.A.J. Struijker-Boudier
P. Stylianou
S. Taddei
M. Tadic
A. Tedgui
I. Tikkanen
G. Tocci
M. Tomaszewski
S. Torbova
R.M. Touyz
B. Trimarco
C.Tsioufis
T. Unger
L.M. Van Bortel
P. van de Borne
A.H. van den Meiracker
F. Veglio
W. Verberk
P. Verdecchia
M. Viigimaa
A. Virdis
C. Vlachopoulos
D. Vlahakos
M. Volpe
K. Wachtell
B. Waeber
J. Wang
S. Wassertheurer
B.H. Watschinger
T. Weber
J. Widimský
I.B. Wilkinson
B. Williams
P. Wohlfahrt
Y. Yagil
A. Zanchetti
M.-C. Zennaro
J. Zicha
F I N A L P R OG R A M M E
9
C O M M I T T E E S A N D A CK N O W L E D G E M E N T S
Sponsor Acknowledgements
TheESHCouncilandtheLocalScientificCommitteewouldliketoexpresstheirgratitudetoall
thosewhohavegenerouslycontributedtotheScientificProgramme:
Platinum
Silver
The Menarini Group
OmronHealthcare
Bronze
Ferrer
Fukuda Denshi
Supporters
Alam Medical
Atcor Medical
Axelife
BPLab
Microlife
Novacor
Quantum Genomics
ReCor Medical
CustoMed
CVRx
Daiichi Sankyo
Dove Medical Press
HealthSTATS Technologies (UK) Limited
iHealth Europe
Imagine Eyes
Maisense
Medtronic
Mesi
SMT Medical Technology
SOMNOmedics
Spacelabs Medical
TelMed
Wisepress
Withings
10
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
M E E T I N G O U T LI N E
Industry Sponsored Satellite Symposium
Saturday, June 11
13.00 - 14.30
ROOM BORDEAUX
TAILORINGHYPERTENSIONTREATMENTTOTHE
PATIENT
Supported by
Industry Sponsored Educational Session
Saturday, June 11
15.30 - 17.00
ROOM HAVANE
CHALLENGESINTHEMANAGEMENTOF
HYPERTENSIVE PATIENTS WITH MULTIPLE
COMORBIDITIES
Supported by Ferrer
F I N A L P R OG R A M M E
11
MEETING OUTLINE
Industry Sponsored Minisymposia
Saturday, June 11
10.00 - 11.00
ROOM 342
OPTIMIZATIONOFHYPERTENSION
MANAGEMENTTHROUGHINFORMATIONAND
COMMUNICATIONTECHNOLOGY/MOBILE
HEALTHTOOLS.ANUPDATEONTHEESHHYPERTENSIONAPPFORSMARTPHONES
Supported by Daiichi Sankyo
Saturday, June 11
11.00 - 12.00
ROOM HAVANE
ROLEOFRENALDENERVATIONINAWORLDOF
EVOLVINGBLOODPRESSURETARGETS
Supported by Medtronic
Sunday, June 12
10.00 - 11.00
ROOM MAILLOT
THERADIANCE-HTNSTUDY:EVALUATINGA
UNIQUEULTRASOUNDRENALDENERVATION
SYSTEMFORTREATINGHYPERTENSION
Supported by ReCor Medical
Sunday, June 12
11.00 - 12.00
ROOM BORDEAUX
IMPROVINGFIRST-LINETREATMENTOF
HYPERTENSION:ANEWAPPROACH
Supported by Servier
Saturday, June 11
11.00 - 12.00
ROOM MAILLOT
HYPERURICAEMIA:ACONSEQUENCEOF
HUMAN(D)EVOLUTION?
Supported by The Menarini Group
Sunday, June 12
11.00 - 12.00
ROOM HAVANE
BRAINAMINOPEPTIDASEAINHIBITORS
(BAPAIS),ANEMERGINGCLASSFORTHE
TREATMENTOFHYPERTENSIONANDHEART
FAILURE
Supported by Quantum Genomics
Saturday, June 11
14.30 - 15.30
ROOM BORDEAUX
UNMETNEEDSINHYPERTENSION:
SHIFTINGTHEGOAL?
Supported by Daiichi Sankyo/The Menarini
Group
Sunday, June 12
14.30 - 15.30
ROOM BORDEAUX
RISINGTOTHECHALLENGEOF
CONCOMITANTHYPERTENSIONAND
HYPERCHOLESTEROLEMIA
Supported by Servier
Saturday, June 11
14.30 - 15.30
ROOM HAVANE
ESTABLISHING“CAVI”CARDIO-ANKLE
VASCULAR INDEX IN CLINICAL PRACTICE
Supported by Fukuda Denshi
Sunday, June 12
14.30 - 15.30
ROOM MAILLOT
CURRENT EVIDENCES AND FUTURE
PERSPECTIVEOF24-HOURPERFECTBLOOD
PRESSURE MANAGEMENT
Supported by Omron Helthcare Japan
Saturday, June 11
15.30 - 16.30
ROOM MAILLOT
GOINGTOWARDSZEROCARDIOVASCULAR
EVENTS.INNOVATIONSINHOMEBLOOD
PRESSUREMONITORINGTOIMPROVE
HYPERTENSIONMANAGEMENT
Supported by Omron Healthcare Europe
12
Sunday, June 12
15.30 - 16.30
ROOM MAILLOT
NEWEVIDENCESINACE-INHIBITION:
BEYONDBLOODPRESSURECONTROL
Supported by The Menarini Group
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
M E E T I N G O U T LI N E
Industry Sponsored How-to Sessions
Saturday, June 11
14.30 - 15.30
ROOM 351
UPDATEINENDOTHELIALFUNCTIONAND
ARTERIAL STIFFNESS TESTING
Supported by SMT Medical Technology
Sunday, June 12
14.30 - 15.30
ROOM 351
HOWTOUSEBAROSTIMTHERAPYTOSAFELY
CONTROLRESISTANTHYPERTENSION
Supported by CVRx
Saturday, June 11
14.30 - 15.30
ROOM 253
HOWTOASSESSCENTRALHEMODYNAMICS
ANDSTIFFNESSINAMBULATORYCONDITIONS
OVERTHE24-HOURS:ANEWTECHNOLOGY,ITS
CLINICALEVIDENCEANDAPPLICATIONS
Supported by BPLab
Sunday, June 12
14.30 - 15.30
ROOM 251
NOCTURNALBLOODPRESSUREDETERMINED
BYPTT:RELIABLEMETHOD.NEWINSIGHTS
Supported by SOMNOmedics
Sunday, June 12
14.30 - 15.30
ROOM 253
CONNECTEDHEALTH,THEFUTUREFOR
HEALTHCAREPROFESSIONALS
Supported by iHealth
Sunday, June 12
15.30 - 16.30
ROOM 253
POPMETRETHEPWVINEVERYDAYPRACTICE
Supported by Axelife
Industry Sponsored Minisymposium
in French language
Saturday, June 11
09.30 - 10.30
ROOM 351
IMPACTDELATRANSITIONEPIDEMIOLOGIQUE
SURLAPRISEENCHARGEDEL’HYPERTENSION
ARTERIELLE
Supported by Servier
F I N A L P R OG R A M M E
13
MEETING OUTLINE
Awards
BJÖRN FOLKOW AWARD AND LECTURE
The Björn Folkow Award has been established with the collaboration of AstraZeneca in recognition
of the contribution made by Björn Folkow to cardiovascular physiology and pathophysiology.
The award is given to a person or persons who have carried out important original research on
pathogenesis of hypertension.
ALBERTO ZANCHETTI LIFE ACHIEVEMENT AWARD
The Award is given to a scientist with a lifelong high quality scientific research in the field of
hypertension.
LENNART HANSSON MEMORIAL LECTURE
TheLennartHanssonmemoriallectureisgiventoascientistwithalifelonghighqualityscientific
researchinthefieldofhypertension.
ESH HONORARY MEMBERSHIP
ESH Honorary Membership is given to scientists who have made extraordinary contributions to
research in hypertension or who have given exceptionally important support to the activities of
ESH.
TALAL ZEIN AWARD
The Talal Zein Foundationhasestablishedthe“TalalZeinAward”tobepresented annually to a
distinguishedscientistfromaMediterraneancountry,in recognition of outstanding workrelated
to basic science, epidemiology, pathophysiology or therapy of hypertension and related cardiovascular diseases.
PAUL MILLIEZ AWARD
The Award is conferred by the French Society of Hypertension to a French scientist acknowledged
forhisaccomplishmentsinthefieldofhypertension.
ALBERTO FERRARI POSTER PRIZES
The prizes are dedicated to the late Prof. Alberto Ferrari in recognition of his great contribution to
the organization of the ESH meetings in Milan.
Each day, a selected number of posters will be awarded with a prize. Winners will receive
notification by email after the end of the meeting. List with names of awardees will be posted
online at the end of the ESH 2016 meeting, on the following websites: www.esh2016.org,
www.eshonline.org.
14
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
M E E T I N G O U T LI N E
Accommodation Grants
Agabiti Rosei C. (Italy)
Agnoletti D. (Italy)
Al Hajj S. (France)
Al-Mawla R. (France)
Alanis G. (Mexico)
Altieri D. (Italy)
Altunyan D. (Armenia)
Andreeva G. (Russia)
Anyfanti P. (Greece)
Barrientos G. (Argentina)
Battista F. (Italy)
Beh H.C. (Malaysia)
Bertacchini F. (Italy)
Boubouchairopoulou N. (Greece)
Bruno R.M. (Italy)
Caletti S. (Italy)
Caniffi C. (Argentina)
Caroccia B. (Italy)
Castiglia A. (Italy)
Cecelja M. (United Kingdom)
Clark B.J. (United Kingdom)
Currie G. (United Kingdom)
Daka B. (Sweden)
Dalbeni A. (Italy)
Di Pilla M. (Italy)
Diemer F. (Netherlands)
Ditisheim A. (Switzerland)
Djordjevic D. (Serbia)
Efremov L. (Belgium)
Eikelis N. (Australia)
Elfimova E. (Russia)
Falkovskaya A. (Russia)
Fonseca Lopes F. (Brazil)
Foulquier S. (Netherlands)
Freitas F. (Brazil)
Garcia-Ortiz L. (Spain)
Gaskina A. (Russia)
Geraci G. (Italy)
Giuli V. (Italy)
Gluszewska A. (Poland)
Gonzalez Marrachelli V. (Spain)
Grabowski K. (Germany)
Graham L. (United Kingdom)
Grave K. (Germany)
Grillo A. (Italy)
Hako Y. (Cameroon)
Hanus K. (Poland)
Ionin V. (Russia)
Ionov M. (Russia)
Iwahori T. (Japan)
Japie C. (Romania)
Karakaya G. (Belgium)
Karamat F. (Netherlands)
Karanovič S. (Croatia)
Kaszuba A.M. (Poland)
Kengne A.P. (South Africa)
Kielbasa G. (Poland)
Kim B.K. (South Korea)
Kong L. (China)
Korompoki E. (Greece)
Koshelyaevskaya Y. (Russia)
Kotliar Lublin C. (Argentina)
Kouchaki Z. (Australia)
Lambert D. (France)
Lazareva I. (Belarus)
Le H.-H. (France)
Legat L. (Belgium)
Leitão C. (Portugal)
Lemogoum D. (Belgium)
Lim K. (Australia)
Lovic M. (Serbia)
Ma L. (China)
Ma Y. (China)
Maffioli P. (Italy)
Maloberti A. (Italy)
Mandraffino G. (Italy)
Maniero C. (United Kingdom)
McCallum L. (United Kingdom)
Mendes P. (Portugal)
Miadziolko M. (Poland)
Michaud A. (Canada)
Milanov S. (Serbia)
Milazzo V. (Italy)
Morgan H. (United Kingdom)
Morreale M. (Italy)
Nechutova H. (Czech Republic)
Ng F.L. (United Kingdom)
Novella Del Campo S. (Spain)
Nowak M.M. (Poland)
Obadia Pereira N. (Brazil)
Olde Engberink R. (Netherlands)
Pacheco Leardini Tristão M. (Brazil)
Pagonas N. (Germany)
Paramonov V. (Russia)
Parini A. (Italy)
Paskar N. (Russia)
Pekarskiy S. (Russia)
Pindao Quesada G. (Spain)
Potthoff S.A. (Germany)
Pozzoli S. (Italy)
Ravarotto V. (Italy)
Ren M. (United Kingdom)
Rosa J. (Czech Republic)
Rossitto G. (Italy)
Ruan C.C. (China)
Saleh L. (Netherlands)
Salinaro F. (Italy)
Salvo F. (Italy)
Samuelsson A.M. (United Kingdom)
Samji S.M. (United Kingdom)
Sanders M. (Netherlands)
Satoh F. (Japan)
Saxton S. (United Kingdom)
Seifar F. (Iran)
Shalimova A. (Ukraine)
Shkurat I. (Ukraine)
Siedlinski M. (Poland)
Sindeeva O. (Russia)
Sivén S. (Finland)
Small H.Y. (United Kingdom)
Stupin A. (Croatia)
Swanepoel B. (South Africa)
Tadic M. (Serbia)
Tagetti A. (Italy)
Talarowska P. (Poland)
Tanios B. (Lebanon)
Tentori S. (Italy)
Terentes-Printzios D. (Greece)
Triantafyllou A. (Greece)
Troistkaya E. (Russia)
Turk M. (Slovenia)
Urbanski K. (Poland)
Vallelonga F. (Italy)
Van Twist D. (Netherlands)
Veugen M. (Netherlands)
Vogt L. (Netherlands)
Voloshyna I. (Ukraine)
Vrdoljak A. (Croatia)
Wang Q. (China)
Warchol-Celinska E. (Poland)
Wei F. (Belgium)
Wirtwein M. (Poland)
Wojciechowska E. (Poland)
Wolf J. (Poland)
Xu T. (China)
Yannick M. (France)
Yu S. (China)
Zhang Z.Y. (Belgium)
Zharikova E. (Russia)
Zhou J. (United Kingdom)
F I N A L P R OG R A M M E
15
MEETING OUTLINE
Meetings
FRIDAY, JUNE 10
SUNDAY, JUNE 12
10.30-13.00 | ROOMLECLUB
ESH Council Meeting
07.00-09.00 | ROOM251
Sino-Euro Hypertension Exchange Summit
SATURDAY, JUNE 11
08.00-09.00 | ROOM253
Artemis Investigator Meeting
13.00-14.00 | ROOM332-333
Editorial Board JH
14.00-16.00 | ROOM334
Board of Management JH
14.30-15.00 | ROOMMAILLOT
Meeting with Presidents of National
Societies
10.00-11.00 | ROOM253
General Assembly
12.00-13.00 | ROOM253
Meeting with WG Coordinators
15.00-15.30 | ROOMMAILLOT
ESH Meeting for ESH Excellence Centres
Investigator Generated Satellite Symposia
Athens, April 15-16, 2016
3rd Official Pre-ESH Congress Satellite Symposium “Update on Resistant Hypertension
and Related Comorbidities”
C.Tsioufis,R.E.Schmieder
Gdansk, May 12-14, 2016
2nd European Forum on Hypertension
K. Narkiewicz
Chalkidiki, June 3-5, 2016
European Society of Hypertension Working Group on Obesity, Diabetes and the
High-Risk Patients: Satellite Symposium of the ESH Paris Meeting
V. Kotsis
Porto Heli, June 23-26, 2016
11th Post Congress Symposium on Hypertension, Cardiovascular Risk Factors and
Diseases
A.J. Manolis
16
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
M E E T I N G O U T LI N E
ESH Working Groups
and related Business Meetings
SATURDAY, JUNE 11
SUNDAY, JUNE 12
18.30-20.30 | ROOMBORDEAUX
ESH Working Group on Hypertension
and the Kidney (Business Meeting)
18.30-20.15 | ROOM351
ESH Working Group on Endocrine
Hypertension (20.00-Business Meeting)
18.30-19.30 | ROOMHAVANE
ESH Working Group on Hypertension,
Arrhythmias and Thrombosis
18.30-20.00|ROOM352
ESH Working Group on Hypertension
and Cardiovascular Risk Assessment in
subjects living in or emigrating from low
resource settings
18.30-20.00 | ROOMMAILLOT
ESH Working Group on Hypertension
and Cardiovascular Risk Assessment
in subjects living in or emigrating from
low resources settings (Business Meeting)
18.30-20.30 | ROOM342
ESH Working Group on Blood Pressure
Monitoring and Cardiovascular Variability
(20.00-Business Meeting)
18.30-20.00|ROOM351
ESH Working Group on Obesity, Diabetes
and the High Risk Patient
(19.45-Business Meeting)
18.30-20.00|ROOM251
ESH Working Group on Hypertension and
the Kidney
18.30-20.00|ROOM252
ESH Working Group on Vascular Structure
and Function
18.30-20.00|ROOM253
ESH Working Group on Children and
Adolescents (Business Meeting)
18.30-20.00|ROOM352
ESH Working Group on Interventional
Treatment of Hypertension
18.30-20.00|ROOM251
ESH Working Group on Endothelins and
Endothelial Factors (close session of the
Working Group, only by invitation)
18.30-20.00|ROOM252
ESH Working Group on Hypertension and
the Brain (Business Meeting and General
Assembly)
18.30-20.15|ROOM253
ESH Working Group on Hypertension and
Sexual Dysfunction
F I N A L P R OG R A M M E
17
MEETING OUTLINE
List of ESH Working Groups
Currently, in the frame of the European Society of Hypertension, there are 12 Working Groups for
thestudyofexperimentalandclinicalhypertensioninthedifferentfieldsofhypertension.
1. WORKING GROUP ON BLOOD
PRESSURE IN CHILDREN AND
ADOLESCENTS
Prof. Empar Lurbe
Pediatric Department
Consorcio Hospital General of Valencia
University of Valencia
Avenida Tres Cruces
46014 Valencia - Spain
Phone:+3496197252214
E-mail:empar.lurbe@uv.es
4. WORKING GROUP ON ENDOTHELIN
AND ENDOTHELIAL FACTORS
Prof. Gian Paolo Rossi
University of Padua
Department of Clinical Medicine IV - Policlinico
Via Giustiniani 2
35128 Padua - Italy
Phone:+390498213304
Fax:+390498754179
E-mail:gianpaolo.rossi@unipd.it
2. WORKING GROUP ON BLOOD
PRESSURE MONITORING AND
CARDIOVASCULAR VARIABILITY
Prof. Gianfranco Parati
Dept. of Clinical Medicine and Prevention
University of Milano-Bicocca
Dept. of Cardiovascular, Neural and Metabolic
Sciences
S. Luca Hospital, IRCCS Istituto Auxologico
Italiano
Piazza Brescia, 20
20149 Milan - Italy
E-mail:gianfranco.parati@unimib.it
5. WORKING GROUP ON
HYPERTENSION AND THE BRAIN
Prof. Antonio Coca
Institute of Internal Medicine (ICMiD) Hospital
Clinic
University of Barcelona
Villarroel 170
08036 Barcelona - Spain
Phone:+34932275759
Fax:+34932275724
E-mail:acoca@clinic.ub.es
3. WORKING GROUP ON ENDOCRINE
HYPERTENSION
Prof. Jiri Widimský
Head Centre of Hypertension
Charles University
General Faculty Hospital
U Nemocnice 2
12808 Prague - Czech Republic
Phone:+420224962960
Fax:+420224966385
E-mail:jiri.widimsky@lf1.cuni.cz
6. WORKING GROUP ON HYPERTENSION
AND CARDIOVASCULAR RISK
ASSESSMENT IN SUBJECTS LIVING IN
OR EMIGRATING FROM LOW RESOURCE
SETTINGS
Prof. Pietro Amedeo Modesti
Department of Critical Care Medicine
and Surgery
University of Florence
50100 Florence - Italy
E-mail:pamodesti@unifi.it
18
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
M E E T I N G O U T LI N E
7. WORKING GROUP ON
HYPERTENSION AND THE KIDNEY
Prof. Alexandre Persu
Université Catholique de Leuven
1, Place de l’Université
B-1348 Leuven-la-Neuve - Belgium
Fax:+32(0)10/47.29.99
E-mail:alexandre.persu@uclovain.be
10. WORKING GROUP ON
INTERVENTIONAL TREATMENT
OF HYPERTENSION
Prof. Kostantinos Tsioufis
Hypertension Unit, 1st Department of
Cardiology
University of Athens, Hippokration Hospital
108VassilissisSofiaAvenue
11527 Athens - Greece
E-mail:ktsioufis@hippocratio.gr
8. WORKING GROUP ON
HYPERTENSION AND SEXUAL
DYSFUNCTION
Prof. Margus Viigimaa
Centre of Cardiology
North Estonia Medical Centre
Sütiste St. 19
13419 Tallinn - Estonia
Phone:+3725110070
Fax:+3726971415
E-mail:margus.viigimaa@regionaalhaigla.ee
11. WORKING GROUP ON OBESIT Y,
DIABETES AND THE HIGH RISK PATIENT
Prof. Vasilios Kotsis
Department of Medicine
Aristotle University of Thessaloniki
University Campus
54124 Thessaloniki - Greece
E-mail:vkotsis@auth.gr
9. WORKING GROUP ON
HYPERTENSION, THROMBOSIS
AND ARRHYTHMIAS
Prof. Enrico Agabiti Rosei
Scienze Cliniche e Sperimentali
I-II Divisione di Medicina
P.le Spedali Civili, 1
25123 Brescia - Italy
Phone:+390303995.251
+39030396044
Fax:+390303388147
E-mail:agabiti@med.unibs.it
12. WORKING GROUP ON VASCULAR
STRUCTURE AND FUNCTION
Prof. Pierre Boutouyrie
Department of Pharmacology
INSERM U970
Assistance Publique HÔpitaux de Paris
Paris Descartes Univerity
Paris - France
E-mail:pierre.boutouyrie@aphp.fr
F I N A L P R OG R A M M E
19
CO N G RE S S I N F O RM AT I O N
Congress Venue
The ESH 2016 is held in Paris at the Palais des Congrès de Paris (2, Porte Maillot).
LEVEL 0
MAIN ENTRANCE
20
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
CO N G RE S S I N F O RM AT I O N
Congress Venue
LEVEL 2
REGISTRATION
AREA
POSTER
AREA
LEVEL 3
PREVIEW ROOM
EXHIBITION
AREA
LUNCH
AREA
F I N A L P R OG R A M M E
21
CO N G RE S S I N F O RM AT I O N
Exhibition
COMPANY
AHA
BOOTH
(American Heart Association)
ALAM MEDICAL
COMPANY
BOOTH
40
MAISENSE INC.
1
20
MEDTRONIC
11
MESI
21
ATCOR
4
AXELIFE
12
MICROLIFE
18
BP LAB
19
NOVACOR
9
CUSTOMED
8
OMRONHEALTHCAREEUROPE
16
CVRX
3
SERVIER
23
DOVEPRESS
14
ESH (European Society of Hypertension)
47-48
SFHTA (Société Française d'Hypertension Artérielle) 44-45
SMTMEDICALTECHNOLOGIES
ESH 2017
46
SOMNOMEDICS
FERRER
17
SPACELABS
FUKUDA DENSHI
24-25-26-27
22
THEMENARINIGROUP
I.E.M.
34
WISEPRESS
IHEALTH
35
WITHINGS
ISH (International Society of Hypertension)
22
36-37
43
15
2
7
TELMED
HEALTHSTATSTECHNOLOGIES
IMAGINE EYES
10
WOLTERSKLUWER/LIPPINCOTT
38-39
6
41
13
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
CO N G RE S S I N F O RM AT I O N
Exhibition
An exhibition of pharmaceutical, technical and research products takes place in the Congress Venue
throughout the Meeting.
Exhibitionopeninghoursforvisitorsare:
DATE
TIME
Friday, June 10
14.00 - 17.00
Saturday, June 11
09.00 - 17.00
Sunday, June 12
09.00 - 17.00
Monday, June 13
09.00 - 16.00
F I N A L P R OG R A M M E
23
CO N G RE S S I N F O RM AT I O N
Useful Information
LANGUAGE
TheofficiallanguageoftheMeetingisEnglish,withtheexceptionofasessiondedicatedtoFrench
doctors held in French language. Simultaneous translation is not provided.
LUNCHES
OnJune11,12and13,2016from12.30to14.00,boxlunchesareservedfreeofchargeatLevel3
of the Congress Venue to participants wearing congress badges and upon presentation of the related
daily coupon lunch (a different coupon for each day) that delegates receive along with the badge.
For sessions scheduled from 13.00 to 14.30 box lunches are offered outside the meeting rooms
from 12.30 to 13.00, upon presentation of the daily lunch coupon. According to the Congress
Venue's rules, participants are not allowed to bring food in the meeting rooms.
CLOAKROOM
A cloakroom is at participants’ disposal at their charge. It is located on Level 3 of the Congress
Venue. Delegates are kindly requested not to leave their personal belongings there after closing.
Security measures have been reinforced with luggage visual inspection, especially for those left at
cloakroom. In order to avoid queue and long delays, we advise participants to leave their luggage
in the hotels.
DATE
TIME
Friday, June 10
Saturday, June 11
Sunday, June 12
Monday, June 13
13.00 - 19.30
07.15 - 20.30
07.15 - 20.30
07.15 - 16.30
BE CONNECTED!
The Congress Venue is covered by free WI-FI connection. The service is available from June 10 to
13, 2016.
ESHMEETING2016
PSW:ESHMEETING2016
Facebook: ESH Annual Meetings
Twitter: #ESH_Annual
CONGRESS APP: browse the Scientific Programme and discover all important
informationoftheCongressonthefreeappESHAnnualMeetingsforiPhone/iPad
and Android mobile devices.
24
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
CO N G RE S S I N F O RM AT I O N
Useful Information
WEBCASTS
Someselectedscientificsessionswillbeavailableaswebcastsonlineonwww.eshonline.org.
PRIVACY DISCLOSURE AND PUBLISHING OF IMAGES
Pursuanttoarticle13ofLegislativeDecreeno.196/2003,thepersonaldataoftheparticipants,
their videos and photos made during the event, will be used by AIM Italy s.r.l. for purposes related
to the communication and the valorization of the event.
Such personal data will be communicated only to those people who are in charge of the activities
necessary to the aforementioned purposes. Photos and videos will be also published on the
website and social networks of AIM Group International (and on the website and social networks
of the event, if any).
Thetreatmentwillbecarriedoutwithappropriatetoolsensuringsecurityandconfidentialityand
may be also carried out by computerized tools that are able to memorize, manage and transmit the
personal data.
The data controller is AIM Italy s.r.l., with legal seat in Milan, Via Giuseppe Ripamonti 129, vat no.
00943621003,e-mailaddressinfo.aimcongress@aimgroup.eu.
With regard to the personal data granted, included photos and videos, each participant can exercise
therightssetforthinarticle7ofLegislativeDecreen.196/2003bycontactingthedatacontroller.
MEDICAL ASSISTANCE
ParticipantsinneedofmedicalassistanceshouldcontacttheCentralSecurityOfficeoftheCongress
Venue located on Level -1, close to the metro entrance.
Inaddition,thefollowingemergencynumberisavailable:+33(0)140681559.
INSURANCE
Congress organisers cannot accept liability for personal injures or for loss of or damage to property
belonging to congress participants, either during or as a result of the Congress.
NO-SMOKING
Smoking in the Meeting area is not allowed.
MOBILE PHONES
Delegates are kindly requested to set their mobile phones on silent mode in the Halls
wherescientificsessionsarebeingheld.
SHIPMENT
MERKUR has been appointed as international freight forwarder, custom broker and on-site
handling agent.
ThefollowingisanoverviewoftheserviceswhichcanbeprovidedbyMERKUR:
• transportation arrangements by road, air or sea
• storage of empty boxes
• transportation arrangements for return shipments
• loading and unloading
• porterage, trolley, transpallet in the Exhibition Area.
MERKUR staff is at your disposal on site in the Exhibition Area for any information on its service.
F I N A L P R OG R A M M E
25
CO N G RE S S I N F O RM AT I O N
Registration Information
REGISTRATION OPENING HOURS
The pre-registration and on-site registration desks are at disposal of participants during the
followinghours:
GROUPS (by appointment)
INDIVIDUALS
Wednesday, June 8
Thursday, June 9
Friday, June 10
13.00 - 18.00
Saturday, June 11
07.15 - 18.00
Sunday, June 12
07.15 - 18.00
Monday, June 13
07.15 - 16.30
14.00 - 19.00
09.00 - 19.00
ACCESS TO THE CONGRESS
Participants are kindly requested to always wear their name badge during the Meeting activities.
The entrance to exhibition and congress area is allowed only to those people registered to the
Congress and equipped with the badge.
The badge holder also contains coupons for box lunches.
Lost badges are replaced against the payment of a handling fee of € 60,00 (French VAT 20%
included) and upon proof of original registration.
For security reasons, children are not allowed to enter in the Congress Area throughout the duration
of the Meeting.
We refuse any responsability for any breach to the above.
WHAT COLOUR IS YOUR BADGE?
Participants TRANSPARENT
Faculty
RED
Exhibition
BLUE
Press
GREEN
Please note that offering your badge to be scanned on exhibition stands or during satellite
symposiaimpliesyouracceptancethatexhibiting/organisingcompaniesmaycontactyou,using
your contact details.
ON-SITE REGISTRATION FEES (FRENCH VAT 20% included)
AllfeesarerequestedinEURO.
CATEGORY
FEE
ESH MEMBER*
NONMEMBER
PARTICIPANTYOUNGERTHAN35**
€ 685,00
€885,00
€430,00
* Reduced fee is only for European Hypertension Society (ESH) members.
It is not applied to members of other Hypertension Associations and to Members of Hypertension National Societies
** Born after June 1st, 1981; please show photocopy of an identity document.
26
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
CO N G RE S S I N F O RM AT I O N
Registration Information
What is covered by the registration fee?
DELEGATE
TheregistrationfeeincludesadmissiontotheOpeningCeremony,reception,unlimitedaccessto
allscientificsessions,accesstotheexhibition,afullsetofcongressmaterialandboxlunchesfrom
Saturday, June 11 to Monday, June 13, 2016.
PRESS REPRESENTATIVE
APressRepresentativeisregisteredtothemeetingfreeofchargeifhe/shefillsintheregistration
formandshowshis/herPressCodeorsimilardocumentconfirmingthestatusofpressrepresentative.
Press registration includes a full set of congress material and free entrance to all meeting activities
includingscientificsessions.
CONGRESS BAG COLLECTION
Delegates can collect their bags at the “Congress bag collection” desk, located in the Registration
Areabypresentingtherelatedcoupondulyfilledin.
CERTIFICATES OF ATTENDANCE
Certificateofattendancewillbesentbye-mailonJune13.
Please refer to the Secretariat Desk to check your e-mail address.
PAYMENT
Due to the Italian Law, it is forbidden to transfer cash between different subjects for an amount
exceeding€3000,00.Therefore,pleasenotethatonsitepaymentsbeyondthisfigurewillonlybe
acceptedbycreditcards(AmericanExpress,VISA,Eurocard/MastercCard).
NAME CHANGES
Name changes on site are charged a handling fee of € 150,00 (French VAT 20% included).
Opening Ceremony and Reception
FRIDAY, JUNE 10
TheofficialOpeningCeremonyoftheMeetingtakesplaceonFriday, June 10 at 17.00 in the
Grand Amphiteatre of the Congress Venue (Level 0).
TheOpeningCeremonywillbefollowedbyaconcertandareception.
AccesstotheOpeningCeremonyandreceptionisincludedintheregistrationfee.
F I N A L P R OG R A M M E
27
S C I E N T I F I C I N F O R M AT I ON
ESH Credits
Attendance at this Meeting provides 3 credits for application as Hypertension Specialist of the
European Society of Hypertension.
Abstract Book
TheAbstractBookwillbeavailableontheJournalofHypertensionwebsite(http://journals.lww.
com/jhypertension/Pages/default.aspx)andontheCongresswebsite(www.esh2016.org)by the
end of August 2016.
Guidelines for Chairpersons and Speakers
GUIDELINES FOR CHAIRPERSONS
•Locateyoursessionroominduetimeandfindyourselfthereatleast10minutesbeforethe
beginning of the session
• Respect the timing allowed to the session and to each presentation
• All presentations, discussions and questions must be in English
GUIDELINES FOR SPEAKERS
• Follow the instructions indicated in the paragraph “Audiovisual Instructions”
•Locateyoursessionroominduetimeandfindyourselfthereforpresentationatleast10minutes
before the beginning of the session to meet the chairpersons
• Respect the timing allowed for your presentation
• All presentations, discussions and questions must be in English
AUDIOVISUAL INSTRUCTIONS
Presentations can be downloaded from one’s notebook at the preview room, provided that the
speakers come there at least 3 hours before the presentation.
Presentations received after this term cannot be guaranteed audiovisual support. Personal
computers cannot be connected to the projectors in sessions’ rooms and presentations cannot be
loaded directly on the computer of the sessions’ rooms. Peak hours of operation in the preview
room are during lunchtime and breaks. We highly recommend speakers to preferably visit the
preview room early in the morning or during the sessions.
IfspeakerscreatedtheirpresentationusingasystemdifferentfromMSWindows(suchOSMACor
Linux), they are kindly requested to provide presentations in a Windows-compatible format and to
come earlier to the preview room, in order to have enough time to solve possible compatibility issue.
In the preview room our hostess will be happy to welcome and help speakers. Experienced
technicians will assist speakers in transferring slides and make changes if needed. Slide
presentations will then be uploaded to the respective sessions’ room.
In the sessions’ rooms speakers will be able to follow their presentations on a monitor at the lectern.
Speakers are asked to use the mouse pointer, instead of any laser pointer.
PREVIEW ROOM
Thepreviewroomisatspeakers’disposalduringthefollowinghours:
DATE
TIME
Friday, June 10
Saturday, June 11
Sunday, June 12
Monday, June 13
13.00 - 19.00
07.15 - 20.30
07.15 - 20.00
07.15 - 16.00
28
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
S CI E N T I F I C I N F O R M AT I O N
Posters
Abstracts accepted as posters are displayed in the Poster Area (Level 2), on June 11, 12 and 13.
Poster sessions will be guided and moderated by a chairperson from 14.00 to 15.30 each day.
Postersmustbehangedonandremovedaccordingtothefollowingschedule:
Saturday, June 11
Sessions 1–13 and Late-Breakers (Session 1):
post up on June 11, 08.00 – 12.00 and removal on June 11, 16.00 – 18.00
Sunday, June 12
Sessions 14-26 and Late-Breakers (Session 2):
post up on June 12, 08.00 – 12.00 and removal on June 12, 16.00 – 18.00
Monday, June 13
Sessions 27-39 and Late-Breakers (Session 3):
post up on June 13, 08.00 – 12.00 and removal on June 13, 15.30 – 16.30
Note: Authors must strictly respect the above mentioned timing for hanging and removing posters.
Iftheyhavenotbeenremovedbythescheduledtime,theywillbethrownaway.TheOrganising
Secretariat cannot be addressed for any responsibility in posters loss or destruction.
GUIDELINES FOR POSTER DISPLAY:
•Postersizemustbe:90x150cm(widthxheight)
•Eachposterhasbeengivenanumberandshouldbefixedontheboardmarkedwiththesame
number. Please refer to the Posters’ Secretariat Desk to check your number
• Authors are kindly requested to stand by their poster from 14.00 – 15.30 for possible questions
by the Congress delegates
• All presentations, discussions and questions must be in English
• Posterdiscussionshouldstartwith1/2minutespresentationofthehighlightsofthework
• Absence from the poster presentation will exclude the poster from competition for the “Alberto
Ferrari” prize, may also have implications for acceptance of abstracts at future meetings and
receiving investigators’ grants in the future
• Each presenting author is allowed to present up to 3 abstracts with one paid registration
• Posters cannot be hanged on by participants who are not among the co-authors
BEST POSTERS DISCUSSION
The 10 best rated posters will be presented each day (June 11, 12 and 13) in the “Poster Presentation
Room” (Level 2) from 15.00 to 15.30.
The presenters will summarise their research within 3 minutes. They will then be available for
questions from chairpersons and audience.
POSTER AREA
Theareaisopenforposterviewingduringthefollowinghours:
DATE
TIME
Saturday, June 11
Sunday, June 12
Monday, June 13
08.00 - 18.00
08.00 - 18.00
08.00 - 16.30
F I N A L P R OG R A M M E
29
30
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
SCIENTIFIC PROGRAMME
32
40
41
76
110
Timetable
Friday, June 10
Saturday, June 11
Sunday, June 12
Monday, June 13
F I N A L P R OG R A M M E
31
TIMETABLE
GRAND
AMPHITHEATRE
15.00
17.00
17.00
19.00
32
ROOM
BORDEAUX
ROOM
HAVANE
ROOM
MAILLOT
15.00-16.30
Joint Session
ESH-CHL
Session 1
VASCULAR STRUCTURE
ANDFUNCTIONAND
HYPERTENSION
OPENING
CEREMONY
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
ROOM
342
Friday, June 10
ROOM
351
ROOM
352
ROOM
251
ROOM
252
ROOM
253
F I N A L P R OG R A M M E
33
TIMETABLE
GRAND
AMPHITHEATRE
ROOM
BORDEAUX
ROOM
HAVANE
07.45
08.45
09.00
11.00
Oral Session 1A
BLOODPRESSURE
MEASUREMENT
11.00
12.30
Oral Session 2A
EPIDEMIOLOGYOF
HYPERTENSIONAND
METABOLICDISORDERS
12.30
14.00
13.00
14.30
11.00-12.00
Topical Workshop
Minisymposium
ASSESSMENTOFDRUG
ADHERENCE:ISTHEREA ROLEOFRENALDENERVATIONINAWORLD
GOLDSTANDARD?
OFEVOLVINGBLOOD
PRESSURE TARGETS
Supported by Medtronic
ROOM
342
Breakfast
Workshop
USEFULNESSOF
REFERENCE VALUES
FORARTERIAL
PARAMETERS
10.00-11.00
Oral Session 1B
CARDIOVASCULARRISK Minisymposium
OPTIMIZATIONOF
FACTORS
HYPERTENSION
MANAGEMENT
THROUGH
INFORMATIONAND
COMMUNICATION
TECHNOLOGY/
MOBILEHEALTH
TOOLS.ANUPDATE
ONTHEESH-HYPERTENSIONAPPFOR
SMARTPHONES
Supported by
Daiichi Sankyo
Oral Session 2B
11.00-12.00
KIDNEY
Minisymposium
HYPERURICAEMIA:A
CONSEQUENCEOFHUMAN(D)EVOLUTION?
Supported by The
Menarini Group
WORKING LUNCH (BOX LUNCH)
Teaching Seminar
MANAGEMENTOF
HYPERTENSION1
14.00
15.30
14.30
15.30
Satellite Symposium
TAILORING
HYPERTENSIONTREATMENTTOTHEPATIENT
Supported by Servier
ATTENDED POSTER SESSIONS
Minisymposium
UNMET NEEDS IN
HYPERTENSION:
SHIFTINGTHEGOAL?
Supported by Daiichi
Sankyo/The Menarini
Group
15.30
17.00
Topical Workshop
FIBROMUSCULAR
DYSPLASIA:
A MULTIFACETED DISEASE
17.00
18.30
18.30
20.00
Plenary Session
KEYNOTELECTURES
34
9.00-10.30
Topical Workshop
PRECISIONMEDICINE
Breakfast
Workshop
CLINICALTRIALSON
RENALDENERVATION:
HAVE WE LEARNED
THELESSONSFROM
PREVIOUSRCTS?
9.00-10.30
Joint Session
ESH-ESC
HOTTOPICSINTHE
MANAGEMENTOF
HYPERTENSION
ROOM
MAILLOT
Minisymposium
ESTABLISHING “CAVI”
CARDIO-ANKLE
VASCULAR INDEX IN
CLINICAL PRACTICE
Supported by Fukuda
Denshi
14.30-15.00
Meeting with
Presidents of National
Societies
Educational Session
CHALLENGES IN THE
MANAGEMENTOF
HYPERTENSIVE PATIENTS
WITH MULTIPLE
COMORBIDITIES
Supported by Ferrer
15.30-16.30
Minisymposium
GOINGTOWARDSZERO
CARDIOVASCULAR
EVENTS.INNOVATIONS
INHOMEBLOODPRESSUREMONITORINGTO
IMPROVEHYPERTENSION
MANAGEMENT
Supported by Omron
Healthcare Europe
18.30-19.30
ESH Working
Group
ONHYPERTENSION,
ARRHYTHMIAS AND
THROMBOSIS
15.00-17.00
Joint Session
ESH-PSH
HTN IN
PORTUGUESE
SPEAKING
COUNTRIES
18.30-20.30
ESH Working
Group
ONBLOOD
PRESSURE
MONITORINGAND
CARDIOVASCULAR
VARIABILITY
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Saturday, June 11
ROOM
351
ROOM
352
ROOM
251
ROOM
252
ROOM
253
Breakfast
Workshop
TREATMENTOF
CONGESTIVEHEART
FAILUREINOLDER
HYPERTENSIVES
Breakfast
Workshop
NEWDRUGSFOR
TREATMENTOF
HYPERTENSION
9.30-10.30
Minisymposium
in French language
IMPACT DE LA
TRANSITIONEPIDEMIOLOGIQUESUR
LA PRISE EN CHARGE
DEL’HYPERTENSION
ARTERIELLE
Supported by Servier
9.00-10.30
Topical Workshop
UPDATEONTHE
PROTECTIVE
RENIN-ANGIOTENSIN
SYSTEM
Oral Session 1C
LARGE ARTERIES
Oral Session 1D
DIABETES
Late-Breakers
SESSION1
Topical Workshop
HOTISSUESIN
HYPERTENSION
Joint Session
FRANCO-MEXICAN
OBESITYAND
HYPERTENSION:APUBLIC
HEALTHPROBLEM
Oral Session 2C
ATRIALFIBRILLATION
AND HEART FAILURE
Oral Session 2D
ENDOTHELIUMAND
ATHEROSCLEROSIS
WORKING LUNCH (BOX LUNCH)
ATTENDED POSTER SESSIONS
How-to Session
UPDATEINENDOTHELIALFUNCTIONAND
ARTERIAL STIFFNESS
TESTING
Supported by SMT
Medical Technology
Meet-the-Expert
HOWTOMANAGEAN
HYPERTENSIVE PATIENT
WITH HYPERURICEMIA
How-to Session
HOWTOEVALUATEAND
MANAGEHYPERTENSIONIN
ATHLETES?
Oral Session 3A
ENDOCRINE
HYPERTENSION
Oral Session 3B
AGEING
Oral Session 3C
CEREBROVASCULAR
DISEASES,STROKEAND
COGNITIVEDYSFUNCTION
ESH Working
Group
ONOBESITY,DIABETES
AND THE HIGH RISK
PATIENT
ESH Working
Group
ONINTERVENTIONAL
TREATMENTOF
HYPERTENSION
14.30-16.30
Clinical Cases
Session 1
How-to Session
HOWTOASSESSCENTRAL
HEMODYNAMICSAND
STIFFNESSINAMBULATORY
CONDITIONSOVERTHE
24-HOURS:ANEWTECHNOLOGY,ITSCLINICALEVIDENCEANDAPPLICATIONS
Supported by BPLab
Oral Session 3D
INFLAMMATIONAND
IMMUNITY
18.30-20.15
ESH Working
Group
ONHYPERTENSIONAND
SEXUALDYSFUNCTION
F I N A L P R OG R A M M E
35
TIMETABLE
GRAND
AMPHITHEATRE
ROOM
BORDEAUX
ROOM
HAVANE
07.45
08.45
Breakfast
Workshop
GOALSAND
MANAGEMENTOF
HYPERTENSION
IN RENAL
TRANSPLANTATION
09.00
11.00
Oral Session 4A
BLOODPRESSURE
VARIABILITY
9.00-10.30
Topical Workshop
EARLY VASCULAR
AGEING (EVA) AND
HYPERTENSION:
HOTISSUES
11.00
12.30
Oral Session 5A
MICROCIRCULATION
AND SMALL VESSELS
11.00-12.00
Minisymposium
IMPROVING
FIRST-LINE TREATMENT
OFHYPERTENSION:
ANEWAPPROACH
Supported by Servier
12.30
14.00
13.00
14.30
14.00
15.30
14.30
15.30
15.30
17.00
17.00
18.30
18.30
20.00
36
ROOM
MAILLOT
9.00-10.30
Joint Session
ESH-LASH
CHALLENGES IN
BLOODPRESSURE
MANAGEMENT IN LATIN
AMERICA
10.00-11-00
Minisymposium
THE RADIANCE-HTN
STUDY:EVALUATINGA
UNIQUEULTRASOUND
RENALDENERVATION
SYSTEMFORTREATING
HYPERTENSION
Supported by ReCor
Medical
Topical Workshop
11.00-12.00
CARDIOVASCULARBIG
Minisymposium
DATA
BRAIN
AMINOPEPTIDASEA
INHIBITORS(BAPAIS),
AN EMERGING CLASS
FORTHETREATMENTOF
HYPERTENSIONAND
HEART FAILURE
Supported by Quantum
Genomics
ROOM
342
Breakfast
Workshop
ALDOSTERONE
ANTAGONISMFOR
CARDIOVASCULAR AND RENAL
PROTECTIONIN
HYPERTENSION
Oral Session 4B
HEART AND
HAEMODYNAMICS
Oral Session 5B
LARGE ARTERIES
WORKING LUNCH (BOX LUNCH)
Teaching Seminar
MANAGEMENTOF
HYPERTENSION2
ATTENDED POSTER SESSIONS
Minisymposium
RISINGTOTHE
CHALLENGEOF
CONCOMITANTHYPERTENSIONANDHYPERCHOLESTEROLEMIA
Supported by Servier
Topical Workshop
Topical Workshop
FROMPREECLAMPSIA RECENTADVANCESON
THEREGULATIONOF
TOANTIANGIOGENIC
RENALIONTRANSPORT
INDUCEDIN THE DISTAL TUBULE
HYPERTENSION.THE
ROLEOFENDOTHELIUM
AND VEGF
Plenary Session
-PRESENTATIONOF
AWARDS
- BJÖRNFOLKOW
AWARD LECTURE
- PRESIDENTIAL
LECTURE
Joint Session
ESH-ERA/EDTA
HYPERTENSIONAND
THEKIDNEY:CURRENT
ISSUES
Minisymposium
CURRENT EVIDENCES
AND FUTURE PERSPECTIVEOF24-HOUR
PERFECTBLOODPRESSURE MANAGEMENT
Supported by Omron
Healthcare Japan
15.30-16.30
Minisymposium
NEW EVIDENCES IN
ACE-INHIBITION:
BEYONDBLOOD
PRESSURECONTROL
Supported by The
Menarini Group
Oral Session 6A
CHILDREN AND
ADOLESCENTS
The Balkanian
Symposium
MEETING
OFBALKAN
COUNTRIES.
ACTIVITIESOF
ESH EXCELLENCE
CENTRES
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Sunday, June 12
ROOM
351
ROOM
352
Breakfast
Workshop
NEWRADIOLOGICAL
INVESTIGATIONSIN
HYPERTENSION
Breakfast
Workshop
DUAL AT1R-NEPRILYSIN
INHIBITORS
Oral Session 4C
THERAPEUTICS AND
CLINICAL TRIALS
Oral Session 4D
KIDNEY
Topical Workshop
ATRIAL
FIBRILLATION,
HYPERTENSION
AND
COMORBIDITIES:
NEEDFORLIFESTYLE
CHANGES
Oral Session 5C
CARDIOVASCULARRISK
FACTORS
ROOM
251
Oral Session 5D
PREGNANCY
ROOM
252
ROOM
253
9.00-10.30
Joint Session
in French Language
ESH-MAGHREBIAN
SOCIETIES OF
HYPERTENSION AND
CARDIOLOGY
HYPERTENSIONINNORTH
AFRICA/HYPERTENSION
AU MAGHREB
10.00-11.00
General Assembly
Joint Session
ESH-CHL
Session 2
VASCULAR DISEASES AS
ASECONDARYCAUSEOF
HYPERTENSION
WORKING LUNCH (BOX LUNCH)
ATTENDED POSTER SESSIONS
How-to Session
How-to Session
HOWTOMANAGE
HOWTOUSE
BAROSTIMTHERAPY HYPERTENSIONDURING
TOSAFELYCONTROL ANDAFTERPREGNANCY?
RESISTANT
HYPERTENSION
Supported by CVRx
How-to Session
NOCTURNALBLOOD
PRESSURE DETERMINED
BYPTT:RELIABLE
METHOD.NEWINSIGHTS
Supported by
SOMNOmedics
Clinical Cases
Session 2
How-to Session
CONNECTEDHEALTH,
THEFUTUREFOR
HEALTHCARE
PROFESSIONALS
Supported by iHealth
Oral Session 6B
BLOODPRESSURE
MEASUREMENT
Oral Session 6C
TREATMENT ADHERENCE
Oral Session 6D
RENIN-ANGIOTENSINALDOSTERONESYSTEM
Late-Breakers
SESSION2
15.30-16.30
How-to Session
POPMETRETHEPWVIN
EVERY DAY PRACTICE
Supported by Axelife
18.30-20.15
ESH Working
Group
ONENDOCRINE
HYPERTENSION
ESH Working
Group
ONHYPERTENSION
ANDCARDIOVASCULAR
RISK ASSESSMENT IN
SUBJECTSLIVINGINOR
EMIGRATINGFROMLOW
RESOURCESETTINGS
ESH Working
Group
ONHYPERTENSION
AND THE KIDNEY
ESH Working
Group
ONVASCULAR
STRUCTURE AND
FUNCTION
F I N A L P R OG R A M M E
37
TIMETABLE
GRAND
AMPHITHEATRE
ROOM
BORDEAUX
ROOM
HAVANE
07.45
08.45
Breakfast Workshop
EMPA-REGOUTCOME
STUDY:ARETHEREBPINDEPENDENT EFFECTS
OFSGLT2INHIBITORS
ONCARDIOVASCULAR
OUTCOME?
09.00
11.00
9.00-10.30
Topical Workshop
JCURVEFOR
HYPERTENSION:THE
DEBATE IS BACK!
11.00
12.30
Plenary Session
DEBATES
12.30
14.00
13.00
14.30
38
Oral Session 7A
EPIDEMIOLOGYOF
HYPERTENSIONAND
METABOLICDISORDERS
ROOM
342
Breakfast
Workshop
WHICHOMICSIN
HYPERTENSION?
9.00-10.30
Topical Workshop
TELEMEDICINE
AND M-HEALTH IN
HYPERTENSION
MANAGEMENT:
TECHNOLOGIES,
APPLICATIONSAND
CLINICAL EVIDENCE
Oral Session 7B
OBESITYAND
METABOLIC
SYNDROME
WORKING LUNCH (BOX LUNCH)
Teaching Seminar
MANAGEMENTOF
HYPERTENSION3
14.00
15.30
14.30
16.00
ROOM
MAILLOT
ATTENDED POSTER SESSIONS
Topical Workshop
THEBONE-KIDNEYVESSELCONNECTION
Oral Session 8A
SPORTANDEXERCISE
Topical Workshop
VISIT-TO-VISITBLOOD
PRESSUREVARIABILITY:
AN UPDATE
Oral Session 8B
SLEEPAPNOEA
AND NEURAL
MECHANISMS
14.30-15.30
How-to Session
HOWTO
USENOVEL
IMAGINGFOR
INVESTIGATING
HEART-VESSEL
COUPLINGIN
HYPERTENSION?
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Monday, June 13
ROOM
351
ROOM
352
Breakfast
Workshop
HYPERTENSION
INDUCED BY DRUGS
Breakfast Workshop
STEP-UP AND STEPDOWNSTRATEGY
FORCOMBINATION
TREATMENT:BEYOND
GUIDELINES
Oral Session 7C
GENETICS,
GENOMICS,
PROTEOMICS,
METABOLOMICS
Oral Session 7D
RESISTANT
HYPERTENSION
ROOM
251
ROOM
252
ROOM
253
9.00-10.00
How-to Session
HOWTOEVALUATEAND
MANAGECONGESTIVE
HEART FAILURE WITH
PRESERVEDSYSTOLIC
FUNCTION?
9.00-10.30
Joint Session
ESH-ARTERY
ARTERIOSCLEROSISVS
ATHEROSCLEROSIS:
IS THE DIFFERENCE
CLINICALLYSOUND?
9.00-10.30
Late-Breakers
SESSION3
WORKING LUNCH (BOX LUNCH)
ATTENDED POSTER SESSIONS
Oral Session 8C
EXPERIMENTAL
HYPERTENSION
AND
PHARMACOLOGY
Oral Session 8D
INNOVATIVETECHNIQUES
AND DEVICES
14.30-15.30
Meet-the-Expert
HOWTOMANAGE
HYPERTENSIVE
PREGNANTWOMEN
WITHPRIMARYALDO,
PHEOCHROMOCYTOMA
ORFIBROMUSCULAR
DYSPLASIA?
Oral Session 8E
LIFESTYLE CHANGES,
LIPIDS, SALT
F I N A L P R OG R A M M E
39
FRIDAY
10
15.00 - 16.30
Room Havane
Joint Session
ESH (European Society of Hypertension)
CHL (Chinese Hypertension League)
SESSION 1: VASCULAR STRUCTURE AND FUNCTION AND HYPERTENSION
SCIENTIFIC PROGRAMME
Chairpersons: E. Agabiti Rosei (Brescia, ITALY)
J. Wang (Shanghai, CHINA)
15.00
Endothelial dysfunction
J. Wang (Shanghai, CHINA)
15.20
Microvasculature
Y. Li (Shanghai, CHINA)
15.40
Small arteries
D. Rizzoni (Brescia, ITALY)
16.00
Large arteries
L.M. Van Bortel (Ghent, BELGIUM)
16.20
Discussion
17.00 - 18.00
Grand Amphitheatre
Opening Ceremony
and Concert
18.00 - 19.00
Lunch Area
Reception
40
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
07.45 - 08.45
Room Havane
Breakfast Workshop
CLINICAL TRIALS ON RENAL DENERVATION: HAVE WE LEARNED THE
LESSONS FROM PREVIOUS RCTS?
Chairpersons: J.A. Staessen (Leuven, BELGIUM)
J. Widimský (Prague, CZECH REPUBLIC)
07.45
Meta-analysis on previous RCT
F.E.FadlElmula(Oslo,NORWAY)
08.05
Have we learned the lessons from previous RCTs?
F. Mahfoud (Homburg, GERMANY)
08.25
Discussion
07.45 - 08.45
Room 342
Breakfast Workshop
USEFULNESS OF REFERENCE VALUES FOR ARTERIAL PARAMETERS
Chairpersons: M.H.Olsen(Glostrup,DENMARK)
P. Wohlfahrt (Prague, CZECH REPUBLIC)
07.45
Central blood pressure
T. Weber (Wels, AUSTRIA)
08.05
Aortic and carotid stiffness
E.R. Rietzschel (Ghent, BELGIUM)
08.25
Discussion
F I N A L P R OG R A M M E
41
07.45 - 08.45
Room 351
Breakfast Workshop
TREATMENT OF CONGESTIVE HEART FAILURE IN OLDER HYPERTENSIVES
Chairpersons: C. Farsang (Budapest, HUNGARY)
G. Gensini (Florence, ITALY)
07.45
The cardiologist’s perspective
M.Viigimaa(Tallinn,ESTONIA)
08.05
The nephrologist’s perspective
E.Nasr(Beirut,LEBANON)
08.25
Discussion
07.45 - 08.45
Room 352
Breakfast Workshop
NEW DRUGS FOR THE TREATMENT OF HYPERTENSION
Chairpersons: J.Brguljan(Ljubljana,SLOVENIA)
F.Pinto(SantaMariaFeira,PORTUGAL)
07.45
New drugs acting on the RAAS
T. Unger (Maastricht, NETHERLANDS)
08.05
Non RAAS acting novel drugs
R. Kreutz (Berlin, GERMANY)
08.25
Discussion
42
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
09.00 - 11.00
Grand Amphitheatre
Parallel Oral Session 1A
BLOOD PRESSURE MEASUREMENT
Chairpersons: E.O’Brien(Dublin,IRELAND)
J.J. Segura (Madrid, SPAIN)
09.00 REPRODUCIBILITY AND ACCURACY OF BLOOD PRESSURE MEASUREMENTS WITH THREE
OSCILLOMETRIC DEVICES IN PATIENTS WITH ATRIAL FIBRILLATION
M. Halfon, G. Wuerzner, P. Marques-Vidal, J. Vaucher, L. Liaudet, B. Waeber, G. Waeber
Lausanne, SWITZERLAND
09.10 SELF-MEASUREMENT OF ORTHOSTATIC HYPOTENSION: FEASIBILITY AND ACCURACY
E. Duron, J.S. Vidal, F. Roca, L. Caillard, E. Chaussade, S. Chauvelier, H. Rananja, C. Boully, A.S. Rigaud,
O.Hanon
Paris, FRANCE
09.20 CORRELATIONS BETWEEN WHITE-COAT EFFECT AND MORNING BLOOD PRESSURE SURGE ON
AMBULATORY BLOOD PRESSURE MONITORING
F. Salvo 1, M. Berardi 1, P. Fogliacco 1, M. Albano 1, C. Vallo 1, A.R. Errani 1, C. Lonati 2, V. Meinero 1,
C.L. Muzzulini 1, A. Morganti 2
1
Ceva, 2 Milan, ITALY
09.30 24H AMBULATORY BLOOD PRESSURE MONITORING PROFILE IN PARKINSON’S DISEASE WITH
AUTONOMIC NEUROPATHY
V. Milazzo, C. Di Stefano, F. Vallelonga, G. Sobrero, A. Milan, M. Zibetti, M. Sarchioto, A. Romagnolo, L. Lopiano,
F. Veglio, S. Maule
Turin, ITALY
09.40 NOCTURNAL BLOOD PRESSURE RELATES MORE CLOSELY TO KIDNEY DISEASE IN THE DUBLIN
OUTCOME STUDY
E. Dolan,E.O’Brien
Dublin, IRELAND
09.50 HYPERTENSIVE TARGET ORGAN DAMAGES ARE BETTER ASSOCIATED WITH CENTRAL THAN
BRACHIAL BLOOD PRESSURE: THE NORTHERN SHANGHAI STUDY
C. Chi, S. Yu, B. Bai, K. Wang, L. Wang, Y. Lu, Y. Zhang, Y. Xu
Shanghai, CHINA
10.00 INCREMENTAL DIFFERENCES BETWEEN HOME AND AMBULATORY BLOOD PRESSURE AND
THEIR RELATION TO ANXIETY AND HYPERTENSIVE ORGAN DAMAGE: EVIDENCE FOR AN ‘AUTO-CUFF’
RESPONSE?
K. Gazzola 1, M. Cammenga 2, N. Van Der Hoeven 2, G. Van Montfrans 2, B.J. Van Den Born 2
1
Ferrara, ITALY, 2 Amsterdam, NETHERLANDS
10.10 COMPARISON BETWEEN OFFICE AND AMBULATORY BLOOD PRESSURE IN ASSESSING THE
REDUCTION OF BLOOD PRESSURE: A META-ANALYSIS
D. Soranna, A. Zambon, G. Corrao, G. Parati, A. Zanchetti, G. Mancia
Milan, ITALY
F I N A L P R OG R A M M E
43
10.20 THE RELATIONSHIP BETWEEN THE AGGRESSION LEVEL OF PATIENTS WITH ARTERIAL
HYPERTENSION AND THE ANTIHYPERTENSIVE DRUG EFFECTIVENESS
G. Andreeva,V.Gorbunov,V.Beloliperskaya,S.Kukushkin,E.Zvolinskaya,O.Lerman
Moscow, RUSSIA
10.30 CONVENTIONAL AND AMBULATORY BLOOD PRESSURE AS PREDICTORS OF RETINAL
ARTERIOLAR NARROWING
F. Wei 1, Z.Y. Zhang 1, L. Thijs 1, W.Y. Yang 1, L. Jacobs 1, N. Cauwenberghs 1, Y.M. Gu 1, T. Kuznetsova 1,
K. Allegaert 1, P. Verhamme 1, Y. Li 2, H.A.J. Struijker-Boudier 3, J.A. Staessen 1
1
Leuven, BELGIUM, 2 Shanghai, CHINA, 3 Maastricht, NETHERLANDS
10.40 LECTURE
ORTHOSTATIC HYPERTENSION. AN EMERGING PEJORATIVE BP PARAMETER?
J.-J. Mourad
Bobigny, FRANCE
09.00 - 10.30
Room Bordeaux
Topical Workshop
PRECISION MEDICINE
Chairpersons: A.F.Dominiczak(Glasgow,UNITEDKINGDOM)
X. Jeunemaitre (Paris, FRANCE)
09.00
Omics in endocrine hypertension
M.-C. Zennaro (Paris, FRANCE)
09.20
IBM Watson Health: more cognitive capabilities brought to care
P. Sempé (Paris, FRANCE)
09.40
When genomics meets proteomics
V. Guryev (Groningen, NETHERLANDS)
10.00
Proteomics biomarkers in kidney disease
C.Delles(Glasgow,UNITEDKINGDOM)
10.20
Discussion
44
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
09.00 - 10.30
Room Havane
Joint Session
ESH (European Society of Hypertension)
ESC (European Society of Cardiology)
HOT TOPICS IN THE MANAGEMENT OF HYPERTENSION
Chairpersons: E. Agabiti Rosei (Brescia, ITALY)
A. Coca (Barcelona, SPAIN)
09.00
Isolated systolic HTN in the young
E. Lurbe (Valencia, SPAIN)
09.20
Very elderly
A. Benetos (Nancy, FRANCE)
09.40
White coat hypertension and masked hypertension
G. Mancia (Milan, ITALY)
10.00
Difficult to treat hypertension
C.Tsioufis(Athens,GREECE)
10.20
Discussion
09.00 - 11.00
Room Maillot
Parallel Oral Session 1B
CARDIOVASCULAR RISK FACTORS
Chairpersons: J. Filipovsky (Pilsen, CZECH REPUBLIC)
P. Gosse (Bordeaux, FRANCE)
09.00 LENNART HANSSON MEMORIAL LECTURE
R.E. Schmieder
Erlangen, GERMANY
09.20 VITAMIN K DEPENDENT PROTECTION OF RENAL FUNCTION IN MULTI-ETHNIC POPULATION
STUDIES
F. Wei 1, N.E.A. Drummen 2, A.E. Schutte 3, L. Thijs 1, L. Jacobs 1, T. Petit 1, W.Y. Yang 1, W. Smith 3, Z.Y. Zhang 1,
Y.M. Gu 1, T. Kuznetsova 1, P. Verhamme 1, K. Allegaert 1, R. Schutte 3, E. Lerut 1, P. Evenepoel 1, C. Vermeer 2,
J.A. Staessen 1
1
Leuven, BELGIUM, 2 Maastricht, NETHERLANDS, 3 Potchefstroom, SOUTH AFRICA
F I N A L P R OG R A M M E
45
09.30 SERUM URIC ACID AND BLOOD PRESSURE IN EUROPEAN RURAL POPULATION WITH NORMAL
KIDNEY FUNCTION. DATA FROM BRISGHELLA HEART STUDY (ITALY) AND ENAH STUDY (CROATIA)
S. Karanovic 1, V. Ivkovic 1, A. Parini 2, A. Vrdoljak 1, M. Abramovic-Baric 3, S. Bacchelli 2, M. Cagnati 2,
A. Francesco 2, A.F.G. Cicero 2, S. D’Addato 2, D. Degli Esposti 2, M. Fucek 1, E. Grandi 2, J. Kos 1, M. Laganovic 1,
M. Rosticci 2, D. Rogic 1, I. Vukovic 1, C. Borghi 2, B. Jelakovic 1
1
Zagreb, CROATIA, 2 Bologna, ITALY, 3 Bebrina, CROATIA
09.40 IDENTIFICATION OF A CUT-OFF LEVEL OF URIC ACID ASSOCIATED WITH VASCULAR
STIFFNESS IN A GENERAL POPULATION
A. Di Leva 1, M. Koretzky 1,2,5,S.Obregon1,2,5, P. Pardini 2,5, G. Maccallini 2,5, M. Haehnel 2,5, E. Huguet 2,5,
F. Botto 1,2,5, A. Scuteri 3,5, P.M. Nilsson 4,5, C. Kotliar 1,2,5
1
Pilar, 2 San Isidro, ARGENTINA, 3 Rome, ITALY, 4 Malmö, SWEDEN, 5 on behalf of the OPTIMO Latinoamerican
Study Investigators
09.50 ASSOCIATIONS OF 15-YEAR AVERAGE POTASSIUM INTAKE WITH LONG-TERM
CARDIOVASCULAR AND RENAL OUTCOME IN THE OUTPATIENT CLINICAL SETTING
N.VanNoordenne,R.H.G.OldeEngberink,T.C.vandenHoek,B.J.vandenBorn,L. Vogt
Amsterdam, NETHERLANDS
10.00 OVER-24H CENTRAL PULSE PRESSURE IS SUPERIOR TO PERIPHERAL PULSE PRESSURE FOR
CARDIOVASCULAR EVENTS PREDICTION. RESULTS FROM THE BORDEAUX HYPERTENSIVE COHORT
A. Cremer, R. Boulestreau, P. Gosse
Bordeaux, FRANCE
10.10 SELECTIVE HEART RATE REDUCTION WITH IVABRADINE INCREASES CENTRAL BLOOD
PRESSURE IN STABLE CORONARY ARTERY DISEASE
S. Rimoldi 1, F.H. Messerli 1, D. Cerny 1, S. Laurent 2, C. Seiler 1
1
Bern, SWITZERLAND, 2 Paris, FRANCE
10.20 CAROTID ATHEROSCLEROSIS PROGRESSION AND REVERSE DIPPER PATTERN IN KIDNEY
TRANSPLANTATION
M. Azancot, N. Ramos, I.B. Torres, E. Espinel, F. Moreso, D. Seron
Barcelona, SPAIN
10.30 ASSOCIATION OF APOB/APOA 1 RATIO WITH TARGET ORGAN DAMAGE IN HYPERTENSIVE
PATIENTS
P. Pietri, C. Vlachopoulos, G. Vyssoulis, N. Ioakeimidis, D. Terentes-Printzios, J. Skoumas, C. Stefanadis,
D. Tousoulis
Athens, GREECE
10.40 RELATIONSHIP BETWEEN CHA2DS2-VASC SCORE AND PRECLINICAL CARDIOVASCULAR
ORGAN DAMAGE IN A GENERAL POPULATION IN NORTHERN ITALY: THE VOBARNO STUDY
A. Paini, M. Salvetti, C. Agabiti Rosei, F. Bertacchini, C. Aggiusti, G. Rubagotti, G. Maruelli, E. Agabiti Rosei,
M.L. Muiesan
Brescia, ITALY
10.50 RISK SCORE FOR INCIDENT HEART FAILURE: A SUBJECT-LEVEL META-ANALYSIS FROM THE
HEART ‘OMICS’ IN AGEING (HOMAGE) DATABASE
L. Jacobs 1, L. Efremov 1, L. Thijs 1, W.Y. Yang 1, Z.Y. Zhang 1, R. Latini 2, S. Masson 2, P. Sever 3, C. Delles 4,
J. Butler 5, T. Kuznetsova 1, J.A. Staessen 1, F. Zannad 6
1
Leuven, BELGIUM, 2 Milan, ITALY, 3 London, 4 Glasgow, UNITED KINGDOM, 5 New York, USA, 6 Nancy, FRANCE
46
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
09.00 - 10.30
Room 352
Topical Workshop
UPDATE ON THE PROTECTIVE RENIN-ANGIOTENSIN SYSTEM
Chairpersons: T. Unger (Maastricht, NETHERLANDS)
M. Volpe (Rome, ITALY)
09.00
AGTR2 as a modifier of Lung disease severity in cystic fibrosis identified with genome-wide
association meta-analysis
D.C. Villela (Diamantina, BRAZIL)
09.20
AT2 receptor and interacting proteins in breast cancer
C. Nahmias (Paris, FRANCE)
09.40
AT2- and MAS receptor in stroke: potential for neuroprotection and neuroregeneration
P. Namsolleck (Maastricht, NETHERLANDS)
10.00
Stimulating the Protective RAS: a target for drug development
L.Paulis(Bratislava,SLOVAKREPUBLIC)
10.20
Discussion
09.00 - 11.00
Room 251
Parallel Oral Session 1C
LARGE ARTERIES
Chairpersons: L.M. Van Bortel (Ghent, BELGIUM)
C. Vlachopoulos (Athens, GREECE)
09.00 HIGH SALT DIET INCREASES AORTIC STIFFNESS AND PRESSURE PULSE AMPLIFICATION IN RAT
M. Butlin 1, K. Connolly 2, B. Spronk 3, D. Georgevsky 1, C. McEneiry 2, I.B. Wilkinson 2, A. Avolio 1
1
Sydney, AUSTRALIA, 2 Cambridge, UNITED KINGDOM, 3 Maastricht, NETHERLANDS
09.10 SPECTRAL ESTIMATION OF PETERSON’S MODULUS VARIABILITY FROM ARTERIAL BLOOD
PRESSURE AND WAVELET ANALYSIS
A.J. Ramirez, F. Pessana, P. Zenone, N. Linale, R. Sanchez
Buenos Aires, ARGENTINA
09.20 REGIONAL VASCULAR STIFFNESS IN RESPONSE TO NITROGLYCERIN AND THEIR IMPACT ON
ARTERIAL STIFFNESS GRADIENT
M. Agharazii, C. Fortier, M. Desjardins, K. Marquis, F. Mac-Way, S. Desmeules, S. De Serres
Quebec City, CANADA
F I N A L P R OG R A M M E
47
09.30 STRUCTURAL AND FUNCTIONAL ARTERIAL ABNORMALITIES IN FIBROMUSCULAR DYSPLASIA
ARE IN THE CONTINUUM OF HYPERTENSION: AN IMAGING AND BIOMECHANICAL STUDY
L. Marais 1, 2, P. Boutouyrie 1, H. Khettab 1, C. Boulanger 1, A. Lorthioir 1, M. Frank 1, R. Niarra 1, J. Renard 1,
Y. Chambon 1, X. Jeunemaitre 1, M. Zidi 2, P.-F. Plouin 1, S. Laurent 1, M. Azizi 1
1
Paris, 2 Créteil, FRANCE
09.40 THE POLISH REGISTRY FOR FIBROMUSCULAR DYSPLASIA. THE PRELIMINARY REPORT
ON DISTRIBUTION OF VASCULAR BED INVOLVEMENT AND COMPLICATIONS IN PATIENTS ENROLLED IN
ARCADIA-POL STUDY
E. Warchol-Celinska 1, K. Hanus 1, P. Talarowska 1, E. Florczak 1, K. Jozwik-Plebanek 1, M. Januszewicz 1,
I. Michalowska 1, A. Prejbisz 1, W. Wojcik 1, H. Janaszek-Sitkowska 1, M. Makowiecka-Ciesla 1, L. Stryczynski 2,
M. Protasiewicz 3, L. Swiatlowski 4, A. Niemirska 1, M. Litwin 1, T. Przewlocki 5, M. Szczerbo-Trojanowska 4,
A. Tykarski 2, A. Januszewicz 1
1
Warsaw, 2 Poznan, 3 Wroclaw, 4 Lublin, 5 Kraków, POLAND
09.50 HIGH PREVALENCE OF MULTISITE FIBROMUSCULAR DYSPLASIA: THE ARCADIA (ASSESSMENT
OF RENAL AND CERVICAL ARTERY DYSPLASIA) REGISTRY
P.-F. Plouin
Paris, FRANCE
10.00 LECTURE
WHEN INCREASE IN CENTRAL BP OVERRIDES BENEFITS OF HR LOWERING
F.H. Messerli
Bern, SWITZERLAND
10.20 AORTIC PULSE WAVE VELOCITY PREDICTS SEVERE CARDIOVASCULAR EVENTS IN PATIENTS
UNDERGOING CORONARY ANGIOGRAPHY
B. Hametner 1, S. Parragh 1, S. Wassertheurer 1, T. Weber 2
1
Vienna, 2 Wels, AUSTRIA
10.30 HEMODYNAMIC PARAMETERS IN HYPERTENSIVE DIABETIC PATIENTS
A. Yannoutsos, M. Ahouah, C. Dreyfuss Tubiana, J. Topouchian, C. Touboul, M.E. Safar, J. Blacher
Paris, FRANCE
10.40 REPRODUCTIVE HISTORY OF WOMEN AS A DETERMINANT OF ARTERIAL STIFFNESS.
THE MALMÖ DIET CANCER STUDY
P.M. Nilsson, E. Carlqvist, M. Gottsäter
Malmö, SWEDEN
10.50 BENEFITS OF AMBULATORY BLOOD PRESSURE MEASUREMENT IN POST ACUTE AORTIC
SYNDROME: PREDICTORS FOR BLOOD PRESSURE CONTROL AND IMPORTANCE OF NOCTURNAL BLOOD
PRESSURE INFLUENCE
P. Delsart, G. Ledieu, P. Devos, J. Sobocinski, R. Clough, S. Haulon, C. Mounier-Vehier
Lille, FRANCE
48
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
09.00 - 11.00
Room 252
Parallel Oral Session 1D
DIABETES
Chairpersons: P.M. Nilsson (Malmö, SWEDEN)
C.D.A. Stehouwer (Maastricht, NETHERLANDS)
09.00 DIASTOLIC ORTHOSTATIC HYPERTENSION PREDICTS A FAVORABLE CARDIOVASCULAR
PROGNOSIS IN TYPE 2 DIABETES
M. Wijkman 1, T. Länne 2, C.J. Östgren 2, F.H. Nystrom 2
1
Norrköping, 2 Linköping, SWEDEN
09.10 ORTHOSTATIC HYPERTENSION IN NORMOTENSIVE PATIENTS PREDICTS PERMANENT ARTERIAL
HYPERTENSION IN TYPE 2 DIABETES MELLITUS
N. Nibouche 1, N. Lanasri 1, A. Chibane 1, F. Zeraoulia 1, A. Bachir-Cherif 2, A. Dahak 1, L. Makhlouf 1,
A. Medjahed 1, A. Biad 1
1
Algiers, 2 Blida, ALGERIA
09.20 NIGHTTIME BLOOD PRESSURE IS THE MAJOR DETERMINANT FACTOR OF BOTH
MACROVASCULAR AND MICROVASCULAR LESIONS IN A COHORT OF TYPE 2 DIABETIC AND
NON-DIABETIC HYPERTENSIVE PATIENTS
J. Polonia, C. Ferreira, P. Castro, S. Penas, L. Martins, E. Azevedo
Porto, PORTUGAL
09.30 LECTURE
DIABETES AND HYPERTENSION: NEW THERAPEUTIC APPROACH WITH INCRETINES AND SLGT2
INHIBITORS
E. Larger
Paris, FRANCE
09.50 SUBCLINICAL LEFT VENTRICULAR DIASTOLIC DYSFUNCTION AND INCIDENT TYPE 2 DIABETES
MELLITUS: A COMMUNITY-BASED COHORT STUDY
S. Kim 1, J.S. Kim 1, S.Y. Lim 1, C. Shin 1, H.E. Lim 2, C.U. Chol 2, S.Y. Suh 3, J. Park 2
1
Ansan-si, 2 Seoul, 3 Incheon, SOUTH KOREA
10.00 TYPE 2 DIABETES IS ASSOCIATED WITH GREATER CAROTID STIFFNESS AND GREATER
PRESSURE-DEPENDENCY OF CAROTID STIFFNESS: THE MAASTRICHT STUDY
M. Veugen, R.M.A. Henry, T. van Sloten, E. Hermeling, H.P. Brunner-La Rocca, M. Schram, P. Dagnelie,
C.D.A. Stehouwer, K. Reesink
Maastricht, NETHERLANDS
10.10 SALT CONSUMPTION AND GLUCOSE METABOLISM IN ESSENTIAL HYPERTENSION
E. Karpanou, G. Vyssoulis, E. Demerouti, H. Grassos, H. Liakos
Athens, GREECE
10.20 EARLY SIGNS OF END-ORGAN DAMAGE IN RETINAL ARTERIOLES IN TYPE 2 DIABETIC IN
COMPARISON WITH HYPERTENSIVE PATIENTS
A. Jumar 1,C.Ott1, I. Kistner 1, S. Friedrich 1, J.M. Harazny 1,2, R.E. Schmieder 1
1
Erlangen, GERMANY, 2 Warmia, POLAND
F I N A L P R OG R A M M E
49
10.30 SYNERGETIC PREVENTION OF SUDDEN DEATH BY ACEI, STATIN AND GLIFLOZIN IN TYPE 2
DIABETES: A SIMULATION STUDY
H. Le 1, I. Marchant 2, J.P. Boissel 1, P. Nony 1, B. Kassai 1, C. Cornu 1,F.Gueyffier1
1
Lyon, FRANCE, 2 Valparaiso, CHILE
10.40 LIVER DAMAGE DUE TO DIABETES INVOLVES MULTIPLE PATHWAYS AND INDUCES
MICROCIRCULATION ALTERATIONS: THE EFFECT OF METFORMIN PLUS INSULIN TREATMENT
A. Daliry, R. Rangel Silvares, E.N.G. da Silva Pereira, E.E. Ilaquita Flores, V. Estato, P.A. Reis, I. José da Silva,
M.P. Machado, H.C. de Castro, F. Neto, E. Tibiriça
Rio de Janeiro, BRAZIL
10.50 THE CKD273 URINARY PROTEOMIC CLASSIFIER IS NOT A MARKER OF GENERALISED
VASCULAR DISEASE IN TYPE 2 DIABETIC PATIENTS WITH NORMAL RENAL FUNCTION
G. Currie 1, J. Flynn 1, M. Lindhardt 2, H. Mischak 1, P. Rossing 2, C. Delles 1
1
Glasgow, UNITED KINGDOM, 2 Copenhagen, DENMARK
09.00 - 11.00
Room 253
Late-Breakers
SESSION 1
Chairpersons: E.Berge(Oslo,NORWAY)
D. Lovic (Niš, SERBIA)
09.00 CARDIOVASCULAR RISK IN RELATION TO ACHIEVED AUTOMATED BLOOD PRESSURE IN
CLINICAL PRACTICE
M. Myers 1, J. Kaczorowski 2,3, J.M. Paterson 1,3, L. Dolovich 4, K. Tu 1,2,3
1
Toronto, 2 Montreal, 3 Hamilton, CANADA
09.10 OPTIMAL SYSTOLIC BLOOD PRESSURE TARGET AFTER SPRINT INSIGHTS FROM A NETWORK
META-ANALYSIS OF RANDOMIZED TRIALS
S. Bangalore, B. Toklu, F.H. Messerli
New York, NY, USA
09.20 BENEFITS OF EARLY BLOOD PRESSURE CONTROL ON CARDIOVASCULAR OUTCOMES:
A SUBGROUP ANALYSIS OF THE FELODIPINE EVENT REDUCTION (FEVER) STUDY
Y. Zhang 1, X. Zhang 1, L. Liu 1, A. Zanchetti 2
1
Beijing, CHINA, 2 Milan, ITALY
09.30 HIGH PREVALENCE OF CARDIAC ELECTRIC ABNORMALITIES IN PATIENTS WITH
PHEOCHROMOCYTOMAS AND SECRETING PARAGANGLIOMAS
E. Berra 1, M.C. Gonzales 1, A. Bersali 1, A. Persu 1,2
1
Brussels, 2 Leuven-la-Neuve, BELGIUM
09.40 AUTOMATED INTERPRETATION OF HOME BLOOD PRESSURE MEASUREMENTS WITH WIRELESS
BLOOD PRESSURE MONITOR AND HY-RESULT SOFTWARE: A USER PERCEPTION STUDY
N. Postel-Vinay 1, G. Bobrie 1,O.Steichen1, S. Savard 2, A. Persu 3, B. Brouard 4, M. Vegreville 4
1
Paris, FRANCE, 2 Quebec, CANADA, 3 Brussels, BELGIUM, 4 Issy-les-Moulineaux, FRANCE
09.50 APPLICATION OF AN EXPERT SYSTEM TO IMPROVE CARDIOVASCULAR RISK IN THE
WORKPLACE
E. Calvo-Bonacho 1, M. Cabrera-Sierra 1, L. Quevedo-Aguado 1, C. Fernández-Labandera 1,
P. Martínez-Muñoz 1, J.C. Sainz-Gutiérrez 1, C. Catalina-Romero 1, A. Fernández-Meseguer 1,
M.Á. Sánchez-Chaparro 2, P. Valdivielso-Felices 2, L.M. Ruilope 1
1
Madrid, 2 Málaga, SPAIN
50
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
10.00 A COMPARISON OF THE IMPACT OF MORNING OR NIGHT DELIVERY OF ANTIHYPERTENSIVE
AGENTS ON 24 HOUR AMBULATORY BLOOD PRESSURE MONITORING (ABPM) LEVELS: A RANDOMISED
CROSS-OVER TRIAL
N.R. Poulter 1, A. Anjum 1, M. Cross 1, E. Falaschetti 1, C. Savopoulos 2, M. Szigeti 1, S. Thom 1, A. Hatzitolios 2
1
London, UNITED KINGDOM, 2 Thessaloniki, GREECE
10.10 THE ASSOCIATION BETWEEN OBESITY AND PARITY IN SURINAMESE WOMEN
Y. Haan 1, I.C. van Seventer 1, F.S. Diemer 1,2, G. van Montfrans 2,G.P.Oehlers2, L.M. Brewster 1,2
1
Amsterdam, NETHERLANDS, 2 Paramaribo, SURINAME
10.20 PREDICTION OF CV EVENT IN DIABETIC NEPHROPATHY
J.-P. Fauvel 1, D. Joly 2, G. Choukroun 3, B. Dussol 4, B. Fiquet 2, J.-M. Halimi 5, S. Quere 2, C. Combe 6,
M. Ducher 1
1
Lyon, 2 Paris, 3 Amiens, 4 Marseille, 5 Tours, 6 Bordeaux, FRANCE
10.30 THE SKIPPING OF EXON 9 IN CULLIN-3 CAUSES A SEVERE FORM OF FAMILIAL HYPERKALEMIC
HYPERTENSION IN MICE
C. Rafael, W. Abdel Khalek, I. Kouranti, E. Clauser, X. Jeunemaitre, J. Hadchouel
Paris, FRANCE
10.40 MEASUREMENT OF ANGIOTENSIN II AT EQUILIBRIUM IN THE DIAGNOSTIC WORKUP OF
PRIMARY ALDOSTERONIS. IMPACT OF PATIENT POSITIONING AND ACE INHIBITOR TREATMENT
M. Poglitsch 1, A.H. Ahmed 2, A. Stoller 3,D.VanOyen1, C. Schwager 1, C. Aigner 1,O.Domenig1,
M. Haschke 3, M. Stowasser 2
1
Vienna, AUSTRIA, 2 Brisbane, AUSTRALIA, 3 Basel, SWITZERLAND
10.50 CACNA1H MUTATIONS ARE ASSOCIATED WITH YOUNG ONSET AND FAMILIAL FORMS OF
PRIMARY ALDOSTERONISM
G. Daniil 1, F.L. Fernandes-Rosa 1, J. Chemin 2, X. Jeunemaitre 1, M. Polak 1, S. Boulkroun 1,2, L. Amar 1,
T.M. Strom 3,4, P. Lory 2, M.-C. Zennaro 1
1
Paris, 2 Montpellier, FRANCE, 3 Neuherberg, 4 Munich, GERMANY
09.30 - 10.30
Room 351
Minisymposium in French Language
Supported by Servier
IMPACT DE LA TRANSITION EPIDEMIOLOGIQUE SUR LA PRISE EN CHARGE
DE L’HYPERTENSION ARTERIELLE
Chairperson:
B. Levy (Paris, FRANCE)
09.30
Introduction
B. Levy (Paris, FRANCE)
09.40
Transition épidémiologique et complications cardiovasculaires
J. Blacher (Paris, FRANCE)
10.00
A chaque profil son traitement
J.-J. Mourad (Bobigny, FRANCE)
10.20
Conclusion
B. Levy (Paris, FRANCE)
F I N A L P R OG R A M M E
51
10.00 - 11.00
Room 342
Minisymposium
Supported by Daiichi Sankyo
OPTIMIZATION OF HYPERTENSION MANAGEMENT THROUGH
INFORMATION AND COMMUNICATION TECHNOLOGY/MOBILE HEALTH
TOOLS. AN UPDATE ON THE ESH-HYPERTENSION APP FOR SMARTPHONES
Chairpersons: R.E. Schmieder (Erlangen, GERMANY)
B.Williams(London,UNITEDKINGDOM)
10.00
Challenges still to face for optimal hypertension management in year 2016
J. Redon (Valencia, SPAIN)
10.20
An update of the ESH APP for smartphones and a call to action for better hypertension
control
G. Parati (Milan, ITALY)
10.40
Discussion and ESH live APP show
10.55
Closing remark by the ESH President
E. Agabiti Rosei (Brescia, ITALY)
11.00 - 12.30
Grand Amphitheatre
Parallel Oral Session 2A
EPIDEMIOLOGY OF HYPERTENSION AND METABOLIC DISORDERS
Chairpersons: P.M. Nilsson (Malmö, SWEDEN)
J. Wang (Shanghai, CHINA)
11.00 URINE CADMIUM LEVELS AND ALBUMINURIA IN A GENERAL POPULATION FROM SPAIN:
A GENE-ENVIRONMENT INTERACTION POPULATION-BASED STUDY
G. Pichler 1, M. Grau-Perez 1, J. Martin-Escudero 2, I. Galan-Chilet 1, A. Dominguez-Lucas 1, F. Chaves 1,3,
J. Redon 1,4, M. Tellez-Plaza 1,5
1
Valencia, 2 Valladolid, 3 Barcelona, 4 Madrid, SPAIN, 5 Baltimore, MD, USA
11.10 UROMODULIN MODULATES THE EFFECT OF SALT ON BLOOD PRESSURE IN THE GENERAL
POPULATION
B. Ponte 1, M. Pruijm 2, I. Guessous 1, D. Ackermann 3, G. Ehret 1, M. Mohaupt 3, F. Paccaud 2, B. Vogt 3,
P.Y. Martin 1, A. Pechère-Berstschi 1, M. Burnier 2,O.Devuyst4, M. Bochud 2
1
Geneva, 2 Lausanne, 3 Bern, 4 Zurich, SWITZERLAND
11.20 METABOLICALLY HEALTHY OBESITY AND METABOLICALLY OBESE NORMAL WEIGHT IN
RUSSIAN POPULATION
O.Rotar 1,A.O.Konradi1, S. Shalnova 2, Y. Balanova 2, A. Deev 2,E.Oshchepkova2, Y. Karpov 2, I.E. Chazova 2,
S. Boytsov 2, E. Shlyakhto 1
1
Saint-Petersburg, 2 Moscow, RUSSIA
52
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
11.30 COMPARISON OF CAROTID-FEMORAL AND BRACHIAL-ANKLE PULSE WAVE VELOCITY
IN THE ASSOCIATION WITH TARGET ORGAN DAMAGES IN THE COMMUNITY-DWELLING ELDERLY:
THE NORTHERN SHANGHAI STUDY
Y. Lyu, B. Bai, C. Chi, S. Yu, K. Wang, J. Xiong, Y. Zhang, Y. Xu
Shanghai, CHINA
11.40 ASSOCIATION BETWEEN BLOOD PRESSURE AND ADHERENCE TO FRENCH DIETARY
GUIDELINES
H. Lelong, J. Blacher, M. Menai, L. Fezeu, S. Hercberg, E. Kesse-Guyot
Paris, FRANCE
11.50 CURRENT DRUG TREATMENT OF HYPERTENSION IN SWEDEN IN RELATION TO GENDER, AGE,
AND COMORBIDITY
F. Wallentin, B. Wettermark, T. Kahan
Stockholm, SWEDEN
12.00 TRENDS IN PATIENTS ATTENDING A TERTIARY HYPERTENSION UNIT: PATIENTS’
CHARACTERISTICS AND TREATMENT STRATEGIES STRONGLY EVOLVED OVER THE LAST 15 YEARS
T. Deborde, L. Amar, G. Bobrie, A. Burgun, G. Chatellier, P.-F. Plouin, M. Azizi, A.-S. Jannot
Paris, FRANCE
12.10 HYPERTENSION AND CARDIOVASCULAR DISEASE IN GREECE: INTERIM ANALYSIS OF THE
EMENO NATIONAL EPIDEMIOLOGICAL STUDY
G.S. Stergiou 1, A. Margetaki 1, N. Boubouchairopoulou 1, A. Mastrokostas 2, A. Vantarakis 3, G. Chlouverakis 4,
G. Rachiotis 5, G. Trypsianis 6, P. Voulgari 7, I. Alamanos 8, A. Karakosta 1, G. Touloumi 1
1
Athens, 2 Thessaloniki, 3 Patras, 4 Heraklion, 5 Larissa, 6 Alexandroupolis, 7 Ioannina, 8 Corfu, GREECE
12.20 SYSTOLIC BLOOD PRESSURE VARIATION DURING 6 YEARS AND MORTALITY. THE AGE
AMPLIFIES THE IMPACT OF A SPONTANEOUS INCREASE OR REDUCTION OF PRESSURE AMONG
HYPERTENSIVE: IPC COHORT
F. Thomas-Jean 1, B. Pannier 1,O.Hanon1, S. Czernichow 2, C. Lemogne 1, T. Simon 1, J. Simon 1, N. Danchin 1
1
Paris, 2 Boulogne Billancourt, FRANCE
11.00 - 12.30
Room Bordeaux
Topical Workshop
ASSESSMENT OF DRUG ADHERENCE: IS THERE A GOLD STANDARD?
Chairpersons: M. Azizi (Paris, FRANCE)
V. Kotsis (Thessaloniki, GREECE)
11.00
Electronic pill monitoring and chip in a pill
M. Schneider Voirol (Lausanne, SWITZERLAND)
11.20
Use of register for assessment of drug adherence
B. Wettermark (Stockholm, SWEDEN)
11.40
Measurement of drugs in plasma/urine
V. Jullien (Paris, FRANCE)
12.00
Low drug levels in body fluids: always due to low adherence?
A. Persu (Brussels, BELGIUM)
12.20
Discussion
F I N A L P R OG R A M M E
53
11.00 - 12.00
Room Havane
Minisymposium
Supported by Medtronic
ROLE OF RENAL DENERVATION IN A WORLD OF EVOLVING BLOOD
PRESSURE TARGETS
Chairperson:
C.Tsioufis(Athens,GREECE)
11.00
Opening Remarks
C.Tsioufis(Athens,GREECE)
11.05
Role of Renal Denervation for Hypertension with evolving Blood Pressure targets
G. Mancia (Milan, ITALY)
11.15
Safety and efficacy of latest generation renal denervation technology
J.E.Davies(London,UNITEDKINGDOM)
11.25
Implications of renal denervation study populations on cost effectiveness
R.E. Schmieder (Erlangen, GERMANY)
11.35
SPYRAL HTN design & latest information
J.E.Davies(London,UNITEDKINGDOM)
11.40
Closing Remarks and moderated Panel Discussion with audience interaction
11.00 - 12.00
Room Maillot
Minisymposium
Supported by The Menarini Group
HYPERURICAEMIA: A CONSEQUENCE OF HUMAN (D)EVOLUTION?
Chairpersons: E. Agabiti Rosei (Brescia, ITALY)
C. Borghi (Bologna, ITALY)
11.00
Introduction
C. Borghi (Bologna, ITALY)
11.05
Hyperuricaemia and CV Disease
A. Coca (Barcelona, SPAIN)
11.20
The painless threat of Uric Acid to the Kidney
J. Kielstein (Hannover, GERMANY)
11.35
The “3T” of Hyperuricaemia: Therapies, Target and Treatment duration
G. Mancia (Milan, ITALY)
11.50
Conclusions
E. Agabiti Rosei (Brescia, ITALY)
54
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
11.00 - 12.30
Room 342
Parallel Oral Session 2B
KIDNEY
Chairpersons: M. Miglinas (Vilnius, LITHUANIA)
A. Mitchell (Essen, GERMANY)
11.00 CIGARETTE USE ALTERS ASSESSMENT OF GLOMERULAR FILTRATION RATE
J. Tian, Y. Xie, K. Ren, T. Chen, P. Brewster, C. Drummond, W. He, D. Kennedy, S. Haller, C. Cooper
Toledo, OH, USA
11.10 COMPARATIVE MICRORNA PROFILING IN RELATION TO URINARY ALBUMIN EXCRETION IN
NEWLY DIAGNOSED HYPERTENSIVE PATIENTS
M. Marketou, F. Parthenakis, J. Kontaraki, F. Maragoudakis, S. Maragkoudakis, H. Nakou, K. Roufas,
A. Patrianakos, J. Logakis, D. Vougia, N. Malliaraki, P. Vardas
Heraklion, GREECE
11.20 GLOMERULAR HYPERFILTRATION AS A RISK FACTOR FOR RENAL IMPAIRMENT AND
HYPERTENSION IN APPARENTLY HEALTHY SUBJECTS
A. Vrdoljak 1, V. Ivkovic 1, S. Karanovic 1, Z. Dika 1, V. Domislovic 1, K. Dapic 1, L. Gallineo 1, E. Ivandic 1,
J. Josipovic 1, I. Vukovic 1, J. Kos 1, M. Laganovic 1, T. Zeljkovic Vrkic 1, M. Fistrek Prlic 1, I. Pecin 1, M. Fucek 1,
J. Sertic 1, N. Leko 2, B. Jelakovic 1
1
Zagreb, 2 Slavonski Brod, CROATIA
11.30 CHRONIC KIDNEY DISEASE EPIDEMIOLOGY COLLABORATION-DERIVED GLOMERULAR
FILTRATION RATE IS BETTER AT DETECTING PRE-CLINICAL END ORGAN CHANGES THAN OTHER
EQUATIONS IN BLACK AFRICANS
G. Norton, H.L. Booysen, A. Raymond, P. Sareli, H.-C. Hsu, P.H. Dessein, A.J. Woodiwiss
Johannesburg, SOUTH AFRICA
11.40 LONG TERM, BUT NOT SHORT TERM, BLOOD PRESSURE VARIABILITY PREDICTS
CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS
F. Mallamaci 1, R. Minutolo 2, G. Stanzione 2, G. D’Arrigo 1, D. Leonardis 1, G. Tripepi 1, T. Cicchetti 3, M. Postorino 1,
L. De Nicola 2, G. Conte 2, S. Borrelli 2, C. Zoccali 1
1
Reggio Calabria, 2 Naples, 3 Rossano, ITALY
11.50 RENAL RESISTIVE INDEX AND PULSE PRESSURE AT 3 MONTHS HAVE A DIFFERENT IMPACT ON
LONG-TERM RISK OF DEATH AND GRAFT LOSS IN RENAL TRANSPLANTATION
J.-M. Halimi, L. Vernier, P. Gatault, C. Barbet, J. Roumy, J. Marliere, H. Longuet, E. Merieau, B. Sautenet,
C. Baron, M. Buchler
Tours, FRANCE
12.00 HIGH PULSE PRESSURE AND OUTCOME IN KIDNEY TRANSPLANTATION: RESULTS FROM THE
COLLABORATIVE TRANSPLANT STUDY
B. Krüger 1, B. Döhler 2,G.Opelz2, H. Mundt 1, B.K. Krämer 1, C. Süsal 2
1
Mannheim, 2 Heidelberg, GERMANY
F I N A L P R OG R A M M E
55
12.10 ETIOLOGY OF RENAL INFARCTIONS: A RETROSPECTIVE ANALYSIS OF 229 CONSECUTIVE CASES
ADMITTED TO A SINGLE TERTIARY CENTER OVER 15 YEARS
A. Faucon, G. Bobrie, A.-S. Jannot, A. Azarine, L. Amar, P.-F. Plouin, M. Azizi
Paris, FRANCE
12.20 PATIENTS WITH ADVANCED KIDNEY DISEASE AND NEPHROANGIOSCLEROSIS MIGHT NOT
BENEFIT OF STRICT BLOOD PRESSURE CONTROL
S. Vettoretti,L.Caldiroli,V.Azzini,R.Meazza,A.Villarini,M.Marcucci,C.Alfieri,P.Messa
Milan, ITALY
11.00 - 12.30
Room 351
Topical Workshop
HOT ISSUES IN HYPERTENSION
Chairpersons: M. Burnier (Lausanne, SWITZERLAND)
S. Julius (Ann Arbor, MI, USA)
11.00
ESH Guidelines for children and adolescents
E. Lurbe (Valencia, SPAIN)
11.15
Discussion
11.17
ESC Guidelines for cardiovascular risk factors
J. Redon (Valencia, SPAIN)
11.32
Discussion
11.34
Significance of Heart Rate as a cardiovascular risk factor
P. Palatini (Padua, ITALY)
11.49
Discussion
11.51
Benefits/side effects ratio of the antihypertensive treatment
A. Zanchetti (Milan, ITALY)
12.06
Discussion
12.08
Persisting sympathetic overdrive during treatment and residual risk
G. Grassi (Milan, ITALY)
12.23
Discussion
12.25
General discussion
56
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
11.00 - 12.30
Room 352
Joint Session Franco Mexican
supported by Franco-Mexican Foundation for Medicine IAP/France Embassy
OBESITY AND HYPERTENSION: A PUBLIC HEALTH PROBLEM
Chairpersons: J. Blacher (Paris, FRANCE)
M. Lopez-Sublet (Bobigny, FRANCE)
11.00
Introduction
M. Lopez-Sublet (Bobigny, FRANCE)
11.05
General and epidemiology of obesity in Mexico
J.A.CordovaVillalobos(MexicoCity,MEXICO)
11.20
Management of hypertension in Mexico
M.MaderoRovalo(MexicoCity,MEXICO)
11.35
Benefits of bariatric surgery on blood pressure and other risk factors
J.-J. Mourad (Bobigny, FRANCE)
11.55
Franco Mexican scientific exchange - Nutrinet program
A.Barriguete(MexicoCity,MEXICO)
12.15
Conclusion
J. Blacher (Paris, FRANCE)
11.00 - 12.30
Room 251
Parallel Oral Session 2C
ATRIAL FIBRILLATION AND HEART FAILURE
Chairpersons: T. Kahan (Stockholm, SWEDEN)
K. Wachtell (Copenhagen, DENMARK)
11.00 TETRAHYDROBIOPTERIN REVERSE LEFT VENTRICULAR HYPERTROPHY AND DIASTOLIC
DYSFUNCTION THROUGH THE PI3K/P-AKT PATHWAY IN SPONTANEOUSLY HYPERTENSIVE RATS
Q. Wang, P. Chang, H. Xu, F. Bai, J. Yu
Lanzhou, CHINA
11.10 ENDOGENOUS OUABAIN AS A BIOMARKER OF HEART FAILURE AND A PREDICTOR OF
MORTALITY AFTER CARDIAC SURGERY
S. Pozzoli, M. Simonini, E. Messaggio, N. Casamassima, E. Bignami, L. Zagato, C. Lanzani, P. Manunta
Milan, ITALY
11.20 ASYMPTOMATIC ATRIAL FIBRILLATION: THE CASE FOR OPPORTUNISTIC SCREENING
BY AUTOMATIC BLOOD PRESSURE MEASUREMENT IN THE COMMUNITY
S.Omboni 1, W.J. Verberk 2,3
1
Solbiate Arno, ITALY, 2 Maastricht, NETHERLANDS, 3 Widnau SWITZERLAND
F I N A L P R OG R A M M E
57
11.30 THE BLOOD PRESSURE LOWERING EFFECT ON NEW-ONSET ATRIAL FIBRILLATION
G. Mourtzinis 1, L. Schiöler 1, K. Bengtsson Boström 2, T. Kahan 3, P. Hjerpe 2, J. Hasselström 3, B. Wettermark 3,
K. Manhem 1
1
Gothenburg, 2 Skövde, 3 Stockholm, SWEDEN
11.40 ATRIAL FIBRILLATION IN HYPERTENSIVE PATIENTS. A SINGLE PILOT ANTICOAGULATION RISK
MANAGEMENT CENTER
A. Varga, C.M. Tatar, A. Mitre, C. Podoleanu, I. Tilea
Tirgu Mures, ROMANIA
11.50 LECTURE
TREATMENT OF HYPERTENSION AS PRIMARY PREVENTION OF ATRIAL FIBRILLATION
E. Marijon
Paris, FRANCE
12.10 NEW RISK FACTORS FOR ATRIAL FIBRILLATION IN PATIENTS WITH HYPERTENSION AND
OBESITY
V. Ionin, E.L.Zaslavskaya,O.D.Belyaeva,A.V.Soboleva,E.A.Bazhenova,D.I.Jatzuk,S.E.Nifontov,
E.A. Polyakova, E.I. Baranova, E.V. Shlyachto
Saint-Petersburg, RUSSIA
12.20 THE GROWING RATE OF ATRIAL FIBRILLATION AMONG HEART FAILURE PATIENTS IN POLISH
PRIMARY HEALTH CARE. DATA FROM 2005 AND 2013
K. Rewiuk 1, B. Wizner 1, M. Fedyk-Lukasik 1, T. Zdrojewski 2,G.Opolski3, J.S. Dubiel 1, T. Grodzicki 1
1
Kraków, 2 Gdansk, 3 Warsaw, POLAND
11.00 - 12.30
Room 252
Parallel Oral Session 2D
ENDOTHELIUM AND ATHEROSCLEROSIS
Chairpersons: M.Dorobantu(Bucharest,ROMANIA)
L. Ghiadoni (Pisa, ITALY)
11.00 LECTURE
AN UPDATE ON ENDOTHELIAL DYSFUNCTION
N. Dhaun
Edinburgh, UNITED KINGDOM
11.20 ANGIOTENSIN-(1-7) IMPROVES ENDOTHELIAL FUNCTION AND THE DEVELOPMENT OF
ATHEROSCLEROSIS THROUGH THE MAS RECEPTOR
K. Grave, G. Yang, L. Hering, S.A. Potthoff, C. Schwandt, G. Iktas, L.C. Rump, J. Stegbauer
Düsseldorf, GERMANY
11.30 LYCOPENE INCREASES NITRIC OXIDE BIOAVAILABILITY AND INHIBITS ENDOTHELIAL CELLS
MIGRATION
A. Dalbeni,D.Treggiari,B.Molesini,C.Fava,T.Pandolfini,P.Minuz
Verona, ITALY
11.40 PULSATILE STRETCH ALTERS EXPRESSION AND PROCESSING OF AMYLOID PRECURSOR
PROTEIN IN HUMAN CEREBRAL ENDOTHELIAL CELLS
S.V.S. Gangoda, M. Butlin, V. Gupta, R. Chung, A. Avolio
Sydney, AUSTRALIA
58
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
11.50 PERIVASCULAR T REGULATORY CELLS AND ENDOTHELIAL DYSFUNCTION IN HUMAN
ATHEROSCLEROSIS
K. Urbanski 1, G. Filip 1, M. Filip 1, D. Ludew 1, P. Szczepaniak 1, R. Nosalski 1, A. Sagan 1, T. Mikolajczyk 1,
B. Kapelak 1, T.J. Guzik 1,2
1
Kraków, POLAND, 2 Glasgow, UNITED KINGDOM
12.00 RELATIONSHIP OF OXIDATIVE STRESS WITH CARDIAC HYPERTROPHY IN HYPERTENSIVE
PATIENTS
S. Cottone, E. Nardi, M. Guarneri, L. Guarino, D. Altieri, G. Cerasola, G. Mulè
Palermo, ITALY
12.10 DIFFERENCES IN ENDOTHELIAL GLYCOCALYX IN RECENTLY DIAGNOSED AND UNTREATED
MIDDLE-AGED HYPERTENSIVE PATIENTS REGARDING INCREASED CARDIOVASCULAR RISK
H. Triantafyllidi, D. Benas, S. Vlachos, A. Schoinas, I. Ikonomidis, G. Pavlidis, L. Palaiodimos, J. Lekakis
Athens, GREECE
12.20 THE EFFECTS OF ALPHA 1-ADRENOCEPTOR-BLOCKADE BY DOXAZOSIN OR ACE-INHIBITION BY
RAMIPRIL ON ENDOTHELIAL FUNCTION IN PRIMARY HYPERTENSION: THE DORA STUDY
A. Jekell, M. Kalani, T. Kahan
Stockholm, SWEDEN
13.00 - 14.30
Grand Amphitheatre
Teaching Seminar
MANAGEMENT OF HYPERTENSION 1
Chairpersons: D.L. Clement (Ghent, BELGIUM)
A.M.Heagerty(Manchester,UNITEDKINGDOM)
13.00
Should we give statins to all hypertensive patients?
H.A.J. Struijker-Boudier (Maastricht, NETHERLANDS)
13.15
Discussion
13.20
How far to lower BP? Revisiting the ESH-ESC Guidelines after SPRINT
R.H. Fagard (Leuven, BELGIUM)
13.35
Discussion
13.40
Is BP control different in women compared to men?
A.O.Konradi(Saint-Petersburg,RUSSIA)
13.55
Discussion
14.00
Central BP: a better means to obtain goal blood pressure?
J.K.Cruickshank(London,UNITEDKINGDOM)
14.15
Discussion
14.20
General Discussion
F I N A L P R OG R A M M E
59
13.00 - 14.30
Room Bordeaux
Satellite Symposium
Supported by Servier
TAILORING HYPERTENSION TREATMENT TO THE PATIENT
Chairpersons: G. Mancia (Milan, ITALY)
A.J. Manolis (Athens, GREECE)
13.00
Introduction
G. Mancia (Milan, ITALY)
13.05
The latest in hypertension: are medical needs covered?
G. Mancia (Milan, ITALY)
13.25
From monotherapy to fixed-dose combination: ACE inhibition is the mainstay
A.Hall(Leeds,UNITEDKINGDOM)
13.45
Responding appropriately to individual treatment needs
J.-J. Mourad (Bobigny, FRANCE)
14.05
Discussion
14.25
Conclusion
A.J. Manolis (Athens, GREECE)
14.30 - 15.30
Room Bordeaux
Minisymposium
Supported by Daiichi Sankyo / The Menarini Group
UNMET NEEDS IN HYPERTENSION: SHIFTING THE GOAL?
Chairperson:
R.E. Schmieder (Erlangen, GERMANY)
14.30
Welcome and introduction
R.E. Schmieder (Erlangen, GERMANY)
14.35
Hypertension and metabolic syndrome: a real life patient case
R.E. Schmieder (Erlangen, GERMANY)
A. de la Sierra (Barcelona, SPAIN)
K.Narkiewicz(Gdansk,POLAND)
15.25
60
Summary and meeting close
A. de la Sierra (Barcelona, SPAIN)
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
14.30 - 15.30
Room Havane
Minisymposium
Supported by Fukuda Denshi
ESTABLISHING “CAVI” CARDIO-ANKLE VASCULAR INDEX IN CLINICAL
PRACTICE
Chairpersons: R. Asmar (Paris, FRANCE)
G. Parati (Milan, ITALY)
14.30
Effects of metabolic syndrome on arterial stiffness in different age groups:
“The Triple A multicenter study”
A. Benetos (Nancy, FRANCE)
14.50
CAVI as a tool for cardiovascular risk stratification at different ages
G. Schillaci (Perugia, ITALY)
15.10
Reference values of CAVI in a Mediterranean population
R. Ramos (Girona, SPAIN)
14.30 - 15.30
Room 351
How-to Session
Supported by SMT Medical Technology
UPDATE IN ENDOTHELIAL FUNCTION AND ARTERIAL STIFFNESS TESTING
Chairpersons: N. Cauwenberghs (Leuven, BELGIUM)
T. Kuznetsova (Leuven, BELGIUM)
14.30
An insight into essential diagnostic parameters and risk factors
N. Cauwenberghs (Leuven, BELGIUM)
15.00
Hands-on in endothelial function and arterial stiffness testing
N. Cauwenberghs (Leuven, BELGIUM)
F I N A L P R OG R A M M E
61
14.30 - 15.30
Room 352
Meet-the-Expert
HOW TO MANAGE A HYPERTENSIVE PATIENT WITH HYPERURICEMIA
Chairperson:
B.Jelakovic(Zagreb,CROATIA)
Expert: C. Borghi (Bologna, ITALY)
14.30 - 15.30
Room 251
How-to Session
HOW TO EVALUATE AND MANAGE HYPERTENSION IN ATHLETES?
Chairpersons: H.M.Berge(Oslo,NORWAY)
A. Schmidt-Truksaas (Basel, SWITZERLAND)
14.30
How to evaluate?
J.-F. Toussaint (Paris, FRANCE)
15.00
How to manage?
R. Leischik (Hagen, GERMANY)
62
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
14.30 - 16.30
Room 252
Clinical Cases
SESSION 1: CLINICAL-PATHOLOGICAL CONFERENCE
Chairpersons: A.F.Dominiczak(Glasgow,UNITEDKINGDOM)
R.M.Touyz(Glasgow,UNITEDKINGDOM)
14.30
A case of asymptomatic carotid artery stenosis in a hypertensive patient
D. Calvet (Paris, FRANCE)
15.30
A case of primary aldosteronism with discordant hormonal and CT findings
L. Amar (Paris, FRANCE)
14.30 - 15.30
Room 253
How-to Session
Supported by BPLab
HOW TO ASSESS CENTRAL HEMODYNAMICS AND STIFFNESS IN
AMBULATORY CONDITIONS OVER THE 24-HOURS: A NEW TECHNOLOGY,
ITS CLINICAL EVIDENCE AND APPLICATIONS
Chairperson:
S.Omboni(Varese,ITALY)
14.30
Central BP and arterial stiffness: available technologies and current evidence
J. Blacher (Paris, FRANCE)
14.45
24-hour pulse wave analysis through oscillometric blood pressure measurement:
a new validated technology
Y. Kotovskaya (Moscow, RUSSIA)
15.00
Clinical application of 24-hour pulse wave analysis: available evidence and ongoing
studies
S.Omboni(Varese,ITALY)
15.15
Discussion
F I N A L P R OG R A M M E
63
15.00 - 17.00
Room 342
Joint Session
ESH (European Society of Hypertension)
PSH (Portuguese Society of Hypertension)
HTN IN PORTUGUESE SPEAKING COUNTRIES
Chairpersons: F.Pinto(SantaMariaFeira,PORTUGAL)
E.C.D. Barbosa (Porto Alegre, BRAZIL)
J.MesquitaBastos(Aveiro,PORTUGAL)
15.00
Introduction
F.Pinto(SantaMariaFeira,PORTUGAL)
15.05
HTN in Portugal
J.Polonia(Porto,PORTUGAL)
15.19
HTN in Brazil
R. Póvoa (São Paulo, BRAZIL)
15.33
HTA in Mozambique
A.Damasceno(Maputo,MOZAMBIQUE)
15.47
HTA in Angola
J.R.Santos(Luanda,ANGOLA)
16.01
Economy and treatment of HTN
L.Martins(Porto,PORTUGAL)
16.15
Nonpharmacological therapy
M. Malachias (Belo Horizonte, BRAZIL)
16.29
Treatment options: which drug(s) and to whom?
W. Sebba Barroso (São Paulo, BRAZIL)
16.45
Discussion, questions and answers
16.55
Conclusions
M.F.T. Neves (Rio de Janeiro, BRAZIL)
64
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
15.30 - 17.00
Grand Amphitheatre
Topical Workshop
on behalf of the ESH Working Group on Hypertension and the Kidney
FIBROMUSCULAR DYSPLASIA: A MULTIFACETED DISEASE
Chairpersons: A. Persu (Brussels, BELGIUM)
P.-F. Plouin (Paris, FRANCE)
15.30
The nephrologist’s perspective
A. Morganti (Milan, ITALY)
15.50
The neurologist’s perspective
E. Touzé (Caen, FRANCE)
16.10
The cardiologist’s perspective
P. Motreff (Clermont-Ferrand, FRANCE)
16.30
The geneticist’s perspective
N. Bouatia-Naji (Paris, FRANCE)
16.50
Discussion
15.30 - 17.00
Room Havane
Educational Session
Supported by Ferrer
CHALLENGES IN THE MANAGEMENT OF HYPERTENSIVE PATIENTS WITH
MULTIPLE COMORBIDITIES
Chairpersons: A. Coca (Barcelona, SPAIN)
A.J. Manolis (Athens, GREECE)
15.30
How do patients stick to polypharmacy for comorbidities
J. Redon (Valencia, SPAIN)
15.50
The gap between efficacy and effectiveness of therapies in CV high risk patients
G. Mancia (Milan, ITALY)
16.10
Is the CV polypill a solution to reduce the gap?
J.M. Castellano Vázquez (Madrid, SPAIN)
16.30
ESH point of view on the CV polypill use
E. Agabiti Rosei (Brescia, ITALY)
16.50
Discussion
F I N A L P R OG R A M M E
65
15.30 - 16.30
Room Maillot
Minisymposium
Supported by Omron Healthcare Europe
GOING TOWARDS ZERO CARDIOVASCULAR EVENTS.
INNOVATIONS IN HOME BLOOD PRESSURE MONITORING TO IMPROVE
HYPERTENSION MANAGEMENT
Chairperson:
G. Parati (Milan, ITALY)
15.30
Can novel cuff technology Improve the accuracy of Blood Pressure Measurement?
Clinical results of the Intelli-Wrap-Wrap Cuff Study
G. Bilo (Milan, ITALY)
15.50
New IT solutions for Home BP Telemonitoring and patient management: role of
ESH smartphones app and “Misuriamo” software
F.L. Albini (Milan, ITALY)
16.10
Health Economic Impacts of Improved Home Blood Pressure Measurements
W.K. Redekop (Rotterdam, NETHERLANDS)
15.30 - 17.00
Room 351
Parallel Oral Session 3A
ENDOCRINE HYPERTENSION
Chairpersons: J. Deinum (Nijmegen, NETHERLANDS)
A.-P. Gimenez-Roqueplo (Paris, FRANCE)
15.30 THE COMPARISON OF THE TRANSCRIPTOME PROFILE OF THE AUTONOMOUS AND THE
PHYSIOLOGICAL ALDOSTERONE-PRODUCING TISSUE, THE ALDOSTERONE-PRODUCING ADENOMA AND
THE ZONA GLOMERULOSA
J. Zhou 1, B.Y.H. Lam 1, S.G. Neogi 1, G.S.H. Yeo 1, A.E.D. Teo 1, C. Maniero 1, E.A.B. Azizan 2, M.J. Brown 1
1
Cambridge, UNITED KINGDOM, 2 Kuala Lumpur, MALAYSIA
15.40 RETINOIC ACID RECEPTOR SIGNALING CONTRIBUTES TO ADRENAL CORTEX MORPHOLOGY
AND FUNCTIONAL ZONATION
S. Boulkroun 1, A.J. Rickard 1, J.F. Golib Dzib 2, B. Samson-Couterie 1, A. Rocha 1, C.E. Gomez-Sanchez 3,
L. Amar 1, F.L. Fernandes-Rosa 1, N.B. Ghyselinck 4, A. Benecke 2, E. Lalli 5, M.-C. Zennaro 1
1
Paris, 2 Bures sur Yvette, FRANCE, 3 Jackson, MS, USA, 4 Illkirch, 5 Valbonne, FRANCE
66
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
15.50 IMPACT OF STRESS REACTION ON THE ASSESSMENT OF LATERALIZATION DURING SEQUENTIAL
ADRENAL VEIN SAMPLING FOR PRIMARY ALDOSTERONISM
G. Rossitto, T.M. Seccia, M. Battistel, G. Barbiero, G. Maiolino, V. Bisogni, M. Plebani, D. Miotto, G.P. Rossi
Padua, ITALY
16.00 LECTURE
PRIMARY ALDOSTERONISM: UPDATE ON EPIDEMIOLOGY AND MANAGEMENT
G.P. Rossi
Padua, ITALY
16.20 ADRENAL HEMORRHAGE FOLLOWING ADRENAL VEIN SAMPLING IN PRIMARY
ALDOSTERONISM: A SIX-CENTER EXPERIENCE
S. Monticone 1, F. Satoh 2, A.S. Dietz 3, R. Goupil 4, K. Lang 5, F. Pizzolo 6, R.D. Gordon 4, R. Morimoto 2,
M. Reincke 3, M. Stowasser 4, P. Mulatero 1
1
Turin, ITALY, 2 Sendai, JAPAN, 3 Munich, GERMANY, 4 Brisbane, AUSTRALIA, 5 Wuerzburg, GERMANY,
6
Verona, ITALY
16.30 THE USE OF PREDICTION SCORE TO DIAGNOSE UNILATERAL DISEASE IN CHINESE PATIENTS
WITH PRIMARY ALDOSTERONISM
Y. Zhang, H. Zhang, W.L. Zhou, Z.J. Shen, J.Z. Xu, X.F. Tang, F.F. Zheng, B. Tao, J. Zhang, X.H. Lu, S.L. Chu,
L. Gao, J.G. Wang, L.M. Zhu
Shanghai, CHINA
16.40 LONG TERM FOLLOW-UP IN PATIENTS OPERATED ON A PHEOCHROMOCYTOMA OR A
PARAGANGLIOMA: COMPILATION OF THE ENS@T DATABASE
L. Amar 1, T. Deutschbein 2, I. Piscaer 3, C. Brugger 4, L. Canu 5, J. Bertherat 1, C. Lepoutre 1,O.Dekkers6,
A. Stell 7, A.-P. Gimenez-Roqueplo 1, M. Fassnacht 2, M. Robledo 8, M. Mannelli 5, J. Lenders 3, H. Timmers 3,
F. Beuschlein 4, M. Curras-Freixes 8, P.-F. Plouin 1,O.Steichen1
1
Paris, FRANCE, 2 Wurzburg, GERMANY, 3 Nijmegen, NETHERLANDS, 4 Munich, GERMANY, 5 Florence, ITALY,
6
Aarhus, DENMARK, 7 Melbourne AUSTRALIA, 8 Madrid, SPAIN
16.50 DROSPIRENONE WITH ESTRADIOL FOR POSTMENOPAUSAL WOMEN WITH HYPERTENSION:
A SYSTEMIC REVIEW AND META-ANALYSIS
X. Zhao, J. Yu
Lanzhou, CHINA
F I N A L P R OG R A M M E
67
15.30 - 17.00
Room 352
Parallel Oral Session 3B
AGEING
Chairpersons: P. Boutouyrie (Paris, FRANCE)
O.Hanon(Paris,FRANCE)
15.30 THE ROLE OF INFLAMMATION IN THE ARTERIAL AGEING AND ITS EFFECTS ON THE STRUCTURE
OF THE AORTIC WALL, HEART FUNCTION AND METABOLISM
D. Lambert, P.-Y. Marie, P. Lacolley, A. Benetos, L. Joly
Vandoeuvre-les-Nancy, FRANCE
15.40 AGEING AND LACK OF ESTROGENS ACTIVATES CYCLOOXYGENASES PATHWAY INCREASING
SUPEROXIDE ANION PRODUCTION IN RESPONSE TO THROMBOXANE A2
S. Novella, X. Vidal-Gómez, A. Mompeón, D. Pérez-Cremades, G. Segarra, P. Medina, C. Hermenegildo
Valencia, SPAIN
15.50 INFLUENCE OF SUBCLINICAL RENAL DAMAGE ON EARLY VASCULAR AGEING IN PATIENT WITH
SYSTEMIC LUPUS ERYTHEMATOSUS
M. Morreale, G. Mulè, C. Cusumano, F. D’Ignoto, V. Cacciatore, G. Geraci, S. Cottone
Palermo, ITALY
16.00 LONG TERM FOLLOW-UP OF PULSE WAVE VELOCITY IN TREATED PATIENTS
A. Kourilsky, P. Blanc Durand, H. Khettab, P. Boutouyrie, S. Laurent
Paris, FRANCE
16.10 MORNING CENTRAL BLOOD PRESSURE SURGE IS RELATED TO AGE
A. Bednarek,P.Jankowski,A.Olszanecka,M.Kloch-Badelek,A.Windak,K.Kawecka-Jaszcz,D.Czarnecka
Kraków, POLAND
16.20 LECTURE
HEALTHY AGEING: EXPERIENCE OF THE AGEING COHORT
P. Cunha
Guimarães, PORTUGAL
16.40 WILL BE CENTENARIANS, HYPERTENSIVE INDIVIDUALS? HOW IS THE BLOOD PRESSURE
CONTROL OF CENTENARIANS IN PORTUGAL?
A. Pereira Da Silva, A. Matos, R. Ribeiro, A. Gil, J. Gorjão Clara, M. Pires Bicho
Lisbon, PORTUGAL
16.50 MULTIDISCIPLINARY TREATMENT FOR THE VERY ELDERLY HYPERTENSIVE PATIENT
T. Jardim, L. Jardim, A. Sousa, W. Barroso, C. Pimenta, P. Jardim
Goiania, BRAZIL
68
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
15.30 - 17.00
Room 251
Parallel Oral Session 3C
CEREBROVASCULAR DISEASES, STROKE AND COGNITIVE DYSFUNCTION
Chairpersons: D.Gasecki(Gdansk,POLAND)
C. Sierra (Barcelona, SPAIN)
15.30 MICROGLIAL ACTIVATION IN HYPERTENSION-MEDIATED COGNITIVE IMPAIRMENT
S. Foulquier, P. Namsolleck, C. Recarti, B.T. Van Hagen, W.M. Honig, H.P. Steinbusch, G.N.M. Swennen,
W.M.Blankestijn,M.J.Post,B.P.Rutten,J.Prickaerts,H.W.M.Steinbusch,R.J.VanOostenbrugge,T.Unger
Maastricht, NETHERLANDS
15.40 LECTURE
GENETIC STUDIES IN COGNITIVE DECLINE AND HYPERTENSION
S. Debette
Bordeaux, FRANCE
16.00 LOOKING FOR THE OPTIMAL BLOOD PRESSURE VALUES IN OLD PEOPLE WITH COGNITIVE
DECLINE: A LONGITUDINAL STUDY BASED ON 24-HOUR AMBULATORY BLOOD PRESSURE MONITORING
C. Lorenzi 1, E. Mossello 1, E. Giuliani 1, N. Nesti 1, M. Bulgaresi 1, V. Caleri 2, M. Pieraccioli 1, E. Tonon 2,
M.C. Cavallini 1, C. Baroncini 1, M. Di Bari 1, C.A. Biagini 2, N. Marchionni 1, A. Ungar 1
1
Florence, 2 Pistoia, ITALY
16.10 ARTERIAL STIFFNESS IS ASSOCIATED WITH LOWER PERFORMANCE ON THE COGNITIVE TESTS
AT DIFFERENT DOMAINS IN HYPERTENSIVE PATIENTS
H.C.S. Muela, V. Costa-Hong, M.F. Machado, M.S. Yassuda, E.B.S. Shu, A.R. Massaro, R. Nitrini, L. Bortolotto
São Paulo, BRAZIL
16.20 PREDICTING POSTURAL HYPOTENSION, FALLS, AND COGNITIVE IMPAIRMENT:
THE INCHIANTI STUDY
C. Clark 1, D. Thomas 1, F. Warren 1, D. Llewellyn 1, L. Ferrucci 2, J. Campbell 1
1
Exeter, UNITED KINGDOM, 2 Baltimore, MD, USA
16.30 CHARACTERISTICS OF CEREBRAL HEMODYNAMICS AND CAROTID STIFFNESS IN PATIENTS
WITH ISCHEMIC LEUKOARAIOSIS AND NEW ULTRASOUND INDICES OF ISCHEMIC LEUKOARAIOSIS
M. Turk,M.Zaletel,J.PretnarOblak
Ljubljana, SLOVENIA
16.40 DIFFERENCE IN SUBACUTE BLOOD PRESSURE BETWEEN OFFICE AND AMBULATORY
VALUES PREDICTS FUNCTIONAL OUTCOME AFTER ISCHEMIC STROKE
D. Gasecki 1, M. Kwarciany 1, K. Kowalczyk 1, A. Rojek 1, M. Skrzypek-Czerko 1, P. Boutouyrie 2, S. Laurent 2,
B. Karaszewski 1, K. Narkiewicz 1
1
Gdansk, POLAND, 2 Paris, FRANCE
16.50 ASSOCIATION BETWEEN WAIST CIRCUMFERENCE AND RISK OF STROKE: A SYSTEMATIC
REVIEW AND A META-ANALYSIS OF PROSPECTIVE STUDIES
L. D’Elia,F.deBlasio,M.LaGreca,P.Strazzullo,L.Scalfi
Naples, ITALY
F I N A L P R OG R A M M E
69
15.30 - 17.00
Room 253
Parallel Oral Session 3D
INFLAMMATION AND IMMUNITY
Chairpersons: D. Mueller (Berlin, GERMANY)
A. Tedgui (Paris, FRANCE)
15.30 EFFECT OF SODIUM CHLORIDE ON HUMAN DENDRITIC CELL FUNCTIONS
S. Al-Hajj, A. Heraud, C. Lefort, L. Lamendour, I. Kazma, P. Gatault, M. Buchler, C. Baron, J.-M. Halimi
Tours, FRANCE
15.40 MICRORNA-214 IS INVOLVED IN THE REGULATION OF PERIVASCULAR FIBROSIS IN
HYPERTENSION
R. Nosalski 1,2, M. Siedlinski 1, A. Nguyen Dinh Cat 2, D. Skiba 1,2, L. Denby 3, E. McGinnigle 2, A. Baker 3, T.J. Guzik 1,2
1
Kraków, POLAND, 2 Glasgow, 3 Edinburgh, UNITED KINGDOM
15.50 ASSOCIATION BETWEEN NEUTROPHIL TO LYMPHOCYTE RATIO AND ARTERIAL STIFFNESS IN A
POPULATION SAMPLE
E. Huguet 1, G. Maccallini 1, P. Pardini 1,S.Obregon1, M. Hidalgo 1, M. Haehnel 1, P. Carrizo 1, M. Koretzky 1,
A. Di Leva 1, F. Inserra 1, F. Botto 1, A. Scuteri 2, P.M. Nilsson 3, C. Kotliar 1
1
San Isidro, ARGENTINA, 2 Rome, ITALY, 3 Malmö, SWEDEN
16.00 ACTIVATED CD4+ AND CD8+ T-CELL SUBPOPULATIONS IN PATIENTS WITH PRIMARY
HYPERALDOSTERONISM AND TRUE RESISTANT HYPERTENSION
A. Kaszuba 1, A. Konior 2, T. Mikolajczyk 2, A. Prejbisz 1, M. Kabat 1, I. Cendrowska-Demkow 1, P. Dobrowolski 1,
B. Pregowska-Chwala 1, K. Michel-Rowicka 1, A. Klisiewicz 1, P. Michalek 1, S. Toutounchi 1, Z. Galazka 1,
M. Reincke 3, A. Januszewicz 1, T.J. Guzik 2
1
Warsaw, 2 Kraków, POLAND, 3 Munich, GERMANY
16.10 HYPERTENSION AND VASCULAR INJURY: CHRONIC TREATMENT WITH C-TYPE NATRIURETIC
PEPTIDE SHOWS BENEFICIAL EFFECTS ON THE LEVEL OF OXIDATIVE STRESS AND PRO-INFLAMMATORY
CYTOKINES
C.Caniffi, M. Gómez, L. Alcober, E. Prentky, F. Ripari, D. González Maglio, J. Toblli, C. Arranz
Buenos Aires, ARGENTINA
16.20 RELATIONSHIP BETWEEN DIFFERENT POPULATIONS OF CIRCULATING T LYMPHOCYTES AND
MICROVASCULAR OXIDATIVE STRESS
C. De Ciuceis, C. Rossini, P. Airò, M. Scarsi, S. Piantoni, A. Gavazzi, L. Solaini, E. Porteri, B. Petroboni,
C. Agabiti Rosei, A. Tincani, E. Agabiti Rosei, D. Rizzoni, F. Bertacchini
Brescia, ITALY
16.30 CORRELATION OF CERULOPLASMIN WITH BIOMARKERS OF CARDIAC REMODELLING
AND MYOFIBROSIS: NT-PROBNP, SST2, GALECTIN-3 IN PATIENTS WITH CHRONIC HEART FAILURE AND
ARTERIAL HYPERTENSION
F. Malek, D. Vondrakova, J. Dvorak, L. Sedlackova, T. Andreasova, L. Taborsky, P. Neuzil
Prague, CZECH REPUBLIC
16.40 LECTURE
OXIDATIVE STRESS AND INFLAMMATION IN HYPERTENSION
R.M. Touyz
Glasgow, UNITED KINGDOM
70
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
17.00 - 18.30
Grand Amphitheatre
Plenary Session
Chairpersons: A.F.Dominiczak(Glasgow,UNITEDKINGDOM)
S. Laurent (Paris, FRANCE)
Keynote Lectures
17.00
Genetics of Coronary Artery Disease: progress and translation
N.Samani(Leicester,UNITEDKINGDOM)
17.30
Hypertension, a disease of dysfunctional mechanosensing in the arterial wall
J. Humphrey (New Haven, CT, USA)
18.00
Systems medicine for understanding disease trajectories and aiding diagnosis
S. Brunak (Copenhagen, DENMARK)
18.30 - 19.30
Room Havane
ESH Working Group on
Hypertension, Arrhythmias and Thrombosis
Chairpersons: E. Agabiti Rosei (Brescia, ITALY)
A.J. Manolis (Athens, GREECE)
Discussion of Clinical Cases
18.30
Case 1. Hypertension, atrial fibrillation and PTCA for acute coronary event
A. Pittaras (Athens, GREECE)
18.45
Case 2. Hypertension, atrial fibrillation and chronic kidney disease
B.Jelakovic(Zagreb,CROATIA)
19.00
Management of atrial fibrillation in Excellence Centres
M. Salvetti (Brescia, ITALY)
19.15
General Discussion
F I N A L P R OG R A M M E
71
18.30 - 20.30
Room 342
ESH Working Group on
Blood Pressure Monitoring and
Cardiovascular Variability
SESSION 1
Chairpersons: G. Parati (Milan, ITALY)
G.S. Stergiou (Athens, GREECE)
18.30
Redefining office BP measurement in the post-SPRINT era
M.G. Myers (Toronto, CANADA)
18.40
Discussion
18.45
Should ambulatory and home BP thresholds be reappraised following SPRINT?
A. Mihailidou (Sydney, AUSTRALIA)
18.55
Discussion
19.00
Standard of medical reporting of ambulatory BP monitoring: current status and
recommendations
S.Omboni(Varese,ITALY)
19.10
Discussion
SESSION 2
Chairpersons: M.Malik(London,UNITEDKINGDOM)
E.O’Brien(Dublin,IRELAND)
19.15
A universal standard for the validation of BP monitors at last. The AAMI-ISO-ESH collaboration
G.S. Stergiou (Athens, GREECE)
19.25
Discussion
19.30
Can autonomic dysfunction be reliably detected by ambulatory BP monitoring?
F. Saladini (Padua, ITALY)
19.40
Discussion
19.45
Post-extrasystolic potentiation of BP in post-infarction patients
G. Schmidt (Munich, GERMANY)
19.55
Discussion
20.00
Take home messages
G. Parati (Milan, ITALY)
G.S. Stergiou (Athens, GREECE)
20.00
Business Meeting
72
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
18.30 - 20.00
Room 351
ESH Working Group on
Obesity, Diabetes and the High Risk Patient
OBESITY AND THE HEART: FRIEND OR FOE?
Chairpersons: G. Mancia (Milan, ITALY)
J. Redon (Valencia, SPAIN)
18.30
Mechanisms how obesity affects the heart
V. Kotsis (Thessaloniki, GREECE)
18.45
Obesity and LVH, heart failure risk. The role of SNS
G. Grassi (Milan, ITALY)
19.00
Influences of weight loss on the heart
J. Jordan (Hannover, GERMANY)
19.15
Metabolically Healthy Obesity (MHO), what it is and what it means in research
P.M. Nilsson (Malmö, SWEDEN)
19.30
The obesity paradox in heart failure
C.Tsioufis(Athens,GREECE)
19.45
Business Meeting
F I N A L P R OG R A M M E
73
18.30 - 20.00
Room 352
ESH Working Group on
Interventional Treatment of Hypertension
INTERVENTIONAL THERAPY OF HYPERTENSION: UPDATE IN HOT ISSUES
Chairpersons: R.E. Schmieder (Erlangen, GERMANY)
C.Tsioufis(Athens,GREECE)
Treatment of difficult to control hypertension.
Can targeting the pathophysiology lead the way?
18.30
Just focus on arterial stiffening
G. Schillaci (Perugia, ITALY)
18.40
Sodium imbalance is the key
M. Burnier (Lausanne, SWITZERLAND)
18.50
Aldosterone excess is the secret
M. Doumas (Thessaloniki, GREECE)
19.00
Reduction of sympathetic overactivity is crucial
G. Grassi (Milan, Italy)
Interventions for essential hypertension
19.10
Efficacy of renal denervation: a multiple faced Janus?
A. Pathak (Toulouse, FRANCE)
19.20
RDN: future directions addressing past misconceptions
F. Mahfoud (Homburg, GERMANY)
19.30
Interventional therapy beyond renal denervation: too much ado about nothing or not?
M.Lobo(London,UNITEDKINGDOM)
Interventions for secondary hypertension
19.40
Bariatric surgery. Has it any role?
V. Kotsis (Thessaloniki, GREECE)
19.50
Renal artery stenting. Has it any place?
K. Dimitriadis (Athens, GREECE)
74
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
18.30 - 20.15
Room 253
ESH Working Group on
Hypertension and Sexual Dysfunction
NOVELTIES IN HYPERTENSION AND SEXUAL DYSFUNCTION
Chairperson:
M.Viigimaa(Tallinn,ESTONIA)
18.30
Sexual dysfunction and low sex desire: a common problem in men and women with
hypertension
A. Pittaras (Athens, GREECE)
18.40
Erectile dysfunction, hypertension, and target organ damage: the last five years
P. Pietri (Athens, GREECE)
18.50
Cardiovascular work-up of a hypertensive patient with ED: practical solutions in common
problems
C. Vlachopoulos (Athens, GREECE)
Debate
19.00
ARBs are beneficial and beta-blockers are detrimental for sexual life
- Pro
D. Lovic (Niš, SERBIA)
- Against
J.Wolf(Gdansk,POLAND)
Debate
19.30
Testosterone replacement therapy is effective and safe
- Pro
M. Doumas (Thessaloniki, GREECE)
- Against
C. Boutari (Thessaloniki, GREECE)
20.00
Concluding remarks
M.Viigimaa(Tallinn,ESTONIA)
F I N A L P R OG R A M M E
75
07.45 - 08.45
Room Havane
Breakfast Workshop
GOALS AND MANAGEMENT OF HYPERTENSION IN RENAL
TRANSPLANTATION
Chairpersons: J.-P. Fauvel (Lyon, FRANCE)
J. Redon (Valencia, SPAIN)
07.45
Management of hypertension in renal transplant patients
J.-M. Krzesinski (Liège, BELGIUM)
08.05
Epidemiology and consequences of hypertension in renal transplant patients
J.-M. Halimi (Tours, FRANCE)
08.25
Discussion
07.45 - 08.45
Room 342
Breakfast Workshop
ALDOSTERONE ANTAGONISM FOR CARDIOVASCULAR AND RENAL
PROTECTION IN HYPERTENSION
Chairpersons: P.J. Blankestijn (Utrecht, NETHERLANDS)
G.P. Rossi (Padua, ITALY)
07.45
Cardiovascular protection
M. Volpe (Rome, ITALY)
08.05
Renal protection
P. Rossignol (Nancy, FRANCE)
08.25
Discussion
76
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
07.45 - 08.45
Room 351
Breakfast Workshop
NEW RADIOLOGICAL INVESTIGATIONS IN HYPERTENSION
Chairpersons: M. Hausberg (Karlsruhe, GERMANY)
P.A. Modesti (Florence, ITALY)
07.45
Renal oxygenation using Bold MRI
M. Pruijm (Lausanne, SWITZERLAND)
08.05
Heart-Vessel coupling using MRI
A. Redheuil (Paris, FRANCE)
08.25
Discussion
07.45 - 08.45
Room 352
Breakfast Workshop
SUNDAY
12
DUAL AT1R-NEPRILYSIN INHIBITORS
Chairpersons: A.E.Berbari(Beirut,LEBANON)
T. Unger (Maastricht, NETHERLANDS)
07.45
Angiotensin Receptor Neprilysin Inhibition: the new paradigm
T. Kahan (Stockholm, SWEDEN)
08.05
Reno and cardioprotective effects of Dual AT1 Receptor-Neprilysin Inhibitors
M. Burnier (Lausanne, SWITZERLAND)
08.25
Discussion
F I N A L P R OG R A M M E
77
09.00 - 11.00
Grand Amphitheatre
Parallel Oral Session 4A
BLOOD PRESSURE VARIABILITY
Chairpersons: R. Kreutz (Berlin, GERMANY)
P. van de Borne (Brussels, BELGIUM)
09.00 SYSTOLIC VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY INCREASES RISK OF MYOCARDIAL
INFARCTION AND CONGESTIVE HEART FAILURE IN PATIENTS GIVEN VALSARTAN OR AMLODIPINE IN THE
VALUE TRIAL
M.H. Mehlum 1, K. Liestøl 1, S. Julius 2, S.E. Kjeldsen 1, T.A. Hua 3, P.M. Rothwell 4, G. Mancia 5, G. Parati 6,
M.A. Weber 7, E. Berge 1
1
Oslo, NORWAY, 2 Ann Arbor, MI, 3 East Hanover, NJ, USA, 4 Oxford, UNITED KINGDOM, 5 Monza,
6
Milan, ITALY, 7 New York, NY, USA
09.10 SHORT TERM BLOOD PRESSURE VARIABILTY AS PREDICTOR OF FUTURE EVENTS IN YOUNG
STAGE I HYPERTENSIVES
F. Saladini 1, L. Mos 2, C. Fania 1, E. Benetti 1, A. Mazzer 3, S. Cozzio 4, A. Bortolazzi 5, G. Garavelli 6, E. Casiglia 1,
P. Palatini 1
1
Padua, 2 Udine, 3 Treviso, 4 Trento, 5 Rovigo, 6 Cremona, ITALY
09.20 IS WHITE COAT EFFECT “PROTECTIVE” FOR THE PROGNOSIS OF CARDIOVASCULAR EVENTS?
J. Mesquita Bastos 1, A. Araújo 1, J. Pires 1, J. Pinto 1, P. Almeida 1, J. Polonia 2
1
Aveiro, 2 Porto, PORTUGAL
09.30 LECTURE
BLOOD PRESSURE VARIABILITY AND TARGET ORGAN DAMAGE
G. Schillaci
Perugia, ITALY
09.50 ASSOCIATION OF CARDIAC STRUCTURE AND FUNCTION WITH CENTRAL AND BRACHIAL
BLOOD PRESSURE VARIABILITY IN HYPERTENSIVE PATIENTS: THE SAFAR STUDY
C. Chi 1, Y. Zhang 1, S. Yu 1, A. Argyris 2, J. Blacher 3, M.E. Safar 3, A. Protogerou 2
1
Shanghai, CHINA, 2 Athens, GREECE, 3 Paris, FRANCE
10.00 24-HOUR AORTIC BLOOD PRESSURE VARIABILITY IS BETTER ASSOCIATED WITH CAROTID
INTIMA-MEDIA THICKNESS THAN BRACHIAL BLOOD PRESSURE VARIABILITY
S. Yu 1, C. Chi 1, Y. Zhang 1, A.A. Argyris 2, J. Blacher 3, M.E. Safar 3, A. Protogerou 2
1
Shanghai, CHINA, 2 Athens, GREECE, 3 Paris, FRANCE
10.10 RELATIONSHIP BETWEEN CIRCADIAN PATTERNS OF BLOOD PRESSURE AND CAROTID
ARTERY STIFFNESS AND WAVE INTENSITY IN PATIENTS WITH ARTERIAL HYPERTENSION
D. Skultetyova, S. Filipova
Bratislava, SLOVAK REPUBLIC
10.20 THE IMPACT OF BLOOD PRESSURE VARIABILITY ON ADVERSE OUTCOMES AFTER KIDNEY
TRANSPLANTATION
N. Pagonas 1, F. Seibert 1, F. Bauer 1, K. Markakis 1, M. Seidel 1, W. Zidek 2, S. Kykalos 1, T. Klein 1, R. Viebahn 1,
T. Westhoff 1
1
Bochum, 2 Berlin, GERMANY
78
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
10.30 ANTIDEPRESSANT USE IS RELATED TO LOWER BAROREFLEX SENSITIVITY INDEPENDENTLY OF
THE SEVERITY OF DEPRESSIVE SYMPTOMS. THE PARIS PROSPECTIVE STUDY III
J.-P. Empana 1, C. Prugger 1, F. Thomas 1, M.C. Perier 1, L. Zanoli 2, C. Guibout 1, C. Lemogne 1, S. Laurent 1,
B. Pannier 1, G. Parati 3, P. Boutouyrie 1, X. Jouven 1
1
Paris, FRANCE, 2 Catania, 3 Milan, ITALY
10.40 THE EFFECT OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST LIRAGLUTIDE ON 24-H
BLOOD PRESSURE VARIATION: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED CROSS OVER
STUDY
P. Kumarathurai,C.Anholm,O.K.Kristiansen,O.W.Nielsen,S.B.Haugaard,A.Sajadieh
Copenhagen, DENMARK
10.50 RENAL DENERVATION VERSUS SPIRONOLACTONE IN RESISTANT HYPERTENSION.
EFFECTS ON CIRCADIAN PATTERNS AND BLOOD PRESSURE VARIABILITY
A. de la Sierra 1, J. Pareja 1, P. Armario 2, A. Barrera 1, L. Sans 3, S. Vazquez 3,A.Oliveras3
1
Terrassa, 2 Sant Joan Despí, 3 Barcelona, SPAIN
09.00 - 10.30
Room Bordeaux
Topical Workshop
EARLY VASCULAR AGEING (EVA) AND HYPERTENSION: HOT ISSUES
Chairpersons: S. Laurent (Paris, FRANCE)
P.M. Nilsson (Malmö, SWEDEN)
09.00
Is arterial ageing postponed nowadays?
M.H.Olsen(Glostrup,DENMARK)
09.20
EVA in the general population: the Guimarães study
P.Cunha(Guimarães,PORTUGAL)
09.40
EVA of large and small artery: do they occur in parallel?
D. Rizzoni (Brescia, ITALY)
10.00
Early ageing of the microconstituents of the arterial wall
P. Boutouyrie (Paris, FRANCE)
10.20
Discussion
SUNDAY
12
F I N A L P R OG R A M M E
79
09.00 - 10.30
Room Havane
Joint Session
ESH (European Society of Hypertension)
LASH (Latin American Society of Hypertension)
CHALLENGES IN BLOOD PRESSURE MANAGEMENT IN LATIN AMERICA
Chairpersons: E.C.D. Barbosa (Porto Alegre, BRAZIL)
A. Coca (Barcelona, SPAIN)
09.00
Latin America Consensus Document on Blood Pressure Control
P.López-Jaramillo(Floridablanca,COLOMBIA)
09.20
Blood pressure targets for high risk patients: what’s new?
J. Redon (Valencia, SPAIN)
09.40
Hypertension and Atrial Fibrillation
J.Lara(Guayaquil,ECUADOR)
10.00
Blood pressure lowering drugs in prevention of new onset heart failure
A. Zanchetti (Milan, ITALY)
10.20
Discussion
09.00 - 11.00
Room 342
Parallel Oral Session 4B
HEART AND HAEMODYNAMICS
Chairpersons: C. Borghi (Bologna, ITALY)
D.L. Clement (Ghent, BELGIUM)
09.00 LECTURE
HEART-VESSEL COUPLING: MRI IS THE NOVEL GALILEO LENS
E. Mousseaux
Paris, FRANCE
09.20 LEFT VENTRICULAR MECHANICS IN PATIENTS WITH MASKED HYPERTENSION
M. Tadic 1, C. Cuspidi 2, V. Vukomanovic 1, B. Pencic 1, V. Kocijancic 1, V. Celic 1
1
Belgrade, SERBIA, 2 Milan, ITALY
09.30 NON INVASIVE EVALUATION OF END SYSTOLIC LEFT VENTRICULAR ELASTANCE ACCORDING TO
PRESSURE-VOLUME CURVE MODELLING DURING EJECTION IN ARTERIAL HYPERTENSION
B. Bonnet, F. Jourdan, G. du Cailar, P. Fesler
Montpellier, FRANCE
80
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
09.40 CIRCULATING ALDOSTERONE LEVELS ARE ASSOCIATED WITH CONCENTRIC LEFT VENTRICULAR
GEOMETRY IN ESSENTIAL HYPERTENSIVE PATIENTS
G. Mulè, E. Nardi, L. Guarino, M. Morreale, D. Altieri, G. Geraci, M. Guarneri, V. Cacciatore, G. Cerasola,
S. Cottone
Palermo, ITALY
09.50 LONGITUDINAL CHANGES IN LEFT VENTRICULAR STRUCTURE AND DIASTOLIC FUNCTION IN
RELATION TO ARTERIAL PROPERTIES IN A GENERAL POPULATION
N. Cauwenberghs 1, J. Knez 1, J. D’Hooge 1, L. Thijs 1, W.Y. Yang 1, F. Haddad 2, J.A. Staessen 1, T. Kuznetsova 1
1
Leuven, BELGIUM, 2 Stanford,CA, USA
10.00 RELATIONSHIPS BETWEEN ALCOHOL INTAKE AND LEFT VENTRICULAR DIASTOLIC
FUNCTION IN HYPERTENSION: A TISSUE-DOPPLER STUDY
C. Catena, G.L. Colussi, M. Novello, F. Nait, F. Pezzutto, L.A. Sechi
Udine, ITALY
10.10 THE IMPACT OF UPDATED LEFT VENTRICULAR GEOMETRY CLASSIFICATION ON RIGHT
VENTRICULAR REMODELLING IN A HYPERTENSIVE POPULATION
M. Tadic 1, C. Cuspidi 2, V. Vukomanovic 1, V. Kocijancic 1, V. Celic 1
1
Belgrade, SERBIA, 2 Milan, ITALY
10.20 EXAGGERATED BLOOD PRESSURE RESPONSE DURING HANDGRIP EXERCISE IN MASKED
HYPERTENSIVE: CAN IT BE USED AS AN ADDITIONAL SCREENING TOOL?
K. Dipla, A. Triantafyllou, N. Koletsos, V. Sachpekidis, P. Poulios, E. Gkaliagkousi, A. Zafeiridis, S. Douma
Thessaloniki, GREECE
10.30 PROGNOSTIC RELEVANCE OF ELECTROCARDIOGRAPHIC TP-TE INTERVAL IN THE GENERAL AND
IN THE HYPERTENSIVE POPULATION: DATA FROM THE PAMELA STUDY
M. Bombelli,G.L.Seravalle,A.Maloberti,M.Macchiarulo,I.Boggioni,R.Dell’Oro,C.Cuspidi,G.Mancia,
G. Grassi
Milan, ITALY
10.40 CARDIAC ORGAN DAMAGE IN HYPERTENSIVE PATIENTS ACCORDING TO ON-TREATMENT
BLOOD PRESSURE VALUES
M. Salvetti, A. Paini, C. Agabiti Rosei, F. Bertacchini, D. Stassaldi, G. Rubagotti, G. Maruelli, L. Verzeri, C. Donini,
E. Agabiti Rosei, M.L. Muiesan
Brescia, ITALY
10.50 LEFT VENTRICULAR MASS AFTER RENAL TRANSPLANTATION. META-ANALYSIS OF CROSSSECTIONAL AND LONGITUDINAL STUDIES
B. Schmidt, K. Bergmann, J. Kaufeld, A. Melk
Hannover, GERMANY
F I N A L P R OG R A M M E
81
SUNDAY
12
09.00 - 11.00
Room 351
Parallel Oral Session 4C
THERAPEUTICS AND CLINICAL TRIALS
Chairpersons: G. Mancia (Milan, ITALY)
N.R.Poulter(London,UNITEDKINGDOM)
09.00 ANTIHYPERTENSIVE DRUG TREATMENT FAILS TO NORMALIZE SYMPATHETIC ACTIVITY:
MICRONEUROGRAPHIC EVIDENCE AND CLINICAL IMPLICATIONS
G.L. Seravalle,G.Brambilla,R.Dell’Oro,F.QuartiTrevano,D.PrataPizzala,S.Ravaro,G.Mancia,G.Grassi
Milan, ITALY
09.10 CHANGES IN SUBCLINICAL ORGAN DAMAGE IN PATIENTS WITH RESISTANT HYPERTENSION
RANDOMIZED TO RECEIVE RENAL DENERVATION OR SPIRONOLACTONE AS ADD-ON THERAPY.
THE DENERVHTA STUDY RESULTS
A.Oliveras 1, P. Armario 2, L. Sans 1, A. Clarà 1, S. Vázquez 1, L.L. Molina 1, J. Pascual 1, A. de la Sierra 3
1
Barcelona, 2 Sant Joan Despí, 3 Terrassa, SPAIN
09.20 24H BLOOD PRESSURE MONITORING TO PREDICT AND ASSESS IMPACT OF RENAL
DENERVATION: THE DENER-HTN STUDY
P. Gosse 1, A. Cremer 1, H. Pereira 2, G. Bobrie 2, P. Delsart 3, P.-Y. Courand 4, T. Denolle 5, C. Dourmap 6,
M. Sapoval 2, M. Azizi 2
1
Bordeaux, 2 Paris, 3 Lille, 4 Lyon, 5 Dinard, 6 Rennes, FRANCE
09.30 SAFETY AND PERFORMANCE OF THE ENLIGHTN RENAL DENERVATION SYSTEM IN PATIENTS
WITH DRUG-RESISTANT HYPERTENSION: POOLED ANALYSES FROM THE ENLIGHTN 1, 2 AND 3 TRIALS
M. Lobo 1, J. Montarello 2, M. Saxena 1, A. Jain 1, D. Walters 3, M. Pincus 3,C.Tsioufis4, V. Papademetriou 5,
S. Worthley 2
1
London, UNITED KINGDOM, 2 Adelaide, 3 Brisbane, AUSTRALIA, 4 Athens, GREECE, 5 Washington DC, USA
09.40 IMPACT OF ACHIEVED SYSTOLIC BLOOD PRESSURE ON RENAL FUNCTION IN HYPERTENSIVE
PATIENTS: THE LIFE STUDY
S.E. Kjeldsen 1,P.M.Okin2, R.B. Devereux 2
1
Oslo, NORWAY, 2 New York, NY, USA
09.50 SLEEP TO LOWER ELEVATED BLOOD PRESSURE: A RANDOMISED CONTROLLED TRIAL (SLEPT)
E.R. McGrath 1,2, C. Espie 3,4, A. Power 1, A.W. Murphy 1, J. Newell 1, C. Kelly 1, N. Duffy 1, P. Gunning 1,
I. Gibson 1,M.J.O’Donnell1
1
Galway, IRELAND, 2 Boston, MA, USA, 3 Oxford, 4 London, UNITED KINGDOM
10.00 LECTURE
RESISTANT HYPERTENSION REVISITED AFTER THE PATHWAY STUDY
B. Williams
London, UNITED KINGDOM
10.20 LOADED SLOW BREATHING TRAINING REDUCES HOME RESTING BLOOD PRESSURE IN OLDER
PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION
C. Jones 1, B. Sangthong 1,2,O.Pachirat1, D. Jones 3
1
Khon Kaen, 2 Patumtani, THAILAND, 3 Manchester, UNITED KINGDOM
82
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
10.30 ROLE OF THE FIXED-DOSE TRIPLE COMBINATION THERAPY IN THE MANAGEMENT OF
UNCONTROLLED HYPERTENSION: FROM THE RANDOMIZED CLINICAL TRIALS TO CLINICAL PRACTICE
A. Mazza 1, S. Lenti 2, L. Schiavon 1, E. Ramazzina 1, D. Bernardini 1, E. Casiglia 3
1
Rovigo, 2 Arezzo, 3 Padua, ITALY
10.40 COMPARISON BETWEEN CANRENONE OR HYDROCHLOROTHIAZIDE IN ADDITION TO SARTANS
IN HYPERTENSIVE DIABETIC PATIENTS
G. Derosa, D. Romano, A. D’Angelo, P.Maffioli
Pavia, ITALY
10.50 CLINICALLY IMPORTANT DIFFERENCES IN SYSTOLIC AMBULATORY BLOOD PRESSURE IN
PATIENTS SWITCHED BETWEEN ALTERNATE NIFEDIPINE OSMOTIC DELIVERY FORMULATIONS
P.T. Pollak 1, R.J. Herman 1, R.D. Feldman 2
1
Calgary, 2 St. John’s, CANADA
09.00 - 11.00
Room 352
Parallel Oral Session 4D
KIDNEY
Chairpersons: P.J. Blankestijn (Utrecht, NETHERLANDS)
P.W. de Leeuw (Maastricht, NETHERLANDS)
09.00 FUNCTIONAL ANALYSIS OF TMEM63C IN ZEBRAFISH REVEALS ITS ROLE AS A NOVEL
CANDIDATE FOR ALBUMINURIA AND CHRONIC KIDNEY DISEASE
R. Kreutz 1, A. Schulz 1, A.M. Meyer 1, T. Lorenzen 1, M. Stoll 2, D. Panakova 1
1
Berlin, 2 Münster, GERMANY
SUNDAY
12
09.10 ADIPONECTIN-MEDIATED EPITHILIAL AUTOPHAGY ATTENUATES HYPERTENSIVE RENAL
FIBROSIS
C. Ruan, Y. Li, Y. Ma, L.-R. Kong, Q. Ge, D.-L. Zhu, L. Gao
Shanghai, CHINA
09.20 CIRCULATING FGF-23 AND MMP-2 ARE ASSOCIATED WITH HYPERTENSION AND
ATHEROSCLEROSIS IN PRIMARY CHRONIC GLOMERULONEPHRITIS TO THE PROGRESSION OF CHRONIC
KIDNEY DISEASE
G. Dimas, T. Tegos, I. Karamouzis, S. Spiroglou, N. Tsiaras, M. Larissi, G. Spagos, C. Savopoulos, A. Hatzitolios,
D. Grekas
Thessaloniki, GREECE
09.30 IMPACT OF THE INHIBITION OF SOLUBLE EPOXIDE HYDROLASE ON CARDIOVASCULAR
CONSEQUENCES OF CHRONIC KIDNEY DISEASE
M. Hamzaoui, C. Roche, A. Lejeune, V. Brunel, V. Richard, J. Bellien, D. Guerrot
Rouen, FRANCE
F I N A L P R OG R A M M E
83
09.40 METABOLOMIC STUDY OF THE EFFECT OF UROMODULIN ON BIOCHEMICAL PATHWAYS
IN THE KIDNEYS
L. Graham, D. Graham, M.W. McBride, A.F. Dominiczak, S. Padmanabhan
Glasgow, UNITED KINGDOM
09.50 A NOVEL MUTATION IN THE RENAL NACL COTRANSPORTER CAUSES IMPAIRED
GLYCOSYLATION AND GITELMAN’S SYNDROME (GS)
V. Ravarotto 1,D.Loffing-Cueni2, E. Pagnin 1, L.A. Calo’ 1, G.P. Rossi 1,L.Loffing2
1
Padua, ITALY, 2 Zürich, SWITZERLAND
10.00 REDUCTION OF CORTICAL OXYGENATION IN CHRONIC KIDNEY DISEASE: EVIDENCE OBTAINED
WITH BOLD-MRI AND A NEW ANALYTIC TECHNIQUE
B. Milani 1, A. Ansaloni 1, S. Sousa-Guimaraes 1, M. Piskunowicz 2, B. Vogt 3, M. Stuber 1, M. Burnier 1,
M. Pruijm 1
1
Lausanne, SWITZERLAND, 2 Gdansk, POLAND, 3 Bern, SWITZERLAND
10.10 PATHOPHYSIOLOGICAL DIFFERENCES BETWEEN MULTIFOCAL FIBROMUSCULAR DYSPLASIA
AND ATHEROSCLEROTIC RENAL ARTERY STENOSIS
D. Van Twist, A.J.H.M. Houben, P.W. de Leeuw, A.A. Kroon
Maastricht, NETHERLANDS
10.20 DISORDERED SLEEP BREATHING (SDB) IS THE MAJOR DETERMINANT OF NON-DIPPING AND
NOCTURNAL HYPERTENSION IN KIDNEY TRANSPLANT PATIENTS
F. Mallamaci, R. Tripepi, M.C. Versace, F. Provenzano, A. Mafrica, C. Torino, G. D’Arrigo, D. Leonardis, G. Tripepi,
C. Zoccali
Reggio Calabria, ITALY
10.30 EFFECT OF HIGH DOSE ROSUVASTATIN LOADING BEFORE DELAYED PERCUTANEOUS
CORONARY INTERVENTION ON CONTRAST-INDUCED ACUTE KIDNEY INJURY
A. Gaskina, S. Villevalde, N. Khodorovich, Z. Kobalava
Moscow, RUSSIA
10.40 LECTURE
THE INTERTITIUM AS A NA SENSOR AND THE IMMUNE SYSTEM AS A REGULATOR OF VOLUME AND BP
HOMEOSTASIS
D. Mueller
Berlin, GERMANY
84
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
09.00 - 10.30
Room 252
Joint Session in French Language
ESH (European Society of Hypertension)
Maghrebian Societies of Hypertension and
Cardiology
HYPERTENSION IN NORTH AFRICA
HYPERTENSION AU MAGHREB
Chairpersons: J. Blacher (Paris, FRANCE)
A.Chaib(Rabat,MOROCCO)
S. Mourali (Tunis, TUNISIA)
A. Remache (Alger, ALGERIA)
09.00
Hypertension and Cardiovascular risk factors in Algeria and MENA Region (Middle East and
North Africa)
Hypertension et facteurs de risque cardiovasculaires en Algérie et dans la région MENA
A. Chibane (Alger, ALGERIA)
09.20
Cardiovascular risk profile in Maghrebian hypertensive patient
Profil de risque cardio vasculaire de l’hypertendu maghrébin
J.ElHangoucheAbdelakder(Rabat,MOROCCO)
09.40
Adherence to guidelines in the treatment of Tunisian hypertensive patients
Adhérence aux recommandations dans le traitement de patients hypertendus tunisiens
A. Joulak (Tunis, TUNISIA)
10.00
Management of hypertension in the Maghreb: are ESH Guidelines relevant?
Prise en charge de l’HTA au Maghreb: les recommandations ESH sont elles applicables?
F. Zannad (Nancy, FRANCE)
10.20
Discussion
F I N A L P R OG R A M M E
85
SUNDAY
12
10.00 - 11.00
Room Maillot
Minisymposium
Supported by ReCor Medical
THE RADIANCE-HTN STUDY: EVALUATING A UNIQUE ULTRASOUND RENAL
DENERVATION SYSTEM FOR TREATING HYPERTENSION
Chairperson: M.Azizi(Paris,FRANCE)
10.00
The State of Renal Denervation for Hypertension in 2016
A. Pathak (Toulouse, FRANCE)
10.20
A Novel Ultrasound System for Renal Denervation
F. Mahfoud (Homburg, GERMANY)
10.40
The Path Forward - the RADIANCE-HTN Trial
M. Azizi (Paris, FRANCE)
11.00 - 12.30
Grand Amphitheatre
Parallel Oral Session 5A
MICROCIRCULATION AND SMALL VESSELS
Chairpersons: X. Girerd (Paris, FRANCE)
E.L. Schiffrin (Montreal, CANADA)
11.00 CENTRAL BLOOD PRESSURE RELATES MORE STRONGLY TO RETINAL ARTERIOLAR NARROWING
THAN BRACHIAL BLOOD PRESSURE
Y. Tabara, K. Kumagai, N. Yoshimura, F. Matsuda
Kyoto, JAPAN
11.10 SHORT AND LONG-TERM EFFECTS OF ANTIHYPERTENSIVE TREATMENT ON HUMAN RETINAL
ARTERIOLE REMODELLING EVALUATED WITH ADAPTIVE OPTICS CAMERA
A. Gallo, D. Rosenbaum, A. Mattina, E. Koch, N. Kachenoura, M. Paques, X. Girerd
Paris, FRANCE
11.20 RELATIONSHIP BETWEEN LOCAL CAROTID STIFFNESS AND WALL-TO-LUMEN RATIO OF RETINAL
ARTERIOLES
S. Caletti, M. Salvetti, D. Rizzoni, C. De Ciuceis, F. Bertacchini, C. Agabiti Rosei, G. Maruelli, G. Rubagotti,
A. Paini, E. Colonetti, E. Casella, E. Agabiti Rosei, M.L. Muiesan
Brescia, ITALY
11.30 EVALUATION OF RETINAL MICROPERFUSION AND ARTERIOLAR STRUCTURE IN PATIENTS
WITH FIBROMUSCULAR DYSPLASIA. THE PRELIMINARY DATA OF THE POLISH REGISTRY FOR
FIBROMUSCULAR DYSPLASIA
E. Warchol-Celinska 1, M. Gosk-Przybylek 1, J. Harazny 2,3, E. Binczyk 1, K. Szymanek 1, K. Hanus 1,
K. Jozwik-Plebanek 1, E. Florczak 1, A. Prejbisz 1, I. Cendrowska-Demkow 1, P. Dobrowolski 1, A. Klisiewicz 1,
I. Kurkowska-Jastrzebska 1, B. Blazejewska-Hyzorek 1, M. Januszewicz 1, I. Michalowska 1,J.P.Szaflik1,
R.E. Schmieder 2,J.Szaflik1, A. Januszewicz 1
1
Warsaw, POLAND, 2 Erlangen, GERMANY, 3 Olsztyn, POLAND
86
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
11.40 GLUCOSE METABOLISM STATUS IS ASSOCIATED WITH IMPAIRED RETINAL ARTERIOLAR
VASODILATATION: THE MAASTRICHT STUDY
B. Sorensen, A. Houben, T. Berendschot, J. Schouten, A.A. Kroon, C. van der Kallen, R.M.A. Henry, A. Koster,
P. Dagnelie, N. Schaper, M. Schram, C.D.A. Stehouwer
Maastricht, NETHERLANDS
11.50 HIGH SALT DIET-INDUCED MICROVASCULAR DYSFUNCTION IS ASSOCIATED WITH REDUCED
ANTIOXIDANT CAPACITY IN YOUNG HEALTHY WOMEN
A. Stupin, A. Cosic, L. Rasic, V. Seric, I. Drenjancevic
Osijek, CROATIA
12.00 THE ROLE OF SYMPATHETIC NERVES AND NORADRENERGIC TRANSMISSION IN
PERIVASCULAR ADIPOSE TISSUE FUNCTION
S. Saxton,S.Withers,J.Ohanian,A.M.Heagerty
Manchester, UNITED KINGDOM
12.10 LECTURE
PERIVASCULAR FAT AND SMALL ARTERIES
A.M. Heagerty
Manchester, UNITED KINGDOM
11.00 - 12.00
Room Bordeaux
Minisymposium
Supported by Servier
IMPROVING FIRST-LINE TREATMENT OF HYPERTENSION: A NEW
APPROACH
SUNDAY
Chairpersons: E. Agabiti Rosei (Brescia, ITALY)
R.E. Schmieder (Erlangen, GERMANY)
12
11.00
Introduction
E. Agabiti Rosei (Brescia, ITALY)
11.02
Is first-line monotherapy of hypertension outmoded?
A.H. Gradman (Philadelphia, PA, USA)
11.17
Managing hypertensive patients: combining the right doses of the right drug classes from
the start
G. Parati (Milan, ITALY)
11.32
Gain in time and efficacy: a new treatment solution
N.R.Poulter(London,UNITEDKINGDOM)
11.47
Discussion
11.59
Conclusion
R.E. Schmieder (Erlangen, GERMANY)
F I N A L P R OG R A M M E
87
11.00 - 12.00
Room Havane
Minisymposium
Supported by Quantum Genomics
BRAIN AMINOPEPTIDASE A INHIBITORS (BAPAIS), AN EMERGING CLASS
FOR THE TREATMENT OF HYPERTENSION AND HEART FAILURE
Chairpersons: M. Azizi (Paris, FRANCE)
P. Corvol (Paris, FRANCE)
11.00
A new strategy for treating hypertension by inhibiting the activity of the brain
renin-angiotensin system (RAS) with orally active aminopeptidase A inhibitors
C. Llorens-Cortes (Paris, FRANCE)
11.20
Role of brain RAS in heart failure
F.Leenen(Ottawa,CANADA)
11.40
New perspectives in the treatment of hypertension
S. Laurent (Paris, FRANCE)
11.00 - 12.30
Room Maillot
Topical Workshop
CARDIOVASCULAR BIG DATA
Chairpersons: J.P. Chalmers (Sydney, AUSTRALIA)
J.-P. Empana (Paris, FRANCE)
11.00
Experience of the Whitehall study
I.B.Wilkinson(Cambridge,UNITEDKINGDOM)
11.20
Experience of the Lombardia cohort study
G. Corrao (Milan, ITALY)
11.40
Experience of the Valencia community
J. Redon (Valencia, SPAIN)
12.00
Experience of the George Institute
M. Woodward (Sydney, AUSTRALIA)
12.20
Discussion
88
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
11.00 - 12.30
Room 342
Parallel Oral Session 5B
LARGE ARTERIES
Chairpersons: J.K.Cruickshank(London,UNITEDKINGDOM)
C. Giannattasio (Milan, ITALY)
11.00 QUANTIFICATION OF HEART RATE DEPENDENCY OF AORTIC PULSE WAVE VELOCITY
I. Tan 1, B. Spronk 2, T. Delhaas 2, K. Reesink 2, H. Kiat 1, E. Barin 1, M. Butlin 1, A. Avolio 1
1
Sydney, AUSTRALIA, 2 Maastricht, NETHERLANDS
11.10 PULSE PRESSURE AMPLIFICATION AND AORTIC REFLECTED WAVE MAGNITUDE BUT NOT
AORTIC PRESSURES OR AUGMENTATION INDICES ADD TO BRACHIAL PULSE PRESSURE ASSOCIATIONS
WITH END-ORGAN CHANGES
G. Norton, M.J. Sibiya, H.L. Booysen, G. Tade, I. Ballim, P. Sareli, A.J. Woodiwiss
Johannesburg, SOUTH AFRICA
11.20 POPULATION-BASED REFERENCE VALUES FOR PULSATILE HEMODYNAMICS IN
MIDDLE-AGED AND ELDERLY INDIVIDUALS. RESULTS OF THE HEINZ NIXDORF RECALL STUDY
T. Weber 1, S. Wassertheurer 2, B. Hametner 2, S. Parragh 2, S. Moebus 3, N. Pundt 3, A.A. Mahabadi 3,
U. Roggenbuck 3, N. Lehmann 3, A. Stang 3, K.H. Jöckel 3, R. Erbel 3
1
Wels, 2 Vienna, AUSTRIA, 3 Essen, GERMANY
11.30 IMPACT OF SIMULTANEOUS CENTRAL BLOOD PRESSURE MEASUREMENTS DURING AORTIC
STRAIN MAGNETIC RESONANCE IMAGING
G. Soulat 1, S. Millasseau 2, S. Stroer 1, N. Kachenoura 1, P. Boutouyrie 1, S. Laurent 1, E. Mousseaux 1
1
Paris, 2 Saint-Leu-la-Forêt, FRANCE
11.40 CHARACTERISATION OF LONGITUDINAL CHANGES IN VASCULAR STRUCTURE AND FUNCTION
OVER A 4 YEAR FOLLOW-UP PERIOD: AS ASSESSED BY MRI
M. Cecelja, T. Hussain, M. Silva Vieira, A. Phinikaridou, G. Greil, T. Spector, P. Chowienczyk
London, UNITED KINGDOM
11.50 TOTAL ARTERIAL COMPLIANCE AND TARGET ORGAN DAMAGE IN HYPERTENSIVES
D. Terentes-Printzios, C. Vlachopoulos, G. Vyssoulis, P. Pietri, N. Ioakeimidis, M. Abdelrasoul, P. Xaplanteris,
E. Paschalidis, D. Tousoulis
Athens, GREECE
12.00 DIASTOLIC EXPONENTIAL DECAY OF CENTRAL BLOOD PRESSURE MEDIATES BETWEEN AORTIC
STIFFNESS AND CORONARY PERFUSION: POTENTIAL IMPLICATION FOR AORTOSCLEROSIS-INDUCED
MYOCARDIAL ISCHEMIA
J. Hashimoto, S. Ito
Sendai, JAPAN
12.10 IMPACT OF SEASONALITY AND AIR POLLUTANTS ON CAROTID-FEMORAL PULSE WAVE
VELOCITY IN HYPERTENSIVE PATIENTS
M. Di Pilla 1, R.M. Bruno 1, L. Ghiadoni 1, F. Stea 1, L. Massetti 2, I. Bertolozzi 2, S. Taddei 1, P.A. Modesti 2
1
Pisa, 2 Florence, ITALY
12.20 ARISTOLOCHIC ACID NEPHROPATHY: A CASE OF SLOWER VASCULAR AGEING?
V. Premuzic 1, V. Ivkovic 1, N. Leko 2, Z. Stipancic 3, T. Teskera 2, M. Vinkovic 2, M. Barisic 2, S. Karanovic 1,
A. Vrdoljak 1, I. Vukovic 1, Z. Dika 1, M. Laganovic 1, B. Jelakovic 1
1
Zagreb, 2 Slavonski Brod, CROATIA, 3 Odzak, BOSNIA AND HERZEGOVINA
F I N A L P R OG R A M M E
89
SUNDAY
12
11.00 - 12.30
Room 351
Topical Workshop
ATRIAL FIBRILLATION, HYPERTENSION AND COMORBIDITIES: NEED FOR
LIFESTYLE CHANGES
Chairpersons: T. Kahan (Stockholm, SWEDEN)
J.-Y. Le Heuzey (Paris, FRANCE)
11.00
Comparative epidemiology of atrial fibrillation and hypertension
O.Hanon(Paris,FRANCE)
11.20
Hypertension, sleep apnoea syndrome and atrial fibrillation: mechanisms and
clinical implications
T. Kahan (Stockholm, SWEDEN)
11.40
Hypertension, obesity and atrial fibrillation: mechanisms and clinical
implications
K.Narkiewicz(Gdansk,POLAND)
12.00
Influence of lifestyle changes on atrial fibrillation
J.-Y. Le Heuzey (Paris, FRANCE)
12.20
Discussion
11.00 - 12.30
Room 352
Parallel Oral Session 5C
CARDIOVASCULAR RISK FACTORS
Chairpersons: L.H. Lindholm (Umeå, SWEDEN)
P. Verdecchia (Perugia, ITALY)
11.00 USING SINGLE VERSUS MULTIPLE 24-HOUR URINE SAMPLES TO ASSESS THE RELATION
BETWEEN SODIUM INTAKE AND CARDIOVASCULAR AND RENAL OUTCOME
R.OldeEngberink, T. van den Hoek, N. van Noordenne, B.J. van den Born, L. Vogt
Amsterdam, NETHERLANDS
11.10 MICROALBUMINURIA PREDICTS THE RECURRENCE OF CARDIOVASCULAR EVENTS IN
PATIENTS WITH ESSENTIAL HYPERTENSION
C. Morisco 1, A. Meccariello 1, F. Buono 1,G.Orefice1, F. Grieco 1, F. Romeo 2, B. Trimarco 1
1
Naples, 2 Rome, ITALY
11.20 HIGHER PREVALENCE OF HYPERTENSION IN MIGRANTS IN ITALY: A SNAPSHOT OF THE 2012
AND 2013 WORLD KIDNEY DAY
A. Clementi, M. Buiatti, R. Mussinelli, F. Salinaro, V.E. Andreucci, A. Balducci, T. Perrone, P. Esposito, S. Perlini
Pavia, ITALY
90
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
11.30 HEART RATE IS ASSOCIATED WITH GLOMERULAR HYPERFILTRATION IN APPARENTLY HEALTHY
SUBJECTS
A. Vrdoljak 1, V. Ivkovic 1, S. Karanovic 1, Z. Dika 1, V. Domislovic 1, K. Dapic 1, L. Gallineo 1, E. Ivandic 1,
J. Josipovic 1, I. Vukovic 1, J. Kos 1, M. Laganovic 1, T. Zeljkovic Vrkic 1, M. Fistrek Prlic 1, I. Pecin 1, M. Fucek 1,
J. Sertic 1, N. Leko 2, B. Jelakovic 1
1
Zagreb, 2 Slavonski Brod, CROATIA
11.40 INCREASED RHO KINASE ACTIVITY IN DIALYSIS AND STAGE 3-4 CHRONIC KIDNEY DISEASE
PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY: IMPLICATIONS WITH CARDIOVASCULAR RISK
L. Calo’, U. Vertolli, E. Pagnin, V. Ravarotto, E. Naso, G. Maiolino, A. Naso
Padua, ITALY
11.50 MASKED TACHYCARDIA PREDICTS ADVERSE OUTCOME IN HYPERTENSION.
THE ABP-INTERNATIONAL STUDY
P. Palatini 1, P. Reboldi 2, S. Pierdomenico 3, K. Eguchi 4, K. Kario 4, Y. Imai 5,T.Ohkubo6, L. Beilin 7, L. Wing 8,
J. Schwartz 9, E. Casiglia 1, P. Verdecchia 10
1
Padua, 2 Perugia, 3 Chieti, ITALY, 4 Tochigi, 5 Sendai, 6 Tokyo, JAPAN, 7 Perth, 8 Adelaide, AUSTRALIA,
9
New York, NY, USA, 10 Assisi, ITALY
12.00 DO COMBINED ELECTROCARDIOGRAPHIC AND ECHOCARDIOGRAPHIC MARKERS OF LEFT
VENTRICULAR HYPERTROPHY IMPROVE CARDIOVASCULAR RISK ESTIMATION?
C. Cuspidi 1, G.L. Seravalle 1, A. Re 1, F. Zanchettin 1, F. Bonomi 1, F. Quarti Trevano 1, R. Facchetti 1, C. Sala 1,
M. Bombelli 1, M. Tadic 2, G. Mancia 1, G. Grassi 1
1
Milan, ITALY, 2 Belgrade, SERBIA
12.10 FIVE-YEARS TRENDS IN DEMOGRAPHIC CHARACTERISTICS OF HYPERTENSIVE PATIENTS
REFERRED TO SPECIALIZED CARDIOLOGICAL CENTRE: AGE AND GENDER
N. Zvartau,A.Krikunov,A.Semakova,E.Bolgova,S.Kovalchuk,A.Boukhanovsky,A.O.Konradi
Saint-Petersburg, RUSSIA
12.20 AGE-RELATED TREATMENT BENEFIT OF AN ACE INHIBITOR ON CARDIOVASCULAR EVENTS:
THE EMERGING ROLE OF BRADYKININ
J. Brugts 1, R. Ferrari 2
1
Rotterdam, NETHERLANDS, 2 Ferrara, ITALY
SUNDAY
11.00 - 12.30
Room 251
Parallel Oral Session 5D
PREGNANCY
Chairpersons: R. Cifková (Prague, CZECH REPUBLIC)
S. Douma (Thessaloniki, GREECE)
11.00 INHIBITON OF TNF-ALPHA SIGNALLING USING ETANERCEPT IMPROVES DEFICIENT UTERINE
ARTERY REMODELLING AND PREGNANCY OUTCOME IN THE STROKE PRONE SPONTANEOUSLY
HYPERTENSIVE RAT
H. Small, R. Nosalski, H. Morgan, E. Beattie, T. Guzik, D. Graham, C. Delles
Glasgow, UNITED KINGDOM
11.10 TRANSCRIPTOMIC CHANGES IN EARLY PREGNANCY-ASSOCIATED UTERINE ARTERY
REMODELLING IN STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT
H. Morgan, H.Y. Small, E. Beattie, M.W. McBride, D. Graham
Glasgow, UNITED KINGDOM
F I N A L P R OG R A M M E
91
12
11.20 CHRONIC INFLAMMATION DURING PREGNANCY INFLUENCE THE PROGRESSION OF EARLY
SYMPATHETIC-MEDIATED HYPERTENSION IN OFFSPRING ARISING FROM MATERNAL OBESITY
A. Samuelsson 1, J.M. Pombo 1, C.W. Coen 1, C. Mallard 2, P. Gressens 1, L. Poston 1
1
London, UNITED KINGDOM, 2 Gothenburg, SWEDEN
11.30 COMPLEMENT C5A-MEDIATED PLACENTAL DYSFUNCTION CONTRIBUTES TO THE
PATHOGENESIS OF PREECLAMPSIA
Y. Ma, C. Ruan, L. Kong, Y. Zhang, P. Gao
Shanghai, CHINA
11.40 LECTURE
BIOMARKERS IN PRE-ECLAMPSIA
V. Kotsis
Thessaloniki, GREECE
12.00 IMPAIRED SKELETAL MUSCLE OXYGENATION AND ENDOTHELIAL FUNCTION IN WOMEN WITH
GESTATIONAL DIABETES MELLITUS ASSESSED BY NEAR-INFRARED SPECTROSCOPY
K. Dipla, E. Kintiraki, I. Grigoriadou, G. Triantafyllou, A. Triantafyllou, I. Zografou, I.S. Vrabas, A. Zafeiridis,
D.G. Goulis, S. Douma
Thessaloniki, GREECE
12.10 HYPERTENSION AS A PATERNAL FACTOR INFLUENCES MATERNAL ADAPTATION TO
PREGNANCY AND IS ASSOCIATED WITH PLACENTAL INSUFFICIENCY AND FETAL GROWTH RESTRICTION
G. Barrientos 1, A. Uceda 1, A. Sgariglia 1, G. Giardina 1, S.M. Blois 2, J.E. Toblli 1
1
Buenos Aires, ARGENTINA, 2 Berlin, GERMANY
12.20 ANGIOGENIC IMBALANCED PREECLAMPSIA VERSUS CLINICAL PREECLAMPSIA
L. Saleh, K. Verdonk, A. Kaya, A.H.J. Danser, A.H. van den Meiracker, W. Visser
Rotterdam, NETHERLANDS
11.00 - 12.30
Room 252
Joint Session
ESH (European Society of Hypertension)
CHL (Chinese Hypertension League)
SESSION 2: VASCULAR DISEASES AS A SECONDARY CAUSE OF
HYPERTENSION
Chairpersons: X. Jeunemaitre (Paris, FRANCE)
Y. Zhang (Beijing, CHINA)
11.00
Large vessel vasculitis
Y. Zhang (Beijing, CHINA)
11.20
Fibromuscular Dysplasia [FMD]
J. Xu (Shanghai, CHINA)
11.40
Atheromatous renal artery stenosis
D. Vlahakos (Athens, GREECE)
12.00
Balkan Nephropathy
B.Jelakovic(Zagreb,CROATIA)
12.20
Discussion
92
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
13.00 - 14.30
Grand Amphitheatre
Teaching Seminar
MANAGEMENT OF HYPERTENSION 2
Chairpersons: S. Laurent (Paris, FRANCE)
K.Narkiewicz(Gdansk,POLAND)
13.00
BP Variability: how to measure? How to treat?
G. Parati (Milan, ITALY)
13.15
Discussion
13.20
Salt and hypertension: where are we?
D.L. Clement (Ghent, BELGIUM)
13.35
Discussion
13.40
Arterial damage in hypertension: which parameter should be investigated in all patients
and how?
C. Vlachopoulos (Athens, GREECE)
13.55
Discussion
14.00
Are there new antihypertensive drugs coming?
S. Laurent (Paris, FRANCE)
14.15
Discussion
14.20
General Discussion
SUNDAY
12
F I N A L P R OG R A M M E
93
14.30 - 15.30
Room Bordeaux
Minisymposium
Supported by Servier
RISING TO THE CHALLENGE OF CONCOMITANT HYPERTENSION AND
HYPERCHOLESTEROLEMIA
Chairpersons: C. Borghi (Bologna, ITALY)
A.F.Dominiczak(Glasgow,UNITEDKINGDOM)
14.30
Introduction
A.F.Dominiczak(Glasgow,UNITEDKINGDOM)
14.32
Multiple cardiovascular risk factors: what more can be done?
B.Williams(London,UNITEDKINGDOM)
14.47
Hypertension with hypercholesterolemia: the lipidologist’s viewpoint
M.J. Chapman (Paris, FRANCE)
15.02
Hypertension with hypercholesterolemia: the cardiologist’s perspective
C. Borghi (Bologna, ITALY)
15.17
Discussion
15.29
Conclusion
C. Borghi (Bologna, ITALY)
14.30 - 15.30
Room Maillot
Minisymposium
Supported by Omron Healthcare Japan
CURRENT EVIDENCES AND FUTURE PERSPECTIVE OF 24-HOUR PERFECT
BLOOD PRESSURE MANAGEMENT
Chairpersons: E.L. Schiffrin (Montreal, CANADA)
M.A. Weber (New York, NY, USA)
14.30
Introduction
M.A. Weber (New York, NY, USA)
14.35
Lecture 1
P. Verdecchia (Perugia, ITALY)
15.00
Lecture 2
K. Kario (Tochigi, JAPAN)
15.25
Closing remarks
E.L. Schiffrin (Montreal, CANADA)
94
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
14.30 - 15.30
Room 351
How-to Session
Supported by CVRx
HOW TO USE BAROSTIM THERAPY TO SAFELY CONTROL RESISTANT
HYPERTENSION
Chairperson:
14.30
M. Azizi (Paris, FRANCE)
How does Barostim Therapy work to treat resistant hypertension?
- Background on resistant hypertension
- Mechanism of action of Barostim Therapy
- Long-term results of Barostim Therapy
A. Pathak (Toulouse, FRANCE)
14.45
How can Barostim Therapy be customized to treat various types of resistant hypertension
patients?
- Overview of Barostim Neo procedure & follow-up
- Case studies:
• Classic resistant hypertension patient
• Post-renal nerve ablation patient
• Patient who is not eligible for renal nerve ablation
•Chronickidneydisease/renally-impairedpatient
A.A. Kroon (Maastricht, NETHERLANDS)
H. Reuter (Köln, GERMANY)
15.20
Questions & Answers
SUNDAY
14.30 - 15.30
Room 352
How-to Session
HOW TO MANAGE HYPERTENSION DURING AND AFTER PREGNANCY?
Chairpersons: R. Cifková (Prague, CZECH REPUBLIC)
M.L. Muiesan (Brescia, ITALY)
14.30
Long-term follow-up of women with hypertension during pregnancy
A. Pechère Bertschi (Geneva, SWITZERLAND)
15.00
Management of hypertension
R. Cifková (Prague, CZECH REPUBLIC)
F I N A L P R OG R A M M E
95
12
14.30 - 15.30
Room 251
How-to Session
Supported by SOMNOmedics
NOCTURNAL BLOOD PRESSURE DETERMINED BY PTT: RELIABLE METHOD.
NEW INSIGHTS
Chairperson:
G. Parati (Milan, ITALY)
14.30
Continuous, undisturbed long-term Blood Pressure Measurement. Problems & Perspectives
G. Parati (Milan, ITALY)
14.50
Continuous and non-invasive blood pressure measurement based on Pulse Transit Time
compared to ambulatory blood pressure measurement
R. Haberl (Munich, GERMANY)
15.10
APNOEA Related Nocturnal Blood Pressure Fluctuations (NBPFs) and Superposition
of the Systolic Blood Pressure. Higher Risk for Hypertension and Cardiovascular Events?
G. Kuchler (Randersacker, GERMANY)
14.30 - 15.30
Room 252
Clinical Cases
SESSION 2
Chairpersons: R. Kalaitzidis (Ioannina, GREECE)
G. Wuerzner (Lausanne, SWITZERLAND)
14.30
A case of polyvascular hypertensive patient with renal artery stenoses
F. Jarraya (Sfax, TUNISIA)
15.00
A case of young hypertensive patient with decline in kidney function
M. Hausberg (Karlsruhe, GERMANY)
96
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
14.30 - 15.30
Room 253
How-to Session
Supported by iHealth
CONNECTED HEALTH, THE FUTURE FOR HEALTHCARE PROFESSIONALS
Chairperson:
U. Diegel (Paris, FRANCE)
14.30
iHealth Pro - The genesis of a perfect product…
U. Diegel (Paris, FRANCE)
15.00
Determination of the Ankle Brachial Index in type 2 diabetics with an automatic
oscillometric device
S. Lemelle (Paris, FRANCE)
15.30 - 17.00
Grand Amphitheatre
Topical Workshop
FROM PREECLAMPSIA TO ANTIANGIOGENIC INDUCED-HYPERTENSION.
THE ROLE OF ENDOTHELIUM AND VEGF
SUNDAY
Chairpersons: S. Erdine (Istanbul, TURKEY)
M. Lopez-Sublet (Bobigny, FRANCE)
12
15.30
Pathophysiology of pre-eclampsia
D. Vaiman (Paris, FRANCE)
15.50
Pathophysiology of antiangiogenic-induced hypertension
A.H. van den Meiracker (Rotterdam, NETHERLANDS)
16.10
Similarity and difference between pre-eclampsia and the effects of antiangiogenic drugs
B. Levy (Paris, FRANCE)
16.30
Persistent maternal cardiac dysfunction after preeclampsia
A.Khalil(London,UNITEDKINGDOM)
16.50
Discussion
F I N A L P R OG R A M M E
97
15.30 - 17.00
Room Bordeaux
Topical Workshop
RECENT ADVANCES ON THE REGULATION OF RENAL ION TRANSPORT IN
THE DISTAL TUBULE
Chairpersons: X. Jeunemaitre (Paris, FRANCE)
K.O’Shaugnessy(Cambridge,UNITEDKINGDOM)
15.30
WNK kinases: expression, regulation, mutations
M. Miglinas (Vilnius, LITHUANIA)
15.50
Regulation of NCC transport
K.O’Shaugnessy(Cambridge,UNITEDKINGDOM)
16.10
The Kelch family of substrates
X. Jeunemaitre (Paris, FRANCE)
16.30
CUL3 and the E3 CR
E. Clauser (Paris, FRANCE)
16.50
Discussion
15.30 - 17.00
Room Havane
Joint Session
ESH (European Society of Hypertension)
ERA/EDTA (European Renal Association /
European Dialysis and Transplant Association)
HYPERTENSION AND THE KIDNEY: CURRENT ISSUES
Chairpersons: E. Agabiti Rosei (Brescia, ITALY)
P. Rossignol (Nancy, FRANCE)
15.30
The kidney as a target of high blood pressure
A. Persu (Brussels, BELGIUM)
15.50
Which future for the treatment of hypertension with renal denervation?
R.E. Schmieder (Erlangen, GERMANY)
16.10
Renal Angioplasty: is there still an indication in hypertensive CKD patients with RAS?
P. Rossignol (Nancy, FRANCE)
16.30
Management of hypertension in patients with CKD
M. Burnier (Lausanne, SWITZERLAND)
16.50
Discussion
98
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
15.30 - 16.30
Room Maillot
Minisymposium
Supported by The Menarini Group
NEW EVIDENCES IN ACE-INHIBITION: BEYOND BLOOD PRESSURE
CONTROL
Chairperson:
C. Borghi (Bologna, ITALY)
15.30
Introduction
C. Borghi (Bologna, ITALY)
15.35
Zofenopril in post-AMI: a patient-oriented point of view
C. Borghi (Bologna, ITALY)
15.50
Pleiotropic effects: what’s beyond blood pressure lowering?
C. Ferri (L’Aquila, ITALY)
16.05
Zofenopril in fixed dose combination: efficacy and ancillary properties
G. Parati (Milan, ITALY)
16.20
Open discussion and closing remarks
C. Borghi (Bologna, ITALY)
15.30 - 17.00
Room 342
Parallel Oral Session 6A
SUNDAY
12
CHILDREN AND ADOLESCENTS
Chairpersons: A. Kollias (Athens, GREECE)
J.Maldonado(Coimbra,PORTUGAL)
15.30 RENALASE IN CHILDREN WITH GLOMERULAR KIDNEY DISEASES
P. Skrzypczyk, M. Panczyk-Tomaszewska, J. Przychodzien, M. Mizerska-Wasiak, E. Kuzma-Mroczkowska,
E. Gorska, A. Stelmaszczyk-Emmel
Warsaw, POLAND
15.40 IDEAL CARDIOVASCULAR HEALTH IS INVERSELY ASSOCIATED WITH INCREASED CAROTIDFEMORAL PULSE WAVE VELOCITY IN ITALIAN ADOLESCENTS. THE MACISTE STUDY
G. Pucci, F. Battista, M. D’Abbondanza, F. Anastasio, M.E. Crapa, L. Sanesi, L. Troiani, F. Desantis, F. Papi,
G. Schillaci
Terni, ITALY
15.50 PREVALENCE AND DETERMINANTS OF HYPERTENSION IN A COHORT OF 15.049 PORTUGUESE
CHILDREN AND ADOLESCENTS. THE AVELEIRA REGISTRY
J. Maldonado, T. Pereira
Coimbra, PORTUGAL
F I N A L P R OG R A M M E
99
16.00 LECTURE
BLOOD PRESSURE IN CHILDREN AND ADOLESCENT: CURRENT INSIGHTS
E. Lurbe
Valencia, SPAIN
16.20 EPIDEMIOLOGICAL TRANSITION IN 30 YEARS OF HIGH BLOOD PRESSURE AND OVERWEIGHT/
OBESITY IN BRAZILIAN ADOLESCENTS. THE RIO DE JANEIRO STUDY I AND II
F.L. Fonseca,M.E.C.Magalhaes,E.M.G.Campana,P.Spineti,G.B.Bouzas,B.B.Harboe,L.O.Miranda,
J.B. Bouzas, R. Pozzan, R.G.A. Freitas, F.A. Baptista, A.P. Brandao, A.A. Brandao
Rio de Janeiro, BRAZIL
16.30 CARDIOVASCULAR DISEASE RISK FACTORS IN ADOLESCENT STUDENTS FROM A BRAZILIAN
STATE CAPITAL
T. Jardim, F. Nascente, M. Peixoto, C. Carneiro, K. Medonça, T. Póvoa, A. Sousa, W. Barroso, H. Shimizu, P. Jardim
Goiania, BRAZIL
16.40 VASCULAR PHENOTYPES BY ASSESSING PERIPHERAL AND CENTRAL BLOOD PRESSURE IN
OBESE YOUTH
E. Lurbe, M.I. Torro, J. Alvarez-Pitti, P. Redon, J. Redon
Valencia, SPAIN
16.50 SLEEP DISORDERED BREATHING IS ASSOCIATED WITH BLOOD PRESSURE AND CAROTID
ARTERIAL STIFFNESS IN A SAMPLE OF OBESE CHILDREN
A. Tagetti,S.Bonafini,M.Zaffanello,P.Cavarzere,F.DalleVedove,C.Maffeis,F.Antoniazzi,C.Fava
Verona, ITALY
15.30 - 17.00
Room 351
Parallel Oral Session 6B
BLOOD PRESSURE MEASUREMENT
Chairpersons: J.Polonia(Porto,PORTUGAL)
G.S. Stergiou (Athens, GREECE)
15.30 DIRECT ESTIMATION OF CENTRAL SYSTOLIC PRESSURE FROM PERIPHERAL PRESSURES:
A PROOF OF CONCEPT BASED ON THE META-ANALYSIS OF HIGH-FIDELITY PRESSURE STUDIES
D. Chemla 1, S. Millasseau 2, E.M.T. Lau 3, P. Attal 4, A. Nittenberg 1
1
Le Kremlin-Bicêtre, 2 Saint-Leu-la-Forêt, FRANCE, 3 Camperdown, AUSTRALIA, 4 Jerusalem, ISRAEL
15.40 PHENOTYPES OF OFFICE SYSTOLIC BLOOD PRESSURE ACCORDING TO BOTH BRACHIAL
AND AORTIC MEASUREMENTS: FREQUENCIES AND ASSOCIATIONS WITH CAROTID HYPERTROPHY IN
1861 ADULTS
P. Athanase 1, A.T. Protogerou 1, E. Aissopou 1, A. Argyris 1, E. Nasothimiou 1, G. Konstantonis 1,
T. Papaioannou 1, J. Blacher 2, M.E. Safar 2,P.Sfikakis1
1
Athens, GREECE, 2 Paris, FRANCE
100
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
15.50 WRIST BLOOD PRESSURE SELF-MEASUREMENT AT HOME IS UNRELIABLE. RESULTS
FROM THE POPULATION-BASED “GROWING OLD WITH LESS DISEASE ENHANCING NEUROFUNCTIONS”
(GOLDEN) STUDY
V. Tikhonoff, E. Casiglia, P. Palatini
Padua, ITALY
16.00 INDIVIDUAL PATIENT DATA META-ANALYSIS OF SELF-MONITORING OF BLOOD PRESSURE
(BP-SMART)
K. Tucker 1, J.P. Sheppard 1, R. Stevens 1, H.B. Bosworth 2, A. Bove 3, E.P. Bray 4, M. Godwin 5, B.B. Green 6,
P. Hebert 7, F.D.R. Hobbs 1, I. Kantola 8, S.M. Kerry 9, D.J. Magid 10, J. Mant 11, K.L. Margolis 12, B. McKinstry 13,
M.A. McLaughlin 14,S.Omboni15,O.Ogedegbe14, G. Parati 16, N. Qamar 17, J. Varis 8, W.J. Verberk 18,
B.J.Wakefield19, R.J. McManus 1
1
Oxford, UNITED KINGDOM, 2 Durham, NC, 3 Philadelphia, PA, USA, 4 Preston, UNITED KINGDOM,
5
St. John's, CANADA, 6 Seattle, WA, 7 Washington, DC, USA, 8 Turku, FINLAND, 9 London, UNITED KINGDOM,
10
Denver, CO, USA, 11 Cambridge, UNITED KINGDOM, 12 Minneapolis, MN, USA,13 Edinburgh, UNITED KINGDOM,
14
New York, NY, USA, 15 Varese, 16 Milan, ITALY, 17 Birmingham, UNITED KINGDOM,18 Maastricht, NETHERLANDS,
19
Iowa, IA, USA
16.10 CHANGE IN HOME BLOOD PRESSURE ASSOCIATES MORE STRONGLY WITH CHANGE IN
ECG-LVH THAN CHANGE IN OFFICE BLOOD PRESSURE DOES: THE FINN-HOME STUDY
S. Sivén 1, V. Langén 1, T. Niiranen 1,2
1
Turku, FINLAND, 2 Framingham, MA, USA
16.20 EVALUATION OF RELATIONSHIP BETWEEN CARDIO-ANKLE VASCULAR INDEX AND 24H
AMBULATORY BLOOD PRESSURE VARIABLES
V. Giuli, L.M. Lonati, V. Guida, G. Bilo, G.L. Seravalle, C. Vergani, G. Parati
Milan, ITALY
16.30 NIGHT-TIME BLOOD PRESSURE MEASURED WITH A TIMER-EQUIPPED HOME DEVICE.
AN ALTERNATIVE TO AMBULATORY MONITORING
A. Lindroos 1, A. Jula 1, P. Puukka 1, I. Kantola 1, V. Salomaa 2, E. Juhanoja 1, S. Sivén 1, P. Jousilahti 2,
J. Johansson 1, T. Niiranen 1
1
Turku, 2 Helsinki, FINLAND
SUNDAY
12
16.40 ASSOCIATION OF NIGHT-TIME HOME BLOOD PRESSURE WITH AMBULATORY BLOOD
PRESSURE AND TARGET-ORGAN DAMAGE: SYSTEMATIC REVIEW AND META-ANALYSIS
A. Kollias, S. Chorepsima, P. Anestis, G.S. Stergiou
Athens, GREECE
16.50 AMONG ALL DATA FROM 24-H BLOOD PRESSURE, NIGHTTIME SYSTOLIC BLOOD PRESSURE
HAS THE HIGHEST PREDICTIVE VALUE OF CV EVENTS, STROKE AND HEART ATTACKS IN A PORTUGUESE
SAMPLE OF TREATED HYPERTENSIVE PATIENTS FOLLOWED FOR 11,8 ± 5,1 YEARS
J. Mesquita Bastos 1, J. Pires 1, J. Pinto 1, A. Araújo 1, P. Almeida 1, J. Polonia 2
1
Aveiro, 2 Porto, PORTUGAL
F I N A L P R OG R A M M E
101
15.30 - 17.00
Room 352
Parallel Oral Session 6C
TREATMENT ADHERENCE
Chairpersons: A. Coca (Barcelona, SPAIN)
S.E.Kjeldsen(Oslo,NORWAY)
15.30 REAL-WORLD MEDICATION COMPLIANCE IN A SAMPLE OF PATIENTS RECEIVING
ANTIHYPERTENSIVE TREATMENT IN GREECE
A. Kasiakogias,C.Tsioufis,K.Athanasakis,E.Andrikou,D.Konstantinidis,D.Aragiannis,G.Vlachos,
D. Tousoulis
Athens, GREECE
15.40 RISK FACTORS ASSOCIATED WITH MEDICATION NON-COMPLIANCE IN ARTERIAL
HYPERTENSION
G. Karakaya, R. Van Tielen, I. Umbach
Brussels, BELGIUM
15.50 DO PATIENTS ACTUALLY DO WHAT WE ASK? PATIENT PERFORMANCE AND PERSISTENCE IN
THE TASMIN-SR BLOOD PRESSURE SELF-MANAGEMENT TRIAL
C. Schwartz 1,A.Seyed-Safi2, M. Sayeed Haque 3, E. Bray 4,S.Greenfield3, R. Hobbs 1, P. Little 4,5, J. Mant 2,
B. Williams 6, R. McManus 1
1
Oxford, 2 Cambridge, 3 Birmingham, 4 Preston, 5 Southampton, 6 London, UNITED KINGDOM
16.00 PREDICTORS OF DRUG NON-ADHERENCE IN OUT-PATIENTS OF A UNIVERSITY HOSPITAL:
URINARY DRUG DETECTION VS. MORISKY 4-ITEMS QUESTIONNAIRE
I. Hamdidouche, V. Jullien, P. Boutouyrie, E.M. Billaud, M. Azizi, S. Laurent
Paris, FRANCE
16.10 THE POSSIBILITY OF IMPROVING THE COMPLIANCE TO THE TREATMENT BY USING OF
ELECTRONIC VERSION OF SCORE IN HYPERTENSIVE PATIENTS
D. Nebieridze, A. Saricheva
Moscow, RUSSIA
16.20 LECTURE
ASSESSMENT OF DRUG ADHERENCE: IS THERE A GOLD STANDARD?
G. Wuerzner
Lausanne, SWITZERLAND
16.40 FIXED-DOSED COMBINATIONS OF ARB ARE SUPERIOR TO EXTEMPORANEOUS COMBINATIONS
IN REDUCING TOTAL MORTALITY AND CARDIOVASCULAR MORBIDITY
E. Rodilla Sala 1, R. Maroto 2, F. Lobo 2, J.M. Pascual 3
1
Moncada, 2 Getafe, 3 Sagunto, SPAIN
16.50 COMPLIANCE WITH ESH/ESC GUIDELINES FOR ARTERIAL HYPERTENSION IN SWISS PRIMARY
CARE: PHARMACOLOGICAL THERAPY
D. Buess 1, S. Giezendanner 1,2, K. Henny-Fullin 1, A. Handschin 1, P. Tschudi 1,2, B. Martina 1,2, A. Zeller 1,2,
T. Dieterle 1
1
Liestal, 2 Basel, SWITZERLAND
102
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
15.30 - 17.00
Room 251
Parallel Oral Session 6D
RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
Chairpersons: A.H.J. Danser (Rotterdam, NETHERLANDS)
M.-C. Zennaro (Paris, FRANCE)
15.30 ESTRADIOL INCREASES ENDOTHELIAL ANGIOTENSIN-(1-7) PRODUCTION THROUGH ESTROGEN
RECEPTOR ALPHA
C. Hermenegildo 1, A. Mompeon 1, D. Perez-Cremades 1, X. Vidal-Gomez 1, M.M. Gironacci 2, S. Novella 1
1
Valencia, SPAIN, 2 Buenos Aires, ARGENTINA
15.40 COGNITIVE IMPAIRMENT IN ANGIOTENSIN CONVERTING ENZYME 2 DEFICIENT MICE
J. Iwanami, M. Mogi, X.L. Wang, K. Tsukuda, A. Higaki, M. Kukida, H. Nakaoka, T. Yamauchi, H.Y. Bai, B.S. Shan,
L.J. Min, M. Horiuchi
Tohon, JAPAN
15.50 MODE OF ACTION OF RB150, AN AMINOPEPTIDASE A INHIBITOR PRODRUG AS A CENTRALLYACTING ANTIHYPERTENSIVE AGENT IN DOCA-SALT HYPERTENSIVE RATS
R. Hmazzou, A. Flahault, M. Yannick, C. Llorens-Cortes
Paris, FRANCE
16.00 ASSOCIATION STUDY OF ANGIOTENSINASE A (ENPEP) GENOTYPE WITH DIABETIC
NEPHROPATHY
T. Konoshita 1, A. Sakai 1, S. Kaeriyama 1, M. Urabe 1, T. Nakaya 1, M. Yamada 1, M. Ichikawa 1, S. Sato 1,
K. Yamamoto 1, M. Imagawa 1, M. Fujii 1, Y. Zenimaru 1, J. Suzuki 1, Y. Makino 1, T. Ishizuka 1, N. Kato 2
1
Fukui, 2 Tokyo, JAPAN
16.10 INFLUENCE OF MULTIDRUG RESISTANCE P-GLYCOPROTEIN GENE POLYMORPHISM OR
INHIBITION ON PLASMA ALDOSTERONE CONCENTRATION IN HEALTHY SUBJECTS
J. Dubourg, A. Blanchard, V. Zhygalina, I. Gouin Thibault, J.E. Salem, C. Funck-Brentano, M.A. Landau Loriot,
M. Azizi
Paris, FRANCE
16.20 THE ACCURATE NOVEL TEN MINUTES MEASUREMENTS OF ALDOSTERONE AND ACTIVE
RENIN CONCENTRATIONS WILL BE USEFUL AT OUTPATIENT OFFICE
F. Satoh,Y.Ono,R.Morimoto,Y.Iwakura,M.Nezu,K.Omata,Y.Tezuka,Y.Igarashi,M.Kudo,S.Ito
Sendai, JAPAN
16.30 ASSESSMENT OF THE QUANTITATIVE VALUE OF THE ALDOSTERONE-RENIN RATIO (ARR) FOR
PRIMARY ALDOSTERONISM (AQUARR) STUDY
G. Maiolino, V. Bisogni, G. Rossitto, M. Cesari, G.P. Rossi
Padua, ITALY
16.40 LECTURE
THE RAS SYSTEM AND LONG TERM OUTCOME IN MALIGNANT HTN: A REVISITED CLINICAL PROBLEM
A.H. van den Meiracker
Rotterdam, NETHERLANDS
F I N A L P R OG R A M M E
103
SUNDAY
12
15.30 - 17.00
Room 252
Late-Breakers
SESSION 2
Chairpersons: J. Filipovsky (Pilsen, CZECH REPUBLIC)
P.M. Nilsson (Malmö, SWEDEN)
15.30 STRATEGY TO OPTIMIZE SODIUM INTAKE FOR INDIVIDUAL PATIENTS
M.H. Alderman 1, D. McCarron 2, N. Graudal 3
1
New York, NY, 2 Davis, CA, USA, 3 Copenhagen, DENMARK
15.40 NEUROMODULATION IN HYPERTENSION
H. Nechutova, M. Soucek, K. Brabencova, R. Stepanova, M. Blaha, J. Vanicek
Brno, CZECH REPUBLIC
15.50 EFFECTS OF MULTIELECTRODE RENAL DENERVATION ON SYMPATHETIC NERVE ACTIVITY AND
INSULIN RESISTANCE IN METABOLIC SYNDROME
C.Tsioufis 1, K. Dimitriadis 1, A. Kasiakogias 1, T. Kalos 1, I. Liatakis 1, E. Koutra 1, L. Nikolopoulou 1, E. Lau 3,
V. Papademetriou 2, D. Tousoulis 1
1
Athens, GREECE, 2 Washington, DC, 3 Irvine, CA, USA
16.00 CENTRAL ILIAC ARTERIOVENOUS ANASTOMOSIS FOR UNCONTROLLED HYPERTENSION.
12 MONTH FOLLOW-UP RESULTS OF THE ROX CONTROL HTN RANDOMISED CONTROLLED TRIAL
M. Lobo 1, M. Saxena 1, P.A. Sobotka 2,C.Ott3, E. Dolan 4, J Foran 1, S.S. Furniss 5, J. Cockcroft 6,
M. Van Der Giet 7, J. Hoyer 8, A. Januszewicz 9, G.A. Ng 10, B. Rensing 11, B. Scott 12, D. Schoors 13,
A. Stanton 4, N. Sulke 6, C. Tsioufis14, A. Witkowski 9, R.E. Schmieder 3
1
London, UNITED KINGDOM, 2 San Clemente, CA, USA, 3 Erlangen, GERMANY, 4 Dublin, IRELAND, 5 East Sussex,
6
Cardiff, UNITED KINGDOM, 7 Berlin, 8 Marburg, GERMANY, 9 Warsaw, POLAND, 10 Leicester, UNITED KINGDOM,
11
Nieuwegein, NETHERLANDS, 12 Antwerp, 13 Brussels, BELGIUM, 14 Athens, GREECE
16.10 A PATIENT WITH MALIGNANT HYPERTENSION SUCCESSFULLY TREATED WITH ECULIZUMAB
AND BOSENTAN. SUGGESTIONS OF SIGNIFICANT INTERACTIONS OF COMPLEMENT AND THE
ENDOTHELIN SYSTEM IN BLOOD PRESSURE CONTROL
A. Mitchell 1, B. Nokay 1, H. Guberina 1,O.Aufberg2, U. Behlen-Wilm 3, M. Nagel 4,M.Kirschfink5, T. Wiech 6,
A. Kribben 1, A. Bienholz 1
1
Essen, 2 Duisburg, 3 Moers, 4 Weisswasser, 5 Heidelberg, 6 Hamburg, GERMANY
16.20 INVESTIGATION OF URINARY PEPTIDOME OVER PREGNANCY IN RODENT MODEL OF
HYPERTENSION
S. Samji 1, H.Y. Small 1, S. Coley 1, H. Mischak 2, W. Mullen 1, C. Delles 1
1
Glasgow, UNITED KINGDOM, 2 Hannover, GERMANY
16.30 BLOOD PRESSURE AND HEXADECANEDIOATE: DISSECTING FUNCTIONAL PATHWAYS
C. Menni 1, S. Metrustry 1, G. Ehret 2, A.F. Dominiczak 1, P. Chowienczyk 3, T.D. Spector 1, S. Padmanabhan 1,
A.M. Valdes 4
1
London, UNITED KINGDOM, 2 Geneva, SWITZERLAND, 3 Glasgow, 4 Nottingham, UNITED KINGDOM
16.40 THE EFFECT OF BLOOD PRESSURE LOWERING ON MORTALITY AND CARDIOVASCULAR DISEASE
IS MODIFIED BY BASELINE SYSTOLIC BLOOD PRESSURE: SYSTEMATIC REVIEW AND META-ANALYSIS
M. Brunström, B. Carlberg
Umeå, SWEDEN
16.50 WHAT ANGIOTENSIN CONVERTING ENZYME GENOTYPE AND HIGH BLOOD PRESSURE HAVE IN
COMMON IN PORTUGUESE CENTENARIANS?
A. Pereira Da Silva, N. Ramos Marques, A. Matos, A. Gil, J. Gorjão Clara, M. Bicho
Lisbon, PORTUGAL
104
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
15.30 - 16.30
Room 253
How-to Session
Supported by Axelife
POPMETRE THE PWV IN EVERY DAY PRACTICE
Chairpersons: S. Laurent (Paris, FRANCE)
E.Nasr(Beirut,LEBANON)
15.30
pOpmètre: from Bench to Bed side
P. Boutouyrie (Paris, FRANCE)
15.45
pOpmètre, Optimisation of Algorithms
H.Obeid(Paris,FRANCE)
16.00
PWV and the well aging
G. Watfa (Riyadh, SAUDI ARABIA)
16.15
Measuring your Arterial Aging
17.00 - 18.30
Grand Amphitheatre
Plenary Session
Chairpersons: E. Agabiti Rosei (Brescia, ITALY)
X. Jeunemaitre (Paris, FRANCE)
17.00
Presentation of Awards
Björn Folkow Award
M.J.Caulfield(London,UNITEDKINGDOM)
SUNDAY
12
Alberto Zanchetti Life Achievement Award
J. Menard (Paris, FRANCE)
Lennart Hansson Memorial Lecture
R.E. Schmieder (Erlangen, GERMANY)
ESH Honorary Membership
J. Redon (Valencia, SPAIN)
Talal Zein Award
A. Coca (Barcelona, SPAIN)
Paul Milliez Award
C. Thuillez (Rouen, FRANCE)
17.30
Björn Folkow Award Lecture
M.J.Caulfield(London,UNITEDKINGDOM)
18.00
Presidential Lecture
Pathophysiological and clinical consequences of small arteries remodeling
E. Agabiti Rosei (Brescia, ITALY)
F I N A L P R OG R A M M E
105
18.30 - 20.00
Room 342
The Balkanian Symposium
MEETING OF BALKAN COUNTRIES. ACTIVITIES OF ESH EXCELLENCE
CENTRES
Chairpersons: J.Brguljan(Ljubljana,SLOVENIA)
D. Lovic (Niš, SERBIA)
18.30
Hypertension prevalence in Romania: preliminary results from SEPHAR III survey
M.Dorobantu(Bucharest,ROMANIA)
18.40
Obesity in youth and hypertension
V. Kotsis (Thessaloniki, GREECE)
18.50
Adiponectin and hypertension: nothing is simple. Data from Croatian Rural Study
V.Ivkovic(Zagreb,CROATIA)
19.00
Vitamin D and arterial stiffness
S.Sokolovic(Sarajevo,BOSNIAANDHERZEGOVINA)
19.10
Exercise capacity and new onset of atrial fibrillation
A. Pittaras (Athens, GREECE)
19.20
Insights in resistant hypertension
K. Imprialos (Thessaloniki, GREECE)
19.30
The Greek experience of Renal Denervation in resistant hypertension
K. Dimitriadis (Athens, GREECE)
19.40
Discussion
106
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
18.30 - 20.15
Room 351
ESH Working Group on
Endocrine Hypertension
Chairpersons: P. Mulatero (Turin, ITALY)
J. Widimský (Prague, CZECH REPUBLIC)
18.30
Reliability of the new immunochemiluminescent methods for renin and aldosterone
measurements
A. Morganti (Milan, ITALY)
18.45
The aldosterone renin ratio (ARR): are we using it properly?
G.P. Rossi (Padua, ITALY)
19.00
DELPHI consensus. The outcome of unilateral adrenalectomy in primary aldosteronism
T.A. Williams (Turin, ITALY)
19.15
Management of primary aldosteronism in pregnancy
L. Amar (Paris, FRANCE)
19.30
Follow-up guideline for pheo: the systematic review data and analysis of ENSAT database
O.Steichen(Paris,FRANCE)
19.45
Gallium-68 labeled somatostatin analogs in the evaluation of pheochromocytoma and
paraganglioma - best option for the visualisation?
D. Taieb (Marseille, FRANCE)
20.00
Business Meeting
SUNDAY
12
F I N A L P R OG R A M M E
107
18.30 - 20.00
Room 352
ESH Working Group on
Hypertension and Cardiovascular Risk
Assessment in subjects living in or
emigrating from low resource settings
STRATEGIES FOR HYPERTENSION CONTROL IN LOW RESOURCE SETTINGS
AND IMPLICATIONS FOR EUROPE
Chairpersons: P.A. Modesti (Florence, ITALY)
G. Parati (Milan, ITALY)
18.30
Cardiovascular risk in low income countries and in ethnic minorities in Europe
C. Agyemang (Amsterdam, NETHERLANDS)
18.50
Hypertension control: perspectives for Africa
F.P.Cappuccio(Coventry,UNITEDKINGDOM)
19.10
Cardiovascular prevention in minority groups, focus on diabetes
A.P.Kengne(CapeTown,SOUTHAFRICA)
19.30
Cardiovascular risk in Chinese living in Europe
P.A. Modesti (Florence, ITALY)
19.50
Discussion
18.30 - 20.00
Room 251
ESH Working Group on
Hypertension and the Kidney
Chairpersons: A. Persu (Brussels, BELGIUM)
G. Wuerzner (Lausanne, SWITZERLAND)
18.30
Metabolomic profiling in renal and cardiovascular diseases
J. Redon (Valencia, SPAIN)
18.50
Klotho, a new player in hypertension and renal disease
P. Evenepoel (Leuven, BELGIUM)
19.10
Potassium supplementation in the management of hypertension with or without CKD
M. Burnier (Lausanne, SWITZERLAND)
19.30
The European Fibromuscular Dysplasia registry: an update
A. Persu (Brussels, BELGIUM)
19.45
Final Discussion
108
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
18.30 - 20.00
Room 252
ESH Working Group on
Vascular Structure and Function
Chairpersons: P. Boutouyrie (Paris, FRANCE)
P.Chowienczyk(London,UNITEDKINGDOM)
18.30
Update on activities
P.Chowienczyk(London,UNITEDKINGDOM)
Using PWV in future clinical trials
18.40
PWV as an outcome: experience from recent trials in hypertension
J.K.Cruickshank(London,UNITEDKINGDOM)
18.55
How to deal with pressure dependence
K. Reesink (Maastricht, NETHERLANDS)
19.10
Targeting PWV as an outcome
A. Avolio (Sydney, AUSTRALIA)
19.25
Key questions for future clinical trials
C. Vlachopoulos (Athens, GREECE)
19.40
Panel discussion on future projects in arterial stiffness
P. Boutouyrie (Paris, FRANCE)
SUNDAY
12
F I N A L P R OG R A M M E
109
07.45 - 08.45
Room Havane
Breakfast Workshop
EMPA-REG OUTCOME STUDY: ARE THERE BP-INDEPENDENT EFFECTS OF
SGLT2 INHIBITORS ON CARDIOVASCULAR OUTCOME?
Chairpersons: P. Pauletto (Padua, ITALY)
P. van de Borne (Brussels, BELGIUM)
07.45
Pharmacology
I. Tikkanen (Helsinki, FINLAND)
08.05
Epidemiology
A.J. Scheen (Liège, BELGIUM)
08.25
Discussion
07.45 - 08.45
Room 342
Breakfast Workshop
WHICH OMICS IN HYPERTENSION?
Chairpersons: M. Castellano (Brescia, ITALY)
M.W.McBride(Glasgow,UNITEDKINGDOM)
07.45
Integrated Omics in Endocrine Hypertension
M.-C. Zennaro (Paris, FRANCE)
08.05
Genomics
S.Padmanabhan(Glasgow,UNITEDKINGDOM)
08.25
Discussion
110
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
07.45 - 08.45
Room 351
Breakfast Workshop
HYPERTENSION INDUCED BY DRUGS
Chairpersons: M. Azizi (Paris, FRANCE)
C.Tsioufis(Athens,GREECE)
07.45
Pharmacology of drug-related hypertension
A. Pathak (Toulouse, FRANCE)
08.05
Antiangiogenic drugs and hypertension
A.H. van den Meiracker (Rotterdam, NETHERLANDS)
08.25
Discussion
07.45 - 08.45
Room 352
Breakfast Workshop
STEP-UP AND STEP-DOWN STRATEGY FOR COMBINATION TREATMENT:
BEYOND GUIDELINES
Chairpersons: F. Martínez García (Valencia, SPAIN)
L.Martins(Porto,PORTUGAL)
07.45
Which strategy for which patient?
G. Tocci (Rome, ITALY)
08.05
How to apply this strategy to polypill?
B.Williams(London,UNITEDKINGDOM)
08.25
Discussion
MONDAY
13
F I N A L P R OG R A M M E
111
09.00 - 10.30
Grand Amphitheatre
Topical Workshop
J CURVE FOR HYPERTENSION: THE DEBATE IS BACK!
Chairpersons: J. Blacher (Paris, FRANCE)
A. Zanchetti (Milan, ITALY)
09.00
Current status of target blood pressure
G. Mancia (Milan, ITALY)
09.20
Epidemiological evidence for the J-curve
J.P. Chalmers (Sydney, AUSTRALIA)
09.40
Evidence from RCTs: SPRINT versus HOT, ACCORD, and SPS3 studies
J. Redon (Valencia, SPAIN)
10.00
Is it time for a unique target BP?
M. Burnier (Lausanne, SWITZERLAND)
10.20
Discussion
09.00 - 11.00
Room Bordeaux
Parallel Oral Session 7A
EPIDEMIOLOGY OF HYPERTENSION AND METABOLIC DISORDERS
Chairpersons: M. Bochud (Lausanne, SWITZERLAND)
M.L. Muiesan (Brescia, ITALY)
09.00 OBESITY, INCIDENT CARDIOVASCULAR EVENTS AND ELECTROCARDIOGRAPHIC LEFT
VENTRICULAR HYPERTROPHY. THE MOLI-SANI STUDY
M.L. Muiesan 1, M. Salvetti 1, A. Di Castelnuovo 2, A. Assanelli 1, A. Paini 1, S. Costanzo 2, F. Badilini 2,
M. Vaglio 2, M.B. Donati 2, G. de Gaetano 2, E. Agabiti Rosei 1, L. Iacoviello 2
1
Brescia, 2 Pozzilli, ITALY
09.10 A COMBINATION OF SMOKING AND METABOLIC SYNDROME INCREASED THE RISK OF
INCIDENT ATRIAL FIBRILLATION: THE SUITA STUDY
Y. Kokubo, M. Watanabe, A. Higashiyama, Y.M. Nakao, T. Watanabe, M. Takegami, K. Kusamo, S. Kamakura,
Y. Miyamoto
Suita, JAPAN
112
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
09.20 MEASUREMENT OF ARTERIAL AGEING IN THE POPULATION
A. Hafez, B. Eber, T. Weber
Wels, AUSTRIA
09.30 ANTIHYPERTENSIVE DRUGS AND THE RISK OF FEMUR FRACTURE IN HYPERTENSIVE PATIENTS
IN SWEDISH PRIMARY HEALTH CARE. RESULTS FROM THE SWEDISH PRIMARY CARE CARDIOVASCULAR
DATABASE (SPCCD)
T. Bokrantz 1, L. Schiöler 1, C. Ljungman 1, T. Kahan 2, K. Bengtsson Boström 2, J. Hasselström 2, P. Hjerpe 3,
D. Mellström 1, K. Manhem 1
1
Gothenburg, 2 Stockholm, 3 Skövde, SWEDEN
09.40 TRENDS IN PREVALENCE, TREATMENT AND CONTROL OF HYPERTENSION IN CROATIAN
CONTINENTAL RURAL POPULATION: ENAH STUDY
A. Vrdoljak 1, V. Ivkovic 1, S. Karanovic 1, Z. Dika 1, V. Domislovic 1, K. Dapic 1, L. Gallineo 1, E. Ivandic 1,
J. Josipovic 1, I. Vukovic 1, J. Kos 1, M. Laganovic 1, T. Zeljkovic Vrkic 1, V. Premuzic 1, M. Abramovic Baric 2,
J. Culig 1, R. Stevanovic 1, B. Jelakovic 1
1
Zagreb, 2 Bebrina, CROATIA
09.50 TREATING HYPERTENSIVE CRISES BETWEEN GUIDELINES AND REAL-WORLD: AN ANTIHYPERTENSIVE ROLE OF ANTI-ANXIETY DRUGS?
M. Gabba, F. Salinaro, R. Mussinelli, M. Boldrini, A. Raimondi, C. Belotti, A. Maggi, T. Perrone, M.A. Bressan,
S. Perlini
Pavia, ITALY
10.00 TRENDS IN HYPERTENSION AMONG POOR FRENCH CARIBBEAN, 2003 TO 2014: BETTER
BUT STILL NOT GOOD ENOUGH
P. Carrère 1,2,3, N. Halbert 1, J. Hélène-Pelage 1, T. Lang 2, J. Inamo 2,4, A. Atallah 3
1
Pointe-à-Pitre, 2 Toulouse, 3 Basse-Terre, 4 Fort-de-France, FRANCE
10.10 AWARENESS, TREATMENT AND CONTROL OF HYPERTENSION IN GREECE: INTERIM
ANALYSIS OF THE EMENO NATIONAL EPIDEMIOLOGICAL STUDY
G.S. Stergiou 1, A. Margetaki 1, N. Boubouchairopoulou 1, B. Haidich 2, E. Papachatzi 3, G. Chlouverakis 4,
C. Chatzichristodoulou 5, G. Trypsianis 6, P. Voulgari 7, I. Alamanos 8, A. Karakosta 1, G. Touloumi 1
1
Athens, 2 Thessaloniki, 3 Patras, 4 Heraklion, 5 Larissa, 6 Alexandroupolis, 7 Ioannina, 8 Corfu, GREECE
10.20 A NATIONWIDE EVALUATION OF BLOOD PRESSURE CONTROL IN FRANCE USING HOME
BLOOD PRESSURE MONITORING: THE FRENCH LEAGUE AGAINST HYPERTENSION SURVEY (FLAHS
2015)
B. Vaïsse,B.Pannier,O.Hanon,J.-J.Mourad,X.Girerd
Paris, FRANCE
10.30 COMMON AND EMERGENT FACTORS ASSOCIATED WITH HYPERTENSION CONTROL IN
ROMANIA
R. Darabont 1,O.Tautu1, M. Ardeleanu 2, M. Dorobantu 1
1
Bucharest, 2 Timisoara, ROMANIA
MONDAY
13
10.40 LECTURE
FROM EPIDEMIOLOGIC TRANSITION THROUGHOUT THE AGES TO MODERN CARDIOVASCULAR
EPIDEMIOLOGY: FOCUS ON HYPERTENSION IN THE 21ST CENTURY
J. Blacher
Paris, FRANCE
F I N A L P R OG R A M M E
113
09.00 - 10.30
Room Maillot
Topical Workshop
TELEMEDICINE AND M-HEALTH IN HYPERTENSION MANAGEMENT:
TECHNOLOGIES, APPLICATIONS AND CLINICAL EVIDENCE
Chairpersons: J.M. Mallion (Grenoble, FRANCE)
S.Omboni(Varese,ITALY)
09.00
Telemedicine and M-Health in hypertension management: technologies, applications and
clinical evidence
S.Omboni(Varese,ITALY)
09.20
Managing hypertension in urban underserved subject using telemedicine
C.L. Neumann (Göttingen, GERMANY)
09.40
Telemedical following of hypertensive subjects resistant to a bitherapy the
BURGUNDY project
J.M. Mallion (Grenoble, FRANCE)
10.00
Telemonitoring and self management in the control of hypertension
R.McManus(Oxford,UNITEDKINGDOM)
10.20
Discussion
09.00 - 11.00
Room 342
Parallel Oral Session 7B
OBESITY AND METABOLIC SYNDROME
Chairpersons: J. Jordan (Hannover, GERMANY)
A.A. Kroon (Maastricht, NETHERLANDS)
09.00 NEUROGENIC HYPERTENSION AND THE SYMPATHO-EXCITATION IN DIET INDUCED OBESITY
K. Lim, B. Barzel, S. Burke, G.A. Head
Melbourne, AUSTRALIA
09.10 METABOLIC SYNDROME IS ASSOCIATED WITH INCREASED SYMPATHETIC NERVOUS SYSTEM
ACTIVITY AND ARTERIAL STIFFNESS IN RESISTANT HYPERTENSIVE PATIENTS
K. Dimitriadis,C.Tsioufis,E.Andrikou,A.Kasiakogias,K.Kyriazopoulos,A.Frantzeskakis,T.Kalos,I.Liatakis,
E. Koutra, D. Tousoulis
Athens, GREECE
09.20 BLOOD PRESSURE AND OBESITY METABOLOMIC STRATIFIED ANALYSIS OF A SPANISH
GENERAL POPULATION
V. Marrachelli 1, D. Monleon 1, J.M. Morales 1, F. Martínez 1, J.C. Martin-Escudero 2, J. Redon 1,2
1
Valencia, 2 Valladolid, SPAIN
114
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
09.30 LECTURE
HYPERTENSION AND NUTRITION: MYTHS AND FACTS
T. Unger
Maastricht, NETHERLANDS
09.50 UP-REGULATION OF THE NATRIURETIC PEPTIDE CLEARANCE RECEPTOR AND INHIBITION
OF LIPOLYSIS BY INSULIN: FILLING THE GAP BETWEEN METABOLIC SYNDROME AND HYPERTENSION
M. Bordicchia, M. Ceresiani, M. Pavani, R. Sarzani
Ancona, ITALY
10.00 EFFECT OF ACUTE HYPERGLYCEMIA ON RENAL TISSUE OXYGENATION AS MEASURED WITH
BOLD-MRI IN OVERWEIGHT INDIVIDUALS
N. Vakilzadeh, B. Milani, C. Anex, M. Stuber, A. Zanchi, M. Burnier, M. Pruijm
Lausanne, SWITZERLAND
10.10 METABOLIC SYNDROME IN EUROPEAN RURAL POPULATION: DATA FROM THE BRISGHELLA
HEART STUDY (ITALY) AND ENAH STUDY (CROATIA)
A. Parini 1, V. Ivkovic 2, A. Vrdoljak 2, M. Abramovic Baric 3, S. Bacchelli 1, M. Cagnati 1, A.F.G. Cicero 1,
S. D’Addato 1, D. degli Esposti 1, M. Fucek 2, E. Grandi 1, E. Ivandic 2, S. Karanovic 2, M. Laganovic 2, I. Pecin 2,
M. Rosticci 1, D. Rogic 4, B. Jelakovic 2, C. Borghi 1
1
Bologna, ITALY, 2 Zagreb, 3 Slavonski Brod, CROATIA
10.20 IMPACT OF LEFT VENTRICULAR GEOMETRIC REMODELLING ON INSULIN-RESISTANCEASSOCIATED DECREASES IN DIASTOLIC FUNCTION IN A COMMUNITY SAMPLE
G. Norton,V.Peterson,A.Raymond,C.D.Libhaber,A.M.E.Millen,O.H.I.Majane,M.J.Maseko,A.J.Woodiwiss
Johannesburg, SOUTH AFRICA
10.30 INFLUENCE OF GENDER ON THE RELATIONSHIPS BETWEEN NEW INDICES OF ADIPOSITY AND
LEFT VENTRICULAR MASS AND HYPERTROPHY IN HYPERTENSIVE PATIENTS
G. Mulè, A. Castiglia, M.K. Schillaci, C. Luna, M. Morreale, G. Geraci, D. Altieri, L. Calandra, S. Cottone, E. Nardi
Palermo, ITALY
10.40 CHEMERIN AND BLOOD PRESSURE AND METABOLIC SYNDROME IN POSTMENOPAUSAL
WOMEN
A.Olszanecka, K. Kawecka-Jaszcz, D. Czarnecka
Kraków, POLAND
10.50 EFFECT OF BARIATRIC SURGERY ON VASCULAR AND RENAL BIOMARKERS IN MORBIDLY
OBESE, NORMOTENSIVE, NON-DIABETIC PATIENTS
R.M. Bruno, E. Vitolo, L. Giannini, S. Taddei, L. Ghiadoni, A. Solini
Pisa, ITALY
MONDAY
13
F I N A L P R OG R A M M E
115
09.00 - 11.00
Room 351
Parallel Oral Session 7C
GENETICS, GENOMICS, PROTEOMICS, METABOLOMICS
Chairpersons: A.F.Dominiczak(Glasgow,UNITEDKINGDOM)
O.Melander(Malmö,SWEDEN)
09.00 UROMODULIN-NACL INTERACTION ON MRNA EXPRESSION OF ION TRANSPORTERS IN
ISOLATED TUBULES OF UMOD+/+ AND UMOD-/- MICE
L. Graham, D. Graham, M.W. McBride, A.F. Dominiczak, S. Padmanabhan
Glasgow, UNITED KINGDOM
09.10 BLOOD PRESSURE-ASSOCIATED POLYMORPHISMS IN SLC4A7 (SODIUM/BICARBONATE
CO-TRANSPORTER NBCN1) ARE LINKED WITH GENE EXPRESSION AND INTRACELLULAR PH REGULATION
F. Ng 1, E. Bødtkjer 2,M.J.Caulfield1, S. Ye 1,3
1
London, UNITED KINGDOM, 2 Aarhus, DENMARK, 3 Leicester, UNITED KINGDOM
09.20 KLOTHO GENE POLYMORPHISM INTERACTS WITH ADDUCIN-ENDOGENOUS OUABAINNA+-K+ ATPASE SYSTEM IN SALT SENSITIVE HYPERTENSION
S. Tentori, C. Lanzani, L. Citterio, E. Brioni, M. Simonini, L. Zagato, E. Messaggio, P. Manunta
Milan, ITALY
09.30 GENETIC ASSOCIATION STUDY IDENTIFIES COMMON VARIATION IN PHACTR1 TO ASSOCIATE
WITH FIBROMUSCULAR DYSPLASIA
S.R. Kiando 1, N. Tucker 2, L.J. Castro-Vega 1, D. Cusi 3, P. Galan 4, J.-P. Empana 1,J.W.Olin5, H.L. Gornik 6,
P.-F. Plouin 1, I.J. Kullo 7, D.J. Milan 2, S.K. Ganesh 8, P. Boutouyrie 1, J. Kovacic 5, X. Jeunemaitre 1,
N. Bouatia-Naji 1
1
Paris, FRANCE, 2 Charlestown, MA, USA, 3 Milan, ITALY, 4 Bobigny FRANCE, 5 New York, NY,
6
Cleveland, OH, 7 Rochester, MN, 8 Ann Arbor, MI, USA
09.40 AORTIC STIFFNESS AND PULSE WAVE ANALYSIS IN CHILDREN AND ADOLESCENTS WITH
MARFAN SYNDROME
A. Grillo 1,2, A. Pini 1, L. Gao 3,G.Trifirò4, S. Marelli 1, F. Viecca 1, L. Salvi 1, P. Salvi 1, M. Rovina 2, R. Carretta 2,
G. Parati 1
1
Milan, 2 Trieste, ITALY, 3 Beijing, CHINA, 4 Rho, ITALY
09.50 VASCULAR TRANSCRIPTOME PROFILING IDENTIFIES SPHINGOSINE KINASE 1 AS A KEY
MODULATOR OF ANGIOTENSIN II-INDUCED HYPERTENSION
M. Siedlinski 1, P. Szczepaniak 1, R. Nosalski 1, A. Ludwig-Galezowska 1, T. Mikolajczyk 1,2, M. Filip 1, P. Wolkow 1,
T. Guzik 1,2
1
Kraków, POLAND, 2 Glasgow, UNITED KINGDOM
10.00 LECTURE
SYSTEMS BIOLOGY APPLIED TO THE DISCOVERY OF NOVEL CV DRUGS
M.J.Caulfield
London, UNITED KINGDOM
116
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
10.20 DIASTOLIC LEFT VENTRICULAR FUNCTION IN RELATION TO COLLAGEN-SPECIFIC URINARY AND
SERUM COLLAGEN BIOMARKERS IN A GENERAL POPULATION
Z. Zhang 1, S. Ravassa 2, W.Y. Yang 1, T. Petit 1, Z. Petra 3, B. Lopez 2, F.F. Wei 1, C. Pontillo 3, L. Thijs 1, L. Jacobs 1,
A. Gonzalez 2, T. Koeck 3, D. Christian 4, J.U. Voigt 1, P. Verhamme 1, T. Kuznetsova 1, J. Diez 2, H. Mischak 3,4,
J.A. Staessen 1,5
1
Leuven, BELGIUM, 2 Pamplona, SPAIN, 3 Hannover, GERMANY, 4 Glasgow, UNITED KINGDOM,
5
Maastricht, NETHERLANDS
10.30 BLOOD-PRESSURE ASSOCIATED VARIANTS IN NPR3 AFFECT HUMAN VASCULAR SMOOTH
MUSCLE CELLS PROLIFERATION AND CALCIUM RESPONSE TO ANGIOTENSIN II
M. Ren,F.Ng,K.Witkowska,M.Baron,A.TownsendNicholson,Q.Xiao,A.Hobbs,S.Ye,M.J.Caulfield
London, UNITED KINGDOM
10.40 COFFEE, SMOKING HABITS AND BLOOD PRESSURE IN THE LIGHT OF A SINGLE NUCLEOTIDE
POLIMORPHYSM OF CYP1A1/1A2 GENE
A. Tagetti 1, U. Ericson 2, M. Montagnana 1, P. Almgren 2, P.M. Nilsson 2, G. Engstrom 2, B. Hedblad 2, P. Minuz 1,
M.Orho-Melander2,O.Melander2, C. Fava 1
1
Verona, ITALY, 2 Lund, SWEDEN
10.50 IDENTIFICATION OF GENE VARIANTS ASSOCIATED WITH ANTIHYPERTENSIVE
RESPONSES TO BETA BLOCKERS AND LOSARTAN
J. Rimpelä, T.P. Hiltunen, F. Fyhrquist, K.K. Kontula
Helsinki, FINLAND
09.00 - 11.00
Room 352
Parallel Oral Session 7D
RESISTANT HYPERTENSION
Chairpersons: S.E.Kjeldsen(Oslo,NORWAY)
R.E. Schmieder (Erlangen, GERMANY)
09.00 SAFETY AND BLOOD PRESSURE EFFECTS OF SECOND-VERSUS FIRST-GENERATION SYSTEM FOR
ADMINISTERING BAROREFLEX ACTIVATION THERAPY
R. Wachter 1, M. Halbach 2, G.L. Bakris 3, J. Bisognano 4, H. Haller 5, J. Beige 6, A.A. Kroon 7, M. Nadim 8,
E. Lovett 9, J. Schafer 9, P.W. de Leeuw 7
1
Göttingen, 2 Cologne, GERMANY, 3 Chicago, IL, 4 Rochester, NY, USA, 5 Hannover, 6 Leipzig, GERMANY,
7
Maastricht, NETHERLANDS, 8 Los Angeles, CA, 9 Minneapolis, MN, USA
09.10 INCREASE IN PLASMA COPEPTIN CONCENTRATION IN PATIENTS WITH CONFIRMED RESISTANT
ESSENTIAL HYPERTENSION
J. Dubourg 1, M. Mendes 2, A. Blanchard 1, M. Frank 1, L. Amar 1, G. Bobrie 1, P.-F. Plouin 1, M. Azizi 1
1
Paris, FRANCE, 2 Funchal, PORTUGAL
09.20 RENAL DENERVATION IN HYPERTENSIVE PATIENTS NOT ON BLOOD PRESSURE
LOWERING DRUGS
M. Sanders 1, R. de Jager 1, M. Bots 1, M. Lobo 2, P.J. Blankestijn 1
1
Utrecht, NETHERLANDS, 2 London, UNITED KINGDOM
F I N A L P R OG R A M M E
117
MONDAY
13
09.30 CHANGES IN RENAL HEMODYNAMIC AND TUBULAR SODIUM HANDLING ONE YEAR
AFTER TRANSCATHETER RENAL DENERVATION IN RESISTANT HYPERTENSION
F. Megdiche, N. Vakilzadeh, M. Maillard, E. Grouzmann, M. Burnier, G. Wuerzner
Lausanne, SWITZERLAND
09.40 DISTAL RENAL DENERVATION VERSUS CONVENTIONAL MODE OF THE INTERVENTION:
A RANDOMISED CONTROLLED TRIAL
S. Pekarskiy, A. Baev, V. Mordovin, T. Ripp, A. Falkovskaya, G. Semke, V. Lichikaki, M. Kuzmichkina, I. Zubanova,
S. Popov
Tomsk, RUSSIA
09.50 RENAL HEMODYNAMIC CHANGES AFTER RENAL DENERVATION
R.S. Schmieder, A. Schmid, R. Janka, T. Ditting, R. Veelken, M. Uder, R.E. Schmieder, C.Ott
Erlangen, GERMANY
10.00 INFLUENCE OF RENAL SYMPATHETIC DENERVATION ON BLOOD PRESSURE VARIABILITY:
EXPERIENCE AT 11 EUROPEAN EXPERT CENTERS
A. Persu 1, D. Gordin 2, L. Jacobs 3, L. Thijs 3, M.L. Bots 4, A. Miroslawska 5, J. Spaak 6, J. Rosa 7, M. De Jong 8,
E. Berra 1, F.E. Fadl Elmula 9, G. Wuerzner 10, A. Taylor 11,A.Olszanecka12, D. Czarnecka 12, P.B. Mark 11,
M. Burnier 10, J. Renkin 1, S.E. Kjeldsen 9, J. Widimský 7, A. Elvan 8, T. Kahan 6, T. Steigen 5, P.J. Blankesteijn 4,
I. Tikkanen 2, J.A. Staessen 3
1
Brussels, BELGIUM, 2 Helsinki, FINLAND, 3 Leuven, BELGIUM, 4 Utrecht NETHERLANDS, 5 Tromsø, NORWAY,
6
Stockholm, SWEDEN, 7 Prague, CZECH REPUBLIC, 8 Zwolle, NETHERLANDS, 9 Oslo, NORWAY,
10
Lausanne, SWITZERLAND, 11 Glasgow, UNITED KINGDOM, 12 Kraków, POLAND
10.10 SEVERE RESISTANT HYPERTENSION EXHIBITS THE GREATEST CARDIOVASCULAR RISK
AMONG TREATED UNCONTROLLED HYPERTENSIVES: A 4-YEAR FOLLOW-UP STUDY
A. Kasiakogias,C.Tsioufis,A.Kordalis,K.Dimitriadis,E.Andrikou,I.Andrikou,D.Flessas,D.Chatzis,
D. Aragiannis, P. Valenti, D. Tousoulis
Athens, GREECE
10.20 LECTURE
IS RDN STILL ALIVE FOR THE TREATMENT OF RESISTANT HYPERTENSION?
C.Tsioufis
Athens, GREECE
10.40 THE ROLE OF ADDING SPIRONOLACTONE AND RENAL DENERVATION IN TRUE RESISTANT
HYPERTENSION. ONE-YEAR OUTCOMES OF RANDOMIZED PRAGUE-15 STUDY
J. Rosa 1, P. Widimský 1, P. Waldauf 1, L. Lambert 1, T. Zelinka 1, M. Taborsky 2, M. Branny 3, P. Tousek 1,
O.Petrak1, K. Curila 1, F. Bednar 1, R. Holaj 1, B. Strauch 1, J. Vaclavik 2, I. Nykl 3, Z. Kratka 1, E. Kocianova 2,
O.Jiravsky3, T. Indra 1, J. Widimský 1
1
Prague, 2 Olomouc, 3 Trinec, CZECH REPUBLIC
10.50 THE EFFECT OF RENAL DENERVATION ON ADIPOKINES IN PATIENTS WITH RESISTANT
HYPERTENSION
N. Eikelis 1, D. Hering 1,2, P. Marusic 1,2, A. Walton 1, E. Lambert 1, H. Krum 1, G. Lambert 1, M. Esler 1,
M.P. Schlaich1,2
1
Melbourne, 2 Perth, AUSTRALIA
118
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
09.00 - 10.00
Room 251
How-to Session
HOW TO EVALUATE AND MANAGE CONGESTIVE HEART FAILURE WITH
PRESERVED SYSTOLIC FUNCTION?
Chairpersons: C. Cuspidi (Milan, ITALY)
S. Taddei (Pisa, ITALY)
09.00
How to manage?
M. Tadic (Belgrade, SERBIA)
09.30
How to evaluate?
P. Gosse (Bordeaux, FRANCE)
09.00 - 10.30
Room 252
Joint Session
ESH (European Society of Hypertension)
ARTERY (Association for Research into Arterial
Structure and Physiology)
on behalf of the ESH Working Group on Vascular Structure and Function, and the ARTERY Society
ARTERIOSCLEROSIS VS ATHEROSCLEROSIS: IS THE DIFFERENCE
CLINICALLY SOUND?
Chairpersons: P. Boutouyrie (Paris, FRANCE)
C. Vlachopoulos (Athens, GREECE)
09.00
Different molecular pathways
P. Lacolley (Nancy, FRANCE)
09.20
How to measure?
L.M. Van Bortel (Ghent, BELGIUM)
09.40
Which surrogate end-point in clinical practice?
C. Vlachopoulos (Athens, GREECE)
10.00
Therapeutic implications
C.D.A. Stehouwer (Maastricht, NETHERLANDS)
10.20
Discussion
MONDAY
13
F I N A L P R OG R A M M E
119
09.00 - 10.30
Room 253
Late-Breakers
SESSION 3
Chairpersons: J.K.Cruickshank(London,UNITEDKINGDOM)
P.Cunha(Guimarães,PORTUGAL)
09.00 CENTRAL BLOOD PRESSURE AND SALT INTAKE IN A POPULATION COHORT FROM A HIGH
STROKE INCIDENCE AREA: THE GUIMARÃES/VIZELA STUDY
P. Cunha 1, J. Cotter 1,P.Oliveira2, I. Vila 1, P. Boutouyrie 3, S. Laurent 3, P.M. Nilsson 4, A. Scuteri 5, N. Sousa 1
1
Guimarães, Braga, 2 Porto, PORTUGAL, 3 Paris, FRANCE, 4 Malmö, SWEDEN, 5 Rome, ITALY
09.10 NON-INVASIVE HEMODYNAMIC MONITORING IN UNCONTROLLED HYPERTENSIVE PATIENTS.
EFFECT ON ARTERIAL STIFFNESS AND CENTRAL BLOOD PRESSURE: THE BEAUTY STUDY
P. Boutouyrie 1, F.E. Fadl Elmula 2, P. Rebora 3, A. Talvik 4, S. Salerno 3, E. Miszkowska-Nagorna 4, X. Liuc 4,
T. Comotti 3, A. Larstorp 2, M. Rostrup 2, E. Qwierblewska 5, M. Valsecchi 3, S.E. Kjeldsen 2, M. Viigimaa 4,
K. Narkiewicz 5, G. Parati 3, S. Laurent 1
1
Paris, FRANCE, 2 Oslo, NORWAY, 3 Milan, ITALY, 4 Tallin, ESTONIA, 5 Gdansk, POLAND
09.20 THE RELATIONSHIP BETWEEN DIASTOLIC FUNCTION AND CENTRAL HEMODYNAMICS IN
DIABETIC HYPERTENSIVE PATIENTS
D. Agnoletti 1, A. Lieber 2, F. Valbusa 1, G. Arcaro 1, M.E. Safar 2, J. Blacher 2
1
Negrar, ITALY, 2 Paris, FRANCE
09.30 FIRST IN MAN MEASUREMENT OF ARTERIAL STIFFNESS USING A CONNECTED BATHROOM
SCALE: CALIBRATION AGAINST SPHYGMOCOR
H. Khettab 1, D. Campo 2, R. Yu 2, N. Buard 2, P. Boutouyrie 1
1
Paris, 2 Issy les Moulineaux, FRANCE
09.40 REDUCING ARTERIAL STIFFNESS INDEPENDENTLY OF BLOOD PRESSURE: PROOF OF
CONCEPT? THE RANDOMISED, FACTORIAL ‘VASERA’ TRIAL
C.E. Mills, V. Govoni, L. Faconti, S. Morant, M.L. Casagrande, P. Maskell, A. Masani, H. Crickmore, F. Iqbal,
A.J. Webb, J.K. Cruickshank
London, UNITED KINGDOM
09.50 EFFECTS OF SPIRONOLACTONE AND INORGANIC NITRATE AS BEETROOT JUICE ON CARDIAC
STRUCTURE AND PERFORMANCE IN PATIENTS AT RISK OF OR WITH TYPE 2 DIABETES: THE VASERA
TRIAL
L. Faconti, C.E. Mills, S. Morant, H. Gu, B. Jiang, J.K. Cruickshank, A.J. Webb
London, UNITED KINGDOM
10.00 EFFECTS OF LERCANIDIPINE/ENALAPRIL COMPARED WITH AMLODIPINE/ENALAPRIL AND
HYDROCHLOROTHIAZIDE/ENALAPRIL ON TARGET ORGAN DAMAGE AND SYMPATHETIC ACTIVITY IN
HYPERTENSION
C.Tsioufis, A. Kasiakogias, K. Dimitriadis, T. Kalos, I. Liatakis, D. Konstantinidis, E. Andrikou,
L. Nikolopoulou, E. Vlachos, K. Kyriazopoulos, D. Tousoulis
Athens, GREECE
10.10 EFFECTS OF LTP2 PEPTIDE RICH WHEAT PRODUCTS ON BLOOD PRESSURE, ENDOTHELIAL
REACTIVITY AND OTHER CARDIOVASCULAR RISK FACTORS: A DOUBLE-BLIND, CROSS-OVER,
RANDOMIZED CLINICAL TRIAL
A.F.G. Cicero, R. Urso, M. Rosticci, F. Fogacci, M. Giovannini, E. Grandi, C. Borghi
Bologna, ITALY
10.20 THE ACUTE EFFECT OF THE SPECIFIC CREATINE KINASE INHIBITOR BETA-GPA IN HEALTHY MAN
(ABC-TRIAL): A RANDOMIZED PLACEBO AND ACTIVE CONTROLLED FIRST-IN-HUMAN TRIAL
F. Karamat 1, D.L. Horjus 1, Y.C. Haan 1, L. van der Woude 1, M.C. Schaap 1,I.Oudman1,G.A. van Montfrans 1,
R. Nieuwland 1, J.F. Clark 2, A. Sturk 1, L.M. Brewster 1,2
1
Amsterdam, NETHERLANDS, 2Cincinnati, OH, USA
120
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
11.00 - 12.30
Grand Amphitheatre
Plenary Session
Chairpersons: M. Azizi (Paris, FRANCE)
G. Mancia (Milan, ITALY)
Debates
11.00
Non instrumental vs instrumental treatment of resistant hypertension
- Medical strategies to lower BP to target
A.Januszewicz(Warsaw,POLAND)
- Devices, the key solution
R.E. Schmieder (Erlangen, GERMANY)
11.40
12.20
Is it necessary to revise BP targets after SPRINT?
- Yes
S.Oparil(Birmigham,AL,USA)
- No
S.E.Kjeldsen(Oslo,NORWAY)
Closing Remarks
E. Agabiti Rosei (Brescia, ITALY)
X. Jeunemaitre (Paris, FRANCE)
13.00 - 14.30
Grand Amphitheatre
Teaching Seminar
MANAGEMENT OF HYPERTENSION 3
Chairpersons: E. Agabiti Rosei (Brescia, ITALY)
B. Waeber (Lausanne, SWITZERLAND)
13.00
13.15
Organ damage and risk factors: can we afford to explore them all?
M.H.Olsen(Glostrup,DENMARK)
Discussion
13.20
Parameters of organ damage in hypertension: do they all react similarly to
antihypertensive treatment?
E. Agabiti Rosei (Brescia, ITALY)
Discussion
13.35
13.40
13.55
13
Renal nerve ablation: is the last word said?
R.E. Schmieder (Erlangen, GERMANY)
Discussion
14.15
Hypertension in surgical patients: how to control before, during and immediately
after surgery?
H. Bouaziz (Nancy, FRANCE)
Discussion
14.20
General Discussion
14.00
MONDAY
F I N A L P R OG R A M M E
121
14.30 - 16.00
Grand Amphitheatre
Topical Workshop
THE BONE-KIDNEY-VESSEL CONNECTION
Chairpersons: F. Jarraya (Sfax, TUNISIA)
P.Sarafidis(Thessaloniki,GREECE)
14.30
Phosphate and cardiovascular disease toxicity
Z.A. Massy (Paris, FRANCE)
14.50
Bone-Vascular axis: the potential role of osteoblasts
C.Shanahan(London,UNITEDKINGDOM)
15.10
Hemodynamic consequence of arterial calcification
G. London (Paris, FRANCE)
15.30
Vascular calcifications and biomarkers
G. Schlieper (Aachen, GERMANY)
15.50
Discussion
14.30 - 16.00
Room Bordeaux
Parallel Oral Session 8A
SPORT AND EXERCISE
Chairpersons: A.Brady(Glasgow,UNITEDKINGDOM)
J. Sharman (Hobart, AUSTRALIA)
14.30 EXERCISE-INDUCED HYPERTENSION AND CARDIAC HYPERTROPHY IN EPINEPHRINE-DEFICIENT
MICE
P. Mendes, R. Martinho, S. Leite, A. Leite-Moreira, A. Lourenço, M. Moreira-Rodrigues
Porto, PORTUGAL
14.40 LECTURE
EXERCISE BLOOD PRESSURE
S.E. Kjeldsen
Oslo, NORWAY
15.00 POST-EXERCISE EFFECTS ON AORTIC WAVE REFLECTION DERIVED FROM WAVE SEPARATION
ANALYSIS IN PRE-HYPERTENSIVES AND HYPERTENSIVES: COMPARISON WITH CHANGES IN
AUGMENTATION INDEXES
A. Millen, A.J. Woodiwiss, G.R. Norton
Johannesburg, SOUTH AFRICA
122
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
15.10 LONG-TERM EFFECTS OF LEISURE TIME PHYSICAL ACTIVITY ON SMALL ARTERY ELASTICITY
INDEX: THE SKARABORG PROJECT
B. Daka 1, M. Allison 2, C.A. Larsson 3, M.I. Hellgren 1, L. Råstam 3, U.L.F. Lindblad 1
1
Gothenburg, SWEDEN, 2 San Diego, CA, USA, 3 Malmö, SWEDEN
15.20 AMBULATORY BLOOD PRESSURE REDUCTION FOLLOWING HIGH-INTENSITY INTERVAL
EXERCISE PERFORMED IN WATER OR DRYLAND CONDITION
P. Sosner 1, M. Gayda 2,O.Dupuy1, M. Garzon 2, C. Lemasson 1, V. Gremeaux 3, J. Lalonge 2, M. Gonzales 2,
D. Hayami 2, M. Juneau 2, A. Nigam 2, L. Bosquet 1
1
Poitiers, FRANCE, 2 Montreal, CANADA, 3 Dijon, FRANCE
15.30 REGULAR PHYSICAL ACTIVITY ATTENUATES THE ASSOCIATION BETWEEN COFFEE
CONSUMPTION AND CARDIOVASCULAR EVENTS IN HYPERTENSION. THE HARVEST
L. Mos 1, C. Fania 2, F. Saladini 2, A. Mazzer 3, S. Cozzio 4, A. Bortolazzi 5, G. Garavelli 6, E. Casiglia 2, P. Palatini2
1
San Daniele del Friuli, 2 Padua, 3 Vittorio Veneto, 4 Trento, 5 Rovigo, 6 Cremona, ITALY
15.40 HYPERCAPNIC-HYPOXIC TRAINING PROTOCOLS IN HYPERTENSIVE PATIENTS’ TREATMENT AND
REHABILITATION
A. Sydorchuk, R. Sydorchuk, L. Sydorchuk, T. Boychuk, I. Sydorchuk
Chernivtsi, UKRAINE
15.50 CARDIAC REHABILITATION IN HYPERTENSIVE PATIENTS: COMPARISON BETWEEN TWO
PROTOCOLS
L.B. Parreira, P. Jardim, A.L.L. Sousa, T. Jardim, W.M. Sousa, A.F.O. Justo, W.K.S.B. Souza,
P.V.O. Vitorino
Goiânia, BRAZIL
14.30 - 16.00
Room Havane
Topical Workshop
VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY: AN UPDATE
Chairpersons: S.Filipova(Bratislava,SLOVAKREPUBLIC)
A. Protogerou (Athens, GREECE)
14.30
Is visit-to-visit BP variability ready for routine clinical practice?
G. Parati (Milan, ITALY)
14.50
Visit-to-visit BP variability versus other BP variabilities
E. Dolan (Dublin, IRELAND)
15.10
Visit-to-visit BP variability in clinical trials
G. Schillaci (Perugia, ITALY)
15.30
Information and Communication Technology applied to BP control in low and
middle countries
P. van de Borne (Brussels, BELGIUM)
15.50
Discussion
MONDAY
13
F I N A L P R OG R A M M E
123
14.30 - 16.00
Room Maillot
Parallel Oral Session 8B
SLEEP APNOEA AND NEURAL MECHANISMS
Chairpersons: I.E. Chazova (Moscow, RUSSIA)
G. Grassi (Milan, ITALY)
14.30 PERIODIC LIMB MOVEMENT DURING SLEEP, SLEEP RELATED BREATHING DISORDERS AND
HYPERTENSION IN THE ESADA COHORT
C. Lombardi 1, G. Parati 1,2, D. Soranna 1, A. Zambon 1, A. Faini 1, P. Mattaliano 1, L. Grote 3, J. Hedner 3
1
Milan, 2 Monza, ITALY, 3 Gothenburg, SWEDEN
14.40 ARTERIAL STIFFNESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNOEA SYNDROME:
AN INDIVIDUAL META-ANALYSIS OF CONTRIBUTING FACTORS
R. Tamisier 1, J.C. Borel 1, S. Millasseau 2, L.L.M. Galerneau 1, M. Destors 1, M. Perrin 1, J.L. Pepin 1
1
Grenoble, 2 Saint-Leu-la-Forêt, FRANCE
14.50 EFFECT OF CPAP THERAPY ON CENTRAL PRESSURE AND RIGIDITY IN PATIENTS WITH TYPE 2
DIABETES
N. Burko,L.Salyamova,I.Matrosova,V.Oleynikov
Penza, RUSSIA
15.00 LECTURE
HYPERTENSION AND HEART RHYTHM DISTURBANCES IN PATIENTS WITH OSAS
K. Narkiewicz
Gdansk, POLAND
15.20 GENDER DIFFERENCES IN THE IMPACT OF DYSFUNCTIONAL COPING IN A HYPERTENSIVE
POPULATION
R.M. Bruno, L. Ghiadoni, S. Cervia, R. Biancheri, M. Mauri, S. Taddei, L. Palagini
Pisa, ITALY
15.30 COAGULATION SYSTEM ACTIVITY IN PATIENTS WITH OBSTRUCTIVE SLEEP APNOEA SYNDROME
AND ARTERIAL HYPERTENSION
T. Bugaev, N.V. Ageeva, A.B. Dobrovolskiy, A.Y. Litvin, I.E. Chazova
Moscow, RUSSIA
15.40 HYPOTENSIVE THERAPY IN PATIENTS WITH OBSTRUCTIVE SLEEP APNOEA
P. Talarowska,A.Segiet,M.Rozanska,O.Mozenska,D.A.Kosior
Warsaw, POLAND
15.50 UTILITY OF SLEEP-POLYGRAPHIC STUDIES IN TERTIARY-CARE HYPERTENSION OUT-PATIENT
CLINIC
M.M. Nowak,A.Komand,D.Ostrowka,M.Jancewicz,R.Nowak,T.Wawrowski,M.Nowak,J.Wolf,K.Narkiewicz
Gdansk, POLAND
124
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
14.30 - 15.30
Room 342
How-to Session
HOW TO USE NOVEL IMAGING FOR INVESTIGATING HEART-VESSEL
COUPLING IN HYPERTENSION?
Chairpersons: T. Denolle (Dinard, FRANCE)
Z.Gaciong(Warsaw,POLAND)
14.30
Tissue tracking technology for assessing cardiac mechanics
M.L. Muiesan (Brescia, ITALY)
15.00
MRI technology for assessing aortic geometry and stiffness
E. Mousseaux (Paris, FRANCE)
14.30 - 16.00
Room 351
Parallel Oral Session 8C
EXPERIMENTAL HYPERTENSION AND PHARMACOLOGY
Chairpersons: F. Jaisser (Paris, FRANCE)
C. Savoia (Rome, ITALY)
14.30 A NOVEL CANDIDATE GENE IDENTIFIED IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE
RATS HAS A MAJOR IMPACT ON ADVERSE LEFT VENTRICULAR REMODELLING IN SALT-INDUCED
HYPERTENSION
K. Grabowski, L. Herlan, A. Eisenreich, A. Schulz, D.N. Müller, R. Plehm, M. Bader, R. Kreutz
Berlin, GERMANY
14.40 SENESCENCE INCREASES VASCULAR SMOOTH MUSCLE CONTRACTIONS THROUGH INCREASED
RHO KINASE ACTIVITY IN FEMALE MOUSE AORTA
S. Novella 1, X. Vidal-Gómez 1, I. Pérez-Monzó 1, A. Mompeón 1, D. Pérez-Cremades 1, A.P. Dantás 2, G. Segarra 1,
C. Hermenegildo 1, P. Medina 1
1
Valencia, 2 Barcelona, SPAIN
MONDAY
14.50 IMPROVED ENDOTHELIAL FUNCTION AND E-NOS EXPRESSION AND FUNCTION IN
TRANSGLUTAMINASE-2 KNOCK-OUT MICE INFUSED WITH ANGIOTENSIN-II
C. Savoia, E. Arrabito, S. Chiandotto, C. Nicoletti, M. Volpe
Rome, ITALY
13
15.00 THE FLOW DETECTION ROLE OF THE VASCULAR EPITHELIAL SODIUM CHANNEL (ENAC) IN AN
EXPERIMENTAL MODEL OF HYPERTENSION: THE NOVEL TARGET FOR SPIRONOLACTONE THERAPY?
Z. Ashley, C. Leader, I. Sammut, F. Mcdonald, R. Walker, M. Fronius
Dunedin, NEW ZEALAND
F I N A L P R OG R A M M E
125
15.10 A2A RECEPTOR-MEDIATED ACTIVATION OF REGULATORY T CELLS ATTENUATES HYPERTENSIONINDUCED CARDIORENAL CONSEQUENCE
L. Kong, C. Ruan, Y. Ma, P. Gao
Shanghai, CHINA
15.20 CENTRAL ANTIHYPERTENSIVE EFFECTS OF CHRONIC TREATMENT WITH RB150/QGC001, AN
ORALLY ACTIVE AMINOPEPTIDASE A INHIBITOR PRODRUG IN DOCA-SALT HYPERTENSIVE RATS
M. Yannick, R. Hmazzou, A. Flahault, C. Llorens-Cortes
Paris, FRANCE
15.30 DEPLETION OF THE P22PHOX GENE REDUCED BLOOD PRESSURE RESPONSE TO GLU
INJECTION INTO RVLM IN SHRSP
H.Zahid,M.Ferdaus,H.Ohara,M.Isomura,T. Nabika
Izumo, JAPAN
15.40 INTERACTION BETWEEN PERIPHERAL ALPHA-ADRENERGIC RECEPTORS AND NEURONAL
NITRIC OXIDE SYNTHASE
F. Khan, S. Jiang, B. Farukh, S. Brett, A.M. Shah, P. Chowienczyk
London, UNITED KINGDOM
15.50 CARDIOVASCULAR RISK FACTORS PROGRAMMED BY ZINC DEFICIENCY DURING GROWTH
C. Arranz, F. Mendez Garrido, N. Gobetto, A. Castañon, S. Schäfer, D. Lucero, R. Elesgaray, L. Schreier, A. Tomat
Buenos Aires, ARGENTINA
14.30 - 16.00
Room 251
Parallel Oral Session 8D
INNOVATIVE TECHNIQUES AND DEVICES
Chairpersons: P.Chowienczyk(London,UNITEDKINGDOM)
F. Mahfoud (Homburg, GERMANY)
14.30 CONTROLLING AND LOWERING BLOOD PRESSURE WITH THE MOBIUSHD DEVICE: FIRST-INMAN INTERIM RESULTS (CALM-FIM STUDY)
W. Spiering 1, J. Van der Heyden 2, A.A. Kroon 3, A.H. van den Meiracker 4, C. Devireddy 5, M.T. Foster III 6,
M.G.H. Ghali 7,F.O.Mendelsohn8, H. Reuter 9, M.C. Bates 10
1
Utrecht, 2 Nieuwegein, 3 Maastricht, 4 Rotterdam, NETHERLANDS, 5 Atlanta, GA, 6 Knoxville, TN,
7
Des Moines, IA, 8 Birmingham, AL, USA, 9 Köln, GERMANY, 10 Charleston, SC, USA
14.40 FIRST IN MAN TREATMENT OF SEVERE BP VARIABILITY WITH BAROREFLEX ACTIVATION
THERAPY
M. Lobo 1, M.Y. Adeel 2, C.B. Wolff 1,P.O.Julu1,3, M. Shah 1, D.M. Collier 1, M. Saxena 1, C. Floyd 1, T. Brier 1,
V. Kapil 1,O.Mukhtar1, A. Radunovic 1, N. Sutcliffe 1, F. Sharif 2
1
London, UNITED KINGDOM, 2 Galway, IRELAND, 3 Froson, SWEDEN
126
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
14.50 MEASUREMENT OF ARTERIAL STIFFNESS BY ULTRAFAST ECHO: COMPARISON WITH
ECHOTRACKING IN NORMOTENSIVE SUBJECTS AND HYPERTENSIVE PATIENTS
L. Marais 1, M. Pernot 1, H. Khettab 1, M. Tanter 1, E. Messas 1, M. Zidi 2, S. Laurent 1, P. Boutouyrie 1
1
Paris, 2 Créteil, FRANCE
15.00 COMPARISON STUDY OF CAROTID DISTENSION WAVES MEASURED WITH A NON-INVASIVE
OPTICAL FIBRE SENSOR AND AORTIC INVASIVE PRESSURE WAVES
C. Leitao 1, P. Antunes 1, V. Afreixo 1, P. Andre 1,2, L. Pinto 1, R. Fernandes 3, M. Costa 3, J. Mesquita Bastos 1
1
Aveiro, 2 Lisbon, 3 Coimbra, PORTUGAL
15.10 LAYER-SPECIFIC QUANTIFICATION OF MYOCARDIAL DEFORMATION MAY DISCLOSE THE
SUBCLINICAL SYSTOLIC DYSFUNCTION AND THE MECHANISM OF RESERVED EJECTION FRACTION IN
HYPERTENSIVE PATIENTS
T. Xu 1, J.P. Sun 2, A.P. Lee 2, Y. Yang 1, X.S. Yang 2, Y. Li 1, C. Yu 2, J. Wang 1
1
Shanghai, 2 Hong Kong, CHINA
15.20 LECTURE
INFORMATION AND COMMUNICATION TECHNOLOGY APPLIED TO BP MEASUREMENT
G. Parati
Milan, ITALY
15.40 OCULAR FUNDUS PHOTOGRAPHY WITH A SMARTPHONE DEVICE IN ACUTE HYPERTENSION
M.L. Muiesan, M. Riviera, C. Pintossi, F. Bertacchini, E. Colonetti, M. Salvetti, A. Paini, M. Poli,
F. Semeraro, E. Agabiti Rosei, A. Russo
Brescia, ITALY
15.50 EFFECTIVENESS OF A SMARTPHONE APPLICATION FOR IMPROVING HEALTHY LIFESTYLES.
A RANDOMIZED CLINICAL TRIAL (EVIDENT II): BASELINE DATA
J.I. Recio-Rodriguez 1, C. Agudo-Conde 1, C. Castaño-Sanchez 1, C. Martin-Martin 1, P. Martínez-Perez 1,
C. Montero-Sanchez 1, R. Alonso-Domínguez 1, N. Sánchez-Aguadero 1, C. Martín-Cantera 2,
N. González-Viejo 3, A. Gómez-Arranz 4, M.S. Arietaleanizbeascoa 5, Y. Schmolling-Guinovart 6,
M.A. Gomez-Marcos 1, L.Garcia-Ortiz 1, for Vident Group
1
Salamanca, 2 Barcelona, 3 Zaragoza, 4 Valladolid, 5 Bilbao, 6 Talavera de la Reina, SPAIN
14.30 - 15.30
Room 252
Meet-the-Expert
HOW TO MANAGE HYPERTENSIVE PREGNANT WOMEN WITH PRIMARY
ALDO, PHEOCHROMOCYTOMA OR FIBROMUSCULAR DYSPLASIA?
Chairperson:
S. Erdine (Istanbul, TURKEY)
Expert: P.-F. Plouin (Paris, FRANCE)
F I N A L P R OG R A M M E
127
MONDAY
13
14.30 - 16.00
Room 253
Parallel Oral Session 8E
LIFESTYLE CHANGES, LIPIDS, SALT
Chairpersons: J.MesquitaBastos(Aveiro,PORTUGAL)
S. Taddei (Pisa, ITALY)
14.30 HIGH SALT INTAKE POTENTIATES THE RELATION BETWEEN BLOOD PRESSURE AND
ALBUMINURIA
J. Polonia, L. Martins, F. Pinto, J. Nazaré
Lisbon, PORTUGAL
14.40 SALT AND POTASSIUM INTAKE IN SOUTH AFRICA: AN EVALUATION OF 24-HOUR URINE
COLLECTIONS IN THREE ETHNIC GROUPS
B. Swanepoel 1, A.E. Schutte 1, K. Steyn 2, E. Wentzel-Viljoen 1
1
Potchefstroom, 2 Cape Town, SOUTH AFRICA
14.50 RELATION BETWEEN 24 HOURS URINARY SODIUM AND POTASSIUM EXCRETION AND
BLOOD PRESSURE IN RURAL AND URBAN PYGMIES AND BANTUS OF SOUTHERN CAMEROON
D. Lemogoum 1, Y. Hako 2, C. Bika Lele 2,C.Okalla2, J. Dissongo 2, J.R. M’Buyamba-Kabangu 3, J.P. Degaute 1,
M. Leeman 1, P. van de Borne 1
1
Brussels, BELGIUM, 2 Douala, CAMEROON, 3 Kinshasa, DR CONGO
15.00 ASSOCIATION BETWEEN DIETARY CHLORIDE, BLOOD PRESSURE AND HEART RATE:
A RANDOMISED CROSS-OVER STUDY
L. McCallum, A.H. Boal, S. Padmanabhan
Glasgow, UNITED KINGDOM
15.10 EFFECT OF DIETARY SODIUM RESTRICTION ON ARTERIAL STIFFNESS: SYSTEMATIC REVIEW
AND META-ANALYSIS OF THE RANDOMIZED CONTROLLED TRIALS
L. D’Elia, F. Galletti, E. La Fata, P. Sabino, P. Strazzullo
Naples, ITALY
15.20 POMEGRANATE JUICE AND BLOOD PRESSURE: A SYSTEMATIC REVIEW AND META-ANALYSIS
OF RANDOMIZED CONTROLLED TRIALS
D. Grassi 1, A. Sahebkar 2, S. Ferri 1
1
L’Aquila, ITALY, 2 Mashhad, IRAN
15.30 A SUFFICIENT PROTEIN INTAKE SHOULD BE ENCOURAGED IN HYPERTENSIVE PATIENTS
WITHOUT CHRONIC KIDNEY DISEASE: A LONG-TERM OUTCOMES STUDY
C. Lesiuk, P.-Y. Courand, H. Milon, A. Defforges-Ranc, D. Fouque, B. Harbaoui, P. Lantelme
Lyon, FRANCE
15.40 MIDDLE-TERM DIETARY SUPPLEMENTATION WITH RED YEAST RICE PLUS COENZYME Q10
IMPROVES LIPID PATTERN, ENDOTHELIAL REACTIVITY AND ARTERIAL STIFFNESS IN MODERATELY
HYPERCHOLESTEROLEMICS
A.F.G. Cicero, M. Morbini, M. Rosticci, S. D’Addato, E. Grandi, C. Borghi
Bologna, ITALY
15.50 REGIONAL VARIATIONS IN THE ASSOCIATIONS OF DIETARY PATTERNS WITH BLOOD PRESSURE
AND HYPERTENSION IN SWITZERLAND
M. Burnier, A. Chappuis, N. Glatz, M. Bochud
Lausanne, SWITZERLAND
128
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
SUNDAY
12
F I N A L P R OG R A M M E
129
130
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
F I N A L P R OG R A M M E
131
132
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
F I N A L P R OG R A M M E
133
134
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
F I N A L P R OG R A M M E
135
136
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
POSTERS
Saturday, June 11
Sunday, June 12
Monday, June 13
POSTERS
138
175
210
14.00 - 15.30
Attended Poster Sessions
138
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
14.00 - 15.30
Attended Poster Sessions
PS 01. BLOOD PRESSURE MEASUREMENT
Chairperson: J. Widimský (Prague, CZECH REPUBLIC)
ROOM
POSTERS FROM 1 TO 37
PS 02. AGEING
Chairperson: C. Rajkumar (Brighton, UNITED KINGDOM)
ROOM
POSTERS FROM 1 TO 13
PS 03. CARDIOVASCULAR RISK FACTORS
Chairperson: F. Martinez Garcia (Valencia, SPAIN)
ROOM
POSTERS FROM 1 TO 51
PS 04. CHILDREN AND ADOLESCENTS
Chairperson: N. Martell-Claros (Madrid, SPAIN)
ROOM
POSTERS FROM 1 TO 15
PS 05. DIABETES
Chairperson: D. Gordin (Helsinki, FINLAND)
ROOM
POSTERS FROM 1 TO 33
PS 06. EPIDEMIOLOGY OF HYPERTENSION
AND METABOLIC DISORDERS
Chairperson: A. Gottsater (Malmö, SWEDEN)
ROOM
POSTERS FROM 1 TO 23
PS 07. GENETICS, GENOMICS, PROTEOMICS, METABOLOMICS
Chairperson: N. Bouatia-Naji (Paris, FRANCE)
ROOM
POSTERS FROM 1 TO 30
PS 08. INNOVATIVE TECHNIQUES AND DEVICES
Chairperson: S. Wassertheurer (Vienna, AUSTRIA)
ROOM
POSTERS FROM 1 TO 19
PS 09. KIDNEY
Chairperson: D. Karasavvidou (Thessaloniki, GREECE)
ROOM
POSTERS FROM 1 TO 26
PS 10. RESISTANT HYPERTENSION
Chairperson: P. Zebekakis (Thessaloniki, GREECE)
ROOM
POSTERS FROM 1 TO 26
PS 11. LARGE ARTERIES
Chairperson: R.M.A. Henry (Maastricht, NETHERLANDS)
ROOM
POSTERS FROM 1 TO 27
PS 12. MICROCIRCULATION AND SMALL VESSELS
Chairperson: D. Rizzoni (Brescia, ITALY)
ROOM
POSTERS FROM 1 TO 25
PS 13. THERAPEUTICS AND CLINICAL TRIALS
Chairperson: Z. Gaciong (Warsaw, POLAND)
ROOM
POSTERS FROM 1 TO 24
LATE-BREAKER POSTERS’ SESSION 1
Chairperson: J. Mesquita Bastos (Aveiro, PORTUGAL)
ROOM
POSTERS FROM 1 TO 19
SATURDAY
15.00-15.30
BEST POSTERS DISCUSSION
Chairpersons: R.M.A. Henry (Maastricht, NETHERLANDS)
M. Salvetti (Brescia, ITALY)
POSTER PRESENTATION ROOM
F I N A L P R OG R A M M E
139
11
14.00 - 15.30
Posters’ Session PS01
BLOOD PRESSURE MEASUREMENT
Chairperson: J. Widimský (Prague, CZECH REPUBLIC)
ROOM
POSTERS FROM 1 TO 37
/ 1 CENTRAL BLOOD PRESSURE VALUES IN A HEALTHY MEXICAN SAMPLE
E. Cardona Muñoz, G. Alanis Sanchez, F. Grover Paez, D. Cardona Muller, S. Totsuka Sutto,
A. Macias Chumacera, C. Ramos Becerra
Guadalajara, MEXICO
/ 2 CORRELATION OF PULSE WAVE ANALYSIS PARAMETERS WITH LEFT VENTRICULAR
HYPERTROPHY, INTIMA-MEDIA-THICKNESS AND PLAQUES IN CAROTID ARTERIES IN A BRAZILIAN
AMBULATORY CARE
L. Resende, M.A.V. Da Silva, E.A.M.R. Resende, J.A.M. Resende, A.P.M. Da Silva, A.L.M. Casemiro, R.M. Lucas Jr.
Uberaba, BRAZIL
/ 3 PUBLIC HEALTH SCREENING FOR HYPERTENSION: IS IT COST EFFECTIVE?
Y.C. Chia, H.C. Beh, P.F. Wong
Kuala Lumpur, MALAYSIA
/ 4 USING TELEMONITORED HOME BLOOD PRESSURE MEASUREMENT TO ASSESS THE TRUE
PREVALENCE OF HYPERTENSION IN SINGAPORE
A. Mondry, G. Tan, V. Ooi
Singapore, SINGAPORE
/ 5 PREVALENCE OF CENTRAL HYPERTENSION AND ITS ASSOCIATION WITH TARGET ORGAN
DAMAGE IN UNTREATED CHINESE PATIENTS
Y.B. Cheng, T.Y. Xu, Y. Yang, Q.H. Guo, J.J. Li, D.Y. Zhang, J. Wang, Y. Li
Shanghai, CHINA
/ 6 AMBULATORY BLOOD PRESSURE CHARACTERISTICS IN PATIENTS WITH AUTONOMIC
DYSFUNCTION
F. Saladini, A. Di Marco, R. Verlato, P. Palatini
Padua, ITALY
/ 7 EFFECTS OF AZILSARTAN MEDOXOMIL ON CENTRAL AORTIC AND AMBULATORY BLOOD
PRESSURE IN PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION
A. Dobrokhod, Y.U. Sirenko, I. Zhyvilo, O. Torbas, S. Kushnir, V. Granich, G. Primac, S. Polishchuk, P. Sidorenko,
O. Rekovets
Kiev, UKRAINE
/ 8 EUROPEAN SOCIETY OF HYPERTENSION INTERNATIONAL PROTOCOL 2010 FOR THE
VALIDATION OF BLOOD PRESSURE MONITORS: A CRITICAL REVIEW OF ITS APPLICATION
N. Boubouchairopoulou 1, S. Davakis 1, K. Kyriakoulis 1, A. Kollias 1, N. Atkins 2, E. O’Brien 2, G.S. Stergiou 1
1
Athens, GREECE, 2 Dublin, IRELAND
/ 9 ASSOCIATION OF NORMOTENSION, WHITE-COAT HYPERTENSION, MASKED HYPERTENSION
AND SUSTAINED HYPERTENSION WITH NON-ALCOHOLIC FATTY LIVER DISEASE
E. Manios, V. Chouzouri, F. Michas, A. Lykka, K. Manousopoulos, C. Papageorgiou, C. Vettou, N. Zakopoulos
Athens, GREECE
/ 10 TREATMENT WITH BETA-BLOCKERS REDUCES THE DIFFERENCE BETWEEN CLINICAL AND
AMBULATORY BLOOD PRESSURE LEVELS IN PATIENTS WITH STABLE ARTERIAL HYPERTENSION
G. Andreeva, V. Gorbunov, O. Molchanova, O. Isaykina, O. Lerman, N. Dmitrieva
Moscow, RUSSIA
140
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 11 THE LOWER THE BETTER? PROGNOSIS DEFINED BY PROGNOSTIC ACCURACY OF AMBULATORY
BLOOD PRESSURE IN PORTUGUESE TREATED HYPERTENSIVE PATIENTS FOLLOWED FOR 11,8 ± 5,1
YEARS
J. Mesquita Bastos 1, J. Pinto 1, J. Pires 1, A. Araújo 1, P. Almeida 1, J. Polonia 2
1
Aveiro, 2 Porto, PORTUGAL
/ 12 DIAGNOSTIC THRESHOLD OF HYPERTENSION BY HOME BLOOD PRESSURE MONITORING:
COMPARISON TO DIAGNOSTIC THRESHOLD OF AMBULATORY BLOOD PRESSURE MONITORING
M. Rhee 1, J.H. Kim 1, J. Namgung 1, D.K. Cho 1, S.Y. Lee 1, T.Y. Choi 1, S.Y. Kim 2, J.S. Park 3, S.H. Lee 4
1
Goyang, 2 Seoul, 3 Suwon, 4 Wonju, SOUTH KOREA
/ 13 MARKED BP DISTRIBUTION SHIFT FROM CASUAL TO AMBULATORY MEASUREMENT IN KENYA:
SCREENING IMPLICATIONS FOR SUB-SAHARAN AFRICA
A. Etyang 1, B. Warne 1, S. Kapesa 1, K. Munge 1, E. Bauni 1, J.K. Cruickshank 2, L. Smeeth 2, J.A.G. Scott 1
1
Kilifi, KENYA, 2 London, UNITED KINGDOM
/ 14 FARMAPRES PROJECT: SELF-PERCEIVED IMPORTANCE BY PHARMACISTS OF THE VALENCIAN
COMMUNITY IN CONTROL OF HYPERTENSIVE PATIENTS
J. Tamarit García 1, B. Roig Espert 2, D. Godoy Rocatí 1, Y. Cabanes 1, A. García Bellot 2, V. Giner Galvañ 3,
V. Pallarés Carratalá 4, V. Gil Guillen 5, P. Rollán García 2, A. González-Cruz Cervellera 1
1
Valencia, 2 Manises, 3 Alcoy, 4 Castellón, 5 Elda, SPAIN
/ 15 HOME BLOOD PRESSURE IN KIDNEY TRANSPLANT RECIPIENTS (KTR)- VALIDITY OF DIFFERENT
SCHEDULES OF SELF-MONITORING
A. Saint-Remy, L. Weekers, C. Bonvoisin, P. Xhignesse, B. Dubois, J.-M. Krzesinski
Liège, BELGIUM
/ 16 AN EVOLVING ROLE OF ALBANIAN COMMUNITY PHARMACISTS IN MANAGING HYPERTENSION
E. Pistja, A. Themeli
Lezhe, ALBANIA
/ 17 ACCURACY OF HOME BLOOD PRESSURE MONITORING IN ARTERIAL HYPERTENSION
DIAGNOSIS
S. Di Monaco, F. Rabbia, M. Covella, C. Bertello, G. Papotti, C. Fulcheri, E. Berra, M. Pappaccogli,
E. Perlo, F. Veglio
Turin, ITALY
/ 18 FARMAPRES PROJECT: ATTITUDE OF PHARMACISTS OF THE VALENCIAN COMMUNITY AFTER
DETECTED POOR CONTROL OF HYPERTENSION
J. Tamarit García 1, B. Roig Espert 2, D. Godoy Rocatí 1, C. De Andrés Miguel 1, A. García Bellot 2,
V. Giner Galvañ 3, V. Pallarés Carratalá 4, V. Gil Guillen 5, P. Rollán García 2, A. González-Cruz Cervellera 1
1
Valencia, 2 Manises, 3 Alcoy, 4 Castellón, 5 Elda, SPAIN
/ 19 CENTRAL BLOOD PRESSURE ASSESSMENT WITH A NEW OSCILLOMETRIC DEVICE
TEL-O-GRAPH®
A. Reshetnik, C. Gohlisch, M. Tölle, W. Zidek, M. Van Der Giet
Berlin, GERMANY
/ 20 DIFFERENCE IN POSTPRANDIAL BLOOD PRESSURE RESPONSES BETWEEN CENTRAL AND
PERIPHERAL SITES
S. Murai 1, H. Takase 2, T. Sugiura 1, S. Yamashita 1, N. Ohte 1, Y. Dohi 3
1
Nagoya, 2 Hamamatsu, 3 Seto, JAPAN
/ 21 BLOOD PRESSURE MEASUREMENTS IN NORMOTENSIVE PREGNANT WOMEN IN THE SITTING
POSITION AND IN THE LEFT LATERAL POSITION: A CROSS-SECTIONAL STUDY
C. Crisp Martins Ribeiro, J. Luiz Tatagiba Lamas
Campinas, BRAZIL
/ 22 COMPARISON OF A NEW FIRST-LINE TREATMENT VERSUS DIFFERENT FIRST-LINE STRATEGIES
USING 24-HOUR AMBULATORY BLOOD PRESSURE MONITORING
G. Parati 1, E. O’Brien 2, R. Asmar 3, G. Mancia 1, N.R. Poulter 4, S. Laurent 3
1
Milan, ITALY, 2 Dublin, IRELAND, 3 Paris, FRANCE, 4 London UNITED KINGDOM
F I N A L P R OG R A M M E
141
SATURDAY
11
/ 23 ARTERIAL STIFFNESS AND NIGHT-TIME BLOOD PRESSURE REDUCTION IN HYPERTENSIVE
PATIENTS AFTER TRANSIENT ISCHEMIC ATTACK
T. Horbat, I. Korobko, S. Charniak, T. Netchessova
Minsk, BELARUS
/ 24 SEASONAL DIFFERENCES IN BLOOD PRESSURE PHENOTYPES: EFFICACY OF
ANTIHYPERTENSIVE TREATMENT
M. Smirnova, V. Gorbunov, S. Boytsov, M. Loukianov, D. Volkov, A. Deev, Y. Koshelyaevskaya
Moscow, RUSSIA
/ 25 INDICATORS OF AORTIC CENTRAL PRESSURE AND AORTIC STIFFNESS IN NORMOTENSIVE
SUBJECTS, PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
L. Salyamova, I. Eliseeva, N. Borisova, V. Oleynikov
Penza, RUSSIA
/ 26 TELMISARTAN/S-AMLODIPINE SINGLE-PILL COMBINATION DRUG SAFETY AND EFFICACY
SURVEILLANCE IN KOREAN PATIENTS WITH HYPERTENSION
S. Jo, W. Park, S. Kim, K. Park, H. Kim, S. Han
Anyang-si, SOUTH KOREA
/ 27 24-H BLOOD PRESSURE PROFILE ON COMBINATION THERAPY WITH PERINDOPRIL AND
INDAPAMIDE IN PATIENTS WITH MILD AND MODERATE ARTERIAL HYPERTENSION
G. Abdullaeva, A. Khalikova, G. Khamidullaeva, D. Kurbanova, E. Zueva
Tashkent, UZBEKISTAN
/ 28 NOCTURNAL HYPERTENSION BUT NOT NON-DIPPING PATTERN IS ASSOCIATED WITH NONALCOHOLIC FATTY LIVER DISEASE IN NORMOTENSIVE AND UNTREATED HYPERTENSIVE SUBJECTS
A. Lykka, E. Manios, V. Chouzouri, K. Manousopoulos, C. Vettou, E. Zampeli, S. Michopoulos, N. Zakopoulos
Athens, GREECE
/ 29 INTER ARM DIFFERENCE IN BLOOD PRESSURE AND CARDIOVASCULAR RISK AMONG BLACK
AFRICANS
K. Adoubi, F. Sall, F. Diby, P. Ouattara, A. Gnaba, A. Yangni-Angate
Bouake, IVORY COAST
/ 30 A NOVEL METHOD FOR MEASURING BLOOD PRESSURE USING BY A PHOTIC SENSOR MODULE
M. Yamazaki 1, H. Eda 2
1
Higashimatsuyama, 2 Hamamatsu, JAPAN
/ 31 BLOOD PRESSURE PHENOTYPES IN HYPERTENSIVE PATIENTS WITH CHRONIC RESPIRATORY
DISEASES
M. Smirnova, A. Kurekhyan, V. Gorbunov, A. Deev, Y. Koshelyaevskaya
Moscow, RUSSIA
/ 32 INTERNATIONAL REGISTRY FOR AMBULATORY BLOOD PRESSURE AND ARTERIAL STIFFNESS
TELEMONITORING (VASOTENS REGISTRY): RATIONALE AND DESIGN
S. Omboni 1, I. Posokhov 2, G. Parati 3, A. Rogoza 4, Y. Kotovskaya 4, G. Mulè 5, M.L. Muiesan 6, I. Orlova 4,
E. Cardona Muñoz 7
1
Varese, ITALY, 2 Nizhniy Novgorod, RUSSIA, 3 Milan, ITALY, 4 Moscow, RUSSIA, 5 Palermo, 6 Brescia, ITALY,
7
Guadalajara, MEXICO
/ 33 DETERMINANTS OF CARDIAC REMODELING IN ARTERIAL HYPERTENSION
A. Vintila, M. Dobrovie, M. Raduna, V. Vintila, S. Dumitrescu, C. Grigore, R. Ianula, A. Gurghean, D. Isacoff
Bucharest, ROMANIA
/ 34 EARLY MORNING SURGE OF SYSTOLIC AND DIASTOLIC BLOOD PRESSURE IS INVERSELY
ASSOCIATED WITH THE DEVELOPMENT OF TARGET ORGAN DAMAGE IN HYPERTENSIVE SUBJECTS.
A PRELIMINARY REPORT
E.A. Andreadis, C.V. Geladari, G.N. Kolyvas, A.I. Georgantoni, E.N. Pantikidi, N.D. Karamichalakis, S.E. Liapis,
E.T. Angelopoulos
Athens, GREECE
142
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 35 AMBULATORY BLOOD PRESSURE MONITORING (ABPM) AND MYOCARDIUM DEFORMATION
PARAMETERS IN PATIENTS WITH HYPERTENSION
H. Nesukay, N. Polenova, E. Titov
Kiev, UKRAINE
/ 36 ASSESSMENT OF UNCOMPLICATED HYPERTENSION THERAPY EFFECTIVENESS IN REAL LIFE
SETTING: HOME BLOOD PRESSURE SELF-MEASUREMENT AS AN ALTERNATIVE TO AMBULATORY
24-HOUR MONITORING
K.M. Amosova, I. Rudenko
Kiev, UKRAINE
/ 37 PSYCHOLOGICAL STATUS SCORES RELATED WITH LEFT VENTRICULAR MASS INDEX AND MEAN
AMBULATORY BLOOD PRESSURE VARIABLES IN PATIENTS WITH ARTERIAL HYPERTENSION
G. Andreeva, V. Gorbunov, E. Zvolinskaya, O. Molchanova, O. Isaykina, S. Kukushkin
Moscow, RUSSIA
Posters’ Session PS02
AGEING
Chairperson: C. Rajkumar (Brighton, UNITED KINGDOM)
ROOM
POSTERS FROM 1 TO 13
SATURDAY
11
/ 1 CENTRAL AORTIC PRESSURE IS INDEPENDENTLY ASSOCIATED DIASTOLIC FUNCTION IN
CHINESE ELDER COHORT
J. Xiong, Y. Zhang, Y.Y. Lv, K. Wang, S.K. Yu, H.Q. Li, B. Bai
Shanghai, CHINA
/ 2 AGE FEATURES OF PARAMETERS OF LOCAL VASCULAR STIFFNESS IN HEALTHY SUBJECTS
V. Oleynikov, I. Matrosova, E. Melnikova, L. Salyamova, Y. Tomashevskaya
Penza, RUSSIA
/ 3 ELDERLY HYPERTENSIVES AND MORNING SURGE PHENOMENON
A.M. Agrati, F. Colombo, L. Beltrami, G. Ferraro
Milan, ITALY
/ 4 ELDERLY HYPERTENSIVES IN MONOTHERAPY: BLOOD PRESSURE VARIABILITY AND PRESSURE
CONTROL
G. Ferraro, F. Colombo, L. Beltrami, A.M. Agrati
Milan, ITALY
/ 5 ATHEROSCLEROSIS AND AGEING: PREVALENCE OF CAROTID PLAQUE AND ROLE OF
CARDIOVASCULAR RISK FACTORS IN A VERY ELDERLY POPULATION
F. Spannella, F. Giulietti, S. Buscarini, P. Giordano, M. Ricci, E. Espinosa, R. Sarzani
Ancona, ITALY
/ 6 PREVALENCE, AWARENESS AND CONTROL OF HYPERTENSION AMONG OLDER ADULTS IN
MIDWESTERN BRAZIL
A.L.L. Sousa, S.R.R. Batista, P. Jardim, A.C. Sousa
Goiania, BRAZIL
/ 7 ASSOCIATION BETWEEN CARDIOVASCULAR RISK FACTORS, TELOMERE BIOLOGY AND
VASCULAR AGEING
O. Isaykina, G. Andreeva, V. Gorbunov
Moscow, RUSSIA
/ 8 IN HYPERTENSION AGE MATTERS, DEPENDING ON AGE…
E. Weiss, C. Japie, A.M. Daraban, D. Penes, E. Badila, D. Bartos
Bucharest, ROMANIA
F I N A L P R OG R A M M E
143
/ 9 SAFETY OF COMBINED PHARMACOTHERAPY IN ELDERLY PATIENTS WITH COMORBID
CARDIAC PATHOLOGY
N. Tofan, V. Shtanko
Odessa, UKRAINE
/ 10 IMPACT OF CARDIOVASCULAR COMORBIDITY ON ANAESTHESIA MANAGEMENT IN ELDERLY
Y. Ploshchenko
Dnipropetrovsk, UKRAINE
/ 11 INTRA-HOSPITAL PROGNOSIS OF ELDERLY PATIENTS HOSPITALIZED FOR ACUTE CORONARY
SYNDROME
M. Azaiez, S. Hamdi, A. Elhraiech, W. Jomaa, K. Ben Hamda, F. Maatouk
Monastir, TUNISIA
/ 12 ASSOCIATION OF ABNORMAL ALBUMINURIA AND CONVENTIONAL RISK FACTORS IN OLDER
PATIENTS WITH ARTERIAL HYPERTENSION
S. Radenkovic, D. Stojanovic, G. Kocic
Niš, SERBIA
/ 13 THE BEHAVIOURAL PATTERNS IN ELDERLY HYPERTENSIVES
L. Popescu, H. Balan
Bucharest, ROMANIA
Posters’ Session PS03
CARDIOVASCULAR RISK FACTORS
Chairperson: F. Martinez Garcia (Valencia, SPAIN)
ROOM
POSTERS FROM 1 TO 51
/ 1 PROCOLLAGEN TYPE I CARBOXY-TERMINAL PROPEPTIDE IS ASSOCIATED WITH BLOOD
PRESSURE, CARDIAC HYPERTROPHY AND DYSFUNCTION, AND PREDICT CARDIOVASCULAR EVENTS IN
HEMODIALYSIS PATIENTS
S. Shin, S. Seo, H. Yoon
Incheon, SOUTH KOREA
/ 2 SYSTOLIC ORTHOSTATIC HYPERTENSION AND MORTALITY. THE HOMO STUDY
M. Prieto Diaz 1, S. Velilla Zancada 2, C. Escobar Cervantes 3, L. Manzano Espinosa 3, E. Ramalle Gomara 4,
L. Vara Gonzalez 5
1
Oviedo, 2 Navarra, 3 Madrid, 4 Logroño, 5 Santander, SPAIN
/ 3 EFFECT OF THE WEEKLY FREQUENCY OF ALCOHOL DRINKING ON VASCULAR STIFFNESS
DETERMINED BY THE PULSE WAVE VELOCITY
F. Botto 1, S. Obregon 1, P. Forcada 1, M. Koretzky 1, A. Di Leva 1, E. Huguet 1, M. Haehnel 1, A. Scuteri 2,
P.M. Nilsson 3, C. Kotliar 1,
1
Pilar, ARGENTINA, 2 Rome, ITALY, 3 Malmö, SWEDEN
/ 4 ADDITIONAL FACTORS ASSOCIATED WITH LEFT VENTRICLE DIASTOLIC FUNCTION IMPAIRMENT
IN PATIENTS WITH MODERATE HYPERTENSION
O. Torbas, Y. Sirenko, S. Kushnir, O. Rekovets
Kiev, UKRAINE
/ 5 PERIPHERAL ARTERIAL DISEASE AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
A. Medvedeva 1, E. Mascaros Balaguer 2, A. Esteban Luque 1, E. Klusova 3, E. Trillo Calvo 4, P. Martinez Rodes 4,
R. Abad Rodriguez 5, J.A. Garcia Donaire 6, D. Cesareo 7, A. Galgo 6
1
Marbella, 2 Valencia, 3 Ibiza, 4 Zaragoza, 5 Oviedo, 6 Madrid, SPAIN, 7 Buenos Aires, ARGENTINA
/ 6 PREVALENCE AND PROGNOSIS OF ELECTROCARDIOGRAPHIC ABNORMALITIES IN
NORMOTENSIVE AND HYPERTENSIVE INDIVIDUALS
A. Lehtonen 1, P. Puukka 1, J. Varis 1, K. Porthan 2, J. Tikkanen 3, M. Nieminen 2, H. Huikuri 3, I. Anttila 4,
K. Nikus 5, M. Kähönen 5, A. Jula 1, T. Niiranen 1
1
Turku, 2 Helsinki, 3 Oulu, 4 Seinäjoki, 5 Tampere, FINLAND
144
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 7 SERUM URIC ACID IS NOT ASSOCIATED WITH ALBUMINURIA IN PREHYPERTENSION AND
NEWLY DIAGNOSED HYPERTENSION
S. Karanovic, V. Ivkovic, A. Vrdoljak, Z. Dika, V. Domislovic, K. Dapic, L. Gallineo, E. Ivandic, J. Josipovic,
I. Vukovic, J. Kos, M. Laganovic, T. Zeljkovic Vrkic, V. Premuzic, D. Rogic, B. Jelakovic
Zagreb, CROATIA
/ 8 THE SIGNATURE OF CIRCULATING ENDOTHELIAL CELL-DERIVED APOPTOTIC MICROPARTICLES
AND INSULIN RESISTANCE IN NON-DIABETIC PATIENTS WITH CHRONIC HEART FAILURE
A. Berezin, A. Kremzer, T. Berezina, Y. Martovitskaya
Zaporozhye, UKRAINE
/ 9 BASELINE DIFFERENCES ACCORDING TO THE PRESENCE OF HYPERTENSION IN PATIENTS
INCLUDED IN THE STUDY IBERICAN
M. Prieto Diaz 1, V. Pallares Carratala 2, G.C. Rodriguez Roca 3, A. Díaz Rodriguez 4, J.L. Polo García 5,
F.J. Alonso Moreno 3, A. Moyá Amengual 6, T. Rama Martinez 7, I. Gil Gil 8, E. Carrasco Carrasco 9
1
Oviedo, 2 Castellón, 3 Toledo, 4 León, 5 Cáceres, 6 Palma de Mallorca, 7 Barcelona, 8 Lleida, 9 Murcia, SPAIN
/ 10 COMPARATIVE EFFICACY OF PHYSICAL TRAININGS ON BICYCLE AND TREADMILL AT PATIENTS
WITH ARTERIAL HYPERTENSION
V. Sujayeva
Minsk, BELARUS
/ 11 CARDIOVASCULAR RISK FACTORS AND MASKED ARTERIAL HYPERTENSION: GENDER
FEATURES IN YOUNG AGE
N. Lyamina 1, A. Nalivaeva 1, V. Senchikhin 1, T. Lipchanskaya 1, S. Lyamina 2
1
Saratov, 2 Moscow, RUSSIA
SATURDAY
/ 12 PREDICTORS OF INCIDENT HYPERTENSION IN PREHYPERTENSIVES
V. Ivkovic 1, A. Parini 2, A. Vrdoljak 1, S. Karanovic 1, M. Abramovic Baric 3, S. Bachelli 2, M. Cagnati 2,
A.F.G. Cicero 2, S. D’Addato 2, D. Degli Esposti 2, M. Fucek 1, E. Grandi 2, J. Kos 1, M. Laganovic 1, D. Rogic 1,
M. Rosticci 2, I. Vukovic 1, C. Borghi 2, B. Jelakovic 1
1
Zagreb, CROATIA, 2 Bologna, ITALY, 3 Slavonski Brod, CROATIA
/ 13 THE ROLE OF BODY FAT AND FAT DISTRIBUTION IN HYPERTENSION RISK IN URBAN BLACK
SOUTH AFRICAN WOMEN
C. George 1, J.H. Goedecke 1,2, N.J. Crowther 2, N.G. Jaff 2, A.P. Kengne 1, S.A. Norris 2,L.K.Micklesfield2
1
Cape Town, 2 Johannesburg, SOUTH AFRICA
/ 14 CARDIOVASCULAR RISK PROFILE IN THE FRENCH CARIBBEAN: SERIOUS SOCIAL
INEQUALITIES
P. Carrère 1,2,3, Y. Harchaoui 1, J. Hélène-Pelage 1, A. Atallah 2, T. Lang 3, J. Inamo 3,4
1
Pointe-à-Pitre, 2 Basse-Terre, 3 Toulouse, 4 Fort-de-France, FRANCE
/ 15 THE EFFECT OF COMMON BETA-ADRENORECEPTOR GENE POLYMORPHISMS ON RISK OF
ESSENTIAL HYPERTENSION IN TATARS FROM RUSSIA
Y. Timasheva, T.R. Nasibullin, E.B. Imaeva, V.V. Erdman, I.A. Tuktarova, A.N. Zakirova, G.K. Mirsaeva,
O.E.Mustafina
Ufa, RUSSIA
/ 16 ASSOCIATION BETWEEN DISEASE SEVERITY AND HYPERTENSION IN PATIENTS WITH
OSTEOARTHRITIS
G. Triantafyllou, P. Anyfanti, P. Panagopoulos, N. Koletsos, A. Triantafyllou, A. Pyrpasopoulou,
S. Chatzimichailidou, Z. Kiourka, S. Aslanidis, S. Douma
Thessaloniki, GREECE
/ 17 PREHYPERTENSION IS ASSOCIATED WITH CHRONIC KIDNEY DISEASE IN EUROPEAN RURAL
POPULATION: DATA FROM BRISGHELLA HEART STUDY (ITALY) AND ENAH STUDY (CROATIA)
A. Parini 1, V. Ivkovic 2, A,. Vrdoljak 2, M. Abramovic Baric 3, S. Bacchelli 1, M. Cagnati 1, A.F.G. Cicero 1,
S. D’Addato 1, D. Degli Esposti 1, M. Fucek 2, D. Grandi 1, E. Ivandic 2, S. Karanovic 2, J. Kos 2, M. Laganovic 2,
M. Rosticci 1, D. Rogic 2, B. Jelakovic 2, C. Borghi 1
1
Bologna, ITALY, 2 Zagreb, 3 Slavonski Brod, CROATIA
F I N A L P R OG R A M M E
145
11
/ 18 PULSE WAVE VELOCITY CHANGES IN PATIENTS WITH ESSENTIAL HYPERTENSION AND
DIFFERENT CATEGORY OF CARDIOVACULAR RISK
E. Kolesnik, G. Dzyak, T. Kolesnik, K. Iegorov, G. Kosova
Dnipropetrovsk, UKRAINE
/ 19 HYPERTENSION IN WOMEN WITH EARLY MENOPAUSE: DEFINITION AND OPTIMIZATION OF
CARDIOVASCULAR RISK
G. Iliushyna, O. Mitchenko, V. Romanov
Kiev, UKRAINE
/ 20 ASSOCIATIONS BETWEEN SERUM URIC ACID AND THE INCIDENCE OF OBSTRUCTIVE SLEEP
APNOEA SYNDROME AND ATRIAL FIBRILLATION IN ESSENTIAL HYPERTENSION PATIENTS
N. Diaconu, A. Grosu, C. Gratii, O. Gherman, A. Lupusor, T. Cuzor
Chisinau, REPUBLIC OF MOLDOVA
/ 21 CLINICAL AND PARACLINICAL IMPACT IN PATIENTS WITH LONGSTANDING SYSTEMIC
HYPERTENSION
C. Tudorica, S. Tudorica, A. Vintila, V. Vintila, C. Serbanete, A. Gurghean
Bucharest, ROMANIA
/ 22 OLD HYPERTENSIVE PATIENTS: ARE THEY DIFFERENT?
D. Penes, E. Badila, E. Weiss, C. Japie, A.M. Daraban, D. Bartos
Bucharest, ROMANIA
/ 23 INCREASED ROS GENERATION INVOLVES MITOCHONDRIA IN MR-OVEREXPRESSING
ADIPOCYTES: IMPACT ON VASCULAR FUNCTION
A. Nguyen Dinh Cat 1, M. Friederich-Persson 1, M.G. Dulak-Lis 1, A. Sanchez 2, R. Nosalski 3, A.C. Montezano 1,
T.J. Guzik 3, F. Jaisser 4, R.M. Touyz 1
1
Glasgow, UNITED KINGDOM, 2 Madrid, SPAIN, 3 Kraków, POLAND, 4 Paris, FRANCE
/ 24 ASSOCIATION BETWEEN SLEEP-DISORDERED BREATHING AND CARDIOVASCULAR RISK
L. Korostovtseva, E. Dubinina, O. Rotar, S. Kravchenko, M. Boyarinova, A. Orlov, V. Solntsev, Y. Sviryaev,
A. Alekhin, A.O. Konradi
Saint-Petersburg, RUSSIA
/ 25 HIGH MOLECULAR WEIGHT ADIPONECTIN AND E-SELECTIN IN SUBJECTS WITH
HYPERGLYCAEMIA FROM SOUTH AFRICA
R. Erasmus, T. Matsha, A.P. Kengne, G.M. Hon, A. Zemlin
Cape Town, SOUTH AFRICA
/ 26 PREVALENCE, AWARENESS, TREATMENT AND CONTROL OF HYPERTENSION IN A URBAN AND
RURAL COMMUNITY IN THE FAR NORTH REGION (CAMEROON)
E. Bika Lele 1, D. Lemogoum 2, C. Okalla 1, J. Dissongo 1, P. Amta 1, M. Leeman 2, J.P. Degaute 2, P. van de Borne 2
1
Douala, CAMEROON, 2 Brussels, BELGIUM
/ 27 THE ROLE OF GAMMA GAMMA-GLUTAMYLTRANSFERASE (GGT) REGARDING
CARDIOVASCULAR RISK EVALUATION OF CAUCASIAN NEWLY DIAGNOSED AND NEVER UNTREATED
PATIENTS WITH ESSENTIAL HYPERTENSION
H. Triantafyllidi, S. Vlachos, A. Schoinas, D. Benas, I. Ikonomidis, G. Pavlidis, L. Palaiodimos, J. Lekakis
Athens, GREECE
/ 28 CARDIOVASCULAR RISK FACTORS IN WOMEN AND MEN
A. Nikolova, M. Milanova
Sofia, BULGARIA
/ 29 EVALUATION OF CIRCADIAN OSCILLATIONS OF THE ARTERIAL WALL STIFFNESS
A. Merezhanova, E. Tarlovskaya, K. Mazalov, A. Kuznetsov, L. Makarova, N. Kamardina, I. Frolova, N. Kozlova,
Y. Kuvanova
Nizhnii Novgorod, RUSSIA
/ 30 RELATIONSHIP BETWEEN DYSLIPIDEMIA AND URINARY ALBUMIN EXCRETION IN
HYPERTENSIVE ADULTS: A NATIONWIDE POPULATION-BASED STUDY
D. Kin 1, S. Lee 1, Y. Kim 1, Y. Roh 2, S. Ju 1, H. Nam 1, G. Nam 1, J. Choi 1, J. Lee 1, J. Sang 1, K. Han 1, Y. Park 1
1
Seoul, 2 Chunchon, SOUTH KOREA
146
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 31 BODY IRON STORE IN POLYCYSTIC OVARY SYNDROME ASSOCIATED TO WEIGHT EXCESS
K. Chaabouni, A. Lahiani, M. Messedi, M. Turki, M. Naifar, D. Louati, K. Jamoussi, F. Ayedi
Sfax, TUNISIA
/ 32 URIC ACID LEVELS PREDICT CORONARY ARTERY DISEASE BUT NOT STROKE IN ESSENTIAL
HYPERTENSION: DATA FROM A GREEK 8-YEAR-FOLLOW-UP STUDY
K. Dimitriadis,C.Tsioufis,D.Konstantinidis,T.H.Kalos,G.Vlachos,F.Lagiou, S. Galanakos, D. Tousoulis
Athens, GREECE
/ 33 ARTERIAL STIFFNESS IN A RANDOM SAMPLE OF A MULTI-ETHNIC POPULATION IN SURINAME:
THE HELISUR STUDY
F. Karamat 1, F.S. Diemer 2, G.A. van Montfrans 1, G.P. Oehlers 2, L.M. Brewster 1
1
Amsterdam, NETHERLANDS, 2 Paramaribo, SURINAME
/ 34 A SINE QUA NON WARNING. PATIENTS WITH LEFT HEART FAILURE MUST BE MONITORED
FOR MASSRY’S PHOSPHATE DEPLETION SYNDROME AND SUPPORTED VIA PHOSPHATE
SUPPLEMENTATIONS
S.O. Keskek 1, H.S. Sagliker 2, Y. Sagliker 1, N. Paylar 1, S. Kirim 1, Y.K. Icen 1, A. Yildirim 1, P. Sagliker Ozkaynak 1
1
Adana, 2 Konya, TURKEY
/ 35 ESTIMATION OF NT-PROBNP LEVEL IN RUSSIAN POPULATION
A. Orlov, O. Rotar, M. Boyarinova, A. Alieva, E. Moguchaya, E. Vasilieva, V. Yudina, V. Solntsev, E. Baranova,
A.O. Konradi
Saint-Petersburg, RUSSIA
/ 36 EFFECT OF DIFFERENT DOSES SINGLE PILL COMBINATION INDAPAMIDE/AMLODIPINE
(NATRIXAM 1.5/ 5 AND NATRIXAM 2.5/10) ON BLOOD PRESSURE IN HIGH RISK PATIENTS WITH
HYPERTENSION
K. Hristova, R. Marinov, T. Katova
Sofia, BULGARIA
SATURDAY
11
/ 37 ASSESSMENT OF PSYCHOSOCIAL FACTORS AMONG PATIENTS WITH OR WITHOUT PROVEN
ATHEROSCLEROSIS AND ARTERIAL HYPERTENSION
S. Tsonev, L. Grozdinski, N. Shtonova
Sofia, BULGARIA
/ 38 LIPID PROFILE AND INCIDENCE OF CARDIOVASCULAR DISEASE IN A MEDITERRANEAN HIGHRISK POPULATION: THE ESCARVAL-RISK STUDY
D. Orozco-Beltran 1, M. Tellez-Plaza 2, V. Gil-Guillen 1, S. Pita Fernandez 3, J. Navarro-Pérez 2,4,
V. Pallares Carratala 5, F. Valls 2, A. Fernandez 2, A.M. Perez-Navarro 2, C. Sanchis 2, A. Dominguez-Lucas 2,
J.M. Martin-Moreno 2, G. Sanz 4, J. Redon 2,4
1
Alicante, 2 Valencia, 3 A Coruña, 4 Madrid, 5 Castellón, SPAIN
/ 39 HEREDITY AND BEHAVIOURAL RISK FACTORS IN YOUNG ADULTS WITH MASKED
HYPERTENSION
N. Lyamina 1, A. Nalivaeva 1, V. Senchikhin 1, T. Lipchanskaya 1, S. Lyamina 2
1
Saratov, 2 Moscow, RUSSIA
/ 40 CENTRAL BLOOD PRESSURES AND ARTERIAL STIFFNESS ARE MUCH HIGHER IN HYPERTENSIVE
WOMEN WITH MORE CARDIOVASCULAR RISK FACTORS DESPITE ADEQUATE TREATMENT
R. Cabrera Sole, L. Urrego Rivera, C. Turpin Lucas, D. Calle Salazar
Albacete, SPAIN
/ 41 TRENDS IN BODY BUILD, BLOOD PRESSURE AND HYPERTENSION IN URBAN CONGOLESE
PEOPLE
J. M’Buyamba-Kabangu 1, P. Bayauli 1, F.B. Lepira 1, S. Ditu 1, D. Lemogoum 2, J.P. Degaute 2,
P. van de Borne 2, J.A. Staessen 6, G. Ngoyi 1, L. Thijs 3, J.R. M’buyamba Kayamba 1, P.K. Kayembe 1
1
Kinshasa, DR CONGO, 2 Brussels, 3 Leuven, BELGIUM
/ 42 RELATIONSHIP BETWEEN KIDNEY FUNCTION AND CARDIOVASCULAR RISK FACTORS IN
HYPERTENSIVE NEPHROPATHY PATIENTS
L. Bezrodna, O. Kupchinska, V. Bezrodnyi
Kiev, UKRAINE
F I N A L P R OG R A M M E
147
/ 43 CARDIOVASCULAR DISEASES RISK FACTORS IN HYPERTENSIVE PATIENTS WITH OSAHS FROM
XINJIANG OF CHINA
X. Yao, N. Li, D. Zhang, G. Chang, J. Hu, K. Zhou
Urumqi, CHINA
/ 44 INFLUENCE OF THE RESTLESS LEGS SYNDROME ON HYPERTENSION EXPRESSION IN YOUNG
PEOPLE
P. Mitrovic, B. Stefanovic, M. Radovanovic, N. Radovanovic, D. Rajic, G. Matic, R. Lasica, I. Subotic, N. Mijic,
Z. Vasiljevic
Belgrade, SERBIA
/ 45 THE EFFECT OF MOXONIDINE ON CARDIOVASCULAR RISK FACTORS OF PATIENTS WITH
ARTERIAL HYPERTENSION, GRADE 1 AND 2
E. Karlafti, A. Hatzitolios, T. Didangelos, M. Baltatzi, G. Koliakos, A. Kalkavouri, V. Chasiotis, C. Savopoulos
Thessaloniki, GREECE
/ 46 ASSESSMENT OF 24-HOUR LOAD AND BLOOD PRESSURE VARIABILITY IN UNTREATED
HYPERTENSIVE PATIENTS AND ITS RELATIONSHIP WITH NON DIPPER PATTERN
R. Penuela 1, T. Penuela 2
1
San Cristobal, 2 Caracas, VENEZUELA
/ 47 RISK OF CARDIOVASCULAR DISEASES IN WOMEN WITH HYPERTENSION AND THE
HYPOTHYROIDISM
A. Logvinenko, E. Kupchynskaya, O. Gulkevych
Kiev, UKRAINE
/ 48 CHALLENGING HEART SCORE IN THE GENERAL PRACTICE OF ROMANIA
I. Brinza, V. Herdea, S. Mosteoru, D. Gaita
Timisoara, ROMANIA
/ 49 OBESITY, A PREDICTIVE CARDIOVASCULAR RISK FACTOR IN HYPERTENSIVE DIABETIC
PATIENTS
E. Nelaj, M. Gjata, M. Tase
Tirana, ALBANIA
/ 50 ALCOHOL CONSUMPTION AND HYPERTENSION IN PATIENTS WITH PREVIOUS
REVASCULARIZATION: A SUBSTUDY OF THE POP-HT STUDY
P. Mitrovic, B. Stefanovic, M. Radovanovic, N. Radovanovic, D. Rajic, G. Matic, R. Lasica, I. Subotic, N. Mijic,
Z. Vasiljevic
Belgrade, SERBIA
/ 51 AMELIORATION OF BLOOD PRESSURE INDUCES CHANGES OF PH AND PCO2 UNDER
PHYSICAL ACTIVITY
K. Kisters 1, B. Gremmler 1, F. Tokmak 1, U. Gröber 1, S. Porta 2, M. Moser 2, H. Gell 2, T. Negreanu Piriol 3,
M.M. Bratu 3
1
Herne, GERMANY, 2 Wiener-Neustadt, AUSTRIA, 3 Constanta, ROMANIA
Posters’ Session PS04
CHILDREN AND ADOLESCENTS
Chairperson: N. Martell-Claros (Madrid, SPAIN)
ROOM
POSTERS FROM 1 TO 15
/ 1 CARDIOVASCULAR RISK FACTORS IN CHILDREN AFTER LIVER TRANSPLANTATION
J. Antoniewicz, P. Czubkowski, A. Wierzbicka, J. Pawlowska, P. Socha
Warsaw, POLAND
148
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 2 SODIUM CONSUMPTION, CENTRAL AND PERIPHERAL BLOOD PRESSURE, AND FOOD HABITS
IN A POPULATION OF HEALTHY ADOLESCENTS. THE MACISTE STUDY
G. Pucci, M. D’Abbondanza, F. Battista, F. Anastasio, M.E. Crapa, L. Sanesi, F. Desantis, L. Troiani, F. Papi,
G. Schillaci
Terni, ITALY
/ 3 VALIDATION OF BLOOD PRESSURE MONITORS IN PEDIATRIC POPULATION: REVIEW OF
PUBLISHED STUDIES
N. Boubouchairopoulou, S. Lagou, A. Kollias, G.S. Stergiou
Athens, GREECE
/ 4 BLOOD PRESSURE PERCENTILES BY AGE AND HEIGHT IN 15,049 PORTUGUESE CHILDREN
AND ADOLESCENTS: THE AVELEIRA REGISTRY
T. Pereira, J. Maldonado
Coimbra, PORTUGAL
/ 5 ACCELERATED DEVELOPMENT OF IMMUNE CELLS IN CHILDREN WITH PRIMARY
HYPERTENSION
A. Niemirska 1, L. Obrycki 1, J. Michalkiewicz 1, L. Gackowska 2, I. Kubiszewska 2, M. Klosowski 2, M. Litwin 1
1
Warsaw, 2 Bydgoszcz, POLAND
/ 6 ARTERIAL STIFFNESS IN ADOLESCENTS AND YOUNG ADULTS: DETERMINANTS AND
ASSOCIATION WITH OTHER TARGET-ORGAN DAMAGE
A. Kollias, A. Ntineri, I. Moyssakis, D. Georgakopoulos, G. Servos, A. Vazeou, G.S. Stergiou
Athens, GREECE
/ 7 AMBULATORY ARTERIAL STIFFNESS INDEX, BLOOD PRESSURE VARIABILITY, AND NOCTURNAL
BLOOD PRESSURE DIP IN CHILDREN WITH IGA AND HENOCH-SCHÖNLEIN NEPHROPATHY
P. Skrzypczyk, M. Mizerska-Wasiak, M. Panczyk-Tomaszewska, B. Jerszow, P. Ruszczykowski,
M. Roszkowska-Blaim
Warsaw, POLAND
/ 8 OXIDATIVE STRESS, CARDIOVASCULAR RISK FACTORS AND LEFT VENTRICULAR HYPERTROPHY
IN CHILDREN WITH CHRONIC KIDNEY DISEASE
D. Drozdz, M. Latka, P. Kwinta, K. Sztefko, Z. Kordon, T. Drozdz, M. Miklaszewska, K. Zachwieja, A. Rudzinski,
J.A. Pietrzyk
Kraków, POLAND
/ 9 HIGH BLOOD PRESSURE IN BRAZILIAN ADOLESCENTS IS ASSOCIATED WITH MALE GENDER,
OBESITY, LOWER BIRTH WEIGHT, AND FAMILY HISTORY OF MYOCARDIAL INFARCTION. THE RIO DE
JANEIRO STUDY II
A. Brandão, F.L. Fonseca, M.E.C. Magalhaes, B.B. Harboe, G.B. Bouzas, J.B. Bouzas, L.O. Miranda,
E.M.G. Campana, P. Spineti, R.G.A. Freitas, F.A. Baptista, R. Pozzan
Rio de Janeiro, BRAZIL
/ 10 CORRELATIONS BETWEEN MOTOR PERFORMANCE, ANTHROPOMETRIC DATA AND ARTERIAL
COMPLIANCE IN 7-10 YEAR OLD CHILDREN
S. Ketelhut 1, S.R. Ketelhut 2, C. Hacke 3, K. Ketelhut 4
1
Halle, 2 Magdeburg, 3 Hamburg, 4 Gera, GERMANY
/ 11 OVERWEIGHT/OBESITY IS IMPORTANT FOR HIGH BLOOD PRESSURE, AND FOR AGGREGATION
OF CARDIOVASCULAR RISK VARIABLES IN BRAZILIAN ADOLESCENTS 10-15 YEARS OLD. THE RIO DE
JANEIRO STUDY II
F.L. Fonseca, R. Pozzan, M.E.C. Magalhaes, E.M.G. Campana, P. Spineti, L.O. Miranda, J.B. Bouzas, G.B. Bouzas,
B.B. Harboe, R.G.A. Freitas, F.A. Baptista, A.Brandão
Rio de Janeiro, BRAZIL
/ 12 SEGMENT-SPECIFIC ASSOCIATIONS OF CAROTID INTIMA-MEDIA THICKNESS IN ADOLESCENTS
AND YOUNG ADULTS
A. Kollias, A. Ntineri, S. Chorepsima, A. Vazeou, G.S. Stergiou
Athens, GREECE
F I N A L P R OG R A M M E
149
SATURDAY
11
/ 13 REGULATORY T CELLS AND CELLS PRODUCING CYTOKINES IN CHILDREN WITH PRIMARY
HYPERTENSION
L. Obrycki 1, L. Gackowska 2, A. Niemirska 1, I. Kubiszewska 2, M. Klosowski 2, J. Michalkiewicz 2, M. Litwin 1
1
Warsaw, 2 Torun, POLAND
/ 14 URINARY EXCRETION OF RENIN AND ANGIOTENSINOGEN IN HYPERTENSIVE CHILDREN AND
ADOLESCENTS
A. Wasilewska, A. Rybi-Szuminska, M. Zajac
Bialystok, POLSKA
/ 15 INFANT PATIENT WITH SEVERE HYPERTENSION DUE TO AORTIC COARCTATION
N. Ali-Tatar Chentir 1, M. Keddari 2, L. Boukari 2, M.T. Chentir 1
Algiers, ALGERIA
Posters’ Session PS05
DIABETES
Chairperson: D. Gordin (Helsinki, FINLAND)
ROOM
POSTERS FROM 1 TO 33
/ 1 THE EFFECT OF A SIDE-TO-SIDE JEJUNOILEAL ANASTOMOSIS ON GLYCEMIC CONTROL.
EXPERIMENTAL STUDY IN A NON-OBESE DIABETIC RAT MODEL
I. Papadakis, D. Peirasmakis, V. Lamprou, J. Melissas
Heraklion, GREECE
/ 2 SERUM THROMBOSPONDIN-2 IS STRONGLY ASSOCIATED WITH INSULIN RESISTANCE IN A
GENERAL POPULATION
N. Morikawa, H. Adachi, M. Enomoto, A. Fukami, E. Kumagai, S. Nakamura, Y. Nohara, E. Nakao, T. Tsuru,
A. Sakaue, S. Kono, Y. Fukumoto
Kurume, JAPAN
/ 3 GLYCATED PROTEINS ARE NOT OPTIMAL DIAGNOSTIC MARKERS OF ORAL GLUCOSE
TOLERANCE TEST DEFINED ABNORMAL GLUCOSE TOLERANCE IN MIXED-ANCESTRY SOUTH AFRICANS
A.P. Kengne, R.T. Erasmus, T.E. Matsha
Cape Town, SOUTH AFRICA
/ 4 DIAGNOSED AND UNDIAGNOSED DIABETES AMONG HIGH RISK PATIENTS WITH
HYPERTENSION
B. Georgiev,N.Gotcheva,E.Trendafilova,V.Baytcheva
Sofia, BULGARIA
/ 5 CLINICAL IMPORTANCE OF ORTHOSTATIC HYPOTENSION IN DIABETIC PATIENTS: 10 YEARS
FOLLOW-UP
L. Gaspar, A. Komornikova, Z. Celecova, A. Dukat, P. Gavornik, D. Mesarosova, I. Gasparova
Bratislava, SLOVAK REPUBLIC
/ 6 IN DIABETIC PORTUGUESE HYPERTENSIVE PATIENTS LOWERING NIGHT SYSTOLIC BLOOD
PRESSURE IS ASSOCIATED WITH LESS CARDIOVASCULAR EVENTS IN A PORTUGUESE SAMPLE OF
TREATED HYPERTENSIVE PATIENTS FOLLOWED FOR 11,8 ± 5,1 YEARS
A. Araújo 1, P. Almeida 1, J. Pinto 1, J. Pires 1, I. Zão 1, J. Polonia 2, J. Mesquita Bastos 1
1
Aveiro, 2 Porto, PORTUGAL
/ 7 COMPARATIVE EFFECTS OF DIRECT RENIN INHIBITOR AND ANGIOTENSIN RECEPTOR BLOCKER
ON ALBUMINURIA IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES
T. Uzu 1, S. Araki 1, A. Kashiwagi 2, D. Koya 3, M. Haneda 4, H. Maegawa 1
1
Otsu, 2 Kusatsu, 3 Kanazawa, 4 Asahikawa, JAPAN
150
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 8 CHEMERIN IS INDEPENDENTLY ASSOCIATED WITH ALBUMINURIA AFTER ADJUSTING THE
BLOOD PRESSURE IN TYPE 2 DIABETIC PATIENTS
C. Kim 1, S.H. Jo 1, Y.C. Hwang 2, J.G. Kang 1, S.J. Lee 1, S.H. Ihm 1, M.G. Choi 1, H.J. Yoo 1
1
Chuncheon, 2 Seoul, SOUTH KOREA
/ 9 CHANGES APELIN BLOOD LEVELS DEPENDING ON TREATMENT WITH ANGIOTENSIN II
RECEPTOR BLOCKER OR ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN HYPERTENSION PATIENTS
WITH TYPE 2 DIABETES
K. Iushko, S. Koval, T. Starchenko
Kharkiv, UKRAINE
/ 10 ASSOCIATION OF CIRCULATING SERUM LEVELS OF GELATINASE-B AND VEGF-A WITH
VASCULAR ULTRASOUND DETERMINANTS OF DEMENTIA IN HYPERTENSIVE PATIENTS WITH TYPE 2
DIABETIC NEPHROPATHY IN EA
G. Dimas, A. Mavromanoli, T. Tegos, G. Konstantinidis, I. Karamouzis, A. Spirou, C. Savopoulos, A. Orologas,
A. Hatzitolios, D. Grekas
Thessaloniki, GREECE
/ 11 SYSTOLIC BLOOD PRESSURE IS A RISK FACTOR FOR DEVELOPMENT AND PROGRESSION OF
RETINOPATHY IN PATIENTS WITH TYPE 1 DIABETES AND NORMAL RENAL FUNCTION
T. Bulum, I. Prkacin, L. Duvnjak
Zagreb, CROATIA
/ 12 BLOOD PRESSURE CONTROL AMONG HYPERTENSIVE DIABETIC AND NON-DIABETIC IN A
COHORT STUDY
A.C. Sousa, P. Jardim, T. Jardim, W. Barroso, Y. Araújo, F.G. Magalhães, A.C. Arantes, T. Costa, L. Mikael,
H. Moreira, M. Montello, W. Sousa, H. Souza, T.C. Neiva, R.B. Rodrigues, A.L. Sousa
Goiânia, BRAZIL
SATURDAY
/ 13 COMPARISON OF PULSE WAVE ANALYSIS PARAMETERS IN HYPERTENSIVE DIABETIC AND
NON-DIABETIC PATIENTS IN A BRAZILIAN AMBULATORY CARE
L. Resende, M.A.V. Da Silva, E. A.M.R. Resende, J.A.M. Resende, A.P.M. Da Silva, A.L.M. Casemiro, R.M. Lucas Jr.
Uberaba, BRAZIL
/ 14 DIABETES MELLITUS AND OBESITY IN THE FRENCH CARIBBEAN: A SPECIAL VULNERABILITY
FOR WOMEN?
P. Carrère 1,2, D. Sportouch 1, J. Hélène-Pelage 1, C. Fagour 3, T. Lang 2, J. Inamo 2,3
1
Pointe-à-Pitre, 2 Toulouse, 3 Fort-de-France, FRANCE
/ 15 SUBCLINICAL ORGAN DAMAGE IN HYPERTENSIVE PATIENTS WITH HIGH CARDIOVASCULAR
RISK: ACTORS CONTRIBUTING TO THE CHANGE OF LEFT VENTRICULAR MASS AND CAROTID INTIMA
MEDIA THICKNESS
I. Tasic, S. Kostic, D. Djordjevic, M. Lovic, M. Rihter, J. Cvetkovic, D. Lovic, D. Mijalkovic, S. Andonov
Niš, SERBIA
/ 16 AZILSARTAN MEDOXOMIL PROPORTIONALLY DECREASES CENTRAL AND BRACHIAL 24-H
AMBULATORY BLOOD PRESSURE IN DIABETIC PATIENTS WITH DIFFICULT-TO-CONTROL ARTERIAL
HYPERTENSION
E. Starostina, Y. Kotovskaya, Z. Kobalava
Moscow, RUSSIA
/ 17 PREVALENCE OF HYPERKALEMIA IN MATCHED DIABETIC AND NON-DIABETIC PATIENTS WITH
CHRONIC KIDNEY DISEASE: A NESTED CASE-CONTROL STUDY
C. Loutradis 1, P. Tolika 2, A. Skodra 2, A. Avdelidou 2, P.Sarafidis 1
1
Thessaloniki, 2 Grevena, GREECE
/ 18 RISK FACTORS FOR INCREASED LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH
DIABETES AND CHRONIC KIDNEY DISEASE
V. Vasilkova 1, T. Mokhort 2, E. Naumenko 1, M. Zmailik 1
1
Gomel, 2 Minsk, BELARUS
F I N A L P R OG R A M M E
151
11
/ 19 IMPACT OF EICOSAPENTAENOIC ACID/ARACHIDONIC ACID RATIO ON DIASTOLIC BLOOD
PRESSURE IN PATIENTS WITH TYPE 2 DIABETES
A. Sato, K. Okamoto, H. Kanno, T. Kasuga, Y. Uchigata
Tokyo, JAPAN
/ 20 BASAL GLYCAEMIA AND GLYCOSILATED HEMOGLOBINE AS A PREDICTORS OF TYPE 2
DIABETES MELLITUS DEVELOPMENT
L. Vigil 1, M. Lopez Jimenez 1, C. Rodriguez de Castro 1, R. García Carretero 1, B. Vargas 2, M. Varela 1,
J. Ruiz Galiana 1
1
Móstoles, 2 Villaviciosa de Odón, SPAIN
/ 21 INCREASED SERUM LEVELS OF TRANSFORMING GROWTH FACTOR–B1 ARE REVERSELY
CORRELATED WITH TIMP-1 IN HYPERTENSION AND ATHEROSCLEROSIS IN EARLY STAGES OF TYPE 2
DIABETIC NEPHROPATHY
G. Dimas, T. Tegos, I. Karamouzis, S. Spiroglou, K. Kapanidis, E. Mavrantoni, A. Mavromanoli, C. Savopoulos,
A. Hatzitolios, D. Grekas
Thessaloniki, GREECE
/ 22 DIABETIC HYPERTENSIVES AND QUALITY OF LIFE
V. Katsi, G. Vamvakou, T. Makris, D. Tousoulis, I. Kallikazaros
Athens, GREECE
/ 23 POSTPRANDIAL LEVELS OF BRANCH CHAINED AND AROMATIC AMINO ACIDS ASSOCIATED
WITH FASTING GLYCAEMIA
F. Ottosson, U. Ericson, P. Almgren, J. Nilsson, M. Magnusson, C. Fernandez, O. Melander
Malmö, SWEDEN
/ 24 CORRELATION BETWEEN OF THE GLYCEMIC VARIABILITY WITH THE CIRCADIAN VARIABILITY
OF BLOOD PRESSURE IN INDIVIDUALS WITH NORMAL WEIGHT, WITHOUT IMPAIRED GLUCOSE
TOLERANCE
L. Rosales Rivera, L. Zuñiga, L. Hernandez Palma, D. Hernandez Molina, G. Cardona Muñoz, C. Ramos Becerra,
J. Ramos Nuñez, M. Gónzalez Ortíz, E. Martínez Abundis
Guadalajara, MEXICO
/ 25 STRATIFICATION OF RISK FOR THE DEVELOPMENT OF DIABETES MELLITUS AND RELATIONSHIP
BETWEEN ITS RISK PREDICTORS
M. Luzardo De La Vega, S. Briceño, J. Villasmil, F. Madueño
Maracaibo, VENEZUELA
/ 26 EFFECTS OF SGLT2 INHIBITORS ON BLOOD PRESSURE, BAPWV, CAROTID ARTERIAL IMT AND
ELASTIC MODULUS IN TYPE 2 DIABETIC PATIENTS WITH OBESITY
T. Yamagishi, H. Hasegawa, H. Kanai
Sendai, JAPAN
/ 27 BIHERBAL FORMULATION FOR ATTENUATING DIABETES INDUCED OXIDATIVE STRESS AND
CARDIVASCULAR COMPLICATION
P. Rai
Allahabad, INDIA
/ 28 THE ROLE OF INTERLEUKIN-10 AND GLYCATED HEMOGLOBIN IN PREDICTING OF THE
DEVELOPMENT OF CARBOHYDRATE METABOLISM DISORDERS IN PATIENTS WITH ARTERIAL
HYPERTENSION
L. Zhuravlyova, M. Kulikova, T. Ascheulova
Kharkiv, UKRAINE
/ 29 MICROALBUMINURIA AS A POTENT CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH
HYPERTENSION, WITH AND WITHOUT DIABETES
E. Nelaj, M. Gjata, E. Sadiku, M. Tase
Tirana, ALBANIA
/ 30 BLOOD PRESSURE PHENOTYPES IN PATIENTS WITH TYPE 1 DIABETES MELLITUS
D. Medvedev, Y.K. Mahamat, F. Tokaeva, A.F. Safarova
Moscow, RUSSIA
152
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 31 THYROID STIMULATING HORMONE LEVELS AT THE UPPER REFERENCE RANGE IN DIABETIC
PATIENTS WITHOUT KNOWN DYSTHRYOÏDIES
K. Chaabouni, M. Turki, A. Lahiani, R. Marrekchi, M. Naifar, M. Abid, F. Ayedi
Sfax, TUNISIA
/ 32 THE GENDER DIFFERENCES OF IGF-1 LEVELS IN PATIENTS WITH COMBINED COURSE OF
HYPERTENSION AND TYPE 2 DIABETES
L. Zhuravlyova, O. Pivovarov
Kharkiv, UKRAINE
/ 33 FROM GLUTATHIONE DETOXIFICATION SYSTEM IN THE LIVER OF ANIMALS TO TIMP-1, OX-LDL
AND 15-F2T-ISOP OF HUMANS WITH DIABETES MELLITUS TYPE 2: THE OXIDATIVE STRESS MODEL
C. Chatzakis 1, G. Dimas 2, I. Karamouzis 2, S. Spiroglou 2, A. Mavromanoli 2, A. Spirou 2, N. Pirou 2,
C. Savopoulos 2, L. Turecky 1, A. Hatzitolios 2
1
Bratislava, SLOVAK REPUBLIC, 2 Thessaloniki, GREECE
Posters’ Session PS06
EPIDEMIOLOGY OF HYPERTENSION AND METABOLIC DISORDERS
Chairperson: A. Gottsater (Malmö, SWEDEN)
ROOM
POSTERS FROM 1 TO 23
SATURDAY
/ 1 CARDIOVASCULAR OUTCOME IN TREATMENT RESISTANT HYPERTENSION: RESULTS FROM THE
SWEDISH PRIMARY CARE CARDIOVASCULAR DATABASE
L. Holmqvist 1, K. Bengtsson Boström 2, T. Kahan 3, L. Schiöler 1, J. Hasselström 3, P. Hjerpe 2, B. Wettermark 3,
K. Manhem 1
1
Gothenburg, 2 Skövde, 3 Stockholm, SWEDEN
/ 2 THE PREVALENCE OF RENAL DYSFUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION IN
RUSSIAN POPULATION BY THE DATA OF EPIDEMIOLOGICAL STUDY ECVD-RF
E. Oshchepkova 1, I. Zhernakova 1, I.E. Chazova 1, S. Shalnova 1, S. Boytsov 1, A.O. Konradi 2, E. Shlyakhto 2,
O. Rotar 2
1
Moscow, 2 Saint-Petersburg, RUSSIA
/ 3 RESISTANT HYPERTENSION IN VERONA: A COLLABORATIVE POPULATION-BASED
OBSERVATIONAL STUDY
C. Idolazzi, L. Fondrieschi, C. Fava, P. Delva, S. Romano, M. Celebrano, P. Minuz
Verona, ITALY
/ 4 COMPARISON OF PULSE WAVE VELOCITY AND PULSE PRESSURE AMPLIFICATION IN THE
ASSOCIATION WITH TARGET ORGAN DAMAGES IN THE COMMUNITY-BASED ELDERLY: THE NORTHERN
SHANGHAI STUDY
B. Bai, J. Xiong, S. Yu, Y.W. Zhou, C. Chi, Y.Y. Lv, K. Wang, L. Wang, J. Teliewubai, Y. Zhang, Y.W. Xu
Shanghai, CHINA
/ 5 RELATIONSHIP BETWEEN URIC ACID AND BLOOD PRESSURE LEVELS IN GENERAL
POPULATION
M. Simonini, C. Lanzani, L. Citterio, E. Brioni, S. Delli Carpini, S. Pozzoli, N. Casamassima, P. Manunta
Milan, ITALY
/ 6 CAN ARTERIAL WAVE AUGMENTATION IN YOUNG ADULTS EXPLAIN VARIABILITY OF
CARDIOVASCULAR RISK IN ETHNIC MINORITIES?
L. Faconti 1, M. Silva 1, O. Molaodi 2, Z.E. Enayat 1, A. Cassidy 2, A. Karamanos 1, U. Read 2, P. Dall 2,B.Stanfield2,
S. Harding 1, J.K. Cruickshank 1
1
London, 2 Glasgow, UNITED KINGDOM
F I N A L P R OG R A M M E
153
11
/ 7 HYPOTHALAMIC APOLIPOPROTEIN E EFFECTS ON ARTERIAL PRESSURE IN OBESE RATS WITH
METABOLIC SYNDROME
M. Bunea, D.N. Bunea
Bucharest, ROMANIA
/ 8 SECULAR TRENDS IN CARDIOVASCULAR RISK FACTORS AMONG MIDDLE-AGED SWEDISH
WOMEN OVER THE LAST 35 YEARS
A. Collén 1, A. Rosengren 1, S. Johansson 2, P.O. Hansson 1
1
Gothenburg, 2 Mölndal, SWEDEN
/ 9 JOINT ACTION OF PHYSICIAN AND PHARMACIST WITH SMS REMINDERS TO INCREASE THE
HYPERTENSIVE PATIENTS’ ADHERENCE TO MEDICATION
I. Prga, M. Bago, J. Culig, M. Leppee
Zagreb, CROATIA
/ 10 ASSOCIATION BETWEEN HYPERTENSION WITH SOCIOECONOMIC STATUS
H. Lee, C. Park
Seoul, SOUTH KOREA
/ 11 DECLINE OF GLOMERULAR FILTRATION RATE WITH PULSE PRESSURE AND POPULATION
CHARACTERISTICS. A CROSS-SECTIONAL STUDY
M. Ahmed 1, S. Al Sheik 2, S. Mirwais 2
1
Abu Dhabi, 2 Dubai, UNITED ARAB EMIRATES
/ 12 THE INFLUENCE OF HYPERTENSION IN MULTIMORBIDITY AMONG OLDER ADULTS IN
MIDWESTERN BRAZIL
S.R.R. Batista, P. Jardim, A.L.L. Souza, D.P. Nunes, F.K.M.S. Pinto, A.Y.K. Nakatani
Goiânia, BRAZIL
/ 13 BLOOD PRESSURE, SUBCLINICAL ATHEROSCLEROSIS AND LEVEL OF LEPTIN IN PATIENT WITH
CORONARY HEART DISEASE IN COMBINATION WITH HEPATIC STEATOSIS
M. Grechanyk, N. Grechanyk, A. Kuryata
Dnepropetrovsk, UKRAINE
/ 14 BLOOD PRESSURE CONTROL IN HYPERTENSIVE PATIENTS ATTENDING AN AMBULATORY
NEPHROLOGY UNIT
A. Del Giudice, R. Grifa, F. Miscio, M. Prencipe, M. Vergura, A. Mangiacotti, F. Aucella
San Giovanni Rotondo, ITALY
/ 15 ANTIANGIOGENETICS AND HYPERTENSION: EPIDEMIOLOGY AND BASAL FEATURES OF
PATIENTS
M. Destro, G.P. Dognini, F. Cagnoni, A. Coinu, G. Maccagni, S. Barni
Treviglio, ITALY
/ 16 POPULATION BASED STUDY OF HYPERTENSION IN HUNGARY - 2015. NATIONWIDE
COMPREHENSIVE HEALTH SCREENING PROGRAMME IN HUNGARY 2010-2015
I. Barna, T. Diaki, G. Dankovics, E. Kékes, I. Kiss
Budapest, HUNGARY
/ 17 THE CLINICAL CHARACTERISTICS AND TREATMENT EFFICACY IN PATIENTS WITH
HYPERTENSION ACCORDING TO THE RUSSIAN FEDERAL REGISTER OF ARTERIAL HYPERTENSION
E. Oshchepkova, A.U. Kantorova, I. E. Chazova
Moscow, RUSSIA
/ 18 INFLUENCE OF ANXIETY AND DEPRESSION ON BLOOD PRESSURE CONTROL IN UKRAINE BY
EUROASPIRE IV-PRIMARY CARE RESULTS
M. Dolzhenko, C. Faradzh, L. Konoplyanik, A. Nudchenko, L. Grubyak, Y.A. Djacheko, S. Lurje, I. Soroka
Kiev, UKRAINE
/ 19 ARTERIAL HYPERTENSION IN PATIENTS WITH HIP REPLACEMENT
A. Platek, P. Legosz, K. Semczuk, A. Rys, A. Dudzik-Plocica, F.M. Szymanski, K.J. Filipiak
Warsaw, POLAND
154
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 20 THE RISK FACTORS OF CARDIOVASCULAR DISEASE IN PERSONS WITH HIGH NORMAL BLOOD
PRESSURE IN RUSSIAN POPULATION BY DATA ESSE-RF
I. Efremova 1, E. Oshchepkova 1, I. Zhernakova 1, I.E. Chazova 1, S. Shalnova 1, S. Boytsov 1, O. Potar 2,
A.O. Konradi 2, E. Shlyakhto 2
1
Moscow, 2 Saint-Petersburg, RUSSIA
/ 21 ARTERIAL HYPERTENSION AND CARDIOVASCULAR DISEASES RISK FACTORS IN RUSSIAN
POPULATION BY THE DATA ESSE-RF
I. Zhernakova 1, I.E. Chazova 1, E. Oshchepkova 1, S. Shalnova 1, S. Boytsov 1, I. Balanova 1, O. Rotar 2,
A.O. Konradi 2, E. Shlyakhto 2
1
Moscow, 2 Saint-Petersburg, RUSSIA
/ 22 EPIDEMIOLOGY AND CLINICAL PRESENTATION OF HYPERTENSIVE URGENCY IN THE
EMERGENCY DEPARTMENT OF UHC, TIRANA (ALBANIA)
M. Lezha, E. Hasani, E. Zaimi
Tirana, ALBANIA
/ 23 PROPERTIES OF CLINICAL SYMPTOMS AND PHYSICAL EXAMINATION IN PATIENTS WITH
DIFFERENT FORMS OF PULMONARY ARTERIAL HYPERTENSION
Z. Valieva, S. Glukhova, T. Martynyuk, I.E. Chazova
Moscow, RUSSIA
Posters’ Session PS07
SATURDAY
GENETICS, GENOMICS, PROTEOMICS, METABOLOMICS
Chairperson: N. Bouatia-Naji (Paris, FRANCE)
ROOM
POSTERS FROM 1 TO 30
/ 1 MIR-483-5P ASSOCIATES WITH OBESITY AND INSULIN RESISTANCE AND INDEPENDENTLY
PREDICTS NEW ONSET DIABETES MELLITUS AND CARDIOVASCULAR DISEASE
H. Gallo, J.S. Esguerra, L. Eliasson, O. Melander
Malmö, SWEDEN
/ 2 AMBULATORY SYSTOLIC-DIASTOLIC PRESSURE REGRESSION INDEX IS GENETICALLY
DETERMINED IN HYPERTENSIVE PATIENTS WITH CORONARY HEART DISEASE
M. Wirtwein 1, O. Melander 2, M. Sjogren 2, M. Hoffmann 1, K. Narkiewicz 1, M. Gruchala 1
1
Gdansk, POLAND, 2 Malmö, SWEDEN
/ 3 GENETIC RISK SCORE AND DIPPING PROFILE IN HYPERTENSIVE PATIENTS WITH CORONARY
HEART DISEASE
M. Wirtwein 1, O. Melander 2, M. Sjogren 2, M. Hoffmann 1, K. Narkiewicz 1, M. Gruchala 1, W. Sobiczewski 1
1
Gdansk, POLAND, 2 Malmö, SWEDEN
/ 4 TRANSCRIPTIONAL REGULATION OF THE UMOD PROMOTER SNP RS4997081 IS SALT
DEPENDENT: IMPLICATIONS FOR SODIUM HOMEOSTASIS AND BLOOD PRESSURE REGULATION
L. Graham 1, N.J. Fraser 2, N.R. Ferreri 3, D. Graham 1, A.F. Dominiczak 1, M.W. McBride 1, S. Padmanabhan 1
1
Glasgow, 2 Dundee, UNITED KINGDOM, 3 New York, NY, USA
/ 5 PLATELET ENDOTHELIAL AGGREGATION RECEPTOR 1 IS NOT A SUSCEPTIBILITY GENE FOR
CARDIOVASCULAR DISEASE IN THE GENERAL POPULATION
W. Yang 1, T. Petit 1, N. Cauwenberghs 1, Z. Zhang 1, L. Thijs 1, E. Salvi 2, B. Izizi 1, C. Vandenbriele 1, F. Wei 1,
Y. Gu 1, L. Jacobs 1, L. Citterio 2, S. Delli Carpini 2, C. Barlassina 2, D. Cusi 2, M.F. Hoylaerts 1, P. Verhamme 1,
T. Kuznetsova 1, J.A. Staessen 1,3
1
Leuven, BELGIUM, 2, Milan, ITALY, 3 Maastricht, NETHERLANDS
/ 6 URINARY PROTEOME ANALYSIS IDENTIFIED NEPRILYSIN AND VCAM AS KEY PROTEINS IN THE
DEVELOPMENT OF DIABETIC NEPHROPATHY
B. Bardaji 1, E. Guillen-Gomez 1, S. Ferrer 1, C. Brotons 1, M.A. Knepper 2, M. Carrascal 1, J. Abian 1, J.M. Mas 1,
F. Calero 1, J.A. Ballarin 1, P. Fernández-Llama 1
1
Barcelona, SPAIN, 2 Bethesda, MD, USA
F I N A L P R OG R A M M E
155
11
/ 7 CIRCULATING MICROVESICLES (C-MVS) LEVELS AND ENDOTHELIAL FUNCTION IN PATIENTS
WITH MULTIFOCAL FIBROMUSCULAR DYSPLASIA (FMD): A CROSS-SECTIONAL STUDY
X. Loyer, H. Kettab, A. Lorthioir, M. Frank, R. Niarra, J.M. Renard, Y. Chambon, X. Jeunemaitre, P.-F. Plouin,
L. Amar, P. Boutouyrie, C.M. Boulanger, M. Azizi
Paris, FRANCE
/ 8 PATTERN OF ENDOTHELIAL PROGENITOR CELLS AND APOPTOTIC ENDOTHELIAL CELL-DERIVED
MICROPARTICLES IN HEART FAILURE PATIENTS
A. Berezin, A. Kremzer
Zaporozhye, UKRAINE
/ 9 METABOLOMIC STUDY OF PATHWAYS UNDERLYING HEXADECANEDIOATE INDUCED BLOOD
PRESSURE ELEVATION
N. Alharbi, M.W. McBride, D. Graham, S. Padmanabhan
Glasgow, UNITED KINGDOM
/ 10 GENETIC RISK SCORE AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH
HYPERTENSION
M. Wirtwein 1, O. Melander 2, M. Sjogren 2, M. Hoffmann 1, K. Narkiewicz 1, M. Gruchala 1, W. Sobiczewski 1
1
Gdansk, POLAND, 2 Malmö, SWEDEN
/ 11 THE TRUNCATED STIM1 CAUSED IMPAIRED STORE-OPERATED CALCIUM ENTRY IN ASTROCYTES
OF SHRSP
H. Ohara, T. Nabika
Izumo, JAPAN
/ 12 INDIVIDUALIZED GENETICALLY BASED VS STANDARD EVIDENCE-BASED TREATMENT
INFLUENCE ON BLOOD PRESSURE PROFILE
A. Sydorchuk 1, L. Sydorchuk 1, K. Amosova 2, R. Sydorchuk 1, I. Sydorchuk 1, Y. Yarynych 1
1
Chernivtsi, 2 Kiev, UKRAINE
/ 13 SUBCLINICAL FRUCTOSE-INDUCED METABOLIC SYNDROME ASSOCIATED TO HOSTMICROBIOTA CO-METABOLISM IN RATS
M. Pardo Tendero, J.M. Morales, M.C. Collado, K.M. Abdelaziz, A. Diaz, D. Monleón
Valencia, SPAIN
/ 14 ARMC5 MUTATIONS IN PATIENTS WITH PRIMARY ALDOSTERONISM AND BILATERAL ADRENAL
LESIONS
P. Mulatero 1, F. Schiavi 2, T.A. Williams 1, S. Monticone 1, G. Barbon 2, G. Opocher 2, F. Fallo 2
1
Turin, 2 Padua, ITALY
/ 15 GLOBAL DNA METHYLATION AND ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE
POLYMORPHISM IN MIXED-ANCESTRY AFRICAN INDIVIDUALS
T. Matsha, C. Pheipher, T. Mutize, R. T. Erasmus, A.P. Kengne
Cape Town, SOUTH AFRICA
/ 16 1-ALKYL-2-ALKYL CARBAMOYL GLYCERINE INFLUENCE ON VASCULAR SMOOTH MUSCLES
CONTRACTILE ACTIVITY
S. Gusakova 1, L. Smaglii 1, I. Kovalev 1, V. Rydchenko 1, S. Orlov 1,2
1
Tomsk, 2 Moscow, RUSSIA
/ 17 THE C3435T POLYMORPHISM OF THE ABCB1 GENE INCREASES THE RISK OF ESSENTIAL
HYPERTENSION IN CIGARETTE SMOKERS
M. Bykanova 1, O. Bushueva 1, M. Solodilova 1, S. Sirotina 1, M. Churnosov 2, A. Polonikov 1
1
Kursk, 2 Belgorod, RUSSIA
/ 18 DISCOVERY OF JAK/STAT SIGNALLING PATHWAY SINGLE NUCLEOTIDE POLYMORPHISMS
ASSOCIATING WITH PRIMARY ARTERIAL HYPERTENSION
P. Uruski, J. Wesoly, H. Bluijssen, A. Tykarski
Poznan, POLAND
156
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 19 POPULATION ANALYSIS OF ALLELE AND GENOTYPE GEOGRAPHIC DISTRIBUTION OF TWO
ADIPONECTIN GENE POLYMORPHISMS
V. Ivkovic, M. Jelakovic, M. Pericic Salihovic, Z. Tomas, N. Bozina, T. Bozina, J. Sertic, M. Laganovic, I. Pecin,
L.J. Fodor, T. Zeljkovic Vrkic, S. Karanovic A. Vrdoljak, B. Jelakovic
Zagreb, CROATIA
/ 20 A PROMOTER POLYMORPHISM -271C>A OF THE CYP2C8 GENE IS ASSOCIATED WITH
INCREASED RISK OF ESSENTIAL HYPERTENSION: A PILOT STUDY
M. Bykanova 1, I. Ponomarenko 1, S. Sirotina 1, A. Bocharova 2, K. Vagaytseva 2, V. Stepanov 2, O. Bushueva 1,
M. Churnosov 3, M. Solodilova 1, A. Polonikov 1
1
Kursk, 2 Tomsk, 3 Belgorod, RUSSIA
/ 21 THE RELATIONSHIP BETWEEN GENES INVOLVING IN ARYL HYDROCARBON RECEPTOR
SIGNALING PATHWAY AND RISK OF ESSENTIAL HYPERTENSION
M. Bykanova 1, O. Bushueva 1, M. Solodilova 1, I. Bulgakova 1, I. Ponomarenko 1, M. Churnosov 2, A. Polonikov 1
1
Kursk, 2 Belgorod, RUSSIA
/ 22 TRANSCRIPTIONAL MAP OF LOCAL ANGIOTENSIN PATHWAYS IN ATHEROMA: GENE
CO-EXPRESSION MODULES AND ASSOCIATED TRANSCRIPTION FACTORS
A. Nehme 1, C. Cerutti 1, G. Bricca 1, K. Zibara 2
1
Lyon, FRANCE, 2 Beirut, LEBANON
/ 23 VITAMIN D RECEPTOR GENE POLYMORPHISMS, FGF-23 AND FETUIN-A IN ESSENTIAL
HYPERTENSION
L. Guarino, C. Scazzone, R. Arsena, F. Vaccaro, M. Guarneri, M. Morreale, D. Altieri, G. Mulè, S. Cottone
Palermo, ITALY
SATURDAY
/ 24 ASSOCIATION BETWEEN THE GENE POLYMORPHISMS MMP2 (-1306) AND MMP9 (-1562)
AND ARTERIAL STIFFNESS AMONG HYPERTENSIVE PATIENTS IN YOUNG AND MIDDLE AGE
A. Sakovskaia, V. Nevzorova, M. Issaeva
Vladivostok, RUSSIA
/ 25 ASSOCIATION OF ADIPONECTIN GENE POLYMORPHISMS WITH BLOOD PRESSURE AND
HYPERTENSION
V. Ivkovic, M. Jelakovic, M. Pericic Salihovic, Z. Tomas, N. Bozina, T. Bozina, J. Sertic, M. Laganovic, I. Pecin,
L.J. Fodor, T. Zeljkovic Vrkic, S. Karanovic, A. Vrdoljak, B. Jelakovic
Zagreb, CROATIA
/ 26 CORRELATION STUDY BETWEEN GENETIC POLYMORPHISMS HYPERTENSION-ASSOCIATED
AND GENOMIC ANCESTRY IN A SAMPLE OF ADMIXED HYPERTENSIVE INDIVIDUALS FROM RIO DE
JANEIRO (BRAZIL)
Y.L.R.C. Machado, R.G.A. Freitas, R. Pozzan, R.A. Faria, E.M.G. Campana, M.E.C. Magalhaes, A. Brandão,
D.A. Silva
Rio de Janeiro, BRAZIL
/ 27 POSITIVE ASSOCIATION OF ADIPONECTIN GENE POLYMORPHISM -11391G>A WITH INSULIN
RESISTANCE
V. Ivkovic, M. Jelakovic, M. Pericic Salihovic, Z. Tomas, N. Bozina, T. Bozina, J. Sertic, M. Laganovic, I. Pecin,
E. Ivandic, T. Zeljkovic Vrkic, S. Karanovic, A. Vrdoljak, B. Jelakovic
Zagreb, CROATIA
/ 28 CORRELATION OF POLYMORPHISM RS699 (G (-6) A) IN THE PROMOTER OF THE GENE CODING
ANGIOTENSINOGEN AND EARLY MANIFESTATION OF HYPERTENSION
T. Chakalova-Yancheva, K. Gospodinov, T. Rashev, Y. Mladenova, N. Stancheva, P. Tonchev, S. Tisheva
Pleven, BULGARIA
/ 29 SHORT TELOMERE LENGTH IN CARDIOVASCULAR COMPLICATIONS: CAUSE OR CONSEQUENCE
N. Doroshchuk, A. Doroshchuk, Z. Khasanova, Y.U. Hesuani, A. Postnov
Moscow, RUSSIA
/ 30 PARG GENE POLYMORPHISM IS ASSOCIATED THE DEVELOPMENT OF LEFT VENTRICULAR
HYPERTROPHY IN ARTERIAL HYPERTENSION
L. Minushkina, A. Nikitin, V. Brazhnik, V. Nosikov, D. Zateyshchikov
Moscow, RUSSIA
F I N A L P R OG R A M M E
157
11
Posters’ Session PS08
INNOVATIVE TECHNIQUES AND DEVICES
Chairperson: S. Wassertheurer (Vienna, AUSTRIA)
ROOM
POSTERS FROM 1 TO 19
/ 1 BLOOD PRESSURE TELEMONITORING EFFECTIVENESS IN PATIENTS WITH UNCONTROLLED
HYPERTENSION, IMPACT OF ANXIETY AND DEPRESSION
M. Ionov, Y. Yudina, N. Avdonina, I. Emelyanov, N. Zvartau, D. Kurapeev, A.O. Konradi
Saint-Petersburg, RUSSIA
/ 2 AUTOMATIC IMAGE ANALYZER TO ASSESS RETINAL VESSEL CALIBER (ALTAIR) TOOL
VALIDATION FOR THE ANALYSIS OF RETINAL VESSELS
L. Garcia-Ortiz, H. Perez-Ramos, P. Chamoso-Santos, J.I. Recio-Rodriguez, A. Garcia-Garcia,
J.A. Maderuelo-Fernandez, L. Gomez-Sanchez, P. Martínez-Perez, C. Rodriguez-Martin, A. De Cabo-Laso,
B. Sanchez-Salgado, S. Rodríguez-González, J.F. De Paz-Santana, J.M. Corchado-Rodríguez, M.A. Gomez-Marcos
Salamanca, SPAIN
/ 3 COULD FLOW MEDIATED SLOWING CONSTITUTE A METHODOLOGICAL ALTERNATIVE TO THE
CONVENTIONAL ECHO-TRACKING FLOW-MEDIATED DILATION TECHNIQUE FOR THE EVALUATION OF
ENDOTHELIAL FUNCTION?
T. Pereira, A. Almeida, J. Maldonado
Coimbra, PORTUGAL
/ 4 CHANGES IN RENAL ARTERY DIMENSIONS PREDICT BLOOD PRESSURE RESPONSE
FOLLOWING RENAL DENERVATION. AN INTRAVASCULAR ULTRASOUND STUDY
T. Weber 1, J. Ligthart 2, K. Witberg 2, B. Eber 1
1
Wels, AUSTRIA, 2 Rotterdam, NETHERLANDS
/ 5 COMPARISON OF ARTERIAL STIFFNESS ASSESSED BY POPMETRE® WITH ARTERIAL STIFFNESS
ASSESSED BY APPLANATION TONOMETRY: A CLINICAL STYDY
H. Obeid 1, P. Boutouyrie 1, S. Laurent 1, H. Khettab 1, M. Hallab 2
1
Paris, 2 Nantes, FRANCE
/ 6 IS THE DEVELOPMENT OF TELEMEDICINE IN HYPERTENSION A DIGITAL IMMIGRANT ISSUE?
M. Lopez-Sublet 1, J.-P. Baguet 2, P.-Y. Courand 3, S. Bally 4, T. Krummel 4, Y. Dimitrov 4, M. Brucker 4,
S. Regnier-Le-Coz 4, C. Dourmap 4, J.-J. Mourad 1, O. Steichen 4, J. Ott 4, J. Barone 4, L. Bogetto-Graham 4,
P. Rossignol 4, N. Barber-Chamoux 4, S. Le Jeune 1, D. Agnoletti 4, S. Baguet 2, P. Sosner 4
1
Bobigny, 2 Grenoble, 3 Lyon, 4 Paris, FRANCE
/ 7 THE IMPORTANCE OF HEMODINAMIC PROFILE IN THE MANAGEMENT OF HYPERTENSIVE
PATIENTS
O. Tautu, I. Ghiurco, M. Dorobantu
Bucharest, ROMANIA
/ 8 THE ROLE OF INTRAVASCULAR ULTRASOUND IN FIBROMUSCULAR DISPLASIA TREATMENT
D. Vassilev, T. Yaneva-Sirakova, R. Ivanova
Sofia, BULGARIA
/ 9 A METHOD FOR DETERMINING CAROTID FEMORAL PULSE WAVE VELOCITY BY FOUR CHANNEL
RHEOVASOGRAPHY IN PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY ARTERY DISEASE
N. Lopina, L. Zhuravlyova, I. Kuznetsov, T. Ermolenko
Kharkiv, UKRAINE
/ 10 CHRONIC MICROVIBRATION TREATMENT DOES NOT INFLUENCE BLOOD PRESSURE BUT
AMELIORATES RENAL PERFUSION AND ANTIOXIDATIVE DEFENSE IN HYPERTENSIVE RATS
Z. Miloradovic, N. Mihailovic-Stanojevic, D.J. Jovovic, M. Ivanov, U.J. Vajic, D. Karanovic, J. Grujic Milanovic
Belgrade, SERBIA
158
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 11 ARTIFICIAL INTELLIGENCE UTILIZING NEURO-FUZZY HYBRID MODEL FOR THE CLASSIFICATION
OF BLOOD PRESSURE
P. Melin, J.C. Guzman, G. Prado-Arechiga
Tijuana, MEXICO
/ 12 A NOVEL CUFFLESS BLOOD PRESSURE MEASUREMENT TECHNOLOGY: CONCEPT AND
FEASIBILITY
A. Kollias 1, B. Chen 2, B. Chiu 2, N. Boubouchairopoulou 1, G.S. Stergiou 1
1
Athens, GREECE, 2 Zhubei, TAIWAN
/ 13 COMPARISON OF THE DETECTION OF PERIPHERAL ARTERY DISEASES WITH AN IMPROVED
AUTOMATED OSCILLOMETRIC DEVICE AND THE STANDARD DOPPLER METHOD
M. Span 1, G. Gersak 2, M. Meza 2, S. Millasseau 3, A. Kosir 2
1
Izola, 2 Ljubljana, SLOVENIA, 3 Saint-Leu-la-Forêt, FRANCE
/ 14 FACTORS PREDICTIVE OF LOWER GLS IN HYPERTENSIVE PATIENTS WITH PRESERVED LVEF
N. Taleb Bendiab, L. Henaoui, A. Meziane-Tani
Tlemcen, ALGERIA
/ 15 CLINICAL VALIDATION OF A NOVEL CUFFLESS BLOOD PRESSURE MONITOR
N. Boubouchairopoulou, A. Kollias, S. Lagou, P. Anestis, G.S. Stergiou
Athens, GREECE
/ 16 EUSTAR: EUROPEAN SOCIETY OF HYPERTENSION TELEMEDICINE IN ARTERIAL HYPERTENSION
REGISTER. DESIGN AND RATIONALE
E. Schulz 1, C. Neumann 1, M. Middeke 2
1
Göttingen, 2 Munich, GERMANY
/ 17 A NEW ARTIFICIAL INTELLIGENCE METHOD BASED ON MODULAR NEURAL NETWORKS FOR
CLASSIFICATION OF ARTERIAL HYPERTENSION
P. Melin, M. Pulido, I. Miramontes, G. Prado-Arechiga
Tijuana, MEXICO
/ 18 AUTOMATICALLY CLASSIFYING ESSENTIAL ARTERIAL HYPERTENSION FROM PHYSIOLOGICAL
AND DAILY LIFE STRESS RESPONSES
M. Danieli 1, E. Berra 2, S. Di Monaco 1, C. Fulcheri 2, A. Gosh 1, E. Perlo 2, F. Rabbia 2, G. Riccardi 1, F. Veglio 2
1
Trento, 2 Turin, ITALY
/ 19 THE NE METH D F EVAL ATI N F -ADREN RECEPT R S ACTIVITY
O. Agapova, K. Zykov, Y. Skoblov, V. Masenko, I.E. Chazova
Moscow, RUSSIA
Posters’ Session PS09
KIDNEY
Chairperson: D. Karasavvidou (Thessaloniki, GREECE)
ROOM
POSTERS FROM 1 TO 26
/ 1 IMPLEMENTATION OF ALGORITHM PREVENTING REDUCED RISK OF CONTRAST-INDUCED
ACUTE KIDNEY INJURY IN CLINICAL PRACTICE IN PATIENT WITH PRIMARY PERCUTANEOUS CORONARY
INTERVENTIONS
A. Gaskina, S. Villevalde, Z. Kobalava
Moscow, RUSSIA
F I N A L P R OG R A M M E
159
SATURDAY
11
/ 2 T-TYPE CALCIUM CHANNEL BLOCKER ATTENUATES UNILATERAL URETERAL OBSTRUCTIONINDUCED RENAL INTERSTITIAL FIBROSIS VIA ACTIVATION OF THE NRF2 ANTIOXIDANT PATHWAY
S. Shin, S. Chung, S. Kim
Seoul, SOUTH KOREA
/ 3 EFFECT OF HIGH-SALT INTAKE ON TUBULAR EPITHELIAL-TO-MESENCHYMAL TRANSITION AND
RENAL FIBROSIS IN DAHL SALT-SENSITIVE RATS
J. Mu, Y. Wang, C. Chu, W.L. Zheng, T.S. Guo
Xian, CHINA
/ 4 ACCESSORY RENAL ARTERIES IN RESISTANT HYPERTENSION
S. Le Jeune 1, I. Radhouani 1, P. Sosner 2, L. Perez 3, N. Barber-Chamoux 4, F. Boudghene-Stambouli 5,
M. Lopez-Sublet 1, M. Brucker 6, P. Delsart 5, S. Baguet 7, C. Dourmap 8, J.-J. Mourad 1
1
Bobigny, 2 Paris, 3 Muret, 4 Clermont Ferrand, 5 Lille, 6 Valence, 7 Avrainville, 8 Rennes, FRANCE
/ 5 THE EFFICACY OF RENAL ARTERY STENTING COMBINED WITH OPTIMAL MEDICAL THERAPY IN
PATIENTS WITH ATHEROSCLEROTIC RENAL ARTERY STENOSIS
X. Jiang, B. Li, M. Peng, H. Dong, Y. Zou
Beijing, CHINA
/ 6 PROTEOMIC ANALYSIS OF KIDNEYS FROM SPONTANEOUSLY HYPERTENSIVE AND NORMAL
RATS REVEALS CLIC-4, AS A PUTATIVE BIOMARKER IN HYPERTENSIVE NEPHROPATHY
A. Hatziioannou, G. Bakras, E. Critselis, J. Zoidakis, A. Vlachou, A. Charonis, D.V. Vlahakos
Athens, GREECE
/ 7 PREDICTORS OF HYPERTENSION IN A HEMODIALYSIS POPULATION ACCORDING TO RESIDUAL
RENAL FUNCTION
J. Cruz Coutinho, C. Reis Santos, R. Sá A. Chorão, R. Filipe, F. Teixeira, E. Rocha
Castelo Branco, PORTUGAL
/ 8 PATTERNS OF RENAL AND CARDIAC HAEMODYNAMICS IN SYMPTOMATIC ESSENTIAL
HYPERTENSIVES
K. Kintis,C.Tsioufis,K.Dimitriadis,D.Konstantinidis,T.H.Kalos,A. Kasiakogias, I. Nikolakopoulos,
G. Bazoukis, S. Patsilinakos, D. Tousoulis
Athens, GREECE
/ 9 HEMODIALYSIS IMPROVES RIGHT VENTRICULAR SIZING AND REDUCES PULMONARY
CIRCULATION LOADING IN PATIENTS WITH END-STAGE RENAL DISEASE
P. Georgianos, V. Kamperidis, H. Loutradis, K. Tsilonis, K. Imprialos, A. Boutou, L. Alexakis,
M. Galani-Manolakou, H. Karvounis, P.Sarafidis
Thessaloniki, GREECE
/ 10 BONE MINERAL DENSITY IS RELATED WITH AORTIC BUT NOT WITH CORONARY
CALCIFICATIONS IN RENAL TRANSPLANTED PATIENTS
C.Alfieri, S. Vettoretti, A. Regalia, M. Meneghini, M.T. Gandolfo, V. Binda, P. Messa
Milan, ITALY
/ 11 KIDNEY INJURY IN HYPERTENSION: RELATION TO VASCULAR REACTIVITY AND STIFFNESS
S. Mironova, I. Iudina, M. Ionov, T. Makhmatova, N. Avdonina, I. Emelyanov, N. Zvartau, A.O. Konradi
Saint-Petersburg, RUSSIA
/ 12 AMBULATORY BLOOD PRESSURE BEHAVIOUR IN END STAGE RENAL DISEASE PATIENTS
UNDERGOING HAEMODIALYSIS
A. Kasiakogias,C.Tsioufis,K.Dimitriadis,E.Andrikou,D.Konstantinidis,D. Chatzis, D. Aragiannis, F. Lagiou,
G. Peskesis, D. Roussos, D. Tousoulis
Athens, GREECE
/ 13 SMOKING ACCELERATES ALBUMIN EXCRETION IN HYPERTENSIVE PATIENTS WITH METABOLIC
SYNDROME
P. Pietri, C. Vlachopoulos, N. Ioakeimidis, D. Terentes-Printzios, M. Abdelrasoul, I. Gourgouli, D. Tousoulis,
C. Stefanadis
Athens, GREECE
160
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 14 EFFECT OF HEMODIALYSIS ON NOVEL ECHOCARDIOGRAPHIC AND TISSUE DOPPLER-DERIVED
INDICES OF LEFT VENTRICULAR FUNCTION IN END-STAGE RENAL DISEASE PATIENTS
P. Georgianos, V. Kamperidis, H. Loutradis, K. Tsilonis, K. Imprialos, G. Ioannidis, E. Barberi, H. Karvounis,
P.Sarafidis
Thessaloniki, GREECE
/ 15 SEX-BASED ANALYSIS OF LOSARTAN INFLUENCE ON RENAL FUNCTION AND SYSTEMIC
INFLAMMATION IN HYPERTENSIVE NEPHROPATHY PATIENTS
V. Bezrodnyi, O. Kupchinska, T. Ovdienko, L. Bezrodna, A. Logvynenko
Kiev, UKRAINE
/ 16 ARTERIAL HYPERTENSION IN THE FIVE-YEAR PROGNOSIS OF SYSTEMIC SCLEROSIS
V. Semenov, T. Lysunets, O. Kuryata
Dnipropetrovsk, UKRAINE
/ 17 LEFT VENTRICULAR HYPERTROPHY (LVH) IN RENAL DISEASE: IMPACT OF CLASSIC
CARDIOVASCULAR RISK FACTORS
N. Robles Perez-Monteoliva 1, M.A. Bayo 1, B. Gonzalez Candia 1, M.E. Fuentes 1, D. Fernandez-Berges 2,
J.J. Cubero 1
1
Badajoz, 2 Don Benito, SPAIN
/ 18 TEMPOL SUPPLEMENTATION DOES NOT OVERCOME BENEFICIAL EFFECT OF LOSARTAN IN
HYPERTENSIVE RATS WITH EARLY COURSE OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS
D. Karanovic, J. Grujic-Milanovic, Z. Miloradovic, M. Ivanov, U.J. Vajic, D. Jovovic, M. Zivotic,
N. Mihailovic-Stanojevic
Belgrade, SERBIA
/ 19 PREVALENCE OF MASKED AND TRUE HYPERTENSION IN MILDLY DISEASED CHRONIC KIDNEY
DISEASE
A. Christina, S. Papakatsika, M. Natsis, S. Stabouli, V. Kotsis
Thessaloniki, GREECE
/ 20 24-HOUR AMBULATORY BLOOD PRESSURE MONITORING IN CHRONIC KIDNEY DISEASE:
INFLUENCE ON TREATMENT AND BLOOD PRESSURE CONTROL
C. Cunha, S. Pereira, J.C. Fernandes, V. Paixão Dias
Vila-Nova de Gaia, PORTUGAL
/ 21 NOVEL BIOMARKERS OF KIDNEY INJURY IN PATIENTS WITH DIFFERENT SEVERITY OF
HYPERTENSION
S. Mironova, I. Iudina, M. Ionov, T. Makhmatova, N. Avdonina, I. Emelyanov, N. Zvartau, A.O. Konradi
Saint-Petersburg, RUSSIA
/ 22 INFLUENCE OF DYSLIPIDAEMIA CORRECTION ON KIDNEY HEMODYNAMICS AND CALCIUM
METABOLISM IN PATIENTS WITH ESSENTIAL HYPERTENSION AND OSTEOARTHRITIS
L. Zhuravlyova, T. Rogachova
Kharkiv, UKRAINE
/ 23 EVALUATION OF AMBULATORY BLOOD PRESSURE MEASUREMENT IN A COHORT OF PATIENTS
AFFECTED BY CHRONIC KIDNEY DISEASES
C.Alfieri, S. Vettoretti, R. Meazza, L. Caldiroli, V. Azzini, E. Margiotta, D. Guenzani, P. Messa
Milan, ITALY
/ 24 SYMPATHETIC NERVOUS SYSTEM ACTIVITY, REFLECTED BY RENALASE AND CATECHOLAMINES,
IN HYPERTENSIVE PATIENTS ACCORDING TO AGE AND PRESENCE OF CHRONIC KIDNEY DISEASE
E. Zbroch, M. Musialowska, E. Koc-Zorawska, J. Malyszko
Bialystok, POLAND
/ 25 ASSESSMENT OF RENAL ARTERY FIBROMUSCULAR DYSPLASIA: FROM DIAGNOSIS TO
TREATMENT. THE DYSART STUDY
F. Silhol, A. Jacquier, G. Sarlon-Bartoli, B. Vaisse
Marseille, FRANCE
F I N A L P R OG R A M M E
161
SATURDAY
11
/ 26 PREDICTORS AND PROGNOSIS OF CONTRAST-INDUCED ACUTE KIDNEY INJURY IN PATIENTS
WITH ELECTIVE PERCUTANEOUS INTERVENTION
A. Gaskina, S. Villevalde, Z. Kobalava
Moscow, RUSSIA
Posters’ Session PS10
RESISTANT HYPERTENSION
Chairperson: P. Zebekakis (Thessaloniki, GREECE)
ROOM
POSTERS FROM 1 TO 26
/ 1 EFFECT OF RENAL DENERVATION ON GLUCOSE METABOLISM IN PATIENTS WITH RESISTANT
HYPERTENSION AND DIABETES MELLITUS TYPE 2 AFTER A 12 MONTH FOLLOW-UP
A. Falkovskaya, V. Mordovin, S. Pekarskiy, A. Baev, G. Semke, T. Ripp, I. Zyubanova, O. Mangataeva
Tomsk, RUSSIA
/ 2 EFFECT OF RENAL DENERVATION ON LEFT VENTRICULAR MASS IN PATIENTS WITH RESISTANT
HYPERTENSION AND DIABETES MELLITUS TYPE 2 AFTER A 12 MONTH FOLLOW-UP
A. Falkovskaya, V. Mordovin, S. Pekarskiy, A. Baev, G. Semke, T. Ripp, I. Zyubanova, T. Ryabova
Tomsk, RUSSIA
/ 3 SUCCESSFUL RENAL DENERVATION FOR RESISTANT HYPERTENSION FAILS TO IMPROVE
INSULIN RESISTANCE AS ASSESSED BY HYPERINSULINEMIC EUGLYCEMIC STEP-CLAMP AND GLUCOSE
TRACER INFUSION
A. Miroslawska 1, P. Gjessing 1, M. Solbu 1, O. Fuskevåg 1, T. Jenssen 1,2, T. Steigen 1
1
Tromsø, 2 Oslo, NORWAY
/ 4 BLOOD PRESSURE RESPONSE TO RENAL DENERVATION ACCORDING TO THE PRESENCE OR
ABSENCE OF RENAL ACCESSORY ARTERIES
L. Jacobs 1, A. Persu 2, F. Hammer 2, J. Renkin 2, J. Widimský 3, J. Rosa 3, S.E. Kjeldsen 4, F.E. Fadl Elmula 4,
A. Elvan 5, D. Czarnecka 6, A. Olszanecka 6, D. Gordin 7, I. Tikkanen 7, J.A. Staessen 1
1
Leuven, 2 Brussels, BELGIUM, 3 Prague, CZECH REPUBLIC, 4 Oslo, NORWAY, 5 Zwolle, NETHERLANDS,
6
Kraków, POLAND, 7 Helsinki, FINLAND
/ 5 ALTERATIONS IN METALLOPROTEINASE 9 AND TISSUE INHIBITOR 1 LEVELS IN RESISTANT
HYPERTENSION AND THEIR RELATIONSHIP TO LEFT VENTRICULAR HYPERTROPHY
N. Barbaro, A. Sabbatini, A. Ritter, A. Almeida, A. Faria, V. Brunelli, N. Correa, R. Modolo, C. Pinho, V. Fontana,
H. Moreno
Campinas, BRAZIL
/ 6 OBESITY-DEPENDENT EFFECTS ON MMP-9 LEVELS IN RESISTANT HYPERTENSION
A. Ritter, A. Faria, R. Modolo, N. Barbaro, A. Sabbatini, N. Correa, V. Brunelli, N. Pires, A. Almeida, H. Moreno
Campinas, BRAZIL
/ 7 DEREGULATION OF SOLUBLE ADHESION MOLECULES IN RESISTANCE TO ANTIHYPERTENSIVE
TREATMENT AND ITS ROLE IN CARDIOVASCULAR REMODELING
A. De Faria, A. Ritter, A. Sabbatini, N. Correa, V. Brunelli, A. Catharina, N. Barbaro, A. Almeida, R. Modolo,
H. Moreno
Campinas, BRAZIL
/ 8 PRESENCE OF AORTIC ABDOMINAL CALCIFICATIONS IN PATIENTS WITH RESISTANT
HYPERTENSION AND BP RESPONSE IN THE RENAL DENERVATION FOR HYPERTENSION (DENERHTN)
TRIAL
P.-Y. Courand 1, H. Pereira 1, P. Gosse 2, G. Bobrie 2, P. Delsart 2, C. Mounier-Vehier 2, P. Lantelme 2, T. Denolle 2,
C. Dourmap 2, J.-M. Halimi 2, X. Girerd 2, P. Rossignol 2, J.-P. Baguet 2, B. Vaisse 2, D. Herpin 2, J. Ribstein 2,
B. Chamontin 2, J.-J. Mourad 2, E. Ferrari 2, M. Azizi 1
1
Paris, 2 DENERHTN investigators, FRANCE
162
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 9 PREVALENCE OF TRUE RESISTANT HYPERTENSION IN UNCOMPLICATED HYPERTENSIVES WITH
APPARENT TREATMENT-RESISTANT HYPERTENSION IN LONGITUDINAL REAL-LIFE STUDY
K.M. Amosova, I. Rudenko
Kiev, UKRAINE
/ 10 GENDER IN RESISTANT HYPERTENSION: IMPACT ON CLINICAL MANIFESTATIONS, ASSOCIATED
FACTORS AND HYPERTENSION TREATMENT
A. Prejbisz 1, J. Gasowski 2, M. Klocek 2, R. Topor-Madry 2,3, W. Lesniak 2, M. Kabat 1, D. Czarnecka 2,
K. Kawecka-Jaszcz 2, K. Narkiewicz 4, A. Januszewicz 1
1
Warsaw, 2 Kraków, 3 Wroclaw, 4 Gdansk, POLAND
/ 11 RADIOFREQUENCY RENAL SYMPATHETIC DENERVATION IN PATIENTS WITH RESISTANT
ARTERIAL HYPERTENSION: 12-MONTH FOLLOW-UP
J. Madaric, I. Vulev, L. Flak, D. Skultetyova, D. Hladikova, T. Madaricova, M. Toth, J. Vaskova, E. Drangova,
J. Mikulas
Bratislava, SLOVAK REPUBLIC
/ 12 EFFECT OF RENAL DENERVATION CHANGES DAILY BLOOD PRESSURE IN PATIENTS WITH
RESISTANT HYPERTENSION
V. Lichikaki, V. Mordovin, S. Pekarskiy, T. Ripp, A. Falkovskaya, G. Semke, A. Baev
Tomsk, RUSSIA
/ 13 ARTERIAL STIFFNESS AND ENDOTHELIAL FUNCTION IN PATIENTS WITH RESISTANT
HYPERTENSION AFTER RENAL DENERVATION
G. Shchelkova, A. Zairova, N. Danilov, A. Rogoza, I.E. Chazova
Moscow, RUSSIA
SATURDAY
/ 14 THE EFFECT OF RENAL DENERVATION IN MODERATE TREATMENT RESISTANT HYPERTENSION
WITH CONFIRMED MEDICATION ADHERENCE
C. Ott 1, F. Mahfoud 2, A. Schmid 1, S. Ewen 2, S.W. Toennes 3, M.R. Meyer 2, A.G. Helfer 2, H.H. Maurer 2,
T. Ditting 1, R. Veelken 1, I. Zivanovic 2, M. Uder 3, M. Böhm 2, R.E. Schmieder 1
1
Erlangen, 2 Homburg/Saar, 3 Frankfurt/Main, GERMANY
/ 15 PREVALENCE OF SEXUAL DYSFUNCTION IN FEMALES WITH RESISTANT HYPERTENSION
K. Imprialos 1, K. Stavropoulos 1, C. Boutari 1, P. Kokkinos 2, A. Pittaras 2, C. Faselis 2, K. Petidis 1, P. Deligkaris 1,
N. Stavropoulos 1, V. Athyros 1, A. Karagiannis 1, M. Doumas 1
1
Thessaloniki, GREECE, 2 Washington, DC, USA
/ 16 INCIDENCE OF RESISTANT HYPERTENSION AND ASSOCIATED FACTORS IN OLDEST PATIENTS IN
CHINA
J. He, L. Gao
Beijing, CHINA
/ 17 ANXIETY AND DEPRESSION AS PREDICTORS OF DRUG INTERRUPTION IN UNCONTROLLED
HYPERTENSION
I. Emelyanov, N. Avdonina, S. Mironova, I. Iudina, N. Zvartau, A.O. Konradi
Saint-Petersburg, RUSSIA
/ 18 REDUCTION IN BLOOD PRESSURE AND CARDIAC HYPERTROPHY IN RESISTANT HYPERTENSIVE
SUBJECTS: A FIVE-YEAR FOLLOW-UP STUDY
V. Brunelli, L.A. Cruz, A. Faria, N. Correa, A. Sabbatini, N. Barbaro, R. Modolo, A. Ritter, H. Moreno
Campinas, BRAZIL
/ 19 RENAL DENERVATION RAPIDLY RESTORES CIRCULATING PROGENITOR CELLS IN PATIENTS
AFFECTED BY RESISTANT HYPERTENSION
G. Trapani 1,G.Mandraffino1, R. Di Stefano 2, S. Quartuccio 1, C.O. Aragona 1, A. Saitta 1, E. Imbalzano 1
1
Messina, 2 Pisa, ITALY
/ 20 FLUORESCENCE ANALYSIS OF URINE SAMPLES FOR EVALUATION OF PHARMACOLOGICAL
ADHERENCE IN RESISTANT HYPERTENSION
N. Correa, A. Faria, A. Ritter, A. Sabbatini, A. Almeida, V. Brunelli, N. Barbaro, A. Catharina, H. Moreno, R. Modolo
Campinas, BRAZIL
F I N A L P R OG R A M M E
163
11
/ 21 MINOXIDIL FOR TREATMENT OF RESISTANT HYPERTENSION: A RETROSPECTIVE COHORT
ANALYSIS
H. Mundt, M. Matanaer, B.K. Krämer, U. Benck
Mannheim, GERMANY
/ 22 THE EFFECT OF RENAL DENERVATION ON INFLAMMATORY MARKERS IN PATIENTS WITH
RESISTANT HYPERTENSION AND DIABETES MELLITUS TYPE 2
A. Falkovskaya, V. Mordovin, S. Pekarskiy, A. Baev, G. Semke, T. Ripp, I. Zyubanova, E. Kravtchenko
Tomsk, RUSSIA
/ 23 HYPERTENSIVE EMERGENCIES: THE LOST OPPORTUNITY OF PREVENTING HYPERTENSION
I. Prkacin, T. Bulum, V. Dermanovic Dobrota, I. Kovacevic, R. Zaja, M. Kovacic
Zagreb, CROATIA
/ 24 EVALUATION OF SODIUM INTAKE IN PATIENTS WITH RESISTANT HYPERTENSION: CLINICAL
PRACTICE IN GREECE
C. Boutari 1, K. Stavropoulos 1, K. Imprialos 1, P. Kokkinos 2, A. Pittaras 2, C. Faselis 2, K. Petidis 1, P. Deligkaris 1,
N. Stavropoulos 1, V. Athyros 1, A. Karagiannis 1, M. Doumas 1
1
Thessaloniki, GREECE, 2 Washington, DC, USA
/ 25 EFFECTS OF TNF-ALPHA INHIBITON ON HEMODYNAMIC PARAMETERS AND BIOMARKERS IN
RESISTANT HYPERTENSION: BACKGROUND, RATIONALE, AND DESIGN
A. Faria, A. Ritter, A. Catharina, V. Brunelli, N. Correa, A. Sabbatini, A. Almeida, N. Barbaro, H. Moreno, R. Modolo
Campinas, BRAZIL
/ 26 AN UNEXPECTED ETIOLOGY FOR HYPERTENSION IN YOUNG WOMEN
C. Homentcovschi, R. Ianula, R. Siliste, S. Lacau, M. Anton
Bucharest, ROMANIA
Posters’ Session PS11
LARGE ARTERIES
Chairperson: R.M.A. Henry (Maastricht, NETHERLANDS)
ROOM
POSTERS FROM 1 TO 27
/ 1 AORTIC PULSE WAVE VELOCITY IS RELATED TO CORONARY HEART DISEASE IN WOMEN BUT
NOT IN MEN
B. Hametner 1, S. Parragh 1, C. Mayer 1, K. Whitelegg 1, T. Weber 2, S. Wassertheurer 1
1
Vienna, 2 Wels, AUSTRIA
/ 2 FIBROMUSCULAR DYSPLASIA: RESULTS OF A MULTICENTRE STUDY IN FLANDERS
M. De Groote 1, B. Callewaert 1, D. Hemelsoet 1, F. Vermassen 1, J.M. Billiouw 3, A. De Vriese 4, I. Montag 1,
P. Van der Niepen 2, T. de Backer 1
1
Ghent, 2 Brussels, 3 Aalst, 4 Bruges, BELGIUM
/ 3 MICRORNA-21 AS A PROGNOSTIC MARKER OF IMPROVEMENT IN ARTERIAL STIFFNESS IN
WELL-CONTROLLED ESSENTIAL HYPERTENSION
M. Marketou, F. Parthenakis, J. Kontaraki, A. Patrianakos, H. Nakou, M. Touloupaki, M. Vernardos, J. Logakis,
D. Vougia, P. Vardas
Heraklion, GREECE
/ 4 OSCILLOMETRIC METHOD IDENTIFIES SUBCLINICAL ATHEROSCLEROSIS EVEN WHEN MILD
DECREASE OF ANKLE-BRACHIAL INDEX
A. Hermida Ameijeiras, J.E. Lopez Paz, M.J. Alende, A. Pascual Montes, V. Martínez Durán, G. Calvo González,
F.L. Lado Lado, C. Calvo Gomez
Santiago de Compostela, SPAIN
164
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 5 RESERVOIR-PRESSURE ANALYSIS IN TYPE 2 DIABETES INDIVIDUALS WITH CARDIOVASCULAR
DISEASE
K. Aizawa 1, F. Casanova 1, D. Mawson 1, S. Elyas 1, D.D. Adingupu 1, K.M. Gooding 1, W.D. Strain 1,
C.M. Park 2, K.H. Parker 2, P.E. Gates 1, A.C. Shore 1, A.D. Hughes 2
1
Exeter, 2 London, UNITED KINGDOM
/ 6 ASSOCIATION BETWEEN AORTIC BACKWARD WAVE PRESSURES, BUT NOT AORTIC STIFFNESS
AND LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN A YOUNG-TO-MIDDLE-AGED COMMUNITY SAMPLE
A. Woodiwiss, V.R. Peterson, C.D. Libhaber, A. Raymond, P. Sareli, G.R. Norton
Johannesburg, SOUTH AFRICA
/ 7 THE POLISH REGISTRY FOR FIBROMUSCULAR DYSPLASIA. THE PRELIMINARY REPORT OF
CLINICAL FEATURES, SYMPTOMS AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS ENROLLED IN
ARCADIA-POL STUDY
K. Hanus 1, E. Warchol-Celinska 1, A. Prejbisz 1, E. Florczak 1, M. Januszewicz 1, I. Michalowska 1,
K. Jozwik-Plebanek 1, M. Miadziolko 1, M. Kabat 1, M. Peczkowska 1, S. Nazarewski 1, K. Madej 1, K. Grygiel 1,
L. Stryczynski 2, L. Swiatlowski 3, K. Paschalis-Purtak 1, A. Czlonkowska 1, M. Szczerbo-Trojanowska 3,
A. Witkowski 1, A. Januszewicz 1
1
Warsaw, 2 Poznan, 3 Lublin, POLAND
/ 8 THE ASSOCIATION OF METABOLIC SYNDROME AND ITS COMPONENTS WITH CARDIO-ANKLE
VASCULAR INDEX: GENDER DIFFERENCES
L. Gomez Sanchez, M.A. Gómez Marcos, M.C. Patino Alonso, J.I. Recio Rodriguez, C. Agudo Conde,
J.A. Maderuelo Fernandez, E. Rodriguez Sánchez, H. Pérez Ramos, M. Gómez Sánchez, S. Mora Simón,
R. Alonso Domínguez, N. Sánchez Aguadero, C. Montero Sanchez, L. García Ortiz,
For the Mark Group, Salamanca, SPAIN
/ 9 PLASMA NT-PROBNP MIRRORS THE DELETERIOUS CARDIOVASCULAR CONTINUUM IN
HYPERTENSION
P.-Y. Courand, B. Harbaoui, M.O. Rial, C. Mouly-Bertin, P. Lantelme
Lyon, FRANCE
/ 10 CYSTATIN C AND ITS ASSOCIATION WITH CAROTID PLAQUE AND INTIMA MEDIA THICKNESS IN
SUBJECTS WITHOUT KNOWN CARDIOVASCULAR AND KIDNEY DISEASES
A. Maloberti, F. Farina, M. Varrenti, P. Vallerio, F. Musca, O. Belli, F. Panzeri, A. Peretti, M. Palazzini, F. Zanni,
F. Casadei, R. Facchetti, P. Palestini, C. Giannattasio
Milan, ITALY
/ 11 ADAPTIVE VASOACTIVE PROPERTIES OF THORACIC AORTA IN YOUNG NORMOTENSIVE AND
SPONTANEOUSLY HYPERTENSIVE RATS
S. Cacanyiova, A. Berenyiova, F. Kristek, M. Drobna
Bratislava, SLOVAK REPUBLIC
/ 12 VASCULAR ABNORMALITIES AS PREDOMINANT FEATURE IN ALAGILLE SYNDROME PATIENTS
WITH A NOVEL MUTATION IN JAG1 GENE
R. Santamaria 1,2, J. Lopez-Aguilera 1, R. Gonzalez De Caldas 1, M. Sanchez-Frias 1, A. Garcia-Rios 1,
P. Buendia 1, P. Aljama 1,2
1
Córdoba, 2 Madrid, SPAIN
/ 13 PULSE PRESSURE AMPLIFICATION IN PATIENTS WITH AORTIC COARCTATION AFTER AORTIC
ARCH REPAIR
T. Murakami 1, T. Nawa 1, M. Shiraishi 1, A. Takeda 2
1
Chiba, 2 Sapporo, JAPAN
/ 14 BLOOD PRESSURE, ANKLE-BRACHIAL INDEX AND CAROTID INTIMA-MEDIA THICKNESS IN
RELATION TO SERUM VITAMIN D CONCENTRATION AND URINARY CALCITROIC ACID EXCRETION IN A
SAMPLE OF GENERAL POPULATION
A. Franczyk, K. Stolarz-Skrzypek, A. Olszanecka, W. Wojciechowska, A. Wesolowska, K. Kawecka-Jaszcz,
D. Czarnecka
Kraków, POLAND
F I N A L P R OG R A M M E
165
SATURDAY
11
/ 15 PROGNOSTIC SIGNIFICANCE OF SLEEP APNOEA SYNDROME ON FALSE LUMEN AORTIC
EXPANSION IN POST ACUTE AORTIC SYNDROME
P. Delsart, J. Ramstein, F. Juthier, J. Sobocinski, N. Rousse, B. Jegou, G. Fayad, T. Modine, A. Mallart, P. Devos,
A. Vincentelli, S. Haulon, C. Mounier-Vehier
Lille, FRANCE
/ 16 NOVEL MODEL TO STUDY VASCULAR CALCIFICATION EX VIVO: THE ISOLATED-PERFUSED
AORTA
M. Schuchardt, M. Tölle, N. Siegel, M. Babic, A. Reshetnik, W. Zidek, M. van der Giet
Berlin, GERMANY
/ 17 THE COMBINATION DRUG VALSARTAN/SACUBITRIL (LCZ696) REDUCED PULSE WAVE
VELOCITY AND AORTIC SYSTOLIC BLOOD PRESSURE IN PATIENTS WITH HEART FAILURE WITH REDUCED
EJECTION FRACTION
Z. Kobalava, L. Babaeva, O. Lukina, E. Zharikova, E. Tyukhmenev, S. Villevalde
Moscow, RUSSIA
/ 18 CENTRAL BLOOD PRESSURE AND ABDOMINAL AORTIC DIAMETERS: ARE THERE ANY
CORRELATIONS?
A. Grossi, L. Tavecchia, M. Agostinis, N. Tandurella, V. Pierobon, C. Mongiardi, L. Robustelli Test, S. Moretti,
L. Merletti, L. Guasti, A.M. Grandi, A.M. Maresca
Varese, ITALY
/ 19 ARTERIAL STIFFNESS AND ARTERIAL FUNCTION IN ADULT CYANOTIC PATIENTS WITH
CONGENITAL HEART DISEASE
L. Szczepaniak-Chichel, O. Trojnarska, M. Gabriel, D. Lipski, A. Bartczak-Rutkowska, J. Rupa-Matysek,
A. Tykarski, S. Grajek
Poznan, POLAND
/ 20 ARTERIAL STIFFNESS AND ARTERIAL AGEING IN AN ARGENTINA RURAL AND URBAN
POPULATION
A.J. Ramirez, A. Diaz, C. Galli, M. Tringler, E.I. Cabrera Fischer
Buenos Aires, ARGENTINA
/ 21 BLOOD PRESSURE CONTROL AND VASCULAR RISK TREATMENT IN PATIENTS WITH
PERIPHERAL ARTERIAL DISEASE OF LOWER EXTREMITY
D. Celovska, L. Gaspar, V. Stvrtinova
Bratislava, SLOVAK REPUBLIC
/ 22 THE RELATIONSHIP AMONG BRACHIAL-ANKLE PULSE WAVE VELOCITY, CAROTID ARTERY
INTIMA-MEDIA THICKNESS AND FLOW-MEDIATED DILATION IN YOUNG SUBJECTS
J. Mu, T. Guo, C. Chu, W.L. Zheng
Xian, CHINA
/ 23 EXTRACRANIAL CAROTID ARTERY LESIONS AND CAROTID DISTENSIBILITY AT DUPLEX IN LOWRENIN HYPERALDOSTERONISM
Z. Valieva, N. Chikhladze, T. Balakhonova, I.E. Chazova
Moscow, RUSSIA
/ 24 GENDER DIFFERENCES OF ARTERIAL STIFFNESS AND CENTRAL BLOOD PRESSURE IN PATIENTS
WITH ARTERIAL HYPERTENSION AND THE INFLUENCE OF MENOPAUSE
L. Bortolotto, V. Costa-Hong, H.C.S. Muela, A.R.K. Sales
São Paulo, BRAZIL
/ 25 ARTERIAL STIFFNESS RECORDINGS WITH POPMETRE® IN A GENERAL PRIMARY CARE
POPULATION: THE IPC COHORT
F. Thomas-Jean 1, H. Obeid 1, P. Boutouyrie 1, M. Hallab 2, P. Coucke 1, N. Danchin 1, B. Pannier 1
1
Paris, 2 Nantes, FRANCE
/ 26 CORRELATIONS OF THE GREAT VESSELS AND INDEXES OF LABORATORY STATUS IN
HYPERTENSIVE PATIENTS WITH DIFFERENT BODY MASS
N. Demikhova, O. Chernatskaya, Y. Smiianova
Sumy, UKRAINE
166
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 27 LINKS BETWEEN BLOOD PRESSURE VARIABLES, ARTERIAL STIFFNESS AND COMPLETE BLOOD
COUNT IN PATIENTS WITH MALIGNANT DISORDERS
I. Mozos, G. Borzak, A. Stoian, R. Mihaescu
Timisoara, ROMANIA
Posters’ Session PS12
MICROCIRCULATION AND SMALL VESSELS
Chairperson: D. Rizzoni (Brescia, ITALY)
ROOM
POSTERS FROM 1 TO 25
/ 1 SYMPATHETIC INHIBITION IMPROVES INFLAMMATION AND ENDOTHELIAL DYSFUNCTION IN
BRAIN MICROCIRCULATION OF RATS WITH METABOLIC SYNDROME
V. Estato 1, A. Nascimento 1, B. Antunes 1, F. Gomes 1, A. Daliry 1, P. Bousquet 2, E. Tibiriçá 1
1
Rio de Janeiro, BRAZIL, 2 Strasbourg, FRANCE
/ 2 IMPAIRED FLOW-INDUCED DILATION OF MIDDLE CEREBRAL ARTERIES OF SPRAGUE-DAWLEY
RATS ON A HIGH SALT DIET IS ASSOCIATED WITH REDUCED ANTIOXIDANT CAPACITY AND RESTORED BY
TEMPOL IN VIVO
I. Drenjancevic, A. Cosic, I. Jukic
Osijek, CROATIA
/ 3 MICROVASCULAR DYSFUNCTION IS ASSOCIATED WITH DEPRESSION: A SYSTEMATIC REVIEW
AND META-ANALYSIS
M. Van Agtmaal, A. Houben, C.D.A. Stehouwer, M. Schram
Maastricht, NETHERLANDS
/ 4 PREDICTORS OF CAPILLARY RAREFACTION IN A POPULATION OF HYPERTENSIVE AND
NORMOTENSIVE INDIVIDUALS
A. Triantafyllou 1, P. Anyfanti 1, G. Triantafyllou 1, X. Zamboulis 2, P. Karamaounas 2, E. Gkaliagkousi 1,
C. Trakateli 1, K. Vogiatzis 1, S. Douma 1
1
Thessaloniki, 2 Heraklion, GREECE
/ 5 EARLY EFFECTS OF BARIATRIC SURGERY ON SKIN MICROCIRCULATION IN EXTREMELY OBESE
PATIENTS
A. Gluszewska, B. Gryglewska, B. Zarzycki, A. Dzieza-Grudnik, M. Fedyk-Lukasik, M. Matlok, A. Budzynski,
T. Grodzicki
Kraków, POLAND
/ 6 THE ROLE OF PERIVASCULAR ADIPOSE TISSUE AND INSULIN IN REGULATING
MICROVASCULAR TONE WITHIN SKELETAL MUSCLE RESISTANCE ARTERIES
B. Clark, S.B. Withers, A.M. Heagerty
Manchester, UNITED KINGDOM
/ 7 PENILE MICROVASCULAR ENDOTHELIAL FUNCTION IN HYPERTENSIVE PATIENTS: EFFECTS OF
THE ACUTE INHIBITION OF TYPE 5 PHOSPHODIESTERASE
E. Tibirica, A.A. Brandão, V. Verri
Rio de Janeiro, BRAZIL
/ 8 EFFECTS OF AGE, BLOOD PRESSURE AND ANTIHYPERTENSIVE TREATMENTS ON RETINAL
ARTERIOLES REMODELING ASSESSED BY ADAPTIVE OPTICS
D. Rosenbaum, A. Mattina, E. Koch, F. Rossant, A. Gallo, N. Kachenoura, M. Paques, A. Redheuil, X. Girerd
Paris, FRANCE
/ 9 EFFECTS OF MELATONIN ON THE PRODUCTION OF ADIPONECTIN AND THE EXPRESSION OF
ADIPONECTIN RECEPTOR IN THE VISCERAL ADIPOSE TISSUE OF AGING MICE
C. Agabiti Rosei, G. Favero, R. Rezzani, C. De Ciuceis, L.F. Rodella, E. Porteri, E. Agabiti Rosei, D. Rizzoni
Brescia, ITALY
F I N A L P R OG R A M M E
167
SATURDAY
11
/ 10 PRESENCE OF RETIGABINE RESPONSE IN HUMAN SUBCUTANEOUS RESISTANCE ARTERIES
R. Dreier 1, B. Abdolalizadeh 2, J.L. Jeppesen 1, M. Sheykhzade 2
1
Glostrup, 2 Copenhagen, DENMARK
/ 11 SEX RELATED DIFFERENCES IN CARDIOVASCULAR HEALTH AND MICROVASCULAR REACTIVITY
AMONG HEALTHY STUDENT POPULATION
M. Stupin, A. Stupin, L. Rasic, I. Drenjancevic
Osijek, CROATIA
/ 12 ENDOTHELIAL FUNCTION IN YOUNG HEALTHY SUBJECTS
P.M. Nilsson, G. Östling, C. Kennbäck, M. Persson
Malmö, SWEDEN
/ 13 HYPERURICEMIA IS ASSOCIATED TO CAPILLARY RAREFACTION, INDEPENDENTLY OF
METABOLIC SYNDROME AND MACROVASCULAR DAMAGE, IN TREATED HYPERTENSIVES
P. Nazzaro, G. Schirosi, F. Caradonna Moscatelli, M. Contini, L. Debenedittis, D. Mezzapesa, F. Federico
Bari, ITALY
/ 14 SEMI AUTOMATED RETINAL VASCULAR CALIBER IS PREDICTIVE OF CARDIAC AND RENAL
TARGET ORGAN DAMAGE IN NEVER-TREATED HYPERTENSION
L. Granados, G. du Cailar, C. Roubille, J. Ribstein, A. Mimran, M. Villain, V. Daien, P. Fesler
Montpellier, FRANCE
/ 15 DIFFERENT EFFECTS OF ACUTE HIGH SALT INTAKE ON ANTIOXIDATIVE GENES EXPRESSION IN
CEREBRAL BLOOD VESSELS IN YOUNG AND MATURE SPRAGUE-DAWLEY RATS
A. Cosic, A. Stupin, I. Drenjancevic
Osijek, CROATIA
/ 16 ROLE OF GASOTRANSMITTERS IN THE REGULATION OF CONTRACTILE FUNCTION OF
VASCULAR SMOOTH MUSCLE CELLS IN HYPOXIA
J. Birulina 1, S. Gusakova 1, I. Kovalev 1, L. Smaglii 1, A. Nosarev 1, S. Orlov 2
1
Tomsk, 2 Moscow, RUSSIA
/ 17 MICROCIRCULATION AND BIOMARKERS IN PATIENTS WITH RESISTANT OR MILD TO
MODERATE ARTERIAL HYPERTENSION
C.L. Junqueira, M.E.C. Magalhaes, A. Brandão, E. Ferreira, F.Z.G.A. Cyrino, P.A. Maranhao, M.G.C. Souza,
D. Bottino, E. Bouskela
Rio de Janeiro, BRAZIL
/ 18 THE POSSIBLE ROLE OF CHANGES IN THE PARAMETERS OF RED BLOOD CELLS IN
PATHOGENESIS OF ISCHEMIC STROKE
M. Kruchinina 1, A. Gromov 1, V. Generalov 2
1
Novosibirsk, 2 Koltsovo, RUSSIA
/ 19 VALSARTAN TREATMENT IMPROVED RETINAL CAPILLARY RAREFACTION IN HYPERTENSIVE
PATIENTS
A. Jumar 1, J.M. Harazny 1,2, C. Ott 1, I. Kistner 1, S. Friedrich 1, R.E. Schmieder 1
1
Erlangen, GERMANY, 2 Olsztyn, POLAND
/ 20 EVALUATION OF SELECTED PARAMETERS OF NEURO-HORMONAL ACTIVITY AND RETINAL AND
INTRARENAL PERFUSION IN PATIENTS WITH POLYCYTHEMIA VERA
J. Wojcicki 1, A. Sikorska 1, A. Kaszuba 1, J.M. Harazny 2,3, J. Lewandowski 1, M. Sinski 1, E. Binczyk 1,
K. Szymanek 1, A. Prejbisz 1,J.P.Szaflik1, M. Gosk-Przybylek 1, J. Janas 1, M. Januszewicz 1,J.Szaflik1,
G. Eisenhofer 4, Z. Gaciong 1, A. Wiecek 5, R.E. Schmieder 2, J. Windyga 2, A. Januszewicz 1
1
Warsaw, POLAND, 2 Erlangen, GERMANY, 3 Olsztyn, POLAND, 4 Dresden, GERMANY, 5 Katowice, POLAND
/ 21 RETINAL CAPILLARY RAREFACTION IN PATIENTS WITH UNTREATED MILD-MODERATE
HYPERTENSION
A. Jumar 1, J.M. Harazny 1,2, C. Ott 1, I. Kistner 1, S. Friedrich 1, J. Wojtkiewicz 2, R.E. Schmieder 1
1
Erlangen, 2 Warmia, GERMANY
168
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 22 THE CHARACTERISTICS OF ARTERIAL STIFFNESS AND CARDIAC REMODELING IN FEMALE
HYPERTENSION PATIENTS
N. Li, X. Zhao, H. Meng, X. Zhang, J. Yu
Lanzhou, CHINA
/ 23 THE IMPACT OF COMBINED ANTIHYPERTENSIVE THERAPY WITH PERINDOPRIL A AND
INDAPAMIDE ON MORPHOFUNCTIONAL PARAMETERS OF SMALL AND MEDIUM VESSELS IN PATIENTS
WITH ARTERIAL HYPERTENSION
I. Chekneva, E. Privalova, Y. Belenkov, E. Zheleznikh, Y. Danilogorskaya, A. Schendrigina, M. Tishman,
N. Pavlov
Moscow, RUSSIA
/ 24 ENDOTHELIN-1 CONTRIBUTION TO THE ENDOTHELIAL FLAXMOTIONS AND MYOGENIC TONE
IN PATIENTS WITH AH AND STROKE
V. Podzolkov, T. Safronova, D. Natkina
Moscow, RUSSIA
/ 25 INDICATORS SKIN MICROCIRCULATION AND HEART RATE VARIABILITY IN WOMEN WITH
ARTERIAL HYPERTENSION
N. Koriagina, A. Petrischeva, A. Tuev, V. Shchekotov, A. Shadrin, L. Vasilets, A. Shaposhnikova
Perm, RUSSIA
Posters’ Session PS13
SATURDAY
11
THERAPEUTICS AND CLINICAL TRIALS
Chairperson: Z. Gaciong (Warsaw, POLAND)
ROOM
POSTERS FROM 1 TO 24
/ 1 THE TREATMENT BENEFIT OF THE ACE-INHIBITOR PERINDOPRIL ON TOP OF BETA-BLOCKER
THERAPY IN PATIENTS WITH VASCULAR DISEASE
J. Brugts 1, M. Bertrand 2, W. Remme 3, R. Ferrari 4, K. Fox 5, S. MacMahon 6, J.P. Chalmers 6, M. Simoons 1,
H. Boersma 1
1
Rotterdam, NETHERLANDS, 2 Lille, FRANCE, 3 Rhoon, NETHERLANDS, 4 Ferrara, ITALY, 5 London, UNITED KINGDOM,
6
Sydney, AUSTRALIA
/ 2 COMPARISON OF A NEW FIRST-LINE STRATEGY WITH ADAPTED DOSAGES OF PERINDOPRIL
AND AMLODIPINE COMPARED WITH AN ARB MONOTHERAPY TREATMENT
G. Mancia
Monza, ITALY
/ 3 IMPACT OF STATINS ON THE PERINDOPRIL/AMLODIPINE ANTIHYPERTENSIVE EFFICACY IN
PATIENTS WITH HYPERCHOLESTEROLEMIA: SUBANALYSIS OF THE PERSPECTIVA STUDY
Y. Sirenko, G. Radchenko
Perspectiva study investigators, Kiev, UKRAINE
/ 4 ANTIANGIOGENETICS AND HYPERTENSION: MANAGEMENT AND PROGNOSTIC IMPLICATIONS
M. Destro, G.P. Dognini, F. Cagnoni, K.F. Borgonovo, G. Maccagni, S. Barni
Treviglio, ITALY
/ 5 ANTIHYPERTENSIVE EFFICACY OF BISOPROLOL/PERINDOPRIL: A SUBANALYSIS OF THE
OPTITEN TRIAL
V. Stojanov
Belgrade, SERBIA
F I N A L P R OG R A M M E
169
/ 6 CAN THE ADDITION OF STATINS TO ANTIHYPERTENSIVE MONOTHERAPY REPLACE
COMBINATION TREATMENT IN SOME HYPERTENSIVE PATIENTS?
D. Nebieridze, A. Safarian
Moscow, RUSSIA
/ 7 FIXED DOSE ANTIHYPERTENSIVE COMBINATIONS STILL NOT COMMON IN RURAL AREAS OF
POLAND
A. Kusiak 1, A. Kusiak 2, D. Czarnecka 1
1
Kraków, 2 Myslenice, POLAND
/ 8 THE IMPACT OF 6-MONTH PARICALCITOL TREATMENT ON CAROTID-FEMORAL PULSE WAVE
VELOCITY IN NON-DIALYSIS CKD PATIENTS
R. Ekart, N. Hojs, S. Bevc, B. Dvorsak, R. Hojs
Maribor, SLOVENIA
/ 9 PLACE OF BETA-BLOCKERS IN ANTIHYPERTENSIVE TRIPLE THERAPIES. THE FRENCH TRIANON
SURVEY
J.-J. Mourad 1, P. Clerson 2, L. Vigie 3
1
Bobigny, 2 Roubaix, 3 Rueil, FRANCE
/ 10 HYPERTENSION AND CARDIOVASCULAR DISEASE RISK REDUCTION IN OBESE PATIENTS WITH
BINGE EATING DISORDER: CONTROLLED TRIAL OF STEPPED-CARE AND BEHAVIOURAL WEIGHT LOSS
C. Grilo
New Haven, CT, USA
/ 11 COLECALCIFEROL DOES NOT LOWER BLOOD PRESSURE ON TOP OF OPTIMAL USUAL CARE IN
VITAMIN D DEFICIENT PATIENTS WITH HYPERTENSION
Y. Sijpkens, A.T.P. van Ittersum, W.J. Liefers, T.J.M. Leenders
The Hague, NETHERLANDS
/ 12 THE EFFECTS OF BAROREFLEX ACTIVATION THERAPY ON BLOOD PRESSURE AND
SYMPATHETIC FUNCTION IN PATIENTS WITH REFRACTORY HYPERTENSION. THE RATIONALE AND
DESIGN OF THE NORDIC BAT STUDY
D. Gordin 1, F.E. Fadl Elmula 2, B. Andersson 3, A. Gottsäter 4, T. Kahan 5, M. Viigimaa 6, S.E. Kjeldsen 2,
K.L.Christensen 7, M.H. Olsen 8, I. Tikkanen 1
1
Helsinki, FINLAND, 2 Ullevål, NORWAY, 3 Gothenburg, 4 Malmö, 5 Stockholm, SWEDEN, 6 Tallinn, ESTONIA,
7
Århus, 8 Odense, DENMARK
/ 13 EFFICACY AND SAFETY OF TWO DIFFERENT DOSAGES OF CANRENONE AS ADD-ON THERAPY
IN HYPERTENSIVE PATIENTS TAKING ACE-INHIBITORS OR SARTANS AND DIURETICS AT MAXIMUM
DOSAGE: THE ESCAPE TRIAL
G. Derosa 1, G. Gaudio 2
1
Pavia, 2 Varese, ITALY
/ 14 BENEFIT IN CENTRAL HAEMODYNAMIC PARAMETERS BY ASSOCIATION ANGIOTENSIN II
RECEPTOR BLOCKERS AND CANRENONE THERAPY IN HYPERTENSIVE PATIENTS WITH NORMAL KIDNEY
FUNCTION
C. Paterno 1, N. Mastrorocco 2, I. Goffredo 2
1
Foggia, 2 Bari, ITALY
/ 15 CAN NEBIVOLOL PREVENT THE DEVELOPMENT OF OSTEOPOROSIS IN POSTMENOPAUSAL
WOMEN WITH HYPERTENSION?
D. Nebieridze, I. Tepoian, I. Skripnikova, A. Safarian
Moscow, RUSSIA
/ 16 COMPARISON OF CLINICAL, HEMODYNAMIC AND FUNCTIONAL CHARACTERISTICS
OF PATIENTS WITH IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION AND CHRONIC
THROMBOEMBOLIC PULMONARY HYPERTENSION IN RUSSIAN NATIONAL REGISTRY
O. Arkhipova, T. Martynyuk, S. Nakonechnikov, I.E. Chazova
Moscow, RUSSIA
170
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 17 ONE MONTH BLOOD PRESSURE LOWERING EFFICACY RESULTS OF A NOVEL FIRST-LINE
TREATMENT IN HYPERTENSION
S. Laurent 1, G. Parati 2, I.E. Chazova 3, Y. Sirenko 4, A. Erglis 5, A. Laucevicius 6, C. Farsang 7
1
Paris, FRANCE, 2 Milan, ITALY, 3 Moscow, RUSSIA, 4 Kiev, UKRAINE, 5 Riga, LATVIA, 6 Vilnius, LITHUANIA,
7
Budapest, HUNGARY
/ 18 QUALITY OF LIFE MEASURED BY SF-36 DID NOT CHANGE DURING SIX MONTHS AFTER
STARTING ANTIHYPERTENSIVE MEDICATION
I. Kantola, J. Johansson, T. Kantola, J. Varis
Turku, FINLAND
/ 19 BISOPROLOL THERAPY REDUCES THE NUMBER OF ANGINA ATTACKS
V. Stojanov, M. Marjanovic, N. Radivojevic, K. Paunovic, B. Jakovljevic
Belgrade, SERBIA
/ 20 EFFECTS OF COMBINATION OF ANGIOTENSIN II RECEPTOR ANTAGONIST WITH CALCIUM
ANTAGONIST IN HYPERTENSIVE PATIENTS WITH CORONARY HEART DISEASE AND CHRONIC
OBSTRUCTIVE PULMONARY DISEASE
M. Bubnova, D. Aronov, U. Sulim, V. Vygodin
Moscow, RUSSIA
/ 21 GENDER DIFFERENCES IN BLOOD PRESSURE CONTROL IN HYPERTENSIVE PATIENTS
G. Radchenko, T. Salascheva, L. Mushtenko, Y. Sirenko
Kiev, UKRAINE
/ 22 LONG-TERM OUTCOMES IN THE TREATMENT IN HYPERTENSIVE PATIENTS WITH ANGIOTENSINCONVERTING ENZYME INHIBITORS OR RENIN-ANGIOTENSIN RECEPTOR BLOCKERS: SYSTEMATIC
REVIEW AND META-ANALYSIS
E. Lima Junior, G.L.O. Salvador, V.M. Marmentini, W.R. Cosmo
Curitiba, BRAZIL
/ 23 MONOTHERAPY WITH RILMENIDINE PRODUCES AN EFFECTIVE BLOOD PRESSURE CONTROL
AND IMPROVES ECHOCARDIOGRAPHIC VARIABLES IN YOUNG MILD TO MODERATE HYPERTENSIVES
L. Popescu, H. Balan
Bucharest, ROMANIA
/ 24 EVALUATION OF THE RIGHT VENTRICULAR MYOCARDIUM PERFUSION IN PATIENTS WITH
IDIOPATIC PULMONARY ARTERIAL HYPERTENSION
E. Valeeva, T. Martynyuk, K. Ivanov, V. Sergienko, I.E. Chazova, V.M. Paramonov
Moscow, RUSSIA
Late-Breaker Posters
SESSION 1
Chairperson: J. Mesquita Bastos (Aveiro, PORTUGAL)
ROOM
POSTERS FROM 1 TO 19
/ 1 HIGH VALUE OF ARTERIAL STIFFNESS AS A PREDICTOR OF A LESS EFFECTIVE RECOVERY OF
LEFT VENTRICULAR SYSTOLIC FUNCTION AFTER ACUTE MYOCARDIAL INFARCTION
E. Zharikova, S. Villevalde, Z. Kobalava
Moscow, RUSSIA
/ 2 SAFETY AND EFFICIENCY OF OLMESARTAN AMLODIPINE IN COLOMBIAN HYPERTENSIVE
PATIENTS (SOAT STUDY)
R. Buendia, M. Zambrano, X. Castañeda
Bogotá, COLOMBIA
F I N A L P R OG R A M M E
171
SATURDAY
11
/ 3 CASE REPORT: HELLP-LIKE SYNDROME IN A 26-YEAR-OLD MAN WITH UNRECOGNIZED
HYPERTENSION
E. Wojciechowska, P. Gryglas, B. Symonides, P. Jedrusik, Z. Gaciong
Warsaw, POLAND
/ 4 THRESHOLD FOR DIAGNOSING HYPERTENSION BY AUTOMATED OFFICE BLOOD PRESSURE
USING RANDOM SAMPLE POPULATION DATA
P. Wohlfahrt 1, R. Cifkova 1, O. Sochor 2, N. Movsisyan 2, S. Kunzova 2, J. Lesovsky 2, M. Homolka 2, V. Soska 2,
H. Bauerova 2, F. Lopez-Jimenez 3
1
Prague, 2 Brno, CZECH REPUBLIC, 3 Rochester, NY, USA
/ 5 INTEGRATION OF HYPERTENSION MANAGEMENT IN HIV SERVICES IN ZOMBA (MALAWI).
CHALLENGES AND LESSONS LEARNED
J. Van Oosterhout 1, C. Pfaff 1, V. Singano 1, H. Akello 1, A. Amberbir 1, M. Joshua 1, A. Matengeni 1, J. Berman 1,
G. Chinomba 1, T. Allain 2, S. Sodhi 1, C. Speight 3, D. Garone 1
1
Zomba, 2 Blantyre, MALAWI, 3 Melbourne, AUSTRALIA
/ 6 USE OF ANTIHYPERTENSIVE DRUG COMBINATIONS BY GENERAL PRACTITIONERS IN BELGIUM
M. Leeman 1, J.R. Thomas 2
1
Brussels, 2 Merchtem, BELGIUM
/ 7 DEMENTIA RISK WITH ANTIHYPERTENSIVE DRUG USE AND BLOOD PRESSURE VARIABILITY:
THE THREE-CITY COHORT STUDY
P. Tully 1, J.F. Dartigues 1, S. Debette 1, C. Helmer 1, S. Artero 2, C. Tzourio 1
1
Bordeaux, 2 Montpellier, FRANCE
/ 8 PREDICTION OF COMPLICATED MYOCARDIAL INFARCTION BY MEAN OF LASER CORRELATION
SPECTROMETRY
N. Tofan, O. Khyzhnyak
Odessa, UKRAINE
/ 9 OBESITY IMPACT ON HEMODYNAMIC, LABORATORY DATA AND SUBFRACTIONAL STATE OF
SERUM IN ELDERLY WITH COMORBID CARDIAC PATHOLOGY
N. Tofan, V. Shtanko, E. Khyzhnyak
Odessa, UKRAINE
/ 10 DESIGN OF A NEW NATIONAL EPIDEMIOLOGICAL SURVEY FOR THE ASSESSMENT OF TREND
IN HYPERTENSION’S PREVALENCE, TREATMENT, CONTROL AND CARDIOVASCULAR RISK AMONG THE
ADULT POPULATION OF ROMANIA
M. Dorobantu 1, R. Darabont 1, D. Dimulescu 1, C. Sinescu 1, C. Arsenescu-Georgescu 2, D. Lighezan 3,
P. Gusbeth-Tatomir 4, I. Brinza 5, M. Udrescu 1, O. Tautu 1
1
Bucharest, 2 Iasi, 3 Timisoara, 4 Pitesti, 5 Braila, ROMANIA
/ 11 IMPACT OF THE NICE/BHS GUIDELINES ON SPECIALIST HYPERTENSION CLINIC SERVICE
L. Tan, L. McCallum, S. Shields, J. Patel, A. Boal, S. Muir, C. Delles, M. Freel, A. Jardine, R.M. Touyz,
A.F. Dominiczak, S. Padmanabhan
Glasgow, UNITED KINGDOM
/ 12 PREDICTORS OF STROKE IN HYPERTENSIVE PATIENTS ACCORDING TO THE FIVE-YEAR
OBSERVATION
G. Semke, V. Mordovin, S. Pekarskiy, T. Ripp, A. Falkowskaya
Tomsk, RUSSIA
/ 13 CEREBROPROTECTIVE EFFICIENCY OF RENAL DENERVATION ONE YEAR AFTER THE
INTERVENTION IN RESISTANT HYPERTENSIVE PATIENTS
G. Semke, V. Mordovin, S. Pekarskiy, T. Ripp, A. Falkowskaya, E. Sitkova
Tomsk, RUSSIA
172
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 14 PREFERRED DRUG CLASSES TO INITIATE ANTIHYPERTENSIVE TREATMENT IN SWEDISH
PRIMARY CARE: RESULTS FROM THE SWEDISH PRIMARY CARE CARDIOVASCULAR DATABASE
M. Qvarnström 1, T. Kahan 1, H. Kieler 1, L. Brandt 1, J. Hasselström 1, K. Bengtsson Boström 2, K. Manhem 3,
P. Hjerpe 2, B. Wettermark 1
1
Stockholm, 2 Skövde, 3 Gothenburg, SWEDEN
/ 15 METABOLIC AND VASCULAR PROFILE IN WOMEN COHORT OF IBERICAN
M. Frías Vargas 1, V. Pallarés Carratalá 2, M. Prieto Díaz 3, S. Cinza Sanjurjo 4, D. Rey Aldana 5,
C. Murillo Jelsbak 1, J. Benitez Rivero 6, A. Moyá Amengual 7, T. Rama Martín 8, I. Gil Gil 8
1
Madrid, 2 Catellón, 3 Oviedo, 4 A Coruña, 5 Pontevedra, 6 Cádiz, 7 Palma de Mallorca, 8 Barcelona, SPAIN
/ 16 THE FEATURES OF DIURNAL BLOOD PRESSURE PROFILE IN AIR TRAFFIC CONTROLLERS
IN CIVIL AVIATION
E.A. Praskurnichey 1, I.V. Morozkina 1, V.D. Yustova 1, A.G. Bystrova 1, V.V. Kniga 1, I.N. Posokhov 2
1
Moscow, 2 Nizhny Novgorod, RUSSIA
/ 17 AMBULATORY BLOOD PRESSURE MONITORING (ABPM) AND MYOCARDIUM DEFORMATION
PARAMETERS IN PATIENTS WITH HYPERTENSION
E. Nesukay, N. Polenova, I. Titov
Kiev, UKRAINE
/ 18 BLOOD PRESSURE AND NON-HIGH DENSITY LIPOPROTEIN CHOLESTEROL: THE IMPLICATION
FOR CARDIOVASCULAR DISEASE
E. Pello 1, T. Kuznetsova 2, Y. Nikitin 1, J.A. Staessen 2
1
Novosibirsk, RUSSIA, 2 Leuven, BELGIUM
11
/ 19 PREDICTIVE VALUES FOR OBESITY AND DIABETES IN PRIMARY CARE
J. Peceliuniene 1, I. Zukauskaite 1, V. Kasiulevicius 1, A. Norkus 2, R. Bunevicius 2
1
Vilnius, 2 Kaunas, LITHUANIA
Best Posters Discussion
Chairpersons: R.M.A. Henry (Maastricht, NETHERLANDS)
M. Salvetti (Brescia, ITALY)
POSTER PRESENTATION ROOM
15.00 CARDIOVASCULAR OUTCOME IN TREATMENT RESISTANT HYPERTENSION: RESULTS
FROM THE SWEDISH PRIMARY CARE CARDIOVASCULAR DATABASE
L. Holmqvist 1, K. Bengtsson Boström 2, T. Kahan 3, L. Schiöler 1, J. Hasselström 3, P. Hjerpe 2, B. Wettermark 3,
K. Manhem 1
1
Gothenburg, 2 Skövde, 3 Stockholm, SWEDEN
15.03 CARDIOVASCULAR RISK FACTORS IN CHILDREN AFTER LIVER TRANSPLANTATION
J. Antoniewicz, P. Czubkowski, A. Wierzbicka, J. Pawlowska, P. Socha
Warsaw, POLAND
15.06 AORTIC PULSE WAVE VELOCITY IS RELATED TO CORONARY HEART DISEASE IN WOMEN
BUT NOT IN MEN
B. Hametner 1, S. Parragh 1, C. Mayer 1, K. Whitelegg 1, T. Weber 2, S. Wassertheurer 1
1
Vienna, 2 Wels, AUSTRIA
15.09 FIBROMUSCULAR DYSPLASIA: RESULTS OF A MULTICENTRE STUDY IN FLANDERS
M. De Groote 1, B. Callewaert 1, D. Hemelsoet 1, F. Vermassen 1, J.M. Billiouw 3, A. De Vriese 4, I. Montag 1,
P. Van der Niepen 2, T. De Backer 1
1
Ghent, 2 Brussels, 3 Aalst, 4 Bruges, BELGIUM
15.12 SYMPATHETIC INHIBITION IMPROVES INFLAMMATION AND ENDOTHELIAL DYSFUNCTION IN
BRAIN MICROCIRCULATION OF RATS WITH METABOLIC SYNDROME
V. Estato 1, A. Nascimento 1, B. Antunes 1, F. Gomes 1, A. Daliry 1, P. Bousquet 2, E. Tibiriçá 1
1
Rio de Janeiro, BRAZIL, 2 Strasbourg, FRANCE
F I N A L P R OG R A M M E
SATURDAY
173
15.15 IMPAIRED FLOW-INDUCED DILATION OF MIDDLE CEREBRAL ARTERIES OF SPRAGUE-DAWLEY
RATS ON A HIGH SALT DIET IS ASSOCIATED WITH REDUCED ANTIOXIDANT CAPACITY AND RESTORED BY
TEMPOL IN VIVO
I. Drenjancevic, A. Cosic, I. Jukic
Osijek, CROATIA
15.18 THE TREATMENT BENEFIT OF THE ACE-INHIBITOR PERINDOPRIL ON TOP OF BETA-BLOCKER
THERAPY IN PATIENTS WITH VASCULAR DISEASE
J. Brugts 1, M. Bertrand 2, W. Remme 3, R. Ferrari 4, K. Fox 5, S. MacMahon 6, J.P. Chalmers 6, M. Simoons 1,
H. Boersma 1
1
Rotterdam, NETHERLANDS, 2 Lille, FRANCE, 3 Rhoon, NETHERLANDS, 4 Ferrara, ITALY, 5 London, UNITED KINGDOM,
6
Sydney, AUSTRALIA
15.21 CENTRAL BLOOD PRESSURE VALUES IN A HEALTHY MEXICAN SAMPLE
E. Cardona Muñoz, G. Alanis Sanchez, F. Grover Paez, D. Cardona Muller, S. Totsuka Sutto,
A. Macias Chumacera, C. Ramos Becerra
Guadalajara, MEXICO
15.24 BLOOD PRESSURE TELEMONITORING EFFECTIVENESS IN PATIENTS WITH UNCONTROLLED
HYPERTENSION, IMPACT OF ANXIETY AND DEPRESSION
M. Ionov, Y. Yudina, N. Avdonina, I. Emelyanov, N. Zvartau, D. Kurapeev, A.O. Konradi
Saint-Petersburg, RUSSIA
15.27 IMPLEMENTATION OF ALGORITHM PREVENTING REDUCED RISK OF CONTRAST-INDUCED
ACUTE KIDNEY INJURY IN CLINICAL PRACTICE IN PATIENT WITH PRIMARY PERCUTANEOUS CORONARY
INTERVENTIONS
A. Gaskina, S. Villevalde, Z. Kobalava
Moscow, RUSSIA
174
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
14.00 - 15.30
Attended Poster Sessions
F I N A L P R OG R A M M E
175
14.00 - 15.30
Attended Poster Sessions
PS 14. ATRIAL FIBRILLATION AND HEART FAILURE
Chairperson: F. Pinto (Santa Maria Feira, PORTUGAL)
ROOM
POSTERS FROM 1 TO 29
PS 15. BLOOD PRESSURE VARIABILITY
Chairperson: G. Bilo (Milan, ITALY)
ROOM
POSTERS FROM 1 TO 20
PS 16. CARDIOVASCULAR RISK FACTORS
Chairperson: O. Steichen (Paris, FRANCE)
ROOM
POSTERS FROM 1 TO 48
PS 17. CEREBROVASCULAR DISEASES, STROKE
AND COGNITIVE DYSFUNCTION
Chairperson: O. Hanon (Paris, FRANCE)
ROOM
POSTERS FROM 1 TO 35
PS 18. CORONARY HEART DISEASE
Chairperson: K. Wachtell (Copenhagen, DENMARK)
ROOM
POSTERS FROM 1 TO 26
PS 19. EPIDEMIOLOGY OF HYPERTENSION
AND METABOLIC DISORDERS
Chairperson: J.-P. Empana (Paris, FRANCE)
ROOM
POSTERS FROM 1 TO 24
PS 20. HEART AND HAEMODYNAMICS
Chairperson: T. Kahan (Stockholm, SWEDEN)
ROOM
POSTERS FROM 1 TO 25
PS 21. INFLAMMATION AND IMMUNITY
Chairperson: TBD
ROOM
POSTERS FROM 1 TO 15
PS 22. KIDNEY
Chairperson: P.Sarafidis(Thessaloniki, GREECE)
ROOM
POSTERS FROM 1 TO 28
PS 23. RESISTANT HYPERTENSION
Chairperson: R. Veelken (Erlangen, GERMANY)
ROOM
POSTERS FROM 1 TO 27
PS 24. PREGNANCY
Chairperson: V. Kotsis (Thessaloniki, GREECE)
ROOM
POSTERS FROM 1 TO 19
PS 25. ENDOCRINE HYPERTENSION
Chairperson: L. Amar (Paris, FRANCE)
ROOM
POSTERS FROM 1 TO 24
PS 26. THERAPEUTICS AND CLINICAL TRIALS
Chairperson: G. Pichler (Valencia, SPAIN)
ROOM
POSTERS FROM 1 TO 25
LATE-BREAKER POSTERS’ SESSION 2
Chairperson: J. Sharman (Hobart, AUSTRALIA)
ROOM
POSTERS FROM 1 TO 21
15.00-15.30
BEST POSTERS DISCUSSION
Chairpersons: G. Grassi (Milan, ITALY)
T. Kahan (Stockholm, SWEDEN)
176
POSTER PRESENTATION ROOM
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
14.00 - 15.30
Posters’ Session PS14
ATRIAL FIBRILLATION AND HEART FAILURE
Chairperson: F. Pinto (Santa Maria Feira, PORTUGAL)
ROOM
POSTERS FROM 1 TO 29
/ 1 ASTRAGALOSIDE IV IMPROVES LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN
HYPERTENSIVE MICE BY INCREASING THE PHOSPHORYLATION OF ENDOTHELIAL NITRIC OXIDE
SYNTHASE
Q. Wang 1, E. Jeong 2, H. Liu 2, L. Gu 2, S.C. Dudley 2, J. Yu 1
1
Lanzhou, CHINA, 2 Providence, RI, USA
/ 2 FLOW-MEDIATED VASODILATORY RESPONSE IN PATIENTS WITH CHRONIC HEART FAILURE
I. Shkurat
Kiev, UKRAINE
/ 3 PLASMA MARKERS OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH HYPERTENSION AND
ATRIAL FIBRILLATION
V. Podzolkov, A. Tarzimanova, M. Pisarev, R. Gataulin
Moscow, RUSSIA
/ 4 RELATIONSHIP BETWEEN CHANGE IN LEFT ATRIAL STRAIN AFTER CARDIOVERTION WITH
RECURRENCE OF ATRIAL FIBRILLATION
A. Shavarov, G. Kiyakbaev, V. Moiseev
Moscow, RUSSIA
/ 5 CHANGES IN NATRIURETIC PEPTIDES LEVELS IN PATIENTS WITH HYPERTENSION AND
PERSISTENT ATRIAL FIBRILLATION
V. Podzolkov, A. Tarzimanova, M. Pisarev, R. Gataulin
Moscow, RUSSIA
/ 6 HEPATO-RENAL INTERACTIONS IN ACUTE DECOMPENSATED HEART FAILURE
A. Soloveva, S. Villevalde, A. Milto, Z. Kobalava
Moscow, RUSSIA
/ 7 PREOPERATIVE PREDICTIVE FACTORS FOR NON-VALVULAR POSTOPERATIVE ATRIAL
FIBRILLATION IN PATIENTS UNDERGOING CORONARY BYPASS SURGERY (ON-PUMP VERSUS
OFF-PUMP)
M. Vukicevic, S. Putnik, M. Polovina, M. Ostojic
Belgrade, SERBIA
/ 8 PHYSICIANS’ IGNORANCE OF PATIENTS’ PREFERENCES CONTRIBUTES TO LOW RATE OF
ANTICOAGULATION IN ATRIAL FIBRILLATION
A. Mondry, D.H. Huang, Z.Z.Y. Ng, Z.K. Low, T.Y.W. Li
Singapore, SINGAPORE
/ 9 PAROXYSMAL ATRIAL FIBRILLATION ORIGINATING FROM NON-PULMONARY VEIN FOCI:
EFFECT OF RADIOFREQUENCY ABLATION AND MECHANISM
Z. Qiyin, H. Jie
Suzhou, CHINA
/ 10 AN ANALYSIS ON THE EFFECT OF RADIOFREQUENCY CATHETER ABLATION FOR THE PATIENTS
OF PAROXYSMAL ATRIAL FIBRILLATION COMBINED WITH TACHY-BRADY SYNDROME
Z. Qiyin, H. Jie
Suzhou, CHINA
F I N A L P R OG R A M M E
177
/ 11 HYPERTENSION, THE DOMINO. ACUTELY DECOMPENSATED CHRONIC HEART FAILURE BY
HYPERTENSIVE URGENCIES IN THE ELDERLY
A.M. Daraban, E. Weiss, C. Japie, D. Penes, E. Badila, D. Bartos
Bucharest, ROMANIA
/ 12 TOTAL BILIRUBIN INCREASE IS ASSOCIATED WITH RIGHT- AND LEFT-SIDE HEART FAILURE
A. Soloveva, S. Villevalde, Z. Kobalava
Moscow, RUSSIA
/ 13 THE VALUE OF TRANS ESOPHAGEAL ECHOCARDIOGRAPHY IN PATIENTS WITH ATRIAL
FIBRILLATION OR ATRIAL FLUTTER BEFORE RADIOFREQUENCY ABLATION OR CARDIOVERSION
Z. Qiyin, H. Jie
Suzhou, CHINA
/ 14 A MULTIFACTORIAL ATRIAL FIBRILLATION
R. Del Pinto, C. Cerasi, P. Giorgini, L. Natali, A. Viscido, S. Moscardelli, C. Ferri
L’Aquila, ITALY
/ 15 PREVALENCE OF ATRIAL FIBRILLATION IN HYPERTENSIVE SUBJECTS. WHAT IS MORE
IMPORTANT: BLOOD PRESSURE VALUES OR DURATION OF HYPERTENSION?
Y. Yotov 1, S. Torbova 2, K. Ramshev 2, S. Tisheva 3
1
Varna, 2 Sofia, 3 Pleven, BULGARIA
/ 16 CARDIOVASCULAR AND NONCARDIAC COMORBIDITY IN PATIENTS WITH COMBINATION OF
ARTERIAL HYPERTENSION, CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION: RECVASA-CLINICA
REGISTRY DATA
E. Stepina, M. Loukianov, M. Bichurina, S. Boytsov
Moscow, RUSSIA
/ 17 IDENTIFICATION OF ELECTROCARDIOLOGIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH
RISK OF ATRIAL FIBRILLATION
S. Filipova, D. Skultetyova, A. Vachulova
Bratislava, SLOVAK REPUBLIC
/ 18 PROGNOSTIC VALUE OF DIFFERENT LIVER FUNCTION TESTS PATTERNS IN ACUTE
DECOMPENSATED HEART FAILURE
A. Soloveva, A. Hassani, S. Villevalde, Z. Kobalava
Moscow, RUSSIA
/ 19 RELATION OF DIFFERENT ANTIHYPERTENSIVE TREATMENT TO THE EFFICACY OF
RADIOFREQUENCY CATHETER ABLATION FOR PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION AND
HYPERTENSION
Z. Qiyin, H. Jie
Suzhou, CHINA
/ 20 GALECTIN 3 INCREASES IN HYPERTENSIVE PATIENTS WITH ATRIAL FIBRILLATION AND
RESTORED SINUS RHYTHM AFTER ONE YEAR
A. Kisheva, Y. Yotov, T. Chervenkov
Varna, BULGARIA
/ 21 ASSESSMENT OF PATTERNS OF INITIATION OF ORAL ANTICOAGULANT THERAPY IN
HYPERTENSIVE PATIENTS WITH ATRIAL FIBRILLATION
M. D’Avino 1, G. Caruso 1, G. Buonomo 2, D. Fiorentino 1, V. Orlando 1, E. Menditto 1
1
Naples, 2 Telese Terme, ITALY
/ 22 RDW AND PLASMA URIC ACID IN ATRIAL FIBRILLATION COMPLICATING ARTERIAL
HYPERTENSION
A. Vintila, C. Stefan, M. Raduna, M. Dobrovie, V. Vintila
Bucharest, ROMANIA
/ 23 USEFULNESS AND FEASIBILITY OF CONCOMITANT ABPM AND ECG MONITORING OF
HYPERTENSIVE PATIENTS IN DETECTING SILENT ATRIAL FIBRILLATION
A. Varga, C.M. Gal, A.E. Negovan, A. Magdas, C.I. Puiac, I. Tilea
Tirgu Mures, ROMANIA
178
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 24 RELATION OF CHADS2-VASC SCORE TO THE EFFICACY OF RADIOFREQUENCY CATHETER
ABLATION FOR PATIENTS OF DIFFERENT SEX WITH PAROXYSMAL ATRIAL FIBRILLATION
Z. Qiyin, H. Jie
Suzhou, CHINA
/ 25 INCIDENCE OF HYPERTENSION IN PATIENTS WITH PAROXYSMAL AND PERMANENT ATRIAL
FIBRILLATION WITH HIGH THROMBOEMBOLIC RISK
M. Zlatar, D. Matic, B. Zlatar, M. Marjanovic, D. Jelic, T. Potpara, M. Gajic
Belgrade, SERBIA
/ 26 STROKE RISK PREVENTION IN HYPERTENSIVE PATIENTS WITH ATRIAL FIBRILLATION
R. Zivkovic, M. Zdravkovic, L. Suric-Lambic
Belgrade, SERBIA
/ 27 GALECTIN 3 IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION AND RESTORED SINUS RHYTHM
A. Kisheva, Y. Yotov, A. Angelov
Varna, BULGARIA
/ 28 CIRCADIAN CARDIAC AUTONOMIC NERVOUS ACTIVITY AND AVERAGE HEART RATE IN
UNTREATED PATIENTS WITH SINUS RHYTHM OF CONGESTIVE HEART FAILURE
Y. Liu, T. Yang
Zigong, CHINA
/ 29 DIASTOLIC DYSFUNCTION IN LIPOTOXIC MYOCARDIAL DAMAGE BY PATIENTS WITH OBESITY
G. Chumakova 1, O. Gritzenko 2, N. Veselovskaya 2
1
Barnaul, 2 Kemerovo, RUSSIA
Posters’ Session PS15
BLOOD PRESSURE VARIABILITY
Chairperson: G. Bilo (Milan, ITALY)
ROOM
POSTERS FROM 1 TO 20
/ 1 EFFECTS OF BLOOD PRESSURE VARIABILITY ON HEART IN HYPERTENSION
W. Tsai, C. Chou, W. Li, Y. Liu
Tainan, TAIWAN
/ 2 VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY IN UNCOMPLICATED AND COMPLICATED
ARTERIAL HYPERTENSION
E. Troitskaya, Y. Kotovskaya, Z. Kobalava
Moscow, RUSSIA
/ 3 RELATIONSHIP BETWEEN PULSE PRESSURE AND BLOOD PRESSURE VARIABILITY IN
UNTREATED HYPERTENSIVE PATIENTS
R. Penuela 1, T. Penuela 2
1
San Cristobal, 2 Caracas, VENEZUELA
/ 4 LOWER HEART RATE VARIABILITY ASSESSED BY 24-HOUR AMBULATORY BLOOD PRESSURE
MONITORING IS ASSOCIATED WITH LEFT VENTRICULAR HYPERTROPHY
G. Pindao Quesada 1, A. Morales Ortega 2, L. Abejón López 3, E. Pérez Martínez 1, M. Torralba 1,2,
C. Hernández Gutiérrez 1, J. Mateos Hernández 1,2, P. Horcajo Aranda 1, M. Rodriguez Zapata 1,2,
J. Garcia De Tena 1,2
1
Guadalajara, 2 Alcala de Henares, 3 San Sebastian de Los Reyes, SPAIN
/ 5 LCZ696 COMPARED WITH ANGIOTENSIN II RECEPTOR BLOCKERS FOR PATIENTS WITH
HYPERTENSION: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Y. Zhao, X. Zhao, N. Li, J. Yu
Lanzhou, CHINA
F I N A L P R OG R A M M E
179
/ 6 LONG-TERM VISIT-TO-VISIT VARIABILITY OF SYSTOLIC BLOOD PRESSURE AND DECLINE IN
RENAL FUNCTION IN HYPERTENSIVE PATIENTS OVER 15 YEARS
H.M. Lim 1, Y.C. Chia 1, S.M. Ching 2
1
Kuala Lumpur, 2 Serdang, MALAYSIA
/ 7 NUMBER OF BLOOD PRESSURE MEASUREMENTS NEEDED TO ESTIMATE LONG TERM VISIT-TOVISIT SYSTOLIC BLOOD PRESSURE VARIABILITY FOR PREDICTING 10-YEAR CARDIOVASCULAR RISK
H.M. Lim 1, Y.C. Chia 1, S.M. Ching 2
1
Kuala Lumpur, 2 Serdang, MALAYSIA
/ 8 INVERSE ASSOCIATION OF THE RATIO OF 24-H AMBULATORY SYSTOLIC TO DIASTOLIC BLOOD
PRESSURE VARIABILITY (BPVR) WITH RENAL FUNCTION IN UNTREATED ARTERIAL HYPERTENSION
A. Castiglia, T. Viola, D. Altieri, C. Cusumano, M.G. Vario, E. Scaduto, G. Mulè, S. Cottone
Palermo, ITALY
/ 9 ASSOCIATION BETWEEN THE POLYMORPHISM OF ENDOTHELIAL NITRIC OXIDE SYNTHASE
GENE G894T AND SALT INTAKE IN DONGXIANG ETHNIC MINORITY WITH ESSENTIAL HYPERTENSION
H. Min, L.Y. Ma, D.Z. Huang, H.F. Zhang
Lanzhou, CHINA
/ 10 HEMODYNAMICS DETERMINANTS OF THE SHORT-TERM BLOOD PRESSURE VARIABILITY
ACCORDING TO THE WAVE TRANSMISSION AND RESERVOIR PRESSURE THEORIES
C. Chen 1, P. Hsu 1, H. Cheng 1, S. Sung 1, S. Chuang 2, E. Lakatta 3, F. Yin 4, P. Chou 1
1
Taipei, 2 Miaoli, TAIWAN, 3 Baltimore, MD, 4 St. Louis, MO, USA
/ 11 BLOOD PRESSURE VARIABILITY IN HYPERTENSIVE PATIENTS AND DIASTOLIC/ SYSTOLIC
FUNCTION OF THE LEFT VENTRICLE
S. Patsianis, D. Mytas, V. Kakiouzi, G. Moustakas, D. Aravantinos, N. Mousa, A. Seretis, M.V. Papavasileiou
Athens, GREECE
/ 12 ASSOCIATION OF BLOOD PRESSURE VARIABILITY RATIO WITH GLOMERULAR FILTRATION RATE
INDEPENDENT OF BLOOD PRESSURE AND PULSE WAVE VELOCITY
A. Woodiwiss 1, G.R. Norton 1, O.H.I. Majane 1, M. Bursztyn 2
1
Johannesburg, SOUTH AFRICA, 2 Jerusalem, ISRAEL
/ 13 AVERAGE STAY AND HISTORY OF HIGH BLOOD PRESSURE IN VASCULAR SURGERY AREA
P. Losada Mora, A. Garrido Castro, J.L. Carrillo Linares, P. García Frias, M.A. Sanchez Chaparro,
M. Jimenez Villodres
Málaga, SPAIN
/ 14 DAILY VARIABILITY OF ARTERIAL PRESSURE AND SUBCLINICAL DAMAGE OF TARGET ORGANS
IN HYPERTENSIVE PATIENTS
D. Mytas, S. Patsianis, V. Kakiouzi, G. Moustakas, N. Mousa, D. Aravantinos, M.V. Papavasileiou
Athens, GREECE
/ 15 CLINICAL CHARACTERISTICS OF PATIENTS WITH PAROXYSMAL HYPERTENSION
J. Vaclavik 1, A. Krenkova 1, E. Kocianova 1, T. Vaclavik 2, M. Kamasova 1
1
Olomouc, 2 Prague, CZECH REPUBLIC
/ 16 PREDICTIVE FACTORS OF THE EVOLUTION OF WHITE COAT (WCHT) TO MAINTAINED (MTHT)
HYPERTENSION
C. Santos Moreira, P. Alcântara, C. Alcântara, V. Ramalhinho, C. Saldanha, J. Martins e Silva, J. Braz Nogueira
Lisbon, PORTUGAL
/ 17 THE EFFECT OF PERINDOPRIL/AMLODIPINE FIXED-DOSE COMBINATION ON THE
HEMODYNAMIC VARIABILITY IN HYPERTENSIVE PATIENTS WITH HIGH CARDIOVASCULAR RISK
V. Nagy, B. Wichmann, Z. Kender, M. Toth
Budapest, HUNGARY
/ 18 EVALUATION OF THE CONTROL OF THE SALT OF ADDITION AND THE PRESSURE RESPONSE
AMONG HYPERTENSION, BORDERING AND NORMOTENSIVE
R. Rodrigues, A. Sousa, T. Neiva, A. Arantes, C. Barros, Y. Araujo, A.C. Sousa, M. Euzébio, F. Magalhães, L. Santos, H.
Moreira, W. Souza, T. Jardim, P. Jardim
Goiânia, BRAZIL
180
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 19 EVALUATION OF BLOOD PRESSURE AND PULSE WAVE VELOCITY IN HEALTHY YOUNG PEOPLE
T. Yokoi 1, K. Tsuta 2
1
Moriguchi, 2 Hirakata, JAPAN
/ 20 DIPPING STATUS IS CHARACTERIZED BY AUGMENTED ADMINISTRATION OF
BENZODIAZEPINES AND ELEVATED ARTERIAL STIFFNESS
V. Katsi, G. Vamvakou, T. Makris, I. Kallikazaros, D. Tousoulis
Athens, GREECE
Posters’ Session PS16
CARDIOVASCULAR RISK FACTORS
Chairperson: O. Steichen (Paris, FRANCE)
ROOM
POSTERS FROM 1 TO 48
/ 1 LEFT VENTRICULAR FUNCTION AND HEART FAILURE RISK IN CHILDHOOD CANCER SURVIVORS
J. Sulicka-Grodzicka, A. Surdacki, J. Krolczyk, T. Grodzicki
Kraków, POLAND
/ 2 EFFECT OF CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY ON BLOOD PRESSURE IN
PATIENTS WITH MODERATE-SEVERE OBSTRUCTIVE SLEEP APNOEA AND DIFFICULT-TO-CONTROL
ARTERIAL
HYPERTENSION
C. Japie, E. Badila, M. Bunea, E. Weiss, D. Penes, A.M. Daraban, D. Bartos
Bucharest, ROMANIA
/ 3 IS TRANSIENT RECEPTOR POTENTIAL VANILLOID TYPE 1 (TRPV1) A NEW TARGET FOR
CARDIOPROTECTION?
R. Al-Mawla, L. Païta, S. Bidault-Ducreux, C. Chouabe, A. Durand, L. Augeul, S. Dupré-Aucouturier, R. Bonvallet,
M. Ovize, F. Van Coppenolle
Lyon, FRANCE
/ 4 CIRCADIAN BLOOD PRESSURE PROFILE, INFLAMMATORY MARKERS AND EPICARDIAL FAT
THICKNESS IN HYPERTENSIVE PATIENTS
I. Tilea, A. Hutanu, S. Voidazan, C.I. Puiac, A. Varga
Tirgu Mures, ROMANIA
/ 5 AORTIC STIFFNESS AGING IS INFLUENCED BY PAST PROFOUND IMMUNODEFICIENCY IN HIVINFECTED INDIVIDUALS
F. Boccara 1, L. Maia-Leite 2, A. Boyd 1, M. Nuernberg 1, E. Catez 3, S. Lang 1, S. Ederhy 1, N. Haddour 1,
P.M. Girard 1, A. Cohen 1
1
Paris, FRANCE, 2 Rio de Janeiro, BRAZIL, 3 Brussels, BELGIUM
/ 6 EVALUATION OF DIASTOLIC FUNCTIONS, PULSE WAVE VELOCITY AND MYOCARDIAL
PERFORMANCE INDEX IN PATIENTS WITH PRIMARY PREMATURE OVARIAN FAILURE
H. Kilic, N. Akdemir, M. Aksoy, S. Yilmaz, R. Akdemir
Sakarya, TURKEY
/ 7 CIGARETTE SMOKING AND MASKED HYPERTENSION IN CHINESE MEN
Y. Kang, Q.F. Huang, J. Song, X.L. Shan, Y. Li, J.Wang
Shanghai, CHINA
/ 8 HYPERTENSIVE DIABETIC AND THE INCIDENCE OF CARDIOVASCULAR OUTCOMES AND
COMMITMENT RENAL IN ELEVEN YEARS OF HISTORICAL COHORT
A.C. Sousa, T.C. Neiva, F. Magalhães, T. Jardim, P. Jardim, W. Barroso, H. Moreira, H. Souza, T. Costa,
L. Rezende, M. Montello, Y.C. Araújo, A.C. Arantes, W. Sousa, R. Rodrigues, C. Oliveira, A.L. Sousa
Goiânia, BRAZIL
F I N A L P R OG R A M M E
181
/ 9 FACTORS ASSOCIATED WITH ISOLATED SYSTOLIC BLOOD PRESSURE IN ELDERLY PATIENTS
A. Bachir Cherif,A.Bouamra,A.Taleb,A.Bouraghda,M.T.Bouafia
Blida, ALGERIA
/ 10 SMOKING HABIT AND CARDIOVASCULAR RISK PROFILE IN ELDERLY OUTPATIENTS
T. Marotta, A. De Mitri, L.A. Ferrara
Naples, ITALY
/ 11 WHICH MEASUREMENT OF BLOOD PRESSURE IS MORE ASSOCIATED WITH ATHEROSCLEROTIC
CARDIOVASCULAR DISEASE WITHOUT HYPERTENSION: CENTRAL BLOOD PRESSURE OR PERIPHERAL
BLOOD PRESSURE?
G. Kim, D. Moon, S.N. Lee, J.H. Kim, K.W. Moon, K.D. Yoo, C.M. Kim
Seoul, SOUTH KOREA
/ 12 HYPERTENSION IN CAMEROONIAN RURAL AND URBAN PYGMIES AND BANTUS OF SOUTHERN
REGION
Y. Hako 1, C. Bika 1, P. Van De Borne 2, C. Okalla 1, J. Dissongo 1, J.P. Degaute 2, M. Leeman 2,
J.R. M’buyamba-Kabangu 3, D. Lemogoum 2
1
Douala, CAMEROON, 2 Brussels, BELGIUM, 3 Kinshasa, ZAIRE
/ 13 IMPACT OF OBSTRUCTIVE SLEEP APNOEA ON THE SEVERITY OF SEGMENTAL CORONARY
ARTERY BURDEN
T. Alekseeva,E.Elfimova,A.Litvin
Moscow, RUSSIA
/ 14 OXYTOCIN PROTECTS CARDIOMYOCYTES AGAINST OXIDATIVE STRESS
J. Gutkowska, A. Gonzales-Ryes, M. Jankowski
Montreal, CANADA
/ 15 42-DAY CHRONIC EXPOSURE TO ALUMINUM CHLORIDE PROMOTES VASCULAR DYSFUNCTION
AND INCREASES BLOOD PRESSURE IN RATS
C. Martinez 1, J. Piagette 1, A. Escobar 1, D. Vassallo 2, M.J. Alonso 3, M. Salaices 3, F.M. Peçanha 1,
M. Miguel 3, G.A. Wiggers 1
1
Uruguaiana, 2 Vitória, BRAZIL, 3 Madrid, SPAIN
/ 16 OBSTRUCTIVE SLEEP APNOEA BUT NOT RESISTANT HYPERTENSION INFLUENCES PLASMA
FIBRIN CLOT PROPERTIES IN PATIENTS WITH HYPERTENSION AT HIGH CARDIOVASCULAR RISK
K. Jozwik-Plebanek 1, A. Prejbisz 1, B. Pregowska-Chwala 1, K. Michel-Rowicka 1, E. Warchol-Celinska 1,
M. Kabat 1, P. Bielen 1, P. Sliwinski 1, A. Januszewicz 1, A. Undas 2
1
Warsaw, 2 Kraków, POLAND
/ 17 COMMUNICATION-OPTIMIZED HEALTH CARE MODEL FOR HYPERTENSIVE PATIENTS IN
ROMANIAN’S PRIMARY CARE
V. Herdea, I. Brinza, E. Paun, M. Udrescu, D. Stoica, M. Dorobantu
Bucharest, ROMANIA
/ 18 PLASMA METHIONINE IS NOT ASSOCIATED WITH RISK OF ACUTE MYOCARDIAL INFARCTION
IN PATIENTS WITH SUSPECTED STABLE ANGINA PECTORIS
I. Dhar, V. Lysne, P. Ueland, A. McCann, O. Nygård
Bergen, NORWAY
/ 19 THE RELATION BETWEEN PULSATILE (STIFFNESS RELATED) AND STEADY BLOOD PRESSURE
COMPONENTS AND LEFT ATRIAL VOLUME IN THE CONTEXT OF LEFT VENTRICULAR MASS INDEX
M. Rojek, M. Rajzer, J. Gasowski, T. Pizon, D. Czarnecka
Kraków, POLAND
/ 20 RISK OF AN ARTERIAL HYPERTENSION IN POPULATION WITH VITAL EXHAUSTION: GENDER
DIFFERENCES. MONICA-PSYCHOSOCIAL EPIDEMIOLOGICAL PROGRAMME
V. Gafarov, E. Gromova, I. Gagulin, A. Gafarova, D. Panov
Novosibirsk, RUSSIA
182
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 21 THE FIRST RISK SCORING SYSTEM FOR SUDDEN DEATH PREDICTION IN PRIMARY
PREVENTION PATIENTS
H. Le 1, F. Subtil 1, M. Cerou 1, M. Fall 1,2, M. Al Gobari 3, I. Marchant 4, B. Kassai 1, P. Chevalier 1,F.Gueyffier1
1
Lyon, FRANCE, 2 Dakar, SENEGAL, 3 Lausanne, SWITZERLAND, 4 Valparaiso, CHILE
/ 22 ARTERIAL HYPERTENSION: A LEADING RISK FACTOR FOR HEART DISEASE OF THE YOUNG
POPULATION
N. Koriagina, V. Schekotov, A. Petrisheva, A. Shadrin, L. Vasiletc, A. Tuev
Perm, RUSSIA
/ 23 OBSTRUCTIVE SLEEP APNOEA PLUS HYPERTENSION INCREASE PREVALENT CARDIOVASCULAR
DISEASE
A. Cai, L. Wang, Y. Feng, Y. Zhou, J. Chen, J. Zhang, L. He, R. Wang, Q. Zhong
Guangzhou, CHINA
/ 24 DO MODERATE TO HIGH CARDIOVASCULAR RISK PATIENTS ACCURATELY PERCEIVE THEIR
OWN VASCULAR AGE?
C. Bergerot, M.B. Giaconia, S. Lamoureux, M. Schaaf, N. Mewto, M. Ovize
Lyon, FRANCE
/ 25 ASSOCIATION BETWEEN HYPERURICEMIA AND ABNORMAL HEART RATE RECOVERY IN
HYPERTENSIVE PATIENTS WITH NON-DIPPING PATTERN
P. Predotti 1, F. Giallauria 2, A. Viggiani 1, R. Citro 1, A. Ravera 1, A. Casciello 1, M. Maggio 4, M. Ciardo 3,
A. Cittadini 2, C. Vigorito 2
1
Salerno, 2 Naples, 3 Scorrano, 4 Parma, ITALY
/ 26 COMPARATIVE PROSPECTIVE EVALUATION OF SUBJECTS WITH HIGH NORMAL BLOOD
PRESSURE AT RISK FOR CARDIOVASCULAR DISEASE IN THE PREVENTIVE INTERVENTION GROUP AND
THE NATURAL DYNAMICS
O. Molchanova, A. Britov, G. Andreeva, E. Grishenkov
Moscow, RUSSIA
/ 27 THE EFFECT OF COMBINED OLMESARTAN+LERCANIDIPINE TREATMENT ON ANGIOPOETIN-2
BLOOD LEVELS IN PATIENTS WITH HYPERTENSION AND ABDOMINAL OBESITY
S. Koval, O. Mysnychenko, I. Snegurskaya, M. Penkova, E. Vysotskaya, V. Bozhko, A. Strashnenko
Kharkov, UKRAINE
/ 28 SEX DIFFERENCES IN PREVALENCE OF DEPRESSION AND ITS INFLUENCE ON PATIENTS
CARDIO-VASCULAR RISK FACTORS IN UKRAINE BY EUROASPIRE IV-PRIMARY CARE RESULTS
M. Dolzhenko, K. Faradzh, A. Nudchenko, Y. Djachenko, S. Lurie, I. Soroka
Kiev, UKRAINE
/ 29 PROTHROMBOTIC EFFECT OF SERUM URIC ACID IN HYPERTENSIVE PATIENTS
D. Aravantinos, S. Patsianis, V. Kakiouzi, G. Moustakas, N. Mousa, A. Seretis, M.V. Papavasileiou
Athens, GREECE
/ 30 A COMPARATIVE STUDY ON SKIN AND PLASMA ADVANCED GLYCATION END PRODUCTS AND
THEIR ASSOCIATIONS WITH ARTERIAL STIFFNESS IN UNTREATED CHINESE
C. Liu, Q. Huang, Y. Li, J. Wang
Shanghai, CHINA
/ 31 BLOOD PRESSURE CONTROL GETTING HARDER WITH TIME AND CV EVENTS
E. Badila, E. Weiss, C. Japie, D. Penes, A.M. Daraban, D. Bartos
Bucharest, ROMANIA
/ 32 WHAT IS THE CLINICAL VALUE OF INCREASED PULSE PRESSURE IN PERITONEAL DIALYSIS
PATIENTS?
M. Rroji, S. Seferi, N. Spahia, E. Likaj, M. Cafka, M. Barbullushi, A. Idrizi, A. Koroshi
Tirana, ALBANIA
/ 33 REVISED DEFINITION OF PREDICTED LEFT VENTRICULAR MASS USING AMBULATORY BLOOD
PRESSURE IN HEALTHY KOREAN ADULTS
B. Kim, Y. Lee, J. Shin, J. Shin, Y. Lim, S. Shim
Seoul, SOUTH KOREA
F I N A L P R OG R A M M E
183
/ 34 EFFECTIVENESS OF COMBINED THERAPY COMPARED TO MONOTHERAPY IN HYPERTENSIVE
PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY AND DIASTOLIC DYSFUNCTION
S. Vatinian, S. Gurgenyan
Yerevan, ARMENIA
/ 35 EFFECTS OF ANTIPHOSPHOLIPID ANTIBODIES ON VASCULAR SMOOTH MUSCLE CELLS
C. Rouillon, P. Lacolley, V. Regnault, D. Wahl
Vandoeuvre-lès-Nancy, FRANCE
/ 36 FEATURES OF FREQUENCY CHARACTERISTICS OF HEART RATE IN HYPERTENSIVE PATIENTS OF
1-2 DEGREE WITH PROLONGED HEART-RATE-LOWERING THERAPY
V. Oleynikov, M. Lukyanova, A. Kulyutsin
Penza, RUSSIA
/ 37 WORKING IN SHIFTS INFLUENCES THE ONSET OF HYPERTENSION, IN THE WORK AND
LIFESTYLES IN NURSING PROFESSIONALS
J. Dos Santos 1, J.O. Valdeviño Nascimento 1, K. Cardoso Meira 2, J. Nery De Souza Talarico 1,
A.M. Geraldo Pierin 1
1
São Paulo, 2 Natal, BRAZIL
/ 38 LIPID PROFILE AMONG THE POPULATION EXPOSED TO RADIATION FROM SEMIPALATINSK
NUCLEAR TEST SITE (KAZAKHSTAN)
A. Markabayeva 1, A. Kerimkulova 2, L. Pivina 1, T. Rakhypbekov 1, A. Ospanova 1
1
Semey, 2 Astana, KAZAKHSTAN
/ 39 ECHOCARDIOGRAPHIC DIAGNOSIS OF HYPERTENSIVE HEART DISEASE: RELATION TO
CARDIOVASCULAR RISK MARKERS?
M. Carvalho-Rodrigues 1, C. Ribeiro 1, L. Bronze 1,2, M. Castelo-Branco 1
1
Covilhã, 2 Lisbon, PORTUGAL
/ 40 LONG-TERM MANAGEMENT OF HYPERTENSION. DOES THE INITIAL GLOBAL CARDIOVASCULAR
RISK HAVE AN IMPACT?
K. Adoubi 1, F. Diby 1, C. Konin 2, A. Gnaba 1, P. Ouattara 1, A. Adoh 2
1
Bouake, 2 Abidjan, IVORY COAST
/ 41 HOMOCYSTEINE LOWERING THERAPY IN HYPERTENSIVE SUBJECTS AT LOW
CARDIOVASCULAR RISK: ROLE OF NUTRACEUTICALS
A. Mazza 1, E. Ramazzina 1, S. Lenti 2, L. Schiavon 1, E. Casiglia 3, G. Gussoni 4
1
Rovigo, 2 Arezzo, 3 Padua, 4 Milan, ITALY
/ 42 CARDIOVASCULAR RISK AND GERIATRIC SYNDROMES AMONG ELDERLY WOMEN
V. Larina, N. Runikhina, I. Chukaeva, D. Karpenko
Moscow, RUSSIA
/ 43 MICROALBUMINURIA IN ESSENTIAL HYPERTENSION, ITS CORRELATION WITH OTHER
CARDIOVASCULAR RISK FACTORS
E. Nelaj, M. Gjata, M. Tase
Tirana, ALBANIA
/ 44 INTERPRESS-IPD: THE INTER-ARM BLOOD PRESSURE DIFFERENCE INDIVIDUAL PATIENT DATA
COLLABORATION
C. Clark 1, F. Warren 1, K. Boddy 1, R. Taylor 1, A. Shore 1, V. Aboyans 2, L. Cloutier 3, R. Mcmanus 4, J. Campbell 1
1
Exeter, UNITED KINGDOM, 2 Limoges, FRANCE, 3 Quebec, CANADA, 4 Oxford, UNITED KINGDOM
/ 45 PREDICTORS OF LENGTH OF HOSPITAL STAY IN PATIENTS WITH ACUTE DECOMPENSATED
HEART FAILURE
K. Amosova, A. Bezrodnyi, I. Gorda, I. Katsytadze, A. Sablin, N. Melnychenko, S. Bogdan, O. Hodakovska,
G. Mostbauer, I. Kovaleva, P. Lazarev, I. Prudkiy
Kiev, UKRAINE
/ 46 EFFECT OF TETRAHYDROBIOPTERIN ON REPERFUSION MYOCARDIAL OF DIASTOLIC FUNCTION
Z. Zhang
Lanzhou, CHINA
184
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 47 EXPOSURE TO CIGARETTE SMOKE AND CALCIFICATION INDEX OF COMMON CAROTID
ARTERIES AND EXTRACRANIAL SEGMENTS OF INTERNAL CAROTID ARTERIES IN PATIENTS WITH
ESSENTIAL HYPERTENSION
P. Gac, P. Jazwiec, G. Mazur, R. Poreba
Wroclaw, POLAND
/ 48 COMORBIDITIES OF HYPERTENSIVE PATIENTS HOSPITALIZED IN THE INTENSIVE CARE UNIT OF
THE CLINICAL EMERGENCY HOSPITAL SF. IOAN (BUCHAREST)
G. Dediu, A. Balaceanu, M. Fronea, C. Diaconu, G. Aron, I. Dina
Bucharest, ROMANIA
Posters’ Session PS17
CEREBROVASCULAR DISEASES, STROKE AND COGNITIVE DYSFUNCTION
Chairperson: O. Hanon (Paris, FRANCE)
ROOM
POSTERS FROM 1 TO 35
/ 1 INCREASED INSPIRATORY RESISTANCE AFFECTS THE CARDIAC CONTRIBUTION TO THE
RELATIONSHIP BETWEEN BLOOD PRESSURE AND PIAL ARTERY PULSATION OSCILLATIONS
J. Wolf, M. Wszedybyl-Winklewska, E. Swierblewska, K. Kunicka, K. Mazur, M. Gruszecki, W. Guminski,
P.J. Winklewski, A. Frydrychowski, L. Bieniaszewski, K. Narkiewicz
Gdansk, POLAND
/ 2 CALORIC RESTRICTION CAN IMPROVE LEARNING AND MEMORY OF C57/BL MICE PROBABLY
VIA REGULATION OF THE SIRT1/AMPK SIGNALING PATHWAY
L. Ma, R. Wang, Y. Li
Beijing, CHINA
/ 3 THE ROLE OF ARTERIAL BLOOD PRESSURE AND PATHOLOGICAL DILATATION OF CEREBRAL
VEINS IN THE DEVELOPMENT OF STRESS-INDUCED CEREBRAL HEMORRHAGIC STROKE IN NEWBORN
RATS
O. Sindeeva
Saratov, RUSSIA
/ 4 STUDY OF STRESS EFFECT ON BLOOD-BRAIN BARRIER PERMEABILITY IN RATS WITH CHRONIC
HYPERTENSION AND STROKE
S. Sindeev
Saratov, RUSSIA
/ 6 BLUNTED CEREBRAL CORTICAL ACTIVATION DURING EXERCISE IN HYPERTENSIVE PATIENTS:
LINKS WITH EXAGGERATED INCREASES IN EXERCISE DIASTOLIC BLOOD PRESSURE AND VASCULAR
STIFFENING
A. Triantafyllou, K. Dipla, A.S. Zafeiridis, N. Koletsos, E. Gkaliagkousi, P. Anyfanti, A. Zafeiridis, S. Douma
Thessaloniki, GREECE
/ 7 INTRADIALYTIC HYPOTENSION AND COGNITIVE FUNCTION IN MAINTENANCE
HAEMODIALYSIS PATIENTS: ARE THEY RELATED?
J. Radic 1, M. Radic 1, V. Kovacic 1, K. Dodig Curkovic 2, M. Sain 1, D. Ljutic 1
1
Split, 2 Osijek, CROATIA
/ 8 PHYSICAL TRAINING RESTORES BRAIN-DERIVED NEUROTROPHIC FACTOR SIGNALING IN
HYPERTENSIVE RATS
A. Monnier Picard 1, C. Mossiat 1, C. Demougeot 2, C. Marie 1, A. Tessier 1
1
Dijon, 2 Besançon, FRANCE
/ 9 DIFFERENCES IN BLOOD PRESSURE AND BLOOD PRESSURE VARIABILITY IN THE ACUTE PHASE
OF LOBAR AND DEEP INTRACEREBRAL HEMORRHAGE
E. Korompoki 1, D. Gill 2, E. Manios 1, A. Vemmou 1, K. Spengos 1, N. Zakopoulos 1, K. Vemmos 1
1
Athens, GREECE, 2 London, UNITED KINGDOM
F I N A L P R OG R A M M E
185
/ 10 EFFECTS OF CALCIUM CHANNEL BLOCKERS AND THIAZIDE DIURETICS ON ACUTE ISCHEMIC
STROKE SEVERITY AND IN-HOSPITAL OUTCOME IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
K. Tziomalos, S.D. Bouziana, M. Spanou, S. Kostaki, M. Papadopoulou, V. Giampatzis, S. Angelopoulou,
M. Tsopozidi, C. Savopoulos, A.I. Hatzitolios
Thessaloniki, GREECE
/ 11 INTER-ARM BLOOD PRESSURE DIFFERENCE AND RISKS OF COGNITIVE DECLINE. A 9-YEAR
PROSPECTIVE COHORT STUDY OF OLDER ADULTS
D. Thomas 1, C. Clark 1, D. Llewellyn 1, L. Ferrucci 2, J. Campbell 1
1
Exeter, UNITED KINGDOM, 2 Baltimore, MD, USA
/ 12 THE RELATIONSHIP BETWEEN CAROTID STENOSIS AND STROKE IN HYPERTHENSIVE DIABETIC
AND NON DIABETIC PATIENTS
C. Revnic 1, S. Voinea 1, C. Pena 1, F. Revnic 1, B. Paltineanu 2, A.S. Nica 1
1
Bucharest, 2 Targu-Mures, ROMANIA
/ 13 NOCTURNAL DECLINE IN SYSTOLIC BLOOD PRESSURE IS RELATED TO COGNITION POST
STROKE: ASPIRE STUDY
L. Brewer, L. Mellon, E. Dolan, F. Horgan, A. Hickey, D. Williams
Dublin, IRELAND
/ 14 THE ASSOCIATION BETWEEN HYPERTENSION AND COGNITIVE IMPAIRMENT
F. Seifar, M. Khalili, H. Ranjbar
Tabriz, IRAN
/ 15 DIFFERENT TYPES OF HYPERCAPNIC BRAIN ARTERIAL REACTIVITY DISORDERS IN PATIENTS
WITH HYPERTENSION
T. Ripp, V. Mordovin, E. Ripp, G. Semke, S. Pekarskiy, A. Falkovskaya, V. Lichikaki, S. Popov
Tomsk, RUSSIA
/ 16 THE EFFECT OF VALSARTAN TREATMENT ON CEREBROVASCULAR REACTIVITY IN PATIENTS
WITH ARTERIAL HYPERTENSION AND RHEUMATOID ARTHRITIS
N. Rebrova, E. Anisimova, T. Ripp, V. Mordovin, R. Karpov, O. Sarkisova, I. Bogomolova
Tomsk, RUSSIA
/ 17 BLOOD PRESSURE IS THE OTHER SIZE OF CHRONIC FATIGUE DISEASE!
J. Meireles-Brandao 1,2, L. Meireles-Brandao 2, R. Coelho 1, F. Rocha-Goncalves 1
1
Porto, 2 Paredes, PORTUGAL
/ 18 ASSOCIATION BETWEEN BLOOD PRESSURE VARIABILITY AND FUNCTIONAL OUTCOME IN
DIFFERENT ISCHEMIC STROKE SUBTYPES
E. Korompoki 1, D. Gill 2, E. Manios 1, A. Vemmou 1, K. Spengos 1, N. Zakopoulos 1, K. Vemmos 1
1
Athens, GREECE, 2 London, UNITED KINGDOM
/ 19 PREVALENCE OF COGNITIVE DYSFUNCTION IN CHRONIC KIDNEY DISEASE
D. Karasavvidou, D. Makridis, M. Skoularopoulou, C. Katsinas
Ptolemaida, GREECE
/ 20 BLOOD PRESSURE PROFILE IN PATIENTS AFFECTED BY DEMENTIA AND HYPERTENSION
CONTROL IN PATIENTS’ CAREGIVERS
F. D’Amico
Messina, ITALY
/ 21 CORRELATION OF DIPPING STATUS TO MILD COGNITIVE IMPAIRMENT IN HYPERTENSIVE
PATIENTS
T. Yaneva-Sirakova, R. Tarnovska-Kadreva, L. Traykov, D. Vassilev
Sofia, BULGARIA
/ 22 BRAIN ARTERIAL REACTIVITY DISORDERS IN PATIENTS WITH HYPERTENSION
T. Ripp, V. Mordovin, E. Ripp, G. Semke, S. Pekarskiy, A. Falkovskaya, E. Sitkova, S. Popov, R. Karpov
Tomsk, RUSSIA
186
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 23 EFFECTIVENESS AND SAFETY OF DABIGATRAN USED IN PATIENTS WITH ATRIAL FIBRILLATION
AFTER RADIOFREQUENCY CATHETER ABLATION
Z. Qiyin, H. Jie
Suzhou, CHINA
/ 24 BLOOD PRESSURE VARIABILITY ENHANCES THE RISK FOR FRONTAL COGNITIVE IMPAIRMENT
IN TREATED HYPERTENSIVES WITH SUBCLINICAL VASCULAR DAMAGE
P. Nazzaro, M.F. De Caro, G. Schirosi, L. Debenedittis, M. Contini, F. Caradonna Moscatelli, F. Federico
Bari, ITALY
/ 25 INFLUENCE OF HYPERTENSION ON STROKE OUTCOME: COMPARISON OF HEMORRHAGIC
AND ISCHEMIC TYPES
L. Mumladze, N. Lobjanidze, N. Akiashvili, K. Zurabishvili, N. Kvirkvelia
Tbilisi, GEORGIA
/ 26 ORTHOSTATIC HYPOTENSION REACTIONS IN HYPERTENSIVE PATIENTS
N. Lazareva, I. Atyunina, E. Oshchepkova, S. Gorieva, A. Rogoza
Moscow, RUSSIA
/ 27 PULSE PRESSURE INDEX IS ASSOCIATED WITH SILENT CEREBROVASCULAR DAMAGE IN
ESSENTIAL HYPERTENSIVE PATIENTS
O. Gulkevych, O. Kupchynska, T. Ovdienko, A. Logvinenko
Kiev, UKRAINE
/ 28 CLASSIFICATION OF BRAIN ARTERIAL REACTIVITY DISORDERS IN PATIENTS WITH
HYPERTENSION
T. Ripp, E. Ripp, V. Mordovin, N. Rebrova, G. Semke, R. Karpov, S. Popov
Tomsk, RUSSIA
/ 29 AN ASSESSMENT OF NEUROTROPHIC THERAPY EFFECT ON NERVE GROWTH FACTOR LEVEL IN
PATIENTS WITH POST STROKE APHASIA AND DIABETES MELLITUS
V. Shishkova
Moscow, RUSSIA
/ 30 SYNDROME COGNITIVE IMPAIRMENT AND QUALITY OF LIFE IN PATIENTS WITH
HYPERTENSION
V. Krotova, T.A. Khomazyuk, O.V. Soya, T.V. Lakiza
Dnipropetrovsk, UKRAINE
/ 31 PHYSICAL CONDITION OF THE HYPERTENSIVE PATIENTS WITH CHRONIC STROKE
O. Guseva, A. Vichodcev, N. Zukova, J. Mironova, N. Aphanasjeva
Tomsk, RUSSIA
/ 32 BIOMARKERS OF CEREBRAL INFARCTIONS AND VASCULAR DEMENTIA
F. D’Amico
Messina, ITALY
/ 33 COGNITIVE STATE IN POSTMENOPAUSAL WOMEN WITH ARTERIAL HYPERTENSION
V. Larina, N. Runikhina, I. Chukaeva, M. Golovko
Moscow, RUSSIA
/ 34 IDENTIFICATION OF CARDIAC SOURCE OF EMBOLISM IN SECONDARY PREVENTION FOR
ACUTE ISCHEMIC STROKE
N. Ali-Tatar Chentir, L. Ouabdesselam, S. Bachtarzi, M.T. Chentir
Algiers, ALGERIA
/ 35 DEPRESSION AMONG HYPERTENSIVE PATIENTS WITH NOT TREATED AND TREATED
HYPERTENSION IN CEREBROVASCULAR DISEASES
I. Giorgishvili, N. Lobjanidze, N. Akiashvili, N. Kvirkvelia, L. Mumladze, K. Zurabishvili
Tbilisi, GEORGIA
F I N A L P R OG R A M M E
187
Posters’ Session PS18
CORONARY HEART DISEASE
Chairperson: K. Wachtell (Copenhagen, DENMARK)
ROOM
POSTERS FROM 1 TO 26
/ 1 VENTRICULAR-ARTERIAL COUPLING MAY BE AN EARLY MARKER OF CARDIAC REMODELING
AFTER MYOCARDIAL INFARCTION TREATED WITH PERCUTANEOUS CORONARY INTERVENTION
E. Zharikova, S. Villevalde, Z. Kobalava
Moscow, RUSSIA
/ 2 OZONETHERAPY PROTECTS AGAINST CORONARY RESTENOSIS REDUCING NEOINTIMAL
HYPERPLASIA AND INFLAMMATION. ROLE OF THE REDOXIN SYSTEM
A. Barone, M. Otero-Losada, G. Cao, F. Azzato, A. Rodríguez, J. Milei
Buenos Aires, ARGENTINA
/ 3 INDEPENDENT LABORATORY PREDICTORS OF THE RISK OF RECURRENT CARDIOVASCULAR
EVENTS IN PATIENTS WITH UNSTABLE ANGINA
I. Lazareva, A. Miadzvedzeva, L. Gelis, T. Rousak, I. Rousskich, N. Shibeka
Minsk, BELARUS
/ 4 THE IMPACT OF ARTERIAL HYPERTENSION ON MORTALITY IN PATIENTS WITH MYOCARDIAL
INFARCTION WITH ST SEGMENT ELEVATION
M. Lovic 1, L. Savic 2, D. Matic 2, D. Djordjevic 1, D. Lovic 1, I. Tasic 1, M. Ostojic 2
1
Niš, 2 Belgrade, SERBIA
/ 5 EFFECTIVENESS OF COMBINATION THERAPY USING METOPROLOL AND IVABRADINE IN
PATIENTS WITH ESSENTIAL HYPERTENSION AND STABLE EFFORT ANGINA
S. Vatinian, S. Gurgenyan
Yerevan, ARMENIA
/ 6 PROGRESSION OF LEFT VENTRICULAR HYPERTROPHY AFTER ST-ELEVATION MYOCARDIAL
INFARCTION PREDICTS THE RECURRENCE OF MYOCARDIAL INFARCTION
J. Shin, J. Park, J.S. Shin
Suwon, SOUTH KOREA
/ 7 EVALUATION OF PLATELET-PLASMA HEMOSTASIS IN PATIENTS WITH UNSTABLE ANGINA AND
ARTERIAL HYPERTENSION
I. Lazareva, A. Miadzvedzeva, L. Gelis, T. Rousak, I. Rousskich, A. Tamasheuski
Minsk, BELARUS
/ 8 AORTIC STIFFNESS IMPROVES THE PREDICTION OF BOTH DIAGNOSIS AND SEVERITY OF
CORONARY ARTERY DISEASE
A. Yannoutsos, M. Ahouah, C. Dreyfuss Tubiana, J. Topouchian, M.E. Safar, J. Blacher
Paris, FRANCE
/ 9 VASCULAR AND METABOLIC PROFILE IN PATIENTS WITH AND WITHOUT CORONARY ARTERY
DISEASE
L. Woznicka-Leskiewicz, A. Posadzy-Malaczynska
Poznan, POLAND
/ 10 INFLUENCE OF FIXED-DOSE COMBINATION PERINDOPRIL/AMLODIPINE ON TARGET ORGAN
DAMAGE IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE
G. Radchenko, L. Mushtenko, O. Torbas, S. Kushnir, Y. Sirenko
Kiev, UKRAINE
/ 11 DYNAMICS OF BLOOD PRESSURE AND RIGIDITY DURING THERAPY WITH DIFFERENT DOSES
OF ATORVASTATIN IN PATIENTS WITH STEMI
L. Salyamova, A. Khromova, V. Oleynikov
Penza, RUSSIA
188
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 12 METABOLIC SYNDROME DOES NOT AFFECT SHORT-TERM OUTCOME OF ACUTE CORONARY
SYNDROME IN WOMEN, BUT IN MEN AND SIGNIFICANTLY IMPARES LONG-TERM PROGNOSIS FOR
BOTH
A. Droganova, A.N. Shishkin, A.A. Semenov
Saint-Peterburg, RUSSIA
/ 13 THE POSSIBLE ROLE OF CALCITONIN GENE-RELATED PEPTIDE IN ESTRADIOL
CARDIOPROTECTION IN CASES OF ISOPROTERENOL-INDUCED MYOCARDIAL ISCHEMIA IN RATS
M. Deif 1, H. El Nounou 2
1
Alexandria, EGYPT, 2 Al Riyadh, SAUDI ARABIA
/ 14 CHARACTERISTICS OF PATIENTS HOSPITALIZED FOR ACUTE CORONARY SYNDROME
COMPLICATED WITH ACUTE HEART FAILURE IN PATIENTS
M. Azaiez, A. Elhraiech, S. Hamdi, W. Jomaa, K. Ben Hamda, F. Maatouk
Monastir, TUNISIA
/ 15 FIBROMUSCULAR DYSPLASIA OF CORONARY AND RENAL VESSELS AS THE CAUSE OF
SECONDARY HYPERTENSION AND ACUTE CORONARY SYNDROME IN WOMEN WITH INTACT TORTUOUS
CORONARY ARTERIES
L. Zhuravlyova, N. Lopina
Kharkiv, UKRAINE
/ 16 EVALUATION OF MMP-7 AND TIMP-1 IN PATIENTS OF DIFFERENT AGES WITH CORONARY
ARTERY DISEASE
C. Revnic, C. Ginghina, C. Pena, F. Revnic, S. Prada, G. Prada, A.S. Nica
Bucharest, ROMANIA
/ 17 THE DYNAMICS OF LEFT VENTRICULAR PARAMETERS AND BRAIN NATRIURETIC PEPTIDE
LEVELS IN PATIENTS WITH MYOCARDIAL INFARCTION AND PRECEDING ARTERIAL HYPERTENSION
L. Zhuravlyova, M. Filonenko
Kharkiv, UKRAINE
/ 18 THE VALUE OF IVUS AND FFR IN THE PATIENTS OF UNSTABLE ANGINA
Z. Qiyin, H. Jie
Suzhou, CHINA
/ 19 INFLUENCE OF MUSIC THERAPY ON HYPERTENSIVE PATIENTS WITH EARLY POST-INFARCTION
ANGINA
P. Mitrovic, B. Stefanovic, A. Paladin, M. Radovanovic, N. Radovanovic, D. Rajic, G. Matic, I. Subotic, Y. Vasiljevic,
V. Bulatovic
Belgrade, SERBIA
/ 20 INDICATORS OF ARTERIAL STIFFNESS IN MALE WITH PROVEN CORONARY HEART DISEASE
V. Oleynikov, I. Eliseeva, N. Borisova, Y. Tomashevskaya
Penza, RUSSIA
/ 21 PHYSICAL EFFICIENCY VARIABILITY IN ELDERLY SUBJECTS WITH ACUTE CORONARY DISEASE
F. D’Amico
Messina, ITALY
/ 22 PROFILE OF THE ROMANIAN ISCHEMIC HEART DISEASE IN WOMEN
D. Pop, T. Marginean, B. Dutu, G. Cismaru, D. Zdrenghea
Cluj-Napoca, ROMANIA
/ 23 SWIMMING TRAINING PREVENTS CORONARY ENDOTHELIAL DYSFUNCTION BY INCREASING
THE EXPRESSION OF ANTIOXIDANT ENZYMES IN OVARIECTOMIZED SPONTANEOUSLY HYPERTENSIVE
RATS
G. Abreu 1, P. Endlich 2, E. Claudio 1, S. Almeida 1, A. Carvalho 1, V. Mengal 1, G. Brasil 1
1
Vitória, 2 Minas Gerais, BRAZIL
/ 24 ETHNIC DIFFERENCES IN OUTCOMES OF DEATH IN PATIENTS SUFFERING FROM
HYPERTENSION
A. Kerimkulova 1, A. Markabayeva 2, V. Weber 3, L. Proshina 1, A. Darybayeva 1, R. Nurpeissova 1
1
Astana, 2 Semey, KAZAKHSTAN, 3 Novgorod, RUSSIA
F I N A L P R OG R A M M E
189
/ 25 WHY IS CARDIOVASCULAR DISEASE PREVENTION NEEDED IN HYPERTENSION AND DIABETES
PATIENTS ? FEATURES OF PTS WITH ST-SEGMENT ELEVATION
A. Ali -Tatar Chentir, S. Mellal, D. Allane, I. Bouzneda, M.T. Chentir
Algiers, ALGERIA
/ 26 IMPACT OF HEART FAILURE ON IN-HOSPITAL OUTCOMES OF ACUTE CORONARY SYNDROME
PATIENTS
M. Azaiez, S. Hamdi, A. Elhraiech, W. Jomaa, K. Ben Hamda, F. Maatouk
Monastir, TUNISIA
Posters’ Session PS19
EPIDEMIOLOGY OF HYPERTENSION AND METABOLIC DISORDERS
Chairperson: J.-P. Empana (Paris, FRANCE)
ROOM
POSTERS FROM 1 TO 24
/ 1 PREVALENCE AND RISK FACTORS RELATED TO DEVELOPMENT OF ARTERIAL HYPERTENSION IN
CIRRHOTIC PATIENTS UNDERGOING LIVER TRANSPLANTATION
C. Di Stefano, E. Vanni, S. Mirabella, R. Ibrahim Kamal Jouness, E. Nada, V. Boano, E. Mosso, V. Milazzo,
F. Vallelonga, G. Sobrero, M. Salizzoni, F. Veglio, A. Milan
Turin, ITALY
/ 2 ELEVATED SER M TGF- 1 LEVELS PREDICTED THE DEVELOPMENT OF HYPERTENSION IN
NORMOTENSIVES IN A GENERAL POPULATION
E. Nakao, H. Adachi, M. Enomoto, A. Fukami, E. Kumagai, S. Nakamura, Y. Nohara, A. Sakaue, N. Morikawa,
T. Tsuru
Kurume, JAPAN
/ 3 SOCIAL AND LIFESTYLE DETERMINANTS OF ARTERIAL STIFFNESS: THE MALMÖ DIET AND
CANCER STUDY
P. Karlsson, M. Gottsäter, P.M. Nilsson
Malmö, SWEDEN
/ 4 PREVALENCE OF HYPERTENSION AND ASSOCIATED VARIABLES AMONG THE INHABITANTS OF
YEMETU COMMUNITY IN IBADAN-NORTH LOCAL GOVERNMENT AREA OF OYO STATE, NIGERIA
I. Sowemimo, I.O. Ajayi, O.M. Akpa
Ibadan, NIGERIA
/ 5 SLEEP HISTORY AND HYPERTENSION BURDEN IN FIRST GENERATION CHINESE MIGRANTS
SETTLED IN THE SOUTH OF EUROPE: THE CHINESE IN PRATO CROSS-SECTIONAL SURVEY
P.A. Modesti 1, E. Perruolo 1, M. Calabrese 2, A. Bussotti 1, D. Malandrino 1, D. Zhao 3
1
Florence, 2 Prato, ITALY, 3 Beijing, CHINA
/ 6 PREHYPERTENSION IN EUROPEAN RURAL POPULATION: DATA FROM THE BRISGHELLA HEART
STUDY (ITALY) AND ENAH STUDY (CROATIA)
V. Ivkovic 1, A. Parini 2, A. Vrdoljak 1, S. Karanovic 1, M. Abramovic Baric 3, S. Bacchelli 2, M. Cagnati 2,
A.F.G. Cicero 2, S. D’Addato 2, D. Degli Esposti 2, M. Fucek 1, E. Grandi 2, J. Kos 2, M. Laganovic 1, M. Rosticci 2,
D. Rogic 1, I. Vukovic 1, C. Borghi 2, B. Jelakovic 1
1
Zagreb, CROATIA, 2 Bologna, ITALY, 3 Slavonski Brod, CROATIA
/ 7 THE PARADOXICAL SIGNIFICANCE OF HEADACHE IN HYPERTENSION
M. Serraille 1, P.-Y. Courand 1, N. Girerd 2, G. Demarquay 1, H. Milon 1, B. Harbaoui 1, P. Lantelme 1
1
Lyon, 2 Nancy, FRANCE
190
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 8 HYPERTENSION AND OTHER MODIFIABLE CARDIOVASCULAR RISK FACTORS IN GREECE:
INTERIM ANALYSIS OF THE EMENO NATIONAL EPIDEMIOLOGICAL STUDY
G.S. Stergiou 1, A. Margetaki 1, N. Boubouchairopoulou 1, M. Gavana 2, A. Vantarakis 3, G. Chlouverakis 4,
C. Chatzichristodoulou 5, G. Trypsianis 6, P. Voulgari 7, I. Alamanos 8, G. Touloumi 1
1
Athens, 2 Thessaloniki, 3 Patras, 4 Heraklion, 5 Larissa, 6 Alexandroupolis, 7 Ioannina, 8 Corfu, GREECE
/ 9 SERUM URIC ACID CHANGE AND MODIFICATION OF BLOOD PRESSURE AND FASTING
PLASMA GLUCOSE IN A PHARMACOLOGICALLY UNTREATED POPOLATION SAMPLE: DATA FROM THE
BRISIGHELLA HEART STUDY
A.F.G. Cicero, M. Rosticci, F. Fogacci, A. Parini, R. Urso, E. Grandi, S. D’Addato, C. Borghi
Bologna, ITALY
/ 10 APELIN AND VISFATIN PLASMA LEVELS IN HEALTHY INDIVIDUALS WITH HIGH NORMAL
BLOOD PRESSURE
D. Papadopoulos, E. Sanidas, D. Perrea, H. Grassos, C. Liakos, J. Barbetseas, T. Makris
Athens, GREECE
/ 11 THE METABOLIC SYNDROME IN APPARENTLY HEALTHY ADOLESCENTS FROM AN URBAN
POPULATION IN GUAYAQUIL (ECUADOR)
F. Aguirre Palacios 1, A. Coca 2, M.F. Aguirre 1
1
Guayaquil, ECUADOR, 2 Barcelona, SPAIN
/ 12 ISOLATED SYSTOLIC HYPERTENSION CHARACTERISTICS: DATA FROM THE BRISIGHELLA HEART
STUDY (ITALY) AND THE ENAH STUDY (CROATIA)
A. Parini 1, V. Ivkovic 2, A. Vrdoljak 2, M. Abramovic Baric 2, S. Bacchelli 1, M. Cagnati 1, A.F.G. Cicero 1,
S. D'Addato 1, D. Degli Esposti 1, M. Fucek 2, E. Grandi 1, E. Ivandic 2, S. Karanovic 2, M. Laganovic 2, I. Pecin 2,
M. Rosticci 1, D. Rogic 2, B. Jelakovic 2, C. Borghi 1
1
Bologna, ITALY, 2 Zagreb, CROATIA
/ 13 PREHYPERTENSION PREVALENCE IN RUSSIA: THE RUSSIAN EPIDEMIOLOGY SURVEY ESSE-RF
A. Erina 1, O. Rotar 1, A.O. Konradi 1, S. Shalnova 2, Y. Balanova 2, A. Deev 2, I. Zhernakova 3, E. Oshchepkova 2,
Y. Karpov 2, I.E. Chazova 2, S. Boytsov 2, E. Shlyakhto 1
1
Saint-Petersburg, 2 Moscow, RUSSIA
/ 14 EASTERN EUROPEAN HYPERTENSIVE IMMIGRANTS ARE CHARACTERIZED BY POOR HEALTHRELATED QUALITY OF LIFE IN COMPARISON TO NATIVE HYPERTENSIVES
V. Katsi, G. Vamvakou, T. Makris, I. Kallikazaros, D. Tousoulis
Athens, GREECE
/ 15 THE RELATIONSHIP OF LEPTIN AND ITS SOLUBLE RECEPTOR WITH INDICATORS OF INSULIN
RESISTANCE IN INDIVIDUALS WITH VISCERAL OBESITY
G. Chumakova 1, A. Ott 2, N. Veselovskaya 2, O. Gritzenko 2
1
Barnaul, 2 Kemerovo, RUSSIA
/ 16 NO GENDER EQUALITY WHEN IT COMES TO HYPERTENSION
D. Bartos, E. Weiss, C. Japie, A.M. Daraban, D. Penes, E. Badila
Bucharest, ROMANIA
/ 17 MODELING OF EXPECTED CARDIOVASCULAR MORTALITY RISKS IN RUSSIA ON THE BASE OF
POPULATION STUDY ESSE-RF
A. Imaeva, S. Shalnova, A. Deev, Y. Balanova, A. Kapustina, V. Konstantinov
Moscow, RUSSIA
/ 18 THE INCIDENCE OF DYSLIPIDEMIA AMONG HYPERTENSIVE WITH AND WITHOUT DIABETES:
ELEVEN YEAR COHORT
A.C. Sousa, P. Jardim, F.G. Magalhães, W. Barroso, T. Jardim, T. Costa, L. Mikael, R.B. Rodrigues, V.R. Ferreira,
H.S. Souza, H.G. Moreira, T.C. Neiva, C.F. Oliveira, W. Sousa, A.L. Sousa
Goiânia, BRAZIL
/ 19 DETERMINANTS OF OSA IN PATIENTS OF A HYPERTENSION CLINIC
P. Marques, L. Nogueira-Silva, M.J. Lima, F. Cunha, C. Pereira
Porto, PORTUGAL
F I N A L P R OG R A M M E
191
/ 20 THE RELATIONSHIP OF PULSE PRESSURE WITH AGEING IN PATIENTS WITH AND WITHOUT
NON INSULIN DEPENDENT DIABETES. A CROSS-SECTIONAL STUDY
S. Mirwais 1, S. Al Sheik 2, A. Al Tikriti 1, M.J. Ahmed 2
1
Abu Dhabi, 2 Dubai, UNITED ARAB EMIRATES
/ 21 HYPERTENSIVE EMERGENCIES AND CRISIS IN AN EMERGENCY DEPARTMENT: EVALUATION
AND MORTALITY IN 9 MONTHS
H. Guiga, G. Sarlon, F. Silhol, W. Radix, P. Michelet, B. Vaisse
Marseille, FRANCE
/ 22 MANAGEMENT OF RESISTANT HYPERTENSION IN A HYPERTENSIVE POPULATION IN THE
SOUTH EAST OF TUNISIA
H. Denguir, I. Yakdhane, C. Zrigue, M. Ben Romdhane, A. Ben Brik
Gabes, TUNISIA
/ 23 SELENIUM AND HYPERTENSION: WHAT IS THE CORRELATION?
K. Kisters 1, L. Schomburg 2, J. Buentzel 3, R. Muecke 4, O. Micke 5
1
Herne, 2 Berlin, 3 Nordhausen, 4 Lemgo, 5 Bielefeld, GERMANY
/ 24 THE PREVALENCE OF RESISTANT HYPERTENSION IN SZEGED HYPERTENSION EXCELLENCE CENTER
I. Fejes, G. Abraham, P. Legrady
Szeged, HUNGARY
Posters’ Session PS20
HEART AND HAEMODYNAMICS
Chairperson: T. Kahan (Stockholm, SWEDEN)
ROOM
POSTERS FROM 1 TO 25
/ 1 LCZ696 THERAPY IS ASSOCIATED WITH IMPROVEMENT OF VENTRICULAR ARTERIAL
COUPLING AND WORK EFFICIENCY IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION
FRACTION
Z. Kobalava, L. Babaeva, O. Lukina, E. Zharikova, E. Tyukhmenev, S. Villevalde
Moscow, RUSSIA
/ 2 FACTORS AFFECTING MYOCARDIAL PERFUSION IN PATIENTS WITH RHEUMATOID ARTHRITIS
P. Anyfanti, A. Triantafyllou, G. Triantafyllou, P. Panagopoulos, N. Koletsos, A. Pyrpasopoulou,
S. Chatzimichailidou, E. Gkaliagkousi, S. Aslanidis, S. Douma
Thessaloniki, GREECE
/ 3 EFFECTIVENESS OF ERYTHROPOIETIN ON CARDIOVASCULAR RESPONSE DURING
HYPOVOLEMIC STATE
M. Puchulu, N.D. Arreche, R. Altalef, M.B. Billordo, N. Ogonowski, M. Donato, A.L. Fellet, A.M. Balaszczuk
Buenos Aires, ARGENTINA
/ 4 ROLE OF NON-INVASIVE HOME TELEMONITORING (HTM) IN DIASTOLIC HEART FAILURE
TREATMENT
S. Persampieri, G. Ferrante, L. Giugno, A. Carretta, B. Caimi, A. Esposito, S. Carugo
Milan, ITALY
/ 5 BETA3-ADRENERGIC RECEPTOR SUPPRESSES NICOTINAMIDE ADENINE DINUCLEOTIDE
PHOSPHATEOXIDASE-DEPENDENT OXIDATIVE STRESS IN PRESSURE OVERLOAD HYPERTROPHY
X. Niu, W. Bin, M. Xu, F. Shang, W. Guo, J. Liu, H. Wang, H. Wang
Xi’an, CHINA
/ 6 EFFECT OF ANTECEDENT CIGARETTE SMOKING ON CARDIOVASCULAR FUNCTION DURING
ISOMETRIC HANDGRIP EXERCISE
P. Anyfanti 1, E. Triantafyllidou 2, A. Triantafyllou 1, A. Kyparos 2, M. Nikolaidis 2, I. Vrabas 2, A. Zafeiridis 2,
S. Douma 1, K. Dipla 2
1
Thessaloniki, 2 Serres, GREECE
192
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 7 THE HEMODYNAMIC CHANGE BY SQUATTING IS INDUCED BY DIMINISHED VASCULAR
DISTENSIBILITY AND ENHANCED PRESSURE WAVE REFLECTION
T. Nawa, T. Murakami, M. Shiraishi, S. Fukuoka, K. Higashi, H. Nakajima, H. Aotsuka
Chiba, JAPAN
/ 8 THE INFLUENCE OF SLOW BREATHING TRAINING ON PHYSICAL EXERCISE CAPACITY AND
SLEEP DISTURBANCES IN PATIENTS WITH CHRONIC HEART FAILURE
G. Kielbasa 1, T. Drozdz 1, D. Debicka-Dabrowska 1, K. Styczkiewicz 1, M. Klocek 1, G. Malfatto 2, A. Bednarek 1,
A. Olszanecka 1, G. Bilo 2, D. Czarnecka 1, G. Parati 2, K. Kawecka-Jaszcz 1
1
Kraków, POLAND, 2 Milan, ITALY
/ 9 THE BEHAVIOUR OF PHYSIOLOGICAL PARAMETERS OF ISOLATED PERFUSED RAT HEART IN
EXPERIMENTALLY INDUCED CARDIAC HYPERTROPHY WITH ISOPROTERENOL
C. Revnic 1, S. Voinea 1, C. Pena 1, F. Revnic 1, B. Paltineanu 2, A.S. Nica 1
1
Bucharest, 2 Targu-Mures, ROMANIA
/ 10 THE INFLUENCE OF SLOW BREATHING TRAINING ON QUALITY OF LIFE IN PATIENTS WITH
CHRONIC HEART FAILURE
T. Drozdz 1, M. Klocek 1, D. Debicka-Dabrowska 1, K. Styczkiewicz 1, G. Malfatto 2, A. Bednarek 1, A. Olszanecka 1,
G. Kielbasa 1, G. Bilo 2, D. Czarnecka 1, G. Parati 2, K. Kawecka-Jaszcz 1
1
Kraków, POLAND, 2 Milan, ITALY
/ 11 EFFECT OF CALCIUM CHANNEL BLOCKER AND DIFFERENT RENIN-ANGIOTENSINALDOSTERONE SYSTEM INHIBITORS ON PULSE WAVE ANALYSIS INDICES IN MILD-MODERATE
UNCOMPLICATED HYPERTENSIVES
K.M. Amosova, K.P. Lazareva, P.A. Lazarev, I. Rudenko
Kiev, UKRAINE
/ 12 SYSTEMIC HEMODYNAMIC COUNTER-REGULATION IN HYPERTENSION AND AGING: IMPACT
OF HEART RATE
K. Elango, S. Bhura, J.L. Izzo, P.J. Osmond
Buffalo, NY, USA
/ 13 DEVELOPMENT OF A NEW MODEL OF RAT SEPTIC SHOCK. A COMPARISON OF
HEMODYNAMICS AND PHYSIOPATHOLOGY WITH REGARD TO THE CONVENTIONAL MODEL
N. Alkattani, S. Orlowski, B. Levy
Nancy, FRANCE
/ 14 VENTRICULAR-ARTERIAL COUPLING AND VENTRICULAR EFFICIENCY AT REST AND DURING
HANDGRIP ISOMETRIC EXERCISE IN UNTREATED HYPERTENSIVE PATIENTS
A. Bogomaz, Y. Kotovskaya, Z. Kobalava
Moscow, RUSSIA
/ 15 SYSTOLIC AND DIASTOLIC DYSFUNCTION AMONG TREATED HYPERTENSIVE PATIENTS:
ASSOCIATIONS WITH RESPECT TO HYPERTENSION CONTROL AND TREATMENT RESISTANCE
A. Kasiakogias,C.Tsioufis,D.Konstantinidis,G.Georgiopoulos,E.Andrikou, G. Vlachos, K. Kintis, G. Bazoukis,
K. Kyriazopoulos, A. Frantzeskakis, A. Milkas, K. Thomopoulos, D. Tousoulis
Athens, GREECE
/ 16 GENDER BASED COMPARISONS OF CENTRAL AORTIC PRESSURE IN HYPERTENSIVE PATIENTS
G. Paudel, X. Zhao, X.F. Zhang, J. Yu
Lanzhou, CHINA
/ 17 ASSESSMENT OF OSTEOPONTIN IN PATIENTS WITH PULMONARY HYPERTENSION OF
DIFFERENT ETIOLOGY
A. Kazimli 1, M. Simakova 2, N. Goncharova 2, A. Naymushin 2, A. Berezina 2, O. Moiseeva 2
1
Baku, AZERBAIJAN, 2 Saint-Petersburg, RUSSIA
/ 18 CLINICAL AND ELECTROCARDIOGRAPHIC FEATURES OF HEART FAILURE WITH PRESERVED
EJECTION FRACTION
M. Azaiez, A. Elhraiech, S. Hamdi, W. Jomaa, K. Ben Hamda, F. Maatouk
Monastir, TUNISIA
F I N A L P R OG R A M M E
193
/ 19 THE ADDITIONAL TO ANTIHYPERTENSIVE TREATMENT EFFECT OF ROSUVASTATIN ON LEFT
VENTRICULAR HYPERTROPHY AT ESSENTIAL HYPERTENSIVE PATIENTS
L. Mishchenko, O. Matova, M. Sheremet, G. Bozhenko
Kiev, UKRAINE
/ 20 ABNORMAL VALUES OF ANKLE-BRACHIAL INDEX ARE ASSOCIATED TO A GREATER
PREVALENCE OF LEFT VENTRICULAR HYPERTROPHY AND OTHER RELEVANT ECHOCARDIOGRAPHIC
FINDINGS IN DIABETIC HYPERTENSIVES
J.C. Pompeu Filho 1,2, R. Silva 2, W. Nojoza 2, R. Nogueira 2, L. Andrade Neto 2, S.N. Falcão 2, J.L. Falcão 2,
J. Gomes Filho 2, L. Bortolotto 1
1
São Paulo, 2 Fortaleza, BRAZIL
/ 21 IMPEDANCE CARDIOGRAPHY BETTER CHARACTERIZES HEMODYNAMIC ALTERATIONS
RELATED WITH LEFT VENTRICULAR DIASTOLIC FUNCTION IN HYPERTENSIVE MEN THAN WOMEN
A. Stanczyk, P. Krzesinski, G. Gielerak, B. Uzieblo-Zyczkowska, K. Piotrowicz, A. Skrobowski
Warsaw, POLAND
/ 22 ASSOCIATION OF INFLAMMATORY MARKERS WITH LEFT VENTRICULAR DIASTOLIC
DYSFUNCTION IN HYPERTENSIVE PATIENTS
O. Matova, L. Mishchenko, M. Mospan
Kiev, UKRAINE
/ 23 PERFORMANCE OF ELECTROCARDIOGRAPHIC CRITERIA FOR DETECTION OF
ECHOCARDIOGRAFICALLY DIAGNOSED LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVES IN
RELATION TO OBESITY
L. Stryczynski, P. Uruski, K. Kostka-Jeziorny, D. Lipski, A. Radziemski, A. Tykarski
Poznan, POLAND
/ 24 MORPHOLOGICAL EXPRESSION OF HYPERTENSION IN THE LEFT VENTRICULAR
MYOCARDIUM. ANALYSIS OF FRACTAL DIMENSION BY ECHOCARDIOGRAPHY
F. Facciuto, L. Carral, M.E. Cabral, M.G. Bertoluzzo, M.A. Vinuesa, D. Piskorz
Rosario, ARGENTINA
/ 25 CORRELATION OF BIOMARKERS OF CARDIAC REMODELLING, INFLAMMATION AND
MYOFIBROSIS WITH PARAMETERS OF CARDIAC STRUCTURE AND FUNCTION IN PATIENTS WITH
ARTERIAL HYPERTENSION
F. Malek, D. Vondrakova, J. Dvorak, L. Sedlackova, L. Taborsky, P. Neuzil
Prague, CZECH REPUBLIC
Posters’ Session PS21
INFLAMMATION AND IMMUNITY
Chairperson: TBD
ROOM
POSTERS FROM 1 TO 15
/ 1 TOLL-LIKE RECEPTOR 4 EXPRESSION AND SERUM LEVEL OF IL17A IN HYPERTENSIVE PATIENTS
T. Simundic, J. Barbic
Osijek, CROATIA
/ 2 INDIVIDUALS WITH HYPERTENSIVE EMERGENCY PRESENT ASSOCIATION BETWEEN RENAL
DYSFUNCTION AND INFLAMMATORY CYTOKINES
J. Vilela-Martin, D. Oliveira-Andrade, L. Cosenso-Martin, M.L. Gregório, D.R. Silva-Souza, M.F. Godoy,
J.C. Yugar-Toledo
São José do Rio Preto, BRAZIL
/ 3 DIPEPTIDYL PEPTIDASE 4 INHIBITOR ATTENUATES OBESITY INDUCED MYOCARDIAL FIBROSIS
BY THE UP-REGULATION OF REGULATORY T CELLS
S. Ihm, S.K. Hong, K. Chang
Seoul, SOUTH KOREA
194
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 4 INTERLEUKIN-17 RELATED TO RISK FACTORS IN HYPERTENSIVE PATIENTS
I. Voloshyna, V. Krivenko, M. Voloshyn, V. Deynega, V. Ponomarenko
Zaporozhye, UKRAINE
/ 5 RELATIONSHIP BETWEEN MICROVASCULAR STRUCTURE AND T REGULATORY LYMPHOCYTES
OF SMALL RESISTANCE ARTERIES
C. Rossini, L. Mori, C. De Ciuceis, S. Duse, F. Semeraro, L. Solaini, E. Porteri, B. Petroboni, A. Gavazzi,
C. Agabiti Rosei, M. Castellano, E. Agabiti Rosei, D. Rizzoni
Brescia, ITALY
/ 6 EARLY IMMUNE ACTIVATION PROFILE IN STAGE I HYPERTENSION AND ITS PREDICTIVE RISK
VALUE IN 5 YEAR FOLLOW UP
S. Obregon, E. Chuluyan, J. Aquino, F. Inserra, F. Botto, C. Kotliar
Pilar, ARGENTINA
/ 7 INFECTIOUS-INFLAMMATORY HISTORY AND VASCULAR RIGIDITY IN YOUNG ADULTS
M. Evsevyeva, E. Italyantseva, M. Eremin, I. Koshel
Stavropol, RUSSIA
/ 8 PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR TYPE C CONCENTRATION AS THE
MODULATOR OF THE RELATION BETWEEN URINARY SODIUM EXCRETION AND BLOOD PRESSURE IN
HUMANS
A. Bednarski, K. Stolarz-Skrzypek, M. Kloch-Badelek, A. Franczyk, G. Kielbasa, K. Kawecka-Jaszcz, D. Czarnecka
Kraków, POLAND
/ 9 C-REACTIVE PROTEIN IN HYPERTENSIVE SUBJECTS IS ASSOCIATED WITH DETERIORATED
HEALTH RELATED QUALITY OF LIFE
V. Katsi, G. Vamvakou, T. Makris, I. Kallikazaros, D. Tousoulis
Athens, GREECE
/ 10 HIV INFECTION AND HYPERTENSION IN ATHEROSCLEROSIS OF TYPE 2 DIABETES MELLITUS
G. Konstantinidis, G. Dimas, T. Tegos, A. Samaras, C.P. Stragalis, K. Pavlopoulos, C. Savopoulos, A. Orologas,
A. Hatzitolios
Thessaloniki, GREECE
/ 11 INFLAMMATORY BIOCHEMICAL MARKERS AND FUNCTIONAL PARAMETERS OF ARTERIAL
WALL IN HYPERTENSIVE PATIENTS WITH METABOLIC DISORDERS
N. Musikhina, T. Retelina, K. Avdeeva, L. Gapon
Tyumen, RUSSIA
/ 12 REFERENCE VALUES AND DISTRIBUTION OF THE NEUTROPHIL TO LYMPHOCYTE RATIO IN A
LARGE-SCALE POPULATION
E. Huguet, G. Maccallini, P. Pardini, M. Hidalgo, S. Obregon, M. Haehnel, P. Carrizo, M. Koretzky, A. Di Leva,
F. Inserra, F. Botto, C. Kotliar
San Isidro, ARGENTINA
/ 13 BETA-AGONISTS WITH DIFFERENT DURATION OF ACTION IN PATIENTS WITH ARTERIAL
HYPERTENSION AND BRONCHOOBSTRUCTIVE DISEASES
O. Agapova, Y. Dolgusheva, K. Zykov, T. Kuznetsova, G. Tkachev, I.E. Chazova
Moscow, RUSSIA
/ 14 IF CHANNEL INHIBITION WITH IVABRADINE DOES NOT IMPROVE CARDIAC AND VASCULAR
FUNCTION IN EXPERIMENTAL SEPTIC SHOCK
C. Wei, N. Al Kattani, H. Louis, E. Albuisson, B. Levy, A. Kimmoun
Vandoeuvre-lès-Nancy, FRANCE
/ 15 PSORIATIC ARTHRITIS AND SUBCLINICAL ATHEROSCLEROSIS
I. Gruev, A. Toncheva
Sofia, BULGARIA
F I N A L P R OG R A M M E
195
Posters’ Session PS22
KIDNEY
Chairperson: P.Sarafidis(Thessaloniki,GREECE)
ROOM
POSTERS FROM 1 TO 28
/ 1 INCREASED APOPTOSIS AND DECREASED EXPRESSION OF NEPHRIN IN AGING
SPONTANEOUSLY HYPERTENSIVE RATS (SHRS)
A. Volakaki, P.E. Tsilibari, G. Drossopoulou, D. Vlahakos
Athens, GREECE
/ 2 DEFICIENCY OF PURINERGIC P2X7 RECEPTOR PROTECTS AGAINST PROGRESSION OF
CHRONIC RENAL INJURY
S. Potthoff 1, M. Tiedge 1, F. Srugies 1, C. Bockmeyer 2, L.C. Rump 1, O. Vonend 1
1
Düsseldorf, 2 Erlangen, GERMANY
/ 3 24-HOUR URINE ALPHA-1-MICROGLOBULIN AS A MARKER OF HYPERTENSION-INDUCED
RENAL IMPAIRMENT AND ITS RESPONSE ON DIFFERENT BP-LOWERING DRUGS
C. Liakos, G. Vyssoulis, M. Markou, C. Grassos, E. Chatzistamatiou, K. Toutouzas, D. Tousoulis
Athens, GREECE
/ 4 HYPERALDOSTERONISM AND CARDIOVASCULAR RISK IN PATIENTS WITH AUTOSOMAL
DOMINANT POLYCYSTIC KIDNEY DISEASE
S. Lai 1, D. Mastroluca 1, T. Gnerre Musto 1, S. Matino 1, A. Perrotta 1, P. Protopapa 1, M. Paiano 1, G. Pintus 1,
A. Galani 2, A.R. D’Angelo 2, C. Letizia 1, L. Petramala 1
1
Rome, 2 Brescia, ITALY
/ 5 ASSOCIATION BETWEEN PLASMA ALDOSTERONE LEVEL AND ALBUMINURIA IN NEVER
TREATED, NON-DIABETIC HYPERTENSIVE PATIENTS
C. Catena, G.L. Colussi, M. Novello, G. Brosolo, N. Bertin, L.A. Sechi
Udine, ITALY
/ 6 INFLUENCE OF DYSLIPIDAEMIA CORRECTION ON KIDNEY HEMODYNAMICS AND CALCIUM
METABOLISM IN PATIENTS WITH ESSENTIAL HYPERTENSION AND OSTEOARTHRITIS
L. Zhuravlyova, T. Rogachova
Kharkiv, UKRAINE
/ 7 HIGH PHOSPHATURIA IS AN INDEPENDENT PREDICTOR OF PROGRESSION OF RENAL
DYSFUNCTION IN PATIENTS WITH METABOLIC SYNDROME AND EARLY CHRONIC KIDNEY DISEASE
A. Robles 1,2, R. Santamaria 1,2, M. Rodriguez 1,2, P. Aljama 1,2
1
Córdoba, 2 Madrid, SPAIN
/ 8 PLASMA D-DIMER LEVELS ARE RELATED TO INTRARENAL VASCULAR RESISTANCE IN NONDIABETIC ESSENTIAL HYPERTENSIVE PATIENTS
C. Catena, G.L. Colussi, M. Novello, F. Martinis, F. Nait, L.A. Sechi
Udine, ITALY
/ 9 RELATIONSHIPS OF SYMMETRICAL AND ASYMMETRICAL AMBULATORY ARTERIAL STIFFNESS
INDEX (AASI) WITH PRECLINICAL RENAL DAMAGE IN UNTREATED HYPERTENSIVE PATIENTS
G. Mulè, A. Castiglia, E. Scaduto, A. Ocello, D. Altieri, L. Guarino, M. Guarneri, F. Vaccaro, S. Cottone
Palermo, ITALY
/ 10 BLOOD PRESSURE AS A MARKER OF THE RISK OF DEATH AND DIALYSIS IN RENAL
TRANSPLANT RECIPIENTS NOT TREATED FOR HYPERTENSION
J.-M. Halimi, P. Gatault, L. Vernier, C. Barbet, H. Longuet, J. Marliere, E. Merieau, B. Sautenet, C. Baron,
M. Buchler
Tours, FRANCE
/ 11 RENAL NATRIURETRIC SYSTEMS ALTERATION IN FRUCTOSE-OVERLOADED HYPERTENSIVE RATS
A. Puyó, N.M. Kouyoumdzian, N.M. Rukavina Mikusic, E. Rouvier, S.M. Cantú, H.J. Lee, J.E. Toblli,
B.E. Fernández, M.R. Choi
Buenos Aires, ARGENTINA
196
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 12 ANTIHYPERTENSIVE TREATMENT IN VERY OLD PATIENTS WITH CHRONIC KIDNEY DISEASE.
NOT EXACTLY WHAT THE GUIDELINES SAY
D. Penes, E. Weiss, A.M. Daraban, C. Japie, E. Badila, D. Bartos
Bucharest, ROMANIA
/ 13 IN RENAL STENOSIS, MULTIDISCIPLINARY SELECTION OF STENTING INDICATIONS IMPROVES
BLOOD PRESSURE CONTROL
T. Fournier, F. Sens, C. Pelletier, S. Luong, A. Millon, O. Rouviere, L. Juillard
Lyon, FRANCE
/ 14 USE OF RENIN-ANGIOTENSIN SYSTEM INHIBITORS AND RETARDED PROGRESSION OF END
STAGE RENAL FAILURE: A RETROSPECTIVE STUDY
G. Yasuda, A. Mori, S. Saka, Y. Yamamoto, T. Murakami, N. Hirawa
Yokohama, JAPAN
/ 15 IMMEDIATE POST RENAL TRANSPLANT PERIOD AND HYPERTENSION: CONCORDANCE
BETWEEN CLINIC AND AMBULATORY BLOOD PRESSURE
J.C. Prado, A. Lopez, G. Ruiz-Hurtado, M. Fernandez, J.M. Aguado, A. Andres, M. Praga, L.M. Ruilope, J. Segura
Madrid, SPAIN
/ 16 CYSTATIN C AND SERUM CREATININE IN THE DIAGNOSIS OF CHRONIC RENAL FAILURE IN
PATIENTS WITH ESSENTIAL HYPERTENSION
L. Vigil 1, M. Lopez Jimenez 1, C. Rodriguez de Castro 1, R. García Carretero 1, B. Vargas 2, M. Varela 1,
J. Ruiz Galiana 1
1
Móstoles, 2 Villaviciosa de Odón, SPAIN
/ 17 DONOR AGE, WARM ISCHEMIA TIME AND IMMUNOSUPPRESSIVE DRUGS DIFFERENTLY
AFFECT ARTERIAL STIFFNESS IN RENAL TRANSPLANTATION
P. D’Halluin, S. Bertin, P. Gatault, C. Barbet, H. Longuet, J. Marliere, E. Merieau, B. Sautenet, C. Baron,
M. Buchler, J.-M. Halimi
Tours, FRANCE
/ 18 THE NEED FOR MULTIPLE ANTIHYPERTENSIVE DRUGS PREDICTS DEATH AND DIALYSIS
INDEPENDENTLY OF BLOOD PRESSURE
J.-M. Halimi, P. Gatault, C. Barbet, H. Longuet, E. Merieau, J.F. Marliere, B. Sautenet, C. Baron, M. Buchler
Tours, FRANCE
/ 19 VITAMIN D AND CALCIFEDIOL IN HEMODIALYSIS
M. Torres Sánchez, E. Avila Barranco
Granada, SPAIN
/ 20 DETECTION OF HYPERTENSION SILENT RENAL DAMAGE BY GENERAL PRACTITIONERS IN TIMIS
COUNTY (ROMANIA)
E. Ardeleanu 1, M. Dorobantu 2, D. Lighezan 1, R. Lighezan 1, R. Darabont 2, D. Gurgus 1, A. Deleanu 1, I. Tilea 3,
S. Baaj 1, T. Baaj 1
1
Timisoara, 2 Bucharest, 3 Targu-Mures, ROMANIA
/ 21 CORRELATION BETWEEN RENAL INVOLVEMENT AND CIRCADIAN PROFILE IN ESSENTIAL
HYPERTENSION
A. Caraba, I. Mozos, D. Nicoara, I. Romosan
Timisoara, ROMANIA
/ 22 ASSOCIATION OF LEFT VENTRICULAR HYPERTROPHY, FIBROSIS WITH BIOCHEMICAL
MARKERS IN PATIENTS IN INITIAL STAGES OF CHRONIC KIDNEY DISEASE
O. Garcia Garcia, M. Ávila, S. Olmos, S. Martinez, F. J. Avelar, G. Melendez, A. Mehave
Mexico City, MEXICO
/ 23 INCREASED SERUM LEVELS OF CREATININE PREDISPOSE OCTOGENARIANS TO
HYPERTENSION AND ATHEROSCLEROSIS
G. Dimas, G. Konstantinidis, T. Tegos, I. Karamouzis, K. Pavlopoulos, N. Tsiaras, M. Larissi, N. Pirou,
C. Savopoulos, A. Hatzitolios
Thessaloniki, GREECE
F I N A L P R OG R A M M E
197
/ 24 CKD-EPI EQUATIONS ESTIMATED GLOMERULAR FILTRATION RATE (GFR): COMPARISON WITH
OTHER CYSTATIN C DERIVED EQUATIONS
N. Robles Perez-Monteoliva 1, C. Mena 2, A. Cidoncha 2, J. Lopez-Gomez 1, B. Gonzalez Candia 1, M.A. Bayo 1,
R. Hernandez Gallego 1
1
Badajoz, 2 Don Benito, SPAIN
/ 25 CHRONIC KIDNEY DISEASE AND PARATHYROID HORMONE DYSFUNCTION
O. Kharoubi, A. Benglia, A. Aoues
Oran, ALGERIA
/ 26 EFFECT OF BLOOD PRESSURE CONTROL AND THERAPY ON RENAL FUNCTION AND CLINICAL
OUTCOMES IN PATIENTS WITH CHRONIC KIDNEY DISEASE ACCORDING TO THEIR AGE
M. Marcucci, S. Vettoretti, L. Caldiroli, R. Meazza, V. Azzini
Milan, ITALY
/ 27 EPIDEMIOLOGICAL PROFILE AND PROGNOSIS OF HYPERTENSION IN PRIMITIVE CHRONIC
GLOMERULONEPHRITIS
A. Zammouri, S. Barbouch, N. Baili, T. Mosbehi, I. Gorsane, A. Harzallah, F. Ben Hamida, T. Ben Abdallah
Tunis, TUNISIA
/ 28 THE LEFT VENTRICLE DIASTOLIC FUNCTION PROFILE IN PATIENTS WITH ARTERIAL
HYPERTENSION AND MILDLY REDUCED KIDNEY FUNCTION
O. Torbas, Y. Sirenko, G. Radchenko, O. Rekovets, S. Kushnir, V. Granich, A. Dobrokhod
Kiev, UKRAINE
Posters’ Session PS23
RESISTANT HYPERTENSION
Chairperson: R. Veelken (Erlangen, GERMANY)
ROOM
POSTERS FROM 1 TO 27
/ 1 EFFECT OF UNILATERAL FIELD STIMULATION OF CAROTID BARORECEPTORS ON
HEMODYNAMIC PROPERTIES IN RATS ON HIGH SALT DIET
Z. Kouchaki 1, A.P. Avolio 1, I.B. Wilkinson 2, M. Butlin 1
1
Sydney, AUSTRALIA, 2 Cambridge, UNITED KINGDOM
/ 2 RESISTANT HYPERTENSION AND RENAL RESISTIVE INDEX
N. Tandurella, L. Tavecchia, M. Agostinis, C. Mongiardi, C. Gadaleta, S. Moretti, L. Robustelli Test, A. Grossi,
V. Pierobon, A.M. Maresca, L. Guasti, A.M. Grandi
Varese, ITALY
/ 3 SCREENING OF PATIENTS WITH AN APPARENTLY RESISTANT HYPERTENSION IN AN ALGERIAN
TEACHING HOSPITAL
B. Kichou, N. Henine, L. Kichou, M. Benbouabdellah, A. Mazeghrane, B. Saheb, A. Hamouche
Tizi-Ouzou, ALGERIA
/ 4 ADIPOKINES LEVELS AND SYMPATHETIC ACTIVITY AFTER RENAL DENERVATION: RELATION TO
VASCULAR REACTIVITY AND STIFFNESS
I. Iudina, M.V. Ionov, N.K. Merkulova, N.G. Avdonina, D.A. Zverev, S.A. Mironova, I.V. Emelyanov, N.E. Zvartau,
A.O. Konradi
Saint-Petersburg, RUSSIA
/ 5 CENTRAL BLOOD PRESSURE AND ARTERIAL WAVE REFLECTION IN RESISTANT HYPERTENSION
O. Siga, A. Dzieza-Grudnik, J. Walczewska, T. Grodzicki
Kraków, POLAND
/ 6 EFFECTS OF CAROTID BARORECEPTOR STIMULATION ON RETINAL ARTERIOLE REMODELING
EVALUATED WITH ADAPTIVE OPTIC CAMERA IN RESISTANT HYPERTENSIVE PATIENTS
A. Gallo, D. Rosenbaum, C. Kanaga, X. Girerd
Paris, FRANCE
198
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 7 PREDICTORS OF BLOOD PRESSURE RESPONSE IN THE NON-INVASIVE RENAL DENERVATION
STUDY USING EXTERNALLY DELIVERED FOCUSED ULTRASOUND IN SEVERE RESISTANT HYPERTENSION
C. Ott 1, O. Dawood 2, Z. Starek 3, P. Kay 4, T. Anderson 2, M. Gertner 2, J. Ormiston 4, P. Neuzil 5, R.E. Schmieder 1
1
Erlangen, GERMANY, 2 Redmond, WA, USA, 3 Brno, CZECH REPUBLIC, 4 Auckland, NEW ZEALAND,
5
Prague, CZECH REPUBLIC
/ 8 ACUTE SILDENAFIL USE LOWER 24H BLOOD PRESSURE LEVELS IN RESISTANT HYPERTENSION:
A RANDOMIZED, PLACEBO CONTROLLED, CROSS-OVER TRIAL
A. Santa Catharina, R. Modolo, A. Ritter, A. Sabbatini, V. Brunelli, N. Correa, T. Quinaglia, H. Moreno,
A. De Faria
Campinas, BRAZIL
/ 9 PREVALENCE OF RESISTANT HYPERTENSION IN THE ELDERLY HYPERTENSIVE SUBJECTS:
THE RESULTS OF THE POPULATION-BASED STUDY ‘POLSENIOR’
B. Wizner 1, O. Siga 1, T. Zdrojewski 2, A. Wiecek 3, J. Chudek 3, M. Mossakowska 4, J. Walczewska 1,
P. Slusarczyk 4, P. Bandosz 2, T. Grodzicki 1
1
Kraków, 2 Gdansk, 3 Katowice, 4 Warsaw, POLAND
/ 10 A RATIONAL ANESTHESIA CARE PROGRAMME FOR ENDOVASCULAR RENAL DENERVATION IN
PATIENTS WITH RESISTANT HYPERTENSION
O. Kemenshchikov, A. Baev, S. Pekarskiy
Tomsk, RUSSIA
/ 11 HYPOTENSIVE EFFICACY AND SAFETY OF EPLERENONE IN PATIENTS WITH RESISTANT
ARTERIAL HYPERTENSION
D. Lipski, K. Kostka-Jeziorny, P. Uruski, L. Stryczynski, L. Szczepaniak-Chichel, A. Radziemski, A. Tykarski
Poznan, POLAND
/ 12 CLINICAL IMPACT OF ANGIOTENSIN CONVERTING ENZYME (ACE) POLYMORPHISM ON
DEVELOPMENT OF CARDIOVASCULAR AND METABOLIC COMPLICATIONS IN SUBJECTS WITH RESISTANT
HYPERTENSION
S. Quartuccio 1,G.Mandraffino1, R. Di Stefano 2, G. Trapani 1, F. Felice 1, G. Lizio 1, A. Saitta 1, E. Imbalzano 1
1
Messina, 2 Pisa, ITALY
/ 13 MATRIX METALLOPROTEINASE 2 GENE POLYMORPHISM ASSOCIATES WITH RESISTANT
HYPERTENSION
A. Sabbatini, A. De Faria, N. Ruggeri, R. Modolo, A. Ritter, N. Batista, V. Brunelli, V. Fontana, H. Moreno Jr.
Campinas, BRAZIL
/ 14 EVALUATION OF ABPM DERIVED INDICES IN PATIENTS WITH RESISTANT HYPERTENSION
K. Mako, Z.S. Jeremias, C. Ureche
Targu Mures, ROMANIA
/ 15 OUT-OF-OFFICE BLOOD PRESSURE MEASUREMENT IN PATIENTS WITH RESISTANT
HYPERTENSION IN EVERYDAY CLINICAL PRACTICE: STILL A LONG JOURNEY TO GO
K. Stavropoulos, K. Imprialos, C. Boutari, N. Papadopoulos, A. Dimakopoulou, E. Georgianou, A. Binas,
A. Sachinidis, N. Stavropoulos, K. Petidis, M. Doumas
Thessaloniki, GREECE
/ 16 ANALYSIS OF ELIGIBILITY CRITERIA FOR RENAL SYMPATHETIC DENERVATION
C. Fulcheri, F. Rabbia, E. Testa, E. Berra, S. Di Monaco, M. Covella, M. Pappaccogli, E. Perlo, F. Veglio
Turin, ITALY
/ 17 CONTROL OF BLOOD PRESSURE AND DIASTOLIC FUNCTION OF LEFT AND RIGHT VENTRICLE IN
HYPERTENSIVE PATIENTS
A. Dzieza-Grudnik, O. Siga, J. Walczewska, J. Krolczyk, K. Rewiuk, T. Grodzicki
Kraków, POLAND
/ 18 RELATIONSHIP BETWEEN PATIENT CHARACTERISTICS, RISK FACTORS, FREQUENCY OF
PRIMARY ALDOSTERONISM AND THE NUMBER OF ANTIHYPERTENSIVE DRUGS IN PATIENTS WITH TRUE
RESISTANT HYPERTENSION
E. Warchol-Celinska 1, E. Florczak 1, A. Prejbisz 1, P. Dobrowolski 1, E. Szwench-Pietrasz 1, A. Klisiewicz 1,
M. Kabat 1, K. Narkiewicz 2, A. Januszewicz 1
1
Warsaw, 2 Gdansk, POLAND
F I N A L P R OG R A M M E
199
/ 19 TIME INTEGRATED SYMPATHETIC ACTIVITY CHANGES PARALLEL SIMULTANEOUS BP CHANGES
AFTER RENAL DENERVATION
G.L. Seravalle 1, G. Brambilla 1, R. Dell’Oro 1, F. Quarti Trevano 1, G. D’Arrigo 2, F. Mallamaci 2, G. Tripepi 2,
C. Zoccali 2, G. Grassi 1
1
Milan, 2 Reggio Calabria, ITALY
/ 20 THE PREVALENCE OF ANXIETY AND DEPRESSION IN PATIENTS WITH RESISTANT
HYPERTENSION
V. Pyankov
Kirov, RUSSIA
/ 21 PREDICTORS OF LONG TERM SUCCESS IN RENAL DENERVATION
G. Fischer, S. Eckert
Bad Oeynhausen, GERMANY
/ 22 ASSOCIATED FACTORS OF NOT ACHIEVING BLOOD PRESSURE GOALS IN TUNISIAN RESISTANT
HYPERTENSION POPULATION: REAL WORLD PRACTICE
H. Denguir, I. Yakdhane, C. Zrigue
Gabes, TUNISIA
/ 23 PRE-OPERATORY TREATMENT STRATEGY IN PATIENTS WITH PHEOCHROMOCYTOMA
T. Sepúlveda Santos, I.M. Nunes, C. Melo Alvim, L. Carvalho
Lisbon, PORTUGAL
/ 24 METABOLIC INDICATORS OF CARDIOVASCULAR DISEASES IN RESISTANT HYPERTENSION
J. Walczewska, O. Siga, A. Dzieza-Grudnik, T. Grodzicki
Kraków, POLAND
/ 25 PREVALENCE AND SEVERITY OF ERECTILE DYSFUNCTION IN PATIENTS WITH RESISTANT
HYPERTENSION
C. Boutari 1, K. Imprialos 1, K. Stavropoulos 1, P. Kokkinos 2, A. Pittaras 2, C. Faselis 2, K. Petidis 1, P. Deligkaris 1,
N. Stavropoulos 1, V. Athyros 1, A. Karagiannis 1, M. Doumas 1
1
Thessaloniki, GREECE, 2 Washington DC, USA
/ 26 THE HYPONATREMIC HYPERTENSIVE SYNDROME: WHEN SHOULD WE THINK ABOUT IT?
R. Siliste, C. Homentcovschi, R. Ianula, D. Vasiliu, D. Spataru
Bucharest, ROMANIA
/ 27 CORRELATION CENTRAL BLOOD PRESSURE RESPONSE WITH CREATININE, EGFR AND HEART
RATE AFTER RENAL DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION IN UKRAINE
O. Rekovets, Y. Sirenko, A. Dobrokhod, O. Torbas, S. Kushnir, G. Primak, A. Vaschylko, P. Sidorenko,
S. Polishchuk, V. Granich
Kiev, UKRAINE
Posters’ Session PS24
PREGNANCY
Chairperson: V. Kotsis (Thessaloniki, GREECE)
ROOM
POSTERS FROM 1 TO 19
/ 1 SERIAL AMBULATORY BLOOD PRESSURE MONITORING, INTENSITY OF ANTIHYPERTENSIVE
DRUG TREATMENT, AND PREGNANCY OUTCOMES IN WOMEN WITH HYPERTENSION FOUND EARLY
DURING PREGNANCY
P. Gryglas, P. Jedrusik, E. Wojciechowska, A. Gryglas, M. Dabrowski, B. Symonides, Z. Gaciong
Warsaw, POLAND
/ 2 THE SFLT-1/PLGF RATIO ASSOCIATES WITH PROLONGATION OF PREGNANCY
L. Saleh, K. Verdonk, A.H.J. Danser, E.A.P. Steegers, H. Russcher, A.H. van den Meiracker, W. Visser
Rotterdam, NETHERLANDS
200
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 3 EFFECT OF NEBIVOLOL TO PROTECT INCIDENCE OF ECLAMPSIA AND PREECLAMPSIA DURING
PREGNANCY IN WOMEN AFTER INVITRO FERTILIZATION
K. Hristova, R. Marinov, G. Stamenov, K. Chacheva, M. Michova, A. Racheva, S. Tsonev, M. Chukanova
Sofia, BULGARIA
/ 4 AMBULATORY BLOOD PRESSURE MONITORING TO STRATIFY THE POSTPARTUM
CARDIOVASCULAR RISK AFTER A PREECLAMPSIA: A PROSPECTIVE CONTROLLED STUDY
A. Ditisheim 1, B. Ponte 1, G. Wuerzner 2, M. Burnier 2, Y. Vial 2, M. Boulvain 1, A. Pechère-Bertschi 1
1
Geneva, 2 Lausanne, SWITZERLAND
/ 5 THE IMPACT OF GESTATIONAL DIABETES IN PREGNANT HYPERTENSIVE WOMEN
S. Vidal 1, A. Cadete 2, A. Correia 1, C. Rainho 1, R. Ferreira 1, C. Palmeira 1, M. Bastos 1
1
Aveiro, 2 Águeda, PORTUGAL
/ 6 GESTATIONAL DIABETES AND DEVELOPMENT OF HYPERTENSION: A STUDY USING
AMBULATORY BLOOD PRESSURE MONITORING
N. Tandurella, L. Tavecchia, M. Agostinis, C. Mongiardi, L. Robustelli Test, S. Moretti, C. Gadaleta, A. Grossi,
V. Pierobon, A.M. Maresca, L. Guasti, A.M. Grandi
Varese, ITALY
/ 7 L-ARGININE IN PREECLAMPSIA PREVENTION
E. Camren Pulido, L. Garcia Benavides, J. Panduro Baron, S. Pascoe Gonzalez, C. Ramos Becerra,
S. Totsuka Sutto, E. Cardona Muñoz
Guadalajara, MEXICO
/ 8 MID-TRIMESTER RISK PREDICTION OF SUPERIMPOSED PRE-ECLAMPSIA IN PREGNANT
WOMEN WITH CHRONIC HYPERTENSION
S. Kim, J.B. Park
Seoul, SOUTH KOREA
/ 9 LATENT ARTERIAL HYPERTENSION AT PREGNANT WOMEN: ASPECTS OF DIAGNOSIS
M. Evsevyeva, O. Sergeeva, E. Markova, K. Pavlov, I. Prohorenko-Kolomoytseva
Stavropol, RUSSIA
/ 10 ABPM AS A PREDICTOR OF EVENT IN PREGNANCY: VALUE OF THE PATTERN OF NIGHT DROP
OF BLOOD PRESSURE AND THE VALUES OF THE DIASTOLIC ARTERIAL PRESSURE
A. Correia, S. Vidal, A. Cadete, R. Ferreira, C. Rainho, F. Leitão, A. Gonzaga, J. Mesquita Bastos
Aveiro, PORTUGAL
/ 11 THE D1 (C/T) - D2 (THR22ALA) - MTHFR (C677T) GENETIC MODEL ASSOCIATED WITH
HYPOTHYROIDISM AS A RISK FACTOR FOR INCREASED MATERNAL-FETAL MORBIDITY IN
PREECLAMPSIA
L. Procopciuc, G. Caracostea, G. Nemeti, F. Stamatian
Cluj-Napoca, ROMANIA
/ 12 INTERVAL BETWEEN BLOOD PRESSURE MEASUREMENTS IN PREGNANT WOMEN WITH HIGH
BLOOD PRESSURE
D. Escouto, M.R. Vieira, B. Pinheiro da Costa, C.E. Poli-de-Figueiredo
Porto Alegre, BRAZIL
/ 13 ECLAMPSIA VERSUS PREECLAMPSIA: INCREASED PROTEINURIA AND URIC ACID LEVELS ARE
ASSOCIATED WITH ECLAMPTIC CRISIS
D. Escouto, L.G. Paula, B. Pinheiro da Costa, C.E. Poli-de-Figueiredo
Porto Alegre, BRAZIL
/ 14 HYPERTENSION IN PREGNANCY: FETAL OUTCOME. A SINGLE-CENTER 4-YEAR RETROSPECTIVE
STUDY
V. Pokorna, T. Pazmanova, J. Kaluzay, D. Skultetyova, Z. Minarikova, P. Pontuch
Bratislava, SLOVAK REPUBLIC
/ 15 PREDICTIVE VALUE OF ANEMIA AND HYPOCHROMIA FOR LOW BIRTH WEIGHT, GESTATIONAL
AGE AND POOR APGAR SCORE IN PREGNANCY INDUCED HYPERTENSION
I. Mozos, R. Nitu, Z. Popa, M. Craina
Timisoara, ROMANIA
F I N A L P R OG R A M M E
201
/ 16 SYSTEMATIC REVIEW OF MICRO-RNA EXPRESSION IN PRE-ECLAMPSIA IDENTIFIES A NUMBER
OF COMMON PATHWAYS ASSOCIATED WITH THE DISEASE
A. Sheikh, H. Small, C. Delles
Glasgow, UNITED KINGDOM
/ 17 CORRELATION BETWEEN PULSE WAVE VELOCITY AND HEART RATE VARIABILITY IN PREGNANT
WOMEN WITH PREECLAMPSIA
K. Hristova, R. Marinov, S. Tsonev
Sofia, BULGARIA
/ 18 HYPERTENSIVE DISORDERS OF PREGNANCY PREVALENCE AND RISK FACTORS
J. Lopez-Rivera, M. Cedeño, J. Leon, G. Lamprea, M. Perez, M. Roa, J. Araque
San Cristobal, VENEZUELA
/ 19 HYPERTENSIVE PREGNANT: RELATIONSHIP BETWEEN DRUG THERAPY AND TENSION
CONTROL
A. Cadete 1, S. Vidal 2, A. Correia 2, C. Rainho 2, R. Ferreira 2, L. Sutil 1, M. Bastos 2
1
Águeda, 2 Aveiro, PORTUGAL
Posters’ Session PS25
ENDOCRINE HYPERTENSION
Chairperson: L. Amar (Paris, FRANCE)
ROOM
POSTERS FROM 1 TO 24
/ 1 NEFM IS A ZONA GLOMERULOSA SELECTIVE GENE INVOLVED IN REGULATING ALDOSTERONE
SECRETION RESPONSE TO DOPAMINE
C. Maniero, J. Zhou, E. Azizan, S. Neogi, G. Yeo, W. Zhao, M.J. Brown
Cambridge, UNITED KINGDOM
/ 2 A NOVEL TREATMENT FOR BILATERAL HYPERPLASIA AS A CAUSE OF PRIMARY
ALDOSTERONISM
M. Abad-Cardiel, J.A. García Donaire, B. Álvarez Álvarez, N. Martell-Claros
Madrid, SPAIN
/ 3 CUSHING SYNDROME ASSOCIATED ARTERIAL DISSECTIONS: A CASE SERIES OF FOUR
PATIENTS
M. Barigou, C. Corticchiato, G. Bobrie, C. Grataloup, S. Baron, M. Azizi, L. Amar
Paris, FRANCE
/ 4 UROTENSIN II EXERTS PRESSOR EFFECTS BY STIMULATING RENIN AND ALDOSTERONE
SECRETION
B. Caroccia, M. Menegolo, T.M. Seccia, F. Gioco, A. Limena, A. Porzionato, G.P. Rossi
Padua, ITALY
/ 5 COMPARISON OF FREE METANEPHRINE WITH TWO CORTISOL CUTOFFS TO ASSESS ADRENAL
VEIN SELECTIVITY DURING ADRENAL VEIN SAMPLING
E. Pivin, F. Christou, M. Maillard, F. Doenz, M. Burnier, E. Grouzmann, G. Wuerzner
Lausanne, SWITZERLAND
/ 6 ANGIOTENSIN-(1-7) PEPTIDE AND MAS RECEPTOR AND ANGIOTENSIN II- TYPE 2 RECEPTOR
ARE INVOLVED IN ALDOSTERONE AND CORTISOL PRODUCTION IN HUMAN ADRENOCORTICAL CELL
LINE (NCI-H295)
P. Vanderriele, B. Caroccia, L. Lenzini, F. Gioco, A. Fassina, T.M. Seccia, G.P. Rossi
Padua, ITALY
202
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 7 EVOLUTION OF COMPUTED TOMOGRAPHY-DETECTABLE ADRENAL NODULES IN PATIENTS
WITH BILATERAL PRIMARY ALDOSTERONISM
P. Mulatero 1, J. Burrello 1, B. Lucatello 1, S. Monticone 1, G. Giacchetti 2, V. Ronconi 2, M. Battocchio 3, F. Fallo 3
1
Turin, 2 Ancona, 3 Padua, ITALY
/ 8 IS ARTERIAL STIFFNESS EVALUATED BY PULSE WAVE VELOCITY PREDICTIVE OF THE
IMPROVEMENT OF HYPERTENSION AFTER ADRENAL SURGERY FOR PRIMARY ALDOSTERONISM?
B. Bouhanick 1, J. Amar 1, L. Amar 2, P. Gosse 3, X. Girerd 2, Y. Reznik 4, C. Mounier-Vehier 5, J.-P. Baguet 6,
P. Boutouyrie 2, B. Lepage 1, P. Lantelme 7, B. Chamontin 1,
1
Toulouse, 2 Paris, 3 Bordeaux, 4 Caen, 5 Lille, 6 Grenoble,7 Lyon, FRANCE
/ 9 POSSIBLE ROLE OF CYTOCHROME P-450 EICOSANOIDS IN HEMODYNAMIC MODULATION IN
A GROUP OF OBESE CHILDREN
S.Bonafini1, A. Tagetti 1, F. Dalle Vedove 1, M.V. Benetti 1, W.H. Schunck 2, M. Rothe 2, F. Antoniazzi 1, C. Maffeis 1,
P. Minuz 1, C. Fava 1
1
Verona, ITALY, 2 Berlin, GERMANY
/ 10 BODY MASS INDEX AND CONTRALATERAL RATIO PREDICT BLOOD PRESSURE OUTCOME
FOLLOWING UNILATERAL ADRENALECTOMY IN PRIMARY ALDOSTERONISM
K. Bokuda, A. Ichihara, M. Yatabe, J. Yatabe, T. Ando, S. Morimoto
Tokyo, JAPAN
/ 11 THE SIGNIFICANCE OF ADIPONECTIN AS A MARKER OF PREHYPERTENSION AND
HYPERTENSION IN PATIENTS WITH METABOLIC SYNDROME
M. Deljanin Ilic, S. Stojanovic
Niš, SERBIA
/ 12 GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM (GRA): A MODEL OF DISCREPANCY
BETWEEN GENOTYPE AND CLINICAL PHENOTYPE
F. Medici, O. Jassim
London, UNITED KINGDOM
/ 13 AMBULATORY BLOOD PRESSURE MONITORING-DERIVED SHORT-TERM BLOOD PRESSURE
VARIABILITY IN PRIMARY HYPERPARATHYROIDISM
A. Concistrè 1, A. Grillo 2, R. Carretta 2, B. Fabris 2, L. Petramala 1, C. Marinelli 1, A. Rebellato 3, F. Fallo 3,
C. Letizia 1
1
Rome, 2 Trieste, 3 Padua, ITALY
/ 14 PRIMARY ALDOSTERONISM AND LEFT VENTRICLE IN 2D ECHOCARDIOGRAPHY: NEW
INSIGHTS
R. Boulestreau, A. Cremer, P. Gaillard, Y. Papaioannou, M. Laine, P. Gosse
Bordeaux, FRANCE
/ 15 RECURRENCE OR NEW TUMOURS AFTER COMPLETE RESECTION OF PHAEOCHROMOCYTOMAS
AND PARAGANGLIOMAS: A SYSTEMATIC REVIEW AND META-ANALYSIS
L. Amar 1, C. Lussey 1, J.W.M. Lenders 2, J. Djadi Pratt 1, P.-F. Plouin 1, O. Steichen 1
1
Paris, FRANCE, 2 Nijmegen, NETHERLANDS
/ 16 THYROID ABNORMALITIES IN PRIMARY ALDOSTERONISM
J. Matrozova, E. Natchev, G. Gantchev, R. Kovatcheva, S. Zacharieva
Sofia, BULGARIA
/ 17 BLOOD PRESSURE IN RECURRENT PHEOCHROMOCYTOMA
G. Potapova, I.E. Chazova, L. Lyutikova, N. Kuznetsov, E. Popov
Moscow, RUSSIA
/ 18 FREQUENCY OF PRIMARY ALDOSTERONISM IN PATIENTS WITH OBSTRUCTIVE SLEEP APNOEA:
OSA-PA STUDY
A. Prejbisz 1, M.K. Karcz 1, J. Obarska 1, E. Warchol-Celinska 1, S. Kolodziejczyk-Kruk 1, B. Pregowska-Chwala 1,
J. Janas 1, H. Janaszek-Sitkowska 1, M. Kabat 1, U. Ambroziak 1, T. Bednarczuk 1, K. Mitkowska 1, B. Bober 1,
P. Sliwinski 1, J.W. Lenders 2,3, A. Januszewicz 1
1
Warsaw, POLAND, 2 Nijmegen, NETHERLANDS, 3 Dresden, GERMANY
F I N A L P R OG R A M M E
203
/ 19 THE AA2-RATIO: IMPROVED SCREENING FOR PRIMARY ALDOSTERONISM IN HYPERTENSION
M. Poglitsch
Vienna, AUSTRIA
/ 20 CHANGES IN BLOOD PRESSURE AND ECHOCARDIOGRAPHIC PARAMETERS BEFORE AND
AFTER 6-MONTHS THERAPY IN PATIENTS WITH GRAVE’S DISEASE
K. Arodites, M. Pikilidou, E. Vourvouri, L. Hadjistavri, P. Zebekakis, E. Papakonstantinou, J. Yovos,
G.K. Efthymiadis, H. Karvounis
Thessaloniki, GREECE
/ 21 WOMEN WITH HYPOTHYROIDISM OF THE HYPERTENSION
A. Logvinenko, E. Kupchynskaya, N. Tsyrulneva, O. Gulkevych, V. Bezrodnyi, V. Radchenko, M. Mospan,
E. Dovhan
Kiev, UKRAINE
/ 22 TREATMENTS OF HYPERTENSION DUE TO PRIMARY HYPERALDOSTERNISM: EFFICACY,
EFFICIENCE AND ADVERSE EFFECTS
C. Dreyfuss Tubiana, B. Mion, S. Kretz, A. Yannoutsos, H. Lelong, S. Bitton, C. Touboul, J. Blacher
Paris, FRANCE
/ 23 RARE CASE OF PHEOCHROMOCYTOMA ASSOCIATED WITH BENIGN THYROID NODULE
A. Nitulescu, R. Ianula, S. Gheghici, C. Homentcovschi, R. Siliste, V. Chioncel
Bucharest, ROMANIA
/ 24 STRIKING EFFICACY OF TRANSCUTANEOUS ELECTRICAL NERVE STIMULATIONS IN PERIPHERAL
POLYNEUROPATHIES IN DIABETES MELLITUS II-I,CKD IV-V AND PRIMARY HYPERTENSION
I. Gokçay 1, Y. Sagliker 2, E. Kozanoglu 2, B. Kelle 2, N. Paylar 1, P. Sagliker Ozkaynak 1, H.S. Sagliker 3
1
Eregli, 2 Adana, 3 Cumra, TURKEY
Posters’ Session PS26
THERAPEUTICS AND CLINICAL TRIALS
Chairperson: G. Pichler (Valencia, SPAIN)
ROOM
POSTERS FROM 1 TO 25
/ 1 SYSTOLIC BLOOD PRESSURE-LOWERING EFFICACY AND TOLERABILITY OF INDAPAMIDE SR/
AMLODIPINE VS VALSARTAN/AMLODIPINE IN HYPERTENSIVE PATIENTS
A.F. Dominiczak 1, R. Asmar 2
1
Glasgow, UNITED KINGDOM, 2 Paris, FRANCE
/ 2 FREE VERSUS FIXED COMBINATION ANTIHYPERTENSIVE THERAPY FOR ESSENTIAL ARTERIAL
HYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS
S. Mallat, B. Tanios,H.Itani,T.Loutfi,E.Akl
Beirut, LEBANON
/ 3 ANTIHYPERTENSIVE EFFICACY OF INDAPAMIDE SR/AMLODIPINE IN HYPERTENSIVE PATIENTS
AGED 65 YEARS AND ABOVE: A SUBANALYSIS OF THE 1-YEAR NESTOR STUDY
O. Hanon
Paris, FRANCE
/ 4 A RANDOMIZED CLINICAL STUDY TO EVALUATE THE EFFICACY OF EXTRACTUM OF ASTRAGALUS
MONGHOLICUS ON MICROALBUMINURIA IN PATIENTS OF HYPERTENSION WITH METABOLIC
SYNDROME
J. Yu, L. Li, Y. Li, Q. Wang, F. Zhao, X. Zhang
Lanzhou, CHINA
/ 5 THE STATUS OF VASOREACTIVITY AND CYTOKINES LEVELS OF PATIENTS WITH IDIOPATHIC
PULMONARY ARTERIAL HYPERTENSION
V. Paramonov, T. Martynyuk, V. Masenko, I.E. Chazova
Moscow, RUSSIA
204
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 6 BLOOD PRESSURE LOWERING IN INTERMEDIATE RISK PEOPLE WITHOUT VASCULAR DISEASE
P. L pez-Jaramillo 1, S. Yusuf 2, E. Lonn 2, J. Bosch 2
1
Bucaramanga, COLOMBIA, 2 Hamilton, CANADA, on behalf of the HOPE 3 Investigators
/ 7 DO DRUGS INTERACT TOGETHER IN CARDIOVASCULAR PREVENTION? A META-ANALYSIS OF
POWERFUL OF FACTORIAL RANDOMIZE CONTROLLED TRIALS
M. Fall 1, H. Le 1, M. Al-Gobari 3, G. Grenet 1, M. Cucherat 1, A. Dieye 2, F.Gueyffier1
1
Lyon, FRANCE, 2 Dakar, SENEGAL, 3 Lausanne, SWITZERLAND
/ 8 IMPACT OF VALSARTAN AND COMBINATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE
ON ERECTILE DYSFUNCTION IN PATIENTS WITH MILD TO MODERATE HYPERTENSION
B. Salobir 1, J. Brguljan-Hitij 1, P. Dolenc 1, I.E. Chazova 2, Y. Sirenko 3, J. Vincelj 4, J. Widimský 5,
B. Barbic-Zagar 6, R. Accetto 1
1
Ljubljana, SLOVENIA, 2 Moscow, RUSSIA, 3 Kiev, UKRAINE, 4 Zagreb, CROATIA, 5 Prague, CZECH REPUBLIC,
6
Novo Mesto, SLOVENIA
/ 9 THE ENDOTHELIAL FUNCTION AND ARTERIAL STIFFNESS DYNAMICS UNDER THE EFFECT OF
ROSUVASTATIN ADDED TO A STANDARD ANTIHYPERTENSIVE THERAPY
K. Protasov 1, O. Fedorishina 1, A. Torunova 1, T. Ignatieva 1, I. Denisova 2
1
Irkutsk, 2 Angarsk, RUSSIA
/ 10 QUALITY OF CLINICAL PRACTICE GUIDELINES FOR THE MANAGEMENT OF HYPERTENSION:
A SYSTEMATIC ANALYSIS USING THE AGREE II INSTRUMENT
X. Zhang, L. Zhang, R. Ma, J. Yu
Lanzhou, CHINA
/ 11 TYPOLOGY OF THE TRIPLE ANTIHYPERTENSIVE THERAPIES PRESCRIBED IN FRANCE.
THE TRIANON SURVEY
J.-J. Mourad 1, P. Clerson 2, L. Vigie 3
1
Bobigny, 2 Roubaix, 3 Rueil, FRANCE
/ 12 RENAL DENERVATION USING THE ENLIGHTN RENAL DENERVATION SYSTEM IN ALTERNATIVE
HYPERTENSIVE POPULATIONS: 24 MONTH RESULTS FROM THE ENLIGHTN II STUDY
M. Lobo 1, J. Montarello 2, M. Saxena 1, A.K. Jain 1, D. Walters 3, M. Pincus 3, S.G. Worthley 2
1
London, UNITED KINGDOM, 2 Adelaide, 3 Brisbane, AUSTRALIA
/ 13 EFFICACY OF NIFEDIPINE GASTROINTESTINAL SYSTEM ON ARTERIAL STIFFNESS AND
STRUCTURAL VASCULAR LESIONS IN MILD HYPERTENSIVE CHINESE PATIENTS WITH INCREASED PULSE
WAVE VELOCITY
J. Zhang, Y. Wang, H. Hu, Z. Tian, D. Liu, G. Gu, H. Zheng, Q. Wang, R. Xie, X. Yang, G. Zhang, W. Cui
Shijiazhuang, CHINA
/ 14 EFFICACY OF A FIXED-DOSE ASSOCIATION OF AMLODIPINE AND LISINOPRIL IN GRADE II AND
III HYPERTENSIVE PATIENTS: AN OBSERVATIONAL STUDY
J. Maldonado, T. Pereira
Coimbra, PORTUGAL
/ 15 ACE INHIBITORS AND ARBS COMBINATION THERAPY: SAFE USE AND GOOD CONTROL OF
HYPERTENSION: OUR STUDY
N. Nenadic, T. Stojanovic, O. Zlatkovic, S. Kulovic, L.J. Kolarski Nenadic, P. Pantic
Belgrade, SERBIA
/ 16 EFFECTIVENESS OF PERINDOPRIL/AMLODIPINE FIXED DOSE COMBINATION IN
HYPERTENSIVE PATIENTS WITH CORONARY ARTERY DISEASE. A PANHELLENIC PROSPECTIVE
NON-INTERVENTIONAL STUDY
V. Kotsis 1, V. Grammatikou 2, E. Kallistratos 2, D. Papadopoulos 2
1
Thessaloniki, 2 Athens, GREECE
/ 17 COMPARISON OF A NEW FIRST-LINE STRATEGY WITH SPECIALLY ADAPTED DOSAGES OF
PERINDOPRIL AND AMLODIPINE WITH ARB MONOTHERAPY
G. Mancia
Milan, ITALY
F I N A L P R OG R A M M E
205
/ 18 INDIVIDUAL DATA META-ANALYSIS IN 5507 SUBJECTS OF PERINDOPRIL 3.5 MG/AMLODIPINE
2.5 MG IN COMPARISON WITH RAS BLOCKER-MONOTHERAPIES
S. Laurent 1, N.R. Poulter 2, G. Mancia 3
1
Paris, FRANCE, 2 London, UNITED KINGDOM, 3 Milan, ITALY
/ 19 EFFICACY OF AZELNIDIPINE ON CARDIO-RENAL PROTECT IN JAPANESE PATIENTS WITH EARLYSTAGE HYPERTENSION
Y. Tanaka, H. Takaishi
Osaka, JAPAN
/ 20 A NEW ENALAPRIL MODIFIED RELEASE FORMULATION SHOWS COMPARABLE
PHARMACODYNAMIC PROFILE TO THE REFERENCE DRUG IN HEALTHY SUBJECTS. PHASE I, PILOT STUDY
G. Ottaviano, M. Tumarkin, M. Otero-Losada, E. Roldán, F. Azzato, A. Müller, J. Milei
Buenos Aires, ARGENTINA
/ 21 EFFECT OF SUPPLEMENTAL INTAKE OF CHOLECALCIFEROL ON BLOOD PRESSURE IN
ANTIHYPERTENSIVE THERAPY
L. Yankouskaya, V. Snezhitskiy, S. Lyalikov
Grodno, BELARUS
/ 22 MONITORING OF EFFECTIVENESS OF RAMIPRIL-AMLODIPINE FIXED COMBINATION IN
METABOLIC SYNDROME, A NON-INTERVENTIONAL TRIAL (THE RAMSES STUDY)
G. Simonyi
Budapest, HUNGARY
/ 23 EFFECT OF LOSARTAN IN COMBINATION WITH AMLODIPINE OR HYDROCHLOROTHIAZIDE ON
MICROALBUMINURIA PREDICTS REGRESSION OF LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE
PATIENTS
O. Bilchenko, A. Bilchenko
Kharkiv, UKRAINE
/ 24 THE NEW COMBINATION TRIAL BY TRADITIONAL CHINESE MEDICINE OF TIANMA-GOUTENG
DECOCTION AND L-AMLODIPINE BESYLATE IN PATIENTS WITH ESSENTIAL HYPERTENSION
Y. Liu, L.F. Du, X. Liu, Y. Fan
Zigong, CHINA
/ 25 INTENSIVE BLOOD PRESSURE CONTROL IN METEOROLOGICALLY SENSITIVE PATIENTS WITH
HYPERTENSION
Z. Gasimov, F. Usubova, G. Nazarova, I. Hasanova, E. Hasanova, E. Abiyeva, S. Alesker-zade, M. Kocharli
Baku, AZERBAIJAN
Late-Breaker Posters
SESSION 2
Chairperson: J. Sharman (Hobart, AUSTRALIA)
ROOM
POSTERS FROM 1 TO 21
/ 1 DETERMINANTS OF DIFFERENT BLOOD PRESSURE VARIABILITY INDICES IN UNTREATED
HYPERTENSIVE PATIENTS. DATA FROM THE DUBLIN STUDY
X. Liu 1, A. Faini 1, G. Bilo 1, E. Dolan 2, E. O’Brien 2, G. Parati 1
1
Milan, ITALY, 2 Dublin, IRELAND
/ 2 COMPARISON OF A NEW FIRST-LINE TREATMENT IN HYPERTENSION VERSUS RAAS
INHIBITOR–BASED FIRST-LINE STRATEGIES USING 24-HOUR AMBULATORY BLOOD
PRESSURE MONITORING
G. Parati
MIlan, ITALY
206
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 3 IMPACT OF CUFF POSITIONING ON BLOOD PRESSURE MEASUREMENT ACCURACY. MAY A
SPECIALLY DESIGNED CUFF MAKE A DIFFERENCE?
G. Bilo 1, O. Sala 1, C. Perego 1, A. Faini 1, L. Gao 1,2, A. Gluszewska 1,3, J.E. Ochoa 1, D. Pellegrini 1, C. Zorzi 1,
A. Grillo 1, L.M. Lonati 1, G. Parati 1
1
Milan, ITALY, 2 Beijing, CHINA, 3 Kraków, POLAND
/ 4 PREVALENCE OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS IN CHINESE
MIGRATING TO MILAN AS COMPARED TO A NORTHERN ITALIAN POPULATION
M. Maisaidi 1, X. Liu 1, Y. Zhang 2, E. Makil 1, A. Faini 1, C. Torlasco 1, A. Villarini 1, R. Meazza 1, F. Lombardi 1,
G. Parati 1
1
Milan, ITALY, 2 Beijing, CHINA
/ 5 THE CORONARY BACKWARD-PROPAGATING ‘SUCTION’ WAVE ARISES FROM A COMBINATION
OF MICROCIRCULATORY DECOMPRESSION AND REFLECTION OF A FORWARD-PROPAGATING WAVE
ORIGINATING IN THE AORTA
J.P. Mynard, J.J. Smolich
Melbourne, AUSTRALIA
/ 6 AORTIC GEOMETRY AND IMPEDANCE MISMATCHING BETWEEN ASCENDING AND PROXIMAL
DESCENDING AORTA CORRELATE WITH BRACHIAL AND CENTRAL SYSTOLIC PRESSURE LATE AFTER
AORTIC COARCTATION REPAIR
J.P. Mynard, G.D. Cahoon, M.G.Y. Lee, R. Kowalski, J.J. Smolich, Y. d’Udekem , M.M.H. Cheung
Melbourne, AUSTRALIA
/ 7 SELF-CHECK OF SODIUM POTASSIUM RATIO IN SPOT URINE IMPROVES DIETARY HEALTH
IN ELEMENTARY SCHOOL CHILDREN
M. Mori, H. Mori, Y. Yamori
Nishinomiya, JAPAN
/ 8 PREVALENCE OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS IN CHINESE.
IMMIGRANTS IN MILAN
M. Meilikemu 1, C. Cuspidi 2, R. Meazza 3, V. Anna 4, F. Lombardi 5
1
Milan, 2 Meda, ITALY
/ 9 UTILISING PULSE WAVE VELOCITY IN ASSESSING ARTERIAL STIFFNESS IN PATIENTS WITH
MILD-TO-MODERATE RENAL IMPAIRMENT
A. Md Radzi, M. Fadzil, S. Kasim
1
Sungai Buloh, MALAYSIA
/ 10 60-DAY ALCL3 EXPOSURE AT HUMAN DIETARY LEVELS INCREASES VASCULAR REACTIVITY IN
CONDUCTANCE AND RESISTANCE ARTERIES IN RATS
C. Martinez 1, A. Escobar 1, J. Piagette 1, D. Vassallo 2, M.J. Alonso 3, M. Salaices 3, F. Peçanha 1, M. Miguel 3,
G. Wiggers 1
1
Uruguaiana, 2 Vitória, BRAZIL, 3 Madrid, SPAIN
/ 11 EGG WHITE HYDROLYSATE PREVENTS VASCULAR DYSFUNCTION AND THE INCREASED BLOOD
PRESSURE CAUSED BY CHRONIC ALUMINUM EXPOSURE IN RATS
C. Martinez 1, J. Piagette 1, A. Escobar 1, D. Vassallo 2, F. Peçanha 1, E. Jiménez 3, M. Miguel 3, G. Wiggers 1
1
Uruguaiana, 2 Vitória, BRAZIL, 3 Madrid, SPAIN
/ 12 EFFECTS OF THE THERAPEUTIC INTERVENTION ON VASCULAR RISK IN SPECIALIZED
CONSULTATIONS
M. Manovel Nogueiras, A. Iza, R. Sáenz Heranz, I. Villar Gomez, A. Epalza Bueno, A. Sebastian Leza,
M. Egurbide Arberas
Barakaldo, SPAIN
/ 13 SOME EPIDEMIOLOGICAL ASPECTS OF HYPERTENSION IN A HEALTH AREA OF THE
COMMUNITY OF MADRID
F. Lucena Marotta
Alcalá de Henares, SPAIN
F I N A L P R OG R A M M E
207
/ 14 RESULTS OF 10 YEARS (2004-2014) OF CARDIOVASCULAR HEALTH PROGRAMME (CHP) IN
THE EAST METROPOLITAN HEALTH SERVICE (EMHS) OF SANTIAGO (CHILE)
E. Lorca Herrera, I. Orellana, V. Soto, C.G. Bezanilla
Santiago, CHILE
/ 15 RENAL DENERVATION DECREASES NA+/CL- CO-TRANSPORTER (NCC) IN GOLDBLATT MODEL
OF HYPERTENSION
C.G. Shimoura, G.S. Lincevicius, E.B. Oliveira-Sales, R.B. Pontes, A.C. Girard, C.T. Bergamaschi, R.R. Campos
São Paulo, BRAZIL
/ 16 RENAL DENERVATION NORMALIZES SYMPATHETIC VASOMOTOR ACTIVITY AND PRODUCES
DIFFERENTIAL EFFECTS ON THE ARTERIAL BARORECEPTOR FUNCTION IN THE GOLDBLATT
RENOVASCULAR HYPERTENSION
G. Lincevicius, C.G. Shimoura, E.E. Nishi, T.L. Oliveira, C.T. Bergamaschi, R.R. Campos
São Paulo, BRAZIL
/ 17 AORTIC DISSECTION AND HYPERTENSION: RESULTS ABOUT 62 PATIENTS
R. Lakehal, R. Boukaroucha, A. Brahami
Constantine, ALGÉRIE
/ 18 EXECUTIVE FUNCTION PERFORMANCE IN HYPERTENSIVE CHILDREN
S. Stabouli, N. Printza, I. Dotis, E. Papadimitriou, D. Gidaris, C. Antza, V. Kotsis, D. Zafeiriou, F. Papachristou
Thessaloniki, GREECE
/ 19 FACTORS ASSOCIATED WITH HIGH AMBULATORY BLOOD PRESSURE AMONG TREATED
HYPERTENSIVE PATIENTS. WINTER AND SUMMER COMPARISON
Y. Koshelyaevskaya 1, M. Smirnova 1, V. Gorbunov 1, D. Volkov 1, S. Boytsov 1, M. Loukianov 1, A. Deev 1,
P. Dolotovskaya 2, P. Dovgalevskij 2, N. Furman 2, N. Puchin’yan 2
1
Moscow, 2 Saratov, RUSSIA
/ 20 ASSOCIATION OF SOLUBLE (PRO)RENIN RECEPTOR WITH BRAIN ATROPHY IN A GENERAL
POPULATION: THE OHASAMA STUDY
T. Hirose 1, M. Satoh 2, H. Suzuki 2, A. Hara 3, T. Murakami 2, R. Inoue 2, K. Asayama 3, M. Kikuya 2, H. Metoki 2,
F. Terzi 1, K. Totsune 2, K. Takahashi 3, Y. Imai 2, T. Ohkubo 3
1
Paris, FRANCE, 2 Sendai, 3 Tokyo, JAPAN
/ 21 COMPARATIVE ANALYSIS OF MEDICAL PRESCRIPTIONS OF ANTIHYPERTENSIVE DRUGS IN
UKRAINE AND NIGERIA
O. Gerasymenko, I. Zupanets, M. Adedoyin
Kharkiv, UKRAINE
Best Posters Discussion
Chairpersons: G. Grassi (Milan, ITALY)
T. Kahan (Stockholm, SWEDEN)
POSTER PRESENTATION ROOM
15.00 INCREASED INSPIRATORY RESISTANCE AFFECTS THE CARDIAC CONTRIBUTION TO THE
RELATIONSHIP BETWEEN BLOOD PRESSURE AND PIAL ARTERY PULSATION OSCILLATIONS
J. Wolf, M. Wszedybyl-Winklewska, E. Swierblewska, K. Kunicka, K. Mazur, M. Gruszecki, W. Guminski,
P.J. Winklewski, A. Frydrychowski, L. Bieniaszewski, K. Narkiewicz
Gdansk, POLAND
15.03 LCZ696 THERAPY IS ASSOCIATED WITH IMPROVEMENT OF VENTRICULAR ARTERIAL
COUPLING AND WORK EFFICIENCY IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION
FRACTION
Z. Kobalava, L. Babaeva, O. Lukina, E. Zharikova, E. Tyukhmenev, S. Villevalde
Moscow, RUSSIA
208
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
15.06 ASTRAGALOSIDE IV IMPROVES LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN
HYPERTENSIVE MICE BY INCREASING THE PHOSPHORYLATION OF ENDOTHELIAL NITRIC OXIDE
SYNTHASE
Q. Wang 1, E. Jeong 2, H. Liu 2, L. Gu 2, S.C. Dudley 2, J. Yu 1
1
Lanzhou, CHINA, 2 Providence, RI, USA
15.09 INCREASED APOPTOSIS AND DECREASED EXPRESSION OF NEPHRIN IN AGING
SPONTANEOUSLY HYPERTENSIVE RATS (SHRS)
A. Volakaki, P.E. Tsilibari, G. Drossopoulou, D. Vlahakos
Athens, GREECE
15.12 CALORIC RESTRICTION CAN IMPROVE LEARNING AND MEMORY OF C57/BL MICE PROBABLY
VIA REGULATION OF THE SIRT1/AMPK SIGNALING PATHWAY
L. Ma, R. Wang, Y. Li
Beijing, CHINA
15.15 NEFM IS A ZONA GLOMERULOSA SELECTIVE GENE INVOLVED IN REGULATING ALDOSTERONE
SECRETION RESPONSE TO DOPAMINE
C. Maniero, J. Zhou, E. Azizan, S. Neogi, G. Yeo, W. Zhao, M.J. Brown
Cambridge, UNITED KINGDOM
15.18 PREVALENCE AND RISK FACTORS RELATED TO DEVELOPMENT OF ARTERIAL HYPERTENSION IN
CIRRHOTIC PATIENTS UNDERGOING LIVER TRANSPLANTATION
C. Di Stefano, E. Vanni, S. Mirabella, R. Ibrahim Kamal Jouness, E. Nada, V. Boano, E. Mosso, V. Milazzo,
F. Vallelonga, G. Sobrero, M. Salizzoni, F. Veglio, A. Milan
Turin, ITALY
15.21 FACTORS AFFECTING MYOCARDIAL PERFUSION IN PATIENTS WITH RHEUMATOID ARTHRITIS
P. Anyfanti, A. Triantafyllou, G. Triantafyllou, P. Panagopoulos, N. Koletsos, A. Pyrpasopoulou,
S. Chatzimichailidou, E. Gkaliagkousi, S. Aslanidis, S. Douma
Thessaloniki, GREECE
15.24 TOLL-LIKE RECEPTOR 4 EXPRESSION AND SERUM LEVEL OF IL17A IN HYPERTENSIVE PATIENTS
T. Simundic, J. Barbic
Osijek, CROATIA
15.27 VENTRICULAR-ARTERIAL COUPLING MAY BE AN EARLY MARKER OF CARDIAC REMODELING
AFTER MYOCARDIAL INFARCTION TREATED WITH PERCUTANEOUS CORONARY INTERVENTION
E. Zharikova, S. Villevalde, Z. Kobalava
Moscow, RUSSIA
F I N A L P R OG R A M M E
209
14.00 - 15.30
Attended Poster Sessions
210
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
14.00 - 15.30
Attended Poster Sessions
PS 27. BLOOD PRESSURE MEASUREMENT
Chairperson: B. Chamontin (Toulouse, FRANCE)
ROOM
POSTERS FROM 1 TO 36
PS 28. BLOOD PRESSURE VARIABILITY
Chairperson: A. Protogerou (Athens, GREECE)
ROOM
POSTERS FROM 1 TO 22
PS 29. OBESITY AND METABOLIC SYNDROME
Chairperson: TBD
ROOM
POSTERS FROM 1 TO 37
PS 30.LIFESTYLE CHANGES, LIPIDS, SALT
Chairperson: B. Vaisse (Marseille, FRANCE)
ROOM
POSTERS FROM 1 TO 32
PS 31. EXPERIMENTAL HYPERTENSION AND PHARMACOLOGY
Chairperson: M. Marketou (Heraklion, GREECE)
ROOM
POSTERS FROM 1 TO 19
PS 32. EPIDEMIOLOGY OF HYPERTENSION
AND METABOLIC DISORDERS
Chairperson: F.Gueyffier(Lyon, FRANCE)
ROOM
POSTERS FROM 1 TO 24
PS 33. HEART AND HAEMODYNAMICS
Chairperson: P.-Y. Courand (Lyon, FRANCE)
ROOM
POSTERS FROM 1 TO 25
PS 34. SLEEP APNOEA AND NEURAL MECHANISMS
Chairperson: D. Papadopoulos (Athens, GREECE)
ROOM
POSTERS FROM 1 TO 15
PS 35. RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
Chairperson: B. Schmidt (Hannover, GERMANY)
ROOM
POSTERS FROM 1 TO 13
PS 36. ENDOTHELIUM AND ATHEROSCLEROSIS
Chairperson: R. Joannides (Rouen, FRANCE)
ROOM
POSTERS FROM 1 TO 17
PS 37. LARGE ARTERIES
Chairperson: G. Schillaci (Perugia, ITALY)
ROOM
POSTERS FROM 1 TO 27
PS 38. SPORT AND EXERCISE
Chairperson: P. Lantelme (Lyon, FRANCE)
ROOM
POSTERS FROM 1 TO 16
PS 39. TREATMENT ADHERENCE
Chairperson: L. Bortolotto (São Paulo, BRAZIL)
ROOM
POSTERS FROM 1 TO 18
LATE-BREAKER POSTERS’ SESSION 3
Chairperson: TBD
ROOM
POSTERS FROM 1 TO 17
15.00-15.30
BEST POSTERS DISCUSSION
Chairpersons: L. Bortolotto (São Paulo, BRAZIL)
G.S. Stergiou (Athens, GREECE)
POSTER PRESENTATION ROOM
F I N A L P R OG R A M M E
211
14.00 - 15.30
Posters’ Session PS27
BLOOD PRESSURE MEASUREMENT
Chairperson: B. Chamontin (Toulouse, FRANCE)
ROOM
POSTERS FROM 1 TO 36
/ 1 COMPARISON OF TWO BLOOD PRESSURE MONITORS USED FOR TELEMEDICAL HOME BLOOD
PRESSURE MEASUREMENT
N. Hoffmann-Petersen, E.B. Pedersen
Holstebro, DENMARK
/ 2 SCREENING FOR HYPERTENSION DURING CONSULTATION IN A WALK-IN SERVICE:
LITERATURE REVIEW AND PROPOSED ALGORITHM
A. Michaud 1, M. Lamarre-Cliche 2 , L. Cloutier 1
1
Trois-Rivières, 2 Montreal, CANADA
/ 3 VALIDATION OF BLOOD PRESSURE MONITORS USING THE AAMI AND ISO PROTOCOLS:
AN OVERVIEW OF THEIR RECENT APPLICATION
N. Boubouchairopoulou 1, A. Kollias 1, N. Atkins 2, E. O’Brien 2, G.S. Stergiou 1
1
Athens, GREECE, 2 Dublin, IRELAND
/ 4 BLOOD PRESSURE CONTROL IN RELATION TO THE SEX OF THE PATIENT AND THE PHYSICIAN:
RESULTS FROM THE SWEDISH PRIMARY CARE CARDIOVASCULAR DATABASE (SPCCD)
C. Ljungman 1, K. Manhem 1, L. Schiöler 1, B. Wettermark 2, K. Bengtsson Boström 3, J. Hasselström 2, T. Kahan 2
1
Gothenburg, 2 Stockholm, 3 Skövde, SWEDEN
/ 5 CONTINUOUS AND NON-INVASIVE BLOOD PRESSURE MEASUREMENT BASED ON PULSE
TRANSIT TIME COMPARED TO AMBULATORY BLOOD PRESSURE MEASUREMENT
R. Haberl 1, M. Wesely 1, K. Thimel 1, J. Gehring 2, G. Küchler 2
1
Munich, 2 Randersacker, GERMANY
/ 6 FREQUENCY OF MASKED HYPERTENSION AND WHITE COAT EFFECT IN UNCONTROLLED
HYPERTENSIVE PATIENTS TREATED WITH MONO OR DUAL THERAPY
B. Kichou, N. Henine, L. Kichou, A. Hamouche, A. Mazeghrane, L. Chaibi, M. Khati
Tizi-Ouzou, ALGERIA
/ 7 SUCCESSIVE BLOOD PRESSURE MEASUREMENT LOSES ACCURACY IN BORDERLINE VALUES OF
BLOOD PRESSURE
M. Vieira Da Silva 1, A. Mendes Da Silva 1, D. Artigas Giorgi 2, F. Ganem 2, L.P. Rodriges De Resende 1
1
Uberaba, 2 São Paulo, BRAZIL
/ 8 UTILISATION OF THE ARTERIAL STIFFNESS ASSESSMENT IN THE EVERYDAY CLINICAL PRACTICE
A. Reshetnik, C. Gohlisch, M. Toelle, W. Zidek, M. Van Der Giet
Berlin, GERMANY
/ 9 INFLUENCE OF SINGLE-PILL COMBINATION ANTIHYPERTENSIVE TREATMENT ON THE RISK OF
CARDIOVASCULAR COMPLICATIONS AND VASCULAR AGE: RESULTS OF THE MULTICENTER OPEN-LABEL
STUDY ADVANT’AGE
Y. Karpov
Moscow, RUSSIA
/ 10 CAN THE ARTERIAL COLLAPSE PRESSURE BE ESTIMATED USING PULSE WAVE VELOCITY
MEASUREMENTS?
B. Gavish 1, G. Pucci 2, F. Battista 2, M. D’Abbondanza 2, G. Schillaci 2
1
Eshtaol, ISRAEL, 2 Terni, ITALY
212
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 11 24 HOUR ARTERIAL DISTENSIBILITY IS RELATED WITH ABPM NON-DIPPING PATTERN IN HIVPOSITIVE PATIENTS
M. Varrenti, A. Maloberti, P. Vallerio, F. Panzeri, L. Pessina, F. Casadei, D. Lucente, I. D’Alessio, G.M. Mondellini,
D. Motta, C. Moioli, G. Parati, M. Puoti, C. Giannattasio
Milan, ITALY
/ 12 VISCERAL ADIPOSITY INDEX IS ASSOCIATED WITH NOCTURNAL HYPERTENSION BUT NOT
NON-DIPPING PATTERN IN UNTREATED HYPERTENSIVE PATIENTS
K. Manousopoulos, E. Manios, V. Chouzouri, F. Michas, A. Lykka, C. Papageorgiou, C. Vettou, N. Zakopoulos
Athens, GREECE
/ 13 USE OF 15-MINUTE AUTOMATED OFFICE BLOOD PRESSURE MEASUREMENT TO REDUCE
WHITE COAT EFFECT: 24 HOUR AMBULATORY BLOOD PRESSURE MONITORING STUDY
S. Choi, J. Youn, S. Han, K. Ryu
Hwaseong, SOUTH KOREA
/ 14 FARMAPRES PROJECT: QUALITY MEASUREMENT OF BLOOD PRESSURE IN PHARMACIES OF
THE VALENCIAN COMMUNITY
J. Tamarit García 1, B. Roig Espert 2, D. Godoy Rocatí 1, C. Nardini 1, A. García Bellot 2, V. Giner Galvañ 3,
V. Pallarés Carratalá 4, V. Gil Guillen 5, P. Rollán García 2, A. González-Cruz Cervellera 1
1
Valencia, 2 Manises, 3 Alcoy, 4 Castellón, 5 Elda, SPAIN
/ 15 CENTRAL AND PERIPHERAL HEMODYNAMIC CHARACTERISTICS IN YOUNG SUBJECTS WITH
SPURIOUS SYSTOLIC HYPERTENSION
C. Ramos Becerra, G. Alanis-Sanchez, F. Grover-Paez, D. Cardona-Muller, R. Garcia-Corral, C. Garcia-Aguilar,
S. Totsuka-Sutto, E. Cardona-Muñoz
Guadalajara, MEXICO
/ 16 EVALUATION OF THE MENTAL STRESS TESTING RESULTS BY DATA MINING
R. Khursa, M. Voitikova
Minsk, BELARUS
/ 17 VALUE OF ROUTINE BLOOD PRESSURE MEASUREMENTS, PERFORMED IN AN OUTPATIENT
HOSPITAL CLINIC
M. Reinhard, P. Poulsen, K.L. Christensen
Aarhus, DENMARK
/ 18 PREVALENCE OF HYPERTENSION DETERMINED IN COMMUNAL PHARMACIES OF THE
VALENCIAN COMMUNITY (RIVALFAR-STUDY)
V. Giner Galvañ 1, S. Alcázar 2, V. Baixauli 3, M. Cano 4, E. Ferrer 5, M.E. García 6, R.M. Prats 7, E. Rodilla Sala 8
1
Alcoy, 2 Alcudia de Crespins, 3 Mislata, 4 La Nucia, 5 Mislata, 6 L´Alfàs del Pi, 7 Denis, 8 Moncada, SPAIN
/ 19 IN HOSPITAL ASSESSMENT OF ARTERIAL BLOOD PRESSURE IN PATIENTS UNDERGOING
ORTHOPAEDIC SURGERY
M. Koutsaki, M.S. Kallistratos, E. Soulioti, A. Skyrlas, A. Koukouzeli, A. Daskalaki, K. Vergis, O. Diakoumakou,
O. Mascha, A. Mela, A.J. Manolis
Athens, GREECE
/ 20 HIGH DAYTIME AND NIGHTTIME BLOOD PRESSURE LOAD IS ASSOCIATED WITH THE
DEVELOPMENT OF PAROXYSMAL ATRIAL FIBRLLATION IN HYPERTENSIVES: A PRELIMINARY REPORT
E.A. Andreadis, C.V. Geladari, G.N. Kolyvas, A.I. Georgantoni, E.N. Pantikidi, N.D. Karamichalakis, S.E. Liapis,
E.T. Angelopoulos
Athens, GREECE
/ 21 CHANGES OF THE VASCULAR WALL RIGIDITY AND MICROCIRCULATION: AGE OR ARTERIAL
HYPERTENSION?
N. Karseladze, N. Orlova, I. Chukaeva, Y. Spiryakina
Moscow, RUSSIA
F I N A L P R OG R A M M E
213
/ 22 THE INDEPENDENT RELATIONSHIP OF BLOOD PRESSURE LOAD WITH TARGET ORGAN
DAMAGE IN UNTREATED HYPERTENSIVE PATIENTS. THE ROLE OF DIPPING STATUS
H. Triantafyllidi, I. Xenogiannis, I. Ikonomidis, G. Pavlidis, A. Schoinas, L. Palaiodimos, S. Vlachos, J. Lekakis
Athens, GREECE
/ 23 MORE SPEED AND NOISE FOR HBPM ADHERENCE IMPROVEMENT: INFLATION VS DEFLATION
TECHNOLOGY
L. Prati 1, V. Pecchioli 1, G. Germanò 2, F. Fedele 2
1
Frosinone, 2 Rome, ITALY
/ 24 MAKING A CASE FOR BLOOD PRESSURE SELF-MONITORING IN AN ARMED FORCES
POPULATION
L. Morris
Birmingham, UNITED KINGDOM
/ 25 RELATIONSHIP OF THE EMOTIONAL INTELLIGENCE AND PSYCHOLOGICAL STATUS SCORES
WITH MEAN AMBULATORY NIGHT AND EVENING BLOOD PRESSURE LEVELS IN PATIENTS WITH
ARTERIAL HYPERTENSION
G. Andreeva, A. Deev, V. Gorbunov, D. Lyusin, O. Lerman, V. Belolipetskaya, N. Dmitrivea
Moscow, RUSSIA
/ 26 EFFECTIVENESS AND SAFETY OF VALSARTAN/AMLODIPINE/HYDROCHLOROTHIAZIDE IN
EGYPTIAN PATIENTS WITH HYPERTENSION UNCONTROLLED ON ANY DUAL THERAPY:
AN OBSERVATIONAL STUDY
A.E. Etriby, S. Rakha
Cairo, EGYPT
/ 27 CLINIC BASED MEASUREMENT OF CENTRAL AORTIC SYSTOLIC PRESSURE. PRACTICAL UTILITY
AND ADVANTAGES: AN INDIAN STUDY
T. Dhakate, H. Shah, D. Kirpalani, S. Devikar, A. Kirpalani
Mumbai, INDIA
/ 28 T323C POLYMORPHISM OF ENDRA GENE AND ASSOCIATION WITH HEART REMODELING IN
ARTERIAL HYPERTENSION
G. Abdullaeva, A. Nagay, A. Abdullaev, D. Kurbanova, E. Zueva
Tashkent, UZBEKISTAN
/ 29 WHAT IS THE OPTIMAL NUMBERS OF SEQUENTIAL MEASUREMENTS TO IMPROVE THE
ACCURACY OF OFFICE BLOOD PRESSURE?
M. Vieira Da Silva 1, A. Mendes Da Silva 1, D. Artigas Giorgi 2, F. Ganem 2, L.P. Rodriges De Resende 1,
E.M. Rodrigues De Resende 1
1
Uberaba, 2 São Paulo, BRAZIL
/ 30 IN PATIENTS WITH WHITE-COAT EFFECT DURING AMBULATORY BLOOD PRESSURE
MONITORING THE THIRD HOUR VALUES PARTIALLY REFLECT MEAN DIURNAL BLOOD PRESSURE VALUES
F. Salvo 1, C. Lonati 2, A.R. Errani 1, M. Berardi 1, P. Fogliacco 1, C. Vallo 1, M. Albano 1, V. Meinero 1,
C.L. Muzzulini 1, A. Morganti 2
1
Ceva, 2 Milan, ITALY
/ 31 STUDY THE EFFECT OF EDUCATIONAL PROGRAMME IN THE PATIENTS WITH ARTERIAL
HYPERTENSION
U. Kamilova, D. Yarmukhamedova, D. Masharipova
Tashkent, UZBEKISTAN
/ 32 EFFECTS OF ASTHMA SEVERITY ON LEFT VENTRICLE OF CARDIAC REMODELING IN PATIENTS
WITH ARTERIAL HYPERTENSION
E. Tarlovskaya 1, A. Odegova 2, T. Chudinovskikh 2
1
Nizhny Novgorod, 2 Kirov, RUSSIA
/ 33 SEASONAL DIFFERENCES OF BLOOD PRESSURE IN PATIENTS WITH ARTERIAL HYPERTENSION
AND HIGH NORMAL BLOOD PRESSURE
D. Volkov, M. Smirnova, V. Gorbunov, S. Boytsov, M. Loukianov, A. Deev, Y. Koshelyaevskaya
Moscow, RUSSIA
214
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 34 FIRST MEDICAL WARNING, A REAL HARAKIRI. HYPERTENSIONOLOGIST’S HYPERTENSION:
SAGLIKER EFFECT. CLASSICAL MANUAL BP MEASUREMENTS MUST BE BANNED BY LEGISLATIONS AND
ESH AND WHO
H.S. Sagliker 1, Y. Sagliker 2, N. Paylar 2, C. Sagliker 2, P. Sagliker Ozkaynak 2, F. Ocal 3, T. Inal 2, P. Kolasin 2,
M. Balal 2
1
Konya, 2 Adana, 3 Kahramanmaras, TURKEY
/ 35 CHARACTERS OF HEART REMODELING IN PATIENTS WITH BRONCHIAL ASTHMA COMBINED
WITH ARTERIAL HYPERTENSION
A. Odegova 1, E. Tarlovskaya 2, T. Chudinovskikh 1
1
Kirov, 2 Nizhny Novgorod, RUSSIA
/ 36 T323C POLYMORPHISM OF ENDRA GENE AND ARTERIAL HYPERTENSION IN UZBEK
POPULATION
G. Abdullaeva, A. Nagay, G. Khamidullaeva, A. Abdullaev, D. Kurbanova, E. Zueva
Tashkent, UZBEKISTAN
Posters’ Session PS28
BLOOD PRESSURE VARIABILITY
Chairperson: A. Protogerou (Athens, GREECE)
ROOM
POSTERS FROM 1 TO 22
/ 1 AMBULATORY BLOOD PRESSURE MONITORING IN DIALYSIS PATIENTS
D. Klaric, K. Artukovic, M. Razov Radas
Zadar, CROATIA
/ 2 CLINICAL PATHOGENIC ASPECTS OF BLOOD PRESSURE CHRONOSTRUCTURE IN THE
CONDITIONS OF SHIFTWORK IN THE ARCTIC
N. Shurkevich 1, A. Vetoshkin 2, L. Gapon 1, N. Shipitsyna 1, D. Gubin 1, F. Poshinov 2
1
Tyumen, 2 Yamburg, RUSSIA
/ 3 EFFECT OF CHOLECALCIFEROL ON BLOOD PRESSURE VARIABILITY IN WOMEN WITH ARTERIAL
HYPERTENSION IN PREMENOPAUSAL AND EARLY POSTMENOPAUSAL PERIODS
L. Kezhun, L. Yankouskaya
Grodno, BELARUS
/ 4 DYNAMICS AND VARIABILITY OF BLOOD PRESSURE IN PATIENTS WITH ACUTE STROKE AND
HYPERTENSIVE CRISIS
L. Baurenski,E.Trendafilova,L.Haralanov
Sofia, BULGARIA
/ 5 CHARACTERISTICS OF BLOOD PRESSURE IN PATIENTS UNDERGOING CHRONIC
HEMODIALYSIS
E. Ivandic, V. Ivkovic, V. Premuzic, I. Barisic, R. Smalcelj, N. Basic Jukic, L.J. Bubic Filipi, I. Mesar, I. Juric,
I. Kovacevic Vojtusek, L. Katalinic, A. Vrdoljak, S. Karanovic, I. Vukovic, L. Gellineo, M. Laganovic, B. Jelakovic
Zagreb, CROATIA
/ 6 DAY AND NIGHT PULSE PRESSURE AMPLIFICATION IN NORMOTENSIVE, HYPERTENSIVE
DIPPER AND HYPERTENSIVE NON-DIPPER PATIENTS
Y. Kotovskaya 1, S. Millasseau 2, J. Topouchian 3, I. Posokhov 4
1
Moscow, RUSSIA, 2 Saint-Leu-la-Forêt, 3 Paris, FRANCE, 4 Nizhny Novgorod, RUSSIA
/ 7 PREVALENCE AND DETERMINANTS OF EXAGGERATED MORNING SURGE AND MORNING
HYPERTENSION IN CHINESE: THE CHINA AMBULATORY AND HOME BLOOD PRESSURE REGISTRY
(ABPR)
Q.H. Guo, Y.Y. Kang, J. Song, Q. Chen, C.Y. Liu, S.K. Xu, Y.B. Cheng, Y. Li, J. Wang
Shanghai, CHINA
F I N A L P R OG R A M M E
215
/ 8 LONG- AND SHORT-TERM BLOOD PRESSURE VARIABILITIES IN PATIENTS WITH CONTROLLED
ARTERIAL HYPERTENSION ARE NOT INTERCHANGEABLE
E. Troitskaya, N. Kotovskaya, Y. Kotovskaya, Z. Kobalava
Moscow, RUSSIA
/ 9 VISIT-TO-VISIT VARIABILITY OF BLOOD PRESSURE AND END-STAGE RENAL DISEASE, LEFT
VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS WITH CHRONIC KIDNEY DISEASE
L. Minushkina, A. Kazakova, S. Nokitina
Moscow, RUSSIA
/ 10 SEASONAL CHANGES OF 24-HOUR BLOOD PRESSURE VARIABILITY IN HYPERTENSIVE
PATIENTS
V. Gorbunov, M. Smirnova, M. Loukianov, A. Deev, Y. Koshelyaevskaya, S. Boytsov
Moscow, RUSSIA
/ 11 CLINICAL SIGNIFICANCE OF BAROREFLEX SENSITIVITY IN RISK STRATIFICATION OF
HYPERTENSIVES AND SUBJECTS WITH HIGH NORMAL BLOOD PRESSURE
D. Celovska 1, J. Gonsorcik 2, A. Dukat 1, L. Gaspar 1
1
Bratislava, 2 Kosice, SLOVAK REPUBLIC
/ 12 24 HOURS CHRONOMICS OF BP/HR IN TERMS OF DOUBLE AMPLITUDE, ACROPHASE,
HYPERBARIC INDEX AND ITS RELATION WITH SALIVARY CORTISOL AND MELATONIN SULPHATE LEVELS
IN NIGHT SHIFT HEALTH CARE
B. Anjum, N. Verma, S. Tiwari, R. Singh, A. Mahdi
Lucknow, INDIA
/ 13 MASKED HYPERTENSION IN OBSTRUCTIVE SLEEP APNOEA SYNDROME (OSAS) PATIENTS: NOT
SUCH A RARE CIRCUMSTANCE
S. Feki, S. Mssead, H. Mahfoudh, Y. Chaabouni, K. Mnif, F. Jarraya, K. Kammoun, S. Kammoun, J. Hachicha
Sfax, TUNISIA
/ 14 BLOOD PRESSURE PROFILE, LEFT VENTRICLE REMODELING AND ENDOTHELIAL DYSFUNCTION
IN PATIENTS WITH ARTERIAL HYPERTENSION AND COPD
N. Demikhova 1, L. Vynnychenko 1, O. Smiianova 1, I. Vilkhova 2, A. Maslenko 1
1
Sumy, 2 Lviv, UKRAINE
/ 15 HIGH BLOOD PRESSURE AND THE SYMPATHETIC NERVOUS SYSTEM AS A DETERMINANT
FACTOR OF THE ALTERATIONS IN THE BLOOD PRESSURE VARIABILITY AND HEART RATE
R. Penuela 1, T. Penuela 2
1
San Cristobal, 2 Caracas, VENEZUELA
/ 16 SEVEN DAY BLOOD PRESSURE MONITORING: VARIABILITY OF 24H BLOOD PRESSURE
PROFILE DURING DIFFERENT KIND OF EXERCISE IN HEALTHY MEN
J. Siegelova 1, A. Havelkova 1, J. Dusek 1, M. Pohanka 1, L. Dunklerova 1, P. Dobsak1, G. Cornelissen 2
1
Brno, CZECH REPUBLIC, 2 Minneapolis, MN, USA
/ 17 24-HOUR PATTERNS OF CENTRAL AORTIC AND BRACHIAL SYSTOLIC BLOOD PRESSURE IN THE
VERY ELDERLY
N. Ezhova, A. Alam, Y. Kotovskaya, Z. Kobalava
Moscow, RUSSIA
/ 18 DIFFERENCES IN THE MONITORING AND DYSFUNCTION OF THE AUTONOMIC NERVOUS
SYSTEM IN PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES
M. Stojanovic, T. Nisic, T. Lalic, M. Stojkovic, B. Beleslin, J. Ciric, S. Savic, M. Zarkovic, M. Barac, S. Vujovic,
V. Stojanov
Belgrade, SERBIA
/ 19 HYPERTENSION IN PERITONEAL DIALYSIS
M. Hamouche, A. Seba, L. Badaoui, K. Khitouche, M. Belgrine
Tizi Ouzou, ALGERIA
216
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 20 EFFECT DISORDERED BREATHING WHILE SLEEPING ON INDICATOR OF VASCULAR STIFFNESS
AND CENTRAL AORTIC PRESSURE IN PATIENTS WITH ACROMEGALY
D. Vaulina,L.Korostovtseva,A.Semenov,V.Nepran,U.Tsoi ,Y.Sviryaev,E.Grineva
Saint-Petersburg, RUSSIA
/ 21 BENEFIT OF FORTY-EIGHT-HOUR AMBULATORY BLOOD PRESSURE MONITORING IN
HEMODIALYSIS POPULATION
K. Mnif, F. Jarraya, H. Chaker, H. Mahfoudh, S. Feki, S. Charfeddine, L. Abid, S. Kammoun, K. Kammoun,
J. Hachicha
Sfax, TUNISIA
/ 22 BLOOD PRESSURE CONTROL, VISIT TO VISIT AND HOME DAY-TIME BLOOD PRESSURE
VARIABILITY IN COHORT
Z. Gasimov, M. Kocharli, E. Hasanova, I. Hasanova
Baku, AZERBAIJAN
Posters’ Session PS29
OBESITY AND METABOLIC SYNDROME
Chairperson: TBD
ROOM
POSTERS FROM 1 TO 37
/ 1 CHANGES OF PRIMARY HEMOSTASIS IN PATIENTS WITH ARTERIAL HYPERTENSION
ASSOCIATED WITH NONALCOHOLIC FATTY LIVER DISEASE
A. Sydorchuk, L. Sydorchuk, Y. Yarynych, V. Macenko, R. Sydorchuk, A. Sokolenko, I. Sydorchuk, O. Bodnarashek
Chernivtsi, UKRAINE
/ 2 FEATURES OF METABOLIC HOMEOSTASIS DEPENDING ON GENETIC POLYMORPHISM
OF INSULIN RECEPTOR SUBSTRATE-1 GENE IN PATIENTS WITH ESSENTIAL HYPERTENSION UNDER
COMORBIDITY
A. Shalimova 1, M. Kochueva 1, V. Psareva 2, N. Kirichenko 2
1
Kharkiv, 2 Sumy, UKRAINE
/ 3 METFORMIN REDUCES HIGH-FAT DIET EFFECTS ON BLOOD PRESSURE, METABOLIC
PARAMETERS AND VASCULAR PROSTANOIDS IN RATS
A. Puyó, H.J. Lee, N.M. Sánchez Eluchans, S.M. Cantú, M.R. Choi, A.S. Donoso, H.A. Peredo
Buenos Aires, ARGENTINA
/ 4 METABOLIC SYNDROME EXACERBATES ISCHEMIA AND REPERFUSION INJURY ON THE BRAIN
MICROCIRCULATION OF RATS
N. Obadia Pereira, M.A. Lessa, E. Tibiriçá, V. Estato
Rio de Janeiro, BRAZIL
/ 5 IVABRADINE THERAPY FAVORABLY MODULATES SYMPATHETIC OVERDRIVE AND ARTERIAL
STIFFENING IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME
K. Dimitriadis,C.Tsioufis,E.Andrikou,D.Konstantinidis,T.Kalos,I.Liatakis,E.Koutra,D. Tousoulis
Athens, GREECE
/ 6 THE RELATIONSHIP BETWEEN OBESITY, BLOOD PRESSURE VARIABILITY AND RIGHT
VENTRICULAR REMODELLING IN HYPERTENSIVE PATIENTS
M. Tadic 1, C. Cuspidi 2, V. Vukomanovic 1, V. Kocijancic 1, V. Celic 1
1
Belgrade, SERBIA, 2 Milan, ITALY
/ 7 ALDOSTERONE IS NOT ASSOCIATED WITH INSULIN-MEDIATED MICROVASCULAR
RECRUITMENT AND INSULIN SENSITIVITY IN ABDOMINALLY OBESE, BUT OTHERWISE HEALTHY MEN
M. Schütten, Y. Kusters, A. Houben, C. Schalkwijk, P. Joris, J. Plat, R. Mensink, P.W. de Leeuw, C.D.A. Stehouwer
Maastricht, NETHERLANDS
F I N A L P R OG R A M M E
217
/ 8 WHICH TARGET ORGAN IS MORE VULNERABLE FOR METABOLIC SYNDROME?
O. Rotar, M. Boyarinova, E. Moguchaya, E. Kolesova, V. Solntsev, A.O. Konradi, E. Shlyakhto
Saint-Petersburg, RUSSIA
/ 9 WORLDWIDE PREVALENCE OF METABOLIC SYNDROME IN PEOPLE LIVING WITH HUMAN
IMMUNODEFICIENCY VIRUS INFECTION: A SYSTEMATIC REVIEW AND META-ANALYSIS
A. Kengne 1, K.A. Nguyen 1, N. Peer 1, E.J. Mills 2
1
Cape Town, SOUTH AFRICA, 2 Vancouver, CANADA
/ 10 FACTORS ASSOCIATED WITH SIGNIFICANT LIVER STEATOSIS AND FIBROSIS AS ASSESSED
BY TRANSIENT ELASTOGRAPHY IN PATIENTS WITH ONE OR MORE COMPONENTS OF THE METABOLIC
SYNDROME
I. Mikolasevic, G. Targher, S. Milic, D. Stimac, N. Franjic, l. Orlic
Rijeka, CROATIA
/ 11 A PROSPECTIVE STUDY OF SERUM GAMMA-GLUTAMYLTRANSFERASE LEVELS AND INCIDENT
METABOLIC SYNDROME: THE ARIRANG STUDY
J. Kim, B. Yoo, S. Park, J. Lee, Y. Youn, M. Ahn, S. Lee, J. Yoon
Wonju, SOUTH KOREA
/ 12 SERUM MIDREGIONAL PROATRAIL NATRIURETIC PEPTIDE CONCENTRATIONS DO NOT
INCREASE WITH HIGHER 24-HOUR AMBULATORY SYSTOLIC BLOOD PRESSURE AND GREATER LEFT
VENTRICULAR MASS IN OBESE MEN
J. Jeppesen 1, C. Asferg 1, U. Andersen 1, J. Goetze 2, A. Linneberg 1
1
Glostrup, 2 Copenhagen, DENMARK
/ 13 EFFECTS OF AMLODIPINE AND ATORVASTATIN ON ENDOTHELIAL VASOACTIVE MEDIATORS IN
PATIENTS WITH METABOLIC SYNDROME
N. Blinova, V. Masenko, I.E. Chazova
Moscow, RUSSIA
/ 14 MODERATE RUNNING PROTECTS AGAINST PANCREAS DAMAGE IN CHRONIC COLA DRINKING
RATS
M. Otero-Losada, J. González, G. Ottaviano, A. Müller, G. Cao, G. Ambrosio, J. Milei
Buenos Aires, ARGENTINA
/ 15 PREVALENCE AND RADIOLOGICAL PECULIARITIES OF METABOLIC SYNDROME AND
HYPERTENSION IN STROKE PATIENTS
L. Mumladze, N. Lobjanidze, N. Akiashvili, K. Zurabishvili, N. Kvirkvelia
Tbilisi, GEORGIA
/ 16 METABOLIC SYNDROME, INSULINE RESISTANCE AND KIDNEY DISEASE IN PATIENTS WITH
ESSENTIAL HYPERTENSION
L. Vigil 1, M. Lopez Jimenez 1, R. García Carretero 1, C. Rodriguez de Castro 1, B. Vargas 2, M. Varela 1,
J. Ruiz Galiana 1
1
Móstoles, 2 Villaviciosa de Odón, SPAIN
/ 17 METABOLIC SYNDROME AS THE PREDICTOR OF NEW CARDIOVASCULAR EVENTS IN PATIENTS
WITH MYOCARDIAL INFARCTION TREATED WITH PRIMARY PERCUTANEOUS CORONARY INTERVENTION
M. Lovic 1, L. Savic 2, D. Matic 2, D. Djordjevic 1, D. Lovic 1, I. Tasic 1, M. Ostojic 2
1
Niš, 2 Belgrade, SERBIA
/ 18 LINKING ULTRASOUND ASSESSMENT OF EXTRACRANIAL CEREBRAL CIRCULATION TO THE
CARDIOVASCULAR AND RENAL EVENTS AT HYPERTENSIVE PATIENTS WITH OR WITHOUT METABOLIC
SYNDROME
A. Gavrila, M. Florea, M. Ciobanu, C. Pritulescu, M. Rusu, I. Sosea, R. Persu, A. Rosu
Craiova, ROMANIA
/ 19 LEFT VENTRICLE HYPERTROPHY AND DIASTOLIC DYSFUNCTION ARE ASSOCIATED WITH
ABDOMINAL OBESITY IN HYPERTENSIVE WOMEN
A. Cunha, T. Isbele, J. D´El-Rei, M. Casanova, M. Trindade, W. Oigman, M.F. Neves
Rio de Janeiro, BRAZIL
218
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 20 BIOCHEMICAL PREDICTORS OF VIOLATION ELASTIC PROPERTIES IN THE VASCULAR WALL IN
HYPERTENSIVE PATIENTS WITH ABDOMINAL OBESITY
T. Petelina, L. Gapon, N. Musikhina, K. Avdeeva, T. Petrashevskaya, N. Tretyakova
Tyumen, RUSSIA
/ 21 CLINICAL CHARACTERISTICS AND METABOLIC PROFILES OF HYPERTENSIVE AND
NORMOTENSIVE PATIENTS WITH ABDOMINAL OBESITY
I. Pchelin, N. Hudiakova, A. Shishkin
Saint-Petersburg, RUSSIA
/ 22 OBESITY INCREASES THE CENTRAL SYSTOLIC AND DIASTOLIC BLOOD PRESSURE DESPITE
HAVING PROPER TREATMENT IN HYPERTENSIVE PATIENTS
R. Cabrera Sole, C. Turpin Lucas, L. Urrego Rivera, D. Calle Salazar, M. Aguilera Saldaña
Albacete, SPAIN
/ 23 EFFECT OF VERY SHORT-TERM WEIGHT REDUCTION ON BLOOD PRESSURE IN EXTREME OBESE
WELL TREATED HYPERTENSIVE PATIENTS
G. Csitári, R. Kollár, T. Ferenci, G. Simonyi
Budapest, HUNGARY
/ 24 THE INFLUENCE OF HORMONAL REPLACEMENT THERAPY ON CARDIOVASCULAR SYSTEM IN
POSTMENOPAUSAL WOMEN WITH CLIMACTERIC SYNDROME
J. Prokhorova ¹, S. Tolstov 2, V. Mychka 1
1
Moscow, 2 Saratov, RUSSIA
/ 25 THE RELATIONSHIP OF CARDIOMETABOLIC RISK FACTORS IN OBESE HYPERTENSIVE PATIENTS
WITH DIFFERENT FINDRISK QUESTIONNAIRE VALUES
O. Pionova
Kharkiv, UKRAINE
/ 26 ABDOMINAL OBESITY AND DEPRESSION AMONG OBESE HEALTHCARE WORKERS
A. Wisetborisut, H. Klibngern, W. Jirapornjaroen, S. Likhitsathian, C. Angkurawaranon
Chiang Mai, THAILAND
/ 27 VISFATIN SERUM LEVEL AND EXPRESSION IN SUBCUTANEOUS AND VISCERAL ADIPOSE
TISSUE IN PREPUBERTERTAL BOYS: RELATION TO BLOOD PRESSURE AND METABOLIC PARAMETERS
K. Selthofer Relatic, S. Novak, D. Divkovic, I. Drenjancevic, A. Cosic
Osijek, CROATIA
/ 28 CIRCADIAN BLOOD PRESSURE PATTERN AND METABOLIC SYNDROME
A. Hermida Ameijeiras, J.E. Lopez Paz, M.J. Alende, A. Pascual Montes, V. Martínez Durán, G. Calvo González,
A. Pose Reino, C. Calvo Gomez
Santiago de Compostela, SPAIN
/ 29 PREVALENCE OF METABOLIC SYNDROME IN POSTMENOPAUSAL WOMEN IN THE AREA OF
BLIDA (ALGERIA)
A. Bachir Cherif,A.Bouamra,A.Taleb,A.Bouraghda,M.T.Bouafia
Blida, ALGERIA
/ 30 CORRECTION OF CARDIOVASCULAR RISK IN PATIENTS WITH MORBID OBESITY USING
BARIATRIC SURGERY
A. Shkroba, O. Mitchenko, A. Lavryk
Kiev, UKRAINE
/ 31 LISINOPRIL EFFICIENCY IN OBESE HYPERTENSIVE MEN
V. Stojanov 1, N. Radivojevic 1, M. Marjanovic 1, B. Jakovljevic 1, D. Lovic 2
1
Belgrade, 2 Niš, SERBIA
/ 32 DIET-INDUCED METABOLIC SYNDROME IN RABBITS AND RATS: LONG-TERM FREE-CHOICE
HIGH FAT HIGH SUCROSE DIET
N. Goncalves-Rosa
Lisbon, PORTUGAL
F I N A L P R OG R A M M E
219
/ 33 OVERWEIGHT AND OBESITY IN THE RISK PROFILE OF HIGH RISK PATIENTS WITH
HYPERTENSION
B. Georgiev, N. Gotcheva, V. Baytcheva, D. Gotchev
Sofia, BULGARIA
/ 34 PREVALENCE OF METABOLICALLY HEALTHY OBESE PHENOTYPE IN SAINT-PETERSBURG
INHABITANTS ACCORDING TO DIFFERENT CRITERIA
M. Boyarinova, A. Orlov, O. Rotar, A. Alieva, E. Moguchaya, E. Vasilieva, V. Yudina, V. Solntsev, E. Baranova,
A.O. Konradi
Saint-Petersburg, RUSSIA
/ 35 METABOLIC EFFECTS DIFFERENT BETA BLOCKERS DEPENDS ON PRESENTS INSULIN
RESISTANCE IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
O. Rekovets, Y. Sirenko, O. Torbas, G. Primak, A. Vaschylko, E. Pavlyuk, S. Savitskiy, P. Sidorenko, S. Polishchuk,
V. Granich, S. Kushnir, A. Dobrokhod
Kiev, UKRAINE
/ 36 ASSOCIATION OF PERIPHERAL AND CENTRAL BLOOD PRESSURE WITH THE COMPONENTS OF
METABOLIC SYNDROME IN A MEXICAN SAMPLE
P. Quezada, F. Grover, C. Ramos, S. Pascoe, E. Cardona, S. Hernandez
Guadalajara, MEXICO
/ 37 AMBULATORY ARTERIAL STIFFNESS INDEX IN PATIENTS WITH METABOLIC SYNDROME AND
NEWLY DIAGNOSED HYPERTENSION BEFORE AND AFTER ONE YEAR OF TREATMENT WITH LOSARTANE
AND TELMISARTANE
I. Rihacek, M. Soucek, B. Kianicka, P. Frana, M. Plachy, J. Spac
Brno, CZECH REPUBLIC
Posters’ Session PS30
LIFESTYLE CHANGES, LIPIDS, SALT
Chairperson: B. Vaisse (Marseille, FRANCE)
ROOM
POSTERS FROM 1 TO 32
/ 1 ESTIMATION OF POPULATIONAL 24-HOUR URINARY SODIUM AND POTASSIUM
EXCRETION FROM SPOT URINE SAMPLES. EVALUATION OF FOUR FORMULAS IN A LARGE NATIONAL
REPRESENTATIVE POPULATION
J. Polonia 1, M. Lobo 2, L. Martins 1, F. Pinto 1, J. Nazaré 1
1
Lisbon, 2 Porto, PORTUGAL
/ 2 IMPACT OF STRESS REDUCTION ON BLOOD PRESSURE CONTROL IN PATIENTS TREATED WITH
PERINDOPRIL: SHAKE THE HABIT II
M. Vasilevski 1, R. Hamel 1, E. Rampakakis 2, J. Sampalis 2
1
Laval, 2 Montreal, CANADA
/ 3 RELATIONSHIP BETWEEN URINE SODIUM/POTASSIUM EXCRETION AND CENTRAL AORTIC
SYSTOLIC BLOOD PRESSURE IN KOREAN PATIENTS WITH HYPERTENSION
M. Rhee 1, J. Kim 1, S. Shin 1, D. Nah 2, K. Sung 3, E. Cho 3, K. Hong 4, S. Jo 5, K. Kim 7, S. Lee 8
1
Goyang, 2 Gyeongju, 3 Seoul, 4 Chuncheon, 5 Anyang, 7 Seongnam, 8 Wonju, SOUTH KOREA
/ 4 ROLE OF EDUCATION IN PREVENTION OF ARTERIAL HYPERTENSION IN SAINT-PETERSBURG
N. Paskar, A. Nedoshivin
Saint-Petersburg, RUSSIA
/ 5 SCREENING OF EXCESSIVE SALT CONSUMPTION AMONG HYPERTENSIVE PATIENTS FOLLOWED
IN PRIMARY CARE BY THE DETERMINATION OF URINARY SODIUM AND PERFORMING THE EXSEL®TEST
X. Girerd 1, F. Villeneuve 1,2, H. Lim 1
1
Paris, 2 Ballainvilliers, FRANCE
220
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 6 BLOOD PRESSURE IN RELATION TO 24-HOUR URINARY SODIUM EXCRETION AND RENAL
SODIUM HANDLING
K. Stolarz-Skrzypek, A. Bednarski, A. Franczyk, M. Folta, H. Barton, A. Olszanecka, M. Kloch-Badelek,
G. Kielbasa, K. Kawecka-Jaszcz, D. Czarnecka
Kraków, POLAND
/ 7 DIETARY SODIUM AND POTASSIUM WERE ASSOCIATED WITH BLOOD PRESSURE IN MIDDLE
AGED ADULT AND OLDER BUT NO ASSOCIATION WERE SHOWN IN YOUNGER ADULTS: A NATIONWIDE
SURVEY (KNHANES V)
S. Kim, S. Chung, M. Park
Seoul, SOUTH KOREA
/ 8 DIURNAL PATTERN OF URINARY SODIUM/POTASSIUM RATIO IN FREE LIVING JAPANESE
INDIVIDUALS
T. Iwahori 1,2, H. Ueshima 1, S. Torii 1, Y. Saito 1, K. Kondo 1, N. Miyagawa 1, H. Arima 1, K. Miura 1
1
Otsu, 2 Muko, JAPAN
/ 9 THE ECONOMICS OF OBESITY: FOOD PRICE POLICIES IMPROVE DIET QUALITY WHILE
INCREASING SOCIOECONOMIC INEQUALITIES IN NUTRITION
M. De Rosa 1, A. Mancini 1, A. Lombardi 1, L. Cerini 2, D. Leosco 1, N. Ferrara 1
1
Naples, 2 Milan, ITALY
/ 10 DOES SALT INTAKE PREDICT THE NEW ONSET OF CHRONIC KIDNEY DISEASE?
H. Takase 1, T. Tanaka 1, D. Nonaka 1, S. Takayama 1, H. Hayashi 1, T. Sugiura 2, N. Ohte 2, Y. Dohi 3
1
Hamamatsu, 2 Nagoya, 3 Seto, JAPAN
/ 11 INFLUENCE OF URINARY SODIUM AND POTASSIUM EXCRETION ON BLOOD PRESSURE IN
CAMEROONIAN PYGMIES AND BANTUS
D. Lemogoum 1, C. Bika Lele 2, C. Okalla 2, F. Akono 2, J. Dissongo 2, M. Lememan 1, J.P. Degaute 1,
P. van de Borne 1
1
Brussels, BELGIUM, 2 Douala, CAMEROON
/ 12 DEFICITS AMONG PHYSICIANS ON SELF-REPORTED AWARENESS AND IMPLEMENTATION
OF EVIDENCE BASED RECOMMENDATIONS ON LIFESTYLE CHANGES FOR MANAGEMENT OF
HYPERTENSION
R. Kreutz 1, J. Bolbrinker 1, H. Gohlke 2, B. Weisser 3
1
Berlin, 2 Ballrechten-Dottingen, 3 Kiel, GERMANY
/ 13 BIOAVAILABILITY AND BENEFICIAL EFFECTS OF OMEGA-3-PUFA-ENRICHED CHICKEN MEAT:
A PILOT STUDY
M. Brennan 1, S. Allen 2, F. Buskandar 2, K. Shortall 2, H. Hayes 3, D. Williams 2, N. Moran 2, A. Stanton 2
1
Galway, 2 Dublin, IRELAND, 3 Belfast, UNITED KINGDOM
/ 14 GENDER DIET PREFERENCES AND CARDIOVASCULAR RISK IN RUSSIAN POPULATION
A. Orlov, M. Boyarinova, O. Rotar, A. Alieva, E. Moguchaya, E. Vasilieva, V. Yudina, V. Solntsev, E. Baranova,
A.O. Konradi
Saint-Petersburg, RUSSIA
/ 15 RELATION OF URINARY SODIUM EXCRETION WITH BLOOD PRESSURE AMONG
CAMEROONIAN RURAL AND URBAN DWELLERS OF THE FAR NORTH REGION
D. Lemogoum 1, C. Bika Lele 2, C. Okalla 2, P. Amta 2, J. Dissongo 2, J.R. M’Buyamba-Kabangu 3, J.P. Degaute 1,
M. Leeman 1, P. van de Borne 1
1
Brussels, BELGIUM, 2 Douala, CAMEROON, 3 Kinshasa, DR CONGO
/ 16 SALT CONSUMPTION IN CROATIAN CONTINENTAL RURAL POPULATION: ENAH STUDY
S. Karanovic 1, A. Vrdoljak 1, V. Ivkovic 1, Z. Dika 1, V. Domislovic 1, K. Dapic 1, L. Gallineo 1, E. Ivandic 1,
J. Josipovic 1, I. Vukovic 1, J. Kos 1, M. Laganovic 1, T. Zeljkovic Vrkic 1, L.J. Fodor 1, V. Matijevic 2, M. Fucek 1,
J. Culig 1, R. Stevanovic 1, B. Jelakovic 1
1
Zagreb, 2 Slavonski Kobas, CROATIA
F I N A L P R OG R A M M E
221
/ 17 PLASMA COPPER AND CERULOPLASMIN IN RELATION TO CAROTID-FEMORAL PULSE WAVE
VELOCITY
J. Platek, K. Stolarz-Skrzypek, H. Mrowiec, S. Walas, W. Wojciechowska, L. Klima, S. Zapotoczny,
K. Kawecka-Jaszcz, D. Czarnecka
Kraków, POLAND
/ 18 KNOWLEDGE OF SALT INTAKE AND BLOOD PRESSURE IN A SAMPLE OF MEDITERRANEAN
HYPERTENSIVE PATIENTS
C. Gonçalves 1,2, N. Campos 3, F. Ribeiro 4, J. Mesquita Bastos 4,5
1
Porto, 2 Viana do Castelo, 3 Braga, 4 Aveiro, 5 Lisbon, PORTUGAL
/ 19 ANTIHYPERTENSIVE EFFECT OF DIETARY INTEGRATION WITH GRANA PADANO DOCG CHEESE.
A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
G. Crippa, D. Zabzuni, E. Bravi, F.M. Cicognini, E. Bighi, A. Cassi, F. Rossi
Piacenza, ITALY
/ 20 RELATIONSHIP BETWEEN SALT INTAKE AND LIFESTYLE INCLUDING DIET IN HYPERTENSIVE
OUTPATIENTS TREATED AT A GENERAL HOSPITAL
Y. Ohta 1, Y. Kimura 1, C. Kitaoka 1, I. Abe 1, Y. Kawano 2
1
Kitakyushu, 2 Fukuoka, JAPAN
/ 21 CONSUMPTION OF COFFEE, TEA AND COCOA CONTAINING PRODUCTS IN PATIENTS WITH
ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE
M. Klocek, J. Przystas, D. Czarnecka
Kraków, POLAND
/ 22 KRILL OIL PHOSPHOLIPIDS IMPROVE LIPID PROFILE IN HYPERTENSIVE PERSONS
V. Stojanov 1, N. Radivojevic 1, M. Marjanovic 1, D. Lovic 2
1
Belgrade, 2 Niš, SERBIA
/ 23 CHANGES OF BLOOD PRESSURE AND LIPID STATUS FOLLOWING DIET THERAPY IN
HYPERTENSIVE WOMEN
B. Jakovljevic 1, V. Stojanov 1, D. Lovic 2
1
Belgrade, 2 Niš, SERBIA
/ 24 EFFECTS OF A COMBINED BLOOD PRESSURE AND LIPID-LOWERING NUTRACEUTICAL ON
MILDLY HYPERTENSIVE HYPERCHOLESTEROLEMIC SUBJECTS: A PILOT, DOUBLE-BLIND, PLACEBOCONTROLLED, RCT?
A.F.G. Cicero, M. Rosticci, S. D’Addato, F. Fogacci, R. Urso, C. Borghi
Bologna, ITALY
/ 25 A NEW METHOD FOR EDUCATING LOW SALT DIET AND LOW CALORIE DIET, USING DOCTOR’S
RESTAURANT WITH COOKING LIVE DEMONSTRATION
A. Oikawa, M. Obara, H. Takahashi, K. Sugawara, R. Takahashi, H. Tamura, S. Fujine
Kitakami City, JAPAN
/ 26 EFFECT OF MONOCLONAL ANTIBODIES TO PCSK9 ON HIGH-SENSITIVITY C-REACTIVE PROTEIN
LEVELS: A META-ANALYSIS OF 16 RANDOMIZED CONTROLLED TREATMENT ARMS
P. Di Giosia 1, A. Sahebkar 2,3, C.A. Stamerra 1, D. Grassi 1, C. Pedone 4, G. Ferretti 5, T. Bacchetti 5, C. Ferri 1,
P. Giorgini 1
1
L’Aquila, ITALY, 2 Mashhad, IRAN, 3 Perth, AUSTRALIA, 4 Rome, 5 Ancona, ITALY
/ 27 EFFECTS OF BODY WEIGHT ON HEPATIC STEATOSIS IN ESSENTIAL HYPERTENSION
C. Chou, W. Tsai
Tainan, TAIWAN
/ 28 NUTRITION PATTERN AND CARDIOVASCULAR RISK FACTORS IN SURVIVORS OF THE SIEGE OF
LENINGRAD
E. Moguchaya, A. Orlov, O. Rotar, E. Kolesova, A. Erina, M. Boyarinova, V. Solntsev, A.O. Konradi, V. Shlykhto
Saint-Petersburg, RUSSIA
/ 29 DIETARY NITRATE LOWERS AMBULATORY BLOOD PRESSURE IN UNCONTROLLED
HYPERTENSION: A 7D, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL
C. Kerley, L. Cormican, E. Dolan
Dublin, IRELAND
222
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 30 PREVALENCE OF PREHYPERTENSION AND ASSOCIATED CONDITIONS IN YOUNG ADULTS
A. Rekhviashvili, A. Minashvili
Tbilisi, GEORGIA
/ 31 SALT INTAKE AND BLOOD PRESSURE CONTROL IN PORTUGUESE HYPERTENSIVE PATIENTS
C. Gonçalves 1,2, N. Campos 3, F. Ribeiro 4, J.M. Bastos 4,5
1
Porto, 2 Viana do Castelo, 3 Braga, 4 Aveiro, 5 Lisbon, PORTUGAL
/ 32 DYSLIPIDEMIA AND AGGRAVATED QUALITY OF LIFE IN HYPERTENSIVES
V. Katsi, G. Vamvakou, T. Makris, I. Kallikazaros, D. Tousoulis
Athens, GREECE
Posters’ Session PS31
EXPERIMENTAL HYPERTENSION AND PHARMACOLOGY
Chairperson: M. Marketou (Heraklion, GREECE)
ROOM
POSTERS FROM 1 TO 19
/ 1 CIRCULATING PROGENITOR CELLS IN HYPERTENSION: EFFECTIVENESS OF A TREATMENT
WITH OLMESARTAN IN IMPROVING CELL NUMBER AND MIRS PROFILE BESIDES EXPECTED
PHARMACOLOGICAL EFFECTS
G.Mandraffino, C.O. Aragona, S. Quartuccio, V. Cairo, F. Mamone, M.A. Sardo, A. Saitta, E. Imbalzano
Messina, ITALY
/ 2 ASTRAGALOSIDE IV AMELIORATED MITOCHONDRIAL OXIDATIVE STRESS IN HYPERTENSIVE
MICE WITH CARDIOMYOPATHY BY REGULATING MITOCHONDRIAL CA2+ FLUX
Q. Wang 1, A. Xie 2, H. Xu 1, J. Yu 1
1
Lanzhou, CHINA, 2 Providence, RI, USA
/ 3 PHARMACEUTICAL TREATMENT OF NEWLY DIAGNOSED PATIENTS WITH ARTERIAL
HYPERTENSION: 5 YEARS DESCRIPTIVE ANALYSIS OF A LARGE COHORT FROM A BELGIAN HEALTH
INSURER (2008-2012)
G. Karakaya, R. Van Tielen, I. Umbach
Brussels, BELGIUM
/ 4 EXTRACELLULAR ATP-DEPENDENT REGULATION OF BLOOD VESSELS
L. Smaglii 1, Y. Birullina 1, V. Rydchenko 1, S. Gusakova 1, S. Orlov 1,2
1
Tomsk, 2 Moscow, RUSSIA
/ 5 SIRTUIN 3: DOES CARDIOMYOCYTE CARE?
C. Villedieu, T. Bochaton, B. Pillot, L. Augeul, D. Baetz, M. Ovize, A. Gharib
Lyon, FRANCE
/ 6 INVOLVEMENT OF RENIN-ANGIOTENSIN SYSTEM IN MONOCROTALINE INDUCED PULMONARY
HYPERTENSION
E. Malikova, K. Galkova, P. Vavrinec, D. Vavrincova-Yaghi, P. Krenek, J. Klimas
Bratislava, SLOVAK REPUBLIC
/ 7 CARDIOVASCULAR TOXICITY OF CARFILZOMIB ON VASCULAR TONE, VASCULAR REACTIVITY
AND ENDOTHELIAL FUNCTION
E. Gorga 1, M. Gavazzoni 1, V. Regazzoni 1, E. Trichaki 1, F. Pasini 1, I. Bonadei 1, E. Sciatti 1, E. Vizzardi 1,
T. Scarabelli 2, R. Raddino 1
1
Brescia, ITALY, 2 Detroit, MI, USA
/ 8 ALTERED CALCIUM SENSITIZATION IN HYPERTENSIVE REN-2 TRANSGENIC RATS
J. Zicha, M. Behuliak, I. Vaneckova
Prague, CZECH REPUBLIC
F I N A L P R OG R A M M E
223
/ 9 EVOLUTION OF NT-PROBNP ACTIVITY AND LEFT VENTRICULAR HYPERTROPHY DURING LONGTERM THERAPY WITH LOSARTAN, VALSARTAN AND EPROSARTAN IN ESSENTIAL HYPERTENSION
N. Sapojnic, A. Caraus, L. Popescu
Chisinau, REPUBLIC OF MOLDOVA
/ 10 CARDIAC UPREGULATION OF ATRIAL NATRIURETIC PEPTIDE IN METABOLIC SYNDROME
INDUCED BY CONSUMPTION OF COLA BEVERAGE IN WISTAR RATS
K. Galkova, E. Malikova, E. Kralova, P. Vavrinec, P. Krenek, J. Klimas
Bratislava, SLOVAK REPUBLIC
/ 11 CHRONIC INHIBITION OF TWO CONSTITUTIVE NO-SYNTHASE ISOFORMS DURING
DEVELOPMENTAL STAGE OF HYPERTENSION
A. Berényiová, M. Drobná, F. Kristek, I. Dovinová, M. Kvandová, S. Cacányiová
Bratislava, SLOVAK REPUBLIC
/ 12 CONDITIONAL INACTIVATION OF INTEGRIN AV SUBUNIT IN VASCULAR SMOOTH MUSCLE
CELLS REGULATES FIBROSIS IN VESSELS
E. Belozertseva 1, Z. Li 2, M. Bourhim 1, H. Louis 1, D. Dumas 1, V. Regnault 1, P. Lacolley 1
1
Vandoeuvre-lès-Nancy, 2 Paris, FRANCE
/ 13 PARTICIPATION OF CARDIAC THYROTROPING RELEASING HORMONE (CTRH) IN THE
DOXORRUBICIN (D) INDUCED CARDIOTOXICITYIN IN MICE
S. García, L. Peres Diaz, M. Schuman, M. Aisicovich, J. Toblli, M.S. Landa
Buenos Aires, ARGENTINA
/ 14 URTICA DIOICA L. LEAF EXTRACT REDUCES BLOOD PRESSURE AND IMPROVES ANTIOXIDATIVE
DEFENCE IN SPONTANEOUSLY HYPERTENSIVE RATS
U. Vajic, J. Grujic-Milanovic, Z. Miloradovic, D. Jovovic, M. Ivanov, D. Karanovic, N. Mihailovic-Stanojevic
Belgrade, SERBIA
/ 15 ENDOTHELIAL CELL GROWTH SUPPLEMENT IMPROVES CARDIAC FUNCTION FOLLOWING
MOUSE MYOCARDIAL INFARCTION
X. Fan, H. Shi, C.A. Drummond, J. Xie, S. Haller, D. Kennedy, C.J. Cooper, J. Tian
Toledo, OH, USA
/ 16 OBSERVATIONAL STUDY ON NACL+CHITOSAN 3% CONFIRMS THE LOWERING OF THE
HYPERTENSIVE TOXICITY OF NACL SALT
F. Allaert
Dijon, FRANCE
/ 17 EFFECT OF VALSARTAN AND FIXED COMBINATION ON CENTRAL BLOOD PRESSURE
S. Softic, R. Accetto, B. Barbic Zagar
Ljubljana, SLOVENIA
/ 18 EFFECTS OF REGULAR CONSUMPTION OF RED WINE AND ALCOHOL-FREE RED WINE
ON SYSTEMIC HAEMODYNAMICS, LIPID PROFILE AND OXIDATIVE STRESS IN SPONTANEOUSLY
HYPERTENSIVE RATS
N. Mihailovic-Stanojevic, K. Savikin, Z. Miloradovic, M. Ivanov, D. Karanovic, U. Vajic, D. Jovovic,
J. Grujic-Milanovic
Belgrade, SERBIA
/ 19 HAEMODYNAMIC DOSE-DEPENDENT RESPONSE TO OLIVE LEAF EXTRACTS IN
SPONTANEOUSLY HYPERTENSIVE RATS
M. Ivanov, Z. Miloradovic, N. Mihailovic-Stanojevic, J. Grujic-Milanovic, U. Vajic, D. Karanovic, D. Jovovic
Belgrade, SERBIA
224
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Posters’ Session PS32
EPIDEMIOLOGY OF HYPERTENSION AND METABOLIC DISORDERS
Chairperson: F.Gueyffier(Lyon,FRANCE)
ROOM
POSTERS FROM 1 TO 24
/ 1 CLOSING CARE GAPS IN HYPERTENSION CONTROL AT A POPULATION LEVEL
R. Lewanczuk
Edmonton, CANADA
/ 2 MORTALITY FROM BLOOD-PRESSURE-RELATED DISEASES IN BRAZIL FROM 1980-2010
H. Moreira, A.P.M. Reis, R.B. Rodrigues, A.C.S. Sousa, C.L.A. Barros, Y.C.L. Araujo, T. Jardim, A.L.L. Sousa,
W.K.S.B. Souza, P. Jardim
Goiania, BRAZIL
/ 3 IMPROVED TREATMENT AND CONTROL OF HYPERTENSION IN SWEDISH PRIMARY CARE:
RESULTS FROM THE SWEDISH PRIMARY CARE CARDIOVASCULAR DATABASE (SPCCD)
C. Holmquist 1, J. Hasselström 1, K. Bengtsson Boström 2, P. Hjerpe 2, B. Wettermark 1, K. Manhem 3, T. Kahan 1
1
Stockholm, 2 Skövde, 3 Gothenburg, SWEDEN
/ 4 CLINICAL CHARACTERISTICS AND BLOOD PRESSURE BEHAVIOUR OF PATIENTS YOUNGER
THAN 30 YEARS WITH APPARENT HYPERTENSION
A. Kasiakogias,D.Konstantinidis,C.Tsioufis,K.Dimitriadis,K.Kintis,A.Kalos, E. Nikolakopoulos, G. Bazoukis,
D. Chatzis, I. Kallikazaros, D. Tousoulis
Athens, GREECE
/ 5 PREDICTORS OF PWV PROGRESSION OVER A THREE YEARS FOLLOW UP: FOCUS ON
PSYCHOLOGICAL CHARACTERISTICS
P. Sormani, G. Colombo, A. Greco, A. Maloberti, C. Franzosi, P. Meani, M. Varrenti, P. Vallerio, B. De Chiara,
F. Casadei, A. Moreo, M. D’Addario, M.E. Magrin, M. Miglioretti, M. Sarini, L. Vecchio, P. Steca, G. Grassi,
G. Mancia, C. Giannattasio
Milan, ITALY
/ 6 HYPERTENSION AND TYPE II DIABETES IN FIRST GENERATION CHINESE MIGRANTS SETTLED IN
THE SOUTH OF EUROPE: THE CHINESE IN PRATO CROSS-SECTIONAL SURVEY
P.A. Modesti 1, E. Perruolo 1, M. Calabrese 2, M. Boddi 1, S. Castellani 1, G. Galanti 1, D. Zhao 3
1
Florence, 2 Prato, ITALY, 3 Beijing, CHINA
/ 7 CARDIOVASCULAR RISK MANAGEMENT IN THE FRENCH WEST INDIES: BETTER
COORDINATION NEEDED
P. Carrère 1,2,3, M. Hérin 1, J. Hélène-Pelage 1, J. Inamo 3,4, A. Atallah 2, T. Lang 3
1
Pointe-à-Pitre, 2 Basse-Terre, 3 Toulouse, 4 Fort-de-France, FRANCE
/ 8 DISTRIBUTION OF CARDIOVASCULAR RISK INDICATORS ACCORDING TO BLOOD PRESSURE
STATUS IN THE GERMAN ADULT POPULATION
D. Krupp 1, J. Esche 1, S. Klenow 2, G.B. Mensink 2, T. Remer 1
1
Bonn, 2 Berlin, GERMANY
/ 9 ARTERIAL HYPERTENSION (AHT): AN ACTUAL AND WORSENING PATHOLOGY
C. Santos Moreira, P. Alcântara, V. Nicolau, A. Escoval, J. Braz-Nogueira
Lisbon, PORTUGAL
/ 10 EPISTAXIS: RELATIONSHIP WITH CLINIC BLOOD PRESSURE
F. Bertacchini, A. Paini, M. Salvetti, A. Bazza, E. Colonetti, C. Agabiti Rosei, L. Verzeri, D. Lombardi, P. Nicolai,
E. Agabiti Rosei, M.L. Muiesan
Brescia, ITALY
/ 11 A COMPARATIVE ANALYSIS OF THE HYPERTENSION TREATMENT DEPENDING ON
COMORBIDITIES: INSIGHTS FROM CLINICAL PRACTICE
C. Diaconu, A. Nastasa, A.R. Zaki, B. Istratie, R. Nazari, M.A. Iancu, L.A. Balaceanu
Bucharest, ROMANIA
F I N A L P R OG R A M M E
225
/ 12 AUGMENTATION INDEX (AI) AND SMOKING HABITS FROM VIEWPOINT OF EPIDEMIOLOGY:
THE TANUSHIMARU STUDY
T. Tsuru, H. Adachi, M. Enomoto, A. Fukami, E. Kumagai, S. Nakamura, Y. Nohara, E. Nakao, A. Sakaue,
N. Morikawa
Kurume, JAPAN
/ 13 GENDER DIFFERENCES IN URIC ACID AND CARDIOVASCULAR RISK
A. Hermida Ameijeiras, J.E. Lopez Paz, M.J. Alende, G. Calvo Gonzalez, V. Martínez Durán, A. Pascual Montes,
I. Rodriguez Lopez, C. Calvo Gomez
Santiago de Compostela, SPAIN
/ 14 AN AGE-RELATED COMPARISON BETWEEN COMORBIDITIES AND TREATMENT OF
HYPERTENSIVE PATIENTS
C. Diaconu, B. Istratie, A. Nastasa, A.R. Zaki, L.A. Balaceanu, M.A. Iancu
Bucharest, ROMANIA
/ 15 CIRCADIAN BLOOD PRESSURE PROFILE AND TARGET ORGAN DAMAGE IN HYPERTENSIVE
PATIENTS. SINGLE PILOT HYPERTENSION CENTER STUDY
I. Tilea, A. Mitre, C. Carasca, A. Varga
Targu Mures, ROMANIA
/ 16 THICKNESS OF EPICADIAL FAT TISSUE AS MARKER INSULIN RESISTANCE
G. Chumakova 1, N. Veselovskaya 1,2, O. Gritzenko 2
1
Barnaul, 2 Kemerovo, RUSSIA
/ 17 HYPERTENSIVE WOMEN COMPARED TO HYPERTENSIVE MEN ARE CHARACTERIZED BY
POORER QUALITY OF LIFE
V. Katsi, G. Vamvakou, T. Makris, I. Kallikazaros, D. Tousoulis
Athens, GREECE
/ 18 RELATIONSHIP BETWEEN SUBCLINICAL ORGAN DAMAGE, CIGARETTE SMOKING AND
CARDIOVASCULAR RISK IN BOTH GENDERS OF HYPERTENSIVE PATIENTS
L. Woznicka-Leskiewicz, A. Posadzy-Malaczynska
Poznan, POLAND
/ 19 THE EPIDEMIOLOGICAL CHARACTERISTIC OF HYPERHOMOCYSTEINEMIA AND H-TYPE
HYPERTENSION IN THE ELDERLY IN BEIJING (CHINA)
L. Ma, L. Li, Z. Tang, Y. Li
Beijing, CHINA
/ 20 PREVALENCE OF DIABETES AND LIPID DISORDERS IN HYPERTENSION PATIENTS REFERRED TO
SPECIALIZED CARDIOLOGICAL CENTRE: FIVE-YEARS TRENDS
N. Zvartau, A. Krikunov, A. Semakova, E. Bolgova, S. Kovalchuk, A. Boukhanovsky, A.O. Konradi
Saint-Petersburg, RUSSIA
/ 21 CARDIOVASCULAR RISK ASSESSMENT AND SOCIAL FRAMEWORK OF COMMUNITY OF CAPE
VERDEAN UNIVERSITY STUDENTS STUDYING IN PORTUGAL
L. Tavares, C. Calhau, J. Polonia
Porto, PORTUGAL
/ 22 TACK TO REQUIREMENTS TREATMENT OF PATIENTS WITH HEART CHRONIC DISEASE AND
HYPERTENSION
M. D’Avino 1, G. Caruso 1, G. Buonomo 2, D. Scala 1, E. Menditto 1
1
Naples, 2 Telese Terme, ITALY
/ 23 GENDER DIFFERENCES OF THE COMORBIDITIES IN HYPERTENSIVE PATIENTS
C. Diaconu, A. Nastasa, A.R. Zaki, B. Istratie, R. Nazari, M.A. Iancu, L.A. Balaceanu
Bucharest, ROMANIA
/ 24 AN ANALYSIS OF HYPERTENSIVE MALE PATIENTS ADDRESSED TO A PRIMARY CARE PRACTICE
M.A. Iancu, C. Diaconu, G. Dediu, L.A. Balaceanu, R.S. Matei, D. Matei
Bucharest, ROMANIA
226
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Posters’ Session PS33
HEART AND HAEMODYNAMICS
Chairperson: P.-Y. Courand (Lyon, FRANCE)
ROOM
POSTERS FROM 1 TO 25
/ 1 EVALUATION OF HYPERTENSIVE PATIENTS: TEN YEARS PROGNOSTIC SIGNIFICANCE OF NONINVASIVE PARAMETERS
D. Djordjevic, I. Tasic, S. Kostic, B. Stamenkovic, M. Lovic, D. Lovic
Niš, SERBIA
/ 2 LEFT VENTRICLE DIASTOLIC DYSFUNCTION IN PATIENTS WITH ESSENTIAL HYPERTENSION
DEPENDING ON THE LEVEL OF HYPERURICEMIA
O. Kotsyuba, M. Hrebenyk, N. Yarema, L. Zelenenka
Ternopil, UKRAINE
/ 3 POTENTIAL VALUE OF THE ASSESSMENT OF STRESS NT-PROBNP LEVELS FOR THE PREDICTING
OF SUBCLINICAL DIASTOLIC DYSFUNCTION IN HYPERTENSIVE PATIENTS
A. Kisko, M. Babcak, N. Kishko
Presov, SLOVAK REPUBLIC
/ 4 FORWARD AND BACKWARD PRESSURE WAVEFORM MORPHOLOGY IN HYPERTENSIVE
SUBJECTS
Y. Li, H. Gu, H. Fok, J. Alastruey, P. Chowienczyk
London, UNITED KINGDOM
/ 5 PREVALENCE AND CORRELATES OF NEW-ONSET LEFT VENTRICULAR GEOMETRIC
ABNORMALITIES IN A GENERAL POPULATION: THE PAMELA STUDY
G.L. Seravalle 1, C. Cuspidi 1, R. Facchetti 1, M. Bombelli 1, G. Brambilla 1, D. Prata Pizzala 1, G. Erba 1,
R. Dell’Oro 1, C. Sala 1, M. Tadjc 2, G. Mancia 1, G. Grassi 1
1
Milan, ITALY, 2 Belgrade, SERBIA
/ 6 DIFFERENCES IN PREDICTORS OF ONE-YEAR MORTALITY BETWEEN PATIENTS WITH
HYPERTENSIVE AND NONHYPERTENSIVE ACUTE HEART FAILURE: USEFULNESS OF E/E’ IN
HYPERTENSIVE HEART FAILURE
K. Matsushita, T. Minamishima, K. Sakata, T. Satoh, H. Yoshino
Tokyo, JAPAN
/ 7 BODY FAT COMPOSITION AFFECTS LEFT VENTRICULAR MASS IN HYPERTENSIVE WOMEN:
A BIOIMPEDANCE STUDY
C. Catena, G.L. Colussi, M. Novello, F. Pezzutto, A. Palomba, L.A. Sechi
Udine, ITALY
/ 8 INTRAVENTRICULAR SEPTAL END DIASTOLE AND END SYSTOLE MEASUREMENTS IN NEWLY
DIAGNOSED ALDOSTERONISM, ESSENTIAL HYPERTENSION AND NORMOTENSIVE SUBJECTS
G. Kladas, M. Pikilidou, M. Antoniou, E. Papakonstantinou, L. Hadjistavri, K. Arodites, P. Zebekakis
Thessaloniki, GREECE
/ 9 SUBCLINICAL ORGAN DAMAGE IN HYPERTENSIVE PATIENTS WITH HIGH CARDIOVASCULAR
RISK. THE IMPORTANCE OF CHANGES IN LEFT VENTRICULAR MASS: FOLLOW UP
I. Tasic 1, S. Kostic 2, D. Djordjevic 1, M. Lovic 2, M. Rihter 2, J. Cvetkovic 2, S. Andonov 2, D. Lovic 1
1
Niš, 2 Niska Banja, SERBIA
/ 10 CHARACTERISATION OF A HYPERCOAGULABLE PHENOTYPE WITH INCREASED THROMBIN
GENERATION IN ACUTE HEART FAILURE
B. Popovic, H. Louis, R. Fay, F. Zannad, P. Lacolley, V. Regnault
Nancy, FRANCE
/ 11 CARDIAC ORGAN DAMAGE IN PARKINSONIAN PATIENTS WITH NOCTURNAL HYPERTENSION
AND AUTONOMIC NEUROPATHY
C. Di Stefano, V. Milazzo, G. Sobrero, F. Vallelonga, A. Milan, F. Veglio, S. Maule
Turin, ITALY
F I N A L P R OG R A M M E
227
/ 12 CORRELATION OF RISK FACTORS AND SYSTOLIC FUNCTION, LEFT VENTRICULAR EJECTION
FRACTION AND ARTERIAL REMODELING, INTIMA-MEDIA-THICKNESS IN PATIENTS WITH ACUTE
LEUKEMIA
A. Militaru, P. Matusz, M. Militaru, S. Iurciuc, S. Zus, D. Lighezan
Timisoara, ROMANIA
/ 13 HEART RATE EVALUATION AS PART OF ANALYSIS OF DAILY BLOOD PRESSURE MONITORING
L. Zhuravlyova, O. Yankevich
Kharkiv, UKRAINE
/ 14 LONGITUDINAL LEFT VENTRICULAR CONTRACTILITY AND ISOLATED SYSTOLIC HYPERTENSION
IN THE YOUNG
D. Piskorz, A. Tommasi
Rosario, ARGENTINA
/ 15 THE RELATIONSHIP BETWEEN RIGHT AND LEFT VENTRICLES IN PATIENTS WITH
HYPERTENSION AND HEALTHY CONTROLS
J. Krolczyk, O. Siga, A. Dzieza-Grudnik, J. Walczewska, T. Grodzicki
Kraków, POLAND
/ 16 AMBULATORY HEMODYNAMIC TRENDS IN HYPERTENSION AND AGEING
S. Bhura, K. Elango, J.L. Izzo, P.J. Osmond
Buffalo, NY, USA
/ 17 COMPARATIVE EFFECTIVENESS OF ANGIOTENSIN II RECEPTOR BLOCKERS VERSUS
ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN LEFT VENTRICULAR STRUCTURE AND FUNCTION
R. Ma, Y. Zhao, Q.Y. Wang, N.Y. Li, H.T. Meng, J. Yu
Lanzhou, CHINA
/ 18 STRUCTURAL LEFT VENTRICULAR CHANGES IN PATIENTS WITH DIABETES MELLITUS
ASSOCIATED WITH HYPERTENSION
N. Dovganych, M. Illyash, O. Yarinkina, O. Bazyka, O. Starshova, N. Thor
Kiev, UKRAINE
/ 19 PROGNOSTIC VALUE OF ANEMIA IN PATIENTS HOSPITALIZED FOR ACUTE HEART FAILURE
M. Azaiez, S. Hamdi, A. Elhraiech, W. Jomaa, K. Ben Hamda, F. Maatouk
Monastir, TUNISIA
/ 20 THE INFLUENCE OF ANTIHYPERTENSIVE TREATMENT ON THE FUNCTION OF LEFT VENTRICLE IN
PATIENTS WITH PRIMARY, UNCOMPLICATED HYPERTENSION
T. Pizon, M. Rajzer, M. Rojek, D. Czarnecka
Kraków, POLAND
/ 21 LEFT VENTRICLE DIASTOLIC FUNCTION IN A COHORT OF TREATED HYPERTENSIVE PATIENTS
E. Swierblewska, K. Kunicka, J. Wolf, W. Kucharska, M. Hoffmann, K. Polonis, A. Szyndler, M. Chrostowska,
L. Bieniaszewski, K. Narkiewicz
Gdansk, POLAND
/ 22 TEI INDEX AS A TOOL FOR THE DIAGNOSIS OF LEFT VENTRICULAR DYSFUNCTION WITH
PRESERVED EJECTION FRACTION IN HYPERTENSIVE PATIENTS
G. Tissera, D. Piskorz, A. Tommasi
Rosario, ARGENTINA
/ 23 BISOPROLOL/AMLODIPINE FIXED DOSE COMBINATION EFFECTS ON LEFT VENTRICULARARTERIAL COUPLING IN HYPERTENSIVE PATIENTS
A. Bogomaz, Y. Kotovskaya, Z. Kobalava
Moscow, RUSSIA
/ 24 HYPONATREMIA AND OUTCOMES IN TUNISIAN PATIENTS ADMITTED FOR ACUTE HEART
FAILURE
M. Azaiez, A. Elhraiech, S. Hamdi, W. Jomaa, K. Ben Hamda, F. Maatouk
Monastir, TUNISIA
228
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 25 IN RESTRICTIVE CARDIOMYOPATHY CAUSED BY CARDIAC AL AMYLOIDOSIS A RESTRICTIVE LV
FILLING PATTERN IS ONLY PRESENT IN A MINORITY OF PATIENTS
R. Mussinelli 1, F. Musca 2, F. Salinaro 1, M. Boldrini 1, A. Raimondi 1, G. Gioia 1, G. Rizzola 1, E. Binot 1,
T. Perrone 1, G. Palladini 1, G. Merlini 1, S. Perlini 1
1
Pavia, 2 Milan, ITALY
Posters’ Session PS34
SLEEP APNOEA AND NEURAL MECHANISMS
Chairperson: D. Papadopoulos (Athens, GREECE)
ROOM
POSTERS FROM 1 TO 15
/ 1 NECK CIRCUMFERENCE AND WAIST-HIP RATIO, INDEPENDENTLY OF BODY MASS INDEX,
ARE MORE RELATED WITH MASKED HYPERTENSION IN OBESE NORMOTENSIVE INDIVIDUALS WITH
OBSTRUCTIVE SLEEP APNOEA
A. Cunha, R. Gismondi, C. Correa, M.F. Neves, W. Oigman
Rio de Janeiro, BRAZIL
/ 2 ENDOTHELIAL FUNCTION IN MIDDLE-AGED MALE PATIENTS WITH ARTERIAL HYPERTENSION
AND ADDITIONAL CONFOUNDING FACTORS: OBESITY AND OBSTRUCTIVE SLEEP APNOEA SYNDROME
E.Elfimova, P. Galitsin, M. Tripoten, O. Pogorelova, A. Zairova, A. Litvin, T. Balakhonova, A. Rogoza, I.E. Chazova
Moscow, RUSSIA
/ 3 MORNING HYPERTENSION: A TARGET TO TREAT IN PATIENTS WITH SLEEP APNOEAHYPOPNOEA SYNDROME
S. Milanov, J. Vuckovic-Filipovic, I. Cekerevac, G. Davidovic
Kragujevac, SERBIA
/ 4 CIRCADIAN BLOOD PRESSURE PROFILE AND SLEEP APNOEA
M. Rozanska, P. Talarowska, A. Segiet, O. Mozenska, D. A. Kosior
Warsaw, POLAND
/ 5 OBSTRUCTIVE SLEEP APNOEA IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS
A. Sadomov
Zaporizhzhia, UKRAINE
/ 6 EFFECT OF EPLERENONE ON APNOEA-HYPOPNOEA INDEX IN PATIENTS WITH RESISTANT
HYPERTENSION AND OBSTRUCTIVE SLEEP APNOEA
B. Krasinska, A. Miazga, S. Cofta, L. Chichel, T. Trafas, Z. Krasinski, A. Tykarski
Poznan, POLAND
/ 7 AMBULATORY SCREENING OF OBSTRUCTIVE SLEEP APNOEA IN PATIENTS WITH RESISTANT
ARTERIAL HYPERTENSION USING APNOEALINK
M. Kamasova 1, J. Vaclavik 1, T. Vaclavik 2, M. Hobzova 1, E. Kocianova 1
1
Olomouc, 2 Prague, CZECH REPUBLIC
/ 8 SEVERE SNORES WITHOUT APNOEA AND UNDERESTIMATED HIGH BLOOD PRESSURE
G. Caruso, D. Fernandez, M. Perez, M. Smurra, J.P. Pezzi
Buenos Aires, ARGENTINA
/ 9 DIETARY NITRATE DECREASED BLOOD PRESSURE PROFILES IN CPAP NAÏVE OBSTRUCTIVE
SLEEP APNOEA SYNDROME: A 2 WEEK, DOUBLE-BLIND RANDOMIZED, PLACEBO-CONTROLLED
CROSSOVER TRIAL
C. Kerley, E. Dolan, L. Cormican
Dublin, IRELAND
/ 10 THE POSSIBLE RELATIONSHIP BETWEEN AIRWAY RESISTANCE AND SURFACTANT PROTEINS IN
OBSTRUCTIVE SLEEP APNOEA: A COMPLEMENTARY STUDY
X. Li, N. Li, L. Shao, M. Heizhati, X. Yao, Y. Wang, L. Zhou, L. Wang
Urumqi, CHINA
F I N A L P R OG R A M M E
229
/ 11 THE RELATIONSHIP BETWEEN SERUM LIPOPOLYSACCHARIDE BINDING PROTEIN AND SLEEP
ARCHITECTURE IN HYPERTENSIVE PATIENTS
N. Li, M. Heizati, X. Yao, L. Shao, Y. Wang, J. Hong
Urumqi, CHINA
/ 12 PECULIARITIES OF INFLAMMATORY MARKERS IN MIDDLE-AGED MALE PATIENTS WITH
ARTERIAL HYPERTENSION, OBESITY AND OBSTRUCTIVE SLEEP APNOEA SYNDROME
E.Elfimova, P. Galitsin, A. Rvacheva, A. Litvin, K. Zykov, I.E. Chazova
Moscow, RUSSIA
/ 13 MRI MEASUREMENT OF AIRWAY SOFT TISSUES PARAMETERS IN PATIENTS WITH OBSTRUCTIVE
SLEEP APNOEA
E. Butorova,E.Elfimova,M.Shariya,A.Litvin
Moscow, RUSSIA
/ 14 SLEEP BREATHING DISORDERS AS A KEY DETERMINANT FOR DEVELOPMENT OF
UNCONTROLLED ARTERIAL HYPERTENSION
P. Zelveian, T. Ustyan, A. Matevosyan, G. Podosyan
Yerevan, ARMENIA
/ 15 CLINICO-PSYCHOLOGICAL STATUS OF PATIENTS WITH OBSTRUCTIVE SLEEP APNOEA
SYNDROME OF VARYING SEVERITY AND HYPERTENSION
K. Konovalova 1, A. Litvin 2, V. Fedorova 3
Moscow, RUSSIA
Posters’ Session PS35
RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
Chairperson: B. Schmidt (Hannover, GERMANY)
ROOM
POSTERS FROM 1 TO 13
/ 1 ATRAP, A NOVEL INTERACTING MOLECULE WITH AT1 RECEPTOR, INHIBITS ANG II INDUCED
PROLIFERATIVE ACTIVITY AND OXIDATIVE STRESS IN RAT SMOOTH MUSCLE CELLS
K. Azuma 1, K. Tamura 2, T. Taira 2, H. Wakui 2, K. Uneda 2
1
Sagamihara, 2 Yokohama, JAPAN
/ 2 BLOOD PRESSURE, ARTERIAL STIFFNESS AND ENDOGENOUS LITHIUM CLEARANCE IN
RELATION TO AGTR1 A1166C AND AGTR2 G1675A GENE POLYMORPHISMS
M. Cwynar, J. Gasowski, A. Gluszewska, J. Krolczyk, H. Barton, A. Slowik, T. Grodzicki
Kraków, POLAND
/ 3 EFFECT OF RENIN–ANGIOTENSIN–ALDOSTERONE SYSTEM GENE POLYMORPHISM ON
PHENOTYPIC MANIFESTATIONS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND
CONCOMITANT ARTERIAL HYPERTENSION
S.M. Komissarova, E.Y. Zakharova, I.V. Lazareva, N.N. Chakova
Minsk, BELARUS
/ 4 EFFECT OF ANGIOTENSIN RECEPTOR STIMULATION IN THE ROSTRAL VENTROLATERAL
MEDULLA ON BLOOD PRESSURE IN NORMOTENSIVE RATS: INTERACTION WITH GLUTAMATE AND
GAMMA-AMINOBUTYRIC ACID
L. Legat, S. Brouwers, I. Smolders, A.D. Dupont
Brussel, BELGIUM
/ 5 ALDOSTERONE, RENIN AND THE ALDOSTERONE-TO-RENIN-RATIO: AGE- AND SEX-SPECIFIC
DISTRIBUTION AND DETERMINATS IN THE POPULATION
M.I. Hermanns, S. Matheis, N. Arnold, J.H. Prochaska, M. Panova-Noeva, A. Schulz, D. Laubert-Reh,
K.J. Lackner, T. Münzel, P.S. Wild
Mainz, GERMANY
230
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 6 MALIGNANT HYPERTENSION: A FRENCH COHORT STUDY
S. Rubin, A. Cremer, P. Gosse
Bordeaux, FRANCE
/ 7 RENAL DENERVATION ATTENUATES CARDIOVASCULAR INFLAMMATION AND REMODELING
IN ANGIOTENSIN II-INDUCED HYPERTENSIVE RATS
M. Hong, X. Li, P. Gao
Shanghai, CHINA
/ 8 HYPOVOLEMIC RENIN-ALDOSTERONE AXIS DEFICIENCY WITHOUT HYPERKALEMIA
FOLLOWING UNILATERAL ADRENALECTOMY FOR PRIMARY ALDOSTERONISM
M. Vallet, A. Martin, E. Huyghe, J. Amar, B. Chamontin, I. Tack, B. Bouhanick
Toulouse, FRANCE
/ 9 PLASMA RENIN ACTIVITY/PLASMA ALDOSTERONE CONCENTRATION RATIO: A USEFUL TOOL
IN EVALUATING THE CLINICAL EFFECTIVENESS OF HIGH BLOOD PRESSURE TREATMENT BASED ON ACEI
OR ARB
F. Giulietti, F. Spannella, E. Borioni, F.E. Lombardi, L. Landi, E. Espinosa, R. Sarzani
Ancona, ITALY
/ 10 ALDOSTERONE RELATES TO PARATHORMONE AND TO FGF23 IN PRIMARY HYPERTENSION
WITH NORMAL RENAL FUNCTION
S. Cottone, G. Mulè, L. Guarino, M. Guarneri, F. Vaccaro, D. Altieri
Palermo, ITALY
/ 11 RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS AFTER KIDNEY TRANSPLANTATION
I. Mikolasevic ¹, L. Zaputovic 1, L. Zibar 2, I. Begic 2, M. Colic 1, L. Orlic 1
1
Rijeka, 2 Osijek, CROATIA
/ 12 CEREBRAL AT2 RECEPTOR-INTERACTING PROTEIN ENHANCES PROTECTIVE EFFECTS OF AT2
RECEPTOR STIMULATION ON ISCHEMIC BRAIN DAMAGE
J. Iwanami, M. Mogi, X.L. Wang, K. Tsukuda, A. Higaki, M. Kukida, H. Nakaoka, T. Yamauchi, H.Y. Bai,
B.S. Shan, L.J. Min, M. Horiuchi
Tohon, JAPAN
/ 13 THE ENZYMATIC AND ENDOCRINE PATTERN IN PATIENTS WITH CONTROLLED ESSENTIAL
HYPERTENSION
A. Vintila, V. Vintila, C.C. Tudorica, S. Tudorica, C. Serbanete, A. Gurghean
Bucharest, ROMANIA
Posters’ Session PS36
ENDOTHELIUM AND ATHEROSCLEROSIS
Chairperson: R. Joannides (Rouen, FRANCE)
ROOM
POSTERS FROM 1 TO 17
/ 1 TRADITIONAL CARDIOVASCULAR RISK FACTORS ARE MAJOR FACTORS IN ACCELERATION OF
ATHEROSCLEROSIS IN ARTHRITIS PATIENTS
A. Dalbeni 1, M. Mazzon 1, G. Orsolini 1, A. Giollo 1,G.Cioffi2, F. Ognibeni 2, M. Rossini 1, C. Fava 1, O. Viapiana 1
1
Verona, 2 Trento, ITALY
/ 2 ASSOCIATION BETWEEN URIC ACID AND RENAL FUNCTION IN HYPERTENSIVE PATIENTS:
WHICH ROLE FOR SYSTEMIC VASCULAR INVOLVEMENT?
G. Geraci, G. Mulè, M. Morreale, D. Altieri, M.G. Vario, C. Geraci, M. Mogavero, S. Cottone
Palermo, ITALY
F I N A L P R OG R A M M E
231
/ 3 REFERENCE VALUES FOR LOCAL ONE-POINT CAROTID STIFFNESS IN A LARGE HEALTHY
POPULATION
S. Favretto 1, S. Carerj 2, J. Jaroch 3, K. Loboz-Grudzien 3, F. Antonini-Canterin 4, C. Zito 2, E. Bossone 5,
M. Pirisi 1, O. Vriz 6
1
Novara, 2 Messina, ITALY, 3 Wroclaw, POLAND, 4 Pordenone, 5 Salerno, 6 San Daniele del Friuli, ITALY
/ 4 THE RELATIONSHIP BETWEEN VARIOUS METHODS OF CARDIOVASCULAR RISK ASSESSMENT
AND NON-INVASIVE ENDOTHELIAL FUNCTION MEASURES
G. Wilk 1, G. Osmenda 1, M. Nowak 1, D. Rajch 2, T. Sliwa 1, J. Maciag 1, M. Czesnikiewicz-Guzik 1, T. Guzik 1
1
Kraków, 2 Tarnow, POLAND
/ 5 EXPRESSION AND CHANGE IN MIRS 145, 221 AND 222 EXPRESSION IN HYPERTENSIVE
SUBJECTS TREATED WITH ENALAPRIL, LOSARTAN OR OLMESARTAN
C.O. Aragona,G.Mandraffino,V.Cairo,F.Mamone,S.Quartuccio,A.D’Ascola,M.Scuruchi,A.LoGullo,
A. Saitta, E. Imbalzano
Messina, ITALY
/ 6 THE IMPACT OF SERUM URIC ACID ON ASYMPTOMATIC CAROTID ATHEROSCLEROSIS AND
RENAL DISEASE IN HYPERTENSIVE PATIENTS
S. Kostic 1, I. Tasic 1,2, D. Djordjevic 1,2
1
Niska Banja, 2 Niš, SERBIA
/ 7 MODIFICATION OF HISTONE INDUCED BY ACROLEIN IN RAT VASCULAR SMOOTH MUSCLE
CELLS
Z.Yousefipour, M.A. Newaz, M. Esmaeilli, K. Ranganna
Houston, TX, USA
/ 8 EFFECT OF PROINFLAMMATORY CYTOKINES LEVEL IN PLASMA ON ENDOTHELIAL FUNCTION
IN PATIENTS WITH CHRONIC HEART FAILURE
A. Marhol, L. Yankouskaya
Grodno, BELARUS
/ 9 MIRNA-REGULATED CARDIOVASCULAR PATHWAYS IN ESTRADIOL-TREATED HUMAN VEIN
ENDOTHELIAL CELLS
C. Hermenegildo 1, D. Perez-Cremades 1, X. Vidal-Gomez 1, A. Mompeon 1, A.P. Dantas 2, S. Novella 1
1
Valencia, 2 Barcelona, SPAIN
/ 10 ENDOTHELIAL GLYCOCALYX DIMENSIONS ARE SIMILAR IN NORMOTENSIVES AND LOW RISK
UNTREATED HYPERTENSIVE PATIENTS
H. Triantafyllidi, I. Ikonomidis, A. Schoinas, S. Vlachos, M. Varoudi, D. Vlastos, G. Pavlidis, L. Palaiodimos,
J. Lekakis
Athens, GREECE
/ 11 “REVERSE” VASCULAR REACTION AFTER BRACHIAL ARTERY OCCLUSION (FMD) IS RELATED TO
THE IMPAIRED HEMODYNAMICS IN HYPERTENSIVES
A. Stanczyk, P. Krzesinski, G. Gielerak, M. Kurpaska, B. Uzieblo-Zyczkowska, K. Piotrowicz, A. Skrobowski
Warsaw, POLAND
/ 12 METABOLIC CHANGES, BIOMARKERS OF ENDOTHELIAL DYSFUNCTION AND COAGULATION
FACTORS ARE PRESENT IN INDIVIDUALS WITH HYPERTENSIVE CRISIS
D. Oliveira De Andrade 1, F. Valente 1, S. Oliveira Santos 1, M. Gregorio 2, M. Pinhel 1, D. Souza 1, M. Godoy 1,
L. Cosenso-Martin 1, J.F. Vilela-Martin 1
1
São José do Rio Preto, 2 Franca, BRAZIL
/ 13 NONINVASIVE METHODS FOR ENDOTHELIAL FUNCTION ASSESSMENT IN PATIENTS WITH RISK
FACTORS FOR ATHEROSCLEROSIS
G. Wilk 1, G. Osmenda 1, M. Nowak 1, D. Rajch 2, T. Sliwa 1, T. Mikolajczyk 1, M. Czesnikiewicz-Guzik 2, T. Guzik 1
1
Kraków, 2 Tarnow, POLAND
/ 14 COMPARATIVE CHARACTERISTICS OF LOCAL STIFFNESS PARAMETERS IN HEALTHY SUBJECTS
AND PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREES
V. Oleynikov, I. Matrosova, E. Melnikova, L. Salyamova
Penza, RUSSIA
232
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 15 VENOUS OCCLUSION PLETHYSMOGRAPHY AND BIOMARKERS AS EVALUATION METHODS OF
ENDOTHELIUM FUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION
C.L. Junqueira, M.E.C. Magalhaes, A. Brandão, E. Ferreira, A.S.M. Junqueira, J.F.N. Neto, D. Bottino,
E. Bouskela
Rio de Janeiro, BRAZIL
/ 16 BLOOD PRESSURE, ENDOTHELIAL DYSFUNCTION, LIPID SPECTRUM, LEVEL OF LEPTIN IN
PATIENT WITH CORONARY HEART DISEASE IN COMBINATION WITH HEPATIC STEATOSIS DEPEND FROM
BODY MASS INDEX
M. Grechanyk, N. Grechanyk, A. Kuryata
Dnepropetrovsk, UKRAINE
/ 17 CORRELATION OF ERECTILE FUNCTION AND SERUM URIC ACID LEVELS IN HYPERTENSIVE
PATIENTS
G. Moustakas, S. Patsianis, V. Kakiouzi, N. Mousa, D. Vythoulkas, A. Seretis, M.V. Papavasileiou
Athens, GREECE
Posters’ Session PS37
LARGE ARTERIES
Chairperson: G. Schillaci (Perugia, ITALY)
ROOM
POSTERS FROM 1 TO 27
/ 1 TIME TO PEAK OF THE AORTIC FORWARD WAVE DETERMINES THE IMPACT OF AORTIC
BACKWARD WAVE AND PULSE PRESSURES ON LEFT VENTRICULAR MASS
A. Woodiwiss, G. Tade, H.L. Booysen, M.J. Sibiya, I. Ballim, P. Sareli, E. Libhaber, O.H.I. Majane, G.R. Norton
Johannesburg, SOUTH AFRICA
/ 2 ASSOCIATION BETWEEN TWO ANGIOGRAPHIC SUBTYPES OF RENAL ARTERY FIBROMUSCULAR
DYSPLASIA AND CLINICAL CHARACTERISTIC. THE PRELIMINARY DATA OF THE REGISTRY FOR
FIBROMUSCULAR DYSPLASIA
E. Florczak 1, M. Miadziolko 1, E. Warchol-Celinska 1, M. Januszewicz 1, I. Michalowska 1, K. Hanus 1,
K. Jozwik-Plebanek 1, A. Prejbisz 1, P. Talarowska 1, J. Kadziela 1, S. Nazarewski 1, K. Madej 1, K. Grygiel 1,
M. Litwin 1, A. Niemirska 1, M. Skowronska 1, A. Witkowski 1, P. Odrowaz-Pieniazek 1, L. Tekieli 1, A. Januszewicz 1
1
Warsaw, 2 Kraków, POLAND
/ 3 BLOOD FLOW VELOCITY IN THE CAROTID ARTERY IS ASSOCIATED WITH PERIPHERAL
DIASTOLIC BLOOD PRESSURE AND PULSE PRESSURE
G. Kim, D. Moon, S.N. Lee, J.H. Kim, K.W. Moon, K.D. Yoo, C.M. Kim
Seoul, SOUTH KOREA
/ 4 IMPACT OF SEASONALITY AND AIR POLLUTANTS ON WAVE REFLECTION IN HYPERTENSIVE
PATIENTS
M. Di Pilla 1, R.M. Bruno 1, L. Ghiadoni 1, F. Stea 1, L. Massetti 2, I. Bertolozzi 2, S. Taddei 1, P.A. Modesti 2
1
Pisa, 2 Florence, ITALY
/ 5 EVOLUTION OF ARTERIAL STIFFNESS AFTER KIDNEY TRANSPLANTATION: A SYSTEMATIC
REVIEW AND META-ANALYSIS
M. Agharazii, A. Sidebe, C. Fortier, M.P. Desjardins, S. De Serres, F. Mac-Way
Quebec, CANADA
/ 6 ASSOCIATION OF AORTIC PULSE WAVE VELOCITY WITH MINERAL METABOLISM FACTORS AND
BLOOD PRESSURE IN UNTREATED CHINESE PATIENTS
Y.B. Cheng, L.H. Li, Q.H. Guo, C.S. Sheng, Q.F. Huang, F.K. Li, D.Y. Zhang, J. Wang, Y. Li
Shanghai, CHINA
F I N A L P R OG R A M M E
233
/ 7 A GENETIC RISK SCORE FOR TYPE 2 DIABETES IS INDEPENDENTLY ASSOCIATED WITH
ARTERIAL STIFFNESS: THE Malmö DIET CANCER STUDY
M. Gottsäter, G. Hindy, M. Orho-Melander, P.M. Nilsson, O. Melander
Malmö, SWEDEN
/ 8 ASSOCIATION BETWEEN NITRIC OXIDE SYNTHASE POLYMORPHISMS AND ARTERIAL
PROPERTIES IN GENERAL POPULATION
J. Filipovsky, J. Seidlerova, O. Mayer, A. Kucerova, M. Pesta, P. Karnosova
Pilsen, CZECH REPUBLIC
/ 9 HEALTHY LIFESTYLE IS ASSOCIATED WITH LOWER RISK OF EARLY VASCULAR AGEING:
THE OPTIMO STUDY IN LATIN AMERICA
P.M. Nilsson 1, A. Scuteri 2, F. Botto 3, S. Obregon 3, P. Forcada 3, M. Koretzky 3, A. Di Leva 3, E. Huguet 3,
M. Haehnel 3, G. Waisman 3, C. Kotliar 3
1
Malmö, SWEDEN, 2 Rome, ITALY, 3 Buenos Aires, ARGENTINA
/ 10 IMPACT OF INFLAMMATORY CYTOKINES ON AORTIC STIFFNESS IN PATIENTS WITH CHRONIC
KIDNEY DISEASE
M.P. Desjardins, C. Fortier, S. De Serres, R. Lariviere, M. Agharazii
Quebec, CANADA
/ 11 LEFT VENTRICULAR DIASTOLIC FUNCTION AND ARTERIAL STIFFNESS IN RELATION TO SODIUM
DIETARY INTAKE AND RENAL HANDLING IN GENERAL POPULATION
W. Wojciechowska, K. Stolarz-Skrzypek, A. Olszanecka, A. Bednarski, J. Gasowski, T. Grodzicki, H. Barton,
M. Folta, A. Franczyk, K. Kawecka-Jaszcz, D. Czarnecka
Kraków, POLAND
/ 12 CORRELATION BETWEEN CARDIO ANKLE VASCULAR STIFFNESS INDEX (CAVI) AND
SUBCLINICAL CARDIOVASCULAR ORGAN DAMAGE
V. Guida, L.M. Lonati, V. Giuli, G.L. Seravalle, G. Bilo, C. Vergani, G. Parati
Milan, ITALY
/ 13 PROGNOSTIC IMPACT OF ARTERIAL STIFFNESS ON MORTALITY IN BLACK AFRICAN PATIENTS
WITH ACUTE STROKE
D. Lemogoum 1, Y. Mapoure 2, F. Kamdem 2, C. Djomou 2, J. Dissongo 2, P. van de Borne 1
1
Brussels, BELGIUM, 2 Douala, CAMEROON
/ 14 INFLUENCE OF WAVE REFLECTION AND VASCULAR STIFFNESS PARAMETERS ON CARDIAC
STRUCTURE AND FUNCTION IN PATIENTS AT RISK OR WITH TYPE 2 DIABETES
L. Faconti, C.E. Mills, V. Govoni, M.L. Casagrande, L. Yao, A. Webb, J.K. Cruickshank
London, UNITED KINGDOM
/ 15 INHERENT BLOOD PRESSURE DEPENDENCE OF ARTERIAL STIFFNESS INDEX BETA AND
CARDIO-ANKLE VASCULAR INDEX: ASSESSMENT OF PROBLEM AND SOLUTION
B. Spronck 1,2, A.P. Avolio 1, I. Tan 1, M. Butlin 1, K.D. Reesink 2, T. Delhaas 2
1
Sydney, AUSTRALIA, 2 Maastricht, NETHERLANDS
/ 16 RELATIONSHIP OF CAROTID FEMORAL PULSE WAVE VELOCITY WITH AGE AND TIME OF
EVOLUTION IN PATIENTS WITH RHEUMATOID ARTHRITIS
C. Ramos Becerra, D. Cardona Muller, M. Vazquez Del Mercado, E. Gonzalez Bañuelos, E. Perez Vazquez,
J.M. Valadez Soto, A. Macias Chumacera, E. Chavarria Avila, F. Grover Paez, M. Jimenez Cazarez,
C. Garcia Aguilar, S. Totsuka Sutto, E. Cardona Muñoz
Guadalajara, MEXICO
/ 17 CLINICAL PRESENTATION OF PATIENTS WITH FIBROMUSCULAR DYSPLASIA ACCORDING TO
THE NUMBER OF VASCULAR BEDS AFFECTED. THE PRELIMINARY DATA OF THE POLISH REGISTRY FOR
FIBROMUSCULAR DYSPLASIA
K. Jozwik-Plebanek 1, M. Januszewicz 1, W. Wojcik 1, E. Warchol-Celinska 1, K. Hanus 1, I. Michalowska 1,
E. Florczak 1, A. Prejbisz 1, M. Kabat 1, H. Janaszek-Sitkowska 1, P. Andziak 1, L. Stryczynski 2, L. Swiatlowski 3,
P. Odrowaz-Pieniazek 4, L. Tekieli 4, L. Stafanczyk 5, M. Szczerbo-Trojanowska 3, A. Witkowski 1, A. Tykarski 2,
A. Januszewicz 1
1
Warsaw, 2 Poznan, 3 Lublin, 4 Kraków, 5 Lodz, POLAND
234
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 18 THE ASSOCIATION OF FOUR-LIMB BLOOD PRESSURE DIFFERENCES WITH CARDIOVASCULAR
RISK FACTORS AND TARGET ORGAN DAMAGES IN COMMUNITY-DWELLING ELDERLY CHINESE:
THE NORTHERN SHANGHAI STUDY
S. Yu, J. Xiong, Y. Lv, B. Bai, C. Chi, K. Wang, J. Teliewubai, Y. Zhou, X. Fan, H. Ji, L. Wang, Y. Zhang, Y. Xu
Shanghai, CHINA
/ 19 PREVALENCE OF VARIABLES ASSOCIATED WITH ARTERIAL STIFFNESS IN COMMUNAL
PHARMACIES OF THE VALENCIAN COMMUNITY (RIVALFAR-STUDY)
E. Rodilla Sala 1, L. Salar 2, E. Alonso 3, C. Aparicio 2, O. Bellver 2, M. Climent 4, V. Colomer 5, V. Giner 6
1
Moncada, 2 Valencia, 3 Castellón, 4 L´Olleria, 5 Bocairent, 6 Alcoi, SPAIN
/ 20 DIFFERENT CORRELATES OF LEFT AND RIGHT CAROTID ARTERIAL STIFFNESS IN HYPERTENSIVE
PATIENTS
G. Bilo, L.M. Lonati, G. Lan, V. Giuli, V. Guida, G. Parati
Milan, ITALY
/ 21 SUBPOPULATION OF T-CELLS AND MACROPHAGES IN THE DEVELOPMENT OF REACTIVE
CHANGES OF THE AORTIC WALL
M. Afanasyev, P. Chumachenko, Y. Leyusova, G. Heumeits, A. Ivanova, A. Postnov
Moscow, RUSSIA
/ 22 ANTIHYPERTENSIVE TREATMENT AND PROGRESSION OF VASCULAR AGEING
D. Terentes-Printzios, C. Vlachopoulos, P. Xaplanteris, P. Pietri, N. Ioakeimidis, A. Aggelis, M. Abdelrasoul,
E. Paschalidis, D. Tousoulis
Athens, GREECE
/ 23 THE RELATIONSHIP BETWEEN CENTRAL BLOOD PRESSURE AND LEFT VENTRICULAR MASS
INDEX IN COMPARISON WITH CASUAL AND AMBULATORY BLOOD PRESSURES
J. Shin 1, B.Y. Choi 1, Y. Yamori 1, Y. Lee 2, B. Kim 2, S. Choi 1, M. Mori 1
1
Seoul, SOUTH KOREA, 2 Hyogo, JAPAN
/ 24 RISK FACTORS OF SUBCLINICAL VASCULAR DAMAGE DETECTED BY DIFFERENT METHODS IN
POPULATION-BASED SAMPLE OF SAINT-PETERSBURG INHABITANTS
A. Alieva 1, O. Rotar 1, A. Orlov 1, M. Boyarinova 1, E. Vasilieva 1, V. Solntsev 1, E. Baranova 1, A. Rogoza 2,
A.O. Konradi 1, E. Shlyakhto 1
1
Saint-Petersburg, 2 Moscow, RUSSIA
/ 25 PROTECTIVE VASCULAR FACTORS ACCORDING TO VASERA EXAMINATION IN RUSSIAN
POPULATION
N. Soldatenkova 1, O. Rotar 1, A. Orlov 1, M. Boyarinova 1, A. Alieva 1, E. Vasilieva 1, V. Solntsev 1, E. Baranova 1,
A. Rogoza 2, A.O. Konradi 1
1
Saint-Petersburg, 2 Moscow, RUSSIA
/ 26 CARDIOVASCULAR REMODELLING IN HYPERTENSIVE PATIENTS: DOES GENDER MATTER?
V. Pierobon, L. Tavecchia, M. Agostinis, N. Tandurella, A. Grossi, C. Mongiardi, L. Robustelli Test, S. Moretti,
C. Gadaleta, L. Guasti, A.M. Grandi, A.M. Maresca
Varese, ITALY
/ 27 IMPACT OF OVERWEIGHT ON PARAMETERS OF AORTIC AUGMENTATION INDEX IN YOUNG
ADULTS
M. Evsevyeva, N. Konovalova, M. Rostovtseva, I. Prohorenko-Kolomoytseva, E. Shchetinin
Stavropol, RUSSIA
F I N A L P R OG R A M M E
235
Posters’ Session PS38
SPORT AND EXERCISE
Chairperson: P. Lantelme (Lyon, FRANCE)
ROOM
POSTERS FROM 1 TO 16
/ 1 THE RELATIONSHIP BETWEEN REGULAR PHYSICAL EXERCISE AND NOCTURNAL BLOOD
PRESSURE IN KOREAN AMBULATORY BLOOD PRESSURE MONITORING (KORABP) STUDY
B. Kim, J. Shin, Y. Lim, S. Kim
Seoul, SOUTH KOREA
/ 2 THE AMBULATORY HYPOTENSIVE EFFECT OF AEROBIC TRAINING: A REAPPRAISAL THROUGH A
META-ANALYSIS OF SELECTED MODERATORS
P. Sosner 1, T. Guiraud 2, V. Gremeaux 3, D. Arvisais 4, D. Herpin 5, L. Bosquet 1
1
Poitiers, 2 Saint-Orens-de-Gameville, 3 Dijon, FRANCE, 4 Montreal, CANADA, 5 Poitiers, FRANCE
/ 3 THE IMPACT OF EARLY OR LATE EXERCISE TRAINING ON THE MICROVASCULAR ALTERATIONS
INDUCED BY CEREBRAL HYPOPERFUSION
M. Pacheco Leardini Tristão, V. Estato, J. Borges, F. Freitas, R. Rangel, A. Daliry, E. Tibiriçá
Rio de Janeiro, BRAZIL
/ 4 THE IMPACT OF ELEVATED BLOOD PRESSURE ON HEART RATE RECOVERY IN SERBIAN ELITE
ATHLETES
T. Durmic 1, M. Djelic 1, D. Lovic 2, T. Gavrilovic 1, S. Hinic 1, M. Zdravkovic 1
1
Belgrade, 2 Niš, SERBIA
/ 5 AMPKALPHA2 MEDIATES EXERCISE TRAINING-RELATED VASCULAR PROTECTION THROUGH
PROMOTING ENDOTHELIAL AND MITOCHONDRIAL FUNCTION IN MICE
X. Chen 1,2, P. Gao 1,2, Y. Zhang 2
1
Shanghai, 2 Beijing, CHINA
/ 6 POSSIBLE ASSOCIATION OF RESTING AND MAXIMAL BLOOD PRESSURE WITH
REMODULATION OF CARDIAC STRUCTURE AND FUNCTION IN ELITE ATHLETES
T. Durmic 1, M. Djelic 1, D. Lovic 2, T. Gavrilovic 1, S. Hinic 1, M. Zdravkovic 1
1
Belgrade, 2 Niš, SERBIA
/ 7 NET BLOOD PRESSURE REDUCTION FOLLOWING 9-MONTH OF LIFESTYLE AND HIGHINTENSITY INTERVAL TRAINING INTERVENTION IN INDIVIDUALS WITH ABDOMINAL OBESITY
P. Sosner 1, L. Bosquet 1, D. Herpin 1, V. Guilbeault 2, E. Latour 2, L. Paquette-Tannir 2, M. Juneau 2, A. Nigam 2,
M. Gayda 2
1
Poitiers, FRANCE, 2 Montreal, CANADA
/ 8 THE ASSOCIATION OF BLOOD PRESSURE AND BODY COMPOSITION MEASURES WITH
MAXIMAL AEROBIC CAPACITY IN A SWISS WORKING POPULATION
U. Schuepbach 1, J. Mundwiler 1, T. Dieterle 1,2, J.D. Leuppi 1,2, D. Miedinger 2,3, S. Zogg 1,4
1
Liestal, 2 Basel, 3 Lucerne, 4 Zurich, SWITZERLAND
/ 9 ARTERIAL STIFFNESS AND HEMODYNAMIC PARAMETERS CAN BE IMPROVED BY NONPHARMACOLOGICAL TREATMENT
S. Iurciuc, M. Iurciuc, C.A. Avram, C. Avram, D. Baibita, O. Cosor, A. Militaru, D. Gaita, S. Dragan, D. Lighezan,
M. Badalica-Petrescu
Timisoara, ROMANIA
/ 10 ENDOTHELIAL NITRIC OXIDE SYNTHASE-DEPENDENT CARDIOPROTECTION IN EXERCISE
TRAINING IS ESSENTIALLY MEDIATED BY CORONARY ENDOTHELIAL CELLS
A. Nascimento 1, C. Farah 2, G. Bolea 2, A. Kleindienst 1, G. Meyer 1, S. Gayrard 1, A. Lacampagne 2, O. Cazorla 2,
C. Reboul 1
1
Avignon, 2 Montpellier, FRANCE
236
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 11 POST AORTIC DISSECTION: A GAP BETWEEN ACTIVITY RECOMMENDATION AND REAL LIFE
PATIENTS’ AEROBIC CAPACITIES
P. Delsart, P. Maldonado, M. Bic, A. Coisne, O. Domanski, F. Juthier, J. Sobocinski, T. Modine, G. Fayad,
B. Jegou, N. Rousse, S. Haulon, A. Vincentelli, C. Mounier-Vehier, D. Montaigne
Lille, FRANCE
/ 12 LOW INTENSITY ISOMETRIC HANDGRIP EXERCISE HAS NO TRANSIENT EFFECT ON BLOOD
PRESSURE IN PATIENTS WITH CORONARY ARTERY DISEASE
K. Goessler 1,2, R. Buys 1, V. Cornelissen 1
1
Leuven, BELGIUM, 2 Londrina, BRAZIL
/ 13 CARDIORESPIRATORY FITNESS AND ADIPOSITY AS MORTALITY PREDICTORS IN ELDERLY
M. De Rosa, A. Mancini, A. Lombardi, D. Leosco, N. Ferrara
Naples, ITALY
/ 14 SLOW LOADED BREATHING TRAINING ATTENUATES THE EXERCISE PRESSOR RESPONSES IN
THE ELDERLY WITH ISOLATED SYSTOLIC HYPERTENSION
B. Sangthong 1, D.A. Jones 2, C.U. Jones 3
1
Pathum Thani, THAILAND, 2 Manchester, UNITED KINGDOM, 3 Khon Kaen, THAILAND
/ 15 EFFECTS OF MILD DYNAMIC EXERCISE ON CIRCULATORY AND AUTONOMIC FUNCTION IN
HEALTHY VOLUNTEERS
C. Wolff 1, P.O. Julu 1,2, D.J. Collier 1, M. Saxena 1, V. Kapil 1, M. Shah 1, S. Eftychiou 1, E. Mills 1, L. Ansley 3,
A. Elliott 3, O. Mukhtar 1, M. Lobo 1
1
London, UNITED KINGDOM, 2 Froson, SWEDEN, 3 Newcastle, UNITED KINGDOM
/ 16 BLOOD PRESSURE VARIABLES, BODY MASS INDEX AND ARM CIRCUMFERENCE PREDICT
ARTERIAL STIFFNESS AND EARLY ARTERIAL AGEING IN SEDENTARY AND PHYSICALLY ACTIVE SUBJECTS
I. Mozos, A. Lascu, A. Caraba, S. Gligor
Timisoara, ROMANIA
Posters’ Session PS39
TREATMENT ADHERENCE
Chairperson: L. Bortolotto (São Paulo, BRAZIL)
ROOM
POSTERS FROM 1 TO 18
/ 1 PERSISTENCE OF CARVEDILOL VERSUS FIRST AND SECOND GENERATION BETA-BLOCKERS IN
THE TREATMENT OF HYPERTENSION. RESULTS OF THE PERSEUS TRIAL
G. Simonyi, T. Ferenci
Budapest, HUNGARY
/ 2 HOW COMMON IS AMLODIPINE OVERDOSE IN THE TREATMENT OF ARTERIAL
HYPERTENSION?
E. Kociánová, J. Vaclavik, H. Janeckova, D. Fridecky, M. Kamasova
Olomouc, CZECH REPUBLIC
/ 3 TREATMENT DISCONTINUATION AND ADHERENCE IN A COHORT OF BELGIAN PATIENTS NEWLY
DIAGNOSED WITH ARTERIAL HYPERTENSION
G. Karakaya, R. Van Tielen, I. Umbach
Brussels, BELGIUM
/ 4 TETRAHYDROBIOPTERIN EFFECTS LEFT VENTRICULAR DIASTOLIC FUNCTION BY
UPREGULATING PROTEIN KINASE C SIGNALING PATHWAY IN DESOXYCORTICOSTERONE ACETATE-SALT
HYPERTENSIVE MICE
H. Xu, Q. Wang, M. Yang, R. Ma, N. Li, X. Li, X. Lin, X. Zhang, J. Yu
Lanzhou, CHINA
F I N A L P R OG R A M M E
237
/ 5 PROSPECTIVE STUDY TO ASSESS THE IMPACT OF EDUCATION IN PATIENTS WITH SYSTEMIC
HYPERTENSION
C. Tudorica, S. Tudorica, A. Vintila, A. Gurghean
Bucharest, ROMANIA
/ 6 PERISTENCE OF RILMENIDINE THERAPY COMPARE TO ANGIOTENSIN CONVERTING
INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN HYPERTENSION. THE PEAK STUDY
G. Simonyi, T. Ferenci
Budapest, HUNGARY
/ 7 FIXED-DOSE COMBINATIONS OF ANTIHYPERTENSIVE DRUGS MAY NOT IMPROVE BLOOD
PRESSURE CONTROL COMPARED TO FREE DRUG COMBINATIONS: FINDINGS FROM THE SWISS
HYPERTENSION COHORT STUDY
D. Buess, T. Dieterle, J.D. Leuppi, A. Zeller, B. Martina, P. Tschudi, K. Henny-Fullin, S. Giezendanner
Basel, SWITZERLAND
/ 8 THE FIXED DOSE COMBINATION THERAPY IN PATIENTS DIAGNOSED WITH HYPERTENSION IS
BETTER THAN ISOLATED DRUG TREATMENT
R. Cabrera Sole, L. Urrego Rivera, C. Turpin Lucas, D. Calle Salazar
Albacete, SPAIN
/ 9 EVALUATION OF DRUG CONTROL EFFICACY OF ARTERIAL HYPERTENSION IN THE PRIMARY
HEALTHCARE SYSTEM OF YEREVAN
P. Zelveian, Z. Hakobyan, D. Altunyan, L. Dheryan, G. Podosyan
Yerevan, ARMENIA
/ 10 A GAP BETWEEN SELF-ASSESSMENT AND SCREENING SURVEY RESULTS AMONG ARMENIAN
POPULATION WITH UNCONTROLLED ARTERIAL HYPERTENSION
P. Zelveian, G. Podosyan, T. Ustyan, L. Dheryan
Yerevan, ARMENIA
/ 11 COMBINED THERAPY OF HYPERTENSIVE PATIENTS
K. Nikoghosyan
Yerevan, ARMENIA
/ 12 REASONS FOR NOT MODYFING PHARMACOTHERAPY IN POORLY CONTROLLED
HYPERTENSION
A. Kusiak 1, A. Kusiak 2, D. Czarnecka 1
1
Kraków, 2 Myslenice, POLAND
/ 13 IMPACT OF A MULTIDISCIPLINARY INTERVENTIONAL PROGRAMME ON BLOOD PRESSURE
CONTROL AND HEALTHY LIFESTYLE ADHERENCE IN PATIENTS WITH HYPERTENSION AND METABOLIC
SYNDROME
L. Bortolotto, R.G.S. Verardino, R.C.C. Santos, E. Ikeda, F.F. Giacchini, A.L. Duenhas, I. Loyola, P.S.A. Derozier,
E.A. Fonseca, F. Marinho, H.F. Lopes
São Paulo, BRAZIL
/ 14 ASSESSMENT OF FACTORS FOR ADHERENCE TO TREATMENT IN HYPERTENSIVE PATIENTS
A. Markabayeva 1, L. Dyussenova 1, A. Kerimkulova 2, L. Pivina 1, T. Belickina 1, A. Ospanova 1
1
Semey, 2 Astana, KAZAKHSTAN
/ 15 CLINICAL EFFICACY OF TRIPLE ANTIHYPERTENSIVE DRUGS COMBINATION IN HYPERTENSIVE
PATIENTS WITH TARGET ORGAN DAMAGE
G.Khamidullaeva,G.Abdullaeva,L.Khafizova,D.Kurbanova,N.Shakirova,N.Srojidinova, E. Zueva
Tashkent, UZBEKISTAN
/ 16 EFFECT OF IMAGE MEDICINE TREATMENT ON COGNITIVE FUNCTION AND AUTONOMIC
NERVOUS SYSTEM BALANCE IN ARTERIAL HYPERTENSION
D. Voita, E. Vasilevskis, I. Kumisars, E. Valevica
Riga, LATVIA
238
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
/ 17 EVALUATION OF THE FIXED COMBINATION DRUGS IN PATIENTS WITH ARTERIAL HYPERTENSION
U. Kamilova, D. Yarmukhamedova, A. Irnazarov, Z. Rasulova, D. Masharipova
Tashkent, UZBEKISTAN
/ 18 THERAPEUTICAL ADHERENCE IN HYPERTENSIVE PATIENTS
A. Correia De Oliveira, R. Mendonça e Moura, P. Pessanha
Porto, PORTUGAL
Late-Breaker Posters
SESSION 3
Chairperson: TBD
ROOM
POSTERS FROM 1 TO 17
/ 1 RENOVASCULAR HYPERTENSION AS INITIAL MANIFESTATION OF SOLITARY RENAL ARTERY
ANEURYSM IN A YOUNG GREEK MALE
M. Gavra, M. Chertsougk, P. Vlastarakos, C. Dimosthenous, C. Badilas, G. Tzatzahou
Thessaloniki, GREECE
/ 2 OCCUPATIONAL INTERVENTION AFTER ACUTE MYOCARDIAL INFARCTION: THE WORKING
OUTCOME
E.M. Garzillo, V. Crispino, G. Ratti, P. Capogrosso, M. Mallardo, G. Giovane, M. Lamberti
Naples, ITALY
/ 3 SIMVASTATIN IMPROVES MICROVASCULAR CEREBRAL BLOOD FLOW AND ATTENUATES
ANGIOTENSIN II-INDUCED MICROCIRCULATORY CHANGES IN A HYPERTENSION MODEL
F. Freitas, V. Estato, M.A. Lessa, E. Tibiriçá
Rio de Janeiro, BRAZIL
/ 4 ASSESSMENT OF CORONARY HEART DISEASES IN DIABETIC PATIENTS
M. Fathelbab, N. Waly
Cairo, EGYPT
/ 5 ASSESSMENT OF CATECHOLAMINE-INDUCED CARDIOMYOPATHY USING STRAIN
ECHOCARDIOGRAPHY: PRELIMINARY DATA FROM A SINGLE TERTIARY CENTRE
A. Elenkova, R. Shabani, V. Vasilev, S. Zacharieva
Sofia, BULGARIA
/ 6 THE EFFECT OF DIFFERENT ERYTHROPOIESIS-STIMULATING AGENT TYPE TO THE INCIDENCE OF
ARTERIAL HYPERTENSION IN EUVOLEMIC MAINTENANCE HEMODIALYSIS PATIENTS
G. Dorcic 1, F. Simunovic 2, S. Racki 2, B. Devcic 2, J. Radic 3, B. Vujicic 2
1
Umag, 2 Rijeka, 3 Split, CROATIA
/ 7 PREHYPERTENSION AND HYPERTENSION IN URBAN SURINAME
F. Diemer 1, S.M. Baldew 1, G. A. Van Montrans 2, G.P. Oehlers 1, L.M. Brewster 2
1
Paramaribo, SURINAME, 2 Amsterdam, NETHERLANDS
/ 8 STUDY ON VARIATIONS OF PHOTOPLETHYSMOGRAPHIC (PPG) SIGNAL IN HYPERTENSION
N. Danushka, K. Priyankara, I. Rajakaruna, C. Vithanage
Colombo, SRI LANKA
/ 9 GENDER DIFFERENCES RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND ITS RELATION
TO HUMORAL FACTORS IN PATIENTS WITH ARTERIAL HYPERTENSION
G. Dadashova, A. Bakhshaliyev
Baku, AZERBAIJAN
/ 10 EFFECTS OF IVABRADINE ON CENTRAL AORTIC PRESSURE IN PATIENTS WITH STABLE
CORONARY ARTERY DISEASE
Y.M. Lopatin, V.A. Uskova
Volvograd, RUSSIA
F I N A L P R OG R A M M E
239
/ 11 LOOKING FOR MISSING HYPERTENSION FOOTPRINTS IN THE CARDIOVASCULAR RISK
LOCUS 9P21.3: A TALE OF 7 SNPS
J.E. Gallo 1,2, J.E. Ochoa 3, E. Misas 1, G. Bedaya 1, G. Parati 3, D. Aristizábal, 1 J.G. McEwen 1, O.K. Clay 1,2
1
Medellín, 2 Bogotá, COLOMBIA, 3 Milan, ITALY
/ 12 WHAT IS THE NORMAL INTER-ARM DIFFERENCE? IT DEPENDS ON LEFT OR RIGHT
HANDEDNESS: SYSTEMATIC REVIEW AND META-ANALYSIS
S. Joshi, C. Clark, J. Campbell
Exeter, UNITED KINGDOM
/ 13 EFFECTIVENESS OF A COMPREHENSIVE HEALTH PROMOTION STRATEGY IN WORKERS
WITH HIGH CARDIOVASCULAR RISK
E. Calvo-Bonacho 1, C. Catalina-Romero 1, J.C. Sainz-Gutiérrez 1, M. Cabrera-Sierra 1, L. Quevedo-Aguado 1,
C. Fernández-Labandera 1, C. Brotons 2, L.M. Ruilope 2
1
Madrid, 2 Barcelona, SPAIN
/ 14 ARTERIAL STIFFNESS IN EXTREME DIPPER TREATED HYPERTENSIVES CORRELATES WITH
24-H BLOOD PRESSURE PARAMETERS
G. Amah, A. Pasteur-Rousseau, A. Vovelle, N. Kubis, P. Bonnin
Paris, FRANCE
/ 15 THE METABOLIC SYNDROME IN APPARENTLY HEALTHY ADOLESCENTS FROM AN URBAN
POPULATION IN GUAYAQUIL (ECUADOR)
F. Aguirre Palacios 1, A. Coca 2, M.A. Paredes 1, M.F. Aguirre 3
1
Guayaquil, ECUADOR, 2 Barcelona, 3 Valencia, SPAIN
/ 16 CAN ARTERIAL STIFFNESS PREDICT LARGE ARTERY DAMAGE IN SHORT TERM IN PATIENTS ON
DIALYSIS?
A. Laucyte-Cibulskiene, M. Petraviciute, L. Ryliskyte, A. Laucevicius, M. Miglinas
Vilnius, LITHUANIA
/ 17 ROLE OF ACID-BASE BALANCE AT ADMISSION IN RISK STRATIFICATION OF PATIENTS WITH
ACUTE MYOCARDIAL INFARCTION
A. Aboualia, A. Ibrahim, A. Younis
Cairo, EGYPT
Best Posters Discussion
Chairpersons: L. Bortolotto (São Paulo, BRAZIL)
G.S. Stergiou (Athens, GREECE)
POSTER PRESENTATION ROOM
15.00 CIRCULATING PROGENITOR CELLS IN HYPERTENSION: EFFECTIVENESS OF A TREATMENT
WITH OLMESARTAN IN IMPROVING CELL NUMBER AND MIRS PROFILE BESIDES EXPECTED
PHARMACOLOGICAL EFFECTS
G.Mandraffino, C.O. Aragona, S. Quartuccio, V. Cairo, F. Mamone, M.A. Sardo, A. Saitta, E. Imbalzano
Messina, ITALY
15.03 THE AMBULATORY HYPOTENSIVE EFFECT OF AEROBIC TRAINING: A REAPPRAISAL THROUGH A
META-ANALYSIS OF SELECTED MODERATORS
P. Sosner 1, T. Guiraud 2, V. Gremeaux 3, D. Arvisais 4, D. Herpin 5, L. Bosquet 1
1
Poitiers, 2 Saint-Orens-de-Gameville, 3 Dijon, FRANCE, 4 Montreal, CANADA, 5 Poitiers, FRANCE
15.06 EVALUATION OF HYPERTENSIVE PATIENTS: TEN YEARS PROGNOSTIC SIGNIFICANCE OF NONINVASIVE PARAMETERS
D. Djordjevic, I. Tasic, S. Kostic, B. Stamenkovic, M. Lovic, D. Lovic
Niš, SERBIA
240
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
15.09 TIME TO PEAK OF THE AORTIC FORWARD WAVE DETERMINES THE IMPACT OF AORTIC
BACKWARD WAVE AND PULSE PRESSURES ON LEFT VENTRICULAR MASS
A. Woodiwiss, G. Tade, H.L. Booysen, M.J. Sibiya, I. Ballim, P. Sareli, E. Libhaber, O.H.I. Majane, G.R. Norton
Johannesburg, SOUTH AFRICA
15.12 ESTIMATION OF POPULATIONAL 24-H URINARY SODIUM AND POTASSIUM EXCRETION FROM
SPOT URINE SAMPLES. EVALUATION OF FOUR FORMULAS IN A LARGE NATIONAL REPRESENTATIVE
POPULATION
J. Polonia 1, M.F. Lobo 2, L. Martins 1, F. Pinto 1, J. Nazaré 1
1
Lisbon, 2 Porto, PORTUGAL
15.15 ATRAP, A NOVEL INTERACTING MOLECULE WITH AT1 RECEPTOR, INHIBITS ANG II INDUCED
PROLIFERATIVE ACTIVITY AND OXIDATIVE STRESS IN RAT SMOOTH MUSCLE CELLS
K. Azuma 1, K. Tamura 2, T. Taira 2, H. Wakui 2, K. Uneda 2
1
Sagamihara, 2 Yokohama, JAPAN
15.18 COMPARISON OF TWO BLOOD PRESSURE MONITORS USED FOR TELEMEDICAL HOME BLOOD
PRESSURE MEASUREMENT
N. Hoffmann-Petersen, E.B. Pedersen
Holstebro, DENMARK
15.21 AMBULATORY BLOOD PRESSURE MONITORING IN DIALYSIS PATIENTS
D. Klaric, K. Artukovic, M. Razov Radas
Zadar, CROATIA
15.24 TRADITIONAL CARDIOVASCULAR RISK FACTORS ARE MAJOR FACTORS IN ACCELERATION OF
ATHEROSCLEROSIS IN ARTHRITIS PATIENTS
A. Dalbeni 1, M. Mazzon 1, G. Orsolini 1, A. Giollo 1,G.Cioffi2, F. Ognibeni 2, M. Rossini 1, C. Fava 1, O. Viapiana 1
1
Verona, 2 Trento, ITALY
15.27 THE RELATIONSHIP BETWEEN REGULAR PHYSICAL EXERCISE AND NOCTURNAL BLOOD
PRESSURE IN KOREAN AMBULATORY BLOOD PRESSURE MONITORING (KORABP) STUDY
B. Kim, J. Shin, Y. Lim, S. Kim
Seoul, SOUTH KOREA
F I N A L P R OG R A M M E
241
242
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
INDEX OF CHAIRPERSONS,
SPEAKERS AND AUTHORS
F I N A L P R OG R A M M E
243
Index of Chairpersons, Speakers and Authors
A
Abad Rodriguez R. 144
Abad-Cardiel M. 202
Abdel Khalek W. 51
Abdelaziz K.M. 156
Abdelrasoul M. 89, 160, 235
Abdolalizadeh B. 168
Abdullaev A. 214, 215
Abdullaeva G. 142, 214, 215,
238
Abe I. 222
Abejón López L. 179
Abian J. 155
Abid L. 217
Abid M. 153
Abiyeva E. 206
Aboualia A. 240
Aboyans V. 184
Abraham G. 192
Abramovic Baric M. 46, 113,
115, 145, 190, 191
Abreu G. 189
Accetto R. 205, 224
Ackermann D. 52
Adachi H. 150, 190, 226
Adedoyin M. 208
Adeel M.Y. 126
Adingupu D.D. 165
Adoh A. 184
Adoubi K. 142, 184
Afanasyev M. 235
Afreixo V. 127
Agabiti Rosei C. 46, 70, 81,
86, 167, 195, 225
Agabiti Rosei E. 40, 45, 46,
52, 54, 65, 70, 71, 81, 86, 87,
98, 105, 112, 121, 127, 167,
195, 225
Agapova O. 159, 195
Ageeva N.V. 124
Aggelis A. 235
Aggiusti C. 46
244
Agharazii M. 47, 233, 234
Agnoletti D. 120, 158
Agostinis M. 166, 198, 201,
235
Agrati A.M. 143
Aguado J.M. 197
Agudo-Conde C. 127, 165
Aguilera Saldaña M. 219
Aguirre M.F. 191, 240
Aguirre Palacios F. 191, 240
Agyemang C. 108
Ahmed A.H. 51
Ahmed M. 154, 192
Ahn M. 218
Ahouah M. 48, 188
Aigner C. 51
Airò P. 70
Aisicovich M. 224
Aissopou E. 100
Aizawa K. 165
Ajayi I.O. 190
Akdemir N. 181
Akdemir R. 181
Akello H. 172
Akiashvili N. 187, 218
Akl E. 204
Akono F. 221
Akpa O.M. 190
Aksoy M. 181
Al Kattani N. 195
Al Sheik S. 154, 192
Al Tikriti A. 192
Al-Gobari M. 183, 205
Al-Hajj S. 70
Al-Mawla R. 181
Alam A. 216
Alamanos I. 53, 113, 191
Alanis Sanchez G. 140, 174,
213
Alastruey J. 227
Albano M. 43, 214
Albini F.L. 66
Albuisson E. 195
Alcântara C. 180
Alcântara P. 180, 225
Alcázar S. 213
Alcober L. 70
Alderman M.H. 104
Alekhin A. 146
Alekseeva T. 182
Alende M.J. 164, 219, 226
Alesker-zade S. 206
Alexakis L. 160
AlfieriC.56,160,161
Alharbi N. 156
Ali-Tatar Chentir A. 190, 150,
187
Alieva A. 147, 220, 221, 235,
235
Aljama P. 165, 196
Alkattani N. 193
Allaert F. 224
Allain T. 172
Allane D. 190
Allegaert K. 44, 45
Allen S. 221
Allison M. 123
Almeida A. 158, 162, 163, 164
Almeida P. 78, 101, 141, 150
Almeida S. 189
Almgren P. 117, 152
Alonso Domínguez R. 165
Alonso E. 235
Alonso M.J. 182, 207
Alonso Moreno F.J. 145
Alonso-Domínguez R. 127
Altalef R. 192
Altieri D. 59, 81, 115, 157,
180, 196, 231
Altunyan D. 238
Álvarez Álvarez B. 202
Alvarez-Pitti J. 100
Amah G. 240
Amar J. 203, 231
Amar L. 51, 53, 56, 63, 66, 67,
107, 117, 156, 176, 202, 203
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Amberbir A. 172
Ambrosio G. 218
Ambroziak U. 203
Amosova K. 143, 156, 163,
184, 193
Amta P. 146, 221
Anastasio F. 99, 149
Andersen U. 218
Anderson T. 199
Andersson B. 170
Ando T. 203
Andonov S. 151, 227
Andrade Neto L. 194
Andre P. 127
Andreadis E.A. 142, 213
Andreasova T. 70
Andreeva G. 44, 140, 143,
183, 214
Andres A. 197
Andreucci V.E. 90
Andrikou E. 102, 114, 118,
120, 160, 193, 217
Andrikou I. 118
Andziak P. 234
Anestis P. 101, 159
Anex C. 115
Angelopoulos E.T. 142, 213
Angelopoulou S. 186
Angelov A. 179
Angkurawaranon C. 219
Anholm C. 79
Anisimova E. 186
Anjum A. 51
Anjum B. 216
Anna V. 207
Ansaloni A. 84
Ansley L. 237
Anton M. 164
Antoniazzi F. 100, 203
Antoniewicz J. 148, 173
Antonini-Canterin F. 232
Antoniou M. 227
Anttila I. 144
Antunes B. 167, 173
Antunes P. 127
Antza C. 208
Anyfanti P. 145, 167, 185,
192, 209
Aotsuka H. 193
Aoues A. 198
Aparicio C. 235
Aphanasjeva N. 187
Aquino J. 195
Aragiannis D. 102, 118, 160
Aragona C.O. 163, 223, 232,
240
Araki S. 150
Arahtes A. 180
Arantes A.C. 151, 181
Araque J. 202
Araújo A. 78, 101, 141, 150
Araújo Y. 151, 180, 181, 225
Aravantinos D. 180, 183
Arcaro G. 120
Ardeleanu E. 197
Ardeleanu M. 113
Argyris A. 78, 100
Arietaleanizbeascoa M.S. 127
Arima H. 221
Aristizábal D. 240
Arkhipova O. 170
Armario P. 79, 82
Arnold N. 230
Arodites K. 204, 227
Aron G. 185
Aronov D. 171
Arrabito E. 125
Arranz C. 70, 126
Arreche N.D. 192
Arsena R. 157
Arsenescu-Georgescu C. 172
Artero S. 172
Artigas Giorgi D. 212, 214
Artukovic K. 215, 241
Arvisais D. 236, 240
Asayama K. 208
Ascheulova T. 152
Asferg C. 218
Ashley Z. 125
Aslanidis S. 145, 192, 209
Asmar R. 61, 141, 204
Assanelli A. 112
Atallah A. 113, 145, 225
Athanasakis K. 102
Athanase P. 100
Athyros V. 163, 164, 200
Atkins N. 140, 212
Attal P. 100
Atyunina I. 187
Aucella F. 154
Aufberg O. 104
Augeul L. 181, 223
Avdeeva K. 195, 219
Avdelidou A. 151
Avdonina N. 158, 160, 161,
163, 174, 198
Avelar F. J. 197
Avila Barranco E. 197
Ávila M. 197
Avolio A. 47, 58, 89, 109, 198,
234
Avram C. 236
Ayedi F. 147, 153
Azaiez M. 144, 189, 190, 193,
228
Azancot M. 46
Azarine A. 56
Azevedo E. 49
Azizan E. 66, 202, 209
Azizi M. 48, 53, 56, 82, 86, 88,
95, 102, 103, 111, 117, 121,
156, 162, 202
Azuma K. 230, 241
Azzato F. 188, 206
Azzini V. 56, 161, 198
B
Baaj S. 197
Baaj T. 197
Babaeva L. 166, 192, 208
Babcak M. 227
Babic M. 166
Bacchelli S. 46, 115, 145, 190,
191, 222
Bachir Cherif A. 49, 182, 219
Bachtarzi S. 187
Badalica-Petrescu M. 236
F I N A L P R OG R A M M E
245
Badaoui L. 216
Bader M. 125
Badila E. 143, 146, 178, 181,
183, 191, 197
Badilas C. 239
Badilini F. 112
Baetz D. 223
Baev A. 118, 162, 163, 164,
199
Bago M. 154
Baguet J.-P. 158, 162, 203
Baguet S. 158, 160
Bai B. 43, 53, 143, 153, 235
Bai F. 57
Bai H.Y. 103, 231
Baibita D. 236
Baili N. 198
Baixauli V. 213
Baker A. 70
Bakhshaliyev A. 239
Bakras G. 160
Bakris G.L. 117
Balaceanu A. 185, 225, 226
Balakhonova T. 166, 229
Balal M. 215
Balan H. 144, 171
Balanova I. 155
Balanova Y. 52, 191
Balaszczuk A.M. 192
Baldew S.M. 239
Balducci A. 90
Ballarin J.A. 155
Ballim I. 89, 233, 241
Bally S. 158
Baltatzi M. 148
Bandosz P. 199
Bangalore S. 50
Baptista F.A. 100, 149
Barac M. 216
Baranova E. 58, 147, 220,
221, 235
Barbaro N. 162, 163, 164
Barber-Chamoux N. 158, 160
Barberi E. 161
Barbet C. 55, 196, 197
Barbetseas J. 191
246
Barbic J. 194, 209
Barbic Zagar B. 205, 224
Barbiero G. 67
Barbon G. 156
Barbosa E.C.D. 64, 80
Barbouch S. 198
Barbullushi M. 183
Bardaji B. 155
Barigou M. 202
Barin E. 89
Barisic I. 215
Barisic M. 89
Barlassina C. 155
Barna I. 154
Barni S. 154, 169
Baron C. 55, 70, 196, 197
Baron M. 117
Baron S. 202
Baroncini C. 69
Barone A. 188
Barone J. 158
Barrera A. 79
Barrientos G. 92
Barriguete A. 57
Barros C. 180, 225
Barroso W. 68, 100, 151, 181,
191
Bartczak-Rutkowska A. 166
Barton H. 221, 230, 234
Bartos D. 143, 146, 178, 181,
183, 191, 197
Barzel B. 114
Basic Jukic N. 215
Bates M.C. 126
Batista N. 199
Batista S.R.R. 143, 154
Battista F. 99, 149, 212
Battistel M. 67
Battocchio M. 203
Bauer F. 78
Bauerova H. 172
Bauni E. 141
Baurenski L. 215
Bayauli P. 147
Bayo M.A. 161, 198
Baytcheva V. 150, 220
Bazhenova E.A. 58
Bazoukis G. 160, 193, 225
Bazyka O. 228
Bazza A. 225
Beattie E. 91, 118
Bedaya G. 240
Bednarczuk T. 203
Bednarek A. 68, 193, 195,
221, 234
Begic I. 231
Beh H.C. 140
Behlen-Wilm U. 104
Behuliak M. 223
Beige J. 117
Beilin L. 91
Belenkov Y. 169
Beleslin B. 216
Belgrine M. 216
Belickina T. 238
Belli O. 165
Bellien J. 83
Bellver O. 235
Beloliperskaya V. 44, 214
Belotti C. 113
Belozertseva E. 224
Beltrami L. 143
Belyaeva O.D. 58
Ben Abdallah T. 198
Ben Brik A. 192
Ben Hamda K. 144, 189, 193,
228
Ben Hamida F. 198
Ben Romdhane M. 192
Benas D. 59, 146
Benbouabdellah M. 198
Benck U. 164
Benecke A. 66
Benetos A. 45, 61, 68
Benetti E. 78
Benetti M.V. 203
Benglia A. 198
Bengtsson Boström K. 58,
113, 153, 173, 212, 225
Benitez Rivero J. 173
Berardi M. 43, 214
Berbari A.E. 77
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Berendschot T. 87
Berenyiova A. 165, 224
Berezin A. 145, 156
Berezina A. 193
Berezina T. 145
Bergamaschi C.T. 208, 208
Berge E. 50, 78
Berge H.M. 62
Bergerot C. 183
Bergmann K. 81
Berman J. 172
Bernardini D. 83
Berra E. 50, 118, 141, 159,
199
Bersali A. 50
Bertacchini F. 46, 70, 81, 86,
127, 225
Bertello C. 141
Bertherat J. 67
Bertin N. 196
Bertin S. 197
Bertolozzi I. 89, 233
Bertoluzzo M.G. 194
Bertrand M. 169, 174
Beuschlein F. 67
Bevc S. 170
Bezanilla C.G. 208
Bezrodna L. 147, 161
Bezrodnyi A. 184
Bezrodnyi V. 147, 161, 204
Bhura S. 193, 228
Biad A. 49
Biagini C.A. 69
Biancheri R. 124
Bic M. 237
Bicho M. 104
Bichurina M. 178
Bidault-Ducreux S. 181
Bielen P. 182
Bienholz A. 104
Bieniaszewski L. 185, 208, 228
Bighi E. 222
Bignami E. 57
Bika C. 182, 221
Bika Lele C. 128, 221
Bika Lele E. 146
Bilchenko A. 206
Bilchenko O. 206
Billaud E.M. 102
Billiouw J.M. 164, 173
Billordo M.B. 192
Bilo G. 66, 101, 176, 179,
193, G. 193, 206, 207, 234,
235
Bin W. 192
Binas A. 199
Binczyk E. 86, 168
Binda V. 160
Binot E. 229
Birulina J. 168
Birullina Y. 223
Bisognano J. 117
Bisogni V. 67, 103
Bitton S. 204
Blacher J. 48, 51, 53, 57, 63,
78, 85, 100, 112, 113, 120,
188, 204
Blaha M. 104
Blanc Durand P. 68
Blanchard A. 103, 117
Blankesteijn W.M. 69
Blankestijn P.J. 76, 83, 117,
118
Blazejewska-Hyzorek B. 86
Blinova N. 218
Blois S.M. 92
Bluijssen H. 156
Boal A. 172
Boal A.H. 128
Boano V. 190, 209
Bober B. 203
Bobrie G. 50, 53, 56, 82, 117,
162, 202
Boccara F. 181
Bocharova A. 157
Bochaton T. 223
Bochud M. 52, 112, 128
Bockmeyer C. 196
Boddi M. 225
Boddy K. 184
Bodnarashek O. 217
Bødtkjer E. 116
Boersma H. 169, 174
Bogdan S. 184
Bogetto-Graham L. 158
Boggioni I. 81
Bogomaz A. 193, 228
Bogomolova I. 186
Böhm M. 163
Boissel J.P. 50
Bokrantz T. 113
Bokuda K. 203
Bolbrinker J. 221
Boldrini M. 113, 229
Bolea G. 236
Bolgova E. 91, 226
Bombelli M. 81, 91, 227
Bonadei I. 223
BonafiniS.100,203
Bonnet B. 80
Bonnin P. 240
Bonomi F. 91
Bonvallet R. 181
Bonvoisin C. 141
Booysen H.L. 55, 89, 233, 241
Bordicchia M. 115
Borel J.C. 124
Borges J. 236
Borghi C. 46, 54, 62, 80, 94,
99, 115, 120, 128, 145, 190,
191, 222
Borgonovo K.F. 169
Borioni E. 231
Borisova N. 142, 189
Borrelli S. 55
Bortolazzi A. 78, 123
Bortolotto L. 69, 166, 194,
211, 237, 238, 240
Borzak G. 167
Bosch J. 205
Bosquet L. 123, 236, 240
Bossone E. 232
Bosworth H.B. 101
Bots M. 117, 118
Bottino D. 168, 233
Botto F. 46, 70, 144, 195, 234
BouafiaM.T.182,219
Bouamra A. 182, 219
F I N A L P R OG R A M M E
247
Bouatia-Naji N. 65, 116, 139,
155
Bouaziz H. 121
Boubouchairopoulou N. 53,
113, 140, 149, 159, 191, 212
Boudghene-Stambouli F. 160
Bouhanick B. 203, 231
Boukari L. 150
Boukaroucha R. 208
Boukhanovsky A. 91, 226
Boulanger C. 48, 156
Boulestreau R. 46, 203
Boulkroun S. 51, 66
Boully C. 43
Boulvain M. 201
Bouraghda A. 182, 219
Bourhim M. 224
Bouskela E. 168, 233
Bousquet P. 167, 173
Boutari C. 75, 163, 164, 199,
200
Boutou A. 160
Boutouyrie P. 48, 68, 69, 79,
89, 102, 105, 109, 116, 119,
120, 127, 156, 158, 166, 203
Bouzas G.B. 100, 149, 149
Bouzas J.B. 100, 149, 149
Bouziana S.D. 186
Bouzneda I. 190
Bove A. 101
Boyarinova M. 146, 147, 218,
220, 221, 222, 235
Boychuk T. 123
Boyd A. 181
Boytsov S. 52, 142, 153, 155,
178, 191, 208, 214, 216
Bozhenko G. 194
Bozhko V. 183
Bozina N. 157
Bozina T. 157
Brabencova K. 104
Brady A. 122
Brahami A. 208
Brambilla G. 82, 200, 227
Brandão A. 100, 149, 157,
168, 233, 167
248
Brandao A.P. 100
Brandt L. 173
Branny M. 118
Brasil G. 189
Bratu M.M. 148
Bravi E. 222
Bray E. 102
Bray E.P. 101
Braz-Nogueira J. 180, 225
Brazhnik V. 157
Brennan M. 221
Bressan M.A. 113
Brett S. 126
Brewer L. 186
Brewster L.M. 51, 120, 147,
239
Brewster P. 55
Brguljan J. 42, 106
Brguljan-Hitij J. 205
Bricca G. 157
Briceño S. 152
Brier T. 126
Brinza I. 148, 172, 182
Brioni E. 116, 153
Britov A. 183
Bronze L. 184
Brosolo G. 196
Brotons C. 155, 240
Brouard B. 50
Brouwers S. 230
Brown M.J. 66, 202, 209
Brucker M. 158, 160
Brugger C. 67
Brugts J. 91, 169, 174
Brunak S. 71
Brunel V. 83
Brunelli V. 162, 163, 164, 199
Brunner-La Rocca H.P. 49
Bruno R.M. 89, 115, 124, 233
Brunström M. 104
Buard N. 120
Bubic Filipi L.J. 215
Bubnova M. 171
Buchler M. 55, 70, 196, 197
Budzynski A. 167, 171
Buentzel J. 192
Buess D. 102, 238
Bugaev T. 124
Buiatti M. 90
Bulatovic V. 189
Bulgakova I. 157
Bulgaresi M. 69
Bulum T. 151, 164
Bunea D.N. 154
Bunea M. 154, 181
Bunevicius R. 173
Buono F. 90
Buonomo G. 178, 226
Burgun A. 53
Burke S. 114
Burko N. 124
Burnier M. 52, 56, 74, 77, 84,
98, 108, 112, 115, 118, 128,
201, 202
Burrello J. 203
Bursztyn M. 180
Buscarini S. 143
Bushueva O. 156, 157
Buskandar F. 221
Bussotti A. 190
Butler J. 46
Butlin M. 47, 58, 89, 198, 234
Butorova E. 230
Buys R. 237
Bykanova M. 156, 157
Bystrova A.G. 173
C
Cabanes Y. 141
Cabral M.E. 194
Cabrera Fischer E.I. 166
Cabrera Sole R. 147, 219, 238
Cabrera-Sierra M. 50, 240
Cacanyiova S. 165, 224
Cacciatore V. 68, 81
Cadete A. 201, 201, 202
Cafka M. 183
Cagnati M. 46, 115, 145, 190,
191
Cagnoni F. 154, 169
Cahoon G.D. 207
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Cai A. 183
Caillard L. 43
Caimi B. 192
Cairo V. 223, 232, 240
Calabrese M. 190, 225
Calandra L. 115
Caldiroli L. 56, 161, 198
Caleri V. 69
Calero F. 155
Caletti S. 86
Calhau C. 226
Calle Salazar D. 147, 219, 238
Callewaert B. 164, 173
Calo’ L.A. 84, 91
Calvet D. 63
Calvo Gomez C. 164, 219, 226
Calvo Gonzalez G. 226, 164,
219
Calvo-Bonacho E. 50, 240
Cammenga M. 43
Campana E.M.G. 100, 149,
157
Campbell J. 69, 184, 186, 240
Campo D. 120
Campos N. 222, 223
Campos R.R. 208, 208
Camren Pulido E. 201
CaniffiC.70
Cano M. 213
Cantú S.M. 196, 217
Canu L. 67
Cao G. 188, 218
Capogrosso P. 239
Cappuccio F.P. 108
Caraba A. 197, 237
Caracostea G. 201
Caradonna Moscatelli F. 168,
187
Carasca C. 226
Caraus A. 224
Cardona E. 142, 220
Cardona Muller D. 140, 174,
234
Cardona Muñoz E. 140, 142,
174, 201, 213, 234
Cardona Muñoz G. 152
Cardona-Muller D. 213
Cardoso Meira K. 184
Carerj S. 232
Carlberg B. 104
Carlqvist E. 48
Carneiro C. 100
Caroccia B. 202
Carral L. 194
Carrascal M. 155
Carrasco Carrasco E. 145
Carrère P. 113, 145, 151, 225
Carretta A. 192
Carretta R. 116, 203
Carrillo Linares J.L. 180
Carrizo P. 70, 195
Carugo S. 192
Caruso G. 178, 226, 229
Carvalho A. 189
Carvalho L. 200
Carvalho-Rodrigues M. 184
Casadei F. 165, 213, 225
Casagrande M.L. 120, 234
Casamassima N. 57, 153
Casanova F. 165
Casanova M. 218
Casciello A. 183
Casella E. 86
Casemiro A.L.M. 140, 151
Casiglia E. 78, 83, 91, 101,
123, 184
Cassi A. 222
Cassidy A. 153
Castañeda X. 171
Castaño-Sanchez C. 127
Castañon A. 126
Castellani S. 225
Castellano M. 110, 195
Castellano Vázquez J.M. 65
Castelo-Branco M. 184
Castiglia A. 115, 180, 196
Castro P. 49
Castro-Vega L.J. 116
Catalina-Romero C. 50, 240
Catena C. 81, 196, 227
Catez E. 181
Catharina A. 162, 163, 164
CaulfieldM.J.105,116,117
Cauwenberghs N. 44, 61, 81,
155
Cavallini M.C. 69
Cavarzere P. 100
Cazorla O. 236
Cecelja M. 89
Cedeño M. 202
Cekerevac I. 229
Celebrano M. 153
Celecova Z. 150
Celic V. 80, 81, 217
Celovska D. 166, 216
Cendrowska-Demkow I. 70, 86
Cerasi C. 178
Cerasola G. 59, 81
Ceresiani M. 115
Cerini L. 221
Cerny D. 46
Cerou M. 183
Cerutti C. 157
Cervia S. 124
Cesareo D. 144
Cesari M. 103
Chaabouni K. 147, 153
Chaabouni Y. 216
Chacheva K. 201
Chaib A. 85
Chaibi L. 212
Chakalova-Yancheva T. 157
Chaker H. 217
Chakova N.N. 230
Chalmers J.P. 88, 112, 169,
174
Chambon Y. 48, 156
Chamontin B. 162, 203, 211,
212, 231
Chamoso-Santos P. 158
Chang G. 148
Chang K. 194
Chang P. 57
Chapman M.J. 94
Chappuis A. 128
Charfeddine S. 217
Charniak S. 142
Charonis A. 160
F I N A L P R OG R A M M E
249
Chasiotis V. 148
Chatellier G. 53
Chatzakis C. 153
Chatzichristodoulou C. 113,
191
Chatzimichailidou S. 145,
192, 209
Chatzis D. 118, 160, 225
Chatzistamatiou E. 196
Chaussade E. 43
Chauvelier S. 43
Chavarria Avila E. 234
Chaves F. 52
Chazova I.E. 52, 124, 153,
154, 155, 159, 163, 166, 170,
171, 191, 195, 203, 204, 205,
218, 229, 230
Chekneva I. 169
Chemin J. 51
Chemla D. 100
Chen B. 159
Chen C. 180
Chen J. 183
Chen Q. 215
Chen T. 55
Chen X. 236
Cheng H. 180
Cheng Y.B. 140, 215, 233
Chentir M.T. 150, 187, 190
Chernatskaya O. 166
Chertsougk M. 239
Chervenkov T. 178
Cheung M.M.H. 207
Chevalier P. 183
Chi C. 43, 53, 78, 153, 235
Chia Y.C. 140, 180
Chiandotto S. 125
Chibane A. 49, 85
Chichel L. 229
Chikhladze N. 166
Ching S.M. 180
Chinomba G. 172
Chioncel V. 204
Chiu B. 159
Chlouverakis G. 53, 113, 191
Cho D.K. 141
250
Cho E. 220
Choi B.Y. 235
Choi J. 146
Choi M.G. 151
Choi M.R. 196, 217
Choi S. 213, 235
Choi T.Y. 141
Chol C.U. 49
Chorão A. 160
Chorepsima S. 101, 149
Chou C. 179, 222
Chou P. 180
Chouabe C. 181
Choukroun G. 51
Chouzouri V. 140, 142, 213
Chowienczyk P. 89, 104, 109,
126, 227
Christensen K.L. 170, 213
Christian D. 117
Christina A. 161
Christou F. 202
Chrostowska M. 228
Chu C. 160, 166
Chu S.L. 67
Chuang S. 180
Chudek J. 199
Chudinovskikh T. 214, 215
Chukaeva I. 184, 187, 213
Chukanova M. 201
Chuluyan E. 195
Chumachenko P. 235
Chumakova G. 179, 191, 226
Chung R. 58
Chung S. 160, 221
Churnosov M. 156, 157
Ciardo M. 183
Cicchetti T. 55
Cicero A.F.G. 46, 115, 120,
128, 145, 190, 191, 222
Cicognini F.M. 222
Cidoncha A. 198
Cifkova R. 91, 95, 172
Cinza Sanjurjo S. 173
Ciobanu M. 218
CioffiG.231,241
Ciric J. 216
Cismaru G. 189
Citro R. 183
Cittadini A. 183
Citterio L. 116, 153, 155
Clarà A. 82
Clark B. 167
Clark C. 69, 184, 186, 240
Clark J.F. 120
Claudio E. 189
Clauser E. 51, 98
Clay O.K. 240
Clement D.L. 59, 80, 93
Clementi A. 90
Clerson P. 170, 205
Climent M. 235
Clough R. 48
Cloutier L. 184, 212
Coca A. 54, 65, 80, 102, 105,
191, 240
Cockcroft J. 104
Coelho R. 186
Coen C.W. 92
Cofta S. 229
Cohen A. 181
Coinu A. 154
Coisne A. 237
Coley S. 104
Colic M. 231
Collado M.C. 156
Collén A. 154
Collier D.J. 237
Collier D.M. 126
Colombo F. 143, 143
Colombo G. 225
Colomer V. 235
Colonetti E. 86, 127, 225
Colussi G.L. 81, 196, 227
Combe C. 51
Comotti T. 120
Concistrè A. 203
Connolly K. 47
Conte G. 55
Contini M. 168, 187
Cooper C. 55, 224
Corchado-Rodríguez J.M. 158
Cordova Villalobos J.A. 57
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Cormican L. 222, 229
Cornelissen G. 216
Cornelissen V. 237
Cornu C. 50
Corrao G. 43, 88
Correa C. 229
Correa N. 162, 163, 164, 199,
201, 202
Correia De Oliveira A. 239
Corticchiato C. 202
Corvol P. 88
Cosenso-Martin L. 194, 232
Cosic A. 87, 167, 168, 174,
219
Cosmo W.R. 171
Cosor O. 236
Costa M. 127
Costa T. 151, 181, 191
Costa-Hong V. 69, 166
Costanzo S. 112
Cotter J. 120
Cottone S. 59, 68, 81, 115,
157, 180, 196, 231
Coucke P. 166
Courand P.-Y. 82, 158, 162,
165, 190, 211, 227
Covella M. 141, 199
Cozzio S. 78, 123
Craina M. 201
Crapa M.E. 99, 149
Cremer A. 46, 82, 203, 231
Crickmore H. 120
Crippa G. 222
Crisp Martins Ribeiro C. 141
Crispino V. 239
Critselis E. 160
Cross M. 51
Crowther N.J. 145
Cruickshank J.K. 59, 89, 109,
120, 141, 153, 234
Cruz Coutinho J. 160
Cruz L.A. 163
Csitári G. 219
Cubero J.J. 161
Cucherat M. 205
Cui W. 205
Culig J. 113, 154, 221
Cunha A. 218, 229
Cunha C. 161
Cunha F. 191
Cunha P. 68, 79, 120
Curila K. 118
Curras-Freixes M. 67
Currie G. 50
Cusi D. 116, 155
Cuspidi C. 80, 81, 91, 119,
207, 217, 227
Cusumano C. 68, 180
Cuzor T. 146
Cvetkovic J. 151, 227
Cwynar M. 230
Cyrino F.Z.G.A. 168
Czarnecka D. 68, 115, 118,
162, 163, 165, 170, 182, 193,
195, 221, 222, 228, 234, 238
Czernichow S. 53
Czesnikiewicz-Guzik M. 232
Czlonkowska A. 165
Czubkowski P. 148, 173
D
D´El-Rei J. 218
D’Abbondanza M. 99, 149,
212
D’Addario M. 225
D’Addato S. 46, 115, 128,
145, 190, 191, 222
D’Alessio I. 213
D’Amico F. 186, 187, 189
D’Angelo A. 83
D’Angelo A.R. 196
D’Arrigo G. 55, 84, 200
D’Ascola A. 232
D’Avino M. 178, 226
D’Elia L. 69, 128
D’Halluin P. 197
D’Hooge J. 81
D’Ignoto F. 68
d’Udekem Y. 207
Da Silva A.P.M. 140, 151
Da Silva M.A.V. 140, 151
da Silva Pereira E.N.G. 50
Dabrowski M. 200
Dadashova G. 239
Dagnelie P. 49, 87
Dahak A. 49
Daien V. 168
Daka B. 123
Dalbeni A. 58, 231, 241
Daliry A. 50, 167, 173, 236
Dall P. 153
Dalle Vedove F. 100, 203
Damasceno A. 64
Danchin N. 53, 166
Danieli M. 159
Daniil G. 51
Danilogorskaya Y. 169
Danilov N. 163
Dankovics G. 154
Danser A.H.J. 92, 103, 200
Dantas A.P. 125, 232
Danushka N. 239
Dapic K. 55, 91, 113, 145, 221
Daraban A.M. 143, 146, 178,
181, 183, 191, 197
Darabont R. 113, 172, 197
Dartigues J.F. 172
Darybayeva A. 189
Daskalaki A. 213
Davakis S. 140
Davidovic G. 229
Davies J.E. 54
Dawood O. 199
De Andrés Miguel C. 141
de Backer T. 164, 173
de Blasio F. 69
De Cabo-Laso A. 158
De Caro M.F. 187
de Castro H.C. 50
De Chiara B. 225
De Ciuceis C. 70, 86, 167, 195
De Faria A. 162, 199
de Gaetano G. 112
De Groote M. 164, 173
de Jager R. 117
De Jong M. 118
de la Sierra A. 60, 79, 82
F I N A L P R OG R A M M E
251
de Leeuw P.W. 83, 84, 117,
217
De Mitri A. 182
De Nicola L. 55
De Paz-Santana J.F. 158
De Rosa M. 221, 237
De Serres S. 47, 233, 234
De Vriese A. 164, 173
Debenedittis L. 168, 187
Debette S. 69, 172
Debicka-Dabrowska D. 193
Deborde T. 53
Dediu G. 185, 226
Deev A. 52, 142, 191, 208,
214, 216
Defforges-Ranc A. 128
Degaute J.P. 128, 146, 147,
182, 221
Degli Esposti D. 46, 115, 145,
190, 191
Deif M. 189
Deinum J. 66
Dekkers O. 67
Del Giudice A. 154
Del Pinto R. 178
Deleanu A. 197
Delhaas T. 89, 234
Deligkaris P. 163, 164, 200
Deljanin Ilic M. 203
Dell’Oro R. 81, 82, 200, 227
Delles C. 44, 46, 50, 91, 104,
172, 202
Delli Carpini S. 153, 155
Delsart P. 48, 82, 160, 162,
166, 237
Delva P. 153
Demarquay G. 190
Demikhova N. 166, 216
Demougeot C. 185
Denby L. 70
Denguir H. 192, 200
Denisova I. 205
Denolle T. 82, 125, 162
Dermanovic Dobrota V. 164
Derosa G. 170, 83
Derozier P.S.A. 238
252
Desantis F. 99, 149
Desjardins M.P. 47, 233, 234
Desmeules S. 47
Dessein P.H. 55
Destors M. 124
Destro M. 154, 169
Deutschbein T. 67
Devcic B. 239
Devereux R.B. 82
Devikar S. 214
Devireddy C. 126
Devos P. 48, 166
Devuyst O. 52
Deynega V. 195
Dhakate T. 214
Dhar I. 182
Dhaun N. 58
Dheryan L. 238, 238
Di Bari M. 69
Di Castelnuovo A. 112
Di Giosia P. 222
Di Leva A. 46, 70, 144, 195,
234
Di Marco A. 140
Di Monaco S. 141, 159, 199
Di Pilla M. 89, 233
Di Stefano C. 43, 190, 209,
227
Di Stefano R. 163, 199
Diaconu C. 185, 225, 226
Diaconu N. 146
Diaki T. 154
Diakoumakou O. 213
Diaz A. 156, 166
Díaz Rodriguez A. 145
Diby F. 142, 184
Didangelos T. 148
Diegel U. 97
Diemer F. 51, 147, 239
Dieterle T. 102, 236, 238
Dietz A.S. 67
Dieye A. 205
Diez J. 117
Dika Z. 55, 89, 91, 113, 145,
221
Dimakopoulou A. 199
Dimas G. 83, 151, 152, 153,
195, 197
Dimitriadis K. 74, 104, 106,
114, 118, 120, 147, 160, 217,
225
Dimitrov Y. 158
Dimosthenous C. 239
Dimulescu D. 172
Dina I. 185
Dipla K. 81, 92, 185, 192
Dissongo J. 128, 146, 182,
221, 234
Ditisheim A. 201
Ditting T. 118, 163
Ditu S. 147
Divkovic D. 219
Djacheko Y.A. 154
Djachenko Y. 183
Djadi Pratt J. 203
Djelic M. 236, 236
Djomou C. 234
Djordjevic D. 151, 188, 218,
227, 232, 240
Dmitrieva N. 140, 214
Dobrokhod A. 140, 198, 200,
220
Dobrovie M. 142, 178
Dobrovolskiy A.B. 124
Dobrowolski P. 70, 86, 199
Dobsak P. 216
Dodig Curkovic K. 185
Doenz F. 202
Dognini G.P. 154, 169
Dohi Y. 141, 221
Döhler B. 55
Dolan E. 43, 104, 123, 186,
206, 222, 229
Dolenc P. 205
Dolgusheva Y. 195
Dolotovskaya P. 208
Dolovich L. 50
Dolzhenko M. 154, 183
Domanski O. 237
Domenig O. 51
Dominguez-Luca A.S 147
Dominguez-Lucas A. 52
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Dominiczak A.F. 44, 63, 71,
84, 94, 104, 116, 155, 172,
204
Domislovic V. 55, 91, 113,
145, 221
Donati M.B. 112
Donato M. 192
Dong H. 160
Donini C. 81
Donoso A.S. 217
Dorcic G. 239
Dorobantu M. 58, 106, 113,
158, 172, 182, 197
Doroshchuk A. 157
Doroshchuk N. 157
Dos Santos J. 184
Dotis I. 208
Douma S. 81, 91, 92, 145,
167, 185, 192, 209
Doumas M. 74, 75, 163, 164,
199, 200
Dourmap C. 82, 158, 160,
162
Dovgalevskij P. 208
Dovganych N. 228
Dovhan E. 204
Dovinová I. 224
Dragan S. 236
Drangova E. 163
Dreier R. 168
Drenjancevic I. 87, 167, 168,
174, 219
Dreyfuss Tubiana C. 48, 188,
204
Drobna M. 165, 224
Droganova A. 189
Drossopoulou G. 196, 209
Drozdz D. 149
Drozdz T. 149, 193
Drummen N.E.A. 45
Drummond C. 55, 224
du Cailar G. 80, 168
Du L.F. 206
Dubiel J.S. 58
Dubinina E. 146
Dubois B. 141
Dubourg J. 103, 117
Ducher M. 51
Dudley S.C. 177, 209
Dudzik-Plocica A. 154
Duenhas A.L. 238
Duffy N. 82
Dukat A. 150, 216
Dulak-Lis M.G. 146
Dumas D. 224
Dumitrescu S. 142
Dunklerova L. 216
Dupont A.D. 230
Dupré-Aucouturier S. 181
Dupuy O. 123
Durand A. 181
Durmic T. 236, 236
Duron E. 43
Duse S. 195
Dusek J. 216
Dussol B. 51
Dutu B. 189
Duvnjak L. 151
Dvorak J. 70, 194
Dvorsak B. 170
Dyussenova L. 238
Dzieza-Grudnik A. 167, 198,
199, 200, 228
Dzyak G. 146
E
Eber B. 113, 158
Eckert S. 200
Eda H. 142
Ederhy S. 181
Efremov L. 46
Efremova I. 155
Efthymiadis G.K. 204
Eftychiou S. 237
Eguchi K. 91
Egurbide Arberas M. 207
Ehret G. 52, 104
Eikelis N. 118
Eisenhofer G. 168
Eisenreich A. 125
Ekart R. 170
El Hangouche Abdelakder
J. 85
El Nounou H. 189
Elango K. 193, 228
Elenkova A. 239
Elesgaray R. 126
ElfimovaE.182,229,230
Elhraiech A. 144, 189, 190,
193, 228
Eliasson L. 155
Eliseeva I. 142, 189
Elliott A. 237
Elvan A. 118, 162
Elyas S. 165
Emelyanov I. 158, 160, 161,
163, 174, 198
Empana J.-P. 79, 88, 116, 176,
190
Enayat Z.E. 153
Endlich P. 189
Engstrom G. 117
Enomoto M. 150, 190, 226
Epalza Bueno A. 207
Erasmus R. T. 146, 156, 150
Erba G. 227
Erbel R. 89
Erdine S. 97, 127
Erdman V.V. 145
Eremin M. 195
Erglis A. 171
Ericson U. 117, 152
Erina A. 191, 222
Ermolenko T. 158
Errani A.R. 43, 214
Esche J. 225
Escobar A. 182, 207
Escobar Cervantes C. 144
Escouto D. 201
Escoval A. 225
Esguerra J.S. 155
Esler M. 118
Esmaeilli M. 232
Espie C. 82
Espinel E. 46
Espinosa E. 143, 231
Esposito A. 192
F I N A L P R OG R A M M E
253
Esposito P. 90
Estato V. 50, 167, 173, 217,
236, 239
Esteban Luque A. 144
Etriby A.E. 214
Etyang A. 141
Euzébio M. 180
Evenepoel P. 108
Evenepoel P. 45
Evsevyeva M. 195, 201, 235
Ewen S. 163
Ezhova N. 216
F
Fabris B. 203
Facchetti R. 91, 165, 227
Facciuto F. 194
Faconti L. 120, 153, 234
Fadl Elmula F.E. 41, 118, 162,
170, 120
Fadzil M. 207
Fagard R.H. 59
Fagour C. 151
Faini A. 124, 206, 207
Falaschetti E. 51
Falcão J.L. 194
Falcão S.N. 194
Falkovskaya A. 118, 162, 163,
164, 186, 172
Fall M. 183, 205
Fallo F. 156, 203
Fan X. 224, 235
Fan Y. 206
Fania C. 78, 123
Faradzh C. 154
Faradzh K. 183
Farah C. 236
Faria A. 162, 163, 164
Faria R.A. 157
Farina F. 165
Farsang C. 42, 171
Farukh B. 126
Faselis C. 163, 164, 200
Fassina A. 202
Fassnacht M. 67
254
Fathelbab M. 239
Faucon A. 56
Fauvel J.-P. 51, 76
Fava C. 58, 100, 117, 153,
203, 231, 241
Favero G. 167
Favretto S. 232
Fay R. 227
Fayad G. 166, 237
Fedele F. 214
Federico F. 168, 187
Fedorishina O. 205
Fedorova V. 230
Fedyk-Lukasik M. 58, 167
Fejes I. 192
Feki S. 216, 217
Feldman R.D. 83
Felice F. 199
Fellet A.L. 192
Feng Y. 183
Ferdaus M. 126
Ferenci T. 219, 237, 238
Fernandes J.C. 161
Fernandes R. 127
Fernandes-Rosa F.L. 51, 66
Fernandez A. 147
Fernández B.E. 196
Fernandez C. 152
Fernandez D. 229
Fernandez M. 197
Fernandez-Berges D. 161
Fernández-Labandera C. 50,
240
Fernández-Llama P. 155
Fernández-Meseguer A. 50
Ferrante G. 192
Ferrara L.A. 182
Ferrara N. 221, 237
Ferrari E. 162
Ferrari R. 91, 169, 174
Ferraro G. 143
Ferreira C. 49
Ferreira E. 168, 233
Ferreira R. 201, 202
Ferreira V.R. 191
Ferrer E. 213
Ferrer S. 155
Ferreri N.R. 155
Ferretti G. 222
Ferri C. 99, 178, 222
Ferri S. 128
Ferrucci L. 69, 186
Fesler P. 80, 168
Fezeu L. 53
Filip G. 59
Filip M. 59, 116
Filipe R. 160
Filipiak K.J. 154
Filipova S. 78, 123, 178
Filipovsky J. 45, 104, 234
Filonenko M. 189
Fiorentino D. 178
Fiquet B. 51
Fischer G. 200
Fistrek Prlic M. 55, 91
Flahault A. 103, 126
Flak L. 163
Flessas D. 118
Florczak E. 48, 86, 165, 199,
233, 234
Florea M. 218
Floyd C. 126
Flynn J. 50
Fodor L.J. 157, 221
Fogacci F. 120, 191, 222
Fogliacco P. 43, 214
Fok H. 227
Folta M. 221, 234
Fondrieschi L. 153
Fonseca E.A. 238
Fonseca F.L. 100, 149
Fontana V. 162, 199
Foran J. 104
Forcada P. 144, 234
Fortier C. 47, 233, 234
Foster III M.T. 126
Foulquier S. 69
Fouque D. 128
Fournier T. 197
Fox K. 169, 174
Frana P. 220
Francesco A. 46
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Franczyk A. 165, 195, 221,
234
Franjic N. 218
Frank M. 48, 117, 156
Frantzeskakis A. 114, 193
Franzosi C. 225
Fraser N.J. 155
Freel M. 172
Freitas F. 236, 239
Freitas R.G.A. 100, 149, 157
Frías Vargas M. 173
Fridecky D. 237
Friederich-Persson M. 146
Friedrich S. 49, 168
Frolova I. 146
Fronea M. 185
Fronius M. 125
Frydrychowski A. 185, 208
Fucek M. 46, 55, 91, 115, 145,
190, 191, 221
Fuentes M.E. 161
Fujii M. 103
Fujine S. 222
Fukami A. 150, 190, 226
Fukumoto Y. 150
Fukuoka S. 193
Fulcheri C. 141, 159, 199
Funck-Brentano C. 103
Furman N. 208
Furniss S.S. 104
Fuskevåg O. 162
Fyhrquist F. 117
G
Gabba M. 113
Gabriel M. 166
Gac P. 185 185
Gaciong Z. 125, 139, 168,
169, 172, 200
Gackowska L. 149, 150
Gadaleta C. 198, 201, 235
Gafarov V. 182
Gafarova A. 182
Gagulin I. 182
Gaillard P. 203
Gaita D. 148, 236
Gajic M. 179
Gal C.M. 178
Galan P. 116
Galan-Chilet I. 52
Galanakos S. 147
Galani A. 196
Galani-Manolakou M. 160
Galanti G. 225
Galazka Z. 70
Galerneau L.l.M. 124
Galgo A. 144
Galitsin P. 229, 230
Galkova K. 223, 224
Galletti F. 128
Galli C. 166
Gallineo L. 55, 91, 113, 145,
221
Gallo A. 86, 167, 198
Gallo H. 155
Gallo J.E. 240
Gandolfo M.T. 160
Ganem F. 212, 214
Ganesh S.K. 116
Gangoda S.V.S. 58
Gantchev G. 203
Gao L. 67, 83, 116, 163, 207
Gao P. 92, 126, 231, 236
Gapon L. 195, 215, 219
Garavelli G. 78, 123
Garcia Aguilar C. 213, 234
García Bellot A. 141, 213
Garcia Benavides L. 201
García Carretero R. 152, 197,
218
Garcia De Tena J. 179
Garcia Donaire J.A. 144, 202
García Frias P. 180
Garcia Garcia O. 197
García M.E. 213
García S. 224
Garcia-Corral R. 213
Garcia-Garcia A. 158
Garcia-Ortiz L. 127, 158, 165
Garcia-Rios A. 165
Garone D. 172
Garrido Castro A. 180
Garzillo E.M. 239
Garzon M. 123
Gasecki D. 69
Gasimov Z. 206, 217
Gaskina A. 84, 159, 162, 174
Gasowski J. 163, 182, 230,
234
Gaspar L. 150, 166, 216
Gasparova I. 150
Gataulin R. 177
Gatault P. 55, 70, 196, 197,
197
Gates P.E. 165
Gaudio G. 170
Gavana M. 191
Gavazzi A. 70, 195
Gavazzoni M. 223
Gavish B. 212
Gavornik P. 150
Gavra M. 239
Gavrila A. 218
Gavrilovic T. 236
Gayda M. 123, 236
Gayrard S. 236
Gazzola K. 43
Ge Q. 83
Gehring J. 212
Geladari C.V. 142, 213
Gelis L. 188
Gell H. 148
Gellineo L. 215
Generalov V. 168
Gensini G. 42
Georgakopoulos D. 149
Georgantoni A.I. 142, 213
George C. 145
Georgevsky D. 47
Georgianos P. 160, 161
Georgianou E. 199
Georgiev B. 150, 220
Georgiopoulos G. 193
Geraci C. 231
Geraci G. 68, 81, 115, 231
Geraldo Pierin A.M. 184
Gerasymenko O. 208
F I N A L P R OG R A M M E
255
Germanò G. 214
Gersak G. 159
Gertner M. 199
Ghali M.G.H. 126
Gharib A. 223
Gheghici S. 204
Gherman O. 146
Ghiadoni L. 58, 89, 115, 124,
233
Ghiurco I. 158
Ghyselinck N.B. 66
Giacchetti G. 203
Giacchini F.F. 238
Giaconia M.B. 183
Giallauria F. 183
Giampatzis V. 186
Giannattasio C. 89, 165, 213,
225
Giannini L. 115
Giardina G. 92
Gibson I. 82
Gidaris D. 208
Gielerak G. 194, 232
Giezendanner S. 102, 238
Gil A. 68, 104
Gil Gil I. 145, 173
Gil Guillen V. 141, 147, 213
Gill D. 185, 186
Gimenez-Roqueplo A.-P. 66, 67
Giner Galvañ V. 141, 213
Giner V. 235
Ginghina C. 189
Gioco F. 202
Gioia G. 229
Giollo A. 231, 241
Giordano P. 143
Giorgini P. 178, 222
Giorgishvili I. 187
Giovane G. 239
Giovannini M. 120
Girard A.C. 208
Girard P.M. 181
Girerd N. 190
Girerd X. 86, 113, 162, 167,
198, 203, 220
Gironacci M.M. 103
256
Gismondi R. 229
Giugno L. 192
Giuli V. 101, 234, 235
Giuliani E. 69
Giulietti F. 143, 231
Gjata M. 148, 152, 184
Gjessing P. 162
Gkaliagkousi E. 81, 167, 185,
192, 209
Glatz N. 128
Gligor S. 237
Glukhova S. 155
Gluszewska A. 167, 207, 230
Gnaba A. 142, 184
Gnerre Musto T. 196
Gobetto N. 126
Godoy M. 194, 232
Godoy Rocatí D. 141, 213
Godwin M. 101
Goedecke J.H. 145
Goessler K. 237
Goetze J. 218
Goffredo I. 170
Gohlisch C. 141, 212
Gohlke H. 221
Gokçay I. 204
Golib Dzib J.F. 66
Golovko M. 187
Gomes F. 167, 173
Gomes Filho J. 194
Gómez M. 70
Gomez Sanchez L. 158, 165
Gómez Sánchez M. 165
Gómez-Arranz A. 127
Gomez-Marcos M.A. 127, 158,
165
Gomez-Sanchez C.E. 66
Gonçalves C. 222, 223
Goncalves-Rosa N. 219
Goncharova N. 193
Gonsorcik J. 216
Gonzaga A. 201
Gonzales M. 123
Gonzales M.C. 50
Gonzales-Ryes A. 182
Gonzalez A. 117
Gonzalez Bañuelos E. 234
Gonzalez Candia B. 161, 198
Gonzalez De Caldas R. 165
González J. 218
González Maglio D. 70
Gónzalez Ortíz M. 152
González-Cruz Cervellera A.
141, 213
González-Viejo N. 127
Gooding K.M. 165
Gorbunov V. 44, 140, 142,
143, 208, 214, 216
Gorda I. 184
Gordin D. 118, 139, 150, 162,
170
Gordon R.D. 67
Gorga E. 223
Gorieva S. 187
Gorjão Clara J. 68, 104
Gornik H.L. 116
Gorsane I. 198
Gorska E. 99
Gosh A. 159
Gosk-Przybylek M. 86, 168
Gospodinov K. 157
Gosse P. 45, 46, 82, 119, 162,
203, 231
Gotchev D. 220
Gotcheva N. 150, 220
Gottsater A. 139, 153, 170
Gottsäter M. 48, 190, 234
Gouin Thibault I. 103
Goulis D.G. 92
Goupil R. 67
Gourgouli I. 160
Govoni V. 120, 234
Grabowski K. 125
Gradman A.H. 87
Graham D. 84, 91, 116, 155,
156
Graham L. 84, 116, 155
Grajek S. 166
Grammatikou V. 205
Granados L. 168
Grandi A.M. 166, 198, 201,
235
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Grandi D. 145
Grandi E. 46, 115, 120, 128,
145, 190, 191
Granich V. 140, 198, 200, 220
Grassi D. 128, 222
Grassi G. 56, 73, 74, 81, 82,
91, 124,176, 200, 208, 225,
227
Grassos C. 196
Grassos H. 191
Grataloup C. 202
Gratii C. 146
Grau-Perez M. 52
Graudal N. 104
Grave K. 58
Grechanyk M. 154, 233
Grechanyk N. 154, 233
Greco A. 225
Green B.B. 101
GreenfieldS.102
Gregorio M. 232
Gregório M.L. 194
Greil G. 89
Grekas D. 83, 151, 152
Gremeaux V. 123, 236, 240
Gremmler B. 148
Grenet G. 205
Gressens P. 92
Grieco F. 90
Grifa R. 154
Grigore C. 142
Grigoriadou I. 92
Grillo A. 116, 203, 207
Grilo C. 170
Grineva E. 217
Grishenkov E. 183
Gritzenko O. 179, 191, 226
Gröber U. 148
Grodzicki T. 58, 167, 181, 198,
199, 200, 228, 230, 234
Gromov A. 168
Gromova E. 182
Grossi A. 166, 198, 201, 235
Grosu A. 146
Grote L. 124
Grouzmann E. 118, 202
Grover F. 220
Grover Paez F. 140, 174, 234,
213
Grozdinski L. 147
Grubyak L. 154
Gruchala M. 155, 156
Gruev I. 195
Grujic J. 158
Grujic-Milanovic J. 158, 161,
224
Gruszecki M. 185, 208
Grygiel K. 165, 233
Gryglas A. 200
Gryglas P. 172, 200
Gryglewska B. 167
Gu G. 205
Gu H. 120, 227
Gu L. 177, 209
Gu Y. 155
Gu Y.M. 44, 45
Guarino L. 59, 81, 157, 196,
231
Guarneri M. 59, 81, 157, 196,
231
Guasti L. 166, 198, 201, 235
Guberina H. 104
Gubin D. 215
Guenzani D. 161
Guerrot D. 83
Guessous I. 52
GueyffierF.50,183,205,211,
225
Guibout C. 79
Guida V. 101, 234, 235
Guiga H. 192
Guilbeault V. 236
Guillen-Gomez E. 155
Guiraud T. 236, 240
Gulkevych O. 148, 187, 204
Guminski W. 185, 208
Gunning P. 82
Guo Q.H. 140, 215, 233
Guo T. 166
Guo T.S. 160
Guo W. 192
Gupta V. 58
Gurgenyan S. 184, 188
Gurghean A. 142, 146, 231,
238
Gurgus D. 197
Guryev V. 44
Gusakova S. 156, 168, 223
Gusbeth-Tatomir P. 172
Guseva O. 187
Gussoni G. 184
Gutkowska J. 182
Guzik T.J. 59, 70, 91, 116,
146, 232
Guzman J.C. 159
H
Haan Y.C. 51, 120
Haberl R. 96, 212
Hachicha J. 216, 217
Hacke C. 149
Hadchouel J. 51
Haddad F. 81
Haddour N. 181
Hadjistavri L. 204, 227
Haehnel M. 46, 70, 144, 195,
234
Hafez A. 113
Haidich B. 113
Hako Y. 128, 182
Hakobyan Z. 238
Halbach M. 117
Halbert N. 113
Halfon M. 43
Halimi J.-M. 51, 55, 70, 76,
162, 196, 197
Hall A. 60
Hallab M. 158, 166
Haller H. 117
Haller S. 55, 224
Hamdi S. 144, 189, 190, 193,
228
Hamdidouche I. 102
Hamel R. 220
Hametner B. 48, 89, 164, 173
Hammer F. 162
Hamouche A. 198, 212
F I N A L P R OG R A M M E
257
Hamouche M. 216
Hamzaoui M. 83
Han K. 146
Han S. 142, 213
Handschin A. 102
Haneda M. 150
Hanon O. 43, 53, 68, 90, 113,
176, 185, 204
Hansson P.O. 154
Hanus K. 48, 86, 165, 233, 234
Hara A. 208
Haralanov L. 215
Harazny J.M. 49, 86, 168
Harbaoui B. 128, 165, 190
Harboe B.B. 100, 149
Harchaoui Y. 145
Harding S. 153
Harzallah A. 198
Hasani E. 155
Hasanova E. 206, 217
Hasanova I. 206, 217
Haschke M. 51
Hasegawa H. 152
Hashimoto J. 89
Hassani A. 178
Hasselström J. 58, 113, 153,
173, 212, 225
Hatziioannou A. 160
Hatzitolios A. 51, 83, 148,
151, 152, 153, 197
Hatzitolios A.I. 186
Haugaard S.B. 79
Haulon S. 48, 166, 237
Hausberg M. 77, 96
Havelkova A. 216
Hayami D. 123
Hayashi H. 221
Hayes H. 221
He J. 163
He L. 183
He W. 55
Head G.A. 114
Heagerty A.M. 59, 87, 167
Hebert P. 101
Hedblad B. 117
Hedner J. 124
258
Heizati M. 230
Heizhati M. 229
Hélène-Pelage J. 113, 145,
151, 225
Helfer A.G. 163
Hellgren M.I. 123
Helmer C. 172
Hemelsoet D. 164, 173
Henaoui L. 159
Henine N. 198, 212
Henny-Fullin K. 102, 238
Henry R.M.A. 49, 87, 139,
164, 173
Heraud A. 70
Hercberg S. 53
Herdea V. 148, 182
Hérin M. 225
Hering D. 118
Hering L. 58, 125
Herman R.J. 83
Hermanns M.I. 230
Hermeling E. 49
Hermenegildo C. 68, 103,
125, 232
Hermida Ameijeiras A. 219,
164, 226
Hernandez Gallego R. 198
Hernández Gutiérrez C. 179
Hernandez Molina D. 152
Hernandez Palma L. 152
Hernandez S. 220
Herpin D. 162, 236, 240
Hesuani Y.U. 157
Heumeits G. 235
Hickey A. 186
Hidalgo M. 70, 195
Higaki A. 103, 231
Higashi K. 193
Higashiyama A. 112
Hiltunen T.P. 117
Hindy G. 234
Hinic S. 236
Hirawa N. 197
Hirose T. 208
Hjerpe P. 58, 113, 153, 173,
225
Hladikova D. 163
Hmazzou R. 103, 126
Hobbs A. 117
Hobbs F.D.R. 101
Hobbs R. 102
Hobzova M. 229
Hodakovska O. 184
Hoffmann M. 155, 156, 228
Hoffmann-Petersen N. 212,
241
Hojs N. 170
Hojs R. 170
Holaj R. 118
Holmquist C. 225
Holmqvist L. 153, 173
Homentcovschi C. 164, 200,
204
Homolka M. 172
Hon G.M. 146
Hong J. 230
Hong K. 220
Hong M. 231
Hong S.K. 194
Honig W.M. 69
Horbat T. 142
Horcajo Aranda P. 179
Horgan F. 186
Horiuchi M. 103, 231
Horjus D.L. 120
Houben A. 87, 167, 217
Houben A.J.H.M. 84
Hoyer J. 104
Hoylaerts M.F. 155
Hrebenyk M. 227
Hristova K. 147, 201, 202
Hsu H.-C. 55
Hsu P. 180
Hu H. 205
Hu J. 148
Hua T.A. 78
Huang D.H. 177
Huang D.Z. 180
Huang Q. 183
Huang Q.F. 181, 233
Hudiakova N. 219
Hughes A.D. 165
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Huguet E. 46, 70, 144, 195,
234
Huikuri H. 144
Humphrey J. 71
Hussain T. 89
Hutanu A. 181
Huyghe E. 231
Hwang Y.C. 151
I
Iacoviello L. 112
Iancu M.A. 225, 226
Ianula R. 142, 164, 200, 204
Ibrahim A. 240
Ibrahim Kamal Jouness R.
190, 209
Icen Y.K. 147
Ichihara A. 203
Ichikawa M. 103
Idolazzi C. 153
Idrizi A. 183
Iegorov K. 146
Igarashi Y. 103
Ignatieva T. 205
Ihm S. 194
Ihm S.H. 151
Ikeda E. 238
Ikonomidis I. 59, 146, 214,
232
Iktas G. 58
Ilaquita Flores E.E. 50
Iliushyna G. 146
Illyash M. 228
Imaeva A. 191
Imaeva E.B. 145
Imagawa M. 103
Imai Y. 91, 208
Imbalzano E. 163, 199, 223,
232, 240
Imprialos K. 106, 160, 161,
163, 164, 199, 200
Inal T. 215
Inamo J. 113, 145, 151, 225
Indra T. 118
Inoue R. 208
Inserra F. 70, 195
Ioakeimidis N. 46, 89, 160,
235
Ioannidis G. 161
Ionin V. 58
Ionov M. 158, 160, 161, 174,
198
Iqbal F. 120
Irnazarov A. 239
Isacoff D. 142
Isaykina O. 140, 143
Isbele T. 218
Ishizuka T. 103
Isomura M. 126
Issaeva M. 157
Istratie B. 225, 226
Italyantseva E. 195
Itani H. 204
Ito S. 89, 103
Iudina I. 160, 161, 163, 198
Iurciuc M. 236
Iurciuc S. 228, 236
Iushko K. 151
Ivandic E. 55, 91, 113, 115,
145, 157, 191, 215, 221
Ivanov K. 171
Ivanov M. 158, 161, 224
Ivanova A. 235
Ivanova R. 158
Ivkovic V. 46, 55, 89, 91, 106,
113, 115, 145, 157, 190, 191,
215, 221
Iwahori T. 221
Iwakura Y. 103
Iwanami J. 103, 231
Iza A. 207
Izizi B. 155
Izzo J.L. 193, 228
J
Jacobs L. 44, 45, 46, 117, 118,
155, 162
Jacquier A. 161
Jaff N.G. 145
Jain A. 82, 205
Jaisser F. 125, 146
Jakovljevic B. 171, 219, 222
Jamoussi K. 147
Janas J. 168, 203
Janaszek-Sitkowska H. 48,
203, 234
Jancewicz M. 124
Janeckova H. 237
Janka R. 118
Jankowski M. 182
Jankowski P. 68
Jannot A.-S. 53, 56
Januszewicz A. 48, 70, 86,
104, 121, 163, 165, 168, 182,
199, 203, 233, 234
Januszewicz M. 48, 86, 165,
168, 233, 234
Japie C. 143, 146, 178, 181,
183, 191, 197
Jardim L. 68
Jardim P. 68, 100, 123, 143,
151, 154, 180, 181, 191, 225
Jardim T. 68, 100, 123, 151,
180, 181, 191, 225
Jardine A. 172
Jaroch J. 232
Jarraya F. 96, 122, 216, 217
Jassim O. 203
Jatzuk D.I. 58
Jazwiec P. 185
Jedrusik P. 172, 200
Jegou B. 166, 237
Jekell A. 59
Jelakovic B. 46, 55, 62, 71,
89, 91, 92, 113, 115, 145,
157, 190, 191, 215, 221
Jelakovic M. 157
Jelic D. 179
Jenssen T. 162
Jeong E. 177, 209
Jeppesen J. 168, 218
Jeremias Z.S. 199
Jerszow B. 149
Jeunemaitre X. 44, 48, 51, 92,
98, 105, 116, 121, 156
Ji H. 235
F I N A L P R OG R A M M E
259
Jiang B. 120
Jiang S. 126
Jiang X. 160
Jie H. 177, 178, 179, 187,
189
Jimenez Cazarez M. 234
Jiménez E. 207
Jimenez Villodres M. 180
Jirapornjaroen W. 219
Jiravsky O. 118
Jo S. 142, 220
Jo S.H. 151
Joannides R. 211, 231
Jöckel K.H. 89
Johansson J. 101, 171
Johansson S. 154
Joly D. 51
Joly L. 68
Jomaa W. 144, 189, 190, 193,
228
Jones C. 82, 237
Jones D. 82, 237
Jordan J. 73, 114
Joris P. 217
José da Silva I. 50
Joshi S. 240
Joshua M. 172
Josipovic J. 55, 91, 113, 145,
221
Joulak A. 85
Jourdan F. 80
Jousilahti P. 101
Jouven X. 79
Jovovic D. 161, 158, 224
Jozwik-Plebanek K. 48, 86,
165, 182, 233, 234
Ju S. 146
Juhanoja E. 101
Juillard L. 197
Jukic I. 167, 174
Jula A. 101, 144
Julius S. 56, 78
Jullien V. 53, 102
Julu P.O. 126, 237
Jumar A. 49, 168
Juneau M. 123, 236
260
Junqueira A.S.M. 233
Junqueira C.L. 168, 233
Juric I. 215
Justo A.F.O. 123
Juthier F. 166, 237
K
Kabat M. 70, 163, 165, 182,
199, 203, 234
Kachenoura N. 86, 89, 167
Kaczorowski J. 50
Kadziela J. 233
Kaeriyama S. 103
Kahan T. 53, 57, 58, 59, 77,
90, 113, 118, 153, 170, 173,
176, 192, 208, 212, 225
Kähönen M. 144
Kakiouzi V. 180, 183, 233
Kalaitzidis R. 96
Kalani M. 59
Kalkavouri A. 148
Kallikazaros I. 152, 181, 191,
195, 223, 225, 226
Kallistratos E. 205
Kallistratos M.S. 213
Kalos A. 225
Kalos T. 104, 114, 120, 147,
160, 217
Kaluzay J. 201
Kamakura S. 112
Kamardina N. 146
Kamasova M. 180, 229, 237
Kamdem F. 234
Kamilova U. 214, 239
Kammoun K. 216, 217
Kammoun S. 216, 217
Kamperidis V. 160, 161
Kanaga C. 198
Kanai H. 152
Kang J.G. 151
Kang Y. 181
Kang Y.Y. 215
Kanno H. 152
Kantola I. 101, 101, 171
Kantola T. 171
Kantorova A.U. 154
Kapanidis K. 152
Kapelak B. 59
Kapesa S. 141
Kapil V. 126, 237
Kapustina A. 191
Karagiannis A. 163, 164, 200
Karakaya G. 102, 223, 237
Karakosta A. 53, 113
Karamanos A. 153
Karamaounas P. 167
Karamat F. 120, 147
Karamichalakis N.D. 142, 213
Karamouzis I. 83, 151, 152,
153, 197
Karanovic D. 158, 161, 224
Karanovic S. 46, 55, 89, 91,
113, 115, 145, 157, 190, 191,
215, 221
Karasavvidou D. 139, 159,
186
Karaszewski B. 69
Karcz M.K. 203
Kario K. 91, 94
Karlafti E. 148
Karlsson P. 190
Karnosova P. 234
Karpenko D. 184
Karpov R. 186, 187
Karpov Y. 52, 191, 212
Karseladze N. 213
Karvounis H. 160, 161, 204
Kashiwagi A. 150
Kasiakogias A. 102, 104, 114,
118, 120, 160, 193, 225
Kasim S. 207
Kasiulevicius V. 173
Kassai B. 50, 183
Kasuga T. 152
Kaszuba A. 70, 168
Katalinic L. 215
Kato N. 103
Katova T. 147
Katsi V. 152, 181, 191, 195,
223, 226
Katsinas C. 186
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Katsytadze I. 184
Kaufeld J. 81
Kawano Y. 222
Kawecka-Jaszcz K. 68, 115,
163, 165, 193, 195, 221, 222,
234
Kay P. 199
Kaya A. 92
Kayembe P.K. 147
Kazakova A. 216
Kazimli A. 193
Kazma I. 70
Keddari M. 150
Kékes E. 154
Kelle B. 204
Kelly C. 82
Kemenshchikov O. 199
Kender Z. 180
Kengne A.P. 108, 145, 146,
150, 156, 218
Kennbäck C. 168
Kennedy D. 55, 224
Kerimkulova A. 184, 189, 238
Kerley C. 222, 229
Kerry S.M. 101
Keskek S.O. 147
Kesse-Guyot E. 53
Ketelhut K. 149
Ketelhut S. 149
Ketelhut S.R. 149
Kettab H. 156
Kezhun L. 215
KhafizovaL.238
Khalikova A. 142
Khalil A. 97
Khalili M. 186
Khamidullaeva G. 142, 215,
238
Khan F. 126
Kharoubi O. 198
Khasanova Z. 157
Khati M. 212
Khettab H. 48, 68, 120, 127,
158
Khitouche K. 216
Khodorovich N. 84
Khomazyuk T.A. 187
Khromova A. 188
Khursa R. 213
Khyzhnyak E. 172
Khyzhnyak O. 172
Kiando S.R. 116
Kianicka B. 220
Kiat H. 89
Kichou B. 198, 212
Kichou L. 198, 212
Kielbasa G. 193, 195, 221
Kieler H. 173
Kielstein J. 54
Kikuya M. 208
Kilic H. 181
Kim B. 183, 235, 236, 241
Kim C. 151
Kim C.M. 182, 233
Kim G. 182, 233
Kim H. 142
Kim J. 218, 220
Kim J.H. 141, 182, 233
Kim J.S. 49
Kim K. 220
Kim S. 49, 142, 160, 201,
221, 236, 241
Kim S.Y. 141
Kim Y. 146
Kimmoun A. 195
Kimura Y. 222
Kin D. 146
Kintiraki E. 92
Kintis K. 160, 193, 225
Kiourka Z. 145
Kirichenko N. 217
Kirim S. 147
Kirpalani A. 214
Kirpalani D. 214
KirschfinkM.104
Kisheva A. 178, 179
Kishko N. 227
Kisko A. 227
Kiss I. 154
Kisters K. 148, 192
Kistner I. 49, 168
Kitaoka C. 222
Kiyakbaev G. 177
Kjeldsen S.E. 78, 82, 102, 117,
118, 120, 121, 122, 162, 170
Kladas G. 227
Klaric D. 215, 241
Klein T. 78
Kleindienst A. 236
Klenow S. 225
Klibngern H. 219
Klima L. 222
Klimas J. 223, 224
Klisiewicz A. 70, 86, 199
Klocek M. 163, 193, 222
Kloch-Badelek M. 68, 195,
221
Klosowski M. 149, 150
Klusova E. 144
Knepper M.A. 155
Knez J. 81
Kniga V.V. 173
Kobalava Z. 84, 151, 159,
162, 166, 171, 174, 177, 178,
179, 188, 192, 193, 208, 209,
216, 228
Koc-Zorawska E. 161
Koch E. 86, 167
Kocharli M. 206, 217
Kochueva M. 217
Kocianova E. 118, 180, 229,
237
Kocic G. 144
Kocijancic V. 80, 81, 217
Koeck T. 117
Kokkinos P. 163, 164, 200
Kokubo Y. 112
Kolarski Nenadic L.J. 205
Kolasin P. 215
Kolesnik E. 146
Kolesnik T. 146
Kolesova E. 218, 222
Koletsos N. 81, 145, 185, 192,
209
Koliakos G. 148
Kollár R. 219
Kollias A. 99, 101, 140, 149,
159, 212
F I N A L P R OG R A M M E
261
Kolodziejczyk-Kruk S. 203
Kolyvas G.N. 142, 213
Komand A. 124
Komissarova S.M. 230
Komornikova A. 150
Kondo K. 221
Kong L. 83, 92, 126
Konin C. 184
Konior A. 70
Kono S. 150
Konoplyanik L. 154
Konoshita T. 103
Konovalova K. 230
Konovalova N. 235
Konradi A.O. 52, 59, 91, 146,
147, 153, 155, 158, 160, 161,
163, 174, 191, 198, 218, 220,
221, 222, 226, 235
Konstantinidis D. 102, 120,
147, 160, 193, 217, 225
Konstantinidis G. 151, 195,
197
Konstantinov V. 191
Konstantonis G. 100
Kontaraki J. 55, 164
Kontula K.K. 117
Kordalis A. 118
Kordon Z. 149
Koretzky M. 46, 70, 144, 195,
234
Koriagina N. 169, 183
Korobko I. 142
Korompoki E. 185, 186
Koroshi A. 183
Korostovtseva L. 146, 217
Kos J. 46, 55, 91, 113, 145,
190, 221
Koshel I. 195
Koshelyaevskaya Y. 142, 208,
214, 216
Kosior D.A. 124, 229
Kosir A. 159
Kosova G. 146
Kostaki S. 186
Koster A. 87
Kostic S. 151, 227, 232, 240
262
Kostka-Jeziorny K. 194, 199
Kotliar C. 46, 70, 144, 195,
234
Kotovskaya N. 216
Kotovskaya Y. 63, 142, 151,
179, 193, 215, 216, 228
Kotsis V. 53, 73, 74, 92, 106,
161, 176, 200, 205, 208
Kotsyuba O. 227
Kouchaki Z. 198
Koukouzeli A. 213
Kouranti I. 51
Kourilsky A. 68
Koutra E. 104, 114, 217
Koutsaki M. 213
Kouyoumdzian N.M. 196
Kovacevic I. 164
Kovacevic Vojtusek I. 215
Kovacic J. 116
Kovacic M. 164
Kovacic V. 185
Koval S. 151, 183
Kovalchuk S. 91, 226
Kovalev I. 156, 168
Kovaleva I. 184
Kovatcheva R. 203
Kowalczyk K. 69
Kowalski R. 207
Koya D. 150
Kozanoglu E. 204
Kozlova N. 146
Kralova E. 224
Krämer B.K. 55, 164
Krasinska B. 229
Krasinski Z. 229
Kratka Z. 118
Kravchenko S. 146
Kravtchenko E. 164
Kremzer A. 145, 156
Krenek P. 223, 224
Krenkova A. 180
Kretz S. 204
Kreutz R. 42, 78, 83, 125, 221
Kribben A. 104
Krikunov A. 91, 226
Kristek F. 165, 224
Kristiansen O.K. 79
Krivenko V. 195
Krolczyk J. 181, 199, 228, 230
Kroon A.A. 84, 87, 95, 114,
117, 126
Krotova V. 187
Kruchinina M. 168
Krüger B. 55
Krum H. 118
Krummel T. 158
Krupp D. 225
Krzesinski J.-M. 76, 141
Krzesinski P. 194, 232
Kubis N. 240
Kubiszewska I. 149, 150
Kucerova A. 234
Kucharska W. 228
Kuchler G. 96, 212
Kudo M. 103
Kukida M. 103, 231
Kukushkin S. 44, 143
Kulikova M. 152
Kullo I.J. 116
Kulovic S. 205
Kulyutsin A. 184
Kumagai E. 150, 190, 226
Kumagai K. 86
Kumarathurai P. 79
Kumisars I. 238
Kunicka K. 185, 208, 228
Kunzova S. 172
Kupchinska O. 147, 161, 187
Kupchynskaya E. 148, 204
Kurapeev D. 158, 174
Kurbanova D. 142, 214, 215,
238
Kurekhyan A. 142
Kurkowska-Jastrzebska I. 86
Kurpaska M. 232
Kuryata A. 154, 233
Kuryata O. 161
Kusamo K. 112
Kushnir S. 140, 144, 188,
198, 200, 220
Kusiak A. 170, 238
Kusters Y. 217
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Kuvanova Y. 146
Kuzma-Mroczkowska E. 99
Kuzmichkina M. 118
Kuznetsov A. 146
Kuznetsov I. 158
Kuznetsov N. 203
Kuznetsova T. 44, 45, 46, 61,
81, 117, 155, 173, 195
Kvandová M. 224
Kvirkvelia N. 187, 218
Kwarciany M. 69
Kwinta P. 149
Kykalos S. 78
Kyparos A. 192
Kyriakoulis K. 140
Kyriazopoulos K. 114, 120,
193
L
La Fata E. 128
La Greca M. 69
Lacampagne A. 236
Lacau S. 164
Lackner K.J. 230
Lacolley P. 68, 119, 184, 224,
227
Lado Lado F.L. 164
Laganovic M. 46, 55, 89, 91,
113, 115, 145, 157, 190, 191,
215, 221
Lagiou F. 147, 160
Lagou S. 149, 159
Lahiani A. 147, 153
Lai S. 196
Laine M. 203
Lakatta E. 180
Lakehal R. 208
Lakiza T.V. 187
Lalic T. 216
Lalli E. 66
Lalonge J. 123
Lam B.Y.H. 66
Lamarre-Cliche M. 212
Lambert D. 68
Lambert E. 118
Lambert G. 118
Lambert L. 118
Lamberti M. 239
Lamendour L. 70
Lamoureux S. 183
Lamprea G. 202
Lamprou V. 150
Lan G. 235
Lanasri N. 49
Landa M.S. 224
Landau Loriot M.A. 103
Landi L. 231
Lang K. 67
Lang S. 181
Lang T. 113, 145, 151, 225
Langén V. 101
Länne T. 49
Lantelme P. 128, 162, 165,
190, 203, 211, 236
Lanzani C. 57, 116, 153
Lara J. 80
Larger E.
Larina V. 184, 187
Larissi M. 83, 197
Lariviere R. 234
Larsson C.A. 123
Larstorp A. 120
Lascu A. 237
Lasica R. 148
Latini R. 46
Latka M. 149
Latour E. 236
Lau E. 104
Lau E.M.T. 100
Laubert-Reh D. 230
Laucevicius A. 171, 240
Laucyte-Cibulskiene A. 240
Laurent S. 46, 48, 68, 69, 71,
79, 88, 89, 93, 102, 105, 120,
127, 141, 158, 171, 206
Lavryk A. 219
Lazarev P. 184, 193
Lazareva I. 188, 230
Lazareva K.P. 193
Lazareva N. 187
Le H. 50, 183, 205
Le Heuzey J.-Y. 90
Le Jeune S. 158, 160
Leader C. 125
Ledieu G. 48
Lee A.P. 127
Lee H. 154
Lee H.J. 196, 217
Lee J. 146, 218
Lee M.G.Y. 207
Lee S. 146, 218, 220
Lee S.H. 141
Lee S.J. 151
Lee S.N. 182, 233
Lee S.Y. 141
Lee Y. 183, 235
Leeman M. 128, 146, 172,
182, 221
Leenders T.J.M. 170
Leenen F. 88
Lefort C. 70
Legat L. 230
Legosz P. 154
Legrady P. 192
Lehmann N. 89
Lehtonen A. 144
Leischik R. 62
Leitao C. 127
Leitão F. 201
Leite S. 122
Leite-Moreira A. 122
Lejeune A. 83
Lekakis J. 59, 146, 214, 232
Leko N. 55, 89, 91
Lelong H. 53, 204
Lemasson C. 123
Lemelle S. 97
Lememan M. 221
Lemogne C. 53, 79
Lemogoum D. 128, 146, 147,
182, 221, 234
Lenders J. 67, 203
Lenti S. 83, 184
Lenzini L. 202
Leon J. 202
Leonardis D. 55, 84
Leosco D. 221, 237
F I N A L P R OG R A M M E
263
Lepage B. 203
Lepira F.B. 147
Lepoutre C. 67
Leppee M. 154
Lerman O. 44, 140, 214
Lerut E. 45
Lesiuk C. 128
Lesniak W. 163
Lesovsky J. 172
Lessa M.A. 217, 239
Letizia C. 196, 203
Leuppi J.D. 236, 238
Levy B. 51, 51, 97, 193, 195
Lewanczuk R. 225
Lewandowski J. 168
Leyusova Y. 235
Lezha M. 155
Li B. 160
Li F.K. 233
Li H.Q. 143
Li J.J. 140
Li L. 204, 226
Li L.H. 233
Li N. 148, 169, 179, 229, 230,
237
Li N.Y. 228
Li T.Y.W. 177
Li W. 179
Li X. 229, 231, 237
Li Y. 40, 44, 83, 127, 140, 181,
183, 185, 204, 209, 215, 226,
227, 233
Li Z. 224
Liakos C. 191, 196
Liapis S.E. 142, 213
Liatakis I. 104, 114, 120, 217
Liaudet L. 43
Libhaber C.D. 115, 165
Libhaber E. 233, 241
Lichikaki V. 118, 163, 186
Lieber A. 120
Liefers W.J. 170
Liestøl K. 78
Lighezan D. 172, 197, 228,
236, 197
Ligthart J. 158
264
Likaj E. 183
Likhitsathian S. 219
Lim H. 220
Lim H.E. 49
Lim H.M. 180
Lim K. 114
Lim S.Y. 49
Lim Y. 183, 236, 241
Lima Junior E. 171
Lima M.J. 191
Limena A. 202
Lin X. 237
Linale N. 47
Lincevicius G. 208
Lincevicius G.S. 208
Lindblad U.L.F. 123
Lindhardt M. 50
Lindholm L.H. 90
Lindroos A. 101
Linneberg A. 218
Lipchanskaya T. 145, 147
Lipski D. 166, 194, 199
Little P. 102
Litvin A. 182, 229, 230
Litvin A.Y. 124
Litwin M. 48, 149, 150, 233
Liu C. 183
Liu C.Y. 215
Liu D. 205
Liu H. 177, 209
Liu J. 192
Liu L. 50
Liu X. 206, 207
Liu Y. 179, 206
Liuc X. 120
Lizio G. 199
Ljungman C. 113, 212
Ljutic D. 185
Llewellyn D. 69, 186
Llorens-Cortes C. 88, 103, 126
Lo Gullo A. 232
Lobjanidze N. 187, 218
Lobo F. 102
Lobo M. 74, 82, 104, 117,
126, 205, 220, 237
Lobo M.F. 241
Loboz-Grudzien K. 232
LoffingL.84
Loffing-CueniD.84
Logakis J. 55, 164
Logvinenko A. 148, 187, 204,
161
Lombardi A. 221, 237
Lombardi C. 124
Lombardi D. 225
Lombardi F. 207, 207
Lombardi F.E. 231
Lonati C. 43, 214
Lonati L.M. 101, 207, 234,
235
London G. 122
Longuet H. 55, 196, 197
Lonn E. 205
Lopatin Y.M. 239
Lopes H.F. 238
Lopez A. 197
Lopez B. 117
Lopez Jimenez M. 152, 172,
197, 218
Lopez Paz J.E. 164, 219, 226
Lopez-Aguilera J. 165
Lopez-Gomez J. 198
López-Jaramillo P. 80, 205
Lopez-Rivera J. 202
Lopez-Sublet M. 57, 97, 158,
160
Lopiano L. 43
Lopina N. 158, 189
Lorca Herrera E. 208
Lorenzen T. 83
Lorenzi C. 69
Lorthioir A. 48, 156
Lory P. 51
Losada Mora P. 180
Louati D. 147
Louis H. 195, 224, 227
Loukianov M. 142, 178, 208,
214, 216
Lourenço A. 122
LoutfiT.204
Loutradis C. 151
Loutradis H. 160, 161
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Lovett E. 117
Lovic D. 50, 75, 106, 151, 188,
218, 219, 222, 227, 236, 240
Lovic M. 151, 188, 218, 227,
240
Low Z.K. 177
Loyer X. 156
Loyola I. 238
Lu X.H. 67
Lu Y. 43
Lucas Jr. R.M. 140, 151
Lucatello B. 203
Lucena Marotta F. 207
Lucente D. 213
Lucero D. 126
Ludew D. 59
Ludwig-Galezowska A. 116
Luiz Tatagiba Lamas J. 141
Lukina O. 166, 192, 208
Lukyanova M. 184
Luna C. 115
Luong S. 197
Lupusor A. 146
Lurbe E. 45, 56, 100
Lurie S. 183, 154
Lussey C. 203
Luzardo De La Vega M. 152
Lv Y. 235
Lv Y.Y. 143, 153
Lyalikov S. 206
Lyamina N. 145, 147
Lyamina S. 145, 147
Lykka A. 140, 142, 213
Lysne V. 182
Lysunets T. 161
Lyu Y. 53
Lyusin D. 214
Lyutikova L. 203
M
M’Buyamba Kayamba J.R.
128, 147, 182, 221
Ma L. 185, 209, 226
Ma L.Y. 180
Ma R. 205, 228, 237
Ma Y. 83, 92, 126
Maatouk F. 144, 189, 190,
193, 228
Mac-Way F. 47, 233
Maccagni G. 154, 169
Maccallini G. 46, 70, 195
Macchiarulo M. 81
Macenko V. 217
Machado M.F. 69
Machado M.P. 50
Machado Y.L.R.C. 157
Maciag J. 232
Macias Chumacera A. 140,
174, 234
MacMahon S. 169, 174
Madaric J. 163
Madaricova T. 163
Madej K. 165, 233
Madero Rovalo M. 57
Maderuelo Fernandez J.A.
158, 165
Madueño F. 152
Maegawa H. 150
Maffeis C. 100, 203
MaffioliP.83
Mafrica A. 84
Magalhães F. 151, 180, 181,
191
Magalhaes M.E.C. 100, 149,
157, 168, 233
Magdas A. 178
Maggi A. 113
Maggio M. 183
Magid D.J. 101
Magnusson M. 152
Magrin M.E. 225
Mahabadi A.A. 89
Mahamat Y.K. 152
Mahdi A. 216
Mahfoud F. 41, 74, 86, 126,
163
Mahfoudh H. 216, 217
Maia-Leite L. 181
Maillard M. 118, 202
Maiolino G. 67, 91, 103
Maisaidi M. 207
Majane O.H.I. 115, 180, 233,
241
Makarova L. 146
Makhlouf L. 49
Makhmatova T. 160, 161
Makil E. 207
Makino Y. 103
Mako K. 199
Makowiecka-Ciesla M. 48
Makridis D. 186
Makris T. 152, 181, 191, 195,
223, 226
Malachias M. 64
Malandrino D. 190
Maldonado J. 99, 149, 158,
205
Maldonado P. 237
Malek F. 70, 194
Malfatto G. 193
Malik M. 72
Malikova E. 223, 224
Mallamaci F. 55, 84, 200
Mallard C. 92
Mallardo M. 239
Mallart A. 166
Mallat S. 204
Malliaraki N. 55
Mallion J.M. 114
Maloberti A. 81, 165, 213,
225
Malyszko J. 161
Mamone F. 223, 232, 240
Mancia G. 43, 45, 54, 60, 65,
73, 78, 81, 82, 91, 112, 121,
141, 169, 205, 206, 225, 227
Mancini A. 221, 237
MandraffinoG.163,199,223,
232, 240
Mangataeva O. 162
Mangiacotti A. 154
Manhem K. 58, 113, 153,
173, 212, 225
Maniero C. 66, 202, 209
Manios E. 140, 142, 185, 186,
213
Mannelli M. 67
F I N A L P R OG R A M M E
265
Manolis A.J. 60, 65, 71, 213
Manousopoulos K. 140, 142,
213
Manovel Nogueiras M. 207
Mant J. 101, 102
Manunta P. 57, 116, 153
Manzano Espinosa L. 144
Mapoure Y. 234
Maragkoudakis S. 55
Maragoudakis F. 55
Marais L. 48, 127
Maranhao P.A. 168
Marchant I. 50, 183
Marchionni N. 69
Marcucci M. 56, 198
Marelli S. 116
Maresca A.M. 166, 198, 201,
235
Margetaki A. 53, 113, 191
Marginean T. 189
Margiotta E. 161
Margolis K.l. 101
Marhol A. 232
Marie C. 185
Marie P.-Y. 68
Marijon E. 58
Marinelli C. 203
Marinho F. 238
Marinov R. 147, 201, 202
Marjanovic M. 171, 179, 219,
222
Mark P.B. 118
Markabayeva A. 184, 189,
238
Markakis K. 78
Marketou M. 55, 164, 211,
223
Markou M. 196
Markova E. 201
Marliere J. 55, 196, 197
Marmentini V.M. 171
Maroto R. 102
Marotta T. 182
Marques P. 43, 191
Marquis K. 47
Marrachelli V. 114
266
Marrekchi R. 153
Martell-Claros N. 139, 148,
202
Martin A. 231
Martin P.Y. 52
Martín-Cantera C. 127
Martin-Escudero J. 52, 114
Martin-Martin C. 127
Martin-Moreno J.M. 147
Martina B. 102, 238
Martínez Abundis E. 152
Martinez C. 182, 207, 207
Martínez Durán V. 164, 219,
226
Martínez F. 114
Martínez García F. 111, 139,
144
Martinez Rodes P. 144
Martinez S. 197
Martínez-Muñoz P. 50
Martínez-Perez P. 127, 158
Martinho R. 122
Martinis F. 196
Martins e Silva J. 180
Martins L. 49, 64, 111, 128,
220, 241
Martovitskaya Y. 145
Martynyuk T. 155, 170, 171,
204
Maruelli G. 46, 81, 86
Marusic P. 118
Mas J.M. 155
Masani A. 120
Mascaros Balaguer E. 144
Mascha O. 213
Maseko M.J. 115
Masenko V. 159, 204, 218
Masharipova D. 214, 239
Maskell P. 120
Maslenko A. 216
Massaro A.R. 69
Massetti L. 89, 233
Masson S. 46
Massy Z.A. 122
Mastrokostas A. 53
Mastroluca D. 196
Mastrorocco N. 170
Matanaer M. 164
Matei D. 226
Matei R.S. 226
Matengeni A. 172
Mateos Hernández J. 179
Matevosyan A. 230
Matheis S. 230
Matic D. 179, 188, 218, 148,
189
Matijevic V. 221
Matino S. 196
Matlok M. 167
Matos A. 68, 104
Matova O. 194, 194
Matrosova I. 124, 143, 232,
203
Matsha T. 146, 150, 156
Matsuda F. 86
Matsushita K. 227
Mattaliano P. 124
Mattina A. 86, 167
Matusz P. 228
Maule S. 43, 227
Maurer H.H. 163
Mauri M. 124
Mavrantoni E. 152
Mavromanoli A. 151, 152,
153
Mawson D. 165
Mayer C. 164, 173
Mayer O. 234
Mazalov K. 146
Mazeghrane A. 198, 212
Mazur G. 185
Mazur K. 185, 208
Mazza A. 83, 184
Mazzer A. 78, 123
Mazzon M. 231, 241
McBride M.W. 84, 91, 110,
116, 155, 156
McCallum L. 128, 172
McCann A. 182
McCarron D. 104
Mcdonald F. 125
McEneiry C. 47
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
McEwen J.G. 240
McGinnigle E. 70
McGrath E.R. 82
McKinstry B. 101
McLaughlin M.A. 101
McManus R. 102, 114, 184
McManus R.J. 101
Md Radzi A. 207
Meani P. 225
Meazza R. 56, 161, 198, 207
Meccariello A. 90
Medici F. 203
Medina P. 68, 125
Medjahed A. 49
Medonça K. 100
Medvedev D. 152
Medvedeva A. 144
Megdiche F. 118
Mehave A. 197
Mehlum M.H. 78
Meilikemu M. 207
Meinero V. 43, 214
Meireles-Brandao J. 186
Meireles-Brandao L. 186
Mela A. 213
Melander O. 116, 117, 152,
155, 156, 234
Melendez G. 197
Melin P. 159
Melissas J. 150
Melk A. 81
Mellal S. 190
Mellon L. 186
Mellström D. 113
Melnikova E. 143, 232
Melnychenko N. 184
Melo Alvim C. 200
Mena C. 198
Menai M. 53
Menard J. 105
Mendelsohn F.O. 126
Mendes Da Silva A. 212, 214
Mendes M. 117
Mendes P. 122
Mendez Garrido F. 126
Menditto E. 178, 226
Mendonça e Moura R. 239
Meneghini M. 160
Menegolo M. 202
Meng H. 169
Meng H.T. 228
Mengal V. 189
Menni C. 104
Mensink G.B. 225
Mensink R. 217
Merezhanova A. 146
Merieau E. 55, 196, 197
Merkulova N.K. 198
Merletti L. 166
Merlini G. 229
Mesar I. 215
Mesarosova D. 150
Mesquita Bastos J. 64, 78,
101, 127, 128, 139, 141, 150,
171, 201, 202, 222, 223
Messa P. 56, 160, 161
Messaggio E. 57, 116
Messas E. 127
Messedi M. 147
Messerli F.H. 46, 48, 50
Metoki H. 208
Metrustry S. 104
Mewto N. 183
Meyer A.M. 83
Meyer G. 236
Meyer M.R. 163
Meza M. 159
Meziane-Tani A. 159
Mezzapesa D. 168
Miadziolko M. 165, 233
Miadzvedzeva A. 188
Miazga A. 229
Michalek P. 70
Michalkiewicz J. 149, 150
Michalowska I. 48, 86, 165,
233, 234
Michas F. 140, 213
Michaud A. 212
Michel-Rowicka K. 70, 182
Michelet P. 192
Michopoulos S. 142
Michova M. 201
Micke O. 192
MicklesfieldL.K.145
Middeke M. 159
Miedinger D. 236
Miglinas M. 55, 98, 240
Miglioretti M. 225
Miguel M. 182, 207
Mihaescu R. 167
Mihailidou A. 72
Mihailovic-Stanojevic N. 158,
161, 224
Mijalkovic D. 151
Mijic N. 148
Mikael L. 151, 191
Miklaszewska M. 149
Mikolajczyk T. 59, 70, 116,
232
Mikolasevic I. 218, 231
Mikulas J. 163
Milan A. 43, 190, 209, 227
Milan D.J. 116
Milani B. 84, 115
Milanov S. 229
Milanova M. 146
Milazzo V. 43, 190, 209, 227
Milei J. 188, 206, 218
Milic S. 218
Militaru A. 228, 236
Militaru M. 228
Milkas A. 193
Millasseau S. 89, 100, 124,
159, 215
Millen A. 115, 122
Millon A. 197
Mills C.E. 120, 234
Mills E. 237
Mills E.J. 218
Milon H. 128, 190
Miloradovic Z. 158, 161, 224
Milto A. 177
Mimran A. 168
Min H. 180
Min L.J. 103, 231
Minamishima T. 227
Minarikova Z. 201
Minashvili A. 223
F I N A L P R OG R A M M E
267
Minushkina L. 157, 216
Minutolo R. 55
Minuz P. 58, 117, 153, 203
Mion B. 204
Miotto D. 67
Mirabella S. 190, 209
Miramontes I. 159
Miranda L.O. 100, 149, 149
Mironova J. 187
Mironova S. 160, 161, 163,
198
Miroslawska A. 118, 162
Mirsaeva G.K. 145
Mirwais S. 154, 192
Misas E. 240
Mischak H. 50, 104, 117
Miscio F. 154
Mishchenko L. 194
Miszkowska-Nagorna E. 120
Mitchell A. 55, 104
Mitchenko O. 146, 219
Mitkowska K. 203
Mitre A. 58, 226
Mitrovic P. 148, 189
Miura K. 221
Miyagawa N. 221
Miyamoto Y. 112
Mizerska-Wasiak M. 99, 149
Mladenova Y. 157
Mnif K. 216, 217
Modesti P.A. 77, 89, 108, 190,
225, 233
Modine T. 166, 237
Modolo R. 162, 163, 164, 199
Moebus S. 89
Mogavero M. 231
Mogi M. 103, 231
Moguchaya E. 147, 218, 220,
221, 222
Mohaupt M. 52
Moioli C. 213
Moiseev V. 177
Moiseeva O. 193
Mokhort T. 151
Molaodi O. 153
Molchanova O. 140, 143, 183
268
Molesini B. 58
Molina L.l. 82
Mompeón A. 68, 125, 103,
232
Mondellini G.M. 213
Mondry A. 140, 177
Mongiardi C. 166, 198, 201,
235
Monleon D. 114, 156
Monnier Picard A. 185
Montag I. 164, 173
Montagnana M. 117
Montaigne D. 237
Montarello J. 82, 205
Montello M. 151, 181
Montero Sanchez C. 165, 127
Montezano A.C. 146
Monticone S. 67, 156, 203
Moon D. 182, 233
Moon K.W. 182, 233
Mora Simón S. 165
Morales J.M. 114, 156
Morales Ortega A. 179
Moran N. 221
Morant S. 120
Morbini M. 128
Mordovin V. 118, 162, 163,
164, 172, 186, 187
Moreira H. 151, 180, 181,
191, 225
Moreira-Rodrigues M. 122
Moreno H. 162, 163, 164,
199
Moreno Jr. H. 199
Moreo A. 225
Moreso F. 46
Moretti S. 166, 198, 201, 235
Morgan H. 91
Morganti A. 43, 65, 107, 214
Mori A. 197
Mori H. 207
Mori L. 195
Mori M. 207, 235
Morikawa N. 150, 190, 226
Morimoto R. 67, 103
Morimoto S. 203
Morisco C. 90
Morozkina I.V. 173
Morreale M. 68, 81, 115, 157,
231
Morris L. 214
Mos L. 78, 123
Mosbehi T. 198
Moscardelli S. 178
Moser M. 148
Mospan M. 194, 204
Mossakowska M. 199
Mossello E. 69
Mossiat C. 185
Mosso E. 190, 209
Mostbauer G. 184
Mosteoru S. 148
Motreff P. 65
Motta D. 213
Mouly-Bertin C. 165
Mounier-Vehier C. 48, 162,
166, 203, 237
Mourad J.-J. 44, 51, 57, 60,
113, 158, 160, 162, 170, 205
Mourali S. 85
Mourtzinis G. 58
Mousa N. 180, 183, 233
Mousseaux E. 80, 89, 125
Moustakas G. 180, 183, 233
Movsisyan N. 172
Moyá Amengual A. 145, 173
Moyssakis I. 149
Mozenska O. 124, 229
Mozos I. 167, 197, 201, 237
Mrowiec H. 222
Mssead S. 216
Mu J. 160, 166
Muecke R. 192
Muela H.C.S. 69, 166
Mueller D. 70, 84
Muiesan M.L. 46, 81, 86, 95,
112, 125, 127, 142, 225
Muir S. 172
Mukhtar O. 126, 237
Mulatero P. 67, 107, 156, 203
Mulè G. 59, 68, 81, 115, 142,
157, 180, 196, 231
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Mullen W. 104
Müller A. 206, 218
Müller D.N. 125
Mumladze L. 187, 218
Mundt H. 55, 164
Mundwiler J. 236
Munge K. 141
Münzel T. 230
Murai S. 141
Murakami T. 165, 193, 197, 208
Murillo Jelsbak C. 173
Murphy A.W. 82
Musca F. 165, 229
Mushtenko L. 171, 188
Musialowska M. 161
Musikhina N. 195, 219
Mussinelli R. 90, 113, 229
MustafinaO.E.145
Mutize T. 156
Muzzulini C.l. 43, 214
Mychka V. 219
Myers M.G. 50, 72
Mynard J.P. 207
Mysnychenko O. 183
Mytas D. 180
N
Nabika T. 126, 156
Nada E. 190, 209
Nadim M. 117
Nagay A. 214, 215
Nagel M. 104
Nagy V. 180
Nah D. 220
Nahmias C. 47
Naifar M. 147, 153
Nait F. 81, 196
Nakajima H. 193
Nakamura S. 150, 190, 226
Nakao E. 150, 190, 226
Nakao Y.M. 112
Nakaoka H. 103, 231
Nakatani A.Y.K. 154
Nakaya T. 103
Nakonechnikov S. 170
Nakou H. 55, 164
Nalivaeva A. 145, 147
Nam G. 146
Nam H. 146
Namgung J. 141
Namsolleck P. 47, 69
Nardi E. 59, 81, 115
Nardini C. 213
Narkiewicz K. 60, 69, 90, 93,
120, 124, 155, 156, 163, 185,
199, 208, 228
Nascente F. 100
Nascimento A. 167, 173, 236
Nasibullin T.R. 145
Naso A. 91
Naso E. 91
Nasothimiou E. 100
Nasr E. 42, 105
Nastasa A. 225, 226
Natali L. 178
Natchev E. 203
Natkina D. 169
Natsis M. 161
Naumenko E. 151
Navarro-Pérez J. 147
Nawa T. 165, 193
Naymushin A. 193
Nazaré J. 128, 220, 241
Nazarewski S. 165, 233
Nazari R. 225, 226
Nazarova G. 206
Nazzaro P. 168, 187
Nebieridze D. 102, 170
Nechutova H. 104
Nedoshivin A. 220
Negovan A.E. 178
Negreanu Piriol T. 148
Nehme A. 157
Neiva T.C. 151, 180, 181, 191
Nelaj E. 148, 152, 184
Nemeti G. 201
Nenadic N. 205
Neogi S. 66, 202, 209
Nepran V. 217
Nery De Souza Talarico J. 184
Nesti N. 69
Nesukay E. 173
Nesukay H. 143
Netchessova T. 142
Neto F. 50
Neto J.F.N. 233
Neumann C.L. 114, 159
Neuzil P. 70, 194, 199
Neves M.F. 64, 218, 229
Nevzorova V. 157
Newaz M.A. 232
Newell J. 82
Nezu M. 103
Ng F. 116, 117
Ng G.A. 104
Ng Z.Z.Y. 177
Ngoyi G. 147
Nguyen Dinh Cat A. 70, 146
Nguyen K.A. 218
Niarra R. 48, 156
Nibouche N. 49
Nica A.S. 186, 189, 193
Nicoara D. 197
Nicolai P. 225
Nicolau V. 225
Nicoletti C. 125
Nielsen O.W. 79
Nieminen M. 144
Niemirska A. 48, 149, 150,
233
Nieuwland R. 120
Nifontov S.E. 58
Nigam A. 123, 236
Niiranen T. 101, 144
Nikitin A. 157
Nikitin Y. 173
Nikoghosyan K. 238
Nikolaidis M. 192
Nikolakopoulos E. 225
Nikolakopoulos I. 160
Nikolopoulou L. 104, 120
Nikolova A. 146
Nikus K. 144
Nilsson J. 152
Nilsson P.M. 46, 48, 49, 52,
70, 73, 79, 117, 104, 120,
144, 168, 190, 234, 234
F I N A L P R OG R A M M E
269
Nishi E.E. 208
Nisic T. 216
Nitrini R. 69
Nittenberg A. 100
Nitu R. 201
Nitulescu A. 204
Niu X. 192
Nogueira R. 194
Nogueira-Silva L. 191
Nohara Y. 150, 190, 226
Nojoza W. 194
Nokay B. 104
Nokitina S. 216
Nonaka D. 221
Nony P. 50
Norkus A. 173
Norris S.A. 145
Norton G.R. 55, 89, 115, 122,
165, 180, 233, 241
Nosalski R. 59, 70, 91, 116, 146
Nosarev A. 168
Nosikov V. 157
Novak S. 219
Novella S. 68, 103, 125, 232
Novello M. 81, 196, 227
Nowak M. 124, 232
Nowak M.M. 124
Nowak R. 124
Ntineri A. 149
Nudchenko A. 154, 183
Nuernberg M. 181
Nunes D.P. 154
Nunes I.M. 200
Nurpeissova R. 189
Nygård O. 182
Nykl I. 118
Nystrom F.H. 49
O
O’Brien E. 43, 72, 140, 141,
206, 212
O’Donnell M.J. 82
O’Shaugnessy K. 98
Obadia Pereira N. 217
Obara M. 222
270
Obarska J. 203
Obeid H. 105, 158, 166
Obregon S. 46, 70, 144, 195,
234
Obrycki L. 149, 150
Ocal F. 215
Ocello A. 196
Ochoa J.E. 207, 240
Odegova A. 214, 215
Odrowaz-Pieniazek P. 233,
234
Oehlers G.P. 51, 147, 239
Ogedegbe O. 101
Ognibeni F. 231, 241
Ogonowski N. 192
Ohanian J. 87
Ohara H. 126, 156
Ohkubo T. 91, 208
Ohta Y. 222
Ohte N. 141, 221
Oigman W. 218, 229
Oikawa A. 222
Okalla C. 128, 146, 182, 221
Okamoto K. 152
Okin P.M. 82
Olde Engberink R. 46, 90
Olde R.H.G. 46
Oleynikov V. 124, 142, 143,
184, 188, 189, 232
Olin J.W. 116
Oliveira C. 181
Oliveira C.F. 191
Oliveira De Andrade D. 232
Oliveira-Sales E.B. 208
Oliveira P. 120
Oliveira Santos S. 232
Oliveira T.L. 208
Oliveira-Andrade D. 194
Oliveras A. 79, 82
Olmos S. 197
Olsen M.H. 41, 79, 121, 170
Olszanecka A. 68, 115, 118,
162, 165, 193, 221, 234
Omata K. 103
Omboni S. 57, 63, 72, 101,
114, 142
Ono Y. 103
Ooi V. 140
Oparil S. 121
Opelz G. 55
Opocher G. 156
Opolski G. 58
OreficeG.90
Orellana I. 208
Orho-Melander M. 117, 234
Orlando V. 178
Orlic l. 218
Orlic L. 231
Orlov A. 146, 147, 220, 221,
222, 235
Orlov S. 156, 168, 223
Orlova I. 142
Orlova N. 213
Orlowski S. 193
Ormiston J. 199
Orologas A. 151, 195
Orozco-Beltran D. 147
Orsolini G. 231, 241
Oshchepkova E. 52, 153, 154,
155, 187, 191
Osmenda G. 232
Osmond P.J. 193, 228
Ospanova A. 184, 238
Östgren C.J. 49
Östling G. 168
Ostojic M. 177, 188, 218
Ostrowka D. 124
Otero-Losada M. 188, 206,
218
Ott A. 191
Ott C. 49, 104, 118, 163, 168,
199
Ott J. 158
Ottaviano G. 206, 218
Ottosson F. 152
Ouabdesselam L. 187
Ouattara P. 142, 184
Oudman I. 120
Ovdienko T. 161, 187
Ovize M. 181, 183, 223
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
P
Paccaud F. 52
Pacheco Leardini Tristão M.
236
Pachirat O. 82
Padmanabhan S. 84, 104,
110, 116, 128, 155, 156, 172
Pagnin E. 84, 91
Pagonas N. 78
Paiano M. 196
Paini A. 46, 81, 86, 112, 127,
225
Païta L. 181
Paixão Dias V. 161
Paladin A. 189
Palagini L. 124
Palaiodimos L. 59, 146, 214,
232
Palatini P. 56, 78, 91, 101,
123, 140
Palazzini M. 165
Palestini P. 165
Palladini G. 229
Pallares Carratala V. 141, 145,
147, 173, 213
Palmeira C. 201
Palomba A. 227
Paltineanu B. 186, 193
Panagopoulos P. 145, 192,
209
Panakova D. 83
Panczyk-Tomaszewska M. 99,
149
PandolfiniT.58
Panduro Baron J. 201
Pannier B. 53, 79, 113, 166
Panov D. 182
Panova-Noeva M. 230
Pantic P. 205
Pantikidi E.N. 142, 213
Panzeri F. 165, 213
Papachatzi E. 113
Papachristou F. 208
Papadakis I. 150
Papademetriou V. 82, 104
Papadimitriou E. 208
Papadopoulos D. 191, 205,
211, 229
Papadopoulos N. 199
Papadopoulou M. 186
Papageorgiou C. 140, 213
Papaioannou T. 100
Papaioannou Y. 203
Papakatsika S. 161
Papakonstantinou E. 204, 227
Papavasileiou M.V. 180, 183,
233
Papi F. 99, 149
Papotti G. 141
Pappaccogli M. 141, 199
Paques M. 86, 167
Paquette-Tannir L. 236
Paramonov V. 171, 204
Parati G. 43, 52, 61, 66, 72,
78, 79, 87, 93, 96, 99, 101,
108, 116, 120, 123, 124, 127,
141, 142, 171, 193, 206, 207,
213, 234, 235, 240
Pardini P. 46, 70, 195
Pardo Tendero M. 156
Paredes M.A. 240
Pareja J. 79
Parini A. 46, 115, 145, 190,
191
Park C. 154
Park C.M. 165
Park J. 49, 188
Park J.B. 201
Park J.S. 141
Park K. 142
Park M. 221
Park S. 218
Park W. 142
Park Y. 146
Parker K.H. 165
Parragh S. 48, 89, 164, 173
Parreira L.B. 123
Parthenakis F. 55, 164
Paschalidis E. 89, 235
Paschalis-Purtak K. 165
Pascoe Gonzalez S. 201
Pascoe S. 220
Pascual J. 82
Pascual J.M. 102
Pascual Montes A. 164, 219,
226
Pasini F. 223
Paskar N. 220
Pasteur-Rousseau A. 240
Patel J. 172
Paterno C. 170
Paterson J.M. 50
Pathak A. 74, 86, 95, 111
Patino Alonso M.C. 165
Patrianakos A. 55, 164
Patsianis S. 180, 183, 233
Patsilinakos S. 160
Paudel G. 193
Paula L.G. 201
Pauletto P. 110
Paulis L. 47
Paun E. 182
Paunovic K. 171
Pavani M. 115
Pavlidis G. 59, 146, 214,
232
Pavlopoulos K. 195, 197
Pavlov K. 201
Pavlov N. 169
Pavlyuk E. 220
Pawlowska J. 148, 173
Paylar N. 147, 204, 215
Pazmanova T. 201
Pchelin I. 219
Peçanha F. 207
Peçanha F.M. 182
Pecchioli V. 214
Peceliuniene J. 173
Pechère-Berstschi A. 52, 95,
201
Pecin I. 55, 91, 115, 157,
191
Peczkowska M. 165
Pedersen E.B. 212, 241
Pedone C. 222
Peer N. 218
Peirasmakis D. 150
F I N A L P R OG R A M M E
271
Peixoto M. 100
Pekarskiy S. 118, 162, 163,
164, 172, 186, 199
Pellegrini D. 207
Pelletier C. 197
Pello E. 173
Pena C. 186, 189, 193
Penas S. 49
Pencic B. 80
Penes D. 143, 146, 178, 181,
183, 191, 197
Peng M. 160
Penkova M. 183
Penuela R. 148, 179, 216
Penuela T. 148, 179, 216
Pepin J.L. 124
Peredo H.A. 217
Perego C. 207, 191
Pereira Da Silva A. 68, 104
Pereira H. 82, 162
Pereira S. 161
Pereira T. 99, 149, 158, 205
Peres Diaz L. 224
Peretti A. 165
Perez L. 160
Perez M. 202, 229
Pérez Martínez E. 179
Pérez Ramos H. 165
Perez Vazquez E. 234
Pérez-Cremades D. 68, 103,
232, 125
Pérez-Monzó I. 125
Perez-Navarro A.M. 147
Perez-Ramos H. 158
Pericic Salihovic M. 157
Perier M.C. 79
Perlini S. 90, 113, 229
Perlo E. 141, 159, 199
Pernot M. 127
Perrea D. 191
Perrin M. 124
Perrone T. 90, 113, 229
Perrotta A. 196
Perruolo E. 190, 225
Persampieri S. 192
Persson M. 168
272
Persu A. 50, 53, 65, 98, 108,
118, 162
Persu R. 218
Peskesis G. 160
Pessana F. 47
Pessanha P. 239
Pessina L. 213
Pesta M. 234
Petelina T. 219
Peterson V. 115, 165
Petidis K. 163, 164, 199, 200
Petit T. 45, 117, 155
Petra Z. 117
Petrak O. 118
Petramala L. 196, 203
Petrashevskaya T. 219
Petraviciute M. 240
Petrischeva A. 169
Petrisheva A. 183
Petroboni B. 70, 195
Pezzi J.P. 229
Pezzutto F. 81, 227
Pfaff C. 172
Pheipher C. 156
Phinikaridou A. 89
Piagette J. 182, 207
Piantoni S. 70
Pichler G. 52, 176, 204
Pieraccioli M. 69
Pierdomenico S. 91
Pierobon V. 166, 198, 201,
235
Pietri P. 46, 75, 89, 160, 235
Pietrzyk J.A. 149
Pikilidou M. 204, 227
Pillot B. 223
Pimenta C. 68
Pincus M. 82, 205
Pindao Quesada G. 179
Pinheiro da Costa B. 201, 201
Pinhel M. 232
Pinho C. 162
Pini A. 116
Pinto F. 64, 128, 176, 177,
220, 241
Pinto F.K.M.S. 154
Pinto J. 78, 101, 141, 150
Pinto L. 127
Pintossi C. 127
Pintus G. 196
Pionova O. 219
Piotrowicz K. 194, 232
Pires Bicho M. 68
Pires J. 78, 101, 141, 150
Pires N. 162
Pirisi M. 232
Pirou N. 153, 197
Pisarev M. 177
Piscaer I. 67
Piskorz D. 194, 228
Piskunowicz M. 84
Pistja E. 141
Pita Fernandez S. 147
Pittaras A. 71, 75, 106, 163,
164, 200
Pivin E. 202
Pivina L. 184, 238
Pivovarov O. 153
Pizon T. 182, 228
Pizzolo F. 67
Plachy M. 220
Plat J. 217
Platek A. 154
Platek J. 222
Plebani M. 67
Plehm R. 125
Ploshchenko Y. 144
Plouin P.-F. 48, 53, 56, 65, 67,
116, 117, 127, 156, 203
Podoleanu C. 58
Podosyan G. 230, 238
Podzolkov V. 169, 177
Poglitsch M. 51, 204
Pogorelova O. 229
Pohanka M. 216
Pokorna V. 201
Polak M. 51
Polenova N. 143, 173
Poli M. 127
Poli-de-Figueiredo C.E. 201
Polishchuk S. 140, 200
Pollak P.T. 83
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Polo García J.L. 145
Polonia J. 49, 64, 78, 100,
101, 128, 141, 150, 220, 226,
241
Polonikov A. 156, 157
Polonis K. 228
Polovina M. 177
Polyakova E.A. 58
Pombo J.M. 92
Pompeu Filho J.C. 194
Ponomarenko I. 157
Ponomarenko V. 195
Ponte B. 52, 201
Pontes R.B. 208
Pontillo C. 117
Pontuch P. 201
Pop D. 189
Popa Z. 201
Popescu L. 144, 171, 224
Popov E. 203
Popov S. 118, 186, 187
Popovic B. 227
Poreba R. 185
Porta S. 148
Porteri E. 70, 167, 195
Porthan K. 144
Porzionato A. 202
Posadzy-Malaczynska A. 188,
226
Pose Reino A. 219
Poshinov F. 215
Posokhov I. 142, 173, 215
Post M.J. 69
Postel-Vinay N. 50
Postnov A. 157, 235
Poston L. 92
Postorino M. 55
Potapova G. 203
Potar O. 155
Potpara T. 179
Potthoff S. 58, 196
Poulios P. 81
Poulsen P. 213
Poulter N.R. 51, 82, 87, 141,
206
Póvoa R. 64
Póvoa T. 100
Power A. 82
Pozzan R. 100, 149, 157
Pozzoli S. 57, 153
Prada G. 189
Prada S. 189
Prado J.C. 197
Prado-Arechiga G. 159
Praga M. 197
Praskurnichey E.A. 173
Prata Pizzala D. 82, 227
Prati L. 214
Prats R.M. 213
Predotti P. 183
Pregowska-Chwala B. 70, 182,
203
Prejbisz A. 48, 70, 86, 163,
165, 168, 182, 199, 203, 233,
234
Premuzic V. 89, 113, 145, 215
Prencipe M. 154
Prentky E. 70
Pretnar Oblak J. 69
Prga I. 154
Prickaerts J. 69
Prieto Diaz M. 144, 145, 173
Primac G. 140, 200, 220
Printza N. 208
Pritulescu C. 218
Privalova E. 169
Priyankara K. 239
Prkacin I. 151, 164
Prochaska J.H. 230
Procopciuc L. 201
Prohorenko-Kolomoytseva I.
201, 235
Prokhorova J. 219
Proshina L. 189
Protasiewicz M. 48
Protasov K. 205
Protogerou A. 78, 100, 123,
211, 215
Protopapa P. 196
Provenzano F. 84
Prudkiy I. 184
Prugger C. 79
Pruijm M. 52, 77, 84, 115
Przewlocki T. 48
Przychodzien J. 99
Przystas J. 222
Psareva V. 217
Pucci G. 99, 149, 212
Puchin’yan N. 208
Puchulu M. 192
Puiac C.I. 178, 181
Pulido M. 159
Pundt N. 89
Puoti M. 213
Putnik S. 177
Puukka P. 101, 144
Puyó A. 196, 217
Pyankov V. 200
Pyrpasopoulou A. 145, 192,
209
Q
Qamar N. 101
Qiyin Z. 177, 178, 179, 187,
189
Quarti F. 82
Quarti Trevano F. 82, 91, 200
Quartuccio S. 163, 199, 223,
232, 240
Quere S. 51
Quevedo-Aguado L. 50, 240
Quezada P. 220
Quinaglia T. 199
Qvarnström M. 173
Qwierblewska E. 120
R
Rabbia F. 141, 159, 199
Racheva A. 201
Rachiotis G. 53
Racki S. 239
Radchenko G. 169, 171, 188,
198
Radchenko V. 204
Raddino R. 223
Radenkovic S. 144
F I N A L P R OG R A M M E
273
Radhouani I. 160
Radic J. 185, 239
Radic M. 185
Radivojevic N. 171, 219, 222
Radix W. 192
Radovanovic M. 148, 189
Radovanovic N. 148, 189
Raduna M. 142, 178
Radunovic A. 126
Radziemski A. 194, 199
Rafael C. 51
Rai P. 152
Raimondi A. 113, 229
Rainho C. 201, 202
Rajakaruna I. 239
Rajch D. 232
Rajic D. 148, 189
Rajkumar C. 139, 143
Rajzer M. 182, 228
Rakha S. 214
Rakhypbekov T. 184
Rama Martín T. 173
Rama Martinez T. 145
Ramalhinho V. 180
Ramalle Gomara E. 144
Ramazzina E. 83, 184
Ramirez A.J. 47, 166
Ramos Becerra C. 140, 152,
174, 201, 213, 234
Ramos C. 220
Ramos Marques N. 104
Ramos N. 46
Ramos Nuñez J. 152
Ramos R. 61
Rampakakis E. 220
Ramshev K. 178
Ramstein J. 166
Rananja H. 43
Ranganna K. 232
Rangel R. 236
Rangel Silvares R. 50
Ranjbar H. 186
Rashev T. 157
Rasic L. 87, 168
Råstam L. 123
Rasulova Z. 239
274
Ratti G. 239
Ravaro S. 82
Ravarotto V. 84, 91
Ravassa S. 117
Ravera A. 183
Raymond A. 55, 115, 165
Razov M. 241
Razov Radas M. 215, 241
Re A. 91
Read U. 153
Rebellato A. 203
Reboldi P. 91
Rebora P. 120
Reboul C. 236
Rebrova N. 186, 187
Recarti C. 69
Recio-Rodriguez J.I. 127, 158,
165
Redekop W.K. 66
Redheuil A. 77, 167
Redon J. 52, 56, 65, 73, 76,
80, 88, 100, 105, 108, 112,
114, 147
Redon P. 100
Reesink K. 49, 89, 109
Reesink K.D. 234
Regalia A. 160
Regazzoni V. 223
Regnault V. 184, 224, 227
Regnier-Le-Coz S. 158
Reincke M. 67, 70
Reinhard M. 213
Reis A.P.M. 225
Reis P.A. 50
Reis Santos C. 160
Rekhviashvili A. 223
Rekovets O. 140, 144, 198,
200, 220
Remache A. 85
Remer T. 225
Remme W. 169, 174
Ren K. 55
Ren M. 117
Renard J. 48
Renard J.M. 156
Renkin J. 118, 162
Rensing B. 104
Resende E. A.M.R. 151, 140
Resende J.A.M. 140, 151
Resende L. 140, 151
Reshetnik A. 141, 166, 212
Retelina T. 195
Reuter H. 95, 126
Revnic C. 186, 189, 193
Revnic F. 186, 189, 193
Rewiuk K. 58, 199
Rey Aldana D. 173
Rezende L. 181
Reznik Y. 203
Rezzani R. 167
Rhee M. 141, 220
Rial M.O. 165
Ribeiro C. 184
Ribeiro F. 222, 223
Ribeiro R. 68
Ribstein J. 162, 168
Riccardi G. 159
Ricci M. 143
Richard V. 83
Rickard A.J. 66
Rietzschel E.R. 41
Rigaud A.S. 43
Rihacek I. 220
Rihter M. 151, 227
Rimoldi S. 46
Rimpelä J. 117
Ripari F. 70
Ripp E. 186, 187
Ripp T. 118, 162, 163, 164,
172, 186, 187
Ritter A. 162, 163, 164, 199
Riviera M. 127
Rizzola G. 229
Rizzoni D. 40, 70, 79, 86, 139,
167, 195
Roa M. 202
Robledo M. 67
Robles A. 196
Robles Perez-Monteoliva N.
161, 198
Robustelli Test L. 166, 198,
201, 235
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Roca F. 43
Rocha A. 66
Rocha E. 160
Rocha-Goncalves F. 186
Roche C. 83
Rodella L.F. 167
Rodilla Sala E. 102, 213, 235
Rodriges De Resende L.P. 214,
212
Rodrigues De Resende E.M.
214
Rodrigues R. 180, 181
Rodrigues R.B. 151, 191, 225
Rodríguez A. 188
Rodriguez de Castro C. 152,
197, 218
Rodriguez Lopez I. 226
Rodriguez M. 196
Rodriguez Roca G.C. 145
Rodriguez Sánchez E. 165
Rodriguez Zapata M. 179
Rodríguez-González S. 158
Rodriguez-Martin C. 158
Rogachova T. 161, 196
Roggenbuck U. 89
Rogic D. 46, 115, 145, 190,
191
Rogoza A. 142, 163, 187, 229,
235
Roh Y. 146
Roig Espert B. 141, 213
Rojek A. 69
Rojek M. 182, 228
Roldán E. 206
Rollán García P. 141, 213
Romagnolo A. 43
Romano D. 83
Romano S. 153
Romanov V. 146
Romeo F. 90
Romosan I. 197
Ronconi V. 203
Rosa J. 118, 162
Rosales Rivera L. 152
Rosenbaum D. 86, 167, 198
Rosengren A. 154
Rossant F. 167
Rossi F. 222
Rossi G.P. 67, 76, 84, 103,
107, 202
Rossignol P. 76, 98, 158, 162
Rossing P. 50
Rossini C. 70, 195
Rossini M. 231, 241
Rossitto G. 67, 103
Rosticci M. 46, 115, 120, 128,
145, 190, 191, 222
Rostovtseva M. 235
Rostrup M. 120
Rosu A. 218
Roszkowsk-Blaim M. 149
Rotar O. 52, 146, 147, 153,
155, 191, 218, 220, 221, 222,
235
Rothe M. 203
Rothwell P.M. 78
Roubille C. 168
Roufas K. 55
Rouillon C. 184
Roumy J. 55
Rousak T. 188
Rousse N. 166, 237
Rousskich I. 188
Roussos D. 160
Rouvier E. 196
Rouviere O. 197
Rovina M. 116
Rozanska M. 124, 229
Rroji M. 183
Ruan C. 83, 92, 126
Rubagotti G. 46, 81, 86
Rubin S. 231
Rudenko I. 143, 163, 193
Rudzinski A. 149
Ruggeri N. 199
Ruilope L.M. 50, 197, 240
Ruiz Galiana J. 152, 197, 218
Ruiz-Hurtado G. 197
Rukavina Mikusic N.M. 196
Rump L.C. 58, 196
Runikhina N. 184, 187
Rupa-Matysek J. 166
Russcher H. 200
Russo A. 127
Rusu M. 218
Ruszczykowski P. 149
Rutten B.P. 69
Rvacheva A. 230
Ryabova T. 162
Rybi-Szuminska A. 150
Rydchenko V. 156, 223
Ryliskyte L. 240
Rys A. 154
Ryu K. 213
S
Sá R. 160
Sabbatini A. 162, 163, 164,
199
Sabino P. 128
Sablin A. 184
Sachinidis A. 199
Sachpekidis V. 81
Sadiku E. 152
Sadomov A. 229
Sáenz Heranz R. 207
Safar M.E. 48, 78, 100, 120,
188
Safarian A. 170
Safarova A.F. 152
Safronova T. 169
Sagan A. 59
Sagliker C. 215
Sagliker H.S. 147, 204, 215
Sagliker Ozkaynak P. 147,
204, 215
Sagliker P. 147, 204
Sagliker Y. 147, 204, 215
Saheb B. 198
Sahebkar A. 128, 222
Sain M. 185
Saint-Remy A. 141
Sainz-Gutiérrez J.C. 50, 240
Saito Y. 221
Saitta A. 163, 199, 223, 232,
240
Sajadieh A. 79
F I N A L P R OG R A M M E
275
Saka S. 197
Sakai A. 103
Sakata K. 227
Sakaue A. 150, 190, 226
Sakovskaia A. 157
Sala C. 91, 227
Sala O. 207
Saladini F. 72, 78, 123, 140
Salaices M. 182, 207
Salar L. 235
Salascheva T. 171
Saldanha C. 180
Saleh L. 92, 200
Salem J.E. 103
Salerno S. 120
Sales A.R.K. 166
Salinaro F. 90, 113, 229
Salizzoni M. 190, 209
Sall F. 142
Salobir B. 205
Salomaa V. 101
Salvador G.L.O. 171
Salvetti M. 46, 71, 81, 86,
112, 127, 139, 173, 225
Salvi E. 155
Salvi L. 116
Salvi P. 116
Salvo F. 43, 214
Salyamova L. 124, 142, 143,
188, 232
Samani N. 71
Samaras A. 195
Samji S. 104
Sammut I. 125
Sampalis J. 220
Samson-Couterie B. 66
Samuelsson A. 92
Sanchez A. 146
Sánchez Aguadero N. 127,
165
Sánchez Eluchans N.M. 217
Sanchez R. 47
Sánchez-Chaparro M.Á. 50,
180
Sanchez-Frias M. 165
Sanchez-Salgado B. 158
276
Sanchis C. 147
Sanders M. 117
Sanesi L. 99, 149
Sang J. 146
Sangthong B. 82, 237
Sanidas E. 191
Sans L. 79, 82
Santa Catharina A. 199
Santamaria R. 165, 196
Santos Moreira C. 180, 225
Santos J.R. 64
Santos L. 180
Santos R.C.C. 238
Sanz G. 147
Sapojnic N. 224
Sapoval M. 82
SarafidisP.151,160,161,
176, 196
Sarchioto M. 43
Sardo M.A. 223, 240
Sareli P. 55, 89, 165, 233, 241
Saricheva A. 102
Sarini M. 225
Sarkisova O. 186
Sarlon G. 192
Sarlon-Bartoli G. 161
Sarzani R. 115, 143, 231
Sato A. 152
Sato S. 103
Satoh F. 67, 103
Satoh M. 208
Satoh T. 227
Sautenet B. 55, 196, 197
Savard S. 50
Savic L. 188, 218
Savic S. 216
Savikin K. 224
Savitskiy S. 220
Savoia C. 125
Savopoulos C. 51, 83, 148,
151, 152, 153, 186, 195, 197
Saxena M. 82, 104, 126, 205,
237
Saxton S. 87
Sayeed Haque M. 102
Scaduto E. 180, 196
Scala D. 226
ScalfiL.69
Scarabelli T. 223
Scarsi M. 70
Scazzone C. 157
Schaaf M. 183
Schaap M.C. 120
Schafer J. 117
Schäfer S. 126
Schalkwijk C. 217
Schaper N. 87
Scheen A.J. 110
Schekotov V. 183
Schendrigina A. 169
Schiavi F. 156
Schiavon L. 83, 184
Schiffrin E.L. 86, 94
Schillaci G. 61, 74, 78, 99,
123, 149, 211, 212, 233
Schillaci M.K. 115
Schiöler L. 58, 113, 153, 173,
212
Schirosi G. 168, 187
Schlaich M.P. 118
Schlieper G. 122
Schmid A. 118, 163
Schmidt B. 81, 211, 230
Schmidt G. 72
Schmidt-Truksaas A. 62
Schmieder R.E. 45, 49, 52, 54,
60, 74, 86, 87, 87, 98, 104,
105, 117, 118, 121, 163, 168,
199
Schmieder R.S. 118
Schmolling-Guinovart Y. 127
Schneider Voirol M. 53
Schoinas A. 59, 146, 214, 232
Schomburg L. 192
Schoors D. 104
Schouten J. 87
Schram M. 49, 87, 167
Schreier L. 126
Schuchardt M. 166
Schuepbach U. 236
Schulz A. 83, 125, 230
Schulz E. 159
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Schuman M. 224
Schunck W.H. 203
Schutte A.E. 45, 128
Schutte R. 45
Schütten M. 217
Schwager C. 51, 58
Schwartz C. 102
Schwartz J. 91
Sciatti E. 223
Scott B. 104
Scott J.A.G. 141
Scuruchi M. 232
Scuteri A. 46, 70, 120, 144, 234
Seba A. 216
Sebastian Leza A. 207
Sebba Barroso W. 64
Seccia T.M. 67, 202
Sechi L.A. 81, 196, 227
Sedlackova L. 70, 194
Seferi S. 183
Segarra G. 68, 125
Segiet A. 124, 229
Segura J.J. 43, 197
Seibert F. 78
Seidel M. 78
Seidlerova J. 234
Seifar F. 186
Seiler C. 46
Selthofer Relatic K. 219
Semakova A. 91, 226
Semczuk K. 154
Semenov A. 189, 217
Semenov V. 161
Semeraro F. 127, 195
Semke G. 118, 162, 163, 164,
172, 186, 187
Sempé P. 44
Senchikhin V. 145, 147
Sens F. 197
Seo S. 144
Sepúlveda Santos T. 200
Seravalle G.L. 81, 82, 91, 101,
200, 227, 234
Serbanete C. 146, 231
Seretis A. 180, 183, 233
Sergeeva O. 201
Sergienko V. 171
Seric V. 87
Seron D. 46
Serraille M. 190
Sertic J. 55, 91, 157
Servos G. 149
Sever P. 46
Seyed-SafiA.102
SfikakisP.100
Sgariglia A. 92
Shabani R. 239
Shadrin A. 169, 183
Shah A.M. 126
Shah H. 214
Shah M. 126, 237
Shakirova N. 238
Shalimova A. 217
Shalnova S. 52, 153, 155, 191
Shan B.S. 103, 231
Shan X.L. 181
Shanahan C. 122
Shang F. 192
Shao L. 229, 230
Shaposhnikova A. 169
Sharif F. 126
Shariya M. 230
Sharman J. 122, 176, 206
Shavarov A. 177
Shchekotov V. 169
Shchelkova G. 163
Shchetinin E. 235
Sheikh A. 202
Shen Z.J. 67
Sheng C.S. 233
Sheppard J.P. 101
Sheremet M. 194
Sheykhzade M. 168
Shi H. 224
Shibeka N. 188
Shields S. 172
Shim S. 183
Shimizu H. 100
Shimoura C.G. 208
Shin C. 49
Shin J. 183, 188, 235, 236,
241
Shin J.S. 188
Shin S. 144, 160, 220
Shipitsyna N. 215
Shiraishi M. 165, 193
Shishkin A. 189, 219
Shishkova V. 187
Shkroba A. 219
Shkurat I. 177
Shlyakhto E. 52, 58, 153, 155,
191, 218, 235
Shlykhto V. 222
Shore A. 165, 184
Shortall K. 221
Shtanko V. 144, 172
Shtonova N. 147
Shu E.B.S. 69
Shurkevich N. 215
Sibiya M.J. 89, 233, 241
Sidebe A. 233
Sidorenko P. 140, 200, 220
Siedlinski M. 70, 116
Siegel N. 166
Siegelova J. 216
Sierra C. 69
Siga O. 198, 199, 200, 228
Sijpkens Y. 170
Sikorska A. 168
Silhol F. 161, 192
Siliste R. 164, 200, 204
Silva D.A. 157
Silva M. 153
Silva R. 194
Silva Vieira M. 89
Silva-Souza D.R. 194
Simakova M. 193
Simon J. 53
Simon T. 53
Simonini M. 57, 116, 153
Simonyi G. 206, 219, 237,
238
Simoons M. 169, 174
Simundic T. 194, 209
Simunovic F. 239
Sindeev S. 185
Sindeeva O. 185
Sinescu C. 172
F I N A L P R OG R A M M E
277
Singano V. 172
Singh R. 216
Sinski M. 168
Sirenko Y. 140, 144, 169, 171,
188, 198, 200, 205, 220
Sirotina S. 156, 157
Sitkova E. 172, 186
Sivén S. 101
Sjogren M. 155, 156
Skiba D. 70
Skoblov Y. 159
Skodra A. 151
Skoularopoulou M. 186
Skoumas J. 46
Skowronska M. 233
Skripnikova I. 170
Skrobowski A. 194, 232
Skrzypczyk P. 99, 149
Skrzypek-Czerko M. 69
Skultetyova D. 78, 163, 178,
201
Skyrlas A. 213
Sliwa T. 232
Sliwinski P. 182, 203
Slowik A. 230
Slusarczyk P. 199
Smaglii L. 156, 168, 223
Smalcelj R. 215
Small H.Y. 91, 104, 202
Smeeth L. 141
Smiianova O. 216
Smiianova Y. 166
Smirnova M. 142, 208, 214,
216
Smith W. 45
Smolders I. 230
Smolich J.J. 207
Smurra M. 229
Snegurskaya I. 183
Snezhitskiy V. 206
Sobiczewski W. 155, 156
Sobocinski J. 48, 166, 237
Soboleva A.V. 58
Sobotka P.A. 104
Sobrero G. 43, 190, 209, 227
Socha P. 148, 173
278
Sochor O. 172
Sodhi S. 172
Softic S. 224
Sokolenko A. 217
Sokolovic S. 106
Solaini L. 70, 195
Solbu M. 162
Soldatenkova N. 235
Solini A. 115
Solntsev V. 146, 147, 218,
220, 221, 222, 235
Solodilova M. 156, 157
Soloveva A. 177, 178
Song J. 181, 215
Soranna D. 43, 124
Sorensen B. 87
Sormani P. 225
Soroka I. 154, 183
Sosea I. 218
Soska V. 172
Sosner P. 123, 158, 160, 236,
240
Soto V. 208
Soucek M. 104, 220
Soulat G. 89
Soulioti E. 213
Sousa A. 68, 100, 143, 151,
180, 181, 191, 225
Sousa A.L. 123, 151, 154,
143, 181, 191, 225
Sousa N. 120
Sousa W. 151, 181, 191
Sousa W.M. 123
Sousa-Guimaraes S. 84
Souza D. 232
Souza H. 151, 181, 191
Souza M.G.C. 168
Souza W. 180
Souza W.K.S.B. 123, 225
Sowemimo I. 190
Soya O.V. 187
Spaak J. 118
Spac J. 220
Spagos G. 83
Spahia N. 183
Span M. 159
Spannella F. 143, 231
Spanou M. 186
Spataru D. 200
Spector T. 89
Spector T.D. 104
Speight C. 172
Spengos K. 185, 186
Spiering W. 126
Spineti P. 100, 149
Spiroglou S. 83, 152, 153
Spirou A. 151, 153
Spiryakina Y. 213
Sportouch D. 151
Spronck B. 47, 89, 234
Srojidinova N. 238
Srugies F. 196
Stabouli S. 161, 208
Staessen J.A. 41, 44, 45, 46,
81, 117, 118, 147, 155, 162,
173
Stafanczyk L. 234
Stamatian F. 201
Stamenkovic B. 227, 240
Stamenov G. 201
Stamerra C.A. 222
Stancheva N. 157
Stanczyk A. 194, 232
StanfieldB.153
Stang A. 89
Stanton A. 104, 221
Stanzione G. 55
Starchenko T. 151
Starek Z. 199
Starostina E. 151
Starshova O. 228
Stassaldi D. 81
Stavropoulos K. 163, 164,
199, 200
Stavropoulos N. 163, 164,
199, 200
Stea F. 89, 233
Steca P. 225
Steegers E.A.P. 200
Stefan C. 178
Stefanadis C. 46, 160
Stefanovic B. 148, 189
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Stegbauer J. 58
Stehouwer C.D.A. 49, 87, 119,
167, 217
Steichen O. 50, 67, 107, 158,
176, 181, 203
Steigen T. 118, 162
Steinbusch H.P. 69
Steinbusch H.W.M. 69
Stell A. 67
Stelmaszczyk-Emmel A. 99
Stepanov V. 157
Stepanova R. 104
Stepina E. 178
Stergiou G.S. 53, 72, 100,
101, 113, 140, 149, 159, 191,
211, 212, 240
Stevanovic R. 113, 221
Stevens R. 101
Steyn K. 128
Stimac D. 218
Stipancic Z. 89
Stoian A. 167
Stoica D. 182
Stojanov V. 169, 171, 216,
219, 222
Stojanovic D. 144
Stojanovic M. 216
Stojanovic S. 203
Stojanovic T. 205
Stojkovic M. 216
Stolarz-Skrzypek K. 165, 195,
221, 222, 234
Stoll M. 83
Stoller A. 51
Stowasser M. 51, 67
Stragalis C.P. 195
Strain W.D. 165
Strashnenko A. 183
Strauch B. 118
Strazzullo P. 69, 128
Stroer S. 89
Strom T.M. 51
Struijker-Boudier H.A.J. 44, 59
Stryczynski L. 48, 165, 194,
199, 234
Stuber M. 84, 115
Stupin A. 87, 168
Stupin M. 168
Sturk A. 120
Stvrtinova V. 166
Styczkiewicz K. 193
Subotic I. 148, 189
Subtil F. 183
Sugawara K. 222
Sugiura T. 141, 221
Suh S.Y. 49
Sujayeva V. 145
Sulicka-Grodzicka J. 181
Sulim U. 171
Sulke N. 104
Sun J.P. 127
Sung K. 220
Sung S. 180
Surdacki A. 181
Suric-Lambic L. 179
Süsal C. 55
Sutcliffe N. 126
Sutil L. 202
Suzuki H. 208
Suzuki J. 103
Sviryaev Y. 146, 217
Swanepoel B. 128
Swennen G.N.M. 69
Swiatlowski L. 48, 165, 234
Swierblewska E. 185, 208,
228
Sydorchuk A. 123, 156, 217
Sydorchuk I. 123, 156, 217
Sydorchuk L. 123, 156, 217
Sydorchuk R. 123, 156, 217
Symonides B. 172, 200
SzaflikJ.86,168
SzaflikJ.P.86,168
Szczepaniak P. 59, 116
Szczepaniak-Chichel L. 166,
199
Szczerbo-Trojanowska M. 48,
165, 234
Szigeti M. 51
Sztefko K. 149
Szwench-Pietrasz E. 199
Szymanek K. 86, 168
Szymanski F.M. 154
Szyndler A. 228
T
Tabara Y. 86
Taborsky L. 70, 194
Taborsky M. 118
Tack I. 231
Taddei S. 89, 115, 119, 124,
128, 233
Tade G. 89, 233, 241
Tadic M. 80, 81, 91, 119, 217,
227
Tagetti A. 100, 117, 203
Taieb D. 107
Taira T. 230, 241
Takahashi H. 222
Takahashi K. 208
Takahashi R. 222
Takaishi H. 206
Takase H. 141, 221
Takayama S. 221
Takeda A. 165
Takegami M. 112
Talarowska P. 48, 124, 229,
233
Taleb A. 182, 219
Taleb Bendiab N. 159
Talvik A. 120
Tamarit García J. 141, 213
Tamasheuski A. 188
Tamisier R. 124
Tamura H. 222
Tamura K. 230, 241
Tan G. 140
Tan I. 89, 234
Tan L. 172
Tanaka T. 221
Tanaka Y. 206
Tandurella N. 166, 198, 201,
235
Tang X.F. 67
Tang Z. 226
Tanios B. 204
Tanter M. 127
F I N A L P R OG R A M M E
279
Tao B. 67
Targher G. 218
Tarlovskaya E. 146, 214, 215
Tarnovska-Kadreva R. 186
Tarzimanova A. 177
Tase M. 148, 152, 184
Tasic I. 151, 188, 218, 227,
232, 240
Tatar C.M. 58
Tautu O. 113, 158, 172
Tavares L. 226
Tavecchia L. 166, 198, 201,
235
Taylor A. 118
Taylor R. 184
Tedgui A. 70
Tegos T. 83, 151, 152, 195,
197
Teixeira F. 160
Tekieli L. 233, 234
Teliewubai J. 153, 235
Tellez-Plaza M. 52, 147
Tentori S. 116
Teo A.E.D. 66
Tepoian I. 170
Terentes-Printzios D. 46, 89,
160, 235
Terzi F. 208
Teskera T. 89
Tessier A. 185
Testa E. 199
Tezuka Y. 103
Themeli A. 141
Thijs L. 44, 45, 46, 81, 117,
118, 147, 155
Thimel K. 212
Thom S. 51
Thomas D. 69, 186
Thomas F. 79
Thomas J.R. 172
Thomas-Jean F. 53, 166
Thomopoulos K. 193
Thor N. 228
Thuillez C. 105
Tian J. 55, 224
Tian Z. 205
280
Tibiriçá E. 50, 167, 173, 217,
236, 239
Tiedge M. 196
Tikhonoff V. 101
Tikkanen I. 110, 118, 162,
170
Tikkanen J. 144
Tilea I. 58, 178, 181, 197, 226
Timasheva Y. 145
Timmers H. 67
Tincani A. 70
Tisheva S. 157, 178
Tishman M. 169
Tissera G. 228
Titov E. 143
Titov I. 173
Tiwari S. 216
Tkachev G. 195
Toblli J. 70, 92, 196, 224
Tocci G. 111
Toelle M. 212
Toennes S.W. 163
Tofan N. 144, 172
Tokaeva F. 152
Toklu B. 50
Tokmak F. 148
Tolika P. 151
Tölle M. 141, 166
Tolstov S. 219
Tomas Z. 157
Tomashevskaya Y. 143, 189
Tomat A. 126
Tommasi A. 228
Tonchev P. 157
Toncheva A. 195
Tonon E. 69
Topor-Madry R. 163
Topouchian J. 48, 188, 215
Torbas O. 140, 144, 188, 198,
200, 220
Torbova S. 178
Torii S. 221
Torino C. 84
Torlasco C. 207
Torralba M. 179
Torres I.B. 46
Torres Sánchez M. 197
Torro M.I. 100
Torunova A. 205
Toth M. 163, 180
Totsuka Sutto S. 140, 174,
201, 213, 234
Totsune K. 208
Touboul C. 48, 204
Touloumi G. 53, 113, 191
Touloupaki M. 164
Tousek P. 118
Tousoulis D. 46, 89, 102, 104,
114, 118, 120, 147, 152, 160,
181, 191, 193, 195, 196, 217,
223, 225, 226, 235
Toussaint J.-F. 62
Toutounchi S. 70
Toutouzas K. 196
Touyz R.M. 63, 70, 146, 172
Touzé E. 65
Townsend Nicholson A. 117
Trafas T. 229
Trakateli C. 167
Trapani G. 163, 199
Traykov L. 186
Treggiari D. 58
TrendafilovaE.150,215
Tretyakova N. 219
Triantafyllidi H. 59, 146, 214,
232
Triantafyllidou E. 192
Triantafyllou A. 81, 92, 145,
167, 185, 192, 209
Triantafyllou G. 92, 145, 167,
192, 209
Trichaki E. 223
TrifiròG.116
Trillo Calvo E. 144
Trimarco B. 90
Trindade M. 218
Tringler M. 166
Tripepi G. 55, 84, 200
Tripepi R. 84
Tripoten M. 229
Troiani L. 99, 149
Troitskaya E. 179, 216
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Trojnarska O. 166
Trypsianis G. 53, 113, 191
Tsai W. 179, 222
Tschudi P. 102, 238
Tsiaras N. 83, 197
Tsilibari P.E. 196, 209
Tsilonis K. 160, 161
TsioufisC.45,54,73,74,82,
102, 104, 111, 114, 118, 120,
147, 160, 193, 217, 225
Tsoi U. 217
Tsonev S. 147, 201, 202
Tsopozidi M. 186
Tsukuda K. 103, 231
Tsuru T. 150, 190, 226
Tsuta K. 181
Tsyrulneva N. 204
Tu K. 50
Tucker K. 101
Tucker N. 116
Tudorica C. 146, 231, 238
Tudorica S. 146, 231, 238
Tuev A. 169, 183
Tuktarova I.A. 145
Tully P. 172
Tumarkin M. 206
Turecky L. 153
Turk M. 69
Turki M. 147, 153
Turpin Lucas C. 147, 219, 238
Tykarski A. 48, 156, 166, 194,
199, 229, 234
Tyukhmenev E. 166, 192, 208
Tzatzahou G. 239
Tziomalos K. 186
Tzourio C. 172
U
Uceda A. 92
Uchigata Y. 152
Uder M. 118, 163
Udrescu M. 172, 182
Ueland P. 182
Ueshima H. 221
Umbach I. 102, 223, 237
Undas A. 182
Uneda K. 230, 241
Ungar A. 69
Unger T. 42, 47, 69, 77, 115
Urabe M. 103
Urbanski K. 59
Ureche C. 199
Urrego Rivera L. 147, 219,
238
Urso R. 120, 191, 222
Uruski P. 156, 194, 199
Uskova V.A. 239
Ustyan T. 230, 238
Usubova F. 206
Uzieblo-Zyczkowska B. 194,
232
Uzu T. 150
V
Vaccaro F. 157, 196, 231
Vachulova A. 178
Vaclavik J. 118, 180, 229, 237
Vaclavik T. 180, 229
Vagaytseva K. 157
Vaglio M. 112
Vaiman D. 97
Vaisse B. 113, 161, 162, 192,
211, 220
Vajic U.J. 158, 161, 224
Vakilzadeh N. 115, 118
Valadez Soto J.M. 234
Valbusa F. 120
Valdes A.M. 104
Valdeviño Nascimento J.O.
184
Valdivielso-Felices P. 50
Valeeva E. 171
Valente F. 232
Valenti P. 118
Valevica E. 238
Valieva Z. 155, 166
Vallelonga F. 43, 190, 209,
227
Vallerio P. 165, 213, 225
Vallet M. 231
Vallo C. 43, 214
Valls F. 147
Valsecchi M. 120
Vamvakou G. 152, 181, 191,
195, 223, 226
Van Agtmaal M. 167
Van Bortel L.M. 40, 47, 119
Van Coppenolle F. 181
van de Borne P. 78, 110, 123,
128, 146, 147, 182, 221, 234
van den Born B.J. 43, 46, 90
van den Hoek T.C. 46, 90
van den Meiracker A.H. 92,
97, 103, 111, 126, 200
Van Der Giet M. 104, 141,
166, 212
Van der Heyden J. 126
Van Der Hoeven N. 43
van der Kallen C. 87
Van der Niepen P. 164, 173
van der Woude L. 120
Van Hagen B.T. 69
van Ittersum A.T.P. 170
van Montfrans G.A. 43, 51,
120, 147, 239
Van Noordenne N. 46, 90
Van Oostenbrugge R.J. 69
Van Oosterhout J. 172
Van Oyen D. 51
Van Tielen R. 223
van Seventer I.C. 51
van Sloten T. 49
Van Tielen R. 102, 237
Van Twist D. 84
Vandenbriele C. 155
Vanderriele P. 202
Vaneckova I. 223
Vanicek J. 104
Vanni E. 190, 209
Vantarakis A. 53, 191
Vara Gonzalez L. 144
Vardas P. 55, 164
Varela M. 152, 197, 218
Varga A. 58, 178, 181, 226
Vargas B. 152, 197, 218
Vario M.G. 180, 231
F I N A L P R OG R A M M E
281
Varis J. 101, 144, 171
Varoudi M. 232
Varrenti M. 165, 213, 225
Vaschylko A. 200, 220
Vasiletc L. 183, 169
Vasilev V. 239
Vasilevski M. 220
Vasilevskis E. 238
Vasilieva E. 147, 220, 221,
235
Vasiliu D. 200
Vasiljevic Y. 189
Vasiljevic Z. 148
Vasilkova V. 151
Vaskova J. 163
Vassallo D. 182, 207
Vassilev D. 158, 186
Vatinian S. 184, 188
Vaucher J. 43
Vaulina D. 217
Vavrincova-Yaghi D. 223
Vavrinec P. 223, 224
Vazeou A. 149, 149
Vazquez Del Mercado M. 234
Vazquez S. 79, 82
Vecchio L. 225
Vedove 203
Veelken R. 118, 163, 176, 198
Veglio F. 43, 141, 159, 190,
199, 227
Vegreville M. 50
Velilla Zancada S. 144
Vemmos K. 185, 186
Vemmou A. 185, 186
Verardino R.G.S. 238
Verberk W.J. 57, 101
Verdecchia P. 90, 91, 94
Verdonk K. 92, 200
Vergani C. 101, 234
Vergis K. 213
Vergura M. 154
Verhamme P. 44, 45, 117, 155
Verlato R. 140
Verma N. 216
Vermassen F. 164, 173
Vermeer C. 45
282
Vernardos M. 164
Vernier L. 55, 196
Verri V. 167
Versace M.C. 84
Vertolli U. 91
Verzeri L. 81, 225
Veselovskaya N. 179, 191,
226
Vetoshkin A. 215
Vettoretti S. 56, 160, 161, 198
Vettou C. 140, 142, 213
Veugen M. 49
Vial Y. 201
Viapiana O. 231, 241
Vichodcev A. 187
Vidal J.S. 43
Vidal S. 201, 202
Vidal-Gómez X. 68, 103, 125,
232
Viebahn R. 78
Viecca F. 116
Vieira Da Silva M. 212, 214
Vieira M.R. 201
Viggiani A. 183
Vigie L. 170, 205
Vigil L. 152, 197, 218
Vigorito C. 183
Viigimaa M. 42, 75, 120, 170
Vila I. 120
Vilela-Martin J. 194, 232
Vilkhova I. 216
Villain M. 168
Villar Gomez I. 207
Villarini A. 56, 207
Villasmil J. 152
Villedieu C. 223
Villela D.C. 47
Villeneuve F. 220
Villevalde S. 84, 159, 162,
166, 171, 174, 177, 178, 188,
192, 208, 209
Vincelj J. 205
Vincentelli A. 166, 237
Vinkovic M. 89
Vintila A. 142, 146, 178, 231,
238
Vintila V. 142, 146, 178, 231
Vinuesa M.A. 194
Viola T. 180
Viscido A. 178
Visser W. 92, 200
Vithanage C. 239
Vitolo E. 115
Vitorino P.V.O. 123
Vizzardi E. 223
Vlachopoulos C. 46, 47, 75,
89, 93, 109, 119, 160, 235
Vlachos E. 120
Vlachos G. 102, 147, 193
Vlachos S. 59, 146, 214, 232
Vlachou A. 160
Vlahakos D. 92, 196, 209
Vlahakos D.V. 160
Vlastarakos P. 239
Vlastos D. 232
Vogiatzis K. 167
Vogt B. 52, 84
Vogt L. 46, 90
Voidazan S. 181
Voigt J.U. 117
Voinea S. 186, 193
Voita D. 238
Voitikova M. 213
Volakaki A. 196, 209
Volkov D. 142, 208, 214
Voloshyn M. 195
Voloshyna I. 195
Volpe M. 47, 76, 125
Vondrakova D. 70, 194
Vonend O. 196
Vougia D. 55, 164
Voulgari P. 53, 113, 191
Vourvouri E. 204
Vovelle A. 240
Vrabas I.S. 92, 192
Vrdoljak A. 46, 55, 89, 91,
113, 115, 145, 157, 190, 191,
215, 221
Vriz O. 232
Vuckovic-Filipovic J. 229
Vujicic B. 239
Vujovic S. 216
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Vukicevic M. 177
Vukomanovic V. 80, 81, 217
Vukovic I. 46, 55, 89, 91, 113,
145, 190, 215, 221
Vulev I. 163
Vygodin V. 171
Vynnychenko L. 216
Vysotskaya E. 183
Vyssoulis G. 46, 89, 196
Vythoulkas D. 233
W
Wachtell K. 57, 176, 188
Wachter R. 117
Waeber B. 43, 121
Waeber G. 43
Wahl D. 184
Waisman G. 234
WakefieldB.J.101
Wakui H. 230, 241
Walas S. 222
Walczewska J. 198, 199, 200,
228
Waldauf P. 118
Walker R. 125
Wallentin F. 53
Walters D. 82, 205
Walton A. 118
Waly N. 239
Wang H. 192, 192
Wang J. 40, 40, 52, 127, 140,
181, 183, 215, 233
Wang J.G. 67
Wang K. 43, 53, 143, 153,
235
Wang L. 43, 153, 183, 229,
235
Wang Q. 57, 177, 204, 205,
209, 223, 237
Wang Q.Y. 228
Wang R. 183, 185, 209
Wang X.L. 103, 231
Wang Y. 160, 205, 229, 230
Warchol-Celinska E. 48, 86,
165, 182, 199, 203, 233, 234
Warne B. 141
Warren F. 69, 184
Wasilewska A. 150
Wassertheurer S. 48, 89, 139,
158, 164, 173
Watanabe M. 112
Watanabe T. 112
Watfa G. 105
Wawrowski T. 124
Webb A.J. 120, 120, 234
Weber M.A. 78 94
Weber T. 41, 48, 89, 113, 158,
164, 173
Weber V. 189
Weekers L. 141
Wei C. 195
Wei F. 44, 45, 117, 155
Weiss E. 143, 146, 178, 181,
183, 191, 197
Weisser B. 221
Wentzel-Viljoen E. 128
Wesely M. 212
Wesolowska A. 165
Wesoly J. 156
Westhoff T. 78
Wettermark B. 53, 58, 153,
173, 212, 225
Whitelegg K. 164, 173
Wichmann B. 180
Widimský J. 41, 107, 117,
118, 139, 140, 162, 205
Widimský P. 118
Wiecek A. 168, 199
Wiech T. 104
Wierzbicka A. 148, 173
Wiggers G. 182, 207
Wijkman M. 49
Wild P.S. 230
Wilk G. 232, 232
Wilkinson I.B. 47, 88, 198
Williams B. 52, 82, 94, 102,
111
Williams D. 186, 221
Williams T.A. 107, 156
Windak A. 68
Windyga J. 168
Wing L. 91
Winklewski P.J. 185, 208
Wirtwein M. 155, 156
Wisetborisut A. 219
Witberg K. 158
Withers S. 87, 167
Witkowska K. 117
Witkowski A. 104, 165, 233,
234
Wizner B. 58, 199
Wohlfahrt P. 41, 172
Wojcicki J. 168
Wojciechowska E. 172, 200
Wojciechowska W. 165, 222,
234
Wojcik W. 48, 234
Wojtkiewicz J. 168
Wolf J. 75, 124, 185, 208,
228
Wolff C.B. 126, 237
Wolkow P. 116
Wong P.F. 140
Woodiwiss A. 55, 89, 115,
122, 165, 180, 233, 241
Woodward M. 88
Worthley S. 82, 205
Woznicka-Leskiewicz L. 188,
226
Wszedybyl-Winklewska M.
185, 208
Wuerzner G. 43, 96, 102, 108,
118, 201, 202
X
Xaplanteris P. 89, 235
Xenogiannis I. 214
Xhignesse P. 141
Xiao Q. 117
Xie A. 223
Xie J. 224
Xie R. 205
Xie Y. 55
Xiong J. 53, 143, 153, 235
Xu H. 57, 223, 237
Xu J. 92
F I N A L P R OG R A M M E
283
Xu J.Z. 67
Xu M. 192
Xu S.K. 215
Xu T. 127
Xu T.Y. 140
Xu Y. 43, 53, 235
Xu Y.W. 153
Y
Yakdhane I. 192, 200
Yamada M. 103
Yamagishi T. 152
Yamamoto K. 103
Yamamoto Y. 197
Yamashita S. 141
Yamauchi T. 103, 231
Yamazaki M. 142
Yamori Y. 207, 235
Yaneva-Sirakova T. 158, 186
Yang G. 58
Yang M. 237
Yang T. 179
Yang W.Y. 44, 45, 46, 81, 117,
155
Yang X. 205
Yang X.S. 127
Yang Y. 127, 140
Yangni-Angate A. 142
Yankevich O. 228
Yankouskaya L. 206, 215, 232
Yannick M. 103, 126
Yannoutsos A. 48, 188, 204
Yao L. 234
Yao X. 148, 229, 230
Yarema N. 227
Yarinkina O. 228
Yarmukhamedova D. 214, 239
Yarynych Y. 156, 217
Yassuda M.S. 69
Yasuda G. 197
Yatabe J. 203
Yatabe M. 203
Ye S. 116, 117
Yeo G. 202, 209
Yeo G.S.H. 66
284
Yildirim A. 147
Yilmaz S. 181
Yin F. 180
Yokoi T. 181
Yoo B. 218
Yoo H.J. 151
Yoo K.D. 182, 233
Yoon H. 144
Yoon J. 218
Yoshimura N. 86
Yoshino H. 227
Yotov Y. 178, 179
Youn J. 213
Youn Y. 218
Younis A. 240
YousefipourZ.232
Yovos J. 204
Z
Yu C. 127
Yu J. 57, 67, 169, 177, 179,
193, 204, 205, 209, 223, 228,
237
Yu R. 120
Yu S. 43, 53, 78, 153, 235
Yu S.K. 143
Yudina V. 147, 220, 221
Yudina Y. 158, 174
Yugar-Toledo J.C. 194
Yustova V.D. 173
Yusuf S. 205
Zabzuni D. 222
Zacharieva S. 203, 239
Zachwieja K. 149
Zafeiridis A. 81, 92, 185, 192
Zafeiriou D. 208
Zaffanello M. 100
Zagato L. 57, 116
Zahid H. 126
Zaimi E. 155
Zairova A. 163, 229
Zaja R. 164
Zajac M. 150
Zakharova E.Y. 230
Zaki A.R. 225, 226
Zakirova A.N. 145
Zakopoulos N. 140, 142, 185,
186, 213
Zaletel M. 69
Zambon A. 43, 124
Zamboulis X. 167
Zambrano M. 171
Zammouri A. 198
Zampeli E. 142
Zanchetti A. 43, 50, 56, 80,
112
Zanchettin F. 91
Zanchi A. 115
Zannad F. 46, 85, 227
Zanni F. 165
Zanoli L. 79
Zão I. 150
Zapotoczny S. 222
Zaputovic L. 231
Zarkovic M. 216
Zarzycki B. 167
Zaslavskaya E.l. 58
Zateyshchikov D. 157
Zbroch E. 161
Zdravkovic M. 179, 236
Zdrenghea D. 189
Zdrojewski T. 58, 199
Zebekakis P. 139, 162, 204,
227
Zelenenka L. 227
Zelinka T. 118
Zeljkovic Vrkic T. 55, 91, 113,
145, 157, 221
Zeller A. 102, 238
Zelveian P. 230, 238
Zemlin A. 146
Zenimaru Y. 103
Zennaro M.-C. 44, 51, 66, 103,
110
Zenone P. 47
Zeraoulia F. 49
Zhang D. 148
Zhang D.Y. 140, 233
Zhang G. 205
Zhang H. 67
Zhang H.F. 180
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
Zhang J. 67, 183, 205
Zhang L. 205
Zhang X. 50, 169, 204, 205,
237
Zhang X.F. 193
Zhang Y. 43, 50, 53, 67, 78,
92, 143, 153, 207, 235, 236
Zhang Z. 117, 155, 184
Zhang Z.Y. 44, 45, 46
Zhao D. 190, 225
Zhao F. 204
Zhao W. 202, 209
Zhao X. 67, 169, 179, 193
Zhao Y. 179, 228
Zharikova E. 166, 171, 188,
192, 208, 209
Zheleznikh E. 169
Zheng F.F. 67
Zheng H. 205
Zheng W.L. 160, 166
Zhernakova I. 153, 155, 191
Zhong Q. 183
Zhou J. 66, 202, 209
Zhou K. 148
Zhou L. 229
Zhou W.L. 67
Zhou Y. 183, 235
Zhou Y.W. 153
Zhu D.-L. 83
Zhu L.M. 67
Zhuravlyova L. 152, 153, 158,
161, 189, 196, 228
Zhygalina V. 103
Zhyvilo I. 140
Zibar L. 231
Zibara K. 157
Zibetti M. 43
Zicha J. 223
Zidek W. 78, 141, 166, 212
Zidi M. 48, 127
Zito C. 232
Zivanovic I. 163
Zivkovic R. 179
Zivotic M. 161
Zlatar B. 179
Zlatar M. 179
Zlatkovic O. 205
Zmailik M. 151
Zoccali C. 55, 84, 200
Zogg S. 236
Zografou I. 92
Zoidakis J. 160
Zorzi C. 207
Zou Y. 160
Zrigue C. 192, 200
Zubanova I. 118
Zueva E. 142, 214, 215, 238
Zukauskaite I. 173
Zukova N. 187
Zuñiga L. 152
Zupanets I. 208
Zurabishvili K. 187, 218
Zus S. 228
Zvartau N. 91, 158, 160, 161,
163, 174, 198, 226
Zverev D.A. 198
Zvolinskaya E. 44, 143
Zykov K. 159, 195, 230
Zyubanova I. 162, 164
F I N A L P R OG R A M M E
285
NOTES
286
26 TH EUR O P EAN M EETI N G O N H Y P E RT E N S I ON A N D C A R D I O VA S CU L A R P RO T E CT I O N
NOTES
F I N A L P R OG R A M M E
287
With the Patronage of
Congress Venue
Scientific and Organising Secreatriat
AIM GROUP INTERNATIONAL
ome ffice
Via Flaminia, 1068 – 00189 Rome, Italy
Ph: +39.06.33053.1 Fax: +39.06.23325630
E-mail: esh2016@aimgroup.eu